N Unused Total %Cov %Cov(50) %Cov(95) Accessions Names Used Annotation Contrib Conf Sequence Modifications Cleavages dMass Prec MW Prec m/z Theor MW Theor m/z Theor z Sc Spectrum Specific Time PrecursorSignal PrecursorElution 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AARLEALKENGGAR cleaved L-A@N-term; missed R-L@3; missed K-E@8 -3.52255010511726E-05 1454.79541015625 485.9391 1454.79541015625 485.939056396484 3 20 1.1.1.3202.4 1 26.3536 16799.96 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AELQEGAR -0.00449468987062573 872.4306640625 437.2226 872.435180664063 437.224884033203 2 10 1.1.1.2890.3 1 19.6135 685.4598 19.4401 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AEYHAKATEHLSTLSEK cleaved L-A@N-term; missed K-A@6 0.00618417980149388 1913.95458984375 638.9921 1913.94836425781 638.990051269531 3 15 1.1.1.3171.15 1 25.6225 984.0093 25.6311 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AHVDALRTHLAPYSDELR missed R-T@7 0.00345592992380261 2063.05859375 516.7719 2063.05493164063 516.77099609375 4 17 1.1.1.3600.8 1 36.2148 92118.63 35.9504 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 -0.00125997001305223 2347.21313476563 783.4117 2347.21459960938 783.412109375 3 15 1.1.1.3554.17 1 35.0434 13457.75 34.779 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AHVDALRTHLAPYSDELRQRLAAR missed R-T@7; missed R-Q@18; missed R-L@20 0.00597885018214583 2758.4794921875 552.7032 2758.47387695313 552.702087402344 5 14 1.1.1.3796.8 1 41.1939 60199.31 41.0369 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.00910388957709074 3897.09252929688 780.4258 3897.08349609375 780.423950195313 5 19 1.1.1.4027.17 1 47.1447 63057.21 47.102 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKPALEDLR -0.0028708700556308 1011.56848144531 506.7915 1011.5712890625 506.792938232422 2 12 1.1.1.3181.12 1 25.8442 38027.04 25.8816 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKPALEDLRQGLLPVLESFK missed R-Q@9 0.00309516000561416 2223.26586914063 556.8237 2223.2626953125 556.822937011719 4 9 1.1.1.4462.4 1 58.273 4328.884 58.0835 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 -0.00223263003863394 3590.95727539063 1197.993 3590.9599609375 1197.99389648438 3 18 1.1.1.5102.21 1 75.0607 47117.5 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 -0.00197749002836645 3719.05297851563 930.7705 3719.05493164063 930.77099609375 4 14 1.1.1.5099.14 1 74.974 24360.19 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00212431000545621 4047.23168945313 810.4536 4047.22973632813 810.453186035156 5 14 1.1.1.5119.12 1 75.488 47757.34 75.2456 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.00377975008450449 4175.2841796875 696.888 4175.2880859375 696.888671875 6 21 1.1.1.5086.8 1 74.6272 4592.697 74.6166 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKVQPYLDDFQK missed K-V@2 0.000422498007537797 1450.74609375 484.5893 1450.74560546875 484.589141845703 3 12 1.1.1.3494.5 1 33.5532 35060.23 33.4729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKVQPYLDDFQKK missed K-V@2; missed K-K@12 -0.00127957004588097 1578.83911132813 527.287 1578.84057617188 527.287475585938 3 12 1.1.1.3352.11 1 30.0408 10347.71 30.202 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.00330681004561484 2859.39379882813 715.8557 2859.39013671875 715.854797363281 4 18 1.1.1.4012.18 1 46.7584 32517.62 46.7142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQK Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.0054084500297904 3115.54931640625 624.1171 3115.54370117188 624.116027832031 5 15 1.1.1.3984.11 1 46.0214 7766.498 46.061 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Delta:H(2)C(2)(K)@12; acrolein addition +38(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24; missed R-A@29 -0.0092551801353693 4564.3408203125 761.7308 4564.35009765625 761.732299804688 6 18 1.1.1.4166.12 0 50.6863 8981.11 50.6736 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ARAHVDALR missed R-A@2 -0.00450485991314054 1007.55804443359 504.7863 1007.56243896484 504.788513183594 2 12 1.1.1.2844.2 1 18.9408 150.6957 18.9577 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.00495254993438721 2574.35766601563 644.5967 2574.35278320313 644.595458984375 4 23 1.1.1.3437.18 1 32.1569 33147.43 32.1896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ARAHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-A@2; missed R-T@9; missed R-Q@20; missed R-L@22; missed R-L@26; missed K-E@31 0.0153780998662114 4124.2373046875 688.3801 4124.2216796875 688.377563476563 6 18 1.1.1.3996.13 1 46.3374 15337.19 46.2707 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ARLEALKENGGAR cleaved A-A@N-term; missed R-L@2; missed K-E@7 -0.00305989990010858 1383.75512695313 462.259 1383.75830078125 462.260040283203 3 14 1.1.1.3201.6 1 26.3327 11465.7 26.2729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEK -0.00186197005677968 1214.61242675781 608.3135 1214.6142578125 608.314392089844 2 17 1.1.1.3067.2 1 23.0533 137196.2 22.8581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLR missed K-A@11 0.00561466999351978 2208.1806640625 553.0524 2208.17504882813 553.051025390625 4 13 1.1.1.3581.10 1 35.7322 26196.82 35.5893 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFK Dehydrated(S)@9; reduced acrolein addition +58(K)@13; Deamidated(Q)@21 missed K-A@11; missed R-Q@20 0.0201986003667116 3460.90209960938 693.1877 3460.8818359375 693.18359375 5 15 1.1.1.4454.13 1 58.0716 3601.007 58.005 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@11; missed R-Q@20; missed K-V@31 0.00983626022934914 4787.5732421875 958.522 4787.5634765625 958.52001953125 5 17 1.1.1.5081.16 1 74.4991 22819.28 74.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.00693668983876705 4915.666015625 820.2849 4915.65869140625 820.28369140625 6 16 1.1.1.5071.8 1 74.2223 7257.837 74.0761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN acrolein addition +76(K)@31; MDA adduct +62(K)@43; reduced acrolein addition +96(K)@44 cleaved N-T@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.00558480015024543 5376.884765625 897.1547 5376.89013671875 897.155639648438 6 12 1.1.1.5091.12 1 74.7639 2676.177 74.7242 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0131189003586769 5243.8466796875 874.9817 5243.83349609375 874.9794921875 6 22 1.1.1.5097.15 1 74.9219 9302.653 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0105080995708704 5371.90185546875 896.3243 5371.89208984375 896.322570800781 6 12 1.1.1.5126.15 1 75.6748 1868.222 75.6054 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00685094995424151 2701.35302734375 901.4583 2701.35986328125 901.460571289063 3 16 1.1.1.4437.21 1 57.6354 26061.06 57.7185 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 -0.0155544001609087 3084.5361328125 772.1413 3084.55151367188 772.145202636719 4 12 1.1.1.4775.6 1 66.3455 901.349 66.3632 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00959307979792356 4470.20751953125 746.0419 4470.19775390625 746.040283203125 6 19 1.1.1.4787.5 1 66.6588 23725.17 66.3894 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DLATVYVDVLK -0.00430779019370675 1234.67663574219 618.3456 1234.68090820313 618.347717285156 2 11 1.1.1.4186.11 1 51.1975 8043.921 50.9282 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DLATVYVDVLKDSGR missed K-D@11 0.00223232991993427 1649.86486816406 550.9622 1649.86242675781 550.96142578125 3 11 1.1.1.4203.6 1 51.6269 11617.44 51.7976 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@11; missed R-D@15 -0.00441097002476454 3031.50830078125 1011.51 3031.51391601563 1011.51190185547 3 21 1.1.1.4526.21 1 59.9768 71651.52 60.0085 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK missed K-D@11; missed R-D@15; missed K-Q@28 -0.000908315996639431 3627.87768554688 907.9767 3627.87841796875 907.976867675781 4 16 1.1.1.4558.13 1 60.8123 6751.09 60.8509 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DLEEVKAK missed K-A@6 -0.00252185994759202 930.499694824219 466.2571 930.502197265625 466.258392333984 2 9 1.1.1.2982.5 1 21.0517 6166.67 20.8542 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.00172923994250596 1814.841796875 605.9545 1814.84350585938 605.955139160156 3 15 1.1.1.3615.9 1 36.6014 7290.874 36.6855 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.00113137997686863 2411.20922851563 603.8096 2411.2080078125 603.809326171875 4 23 1.1.1.4009.14 1 46.6768 86869.16 46.6101 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed R-D@4; missed K-Q@17; missed K-L@22 0.000604898028541356 4004.97485351563 1002.251 4004.9755859375 1002.25115966797 4 16 1.1.1.4541.20 1 60.3719 7582.037 60.4577 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DYVSQFEGSALGK -0.00465937983244658 1399.6572265625 700.8359 1399.66198730469 700.838256835938 2 17 1.1.1.3909.12 1 44.117 4542.331 44.1045 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DYVSQFEGSALGKQLNLK Acetyl(K)@13 missed K-Q@13 0.00996060017496347 2038.04711914063 680.3563 2038.037109375 680.352966308594 3 17 1.1.1.4192.10 1 51.3501 2626.186 51.3899 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 EHLSTLSEK cleaved T-E@N-term -0.00352715002372861 1042.52612304688 522.2703 1042.52954101563 522.272033691406 2 14 1.1.1.3063.6 1 22.9842 4910.769 22.8877 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 EQLGPVTQEFWDNLEK Oxidation(W)@11 -0.000528252974618226 1947.92102050781 650.3143 1947.92138671875 650.314392089844 3 20 1.1.1.3869.10 1 43.0934 4667.133 43.0557 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 EQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@11 missed K-E@16 0.0131511995568871 2621.27416992188 874.7653 2621.26098632813 874.760925292969 3 15 1.1.1.4396.19 1 56.5716 7635.578 56.6304 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@25 missed K-E@16; missed R-Q@22 0.00159972999244928 3236.53125 810.1401 3236.52954101563 810.1396484375 4 13 1.1.1.4509.19 1 59.5233 29861.54 59.5037 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@25 missed K-E@16; missed R-Q@22; missed K-D@27; missed K-A@33 0.0134920002892613 4149.03515625 692.5131 4149.02099609375 692.510803222656 6 13 1.1.1.4473.12 1 58.5682 3971.389 58.6339 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ETEGLRQEMSK Oxidation(M)@9 missed R-Q@6 0.00132889999076724 1322.61486816406 441.8789 1322.61364746094 441.878479003906 3 13 1.1.1.2817.2 1 18.3779 15310.27 18.3037 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ETEGLRQEMSKDLEEVK Glu->pyro-Glu@N-term; Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.00338438991457224 2017.96594238281 673.6626 2017.96264648438 673.661499023438 3 17 1.1.1.3423.19 1 31.8008 5703.372 31.833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ETEGLRQEMSKDLEEVKAK Oxidation(M)@9 missed R-Q@6; missed K-D@11; missed K-A@17 0.000245520990574732 2235.10546875 559.7836 2235.10522460938 559.783569335938 4 14 1.1.1.3176.4 1 25.738 22754.61 25.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 KDSGRDYVSQFEGSALGK Deamidated(R)@5; Oxidation(D)@6 cleaved L-K@N-term; missed K-D@1; missed R-D@5 0.00229643005877733 1959.91955566406 654.3138 1959.91735839844 654.313049316406 3 19 1.1.1.3758.19 1 40.2523 39901.86 40.154 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 KLLDNWDSVTSTFSK Oxidation(K)@1 cleaved L-K@N-term; missed K-L@1 -0.00104074995033443 1755.8671875 586.2963 1755.86791992188 586.296569824219 3 16 1.1.1.4148.13 1 50.2286 4227.893 50.164 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 KQLNLKLLDNWDSVTSTFSK Oxidation(K)@1 cleaved G-K@N-term; missed K-Q@1; missed K-L@6 -0.000586971000302583 2352.23193359375 785.0846 2352.232421875 785.084777832031 3 19 1.1.1.4382.13 1 56.2053 12386.57 56.1657 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 KVQPYLDDFQKKWQEEMELYR Oxidation(K)@1; Dioxidation(W)@13; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 -0.000650183006655425 2836.33740234375 710.0916 2836.337890625 710.091735839844 4 20 1.1.1.3961.17 1 45.4389 17414.36 45.4729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 KWQEEMELYR Oxidation(M)@6 missed K-W@1 -0.000244935014052317 1426.65490722656 476.5589 1426.65515136719 476.558990478516 3 15 1.1.1.3281.9 1 28.2889 128776.2 28.3042 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 KWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@6 missed K-W@1; missed R-Q@10; missed K-V@12; missed R-A@17 0.00870025996118784 3131.59057617188 627.3254 3131.58227539063 627.32373046875 5 19 1.1.1.3796.14 1 41.1989 12757.03 41.2099 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LAARLEALKENGGAR Ammonia-loss(N)@11 missed R-L@4; missed K-E@9 0.00442284997552633 1550.85729980469 776.4359 1550.85290527344 776.433715820313 2 14 1.1.1.3276.17 1 28.1759 1321.394 28.181 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LAEYHAK -0.00182617001701146 830.426879882813 416.2207 830.428649902344 416.221588134766 2 9 1.1.1.2840.2 1 18.8342 866.9883 18.6552 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LAEYHAKATEHLSTLSEK missed K-A@7 0.00362085993401706 2027.03552246094 1014.525 2027.03234863281 1014.5234375 2 13 1.1.1.3169.21 1 25.5763 4696.751 25.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38 0.0183774996548891 5600 934.3406 5599.98193359375 934.337585449219 6 12 1.1.1.5043.16 1 73.4744 2026.75 73.3229 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.0276507008820772 6184.33740234375 884.4841 6184.31005859375 884.480163574219 7 17 1.1.1.5079.14 1 74.4432 13456.71 74.1842 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LEALKENGGAR missed K-E@5 -0.000829897995572537 1156.61926269531 579.3169 1156.61999511719 579.317321777344 2 15 1.1.1.3003.3 1 21.5417 19779.3 21.6733 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LHELQEK -0.00328051997348666 895.473083496094 448.7438 895.476318359375 448.745452880859 2 10 1.1.1.2857.2 1 19.1505 350.6968 18.9888 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LHELQEKLSPLGEEMR Oxidation(M)@15 missed K-L@7 -0.000290035997750238 1923.97204589844 642.3313 1923.97241210938 642.331420898438 3 12 1.1.1.3479.14 1 33.1929 14013.36 33.0533 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 -0.00204949988983572 2195.0986328125 549.7819 2195.1005859375 549.782409667969 4 14 1.1.1.3386.5 1 30.8786 10081.38 30.9466 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LHELQEKLSPLGEEMRDRAR Oxidation(M)@15 missed K-L@7; missed R-D@16; missed R-A@18 0.00463039986789227 2422.24340820313 606.5681 2422.23876953125 606.566955566406 4 16 1.1.1.3296.15 1 28.6665 21513.12 28.7978 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LLDNWDSVTSTFSK -0.00523774977773428 1611.77282714844 806.8937 1611.77807617188 806.896301269531 2 20 1.1.1.3964.20 1 45.518 17984.66 45.3705 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LLDNWDSVTSTFSKLR Dioxidation(W)@5 missed K-L@14 -0.000208062992896885 1912.95275878906 638.6582 1912.95300292969 638.658325195313 3 15 1.1.1.4085.10 1 48.6179 28073.16 48.4544 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEK missed K-L@14; missed R-E@16 0.000804599025286734 3794.88012695313 949.7273 3794.87915039063 949.72705078125 4 8 1.1.1.5011.18 1 72.6125 689.2357 72.5931 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEF cleaved F-W@C-term; missed R-E@2 0.00026225799228996 1415.74133300781 708.8779 1415.74084472656 708.877685546875 2 15 1.1.1.3809.18 1 41.5326 3317.084 41.3847 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFW Trp->Hydroxykynurenin(W)@13 cleaved W-D@C-term; missed R-E@2 -0.00645224004983902 1621.8037109375 811.9091 1621.81005859375 811.912292480469 2 16 1.1.1.3966.19 1 45.568 5029.243 45.6765 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 -0.0403647981584072 2201.0712890625 734.6977 2201.11157226563 734.711181640625 3 17 1.1.1.3818.17 1 41.7695 26672.18 41.6991 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 -0.0346873998641968 2886.41650390625 722.6114 2886.451171875 722.620056152344 4 20 1.1.1.4012.19 1 46.7593 4492.534 46.7142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00811858009546995 3521.7177734375 705.3508 3521.70971679688 705.349182128906 5 19 1.1.1.4013.18 1 46.7845 7217.006 46.7142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dioxidation(W)@13; Oxidation(D)@30 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0242161992937326 4251.08837890625 709.522 4251.06396484375 709.517944335938 6 17 1.1.1.4311.11 1 54.3841 14617.55 54.5761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0261138007044792 4434.2275390625 740.0452 4434.201171875 740.040832519531 6 17 1.1.1.4010.20 1 46.7081 6788.044 46.5581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LSPLGEEMR Oxidation(M)@8 -0.00140546995680779 1046.50524902344 524.2599 1046.50659179688 524.260620117188 2 14 1.1.1.3180.13 1 25.8205 155542 25.8816 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 -0.00186049996409565 1238.67126464844 620.3429 1238.67309570313 620.343872070313 2 14 1.1.1.3352.13 1 30.0425 6752.46 30.1035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 PYLDDFQKKWQEEMELYR Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.00951370038092136 2433.14038085938 812.0541 2433.13110351563 812.050964355469 3 14 1.1.1.4063.17 1 48.0644 2510.551 48.0984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QEMSKDLEEVK Gln->pyro-Glu@N-term; Oxidation(M)@3 missed K-D@5 -0.00185775000136346 1333.60522460938 667.8099 1333.60717773438 667.810852050781 2 16 1.1.1.3154.11 1 25.2082 14599.88 25.1407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QEMSKDLEEVKAK Gln->pyro-Glu@N-term; Oxidation(M)@3 missed K-D@5; missed K-A@11 0.000967108004260808 1532.740234375 511.9207 1532.7392578125 511.920349121094 3 16 1.1.1.3116.9 1 24.2692 8080.88 24.2072 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QGLLPVLESFK Gln->pyro-Glu@N-term -0.00332074007019401 1212.67211914063 607.3433 1212.67541503906 607.344970703125 2 10 1.1.1.4650.3 1 63.1431 4169.343 63.1384 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK Gln->pyro-Glu@N-term missed K-V@11 -0.00155211996752769 2580.37109375 861.131 2580.37280273438 861.131530761719 3 25 1.1.1.5169.8 1 76.7792 6165.292 76.8145 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKK missed K-V@11; missed K-K@23 -0.00485706003382802 2725.4892578125 909.5037 2725.494140625 909.50537109375 3 13 1.1.1.5090.17 1 74.742 3590.864 74.7767 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-V@11; missed K-K@23; missed K-L@24 -0.00123644003178924 3053.66772460938 764.4242 3053.6689453125 764.424499511719 4 8 1.1.1.5126.11 1 75.6714 6073.136 75.3985 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ Gln->pyro-Glu@N-term missed K-V@11; missed K-K@23; missed K-L@24 0.00382945989258587 3164.70483398438 792.1835 3164.70092773438 792.182495117188 4 15 1.1.1.5161.12 1 76.5759 2762.068 76.6138 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QKLHELQEK Gln->pyro-Glu@N-term missed K-L@2 -0.00433875015005469 1134.59912109375 568.3068 1134.60327148438 568.308959960938 2 9 1.1.1.3091.11 1 23.643 20946.19 23.3802 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QKLHELQEKLSPLGEEMR Oxidation(M)@17 missed K-L@2; missed K-L@9 0.00528876017779112 2180.13134765625 546.0401 2180.1259765625 546.038757324219 4 13 1.1.1.3474.6 1 33.0644 3924.497 33.0533 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QKLHELQEKLSPLGEEMRD Gln->pyro-Glu@N-term; Oxidation(M)@17 cleaved D-R@C-term; missed K-L@2; missed K-L@9; missed R-D@18 0.00119652005378157 2278.12768554688 570.5392 2278.12646484375 570.538879394531 4 17 1.1.1.3739.13 1 39.7576 3188.492 39.7187 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00837481021881104 2451.26245117188 613.8229 2451.25390625 613.82080078125 4 15 1.1.1.3392.7 1 31.0317 281865.5 31.0699 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QKLHELQEKLSPLGEEMRDRAR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0138875003904104 2678.40600585938 536.6885 2678.39233398438 536.685729980469 5 14 1.1.1.3323.6 1 29.329 90992.55 29.4647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QKVEPLR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-V@2 0.00718333991244435 909.53564453125 455.7751 909.528381347656 455.771453857422 2 9 1.1.1.2972.4 1 20.8699 420.296 20.9363 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 -0.00274264998733997 1705.90832519531 569.6434 1705.9111328125 569.644348144531 3 13 1.1.1.3588.9 1 35.9102 4443.695 35.9003 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 -0.0103484997525811 2212.12719726563 738.383 2212.13745117188 738.386474609375 3 16 1.1.1.4170.17 1 50.7919 5934.972 50.8261 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Dioxidation(W)@10 missed K-L@5; missed K-L@19 0.00558699993416667 2509.3232421875 628.3381 2509.31762695313 628.336669921875 4 16 1.1.1.4300.5 1 54.0984 11797.1 54.0404 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 RHFWQQDEPPQSPWDR cleaved A-R@N-term; missed R-H@1 -0.000493753992486745 2107.9609375 703.6609 2107.96118164063 703.661010742188 3 13 1.1.1.3638.21 1 37.1796 1504.595 37.2881 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 RHFWQQDEPPQSPWDRVK cleaved A-R@N-term; missed R-H@1; missed R-V@16 0.0111827999353409 2335.13623046875 584.7913 2335.12475585938 584.788452148438 4 18 1.1.1.3628.6 1 36.9165 1351.867 36.9566 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 TEHLSTLSEK cleaved A-T@N-term -0.00159267999697477 1143.57543945313 572.795 1143.5771484375 572.795837402344 2 15 1.1.1.3055.11 1 22.8204 6089.543 22.8823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 THLAPYSDELR -0.00187122996430844 1300.63928222656 434.5537 1300.64111328125 434.554321289063 3 13 1.1.1.3312.4 1 29.0518 33968.64 28.7978 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.000967493979260325 1584.80163574219 529.2745 1584.80090332031 529.274230957031 3 12 1.1.1.3244.5 1 27.383 32335.05 27.1269 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.00766644021496177 3134.67700195313 627.9427 3134.66967773438 627.941223144531 5 18 1.1.1.3985.13 1 46.0491 177151 45.7787 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VEPLRAELQEGAR missed R-A@5 -0.00646668998524547 1466.77770996094 489.9332 1466.7841796875 489.935333251953 3 13 1.1.1.3418.5 1 31.6689 7455.893 31.6106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.00355089991353452 1461.84069824219 731.9276 1461.84423828125 731.929443359375 2 21 1.1.1.3972.16 1 45.7183 53195.35 45.4475 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 -0.00207949988543987 1877.02380371094 626.6819 1877.02587890625 626.682556152344 3 22 1.1.1.4000.11 1 46.4402 43469.34 46.5581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 2.02621006965637 3260.70336914063 816.1831 3258.67724609375 815.676574707031 4 18 1.1.1.4326.18 1 54.7739 30680.34 54.9352 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.00420816009864211 3855.0458984375 772.0165 3855.04174804688 772.015625 5 12 1.1.1.4455.18 1 58.102 23378.84 58.2405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.0281323995441198 5448.837890625 909.1469 5448.80908203125 909.142150878906 6 21 1.1.1.4811.13 1 67.3067 3919.291 67.2928 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VQPYLDDFQK -0.00424683000892401 1251.60949707031 626.812 1251.61352539063 626.814025878906 2 12 1.1.1.3637.17 1 37.1507 143517.5 36.8822 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VQPYLDDFQKK missed K-K@10 0.0012408799957484 1379.70959472656 460.9105 1379.70849609375 460.910125732422 3 8 1.1.1.3562.4 1 35.2302 1373.946 35.224 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VQPYLDDFQKKWQEEMELYR Lys-add@N-term; Deamidated(Q)@2; Oxidation(P)@3; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.00115828996058553 2805.3310546875 702.34 2805.33203125 702.340270996094 4 18 1.1.1.4177.16 1 50.9699 18276.44 51.005 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.00658077001571655 2916.41821289063 730.1118 2916.41162109375 730.110168457031 4 15 1.1.1.3995.14 1 46.3123 88208.97 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR MDA adduct +54(K)@10; acrolein addition +38(K)@11; Trp->Kynurenin(W)@12; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 -0.0208532996475697 3542.7626953125 591.4677 3542.78344726563 591.47119140625 6 18 1.1.1.3978.10 1 45.8665 41348.94 45.958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0278881993144751 4369.2080078125 729.2086 4369.18017578125 729.203979492188 6 17 1.1.1.4136.21 1 49.9298 15331.41 49.9351 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VSFLSALEEYTK -0.00529531994834542 1385.70263671875 693.8586 1385.70788574219 693.861206054688 2 17 1.1.1.4384.12 1 56.2559 8398.129 56.1657 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VSFLSALEEYTKK missed K-K@12 -0.00531475991010666 1513.79736328125 505.6064 1513.80285644531 505.608215332031 3 13 1.1.1.4233.3 1 52.3876 12119.74 52.3569 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-K@12; missed K-L@13 -0.00378290005028248 1841.9736328125 614.9985 1841.9775390625 614.999755859375 3 13 1.1.1.4501.8 1 59.3027 5391.553 59.5037 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VSFLSALEEYTKKLNTQ missed K-K@12; missed K-L@13 -0.00649610999971628 1970.02941894531 986.022 1970.03601074219 986.025329589844 2 10 1.1.1.4508.21 1 59.4985 10031.84 59.2665 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 WQEEMELYR Oxidation(M)@5 -0.00181189004797488 1298.55822753906 650.2864 1298.56018066406 650.287353515625 2 14 1.1.1.3414.9 1 31.5774 100495 31.8078 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.95860815048218 99.0000009536743 PALEDLR cleaved K-P@N-term -0.00164181995205581 812.437683105469 407.2261 812.439208984375 407.226898193359 2 10 1.1.1.3286.5 1 28.4099 6664.782 28.3289 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.92081785202026 99.0000009536743 LRTHLAPYSDELRQR cleaved A-L@N-term; missed R-T@2; missed R-Q@13 0.00471661007031798 1853.99096679688 464.505 1853.98608398438 464.503784179688 4 15 1.1.1.3262.3 1 27.8191 7625.831 27.787 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.72124660015106 99.0000009536743 EYHAKATEHLSTLSEK reduced HNE(H)@3; acrolein addition +112(K)@5 cleaved A-E@N-term; missed K-A@5 -0.028294300660491 2113.06591796875 705.3626 2113.09423828125 705.3720703125 3 16 1.1.1.3695.20 1 38.6206 17461.35 38.7305 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.69897043704987 99.0000009536743 KPALEDLRQGLLPVLESFK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8 0.00741522992029786 2264.28540039063 567.0786 2264.27807617188 567.076782226563 4 10 1.1.1.4443.8 1 57.7804 2394.209 57.7185 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.63827216625214 99.0000009536743 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.00483840005472302 1162.578125 582.2963 1162.57312011719 582.293823242188 2 14 1.1.1.3203.11 1 26.3863 1695.085 26.3462 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.63827216625214 99.0000009536743 SGRDYVSQFEGSALGK cleaved D-S@N-term; missed R-D@3 -0.00171431002672762 1699.81469726563 567.6122 1699.81652832031 567.61279296875 3 16 1.1.1.3705.13 1 38.8747 10110.75 38.9652 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.31875896453857 99.0000009536743 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@9; ONE addition +154(K)@11; Deamidated(Q)@19 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41; missed K-L@42 6.31126968073659E-05 5412.93212890625 774.2833 5412.9326171875 774.283325195313 7 21 1.1.1.5097.12 1 74.9194 21809.26 74.9851 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.18045616149902 99.0000009536743 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.00868035014718771 4216.3125 703.726 4216.3037109375 703.724548339844 6 16 1.1.1.5105.3 1 75.1238 9324.122 75.2456 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.04095852375031 99.0000009536743 PYLDDFQKK cleaved Q-P@N-term; missed K-K@8 -0.000429567007813603 1152.58129882813 577.2979 1152.58154296875 577.298034667969 2 11 1.1.1.3448.13 1 32.4263 6699.14 32.1647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.99999988079071 97.8399991989136 WQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@5 missed R-Q@9; missed K-V@11; missed R-A@16 0.00969761982560158 3003.49731445313 601.7067 3003.4873046875 601.704711914063 5 13 1.1.1.3822.8 1 41.8651 6892.038 41.7252 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.950782001018524 99.0000009536743 SALGKQLNLKLLDNWDSVTSTFSK MDA adduct +62(K)@5; MDA adduct +62(K)@10 cleaved G-S@N-term; missed K-Q@5; missed K-L@10 0.00505348015576601 2788.44873046875 930.4902 2788.44360351563 930.488464355469 3 11 1.1.1.4066.20 1 48.1434 1841.647 48.0984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.931814193725586 99.0000009536743 DSVTSTFSK cleaved W-D@N-term -0.00198010005988181 970.458862304688 486.2367 970.460754394531 486.237640380859 2 13 1.1.1.3157.3 1 25.2727 21272.09 25.3106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.823908805847168 99.0000009536743 AHVDALR Carbamidomethyl@N-term -0.00424935016781092 837.441467285156 419.728 837.445678710938 419.730133056641 2 9 1.1.1.2852.2 1 19.0557 262.2367 19.1251 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.818156361579895 98.1299996376038 LAPYSDELRQR cleaved H-L@N-term; missed R-Q@9 0.00505296001210809 1346.69921875 674.3569 1346.69421386719 674.354431152344 2 9 1.1.1.3218.9 1 26.7553 853.0361 26.7118 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.818156361579895 99.0000009536743 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR HPNE addition +172(K)@8; acrolein addition +56(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.0143191004171968 4366.208984375 624.7514 4366.1943359375 624.749328613281 7 15 1.1.1.4206.6 1 51.7034 32857.15 51.8231 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.804100334644318 99.0000009536743 RDYVSQFEGSALGK cleaved G-R@N-term; missed R-D@1 -0.00985503010451794 1555.75317382813 519.5917 1555.76306152344 519.594970703125 3 10 1.1.1.3683.6 1 38.2976 919.2991 38.3153 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.619788765907288 99.0000009536743 TEHLSTLSEKAKPALEDLRQGLLPVLESFK MDA adduct +54(K)@10; reduced acrolein addition +58(K)@12 cleaved A-T@N-term; missed K-A@10; missed R-Q@19 0.0223347004503012 3460.90405273438 693.1881 3460.8818359375 693.18359375 5 11 1.1.1.4447.11 1 57.887 3582.692 57.8748 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.596879422664642 99.0000009536743 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.00198987009935081 1241.53332519531 414.8517 1241.53125 414.851043701172 3 13 1.1.1.2997.3 1 21.4372 306.5748 21.1637 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.563837349414825 98.1800019741058 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.00992233958095312 5062.57763671875 844.7702 5062.5673828125 844.7685546875 6 15 1.1.1.4942.13 1 70.7503 20750.16 70.7096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.431798279285431 98.5000014305115 ALRTHLAPYSDELRQR cleaved D-A@N-term; missed R-T@3; missed R-Q@14 0.00398874981328845 1925.02734375 482.2641 1925.02319335938 482.263061523438 4 11 1.1.1.3294.12 1 28.6111 6011.116 28.6981 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.427128374576569 99.0000009536743 GKQLNLKLLDNWDSVTSTFSK MDA adduct +62(K)@2; Deamidated(N)@5; acrolein addition +94(K)@7 cleaved L-G@N-term; missed K-Q@2; missed K-L@7 0.02470269985497 2550.32543945313 851.1157 2550.30053710938 851.107482910156 3 13 1.1.1.4052.17 1 47.7842 2170.123 47.7928 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.421360790729523 98.8499999046326 GRDYVSQFEGSALGK cleaved S-G@N-term; missed R-D@2 -0.00162285997066647 1612.78308105469 538.6016 1612.78454589844 538.602111816406 3 11 1.1.1.3690.10 1 38.4822 2179.792 38.5225 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.371611058712006 99.0000009536743 KDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK MDA adduct +54(K)@12; acrolein addition +38(K)@29; hexanoyl addition +98(K)@34 cleaved V-K@N-term; missed K-D@1; missed K-D@12; missed R-D@16; missed K-Q@29; missed K-L@34 -0.00427601020783186 5539.83349609375 1108.974 5539.84033203125 1108.97534179688 5 10 1.1.1.4590.20 1 61.6415 8255.21 61.7492 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.343901783227921 98.1400012969971 QLNLKLLDN cleaved N-W@C-term; missed K-L@5 -0.0042623900808394 1069.60888671875 535.8117 1069.61315917969 535.813842773438 2 10 1.1.1.3877.8 1 43.3006 3026.668 43.2904 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.318758755922318 99.0000009536743 LREQLGPVTQ cleaved Q-E@C-term; missed R-E@2 -0.00525172986090183 1139.62463378906 570.8196 1139.6298828125 570.822204589844 2 12 1.1.1.3285.9 1 28.3946 1117.841 28.3779 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.312471061944962 98.6100018024445 YSDELRQR cleaved P-Y@N-term; missed R-Q@6 -0.000876633974257857 1065.51953125 533.767 1065.52026367188 533.767456054688 2 11 1.1.1.3217.5 1 26.7209 7586.958 26.6874 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.293282210826874 98.8099992275238 DYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@23 missed K-Q@13; missed K-L@18 0.0042552100494504 3621.7880859375 906.4543 3621.78393554688 906.453247070313 4 10 1.1.1.4530.17 1 60.0778 2610.446 60.0863 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.254144787788391 98.5300004482269 LATVYVDVLK cleaved D-L@N-term -0.00113121001049876 1119.65283203125 560.8337 1119.65393066406 560.834228515625 2 11 1.1.1.3885.5 1 43.5042 2303.499 43.4975 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.247183561325073 99.0000009536743 EALKENGGAR Deamidated(N)@6 cleaved L-E@N-term; missed K-E@4 -0.00530171999707818 1044.5146484375 523.2646 1044.52001953125 523.267272949219 2 12 1.1.1.3034.2 1 22.3138 2056.226 22.4193 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.225483030080795 97.680002450943 TEHLSTLSEKAKPALEDLR acrolein addition +112(K)@10 cleaved A-T@N-term; missed K-A@10 0.0185001995414495 2249.20849609375 450.849 2249.1904296875 450.845336914063 5 12 1.1.1.3626.4 1 36.8653 7690.12 36.8822 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.225483030080795 98.8099992275238 YVSQFEGSALGK cleaved D-Y@N-term -0.00175600999500602 1284.63330078125 643.3239 1284.63500976563 643.324768066406 2 12 1.1.1.3451.7 1 32.507 5337.165 32.2886 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.224753752350807 99.0000009536743 ALGKQLNLKLLDNWDSVTSTFSK MDA adduct +54(K)@4; Deamidated(N)@7; acrolein addition +112(K)@9 cleaved S-A@N-term; missed K-Q@4; missed K-L@9 0.00299250008538365 2744.43041992188 915.8174 2744.42724609375 915.816345214844 3 12 1.1.1.4043.20 1 47.5575 2158.928 47.6144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.196542873978615 93.639999628067 PPQSPWDRVK cleaved E-P@N-term; missed R-V@8 -0.00103808997664601 1208.62902832031 605.3218 1208.63024902344 605.322387695313 2 8 1.1.1.3405.10 1 31.355 1198.574 31.3407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.15552282333374 99.0000009536743 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +94(K)@10; ONE addition +154(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 -0.0555809997022152 4470.21923828125 895.0511 4470.27490234375 895.062194824219 5 11 1.1.1.4785.10 1 66.6104 38031.92 66.337 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.139661997556686 92.6500022411346 SEKAKPALEDLR acrolein addition +112(K)@3; acrolein addition +112(K)@5 cleaved L-S@N-term; missed K-A@3 0.0248015001416206 1579.87060546875 527.6308 1579.845703125 527.622497558594 3 7 1.1.1.3225.8 1 26.9152 3628.887 26.7605 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.122053049504757 94.1999971866608 KPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19 0.0131727000698447 3631.98876953125 727.405 3631.97534179688 727.40234375 5 14 1.1.1.5105.5 1 75.1255 4595.764 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.102372907102108 92.0899987220764 LKENGGAR cleaved A-L@N-term; missed K-E@2 -0.00413696002215147 843.452087402344 422.7333 843.456237792969 422.735412597656 2 5 1.1.1.3006.4 1 21.6141 363.3021 21.6733 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.102372907102108 94.0900027751923 QRLAARLEALKENGGAR Deamidated(Q)@1; Deamidated(N)@13 missed R-L@2; missed R-L@6; missed K-E@11 -0.0164128001779318 1853.99096679688 464.505 1854.00720214844 464.509063720703 4 9 1.1.1.3270.12 1 28.0194 7858.742 27.787 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0952844545245171 86.8099987506866 SDELRQR cleaved Y-S@N-term; missed R-Q@5 -0.00191585998982191 902.455078125 452.2348 902.456970214844 452.235778808594 2 7 1.1.1.3188.7 1 26.0138 17949.42 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0899094566702843 88.9299988746643 HAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +76(K)@3; reduced HNE(H)@7; acrolein addition +56(K)@14 cleaved Y-H@N-term; missed K-A@3; missed K-A@14; missed R-Q@23; missed K-V@34 -0.00388569990172982 5413.93896484375 774.4271 5413.94287109375 774.427673339844 7 13 1.1.1.5102.8 1 75.0498 14116.35 74.9851 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0840727910399437 95.2400028705597 AHVDALRTHLAPYSD cleaved D-E@C-term; missed R-T@7 0.0113802999258041 1664.83850097656 555.9534 1664.82702636719 555.949645996094 3 11 1.1.1.3393.5 1 31.0547 899.479 31.0453 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0824944898486137 99.0000009536743 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +94(K)@9; MDA adduct +62(K)@11; Carbamidomethyl(E)@15 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29 0.0416349992156029 4828.599609375 966.7272 4828.55810546875 966.718872070313 5 16 1.1.1.5083.16 1 74.5537 10038.81 74.6433 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0803989768028259 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEM Dicarbamidomethyl(D)@14; Deamidated(N)@15; acrolein addition +112(K)@18 cleaved M-S@C-term; missed R-E@2; missed K-E@18; missed R-Q@24 0.0140060000121593 3501.68603515625 701.3445 3501.67211914063 701.341735839844 5 17 1.1.1.3833.19 1 42.1649 8463.836 42.0917 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0798766762018204 16.7999997735024 THLAPYSDELRQRLAAR missed R-Q@11; missed R-L@13 0.00937754008919001 1996.06958007813 400.2212 1996.06030273438 400.219329833984 5 10 1.1.1.3580.2 1 35.6993 7829.405 35.7731 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0695604085922241 86.2800002098084 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@2; MDA adduct +62(K)@13; acrolein addition +56(K)@15 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33 -0.0306678991764784 5258.80615234375 877.475 5258.8369140625 877.480102539063 6 11 1.1.1.5083.12 1 74.5503 969.3633 74.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0655015483498573 96.1600005626678 EPLRAELQEGAR cleaved V-E@N-term; missed R-A@4 -0.00571799976751208 1367.71008300781 684.8623 1367.71569824219 684.865112304688 2 9 1.1.1.3355.15 1 30.1228 729.059 30.1773 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0639891996979713 87.7399981021881 EHLSTLSEKAKPALEDLR HPNE addition +172(K)@11 cleaved T-E@N-term; missed K-A@9 -0.017365999519825 2208.1826171875 442.6438 2208.2001953125 442.647308349609 5 8 1.1.1.3582.7 1 35.7561 11609.93 35.5893 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0634862631559372 97.1199989318848 LSPLGEEMRD Oxidation(M)@8 cleaved D-R@C-term; missed R-D@9 -0.0010493800509721 1161.53271484375 581.7736 1161.53356933594 581.774047851563 2 11 1.1.1.3187.9 1 25.9959 5383.301 26.0534 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.061480276286602 76.8100023269653 AEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6; missed K-A@17; missed R-Q@26; missed K-V@37; missed K-K@49; missed K-L@50 0.033288698643446 6225.3583984375 890.3442 6225.3251953125 890.339477539063 7 11 1.1.1.5073.11 1 74.2787 3735.403 74.4274 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.061480276286602 95.0699985027313 ALKENGGAR cleaved E-A@N-term; missed K-E@3 -0.00237003993242979 914.491088867188 458.2528 914.493408203125 458.253967285156 2 8 1.1.1.3011.3 1 21.7318 5036.572 21.6733 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0506099946796894 92.4700021743774 DNLEKETEGLRQEMSKDLEEVK Oxidation(M)@14 cleaved W-D@N-term; missed K-E@5; missed R-Q@11; missed K-D@16 0.00328686996363103 2635.26806640625 659.8243 2635.2646484375 659.823425292969 4 11 1.1.1.3663.5 1 37.809 1936.529 37.7929 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0486624799668789 96.6000020503998 DSGRDYVSQFEGSALGKQL acrolein addition +56(K)@17; Deamidated(Q)@18 cleaved L-N@C-term; missed R-D@4; missed K-Q@17 -0.00324536999687552 2112.9931640625 705.3383 2112.99633789063 705.339416503906 3 12 1.1.1.3765.10 1 40.4287 3816.438 40.4656 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0428717993199825 79.7100007534027 WDSVTSTFSK cleaved N-W@N-term -0.00165681994985789 1156.53845214844 579.2765 1156.5400390625 579.277282714844 2 8 1.1.1.3514.9 1 34.0529 876.6998 33.9432 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0414361171424389 93.1599974632263 KATEHLSTLSEKAKPALEDLR acrolein addition +94(K)@1; acrolein addition +76(K)@12 cleaved A-K@N-term; missed K-A@1; missed K-A@12 -0.0270019005984068 2506.31616210938 502.2705 2506.34301757813 502.275909423828 5 9 1.1.1.3579.10 1 35.6796 1460.22 35.5893 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.040005162358284 91.4900004863739 THLAPYSD cleaved D-E@C-term 0.000299370993161574 902.413696289063 452.2141 902.413391113281 452.213989257813 2 8 1.1.1.3118.6 1 24.3217 1266.888 24.3592 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0395292229950428 99.0000009536743 LDNWDSVTSTFSK Acetyl@N-term cleaved L-L@N-term 0.0180192999541759 1540.72265625 771.3686 1540.70458984375 771.359558105469 2 15 1.1.1.3618.5 1 36.6802 5094.901 36.5625 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0381045266985893 99.0000009536743 LKLLDNWDSVTSTFSK Dioxidation(W)@7 cleaved N-L@N-term; missed K-L@2 0.00603740010410547 1884.95324707031 629.325 1884.94689941406 629.322937011719 3 14 1.1.1.4012.9 1 46.7509 2366.317 46.7922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0357403717935085 31.2900006771088 AKATEHLSTLSEK cleaved H-A@N-term; missed K-A@2 -0.00509503018110991 1413.74133300781 472.2544 1413.74633789063 472.256072998047 3 10 1.1.1.3028.2 1 22.1535 268.9262 22.1924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0357403717935085 56.9500029087067 QKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@32 missed K-V@2; missed R-A@7; missed R-Q@15; missed K-L@17; missed K-L@24; missed R-D@33 0.0267430990934372 4139.18115234375 690.8708 4139.15478515625 690.866394042969 6 9 1.1.1.4114.15 1 49.3619 3785.742 49.27 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0347982980310917 84.4799995422363 TEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@12 cleaved A-T@N-term; missed K-A@10; missed R-Q@19; missed K-V@30 0.0278111007064581 4828.60693359375 805.7751 4828.5791015625 805.770446777344 6 12 1.1.1.5083.9 1 74.5478 16954.52 74.6433 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0324520207941532 83.6000025272369 YVDVLKDSGR cleaved V-Y@N-term; missed K-D@6 0.00824244972318411 1150.6064453125 576.3105 1150.59826660156 576.306396484375 2 7 1.1.1.4006.10 1 46.5956 1397.11 46.584 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0287241525948048 75.0299990177155 AHVDALRTHLAPYSDE cleaved E-L@C-term; missed R-T@7 0.0013776000123471 1793.87109375 598.9643 1793.86962890625 598.963806152344 3 8 1.1.1.3430.15 1 31.9747 1844.871 32.0106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0259490963071585 99.0000009536743 NWDSVTSTFSK Dioxidation(W)@2 cleaved D-N@N-term 0.00164898997172713 1302.57446289063 652.2945 1302.57275390625 652.293701171875 2 12 1.1.1.3577.17 1 35.6331 909.977 35.5893 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.021819481626153 98.9000022411346 DEPPQSPWDRVK Oxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 -3.53438008460216E-06 1468.69482421875 490.5722 1468.69470214844 490.572174072266 3 9 1.1.1.3102.9 1 23.9105 601.7899 23.9509 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0186344906687737 77.8299987316132 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT HPNE addition +172(K)@18; acrolein addition +112(K)@31; Deamidated(N)@33 cleaved K-P@N-term; cleaved T-Q@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0232362002134323 4133.2666015625 689.8851 4133.244140625 689.881286621094 6 11 1.1.1.5090.3 1 74.7303 3587.104 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0177287664264441 82.4000000953674 LSPLGEEMRDR Dioxidation(M)@8 missed R-D@9 0.000274416990578175 1333.63000488281 445.5506 1333.62963867188 445.550476074219 3 10 1.1.1.3161.4 1 25.3665 40394.37 25.4079 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0168249271810055 78.82000207901 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.00539579009637237 3719.06005859375 744.8193 3719.05493164063 744.818237304688 5 11 1.1.1.5088.6 1 74.6794 86124.7 74.7767 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0154726868495345 24.889999628067 LAPYSDELRQRLAARLEALKENGGAR cleaved H-L@N-term; missed R-Q@9; missed R-L@11; missed R-L@15; missed K-E@20 0.0047945799306035 2896.56811523438 580.3209 2896.56323242188 580.319885253906 5 8 1.1.1.4001.12 1 46.467 2793.854 46.4797 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0127807697281241 32.8099995851517 LAARLEALKEN cleaved N-G@C-term; missed R-L@4; missed K-E@9 -0.00293423002585769 1226.6953125 409.9057 1226.6982421875 409.906707763672 3 6 1.1.1.3298.3 1 28.7026 2015.513 28.6734 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0118871601298451 73.2900023460388 DNLEKETEGLRQEMSK Oxidation(M)@14 cleaved W-D@N-term; missed K-E@5; missed R-Q@11 0.00546893989667296 1921.91088867188 641.6442 1921.90515136719 641.642333984375 3 10 1.1.1.3269.17 1 28.0022 1805.697 28.0074 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0114410435780883 35.4299992322922 AEYHAKATEHLSTLSEKAKPALEDLR acrolein addition +112(K)@17 cleaved L-A@N-term; missed K-A@6; missed K-A@17 0.000557688996195793 3019.56225585938 755.8978 3019.5615234375 755.897644042969 4 7 1.1.1.3610.19 1 36.4815 679.7665 36.4625 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0114410435780883 88.0500018596649 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +54(K)@1; acrolein addition +112(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.0163516998291016 4469.46240234375 894.8998 4469.4462890625 894.896484375 5 13 1.1.1.5106.11 1 75.1557 5283.228 75.1947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0101054366677999 69.1100001335144 PQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@9; HPNE addition +172(K)@20 cleaved P-P@N-term; missed R-V@7; missed K-D@9; missed K-D@20; missed R-D@24 -0.00939415022730827 4351.19140625 726.2059 4351.201171875 726.207458496094 6 8 1.1.1.4867.5 1 68.8031 853.015 68.8756 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00833099242299795 85.8200013637543 SVTSTFSK cleaved D-S@N-term -0.00432279007509351 855.429443359375 428.722 855.433776855469 428.724182128906 2 8 1.1.1.3074.2 1 23.2185 1569.142 23.3077 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00788851175457239 99.0000009536743 KLREQLGPVTQEFWDNLEK Oxidation(R)@3; Deamidated(Q)@5 cleaved S-K@N-term; missed K-L@1; missed R-E@3 0.0111702000722289 2346.19677734375 783.0729 2346.185546875 783.069152832031 3 16 1.1.1.4259.18 1 53.0634 2077.603 53.0453 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00656376918777823 99.0000009536743 KVQPYLDDFQKK Oxidation(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11 0.00169496994931251 1523.80004882813 508.9406 1523.79833984375 508.940063476563 3 18 1.1.1.3552.4 1 34.9876 5174.642 34.9751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00612308504059911 45.9899991750717 SPLGEEMRDR Oxidation(M)@7 cleaved L-S@N-term; missed R-D@8 0.000996288959868252 1204.55163574219 603.2831 1204.55065917969 603.282592773438 2 9 1.1.1.3133.3 1 24.693 2763.068 24.7041 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00568284746259451 59.6300005912781 DNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@14 cleaved W-D@N-term; missed K-E@5; missed R-Q@11; missed K-D@16; missed K-A@22 -0.0078167300671339 2834.38891601563 709.6045 2834.39672851563 709.6064453125 4 7 1.1.1.3672.19 1 38.0335 2281.25 38.0404 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00568284746259451 99.0000009536743 HVDALRTHLAPYSDELRQRLAARLEALKENGGAR reduced HNE(H)@1; Deamidated(R)@6 cleaved A-H@N-term; missed R-T@6; missed R-Q@17; missed R-L@19; missed R-L@23; missed K-E@28 0.0125610996037722 3985.17358398438 665.2029 3985.16088867188 665.200744628906 6 15 1.1.1.3970.13 1 45.6645 4019.023 45.7277 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00568284746259451 76.6799986362457 LQEKLSPLGEEMRDR Oxidation(M)@12 cleaved E-L@N-term; missed K-L@4; missed R-D@13 0.00417265994474292 1815.9189453125 454.987 1815.91491699219 454.985992431641 4 10 1.1.1.3230.8 1 27.0398 1409.304 27.0289 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00524305552244186 96.8400001525879 DLEEVKAKVQPYLDDFQKKWQEEMELYR Delta:H(2)C(2)(K)@8; Oxidation(M)@24 missed K-A@6; missed K-V@8; missed K-K@18; missed K-W@19 0.032423198223114 3598.7978515625 900.7067 3598.76538085938 900.698608398438 4 13 1.1.1.4055.19 1 47.8626 5313.354 47.8695 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0048037082888186 98.8499999046326 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; MDA adduct +54(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 -0.00449040019884706 4462.20361328125 893.448 4462.2080078125 893.448913574219 5 13 1.1.1.4427.21 1 57.3755 8028.822 57.2774 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00392634514719248 98.2599973678589 AHVDALRTHLAPYSDELRQRL Phospho(S)@14 cleaved L-A@C-term; missed R-T@7; missed R-Q@18; missed R-L@20 -0.0014997300459072 2540.263671875 509.06 2540.26489257813 509.060272216797 5 14 1.1.1.3482.4 1 33.2659 1642.379 33.2753 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00392634514719248 96.6799974441528 EMSKDLEEVKAK Glu->pyro-Glu@N-term; Oxidation(M)@2 cleaved Q-E@N-term; missed K-D@4; missed K-A@10 0.00115368003025651 1403.69763183594 468.9065 1403.69665527344 468.906158447266 3 8 1.1.1.3097.10 1 23.7867 639.9831 23.8507 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00392634514719248 95.8999991416931 KPALEDLRQGLLPVLESFKVSFLSALEEYTKK MDA adduct +54(K)@1; Oxidation(P)@2 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31 -0.00144675001502037 3718.021484375 744.6116 3718.02319335938 744.611938476563 5 14 1.1.1.5129.13 1 75.753 1685.806 75.7649 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00392634514719248 71.5099990367889 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQK Deamidated(N)@15; acrolein addition +94(K)@18; MDA adduct +62(K)@35; hexanoyl addition +98(K)@37 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35; missed K-V@37 0.123952001333237 5891.05322265625 842.5863 5890.92919921875 842.568603515625 7 11 1.1.1.4282.14 1 53.6466 7491.347 53.6577 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00392634514719248 98.3900010585785 PLRAELQEGARQKLHELQEKLSPLG cleaved E-P@N-term; cleaved G-E@C-term; missed R-A@3; missed R-Q@11; missed K-L@13; missed K-L@20 1.9860600233078 2841.55297851563 569.3179 2839.56689453125 568.920654296875 5 14 1.1.1.3483.8 1 33.2846 10704.2 33.2261 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00392634514719248 98.7100005149841 RLAARLEALKENGGAR cleaved Q-R@N-term; missed R-L@1; missed R-L@5; missed K-E@10 -11.0289001464844 1712.95178222656 429.2452 1723.98059082031 432.002410888672 4 14 1.1.1.3519.2 1 34.1693 26473.26 34.0665 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00348832807503641 98.4399974346161 EPPQSPWDRVKDLATVYVDVLK Oxidation(P)@6; MDA adduct +54(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11 0.0033900800626725 2624.35205078125 875.7913 2624.3486328125 875.790161132813 3 11 1.1.1.4755.4 1 65.8251 4964.941 65.8445 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00348832807503641 33.3600014448166 HAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK reduced HNE(H)@1; MDA adduct +62(K)@14; acrolein addition +76(K)@16; acrolein addition +94(K)@34 cleaved Y-H@N-term; missed K-A@3; missed K-A@14; missed R-Q@23; missed K-V@34; missed K-K@46 -0.00280160992406309 5642.06640625 941.3517 5642.0693359375 941.352111816406 6 9 1.1.1.5096.15 1 74.8973 1451.176 74.8799 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00348832807503641 59.7699999809265 LAARLEALK Deamidated(R)@4 missed R-L@4 0.0146757997572422 984.611450195313 493.313 984.596801757813 493.3056640625 2 9 1.1.1.3284.8 1 28.3643 3831.458 28.3779 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00348832807503641 40.2399986982346 PALEDLRQGLLPVLESFKVSFLSALEEYTKKL reduced acrolein addition +96(K)@18; reduced acrolein addition +96(K)@30; HPNE addition +172(K)@31 cleaved K-P@N-term; cleaved L-N@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.00540103996172547 3997.2265625 800.4526 3997.23193359375 800.453674316406 5 8 1.1.1.5093.10 1 74.8139 1643.451 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00305075151845813 60.1899981498718 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +62(K)@13; acrolein addition +112(K)@15; Deamidated(Q)@23; acrolein addition +56(K)@33 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33; missed K-K@45; missed K-L@46 0.0174947995692492 5802.11962890625 968.0272 5802.1025390625 968.024353027344 6 10 1.1.1.5097.21 1 74.9269 3133.544 74.9058 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00305075151845813 99.0000009536743 FEGSALGKQLNLKLLDNWDSVTSTFSK Cation:K(E)@2; acrolein addition +112(K)@8; acrolein addition +76(K)@13 cleaved Q-F@N-term; missed K-Q@8; missed K-L@13 -0.0125120002776384 3223.5712890625 1075.531 3223.58447265625 1075.53540039063 3 12 1.1.1.4057.21 1 47.9153 10041.18 47.6398 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00305075151845813 99.0000009536743 LREQLGPVTQEFWDNLE Carbamidomethyl(E)@17 cleaved E-K@C-term; missed R-E@2 0.0194176994264126 2130.0576171875 711.0265 2130.0380859375 711.02001953125 3 14 1.1.1.3830.20 1 42.0856 1959.63 42.1183 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00217691925354302 99.0000009536743 ATEHLSTLSEKAKPALED Delta:H(2)C(2)(K)@11; MDA adduct +62(K)@13 cleaved D-L@C-term; missed K-A@11 0.0156459007412195 2027.03698730469 507.7665 2027.02111816406 507.762573242188 4 15 1.1.1.3518.5 1 34.1498 5975.112 34.1404 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00174066168256104 99.0000009536743 KVQPYLDDFQK Oxidation(K)@1 cleaved A-K@N-term; missed K-V@1 -0.00270011997781694 1395.70092773438 698.8577 1395.70349121094 698.859008789063 2 17 1.1.1.3710.17 1 39.0084 9970.268 39.0946 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00174066168256104 99.0000009536743 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(4)C(2)@N-term cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 0.027105500921607 4750.37841796875 951.083 4750.3515625 951.077575683594 5 17 1.1.1.4895.3 1 69.5643 1837.44 69.52 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00130484171677381 34.1199994087219 ATEHLSTLSE cleaved E-K@C-term -0.00586003018543124 1086.51342773438 544.264 1086.51928710938 544.266906738281 2 6 1.1.1.3162.13 1 25.396 443.8339 25.4324 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00130484171677381 26.7899990081787 LREQLGPVTQEFWDNLEKETE acrolein addition +56(K)@18 cleaved E-G@C-term; missed R-E@2; missed K-E@18 0.0266325995326042 2616.29736328125 873.1064 2616.27075195313 873.097534179688 3 7 1.1.1.4183.15 1 51.124 949.3297 51.1083 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00130484171677381 17.1700000762939 LRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved D-L@N-term; missed R-Q@2; missed K-V@13; missed K-K@25; missed K-L@26 0.0215486995875835 3450.93408203125 863.7408 3450.91259765625 863.735412597656 4 7 1.1.1.5089.12 1 74.7115 1145.033 74.6971 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00130484171677381 41.9099986553192 LSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +56(K)@4 cleaved T-L@N-term; missed K-A@4; missed R-Q@13; missed K-V@24 0.0624981001019478 4104.302734375 1027.083 4104.23974609375 1027.06726074219 4 9 1.1.1.5103.20 1 75.0863 823.0535 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00130484171677381 43.3600008487701 PLGEEMRDR Oxidation(M)@6 cleaved S-P@N-term; missed R-D@7 -0.00246608001179993 1117.51611328125 559.7653 1117.5185546875 559.7666015625 2 9 1.1.1.3144.9 1 24.9632 16334.03 24.7527 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00130484171677381 88.7000024318695 SKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Carbamidomethyl@N-term; reduced acrolein addition +58(K)@2; ONE addition +154(K)@10; Oxidation(M)@26 cleaved M-S@N-term; missed K-D@2; missed K-A@8; missed K-V@10; missed K-K@20; missed K-W@21; missed R-Q@30; missed K-V@32; missed R-A@37 0.0447643995285034 5762.0107421875 824.1517 5761.96630859375 824.145385742188 7 12 1.1.1.4217.15 1 51.9917 7558.702 52.0272 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000869458774104714 66.6899979114532 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Glu->pyro-Glu@N-term; MDA adduct +62(K)@2 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 0.00376166007481515 4476.4345703125 896.2942 4476.4306640625 896.29345703125 5 11 1.1.1.5107.13 1 75.1827 4066.628 75.2201 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000869458774104714 61.6999983787537 FSKLREQLGPVTQEFWDNLEKETEGLR acrolein addition +56(K)@3 cleaved T-F@N-term; missed K-L@3; missed R-E@5; missed K-E@21 -0.0495037995278835 3304.62329101563 827.1631 3304.6728515625 827.175476074219 4 8 1.1.1.4492.17 1 59.0733 2410.496 58.9764 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000869458774104714 51.1699974536896 KWQEEMELYRQK Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1; missed R-Q@10 0.00607491983100772 1714.80456542969 429.7084 1714.79846191406 429.706909179688 4 10 1.1.1.3158.3 1 25.2928 2314.962 25.3106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000869458774104714 18.9899995923042 LLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +96(K)@9 cleaved G-L@N-term; missed K-V@9; missed K-K@21; missed K-L@22 -0.0210823006927967 3092.68383789063 774.1782 3092.70483398438 774.183532714844 4 8 1.1.1.5071.5 1 74.2198 2732.422 74.2117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 83.569997549057 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN Carboxy(E)@29; hexanoyl addition +98(K)@33 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.03950310125947 4088.28442382813 682.388 4088.24487304688 682.381408691406 6 11 1.1.1.5124.8 1 75.6158 2168.749 75.5527 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 67.9099977016449 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Glu->pyro-Glu@N-term; MDA adduct +62(K)@2 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22 0.0268665999174118 3892.12963867188 974.0397 3892.1025390625 974.032958984375 4 10 1.1.1.5104.15 1 75.108 1578.638 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 99.0000009536743 KATEHLSTLSEK Oxidation(K)@1 cleaved A-K@N-term; missed K-A@1 -0.00236563989892602 1358.70190429688 453.9079 1358.7041015625 453.908660888672 3 16 1.1.1.3128.8 1 24.5692 68062.12 24.4601 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 49.3800014257431 KDLEEVKAKVQPYLDDFQKKWQEEMELYR acrolein addition +38(K)@7; hexanoyl addition +98(K)@9; Oxidation(M)@25 cleaved S-K@N-term; missed K-D@1; missed K-A@7; missed K-V@9; missed K-K@19; missed K-W@20 0.00936788972467184 3836.94287109375 960.243 3836.93359375 960.240661621094 4 10 1.1.1.4067.21 1 48.1695 12480.54 48.1748 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 97.2800016403198 QFEGSALGKQLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; acrolein addition +38(K)@9; Deamidated(N)@12; acrolein addition +76(K)@14 cleaved S-Q@N-term; missed K-Q@9; missed K-L@14 -0.0406553000211716 3223.568359375 1075.53 3223.60766601563 1075.54321289063 3 12 1.1.1.4050.21 1 47.7365 11282.51 47.6144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 79.9300014972687 QKLHELQEKLSPLGEEMRDRARA Gln->pyro-Glu@N-term; Oxidation(M)@17 cleaved A-H@C-term; missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20; missed R-A@22 -0.0344847999513149 2732.3681640625 911.7967 2732.40283203125 911.808227539063 3 8 1.1.1.3652.20 1 37.5386 2258.633 37.5943 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 32.9699993133545 SKDLEEVKAKVQPYLDDFQKKWQEEMELYR acrolein addition +38(K)@8; acrolein addition +76(K)@10; Dethiomethyl(M)@26 cleaved M-S@N-term; missed K-D@2; missed K-A@8; missed K-V@10; missed K-K@20; missed K-W@21 0.00219258992001414 3837.927734375 960.4892 3837.92529296875 960.488647460938 4 9 1.1.1.4053.21 1 47.8131 5507.105 48.0476 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 22.6300001144409 STLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK MDA adduct +62(K)@6; MDA adduct +62(K)@8; Deamidated(Q)@16; reduced acrolein addition +58(K)@26 cleaved L-S@N-term; missed K-A@6; missed R-Q@15; missed K-V@26; missed K-K@38 0.0347699001431465 4547.48046875 910.5034 4547.4453125 910.496398925781 5 9 1.1.1.5092.14 1 74.7915 1476.146 74.7767 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR cleaved L-A@N-term; missed R-L@3; missed K-E@8 -3.52255010511726E-05 1454.79541015625 485.9391 1454.79541015625 485.939056396484 3 16 1.1.1.3195.6 1 26.1819 16799.96 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.00088028097525239 1454.79638671875 485.9394 1454.79541015625 485.939056396484 3 14 1.1.1.3218.4 1 26.7436 6181.341 26.4924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00628957990556955 1455.77319335938 486.265 1455.77941894531 486.267059326172 3 18 1.1.1.3247.5 1 27.4522 7829.022 27.4447 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00333105004392564 1454.79211425781 485.938 1454.79541015625 485.939056396484 3 12 1.1.1.3227.7 1 26.9631 7375.819 27.0289 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00839524995535612 1455.77111816406 486.2643 1455.77941894531 486.267059326172 3 14 1.1.1.3270.13 1 28.0203 9911.237 28.1068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00628957990556955 1455.77319335938 486.265 1455.77941894531 486.267059326172 3 15 1.1.1.3240.6 1 27.2845 7829.022 27.4447 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00839524995535612 1455.77111816406 486.2643 1455.77941894531 486.267059326172 3 15 1.1.1.3277.7 1 28.1921 9911.237 28.1068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00333105004392564 1454.79211425781 485.938 1454.79541015625 485.939056396484 3 14 1.1.1.3209.4 1 26.5225 16083.03 26.2729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00299375993199646 1455.77648925781 486.2661 1455.77941894531 486.267059326172 3 14 1.1.1.3254.5 1 27.6249 8348.631 27.6157 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 AARLEALKENGGAR Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00299375993199646 1455.77648925781 486.2661 1455.77941894531 486.267059326172 3 13 1.1.1.3262.5 1 27.8241 8348.631 27.6157 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7600028514862 AARLEALKENGGAR ONE addition +154(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.0114877000451088 1608.90612792969 403.2338 1608.89477539063 403.23095703125 4 11 1.1.1.3293.2 1 28.578 7181.272 28.6734 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.199999332428 AARLEALKENGGAR Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00839524995535612 1455.77111816406 486.2643 1455.77941894531 486.267059326172 3 12 1.1.1.3269.10 1 27.993 9911.237 28.1068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0099985599518 AARLEALKENGGAR HPNE addition +172(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.0337482988834381 1626.87170410156 407.7252 1626.9052734375 407.733612060547 4 10 1.1.1.3237.2 1 27.2046 7823.662 27.0779 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 AARLEALKENGGAR ONE addition +154(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.0119759002700448 1608.90649414063 403.2339 1608.89477539063 403.23095703125 4 11 1.1.1.3286.2 1 28.4057 71523.48 28.3534 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 AARLEALKENGGAR ONE addition +154(K)@8; Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.0195172000676394 1609.89819335938 403.4818 1609.87878417969 403.476959228516 4 8 1.1.1.3337.2 1 29.6648 4406.657 29.5382 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 AARLEALKENGGAR ONE addition +154(K)@8; Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.0147564997896552 1609.89379882813 403.4807 1609.87878417969 403.476959228516 4 8 1.1.1.3557.2 1 35.1017 2129.407 34.9506 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 AARLEALKENGGAR HPNE addition +172(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00823615025728941 1626.89697265625 407.7315 1626.9052734375 407.733612060547 4 10 1.1.1.3205.3 1 26.425 1415.827 26.468 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 AARLEALKENGGAR ONE addition +154(K)@8; Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.0103620998561382 1609.88940429688 403.4796 1609.87878417969 403.476959228516 4 11 1.1.1.3300.2 1 28.7516 31001.81 28.823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9899990558624 AARLEALKENGGAR acrolein addition +94(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.000681815028656274 1548.83642578125 517.2861 1548.83728027344 517.286376953125 3 8 1.1.1.3888.7 1 43.582 1299.697 43.5989 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 AARLEALKENGGAR ONE addition +154(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.0216688998043537 1608.91650390625 805.4655 1608.89477539063 805.454650878906 2 8 1.1.1.3284.13 1 28.3727 1758.432 28.3534 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.7999982833862 AARLEALKENGGAR ONE addition +154(K)@8; Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.0139020998030901 1609.892578125 403.4804 1609.87878417969 403.476959228516 4 6 1.1.1.3561.2 1 35.2029 1007.899 35.224 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 AARLEALKENGGAR acrolein addition +112(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00528164021670818 1566.84240722656 523.2881 1566.84777832031 523.289855957031 3 7 1.1.1.3540.7 1 34.6885 1452.624 34.5828 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.5800020694733 AARLEALKENGGAR acrolein addition +94(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.000132511006086133 1548.83715820313 517.2863 1548.83728027344 517.286376953125 3 7 1.1.1.3858.4 1 42.8065 2304.068 42.7249 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 AARLEALKENGGAR acrolein addition +112(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00528164021670818 1566.84240722656 523.2881 1566.84777832031 523.289855957031 3 9 1.1.1.3532.5 1 34.4939 1452.624 34.5828 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.3199980258942 AARLEALKENGGAR ONE addition +154(K)@8; Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.0147564997896552 1609.89379882813 403.4807 1609.87878417969 403.476959228516 4 8 1.1.1.3548.2 1 34.8821 2129.407 34.9506 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 AARLEALKENGGAR acrolein addition +94(K)@8; Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.00968194007873535 1549.81140136719 517.6111 1549.8212890625 517.614379882813 3 7 1.1.1.3826.8 1 41.9694 1562.665 41.907 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 AARLEALKENGGAR acrolein addition +94(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.000132511006086133 1548.83715820313 517.2863 1548.83728027344 517.286376953125 3 7 1.1.1.3850.8 1 42.6052 2304.068 42.7249 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 AARLEALKENGGAR HPNE addition +172(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 -0.0337482988834381 1626.87170410156 407.7252 1626.9052734375 407.733612060547 4 8 1.1.1.3235.2 1 27.1556 7823.662 27.0779 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 AARLEALKENGGAR ONE addition +154(K)@8; Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.0103620998561382 1609.88940429688 403.4796 1609.87878417969 403.476959228516 4 9 1.1.1.3307.2 1 28.9273 31001.81 28.823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AELQEGAR 0.000326981011312455 872.435485839844 437.225 872.435180664063 437.224884033203 2 11 1.1.1.2809.2 1 18.2362 42533.79 18.4075 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AELQEGAR -0.00168713997118175 872.433471679688 437.224 872.435180664063 437.224884033203 2 13 1.1.1.2818.2 1 18.3939 57197.75 18.4372 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AELQEGAR -0.00168713997118175 872.433471679688 437.224 872.435180664063 437.224884033203 2 13 1.1.1.2826.3 1 18.5691 57197.75 18.4372 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AELQEGAR -0.00168713997118175 872.433471679688 437.224 872.435180664063 437.224884033203 2 13 1.1.1.2843.3 1 18.9103 13709.17 18.7279 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AELQEGAR -0.00388434994965792 872.431274414063 437.2229 872.435180664063 437.224884033203 2 11 1.1.1.2878.2 1 19.429 1297.642 19.3117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AELQEGAR -0.00406746007502079 872.431091308594 437.2228 872.435180664063 437.224884033203 2 10 1.1.1.2933.2 1 20.1628 239.9085 20.1419 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AELQEGAR -0.00168713997118175 872.433471679688 437.224 872.435180664063 437.224884033203 2 9 1.1.1.2972.2 1 20.8615 162.3233 20.8542 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AELQEGAR -0.00388434994965792 872.431274414063 437.2229 872.435180664063 437.224884033203 2 12 1.1.1.2833.3 1 18.741 47141.84 18.4858 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AELQEGAR -0.00168713997118175 872.433471679688 437.224 872.435180664063 437.224884033203 2 7 1.1.1.2982.3 1 21.045 145.1076 21.0862 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AELQEGAR -0.00388434994965792 872.431274414063 437.2229 872.435180664063 437.224884033203 2 11 1.1.1.2862.2 1 19.2491 4153.766 19.0445 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AELQEGAR -0.00425055995583534 872.430847167969 437.2227 872.435180664063 437.224884033203 2 10 1.1.1.2900.2 1 19.7863 472.3026 19.5935 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.2199976444244 AELQEGAR Delta:H(2)C(2)@N-term -0.0016622799448669 898.449279785156 450.2319 898.450866699219 450.232696533203 2 7 1.1.1.3004.2 1 21.5541 429.6176 21.6487 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 AELQEGAR Acetyl@N-term -0.00272370991297066 914.443054199219 458.2288 914.445739746094 458.230163574219 2 7 1.1.1.2989.5 1 21.2327 125.5653 21.2672 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.0800020694733 AELQEGAR -0.00425055995583534 872.430847167969 437.2227 872.435180664063 437.224884033203 2 9 1.1.1.2942.2 1 20.334 255.53 20.282 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.8699998855591 AELQEGAR -0.00486089987680316 872.430297851563 437.2224 872.435180664063 437.224884033203 2 7 1.1.1.3033.3 1 22.2801 80.0826 22.243 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.5300009250641 AELQEGAR -0.0020533399656415 872.433044433594 437.2238 872.435180664063 437.224884033203 2 11 1.1.1.2853.3 1 19.0889 6716.93 18.8969 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.529999256134 AELQEGAR Delta:H(2)C(2)@N-term -0.00227262009866536 898.448669433594 450.2316 898.450866699219 450.232696533203 2 9 1.1.1.2986.2 1 21.1584 718.8742 21.0862 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.7899980545044 AELQEGAR -0.00467779021710157 872.430480957031 437.2225 872.435180664063 437.224884033203 2 9 1.1.1.2915.2 1 19.973 253.293 19.9155 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 AELQEGAR Methyl(E)@2 -0.00244035990908742 886.448486328125 444.2315 886.450866699219 444.232696533203 2 5 1.1.1.2974.5 1 20.9211 157.9265 20.9821 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3900007009506 AELQEGAR Delta:H(2)C(2)@N-term -0.0016622799448669 898.449279785156 450.2319 898.450866699219 450.232696533203 2 5 1.1.1.3011.2 1 21.7284 429.6176 21.6487 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 AELQEGAR Delta:H(2)C(2)@N-term -0.00227262009866536 898.448669433594 450.2316 898.450866699219 450.232696533203 2 8 1.1.1.2979.2 1 20.9768 718.8742 21.0862 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.0699987411499 AELQEGAR -0.00406746007502079 872.431091308594 437.2228 872.435180664063 437.224884033203 2 5 1.1.1.2962.3 1 20.6858 206.3702 20.6737 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.0899996757507 AELQEGAR -0.00425055995583534 872.430847167969 437.2227 872.435180664063 437.224884033203 2 6 1.1.1.2954.2 1 20.4998 228.6605 20.4617 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.0190361998975277 2068.06689453125 518.024 2068.04760742188 518.019226074219 4 15 1.1.1.3182.10 1 25.8671 95284.45 25.9555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.0202063005417585 2068.0673828125 1035.041 2068.04760742188 1035.03112792969 2 11 1.1.1.3183.16 1 25.9011 1706.155 25.9308 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.0297210998833179 2068.07739257813 690.3664 2068.04760742188 690.356506347656 3 14 1.1.1.3208.8 1 26.5115 1436.044 26.5168 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.0190361998975277 2068.06689453125 518.024 2068.04760742188 518.019226074219 4 13 1.1.1.3196.8 1 26.2105 94767.07 25.9555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.0190361998975277 2068.06689453125 518.024 2068.04760742188 518.019226074219 4 12 1.1.1.3189.9 1 26.0432 95284.45 25.9555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.0170872006565332 2068.06469726563 690.3622 2068.04760742188 690.356506347656 3 12 1.1.1.3196.13 1 26.2189 20402.66 25.9555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4699974060059 AEYHAKATEHLSTLSEK acrolein addition +112(K)@6 cleaved L-A@N-term; missed K-A@6 0.00114068994298577 2026.00219726563 507.5078 2026.00073242188 507.507446289063 4 10 1.1.1.3649.8 1 37.4542 1917.143 37.4182 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.0141535000875592 2068.06225585938 518.0228 2068.04760742188 518.019226074219 4 11 1.1.1.3206.7 1 26.4577 6704.252 26.4924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 AEYHAKATEHLSTLSEK Acetyl@N-term; acrolein addition +112(K)@6 cleaved L-A@N-term; missed K-A@6 -0.000240039997152053 2068.01098632813 690.3443 2068.01123046875 690.344360351563 3 9 1.1.1.3877.12 1 43.3039 603.4942 43.3167 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.8400018215179 AEYHAKATEHLSTLSEK Carbamyl@N-term; reduced acrolein addition +96(K)@6 cleaved L-A@N-term; missed K-A@6 -3.22558989864774E-05 2053.01171875 685.3445 2053.01171875 685.344482421875 3 11 1.1.1.3874.15 1 43.2278 2821.709 43.2645 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.1899991035461 AEYHAKATEHLSTLSEK Amino(Y)@3; acrolein addition +76(K)@6 cleaved L-A@N-term; missed K-A@6 0.0167516991496086 2005.00732421875 502.2591 2004.99047851563 502.254913330078 4 12 1.1.1.3470.3 1 32.9642 6199.554 32.881 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.1899991035461 AEYHAKATEHLSTLSEK acrolein addition +94(K)@6 cleaved L-A@N-term; missed K-A@6 0.00505498005077243 2007.99536132813 503.0061 2007.99011230469 503.004821777344 4 8 1.1.1.3606.9 1 36.3692 3278.88 36.282 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.0141535000875592 2068.06225585938 518.0228 2068.04760742188 518.019226074219 4 10 1.1.1.3213.6 1 26.625 6704.252 26.4924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.021721700206399 2068.06982421875 518.0247 2068.04760742188 518.019226074219 4 10 1.1.1.3228.11 1 26.9925 2401.027 26.9312 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 AHVDALR Carbamidomethyl@N-term -0.00180800002999604 837.44384765625 419.7292 837.445678710938 419.730133056641 2 8 1.1.1.2838.2 1 18.8008 113.8899 18.8178 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 AHVDALR Carbamidomethyl@N-term -0.00424935016781092 837.441467285156 419.728 837.445678710938 419.730133056641 2 9 1.1.1.2861.2 1 19.2327 262.2367 19.1251 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.409999370575 AHVDALR Delta:H(2)C(2)(H)@2 -0.00578807992860675 806.43408203125 404.2243 806.439880371094 404.227233886719 2 8 1.1.1.3079.2 1 23.3374 918.3177 23.356 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 AHVDALR Acetyl@N-term 0.000187676007044502 822.43505859375 412.2248 822.434814453125 412.224670410156 2 6 1.1.1.3065.2 1 23.019 361.1144 23.0376 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELR missed R-T@7 0.00345592992380261 2063.05859375 516.7719 2063.05493164063 516.77099609375 4 12 1.1.1.3579.11 1 35.6804 110244.8 35.8752 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELR missed R-T@7 0.00345592992380261 2063.05859375 516.7719 2063.05493164063 516.77099609375 4 19 1.1.1.3586.5 1 35.8566 110962.7 35.8752 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELR missed R-T@7 0.00345592992380261 2063.05859375 516.7719 2063.05493164063 516.77099609375 4 18 1.1.1.3593.10 1 36.0366 110962.7 35.8752 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELR missed R-T@7 0.00662969006225467 2063.06127929688 516.7726 2063.05493164063 516.77099609375 4 14 1.1.1.3607.8 1 36.3942 7091.119 36.1281 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELR missed R-T@7 0.0104868998751044 2063.06518554688 413.6203 2063.05493164063 413.618255615234 5 12 1.1.1.3588.2 1 35.9044 26585.53 35.8752 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 AHVDALRTHLAPYSDELR Carbamidomethyl@N-term missed R-T@7 0.00923230033367872 2120.08569335938 531.0287 2120.07641601563 531.0263671875 4 11 1.1.1.3601.12 1 36.2437 1479.138 36.2308 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4100012779236 AHVDALRTHLAPYSDELR Deamidated(R)@7; Oxidation(P)@12 missed R-T@7 0.0260856002569199 2080.05981445313 521.0222 2080.03369140625 521.015747070313 4 10 1.1.1.3582.13 1 35.7611 1788.12 35.8254 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4800028800964 AHVDALRTHLAPYSDELR Acetyl@N-term; Arg->GluSA(R)@7 missed R-T@7 0.00820691045373678 2062.0205078125 688.3474 2062.01196289063 688.344604492188 3 11 1.1.1.3830.19 1 42.0848 946.686 42.1183 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 AHVDALRTHLAPYSDELR Deamidated(R)@7; Oxidation(Y)@13 missed R-T@7 0.0133905997499824 2080.046875 521.019 2080.03369140625 521.015747070313 4 10 1.1.1.3590.4 1 35.9559 1531.812 35.9504 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0299973487854 AHVDALRTHLAPYSDELR Methyl(E)@16 missed R-T@7 0.0043799402192235 2077.07495117188 520.276 2077.07055664063 520.27490234375 4 8 1.1.1.3695.12 1 38.6139 783.2269 38.6527 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 AHVDALRTHLAPYSDELR Pro->pyro-Glu(P)@12 missed R-T@7 0.00946369022130966 2077.04370117188 520.2682 2077.0341796875 520.265808105469 4 8 1.1.1.3589.9 1 35.9352 1098.188 35.9254 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.9900004863739 AHVDALRTHLAPYSDELR Dioxidation(P)@12 missed R-T@7 0.00775858014822006 2095.05249023438 524.7704 2095.04467773438 524.768432617188 4 8 1.1.1.3584.6 1 35.8076 1425.983 35.9003 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.3199980258942 AHVDALRTHLAPYSDELR Dehydrated(S)@14 missed R-T@7 -0.00436295010149479 2045.0400390625 512.2673 2045.04431152344 512.268371582031 4 8 1.1.1.3578.10 1 35.6534 921.1665 35.7203 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 AHVDALRTHLAPYSDELR Carbamidomethyl(H)@9 missed R-T@7 0.00923230033367872 2120.08569335938 531.0287 2120.07641601563 531.0263671875 4 10 1.1.1.3573.11 1 35.5231 2848.327 35.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.1799986362457 AHVDALRTHLAPYSDELR Delta:H(2)C(2)(H)@2 missed R-T@7 -0.00467034010216594 2089.06567382813 523.2737 2089.07055664063 523.27490234375 4 6 1.1.1.3758.8 1 40.2432 614.8952 40.3383 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 18.690000474453 AHVDALRTHLAPYSDELR missed R-T@7 0.00345592992380261 2063.05859375 516.7719 2063.05493164063 516.77099609375 4 8 1.1.1.3589.8 1 35.9343 110962.7 35.8752 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00973044987767935 2347.22412109375 470.4521 2347.21459960938 470.4501953125 5 16 1.1.1.3423.6 1 31.79 7992.864 31.833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0167493000626564 2347.23095703125 470.4535 2347.21459960938 470.4501953125 5 11 1.1.1.3465.8 1 32.8402 2540.729 32.8072 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Carbamidomethyl(H)@9 missed R-T@7; missed R-Q@18 0.0131456004455686 2404.24926757813 602.0696 2404.23608398438 602.066284179688 4 19 1.1.1.3484.9 1 33.3143 21648.35 33.3245 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0111036999151111 2347.2255859375 470.4524 2347.21459960938 470.4501953125 5 11 1.1.1.3485.3 1 33.3306 308787.6 33.5718 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00499605014920235 2347.21923828125 587.8121 2347.21459960938 587.810913085938 4 18 1.1.1.3486.14 1 33.3629 203614 33.5966 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 -0.00125997001305223 2347.21313476563 783.4117 2347.21459960938 783.412109375 3 18 1.1.1.3493.14 1 33.5401 51221.85 33.7206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0111036999151111 2347.2255859375 470.4524 2347.21459960938 470.4501953125 5 17 1.1.1.3494.3 1 33.5515 495785.9 33.7454 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0103669995442033 2347.22485351563 587.8135 2347.21459960938 587.810913085938 4 15 1.1.1.3498.10 1 33.659 286340.1 33.7206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 -0.00125997001305223 2347.21313476563 783.4117 2347.21459960938 783.412109375 3 21 1.1.1.3500.13 1 33.7121 51137.53 33.7206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0111036999151111 2347.2255859375 470.4524 2347.21459960938 470.4501953125 5 14 1.1.1.3505.6 1 33.8267 509019.9 33.795 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0103669995442033 2347.22485351563 587.8135 2347.21459960938 587.810913085938 4 16 1.1.1.3506.7 1 33.8572 283321.3 33.8691 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00276824994944036 2347.21728515625 783.413 2347.21459960938 783.412109375 3 24 1.1.1.3507.13 1 33.8869 41687.64 33.9185 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0111036999151111 2347.2255859375 470.4524 2347.21459960938 470.4501953125 5 18 1.1.1.3514.4 1 34.0471 520129.2 34.0419 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00597258005291224 2347.22045898438 587.8124 2347.21459960938 587.810913085938 4 17 1.1.1.3514.12 1 34.0579 273408.8 33.9925 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0117140002548695 2347.22607421875 470.4525 2347.21459960938 470.4501953125 5 18 1.1.1.3521.5 1 34.2235 511718.4 34.2634 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0103669995442033 2347.22485351563 587.8135 2347.21459960938 587.810913085938 4 16 1.1.1.3521.10 1 34.2336 273122.1 34.1404 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0117140002548695 2347.22607421875 470.4525 2347.21459960938 470.4501953125 5 19 1.1.1.3528.5 1 34.3981 511718.4 34.2634 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00597258005291224 2347.22045898438 587.8124 2347.21459960938 587.810913085938 4 16 1.1.1.3529.6 1 34.4219 261021.1 34.4109 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Deamidated(Q)@19 missed R-T@7; missed R-Q@18 0.0263270996510983 2348.22485351563 588.0635 2348.19848632813 588.056884765625 4 15 1.1.1.3530.5 1 34.4473 129159.4 34.3127 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0117140002548695 2347.22607421875 470.4525 2347.21459960938 470.4501953125 5 18 1.1.1.3535.4 1 34.5675 497436.3 34.3127 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Oxidation(Y)@13 missed R-T@7; missed R-Q@18 0.0128434998914599 2363.22216796875 473.6517 2363.20947265625 473.649169921875 5 17 1.1.1.3541.2 1 34.7097 6743.682 34.6319 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0117140002548695 2347.22607421875 470.4525 2347.21459960938 470.4501953125 5 20 1.1.1.3542.4 1 34.7351 437161.6 34.4847 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00621672021225095 2347.22045898438 587.8124 2347.21459960938 587.810913085938 4 14 1.1.1.3543.8 1 34.7688 235849.6 34.5337 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Deamidated(Q)@19 missed R-T@7; missed R-Q@18 0.0251064002513886 2348.2236328125 588.0632 2348.19848632813 588.056884765625 4 13 1.1.1.3548.4 1 34.8871 90888.84 34.6319 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0161390006542206 2347.23071289063 470.4534 2347.21459960938 470.4501953125 5 20 1.1.1.3549.4 1 34.9091 346379.7 34.6564 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0156811997294426 2347.23022460938 470.4533 2347.21459960938 470.4501953125 5 20 1.1.1.3556.5 1 35.0793 227012.5 34.8281 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Carbamidomethyl@N-term missed R-T@7; missed R-Q@18 0.0100068999454379 2404.24609375 481.8565 2404.23608398438 481.854461669922 5 17 1.1.1.3561.8 1 35.2079 41260.48 35.1228 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0156811997294426 2347.23022460938 470.4533 2347.21459960938 470.4501953125 5 18 1.1.1.3563.4 1 35.256 93570.21 34.9996 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0152235003188252 2347.2294921875 470.4532 2347.21459960938 470.4501953125 5 16 1.1.1.3570.3 1 35.4379 44274.3 35.1731 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00469515984877944 2347.21923828125 470.4511 2347.21459960938 470.4501953125 5 13 1.1.1.3577.5 1 35.6231 20387.54 35.3535 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0036270699929446 2347.21801757813 470.4509 2347.21459960938 470.4501953125 5 13 1.1.1.3591.4 1 35.9812 6746.571 35.9754 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0036270699929446 2347.21801757813 470.4509 2347.21459960938 470.4501953125 5 12 1.1.1.3599.5 1 36.1866 6746.571 35.9754 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00279882992617786 2347.21728515625 587.8116 2347.21459960938 587.810913085938 4 13 1.1.1.3602.16 1 36.2726 4289.624 36.0006 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.0101881995797157 2347.224609375 470.4522 2347.21459960938 470.4501953125 5 13 1.1.1.3614.2 1 36.5677 2324.997 36.6117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Acetyl@N-term; Arg->GluSA(R)@7 missed R-T@7; missed R-Q@18 0.0158690009266138 2346.18725585938 587.5541 2346.17163085938 587.550170898438 4 19 1.1.1.3753.15 1 40.1169 33442.74 40.1803 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Carbamidomethyl(D)@4 missed R-T@7; missed R-Q@18 -0.0168830007314682 2404.21923828125 602.0621 2404.23608398438 602.066284179688 4 16 1.1.1.3498.12 1 33.6624 2056.639 33.7702 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Acetyl@N-term; Arg->GluSA(R)@7 missed R-T@7; missed R-Q@18 0.0158690009266138 2346.18725585938 587.5541 2346.17163085938 587.550170898438 4 17 1.1.1.3760.9 1 40.2964 33442.74 40.1803 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Delta:H(2)C(2)(H)@2 missed R-T@7; missed R-Q@18 0.00859067961573601 2373.23852539063 475.655 2373.23022460938 475.6533203125 5 13 1.1.1.3701.3 1 38.762 3632.652 38.7822 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Carbamidomethyl@N-term missed R-T@7; missed R-Q@18 0.0100068999454379 2404.24609375 481.8565 2404.23608398438 481.854461669922 5 14 1.1.1.3554.3 1 35.0283 41260.48 35.1228 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Carbamidomethyl(H)@9 missed R-T@7; missed R-Q@18 -0.00484579987823963 2404.2314453125 802.4177 2404.23608398438 802.419250488281 3 14 1.1.1.3481.7 1 33.2454 2381.035 33.3245 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 AHVDALRTHLAPYSDELRQR Carbamidomethyl@N-term missed R-T@7; missed R-Q@18 0.0131456004455686 2404.24926757813 602.0696 2404.23608398438 602.066284179688 4 13 1.1.1.3491.5 1 33.4824 21648.35 33.3245 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 AHVDALRTHLAPYSDELRQR Carbamidomethyl(H)@9 missed R-T@7; missed R-Q@18 -6.36593031231314E-05 2404.23608398438 481.8545 2404.23608398438 481.854461669922 5 14 1.1.1.3504.6 1 33.8061 2877.022 33.7454 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6599981784821 AHVDALRTHLAPYSDELRQR Arg->GluSA(R)@7; reduced HNE(H)@9 missed R-T@7; missed R-Q@18 -0.0046334401704371 2462.287109375 493.4647 2462.29174804688 493.465637207031 5 14 1.1.1.3562.7 1 35.2327 7445.813 35.2754 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 AHVDALRTHLAPYSDELRQR Dioxidation(R)@7 missed R-T@7; missed R-Q@18 0.010614899918437 2379.21508789063 476.8503 2379.20434570313 476.84814453125 5 14 1.1.1.3489.4 1 33.4288 3727.242 33.5223 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 AHVDALRTHLAPYSDELRQR Formyl@N-term missed R-T@7; missed R-Q@18 0.00773916998878121 2375.21704101563 476.0507 2375.20947265625 476.049163818359 5 10 1.1.1.3718.4 1 39.2041 1922.426 39.1977 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 AHVDALRTHLAPYSDELRQR Carbamidomethyl(D)@4 missed R-T@7; missed R-Q@18 0.0159577000886202 2404.25219726563 481.8577 2404.23608398438 481.854461669922 5 13 1.1.1.3465.9 1 32.841 6820.267 32.8072 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 AHVDALRTHLAPYSDELRQR Oxidation(P)@12 missed R-T@7; missed R-Q@18 0.00310034002177417 2363.21264648438 591.8104 2363.20947265625 591.809631347656 4 12 1.1.1.3497.13 1 33.6343 4924.163 33.7206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 AHVDALRTHLAPYSDELRQR Carbamidomethyl@N-term missed R-T@7; missed R-Q@18 -0.0156622994691134 2404.22045898438 602.0624 2404.23608398438 602.066284179688 4 12 1.1.1.3514.14 1 34.0613 1603.61 34.0419 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 AHVDALRTHLAPYSDELRQR Oxidation(P)@12 missed R-T@7; missed R-Q@18 0.0139116002246737 2363.22314453125 473.6519 2363.20947265625 473.649169921875 5 12 1.1.1.3531.6 1 34.4677 8047.507 34.3863 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 AHVDALRTHLAPYSDELRQR Dioxidation(P)@12 missed R-T@7; missed R-Q@18 0.00681876018643379 2379.21142578125 595.8101 2379.20434570313 595.808349609375 4 13 1.1.1.3496.11 1 33.6112 4120.267 33.795 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.3800003528595 AHVDALRTHLAPYSDELRQR Formyl@N-term; Delta:H(2)C(2)(H)@2 missed R-T@7; missed R-Q@18 0.00899752043187618 2401.23413085938 481.2541 2401.22509765625 481.252288818359 5 11 1.1.1.3763.7 1 40.3737 1484.177 40.3646 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.2199976444244 AHVDALRTHLAPYSDELRQR Oxidation(P)@12 missed R-T@7; missed R-Q@18 0.00689266994595528 2363.21606445313 473.6505 2363.20947265625 473.649169921875 5 11 1.1.1.3517.6 1 34.1227 9181.632 34.1158 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.2199976444244 AHVDALRTHLAPYSDELRQR Dioxidation(P)@12 missed R-T@7; missed R-Q@18 0.0110726999118924 2379.21557617188 476.8504 2379.20434570313 476.84814453125 5 13 1.1.1.3524.5 1 34.2974 6676.878 34.2388 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4100012779236 AHVDALRTHLAPYSDELRQR Carbamyl(R)@7 missed R-T@7; missed R-Q@18 0.0208432003855705 2390.2412109375 479.0555 2390.22045898438 479.051330566406 5 12 1.1.1.3522.4 1 34.2449 992.0385 34.2142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8700020313263 AHVDALRTHLAPYSDELRQR Methyl(E)@16 missed R-T@7; missed R-Q@18 -0.0300372000783682 2361.2001953125 591.3073 2361.23022460938 591.314819335938 4 12 1.1.1.3583.14 1 35.7881 11858.65 35.8752 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 AHVDALRTHLAPYSDELRQR Dehydrated(S)@14 missed R-T@7; missed R-Q@18 0.0141014996916056 2329.21801757813 466.8509 2329.20385742188 466.848083496094 5 10 1.1.1.3564.6 1 35.2836 3607.63 35.3274 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 AHVDALRTHLAPYSDELRQR Dioxidation(Y)@13 missed R-T@7; missed R-Q@18 0.0053539602085948 2379.20971679688 595.8097 2379.20434570313 595.808349609375 4 12 1.1.1.3525.10 1 34.327 4988.383 34.2142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 AHVDALRTHLAPYSDELRQR Oxidation(D)@4 missed R-T@7; missed R-Q@18 -0.00935052987188101 2363.2001953125 591.8073 2363.20947265625 591.809631347656 4 9 1.1.1.3433.14 1 32.0512 924.7237 32.0363 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.3200008869171 AHVDALRTHLAPYSDELRQR Oxidation(P)@12 missed R-T@7; missed R-Q@18 0.0087154395878315 2363.21826171875 591.8118 2363.20947265625 591.809631347656 4 10 1.1.1.3542.11 1 34.7443 4673.294 34.6074 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 AHVDALRTHLAPYSDELRQR Trioxidation(Y)@13 missed R-T@7; missed R-Q@18 0.0144424000754952 2395.2138671875 599.8107 2395.19921875 599.807067871094 4 10 1.1.1.3424.17 1 31.8244 1721.38 31.8078 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.8700013160706 AHVDALRTHLAPYSDELRQR Carbamidomethyl@N-term missed R-T@7; missed R-Q@18 0.000394094007788226 2404.23657226563 481.8546 2404.23608398438 481.854461669922 5 10 1.1.1.3497.6 1 33.6284 2470.501 33.5966 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.3900010585785 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00914632994681597 2347.2236328125 587.8132 2347.21459960938 587.810913085938 4 11 1.1.1.3431.19 1 32.0036 3039.305 32.0363 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.4999983310699 AHVDALRTHLAPYSDELRQR Pro->pyro-Glu(P)@12 missed R-T@7; missed R-Q@18 0.00634826999157667 2361.2001953125 591.3073 2361.19384765625 591.305725097656 4 11 1.1.1.3590.12 1 35.9626 11858.65 35.8752 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.529999256134 AHVDALRTHLAPYSDELRQR Oxidation(Y)@13 missed R-T@7; missed R-Q@18 0.0108599001541734 2363.22021484375 473.6513 2363.20947265625 473.649169921875 5 10 1.1.1.3510.6 1 33.95 8701.14 33.9925 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.3199980258942 AHVDALRTHLAPYSDELRQR Trioxidation(Y)@13 missed R-T@7; missed R-Q@18 0.0120010003447533 2395.21142578125 599.8101 2395.19921875 599.807067871094 4 11 1.1.1.3535.7 1 34.575 1585.572 34.4847 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 AHVDALRTHLAPYSDELRQR Deamidated(R)@7; Oxidation(H)@9 missed R-T@7; missed R-Q@18 0.00100565003231168 2364.19458007813 473.8462 2364.193359375 473.845977783203 5 11 1.1.1.3759.6 1 40.2678 5349.904 40.2066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.3899984359741 AHVDALRTHLAPYSDELRQR Trioxidation(Y)@13 missed R-T@7; missed R-Q@18 0.0183485001325607 2395.2177734375 599.8117 2395.19921875 599.807067871094 4 11 1.1.1.3490.11 1 33.4626 1379.521 33.6959 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.3899984359741 AHVDALRTHLAPYSDELRQR Dioxidation(R)@7 missed R-T@7; missed R-Q@18 0.00803944002836943 2379.21264648438 595.8104 2379.20434570313 595.808349609375 4 11 1.1.1.3532.8 1 34.4989 4387.216 34.4355 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.7899980545044 AHVDALRTHLAPYSDELRQR Deamidated(Q)@19 missed R-T@7; missed R-Q@18 0.0258389003574848 2348.224609375 588.0634 2348.19848632813 588.056884765625 4 12 1.1.1.3495.7 1 33.5797 130703.1 33.7454 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.889999628067 AHVDALRTHLAPYSDELRQR Trioxidation(Y)@13 missed R-T@7; missed R-Q@18 0.00731721986085176 2395.20678710938 480.0486 2395.19921875 480.047119140625 5 10 1.1.1.3425.6 1 31.8405 2765.304 31.8078 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.889999628067 AHVDALRTHLAPYSDELRQR Amino(Y)@13 missed R-T@7; missed R-Q@18 -0.0120296999812126 2362.21362304688 473.45 2362.22534179688 473.452362060547 5 10 1.1.1.3503.3 1 33.7747 5398.376 33.795 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 47.299998998642 AHVDALRTHLAPYSDELRQR reduced HNE(H)@2; Dehydrated(T)@8; reduced HNE(H)@9 missed R-T@7; missed R-Q@18 -0.0982839986681938 2645.36694335938 530.0807 2645.46533203125 530.100341796875 5 11 1.1.1.3579.13 1 35.6821 834.4487 35.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 AHVDALRTHLAPYSDELRQR Deamidated(R)@7 missed R-T@7; missed R-Q@18 0.0275848004966974 2348.22607421875 470.6525 2348.19848632813 470.64697265625 5 9 1.1.1.3584.4 1 35.806 6037.706 35.5367 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.1199994087219 AHVDALRTHLAPYSDELRQR Carbamidomethyl(D)@15 missed R-T@7; missed R-Q@18 0.00655393023043871 2404.24243164063 602.0679 2404.23608398438 602.066284179688 4 10 1.1.1.3459.8 1 32.6971 3530.19 32.8072 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.1199994087219 AHVDALRTHLAPYSDELRQR Arg->GluSA(R)@7; reduced HNE(H)@9 missed R-T@7; missed R-Q@18 0.00810925010591745 2462.2998046875 411.3906 2462.29174804688 411.389251708984 6 9 1.1.1.3564.3 1 35.2811 1815.818 35.2754 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.690000295639 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00316932005807757 2347.21752929688 470.4508 2347.21459960938 470.4501953125 5 10 1.1.1.3606.4 1 36.365 5346.693 36.1022 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.0699987411499 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00559870013967156 2347.21923828125 1174.617 2347.21459960938 1174.61450195313 2 7 1.1.1.3511.11 1 33.9872 2561.296 33.9925 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.8599996566772 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00304297008551657 2347.21728515625 587.8116 2347.21459960938 587.810913085938 4 9 1.1.1.3609.12 1 36.4498 2807.494 36.3331 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.2000007033348 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.00401951000094414 2347.21850585938 587.8119 2347.21459960938 587.810913085938 4 10 1.1.1.3583.13 1 35.7873 5163.153 35.7731 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.5199995040894 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 -0.00162617000751197 2347.21313476563 783.4116 2347.21459960938 783.412109375 3 7 1.1.1.3560.19 1 35.1915 6886.977 34.9261 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3699977397919 AHVDALRTHLAPYSDELRQRLAAR missed R-T@7; missed R-Q@18; missed R-L@20 0.00606964994221926 2758.47973632813 460.7539 2758.47387695313 460.7529296875 6 13 1.1.1.3792.3 1 41.0924 30429.67 41.0369 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.9300012588501 AHVDALRTHLAPYSDELRQRLAAR missed R-T@7; missed R-Q@18; missed R-L@20 0.00718152988702059 2758.4814453125 690.6276 2758.47387695313 690.625732421875 4 11 1.1.1.3782.9 1 40.8519 13734.78 41.0369 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.1799988746643 AHVDALRTHLAPYSDELRQRLAAR missed R-T@7; missed R-Q@18; missed R-L@20 0.00718152988702059 2758.4814453125 690.6276 2758.47387695313 690.625732421875 4 11 1.1.1.3789.9 1 41.0292 13743.3 41.0122 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0312786996364594 3898.09887695313 650.6904 3898.0673828125 650.685180664063 6 18 1.1.1.4012.11 1 46.7526 146656.6 46.9219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0312786996364594 3898.09887695313 650.6904 3898.0673828125 650.685180664063 6 20 1.1.1.4019.9 1 46.9327 146656.6 46.9219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.995101988315582 3898.07861328125 780.623 3897.08349609375 780.423950195313 5 23 1.1.1.4020.20 1 46.9679 71134.53 46.9219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0145528996363282 3897.09741210938 557.7355 3897.08349609375 557.733459472656 7 22 1.1.1.4024.8 1 47.0599 130342.6 47.102 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.022885899990797 3897.1064453125 650.525 3897.08349609375 650.521179199219 6 27 1.1.1.4028.12 1 47.1662 147114.7 47.102 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0145528996363282 3897.09741210938 557.7355 3897.08349609375 557.733459472656 7 23 1.1.1.4031.9 1 47.2408 130342.6 47.102 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.00940905977040529 3897.09252929688 780.4258 3897.08349609375 780.423950195313 5 21 1.1.1.4034.20 1 47.3264 40166.62 47.3835 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.022885899990797 3897.1064453125 650.525 3897.08349609375 650.521179199219 6 26 1.1.1.4035.15 1 47.3478 151874.3 47.076 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0145528996363282 3897.09741210938 557.7355 3897.08349609375 557.733459472656 7 23 1.1.1.4038.8 1 47.4188 82646.48 47.3581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.00940905977040529 3897.09252929688 780.4258 3897.08349609375 780.423950195313 5 20 1.1.1.4041.20 1 47.5061 40166.62 47.3835 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.022885899990797 3897.1064453125 650.525 3897.08349609375 650.521179199219 6 27 1.1.1.4042.17 1 47.5292 91929.52 47.3835 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0226703993976116 3897.10595703125 557.7367 3897.08349609375 557.733459472656 7 23 1.1.1.4045.9 1 47.5991 65941.84 47.6144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0217873007059097 3897.10498046875 650.5248 3897.08349609375 650.521179199219 6 23 1.1.1.4049.13 1 47.7043 72116.23 47.6144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0200171992182732 3898.08740234375 557.8769 3898.0673828125 557.8740234375 7 17 1.1.1.4053.9 1 47.8031 36537.41 47.8184 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.016813000664115 3898.08422851563 650.688 3898.0673828125 650.685180664063 6 17 1.1.1.4063.14 1 48.0619 46564.82 47.7928 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0190101992338896 3898.0869140625 650.6884 3898.0673828125 650.685180664063 6 13 1.1.1.4070.16 1 48.2416 8734.306 48.0984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(R)@35 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0110868001356721 3898.07861328125 780.623 3898.0673828125 780.620788574219 5 15 1.1.1.4013.20 1 46.7862 71134.53 46.9219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0100194001570344 3897.09375 780.426 3897.08349609375 780.423950195313 5 14 1.1.1.4048.17 1 47.6823 40238.62 47.409 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0122360996901989 3898.07958984375 650.6872 3898.0673828125 650.685180664063 6 14 1.1.1.4056.13 1 47.8831 44904.33 47.8184 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0230078995227814 3898.09033203125 557.8773 3898.0673828125 557.8740234375 7 14 1.1.1.4015.9 1 46.8289 125330.4 46.9219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(Q)@19 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0312786996364594 3898.09887695313 650.6904 3898.0673828125 650.685180664063 6 14 1.1.1.4018.13 1 46.91 146656.6 46.9219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Ammonia-loss(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0213929992169142 3880.07836914063 647.687 3880.05688476563 647.683410644531 6 12 1.1.1.4058.9 1 47.9307 5739.353 47.8441 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.619998216629 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Oxidation(P)@12 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 -0.00817108992487192 3913.07006835938 653.1856 3913.07836914063 653.18701171875 6 11 1.1.1.4024.12 1 47.0633 3223.624 47.1279 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.3100020885468 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0211573000997305 3898.08862304688 780.625 3898.0673828125 780.620788574219 5 12 1.1.1.4056.15 1 47.8848 18720 47.7928 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0299973487854 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Oxidation(P)@12; Deamidated(Q)@19 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.00388362002559006 3914.06616210938 653.3516 3914.06225585938 653.351013183594 6 11 1.1.1.4026.14 1 47.1169 2566.646 47.1533 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.8400025367737 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Carbamidomethyl@N-term; Deamidated(Q)@19 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0403303988277912 3955.12939453125 660.1955 3955.0888671875 660.188781738281 6 11 1.1.1.4054.10 1 47.8297 4058.815 47.7928 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Oxidation(P)@12 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 -0.00817108992487192 3913.07006835938 653.1856 3913.07836914063 653.18701171875 6 10 1.1.1.4033.10 1 47.2926 3223.624 47.1279 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.3999998569489 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Oxidation(P)@12 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 -0.0111140999943018 3913.0673828125 560.0169 3913.07836914063 560.018493652344 7 10 1.1.1.4023.13 1 47.0384 3470.649 47.102 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.3999998569489 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Ammonia-loss(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0213929992169142 3880.07836914063 647.687 3880.05688476563 647.683410644531 6 11 1.1.1.4051.13 1 47.7553 5739.353 47.8441 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.3999998569489 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Ammonia-loss(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0217064004391432 3880.07836914063 555.3042 3880.05688476563 555.301086425781 7 11 1.1.1.4056.6 1 47.8773 5563.92 47.8695 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.4400000572205 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Carbamidomethyl@N-term missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0081346295773983 3954.11303710938 660.0261 3954.10498046875 660.024780273438 6 10 1.1.1.4053.16 1 47.8089 4706.567 47.7928 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.7599983215332 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Ammonia-loss(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0265967007726431 3880.08325195313 555.3049 3880.05688476563 555.301086425781 7 10 1.1.1.4064.7 1 48.0815 5626.51 47.8695 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.0100018978119 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Ammonia-loss(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.0252257008105516 3880.08203125 647.6876 3880.05688476563 647.683410644531 6 9 1.1.1.4066.9 1 48.1342 5756.102 47.8695 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.2199988365173 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Carbamidomethyl(D)@4 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.011064300313592 3954.11596679688 660.0266 3954.10498046875 660.024780273438 6 9 1.1.1.4030.13 1 47.2186 3729.967 47.076 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.739999294281 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@2; MDA adduct +62(K)@13; acrolein addition +38(K)@15; HPNE addition +172(K)@33 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33 0.00905926991254091 5412.94580078125 903.1649 5412.9365234375 903.163330078125 6 9 1.1.1.5104.11 1 75.1046 26355.66 74.9586 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLR -0.0028708700556308 1011.56848144531 506.7915 1011.5712890625 506.792938232422 2 9 1.1.1.3188.10 1 26.0188 38027.04 25.8816 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3900007009506 AKPALEDLR Lys->Allysine(K)@2 0.0019926899112761 1010.54168701172 506.2781 1010.53967285156 506.277099609375 2 6 1.1.1.3558.9 1 35.1326 749.6402 35.224 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFK missed R-Q@9 0.00480409013107419 2223.26782226563 556.8242 2223.2626953125 556.822937011719 4 12 1.1.1.4448.7 1 57.9098 4243.719 57.9268 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFK missed R-Q@9 -2.89379004243528E-05 2223.26245117188 556.8229 2223.2626953125 556.822937011719 4 12 1.1.1.4415.4 1 57.0509 65342.53 57.2514 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFK missed R-Q@9 -0.00575353996828198 2223.25732421875 1112.636 2223.2626953125 1112.638671875 2 10 1.1.1.4419.20 1 57.1677 6887.705 57.2259 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFK missed R-Q@9 -2.89379004243528E-05 2223.26245117188 556.8229 2223.2626953125 556.822937011719 4 16 1.1.1.4426.5 1 57.3364 65791.83 57.2514 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFK missed R-Q@9 0.000459333008620888 2223.26342773438 556.8231 2223.2626953125 556.822937011719 4 18 1.1.1.4433.5 1 57.5178 65339.27 57.2514 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFK missed R-Q@9 -0.000761343981139362 2223.26220703125 556.8228 2223.2626953125 556.822937011719 4 14 1.1.1.4440.4 1 57.6991 37188.28 57.4327 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.00573292002081871 3590.96557617188 719.2004 3590.9599609375 719.199279785156 5 11 1.1.1.5069.8 1 74.1681 3649.894 74.0761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.00554327992722392 3590.96557617188 599.5015 3590.9599609375 599.500610351563 6 16 1.1.1.5103.2 1 75.0713 11177.71 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.00740002980455756 3590.96728515625 898.7491 3590.9599609375 898.747253417969 4 11 1.1.1.5106.12 1 75.1566 178038.5 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.00695357983931899 3590.96704101563 719.2007 3590.9599609375 719.199279785156 5 17 1.1.1.5109.3 1 75.2254 192926.7 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.00740002980455756 3590.96728515625 898.7491 3590.9599609375 898.747253417969 4 13 1.1.1.5113.10 1 75.3334 207492.1 75.0659 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 -0.00223263003863394 3590.95727539063 1197.993 3590.9599609375 1197.99389648438 3 8 1.1.1.5113.21 1 75.3426 54829.23 75.0659 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 -0.00128587998915464 3590.95849609375 719.199 3590.9599609375 719.199279785156 5 16 1.1.1.5116.6 1 75.4061 52182.84 75.144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 -0.00250653992407024 3590.95751953125 719.1988 3590.9599609375 719.199279785156 5 9 1.1.1.5132.14 1 75.8337 4487.669 75.7116 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.3100016117096 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl(E)@17; HexNAc(S)@18; ONE addition +154(K)@20 missed R-Q@9; missed K-V@20 0.0115807997062802 4005.17163085938 802.0416 4005.16015625 802.039306640625 5 17 1.1.1.5102.11 1 75.0523 10907.16 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.7699973583221 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Acetyl@N-term missed R-Q@9; missed K-V@20 0.0238474998623133 3632.99462890625 909.2559 3632.97045898438 909.249938964844 4 13 1.1.1.5134.19 1 75.8915 2285.701 75.9251 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.4899973869324 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@2; Methyl(R)@9; Deamidated(Q)@10; acrolein addition +38(K)@20 missed R-Q@9; missed K-V@20 0.0417121015489101 3816.12719726563 764.2327 3816.08520507813 764.224304199219 5 14 1.1.1.5104.6 1 75.1005 2459.534 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.4899973869324 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Hex(S)@18; acrolein addition +112(K)@20; Phospho(S)@22 missed R-Q@9; missed K-V@20 -0.0535685010254383 3944.97827148438 790.0029 3945.03149414063 790.013610839844 5 16 1.1.1.5109.7 1 75.2287 55464.02 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.2399983406067 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +56(K)@20; Ser->LacticAcid(S)@22 missed R-Q@9; missed K-V@20 0.0281258001923561 3632.00366210938 727.408 3631.97534179688 727.40234375 5 13 1.1.1.5120.4 1 75.5073 4301.136 75.4494 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.00573292002081871 3590.96557617188 719.2004 3590.9599609375 719.199279785156 5 8 1.1.1.5062.8 1 73.9788 3649.894 74.0761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.2799999713898 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Trimethyl(K)@20 missed R-Q@9; missed K-V@20 0.0184896998107433 3633.02563476563 727.6124 3633.0068359375 727.608642578125 5 12 1.1.1.5123.12 1 75.5927 2522.301 75.4751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.2799999713898 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +56(K)@20; Ser->LacticAcid(S)@22 missed R-Q@9; missed K-V@20 0.0275155007839203 3632.00244140625 727.4078 3631.97534179688 727.40234375 5 11 1.1.1.5127.11 1 75.698 4513.753 75.4239 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.0700023174286 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Deamidated(Q)@10 missed R-Q@9; missed K-V@20 0.0440987981855869 3591.98803710938 899.0043 3591.94409179688 898.993286132813 4 9 1.1.1.5126.16 1 75.6756 6074.386 75.3985 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Delta:H(2)C(2)(K)@2 missed R-Q@9; missed K-V@20 0.00494991010054946 3616.98046875 905.2524 3616.9755859375 905.251159667969 4 9 1.1.1.5125.16 1 75.6491 1811.623 75.6319 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.2099995613098 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@2; Carbamidomethyl(E)@17; acrolein addition +112(K)@20 missed R-Q@9; missed K-V@20 0.00951629970222712 3872.09619140625 969.0313 3872.08642578125 969.028869628906 4 10 1.1.1.5103.15 1 75.0822 2304.759 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.1800010204315 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@2; Deamidated(Q)@10; Oxidation(P)@14; HPNE addition +172(K)@20 missed R-Q@9; missed K-V@20 0.0282041002064943 3892.12963867188 974.0397 3892.10131835938 974.032592773438 4 9 1.1.1.5104.15 1 75.108 1578.638 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.2299997806549 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@2; Deamidated(Q)@10; MDA adduct +54(K)@20 missed R-Q@9; missed K-V@20 0.0798937976360321 3818.14477539063 764.6362 3818.064453125 764.620178222656 5 9 1.1.1.5105.8 1 75.128 1827.111 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.480001449585 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Delta:H(2)C(2)(K)@2 missed R-Q@9; missed K-V@20 0.012440700083971 3616.98803710938 724.4049 3616.9755859375 724.402404785156 5 7 1.1.1.5126.8 1 75.6689 1047.518 75.6319 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.00753194000571966 3719.06274414063 744.8198 3719.05493164063 744.818237304688 5 9 1.1.1.5029.8 1 73.093 839.8748 73.0555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.00811314024031162 3719.06274414063 620.8511 3719.05493164063 620.849792480469 6 19 1.1.1.5089.3 1 74.7039 47307.92 74.7767 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.00539579009637237 3719.06005859375 744.8193 3719.05493164063 744.818237304688 5 22 1.1.1.5095.4 1 74.8604 86124.7 74.7767 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.00811314024031162 3719.06274414063 620.8511 3719.05493164063 620.849792480469 6 18 1.1.1.5096.5 1 74.8872 47307.92 74.7767 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 -0.00197749002836645 3719.05297851563 930.7705 3719.05493164063 930.77099609375 4 16 1.1.1.5096.14 1 74.8956 24360.19 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 -0.00197749002836645 3719.05297851563 930.7705 3719.05493164063 930.77099609375 4 11 1.1.1.5097.18 1 74.9244 24360.19 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 -0.00197749002836645 3719.05297851563 930.7705 3719.05493164063 930.77099609375 4 15 1.1.1.5098.17 1 74.95 24360.19 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 -0.00197749002836645 3719.05297851563 930.7705 3719.05493164063 930.77099609375 4 18 1.1.1.5100.14 1 75.0006 24360.19 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.00774694001302123 3719.06274414063 620.8511 3719.05493164063 620.849792480469 6 10 1.1.1.5103.3 1 75.0721 45033.79 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.00692160986363888 3719.0615234375 744.8196 3719.05493164063 744.818237304688 5 13 1.1.1.5104.3 1 75.098 67683.8 74.8282 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.2599995136261 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Iodo(Y)@30; MDA adduct +62(K)@32; acrolein addition +38(K)@33 missed R-Q@9; missed K-V@20; missed K-K@32 -0.00489130010828376 3944.97827148438 790.0029 3944.98291015625 790.003845214844 5 10 1.1.1.5102.9 1 75.0506 55464.02 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.2299997806549 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Iodo(Y)@30; MDA adduct +62(K)@32; acrolein addition +38(K)@33 missed R-Q@9; missed K-V@20; missed K-K@32 -0.00489130010828376 3944.97827148438 790.0029 3944.98291015625 790.003845214844 5 10 1.1.1.5109.7 1 75.2287 55464.02 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.2599995732307 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@32; acrolein addition +56(K)@33; Deamidated(N)@35 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0155402002856135 4175.3173828125 836.0708 4175.30224609375 836.067687988281 5 8 1.1.1.5158.7 1 76.5013 2267.23 76.6389 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00273463991470635 4047.23193359375 810.4537 4047.22973632813 810.453186035156 5 13 1.1.1.5105.12 1 75.1313 46257.79 75.2456 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0167743004858494 4047.24609375 675.5483 4047.22973632813 675.545532226563 6 17 1.1.1.5107.2 1 75.1736 22359.09 75.2713 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00264030997641385 4047.23095703125 1012.815 4047.22973632813 1012.81469726563 4 18 1.1.1.5111.17 1 75.2883 12361.81 75.2456 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00273463991470635 4047.23193359375 810.4537 4047.22973632813 810.453186035156 5 16 1.1.1.5112.9 1 75.3071 46257.79 75.2456 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0167743004858494 4047.24609375 675.5483 4047.22973632813 675.545532226563 6 16 1.1.1.5114.2 1 75.3521 22359.09 75.2713 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00264030997641385 4047.23095703125 1012.815 4047.22973632813 1012.81469726563 4 12 1.1.1.5118.19 1 75.4683 12361.81 75.2456 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0171405002474785 4047.24682617188 675.5484 4047.22973632813 675.545532226563 6 12 1.1.1.5121.7 1 75.5359 21784.01 75.2713 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.5300004482269 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT MDA adduct +62(K)@20; HPNE addition +172(K)@32; acrolein addition +56(K)@33 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.0490974001586437 4337.33251953125 723.896 4337.38134765625 723.904174804688 6 8 1.1.1.5101.8 1 75.0223 2325.969 75.0659 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0375603996217251 4176.3095703125 697.0589 4176.27197265625 697.052673339844 6 24 1.1.1.5102.2 1 75.0448 83779.8 75.1693 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0112624997273088 4232.32080078125 706.3941 4232.3095703125 706.392211914063 6 24 1.1.1.5102.4 1 75.0465 11595.11 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0335667990148067 4176.3056640625 836.2684 4176.27197265625 836.26171875 5 13 1.1.1.5102.13 1 75.054 154966.8 75.1693 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0200532991439104 4176.29052734375 1045.08 4176.27197265625 1045.07531738281 4 20 1.1.1.5102.19 1 75.059 51596.04 75.1693 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.026248499751091 4175.314453125 696.893 4175.2880859375 696.888671875 6 21 1.1.1.5109.2 1 75.2245 133327.2 75.2201 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0206090994179249 4175.30859375 836.069 4175.2880859375 836.06494140625 5 19 1.1.1.5109.10 1 75.2312 265966.9 75.1693 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00117771001532674 4175.29052734375 1044.83 4175.2880859375 1044.82934570313 4 16 1.1.1.5112.14 1 75.3113 89756.23 75.1947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00117771001532674 4175.29052734375 1044.83 4175.2880859375 1044.82934570313 4 15 1.1.1.5114.15 1 75.3629 89756.23 75.1947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00117771001532674 4175.29052734375 1044.83 4175.2880859375 1044.82934570313 4 17 1.1.1.5115.16 1 75.389 89756.23 75.1947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.026248499751091 4175.314453125 696.893 4175.2880859375 696.888671875 6 26 1.1.1.5116.5 1 75.4053 133327.2 75.2201 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0206090994179249 4175.30859375 836.069 4175.2880859375 836.06494140625 5 15 1.1.1.5116.8 1 75.4078 273565.2 75.144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00166596996132284 4175.29052734375 1044.83 4175.2880859375 1044.82934570313 4 11 1.1.1.5119.19 1 75.4938 83929.35 75.2201 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00215423991903663 4175.29052734375 1044.83 4175.2880859375 1044.82934570313 4 12 1.1.1.5120.20 1 75.5207 75406.93 75.2456 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00215423991903663 4175.29052734375 1044.83 4175.2880859375 1044.82934570313 4 14 1.1.1.5121.18 1 75.545 64813.31 75.2713 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00117771001532674 4175.29052734375 1044.83 4175.2880859375 1044.82934570313 4 14 1.1.1.5122.19 1 75.5721 54296.99 75.2969 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0251499004662037 4175.3134765625 696.8928 4175.2880859375 696.888671875 6 20 1.1.1.5123.10 1 75.591 90598.69 75.3224 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0199988000094891 4175.30810546875 836.0689 4175.2880859375 836.06494140625 5 14 1.1.1.5123.16 1 75.596 154588.2 75.3224 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00703686010092497 4175.294921875 1044.831 4175.2880859375 1044.82934570313 4 15 1.1.1.5124.19 1 75.625 40094.24 75.3478 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00117771001532674 4175.29052734375 1044.83 4175.2880859375 1044.82934570313 4 13 1.1.1.5125.21 1 75.6533 36779.49 75.3731 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0167273990809917 4175.3046875 696.8914 4175.2880859375 696.888671875 6 22 1.1.1.5130.9 1 75.7763 29737.6 75.5008 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0181677993386984 4175.30615234375 836.0685 4175.2880859375 836.06494140625 5 11 1.1.1.5130.17 1 75.7829 54376.75 75.5008 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00830479990690947 4175.29638671875 696.89 4175.2880859375 696.888671875 6 12 1.1.1.5137.13 1 75.966 16930.56 75.685 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Nitro(Y)@30 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0348750986158848 4220.30859375 704.392 4220.2734375 704.386169433594 6 21 1.1.1.5140.11 1 76.0431 3587.926 76.0304 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0187551993876696 4175.306640625 1044.834 4175.2880859375 1044.82934570313 4 9 1.1.1.5189.19 1 77.2876 1850.611 77.216 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.020023200660944 4175.30859375 696.892 4175.2880859375 696.888671875 6 9 1.1.1.5226.19 1 78.2711 936.8011 78.2246 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0110892001539469 4217.3095703125 844.4692 4217.298828125 844.467041015625 5 17 1.1.1.5168.8 1 76.7567 2540.138 76.7895 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8399991989136 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@33; Ammonia-loss(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0221819002181292 4216.32568359375 844.2724 4216.3037109375 844.268005371094 5 16 1.1.1.5115.8 1 75.3824 27826.26 75.4751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1000015735626 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(2)C(2)(K)@2 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0161819998174906 4201.3203125 701.2273 4201.3037109375 701.224609375 6 15 1.1.1.5128.8 1 75.7224 2350.743 75.7116 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6300029754639 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(E)@17; HexNAc(S)@18; MDA adduct +62(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.0525139011442661 4497.35205078125 750.566 4497.40478515625 750.57470703125 6 17 1.1.1.5106.4 1 75.1499 7593.953 75.1693 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.7699973583221 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hex(S)@18; acrolein addition +112(K)@20; Phospho(S)@22 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.0487667992711067 4529.3115234375 755.8925 4529.35986328125 755.900573730469 6 17 1.1.1.5105.7 1 75.1271 67216.45 75.1693 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.7699973583221 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hex(S)@18; acrolein addition +112(K)@20; Phospho(S)@22 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.0487667992711067 4529.3115234375 755.8925 4529.35986328125 755.900573730469 6 17 1.1.1.5112.5 1 75.3038 67216.45 75.1693 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.7699973583221 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hex(S)@18; acrolein addition +112(K)@20; Phospho(S)@22 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.0491329990327358 4529.310546875 755.8924 4529.35986328125 755.900573730469 6 17 1.1.1.5119.9 1 75.4855 58894.15 75.2201 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8900003433228 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Cation:K(E)@17; Hex(S)@18; ONE addition +154(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.0742824971675873 4529.322265625 755.8943 4529.396484375 755.906677246094 6 17 1.1.1.5126.10 1 75.6706 15599.78 75.3985 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.3099999427795 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@33; Ammonia-loss(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0221819002181292 4216.32568359375 844.2724 4216.3037109375 844.268005371094 5 12 1.1.1.5122.16 1 75.5696 27826.26 75.4751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.3099994659424 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Lys-add@N-term; Oxidation(P)@3 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0303137991577387 4319.40869140625 720.9087 4319.3779296875 720.903625488281 6 12 1.1.1.5112.3 1 75.3021 5688.19 75.2713 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(E)@28 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.000958701013587415 4232.310546875 1059.085 4232.3095703125 1059.08471679688 4 10 1.1.1.5103.21 1 75.0872 6997.057 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Oxidation(P)@14; MDA adduct +54(K)@20; HPNE addition +172(K)@32; Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0708857029676437 4418.45849609375 884.699 4418.3876953125 884.684814453125 5 10 1.1.1.5111.8 1 75.2808 1524.753 75.1947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.2599995136261 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@2; Deamidated(Q)@10; Oxidation(P)@14; HPNE addition +172(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00509908981621265 4476.4345703125 896.2942 4476.4296875 896.293151855469 5 10 1.1.1.5107.13 1 75.1827 4066.628 75.2201 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.1800010204315 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@2; Deamidated(Q)@10; reduced acrolein addition +96(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.0527447015047073 4444.49267578125 889.9058 4444.439453125 889.895202636719 5 9 1.1.1.5109.11 1 75.232 2939.069 75.2456 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.2299997806549 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +76(K)@20; HexNAc(S)@25 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.048319898545742 4454.447265625 891.8967 4454.39892578125 891.887023925781 5 10 1.1.1.5115.10 1 75.384 8283.583 75.2201 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.140000462532 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl@N-term missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.00956333987414837 4217.30810546875 844.4689 4217.298828125 844.467041015625 5 9 1.1.1.5137.19 1 75.971 13747.51 75.9251 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQK Acetyl@N-term missed K-V@2 -0.00459901010617614 1492.75170898438 747.3831 1492.75622558594 747.385375976563 2 16 1.1.1.3770.7 1 40.555 10108.79 40.4656 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQK Carbamidomethyl@N-term missed K-V@2 0.000176895002368838 1507.76733398438 754.8909 1507.76708984375 754.890808105469 2 13 1.1.1.3489.14 1 33.4371 2987.815 33.4729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQK Formyl@N-term missed K-V@2 0.000163773001986556 1478.74072265625 740.3776 1478.74060058594 740.377563476563 2 11 1.1.1.3754.19 1 40.1471 1870.647 40.1008 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7999975681305 AKVQPYLDDFQK Acetyl@N-term missed K-V@2 -0.00459901010617614 1492.75170898438 747.3831 1492.75622558594 747.385375976563 2 11 1.1.1.3763.16 1 40.3812 10108.79 40.4656 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 AKVQPYLDDFQK Formyl@N-term missed K-V@2 -0.00614712992683053 1478.73425292969 493.9187 1478.74060058594 493.920776367188 3 9 1.1.1.3753.6 1 40.1094 694.7883 40.1272 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 AKVQPYLDDFQK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-V@2 -0.00284535996615887 1536.77941894531 769.397 1536.78234863281 769.398498535156 2 12 1.1.1.4020.19 1 46.9671 3801.555 47.0503 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.5800020694733 AKVQPYLDDFQK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-V@2 -0.00284535996615887 1536.77941894531 769.397 1536.78234863281 769.398498535156 2 8 1.1.1.4027.16 1 47.1439 3801.555 47.0503 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.9400011301041 AKVQPYLDDFQK Carbamyl@N-term; acrolein addition +56(K)@2 missed K-V@2 -0.026273999363184 1549.75146484375 775.883 1549.77770996094 775.896118164063 2 10 1.1.1.3614.7 1 36.5819 12311.3 36.5625 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKK missed K-V@2; missed K-K@12 -0.00127957004588097 1578.83911132813 527.287 1578.84057617188 527.287475585938 3 18 1.1.1.3359.14 1 30.2157 10347.71 30.202 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed K-K@12 -0.00156072003301233 1664.87585449219 555.9659 1664.87731933594 555.966430664063 3 13 1.1.1.3888.9 1 43.5837 3846.591 43.5989 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKK Acetyl@N-term missed K-V@2; missed K-K@12 -0.000376693991711363 1620.85083007813 541.2909 1620.85119628906 541.291015625 3 14 1.1.1.3645.13 1 37.3541 9055.157 37.4182 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKK Carbamidomethyl@N-term missed K-V@2; missed K-K@12 -0.00100958999246359 1635.86108398438 546.2943 1635.86206054688 546.294616699219 3 13 1.1.1.3353.9 1 30.0712 3235.578 30.202 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 AKVQPYLDDFQKK Carbamidomethyl@N-term missed K-V@2; missed K-K@12 -0.00100958999246359 1635.86108398438 546.2943 1635.86206054688 546.294616699219 3 12 1.1.1.3360.14 1 30.2406 3235.578 30.202 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 AKVQPYLDDFQKK Carbamidomethyl@N-term missed K-V@2; missed K-K@12 0.00810686033219099 1635.8701171875 409.9748 1635.86206054688 409.972778320313 4 9 1.1.1.3359.2 1 30.2057 4110.361 30.202 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Dioxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.00391231011599302 2891.38403320313 723.8533 2891.3798828125 723.852294921875 4 17 1.1.1.3870.14 1 43.1226 39886.43 43.1337 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Dioxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.00391231011599302 2891.38403320313 723.8533 2891.3798828125 723.852294921875 4 18 1.1.1.3877.15 1 43.3064 39886.43 43.1337 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Acetyl@N-term; Dioxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.00624048011377454 2933.39697265625 734.3565 2933.390625 734.354919433594 4 18 1.1.1.4000.16 1 46.4444 12121.34 46.5319 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.0045274798758328 2859.39501953125 715.856 2859.39013671875 715.854797363281 4 16 1.1.1.3998.17 1 46.3927 57278.81 46.4797 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.0045274798758328 2859.39501953125 715.856 2859.39013671875 715.854797363281 4 14 1.1.1.4005.16 1 46.5747 57278.81 46.4797 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Dioxidation(W)@14; Dioxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.00250517996028066 2907.37744140625 727.8516 2907.375 727.851013183594 4 15 1.1.1.3910.9 1 44.1429 13161.93 44.2053 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 AKVQPYLDDFQKKWQEEMELYR Trp->Hydroxykynurenin(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.00786578003317118 2879.3876953125 720.8542 2879.3798828125 720.852294921875 4 12 1.1.1.3889.13 1 43.6123 3707.662 43.6751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0300009250641 AKVQPYLDDFQKKWQEEMELYR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.00389700010418892 2859.39404296875 954.1386 2859.39013671875 954.137329101563 3 13 1.1.1.4001.21 1 46.4745 9298.748 46.5059 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 AKVQPYLDDFQKKWQEEMELYR Oxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.0116662997752428 2875.396484375 719.8564 2875.38500976563 719.853576660156 4 12 1.1.1.3679.14 1 38.2078 2594.052 38.29 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0199971199036 AKVQPYLDDFQKKWQEEMELYR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.0100261997431517 2859.40014648438 572.8873 2859.39013671875 572.885314941406 5 12 1.1.1.4006.9 1 46.5948 31613.79 46.4797 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 AKVQPYLDDFQKKWQEEMELYR Dioxidation(W)@14; Dioxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.0115630002692342 2907.38671875 582.4846 2907.375 582.482238769531 5 11 1.1.1.3911.9 1 44.1648 7686.324 44.2305 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2100005149841 AKVQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.000727098027709872 2863.3857421875 716.8537 2863.38500976563 716.853576660156 4 10 1.1.1.3915.15 1 44.2708 10067 44.1801 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.8900010585785 AKVQPYLDDFQKKWQEEMELYR Deamidated(Q)@4; MDA adduct +54(K)@12; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.0285082999616861 2850.4150390625 713.611 2850.38647460938 713.603881835938 4 11 1.1.1.4074.19 1 48.3458 3276.535 48.48 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 AKVQPYLDDFQKKWQEEMELYR Acetyl@N-term; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.00863850954920053 2901.40942382813 726.3596 2901.40063476563 726.357482910156 4 11 1.1.1.4167.18 1 50.7167 9364.214 50.6225 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.4400000572205 AKVQPYLDDFQKKWQEEMELYR acrolein addition +76(K)@13; Trp->Kynurenin(W)@14; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 -0.0197289995849133 2875.3984375 576.087 2875.41821289063 576.090881347656 5 8 1.1.1.3686.8 1 38.3765 2070.491 38.2648 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 AKVQPYLDDFQKKWQEEMELYR Dioxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.00391231011599302 2891.38403320313 723.8533 2891.3798828125 723.852294921875 4 10 1.1.1.3863.16 1 42.9429 39832.9 43.1337 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.0100018978119 AKVQPYLDDFQKKWQEEMELYR Acetyl@N-term; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.00863850954920053 2901.40942382813 726.3596 2901.40063476563 726.357482910156 4 10 1.1.1.4160.17 1 50.5377 9364.214 50.6225 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 38.9299988746643 AKVQPYLDDFQKKWQEEMELYR acrolein addition +38(K)@2; MDA adduct +54(K)@12; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 -0.0323196984827518 2887.3857421875 722.8537 2887.41821289063 722.86181640625 4 8 1.1.1.4158.19 1 50.4884 1790.45 50.4953 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.8199990987778 AKVQPYLDDFQKKWQEEMELYR MDA adduct +54(K)@2; Deamidated(Q)@4; MDA adduct +54(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.00947344955056906 2904.40600585938 581.8885 2904.39697265625 581.886657714844 5 8 1.1.1.3918.9 1 44.3419 2164.466 44.3064 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.8700013160706 AKVQPYLDDFQKKWQEEMELYR Carbamidomethyl@N-term; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.0142289996147156 2916.42602539063 730.1138 2916.41162109375 730.110168457031 4 8 1.1.1.4089.15 1 48.724 823.4634 48.7342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 17.5200000405312 AKVQPYLDDFQKKWQEEMELYR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.0104885995388031 2859.40063476563 954.1408 2859.39013671875 954.137329101563 3 11 1.1.1.4011.20 1 46.734 5677.775 46.7142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.9999996423721 AKVQPYLDDFQKKWQEEMELYR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.00330681004561484 2859.39379882813 715.8557 2859.39013671875 715.854797363281 4 11 1.1.1.4019.14 1 46.9369 32517.62 46.7142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.7400004863739 AKVQPYLDDFQKKWQEEMELYRQK reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 -0.0681037977337837 3147.53491210938 787.891 3147.60302734375 787.908020019531 4 11 1.1.1.3828.18 1 42.0308 2186.496 42.0386 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.7099993228912 AKVQPYLDDFQKKWQEEMELYRQK reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 -0.0669549033045769 3147.5361328125 630.5145 3147.60302734375 630.527893066406 5 12 1.1.1.3825.10 1 41.9447 5951.57 42.0386 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24; missed R-A@29 0.0230270996689796 4564.3408203125 761.7307 4564.3173828125 761.726806640625 6 17 1.1.1.4178.16 1 50.9956 14274.2 51.0566 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 AKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +62(K)@13; Deamidated(Q)@15; Deamidated(Q)@23 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24; missed R-A@29 0.0422596000134945 4612.34814453125 769.732 4612.30615234375 769.724975585938 6 10 1.1.1.4090.19 1 48.7529 2596.35 48.7598 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.4200013875961 AKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dioxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24; missed R-A@29 0.0163521002978086 4596.3232421875 920.272 4596.30712890625 920.268676757813 5 8 1.1.1.4064.20 1 48.0923 2532.459 48.1239 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 ALKENGGAR Deamidated(N)@5 cleaved E-A@N-term; missed K-E@3 -0.00337489997036755 915.474060058594 458.7443 915.477416992188 458.745971679688 2 8 1.1.1.3040.4 1 22.4567 4871.485 22.3697 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.9900004863739 ALRTHLAPYSDELRQR cleaved D-A@N-term; missed R-T@3; missed R-Q@14 -0.0188379008322954 1925.00451660156 482.2584 1925.02319335938 482.263061523438 4 11 1.1.1.3532.4 1 34.4923 1452.263 34.4355 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.00976928975433111 2574.36279296875 515.8798 2574.35278320313 515.877807617188 5 21 1.1.1.3432.11 1 32.0227 107877.7 32.1896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.0144835002720356 2574.36743164063 430.0685 2574.35278320313 430.066070556641 6 16 1.1.1.3433.5 1 32.0436 45437.59 32.1896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.00495254993438721 2574.35766601563 644.5967 2574.35278320313 644.595458984375 4 16 1.1.1.3433.19 1 32.0553 33147.43 32.1896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.00495254993438721 2574.35766601563 644.5967 2574.35278320313 644.595458984375 4 20 1.1.1.3436.20 1 32.1333 33147.43 32.1896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.00976928975433111 2574.36279296875 515.8798 2574.35278320313 515.877807617188 5 26 1.1.1.3439.9 1 32.2059 107877.7 32.1896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.0144835002720356 2574.36743164063 430.0685 2574.35278320313 430.066070556641 6 20 1.1.1.3441.4 1 32.2444 45437.59 32.1896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.00976928975433111 2574.36279296875 515.8798 2574.35278320313 515.877807617188 5 21 1.1.1.3446.12 1 32.375 107877.7 32.1896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.199999332428 ARAHVDALRTHLAPYSDELRQR Oxidation(P)@14 missed R-A@2; missed R-T@9; missed R-Q@20 0.0151564003899693 2590.36254882813 519.0798 2590.34765625 519.076782226563 5 12 1.1.1.3436.15 1 32.1291 2318.935 32.1896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 ARAHVDALRTHLAPYSDELRQR Delta:H(2)C(2)(H)@4 missed R-A@2; missed R-T@9; missed R-Q@20 0.0045651700347662 2600.37255859375 521.0818 2600.36840820313 521.080932617188 5 10 1.1.1.3565.11 1 35.3138 1046.557 35.3274 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(Q)@21 missed R-A@2; missed R-T@9; missed R-Q@20; missed R-L@22; missed R-L@26; missed K-E@31 0.0199174005538225 4125.2255859375 590.3252 4125.20556640625 590.322387695313 7 19 1.1.1.3989.13 1 46.154 21173.98 46.1922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-A@2; missed R-T@9; missed R-Q@20; missed R-L@22; missed R-L@26; missed K-E@31 0.0182987004518509 4124.23974609375 590.1844 4124.2216796875 590.181823730469 7 21 1.1.1.3997.9 1 46.3603 21665.24 46.2707 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@33 missed R-A@2; missed R-T@9; missed R-Q@20; missed R-L@22; missed R-L@26; missed K-E@31 0.0219394005835056 4125.2275390625 688.5452 4125.20556640625 688.541564941406 6 15 1.1.1.3989.14 1 46.1549 12497.29 46.1922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1300005912781 ARAHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(Q)@21 missed R-A@2; missed R-T@9; missed R-Q@20; missed R-L@22; missed R-L@26; missed K-E@31 0.0219394005835056 4125.2275390625 688.5452 4125.20556640625 688.541564941406 6 13 1.1.1.3996.14 1 46.3383 12497.29 46.1922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.8400008678436 ARAHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@33 missed R-A@2; missed R-T@9; missed R-Q@20; missed R-L@22; missed R-L@26; missed K-E@31 0.0217196997255087 4125.22705078125 826.0527 4125.20556640625 826.048400878906 5 11 1.1.1.3991.18 1 46.2108 3138.721 46.1922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR Deamidated(N)@9 cleaved A-A@N-term; missed R-L@2; missed K-E@7 0.000207516000955366 1384.74243164063 462.5881 1384.74230957031 462.588043212891 3 12 1.1.1.3270.11 1 28.0186 6881.083 28.1068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR cleaved A-A@N-term; missed R-L@2; missed K-E@7 -0.00305989990010858 1383.75512695313 462.259 1383.75830078125 462.260040283203 3 13 1.1.1.3194.5 1 26.16 11465.7 26.2729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR Deamidated(N)@9 cleaved A-A@N-term; missed R-L@2; missed K-E@7 0.000482167990412563 1384.74279785156 462.5882 1384.74230957031 462.588043212891 3 13 1.1.1.3258.5 1 27.7228 4889.204 27.7136 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR cleaved A-A@N-term; missed R-L@2; missed K-E@7 -0.00342609989456832 1383.7548828125 462.2589 1383.75830078125 462.260040283203 3 12 1.1.1.3215.3 1 26.6705 6329.123 26.4193 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR cleaved A-A@N-term; missed R-L@2; missed K-E@7 -0.00305989990010858 1383.75512695313 462.259 1383.75830078125 462.260040283203 3 13 1.1.1.3208.4 1 26.5015 11997.51 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR Deamidated(N)@9 cleaved A-A@N-term; missed R-L@2; missed K-E@7 0.000482167990412563 1384.74279785156 462.5882 1384.74230957031 462.588043212891 3 12 1.1.1.3241.5 1 27.3056 4750.618 27.3713 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR Deamidated(N)@9 cleaved A-A@N-term; missed R-L@2; missed K-E@7 -0.000158687005750835 1384.7421875 462.588 1384.74230957031 462.588043212891 3 13 1.1.1.3248.9 1 27.4815 5254.532 27.5912 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 ARLEALKENGGAR Deamidated(N)@9 cleaved A-A@N-term; missed R-L@2; missed K-E@7 0.000207516000955366 1384.74243164063 462.5881 1384.74230957031 462.588043212891 3 11 1.1.1.3277.5 1 28.1887 6881.083 28.1068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 ARLEALKENGGAR cleaved A-A@N-term; missed R-L@2; missed K-E@7 -0.00223593995906413 1383.75610351563 462.2593 1383.75830078125 462.260040283203 3 6 1.1.1.3227.6 1 26.9622 4399.777 27.0289 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.00212633004412055 1214.61633300781 405.8794 1214.6142578125 405.878692626953 3 15 1.1.1.3054.2 1 22.7885 690148.8 22.8823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.00212633004412055 1214.61633300781 405.8794 1214.6142578125 405.878692626953 3 18 1.1.1.3063.2 1 22.9708 690148.8 22.8823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.00212633004412055 1214.61633300781 405.8794 1214.6142578125 405.878692626953 3 17 1.1.1.3071.3 1 23.1497 671821.4 22.9358 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK -0.000894850993063301 1214.61328125 405.8784 1214.6142578125 405.878692626953 3 17 1.1.1.3078.2 1 23.3149 466877.5 23.0669 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK -0.00153570994734764 1214.61279296875 405.8782 1214.6142578125 405.878692626953 3 14 1.1.1.3085.2 1 23.4809 163668.9 23.2355 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK -0.00153570994734764 1214.61279296875 405.8782 1214.6142578125 405.878692626953 3 14 1.1.1.3092.2 1 23.6555 34862.84 23.7514 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK -0.00153570994734764 1214.61279296875 405.8782 1214.6142578125 405.878692626953 3 15 1.1.1.3099.3 1 23.8321 34862.84 23.7514 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK -0.00126104999799281 1214.61303710938 405.8783 1214.6142578125 405.878692626953 3 11 1.1.1.3106.2 1 24.0054 35618.1 23.7514 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.0012108200462535 1214.61547851563 405.8791 1214.6142578125 405.878692626953 3 14 1.1.1.3120.4 1 24.3646 3917.455 24.3345 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Delta:H(2)C(2)@N-term -0.00570377008989453 1240.62426757813 621.3194 1240.6298828125 621.322265625 2 14 1.1.1.3131.5 1 24.6402 1319.984 24.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Formyl@N-term -0.00308392010629177 1242.60607910156 622.3103 1242.60925292969 622.311889648438 2 16 1.1.1.3278.19 1 28.2233 5329.529 28.1316 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Formyl@N-term -0.00308392010629177 1242.60607910156 622.3103 1242.60925292969 622.311889648438 2 12 1.1.1.3271.19 1 28.0501 5329.529 28.1316 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Acetyl@N-term 0.000851539021823555 1256.62573242188 419.8825 1256.62487792969 419.882232666016 3 12 1.1.1.3130.2 1 24.6109 3069.978 24.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Delta:H(2)C(2)(H)@4 0.00220366008579731 1240.63208007813 414.5513 1240.6298828125 414.550598144531 3 12 1.1.1.3154.3 1 25.1949 2598.725 25.165 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Carbamidomethyl(H)@4 -0.00139075994957238 1271.63439941406 424.8854 1271.6357421875 424.885864257813 3 14 1.1.1.3052.3 1 22.7476 16059.78 22.8096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Delta:H(2)C(2)@N-term -0.00109217001590878 1240.62878417969 414.5502 1240.6298828125 414.550598144531 3 14 1.1.1.3129.2 1 24.5883 4566.719 24.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6599981784821 ATEHLSTLSEK -0.00245122006163001 1214.61181640625 405.8779 1214.6142578125 405.878692626953 3 9 1.1.1.3113.2 1 24.1862 6490.407 23.9257 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 ATEHLSTLSEK Acetyl@N-term 0.00112618994899094 1256.6259765625 419.8826 1256.62487792969 419.882232666016 3 10 1.1.1.3156.2 1 25.2418 1939.119 25.2378 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.6599991321564 ATEHLSTLSEK -9.00660991668701 1205.60766601563 603.8111 1214.6142578125 608.314392089844 2 9 1.1.1.3696.15 1 38.6424 2037.569 38.7305 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 ATEHLSTLSEK Carbamidomethyl(E)@3 -0.00230626994743943 1271.63342285156 424.8851 1271.6357421875 424.885864257813 3 11 1.1.1.3075.3 1 23.2542 545.2651 23.1632 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 ATEHLSTLSEK Oxidation(H)@4 -0.00224330998025835 1230.60693359375 411.2096 1230.60925292969 411.210327148438 3 10 1.1.1.3059.2 1 22.8981 518.8708 22.9117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 ATEHLSTLSEK Carbamidomethyl(T)@7 0.0385253988206387 1271.67431640625 424.8987 1271.6357421875 424.885864257813 3 8 1.1.1.3084.3 1 23.4588 2442.149 23.5764 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 ATEHLSTLSEK Ser->LacticAcid(S)@9; acrolein addition +56(K)@11 0.00790099985897541 1255.63745117188 419.5531 1255.62963867188 419.550476074219 3 7 1.1.1.3117.4 1 24.2904 841.5804 24.2845 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.889999628067 ATEHLSTLSEK Cation:Na(E)@3 0.0235843006521463 1236.61987304688 619.3172 1236.59619140625 619.305419921875 2 9 1.1.1.3350.9 1 29.9977 1440.834 29.9809 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.7500007152557 ATEHLSTLSEK Methyl(E)@10 -0.000293746998067945 1228.62963867188 410.5505 1228.6298828125 410.550598144531 3 6 1.1.1.3162.3 1 25.3876 2472.285 25.4573 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 ATEHLSTLSEK Carbamidomethyl@N-term 0.00611640978604555 1271.64184570313 424.8879 1271.6357421875 424.885864257813 3 8 1.1.1.3068.3 1 23.0758 753.5614 23.0669 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.6300014257431 ATEHLSTLSEK 0.00597146013751626 1214.62023925781 405.8807 1214.6142578125 405.878692626953 3 9 1.1.1.3161.2 1 25.3632 1556.06 25.3834 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.0699987411499 ATEHLSTLSEK -0.00564604997634888 1214.60864257813 608.3116 1214.6142578125 608.314392089844 2 7 1.1.1.3154.9 1 25.2049 661.1257 25.165 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.5699998140335 ATEHLSTLSEK 0.0012108200462535 1214.61547851563 405.8791 1214.6142578125 405.878692626953 3 8 1.1.1.3127.4 1 24.5396 3917.455 24.3345 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 ATEHLSTLSEKAK Ser->LacticAcid(S)@9; acrolein addition +56(K)@11 cleaved K-P@C-term; missed K-A@11 0.0157210007309914 1454.77746582031 485.9331 1454.76171875 485.927825927734 3 11 1.1.1.3081.6 1 23.3917 442.8995 23.4044 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLR Carbamidomethyl(E)@10 missed K-A@11 0.00232159998267889 2265.19848632813 567.3069 2265.19653320313 567.306396484375 4 17 1.1.1.3569.11 1 35.4184 7930.091 35.4843 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLR missed K-A@11 0.00561466999351978 2208.1806640625 553.0524 2208.17504882813 553.051025390625 4 21 1.1.1.3574.9 1 35.5479 26196.82 35.5893 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLR Formyl(K)@11 missed K-A@11 6.25608008704148E-05 2236.16967773438 560.0497 2236.169921875 560.049743652344 4 18 1.1.1.3819.11 1 41.7906 3121.216 41.6991 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLR Acetyl(K)@11 missed K-A@11 -0.00491487002000213 2250.1806640625 563.5524 2250.185546875 563.553649902344 4 23 1.1.1.3822.5 1 41.8626 9401.265 41.907 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLR Acetyl(S)@9 missed K-A@11 -0.0137146003544331 2250.171875 751.0646 2250.185546875 751.069152832031 3 16 1.1.1.3822.18 1 41.8734 3442.019 41.9327 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLR Formyl(K)@11 missed K-A@11 6.25608008704148E-05 2236.16967773438 560.0497 2236.169921875 560.049743652344 4 12 1.1.1.3812.10 1 41.6051 3121.216 41.6991 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLR Ser->LacticAcid(S)@9; acrolein addition +56(K)@11 missed K-A@11 0.0139795998111367 2249.2041015625 563.3083 2249.1904296875 563.304870605469 4 16 1.1.1.3622.6 1 36.7702 13819.09 36.8822 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLR Ser->LacticAcid(S)@9; acrolein addition +56(K)@13 missed K-A@11 0.0139795998111367 2249.2041015625 563.3083 2249.1904296875 563.304870605469 4 15 1.1.1.3629.10 1 36.9422 13819.09 36.8822 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2100009918213 ATEHLSTLSEKAKPALEDLR Acetyl(K)@11 missed K-A@11 -0.00491487002000213 2250.1806640625 563.5524 2250.185546875 563.553649902344 4 11 1.1.1.3829.8 1 42.049 9401.265 41.907 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 ATEHLSTLSEKAKPALEDLR Formyl(K)@11; reduced acrolein addition +58(K)@13 missed K-A@11 -0.00233477004803717 2294.20922851563 574.5596 2294.21166992188 574.560241699219 4 13 1.1.1.4033.5 1 47.2884 2862.776 47.2818 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 ATEHLSTLSEKAKPALEDLR Methyl(S)@9; acrolein addition +112(K)@11; HPNE addition +172(K)@13 missed K-A@11 -0.0441673994064331 2506.30883789063 627.5845 2506.35302734375 627.595520019531 4 13 1.1.1.3577.14 1 35.6306 2814.444 35.5893 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.0100002288818 ATEHLSTLSEKAKPALEDLR Methyl(S)@6; MDA adduct +54(K)@11; acrolein addition +94(K)@13 missed K-A@11 -0.0131436996161938 2370.23022460938 593.5648 2370.2431640625 593.568054199219 4 10 1.1.1.3569.16 1 35.4226 924.8062 35.3796 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1500015258789 ATEHLSTLSEKAKPALEDLR Formyl(K)@11; reduced acrolein addition +58(K)@13 missed K-A@11 -0.0133207999169827 2294.19848632813 574.5569 2294.21166992188 574.560241699219 4 11 1.1.1.4009.13 1 46.676 5725.436 46.584 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 ATEHLSTLSEKAKPALEDLR Carbamidomethyl(K)@11 missed K-A@11 0.0114548997953534 2265.2080078125 454.0489 2265.19653320313 454.046569824219 5 7 1.1.1.3568.4 1 35.3863 4181.743 35.4843 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 ATEHLSTLSEKAKPALEDLR Formyl(K)@13 missed K-A@11 -0.0157258994877338 2236.154296875 746.392 2236.169921875 746.397277832031 3 8 1.1.1.3818.18 1 41.7704 1352.15 41.6991 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.529999256134 ATEHLSTLSEKAKPALEDLR Ser->LacticAcid(S)@9; acrolein addition +56(K)@11 missed K-A@11 0.0139795998111367 2249.2041015625 563.3083 2249.1904296875 563.304870605469 4 9 1.1.1.3636.9 1 37.1183 14165.99 36.8576 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFK missed K-A@11; missed R-Q@20 0.0147230997681618 3419.880859375 855.9775 3419.86645507813 855.973876953125 4 14 1.1.1.4401.16 1 56.6988 2061.942 56.6823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFK missed K-A@11; missed R-Q@20 0.0245389994233847 3419.89086914063 684.9855 3419.86645507813 684.980590820313 5 16 1.1.1.4402.13 1 56.7221 7723.209 56.7082 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFK Acetyl(S)@9 missed K-A@11; missed R-Q@20 -0.00309409992769361 3461.8740234375 693.3821 3461.876953125 693.382690429688 5 12 1.1.1.4569.10 1 61.0967 2488.5 61.1112 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.4699981212616 ATEHLSTLSEKAKPALEDLRQGLLPVLESFK Formyl(K)@11; reduced acrolein addition +58(K)@13 missed K-A@11; missed R-Q@20 0.0144988996908069 3505.91748046875 702.1908 3505.9033203125 702.187927246094 5 8 1.1.1.4833.9 1 67.8906 732.7958 68.0113 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.1400017738342 ATEHLSTLSEKAKPALEDLRQGLLPVLESFK Dehydrated(T)@2; reduced acrolein addition +58(K)@13; Deamidated(Q)@21 missed K-A@11; missed R-Q@20 0.0223347004503012 3460.90405273438 693.1881 3460.8818359375 693.18359375 5 10 1.1.1.4447.11 1 57.887 3582.692 57.8748 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.1400017738342 ATEHLSTLSEKAKPALEDLRQGLLPVLESFK Formyl@N-term; reduced acrolein addition +58(K)@13 missed K-A@11; missed R-Q@20 0.00686975987628102 3505.90991210938 702.1893 3505.9033203125 702.187927246094 5 6 1.1.1.4845.6 1 68.2101 286.8707 68.1456 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@11; missed R-Q@20; missed K-V@31 0.0271332003176212 4787.5908203125 798.9391 4787.5634765625 798.9345703125 6 16 1.1.1.5080.11 1 74.4678 36624.42 74.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31 -0.0017468900186941 4844.58349609375 969.924 4844.5849609375 969.92431640625 5 19 1.1.1.5082.16 1 74.5265 3327.616 74.5359 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl(E)@28; HexNAc(S)@29; ONE addition +154(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 -0.0129848001524806 5201.7490234375 1041.357 5201.76416015625 1041.36010742188 5 18 1.1.1.5082.18 1 74.5282 3628.767 74.5898 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@11; missed R-Q@20; missed K-V@31 0.0132839996367693 4787.57470703125 1197.901 4787.5634765625 1197.89819335938 4 8 1.1.1.5083.21 1 74.5578 2597.787 74.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@11; missed R-Q@20; missed K-V@31 0.0271332003176212 4787.5908203125 798.9391 4787.5634765625 798.9345703125 6 35 1.1.1.5085.10 1 74.6021 36624.42 74.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@11; missed R-Q@20; missed K-V@31 0.0123071996495128 4787.576171875 684.9467 4787.5634765625 684.944946289063 7 16 1.1.1.5087.10 1 74.6558 10939.83 74.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@11; missed R-Q@20; missed K-V@31 0.0271332003176212 4787.5908203125 798.9391 4787.5634765625 798.9345703125 6 23 1.1.1.5087.12 1 74.6574 36624.42 74.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@11; missed R-Q@20; missed K-V@31 0.0179782994091511 4787.58203125 798.9376 4787.5634765625 798.9345703125 6 12 1.1.1.5096.8 1 74.8897 21077.25 74.6166 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +56(K)@13; Deamidated(Q)@21 missed K-A@11; missed R-Q@20; missed K-V@31 0.0148695996031165 4844.5888671875 808.4387 4844.57373046875 808.436279296875 6 14 1.1.1.5080.12 1 74.4687 5672.025 74.5359 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +54(K)@11; HPNE addition +172(K)@13; Oxidation(P)@25; HPNE addition +172(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 0.00215820991434157 5201.791015625 867.9725 5201.7890625 867.972106933594 6 16 1.1.1.5081.12 1 74.4958 5378.64 74.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.4899997711182 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +56(K)@13; Deamidated(Q)@21 missed K-A@11; missed R-Q@20; missed K-V@31 0.0148695996031165 4844.5888671875 808.4387 4844.57373046875 808.436279296875 6 15 1.1.1.5085.11 1 74.603 5672.025 74.5359 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8900003433228 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Dehydrated(S)@9; reduced acrolein addition +58(K)@13; Deamidated(Q)@21 missed K-A@11; missed R-Q@20; missed K-V@31 0.031733799725771 4828.6103515625 690.8088 4828.5791015625 690.804260253906 7 14 1.1.1.5085.5 1 74.598 4751.138 74.6433 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.0199990272522 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Dehydrated(T)@7; acrolein addition +38(K)@13; Cation:Na(E)@17 missed K-A@11; missed R-Q@20; missed K-V@31 0.0287183001637459 4829.57958984375 805.9372 4829.55078125 805.932373046875 6 15 1.1.1.5105.11 1 75.1305 1693.345 75.1182 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.3099999427795 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced acrolein addition +58(K)@11; hexanoyl addition +98(K)@13; HexNAc(S)@29; reduced acrolein addition +96(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 0.0207726005464792 5242.83837890625 1049.575 5242.8154296875 1049.57043457031 5 12 1.1.1.5087.19 1 74.6633 2030.308 74.6702 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.0146132996305823 4915.6728515625 703.2463 4915.65869140625 703.244201660156 7 14 1.1.1.5063.7 1 74.0049 5052.956 74.0761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.00693668983876705 4915.666015625 820.2849 4915.65869140625 820.28369140625 6 23 1.1.1.5064.10 1 74.0346 7257.837 74.0761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.0146132996305823 4915.6728515625 703.2463 4915.65869140625 703.244201660156 7 12 1.1.1.5070.14 1 74.2006 5052.956 74.0761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.7000026702881 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Ser->LacticAcid(S)@6; acrolein addition +56(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.030307000502944 4956.70361328125 827.1246 4956.673828125 827.11962890625 6 12 1.1.1.5071.9 1 74.2231 3191.203 74.3194 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0206891000270844 5243.85400390625 750.1293 5243.83349609375 750.126342773438 7 17 1.1.1.5090.6 1 74.7328 7343.118 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0131189003586769 5243.8466796875 874.9817 5243.83349609375 874.9794921875 6 18 1.1.1.5090.11 1 74.737 9302.653 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@11; Deamidated(Q)@21; acrolein addition +112(K)@44; Oxidation(N)@46 cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0443263985216618 5428.935546875 776.5695 5428.89111328125 776.563110351563 7 22 1.1.1.5092.9 1 74.7873 9576.01 74.7242 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0168117992579937 5243.8486328125 1049.777 5243.83349609375 1049.77392578125 5 14 1.1.1.5094.18 1 74.8471 2685.604 74.8282 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0206891000270844 5243.85400390625 750.1293 5243.83349609375 750.126342773438 7 21 1.1.1.5097.11 1 74.9186 7343.118 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.3099999427795 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@11; Oxidation(P)@25; reduced acrolein addition +96(K)@44; Deamidated(N)@46 cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0355941988527775 5412.931640625 774.2832 5412.89599609375 774.278137207031 7 12 1.1.1.5090.8 1 74.7345 21487.24 74.9851 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0160966999828815 5371.908203125 768.4227 5371.89208984375 768.42041015625 7 33 1.1.1.5088.7 1 74.6802 79460.78 74.7506 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0111589003354311 5371.9033203125 1075.388 5371.89208984375 1075.38562011719 5 19 1.1.1.5088.19 1 74.6903 24422.22 74.7506 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0118425004184246 5428.92529296875 905.8281 5428.91357421875 905.826171875 6 20 1.1.1.5089.15 1 74.714 12838.32 74.7242 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0192968007177114 5371.9111328125 896.3258 5371.89208984375 896.322570800781 6 34 1.1.1.5091.11 1 74.7631 86575.61 74.7506 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(E)@28; HexNAc(S)@29; ONE addition +154(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0208213999867439 5786.11279296875 965.3594 5786.09228515625 965.35595703125 6 24 1.1.1.5092.17 1 74.794 15615.06 74.7242 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0160966999828815 5371.908203125 768.4227 5371.89208984375 768.42041015625 7 28 1.1.1.5095.5 1 74.8613 79460.78 74.7506 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0111589003354311 5371.9033203125 1075.388 5371.89208984375 1075.38562011719 5 16 1.1.1.5095.17 1 74.8713 24422.22 74.7506 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0192968007177114 5371.9111328125 896.3258 5371.89208984375 896.322570800781 6 30 1.1.1.5098.14 1 74.9475 86575.61 74.7506 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +54(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.0448941998183727 5425.85791015625 905.3169 5425.90234375 905.324340820313 6 13 1.1.1.5098.15 1 74.9483 1245.992 74.8799 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0160966999828815 5371.908203125 768.4227 5371.89208984375 768.42041015625 7 23 1.1.1.5102.7 1 75.049 63978.38 74.7767 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8900003433228 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.00285358005203307 5413.93603515625 774.4267 5413.93896484375 774.427124023438 7 15 1.1.1.5113.8 1 75.3318 2639.843 75.2969 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1400020122528 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(Q)@21; acrolein addition +56(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0287498999387026 5428.92822265625 1086.793 5428.90234375 1086.78771972656 5 12 1.1.1.5088.20 1 74.6911 3036.048 74.7242 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.610000371933 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl@N-term missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0163378994911909 5413.9189453125 903.3271 5413.90234375 903.324340820313 6 13 1.1.1.5111.11 1 75.2833 5396.253 75.2969 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.7200016975403 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@31; Deamidated(N)@46 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0361094996333122 5430.95361328125 776.8578 5430.91796875 776.852661132813 7 12 1.1.1.5085.9 1 74.6013 4568.784 74.7242 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.3099999427795 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(S)@9; reduced acrolein addition +58(K)@13; Deamidated(Q)@21 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0288009997457266 5412.93359375 1083.594 5412.9072265625 1083.58874511719 5 12 1.1.1.5099.21 1 74.9798 6695.074 74.9586 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.1000006198883 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@13; Deamidated(Q)@21; Dehydrated(S)@29 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0012481800513342 5412.90869140625 903.1587 5412.9072265625 903.158508300781 6 12 1.1.1.5118.13 1 75.4632 3284.88 75.4239 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.5100018978119 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@13; Deamidated(Q)@21 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0330930016934872 5428.935546875 776.5695 5428.90234375 776.564697265625 7 10 1.1.1.5090.9 1 74.7353 9576.01 74.7242 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 47.6099997758865 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.0332585014402866 5414.93115234375 903.4958 5414.89794921875 903.490234375 6 10 1.1.1.5120.14 1 75.5157 3924.434 75.2969 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term -0.00197415007278323 1225.53442382813 613.7745 1225.53637695313 613.775451660156 2 15 1.1.1.3320.11 1 29.2578 73143.46 29.3665 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term -0.00258447998203337 1225.53381347656 613.7742 1225.53637695313 613.775451660156 2 15 1.1.1.3327.9 1 29.4349 73592.38 29.4401 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term -0.00246240990236402 1225.53381347656 613.7742 1225.53637695313 613.775451660156 2 15 1.1.1.3334.9 1 29.6016 72883.5 29.5382 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term -0.00246240990236402 1225.53381347656 613.7742 1225.53637695313 613.775451660156 2 15 1.1.1.3341.8 1 29.7744 78371.78 29.8337 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term -0.00246240990236402 1225.53381347656 613.7742 1225.53637695313 613.775451660156 2 15 1.1.1.3348.6 1 29.951 78371.78 29.8337 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term -0.00221827998757362 1225.53430175781 613.7744 1225.53637695313 613.775451660156 2 15 1.1.1.3355.13 1 30.1195 70137.29 30.1035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00199666991829872 1257.52404785156 629.7693 1257.52624511719 629.770385742188 2 14 1.1.1.3028.3 1 22.1618 983.1843 21.8933 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00126426003407687 1257.52490234375 629.7697 1257.52624511719 629.770385742188 2 12 1.1.1.3065.5 1 23.0291 733.9771 22.9895 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.000810881028883159 1257.52709960938 629.7708 1257.52624511719 629.770385742188 2 12 1.1.1.3108.11 1 24.0705 844.7162 24.0518 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -4.35898982686922E-05 1257.52612304688 629.7703 1257.52624511719 629.770385742188 2 13 1.1.1.3080.5 1 23.3716 1787.015 23.2595 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.00715838000178337 1257.53332519531 629.7739 1257.52624511719 629.770385742188 2 11 1.1.1.3056.6 1 22.8528 654.53 22.8823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00187459995504469 1257.52429199219 629.7694 1257.52624511719 629.770385742188 2 12 1.1.1.3021.6 1 21.9824 976.6964 21.9176 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00309526990167797 1257.52307128906 629.7688 1257.52624511719 629.770385742188 2 13 1.1.1.3316.17 1 29.1644 2203.41 29.3911 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00285113998688757 1257.52331542969 629.7689 1257.52624511719 629.770385742188 2 12 1.1.1.3271.20 1 28.051 4590.088 27.8604 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term -0.00221827998757362 1225.53430175781 613.7744 1225.53637695313 613.775451660156 2 13 1.1.1.3362.19 1 30.2947 70137.29 30.1035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.000204828000278212 1229.53149414063 615.773 1229.53125 615.772888183594 2 13 1.1.1.3233.11 1 27.1217 5328.787 26.8825 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00346146989613771 1257.52270507813 629.7686 1257.52624511719 629.770385742188 2 12 1.1.1.3345.10 1 29.8741 2071.047 29.9318 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term -0.00158061005640775 1241.52966308594 414.8505 1241.53125 414.851043701172 3 13 1.1.1.2990.2 1 21.2618 338.5981 21.112 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.00313016003929079 1257.529296875 629.7719 1257.52624511719 629.770385742188 2 11 1.1.1.3007.7 1 21.6435 975.4386 21.8205 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00309526990167797 1257.52307128906 629.7688 1257.52624511719 629.770385742188 2 10 1.1.1.3042.9 1 22.5129 582.1808 22.5181 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00346146989613771 1257.52270507813 629.7686 1257.52624511719 629.770385742188 2 14 1.1.1.3215.7 1 26.6821 21388.29 26.6874 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term 0.0149218002334237 1241.54626464844 621.7804 1241.53125 621.772888183594 2 8 1.1.1.3054.13 1 22.8043 303.1266 22.9117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -4.35898982686922E-05 1257.52612304688 629.7703 1257.52624511719 629.770385742188 2 14 1.1.1.3073.2 1 23.1978 1787.015 23.2595 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Trp->Hydroxykynurenin(W)@8 cleaved Q-D@N-term -0.00157594995107502 1245.52465820313 623.7696 1245.52624511719 623.770385742188 2 13 1.1.1.3124.12 1 24.4794 3935.42 24.4847 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00224080006591976 1257.52392578125 629.7692 1257.52624511719 629.770385742188 2 14 1.1.1.3180.17 1 25.8271 77347.37 25.8323 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00224080006591976 1257.52392578125 629.7692 1257.52624511719 629.770385742188 2 14 1.1.1.3187.11 1 25.9992 77347.37 25.8323 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00285113998688757 1257.52331542969 629.7689 1257.52624511719 629.770385742188 2 14 1.1.1.3194.8 1 26.1675 60457.44 25.9063 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term -0.00221827998757362 1225.53430175781 613.7744 1225.53637695313 613.775451660156 2 13 1.1.1.3313.14 1 29.0872 62564.53 29.2681 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00248493999242783 1257.52368164063 629.7691 1257.52624511719 629.770385742188 2 14 1.1.1.3172.8 1 25.6503 75968.42 25.8077 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term -0.00158061005640775 1241.52966308594 414.8505 1241.53125 414.851043701172 3 12 1.1.1.2983.2 1 21.0726 338.5981 21.112 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00309526990167797 1257.52307128906 629.7688 1257.52624511719 629.770385742188 2 12 1.1.1.3035.4 1 22.3391 575.2299 22.5181 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.000283442001091316 1229.53112792969 615.7728 1229.53125 615.772888183594 2 13 1.1.1.3212.9 1 26.6057 5599.591 26.663 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.00316241011023521 1229.52819824219 410.85 1229.53125 410.851043701172 3 11 1.1.1.3248.4 1 27.474 3255.025 27.5912 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.00459497002884746 1257.53063964844 629.7726 1257.52624511719 629.770385742188 2 11 1.1.1.3144.10 1 24.9657 1662.604 25.1163 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.00154327997006476 1257.52770996094 629.7711 1257.52624511719 629.770385742188 2 11 1.1.1.3294.18 1 28.6161 1500.506 28.525 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7600028514862 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term -0.00692821014672518 1241.5244140625 621.7695 1241.53125 621.772888183594 2 11 1.1.1.3190.10 1 26.0693 1830.582 26.0045 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7600028514862 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.000409792002756149 1257.52563476563 629.7701 1257.52624511719 629.770385742188 2 13 1.1.1.3236.8 1 27.1951 18962.41 26.9312 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6599981784821 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.00149443000555038 1241.53283691406 621.7737 1241.53125 621.772888183594 2 13 1.1.1.3218.8 1 26.7528 2654.578 26.7118 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6599981784821 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.000409792002756149 1257.52563476563 629.7701 1257.52624511719 629.770385742188 2 13 1.1.1.3229.14 1 27.0236 18781.17 26.9556 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.4499990940094 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.000322612002491951 1257.52648925781 629.7705 1257.52624511719 629.770385742188 2 12 1.1.1.3014.4 1 21.8152 996.0456 21.8933 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.000409792002756149 1257.52563476563 629.7701 1257.52624511719 629.770385742188 2 10 1.1.1.3094.12 1 23.718 1561.175 23.502 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.0024806500878185 1229.52893066406 615.7717 1229.53125 615.772888183594 2 11 1.1.1.3152.10 1 25.1564 2246.984 25.1407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term -0.00351033010520041 1241.52783203125 621.7712 1241.53125 621.772888183594 2 13 1.1.1.3204.5 1 26.4107 1816.141 26.4193 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00602489011362195 1257.52001953125 629.7673 1257.52624511719 629.770385742188 2 13 1.1.1.3208.7 1 26.509 21718.06 26.468 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.000283442001091316 1229.53112792969 615.7728 1229.53125 615.772888183594 2 13 1.1.1.3219.5 1 26.7796 5599.591 26.663 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.000326895009493455 1229.53161621094 615.7731 1229.53125 615.772888183594 2 13 1.1.1.3226.7 1 26.9504 5286.18 26.8825 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 DEPPQSPWDR cleaved Q-D@N-term -0.00197415007278323 1225.53442382813 613.7745 1225.53637695313 613.775451660156 2 12 1.1.1.3316.16 1 29.1627 70586.02 29.3418 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.199999332428 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00248493999242783 1257.52368164063 629.7691 1257.52624511719 629.770385742188 2 10 1.1.1.3338.18 1 29.7029 2072.307 29.6611 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.00343706994317472 1229.52795410156 410.8499 1229.53125 410.851043701172 3 13 1.1.1.3184.2 1 25.9106 19016.65 25.9308 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.00503438012674451 1241.53649902344 621.7755 1241.53125 621.772888183594 2 12 1.1.1.3225.15 1 26.9227 2508.641 26.9312 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00382767990231514 1257.52221679688 629.7684 1257.52624511719 629.770385742188 2 10 1.1.1.3101.11 1 23.892 998.9449 23.8507 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.00149443000555038 1241.53283691406 621.7737 1241.53125 621.772888183594 2 9 1.1.1.3109.14 1 24.0964 907.8964 24.3345 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00321733998134732 1257.52282714844 629.7687 1257.52624511719 629.770385742188 2 9 1.1.1.3115.20 1 24.2526 852.9583 24.3592 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 DEPPQSPWDR Trp->Hydroxykynurenin(W)@8 cleaved Q-D@N-term 0.00428328011184931 1245.53051757813 623.7725 1245.52624511719 623.770385742188 2 13 1.1.1.3138.4 1 24.8203 3679.182 24.7527 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.00789078045636415 1257.53405761719 629.7743 1257.52624511719 629.770385742188 2 11 1.1.1.3151.16 1 25.1354 1670.252 25.0921 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00285113998688757 1257.52331542969 629.7689 1257.52624511719 629.770385742188 2 11 1.1.1.3264.19 1 27.878 4590.088 27.8604 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -4.35898982686922E-05 1257.52612304688 629.7703 1257.52624511719 629.770385742188 2 11 1.1.1.3331.8 1 29.528 2033.464 29.5137 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00285113998688757 1257.52331542969 629.7689 1257.52624511719 629.770385742188 2 10 1.1.1.3352.15 1 30.0442 1810.379 30.0299 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.409999370575 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -3.93070986319799E-05 1229.53125 615.7729 1229.53125 615.772888183594 2 12 1.1.1.3198.6 1 26.2643 8882.966 26.0045 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.2199976444244 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.00279621011577547 1229.52844238281 410.8501 1229.53125 410.851043701172 3 10 1.1.1.3241.3 1 27.3023 3988.568 27.2004 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0099985599518 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term -0.00167932000476867 1241.52966308594 621.7721 1241.53125 621.772888183594 2 10 1.1.1.3197.6 1 26.2349 1728.609 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0099985599518 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00346146989613771 1257.52270507813 629.7686 1257.52624511719 629.770385742188 2 11 1.1.1.3278.20 1 28.225 2556.533 28.2303 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00321733998134732 1257.52282714844 629.7687 1257.52624511719 629.770385742188 2 9 1.1.1.3122.19 1 24.4276 852.9583 24.3592 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 DEPPQSPWDR Trp->Hydroxykynurenin(W)@8 cleaved Q-D@N-term -0.00352902989834547 1245.52270507813 623.7686 1245.52624511719 623.770385742188 2 12 1.1.1.3131.6 1 24.6427 3785.121 24.6312 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term -0.00119105004705489 1241.53002929688 621.7723 1241.53125 621.772888183594 2 12 1.1.1.3147.6 1 25.0333 2704.071 25.1892 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term -0.00216758996248245 1241.529296875 621.7719 1241.53125 621.772888183594 2 12 1.1.1.3161.9 1 25.3757 5745.607 25.4573 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.00343706994317472 1229.52795410156 410.8499 1229.53125 410.851043701172 3 12 1.1.1.3191.2 1 26.0853 19016.65 25.9308 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00370561005547643 1257.5224609375 629.7685 1257.52624511719 629.770385742188 2 12 1.1.1.3201.8 1 26.336 28873.54 26.0779 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00346146989613771 1257.52270507813 629.7686 1257.52624511719 629.770385742188 2 12 1.1.1.3222.9 1 26.8503 21388.29 26.6874 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00346146989613771 1257.52270507813 629.7686 1257.52624511719 629.770385742188 2 10 1.1.1.3287.13 1 28.4411 2556.533 28.2303 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 DEPPQSPWDR Oxidation(P)@3; Dioxidation(W)@8 cleaved Q-D@N-term -0.00170547002926469 1273.51953125 637.767 1273.52111816406 637.767822265625 2 13 1.1.1.3324.11 1 29.3578 3054.382 29.3665 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 DEPPQSPWDR Carbamidomethyl@N-term cleaved Q-D@N-term 4.43325989181176E-05 1282.55786132813 642.2862 1282.55786132813 642.286193847656 2 9 1.1.1.3578.14 1 35.6567 1070.521 35.6155 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 DEPPQSPWDR Trioxidation(W)@8 cleaved Q-D@N-term -0.00219374010339379 1273.51892089844 637.7667 1273.52111816406 637.767822265625 2 8 1.1.1.3085.11 1 23.4951 324.6545 23.6265 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 DEPPQSPWDR Trp->Hydroxykynurenin(W)@8 cleaved Q-D@N-term -0.000355280993971974 1245.52587890625 623.7702 1245.52624511719 623.770385742188 2 11 1.1.1.3145.8 1 24.9899 3750.009 24.7284 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.00279621011577547 1229.52844238281 410.8501 1229.53125 410.851043701172 3 10 1.1.1.3234.3 1 27.1312 9686.308 26.9312 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term -0.00473099993541837 1241.52673339844 621.7706 1241.53125 621.772888183594 2 9 1.1.1.3321.19 1 29.2858 1434.489 29.4647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0200011730194 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.00118136999662966 1229.53247070313 615.7735 1229.53125 615.772888183594 2 10 1.1.1.3159.15 0 25.3262 1932.521 25.2863 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0200011730194 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term -0.00167932000476867 1241.52966308594 621.7721 1241.53125 621.772888183594 2 11 1.1.1.3211.6 1 26.5846 2230.648 26.5655 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0200011730194 DEPPQSPWDR Oxidation(P)@3; Dioxidation(W)@8 cleaved Q-D@N-term -0.00280408002436161 1273.51831054688 637.7664 1273.52111816406 637.767822265625 2 12 1.1.1.3352.16 1 30.0458 3047.366 30.1035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 DEPPQSPWDR Pro->pyro-Glu(P)@7 cleaved Q-D@N-term -0.00844001956284046 1239.50732421875 620.7609 1239.515625 620.765075683594 2 9 1.1.1.3272.21 1 28.0766 832.4639 28.1068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term -0.00473099993541837 1241.52673339844 621.7706 1241.53125 621.772888183594 2 9 1.1.1.3329.12 1 29.4823 1447.537 29.4647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.000499619985930622 1229.53173828125 410.8512 1229.53125 410.851043701172 3 10 1.1.1.3341.3 1 29.7661 3072.112 29.7106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.00161649996880442 1241.53283691406 621.7737 1241.53125 621.772888183594 2 8 1.1.1.3007.6 1 21.6401 200.6965 21.7471 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term -0.00216758996248245 1241.529296875 621.7719 1241.53125 621.772888183594 2 11 1.1.1.3168.10 1 25.5482 5745.607 25.4573 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.000200544993276708 1257.52624511719 629.7704 1257.52624511719 629.770385742188 2 11 1.1.1.3243.7 1 27.3611 7526.647 27.2981 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.00882815010845661 1229.5224609375 615.7685 1229.53125 615.772888183594 2 9 1.1.1.3247.10 1 27.4605 1929.971 27.4203 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 DEPPQSPWDR Pro->pyro-Glu(P)@7 cleaved Q-D@N-term 0.0099921403452754 1239.52563476563 620.7701 1239.515625 620.765075683594 2 7 1.1.1.3293.11 1 28.5855 529.6275 28.5743 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00285113998688757 1257.52331542969 629.7689 1257.52624511719 629.770385742188 2 10 1.1.1.3324.10 1 29.3562 2051.544 29.2927 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 DEPPQSPWDR Carbamidomethyl@N-term cleaved Q-D@N-term 0.0253123007714748 1282.58312988281 642.2988 1282.55786132813 642.286193847656 2 9 1.1.1.3615.12 1 36.6064 1057.542 36.5625 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7000026702881 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00309526990167797 1257.52307128906 629.7688 1257.52624511719 629.770385742188 2 11 1.1.1.3158.8 1 25.3053 13698.4 25.5321 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7000026702881 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -3.93070986319799E-05 1229.53125 615.7729 1229.53125 615.772888183594 2 11 1.1.1.3205.10 1 26.4367 5622.554 26.468 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8700020313263 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00384835992008448 1257.52233886719 420.1814 1257.52624511719 420.182678222656 3 8 1.1.1.3165.3 1 25.4621 11497.93 25.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.00252411002293229 1229.53381347656 615.7742 1229.53125 615.772888183594 2 10 1.1.1.3255.9 1 27.6594 2000.469 27.6402 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term -0.00487643992528319 1241.5263671875 414.8494 1241.53125 414.851043701172 3 6 1.1.1.3095.3 1 23.7312 603.8168 23.6516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00174269999843091 1257.5244140625 420.1821 1257.52624511719 420.182678222656 3 10 1.1.1.3175.4 1 25.712 17448.51 25.8323 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.7999982833862 DEPPQSPWDR Pro->pyro-Glu(P)@7 cleaved Q-D@N-term 0.0175602994859219 1239.53332519531 620.7739 1239.515625 620.765075683594 2 8 1.1.1.3225.14 1 26.921 437.6382 26.9556 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.7999982833862 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.000200544993276708 1257.52624511719 629.7704 1257.52624511719 629.770385742188 2 11 1.1.1.3257.9 1 27.7049 5917.776 27.6402 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 DEPPQSPWDR Trioxidation(W)@8 cleaved Q-D@N-term -0.00219374010339379 1273.51892089844 637.7667 1273.52111816406 637.767822265625 2 7 1.1.1.3092.12 1 23.6697 324.6545 23.6265 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 DEPPQSPWDR Trp->Hydroxykynurenin(W)@8 cleaved Q-D@N-term -0.00352902989834547 1245.52270507813 623.7686 1245.52624511719 623.770385742188 2 9 1.1.1.3152.11 1 25.1581 2830.8 25.0436 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term 0.00503438012674451 1241.53649902344 621.7755 1241.53125 621.772888183594 2 9 1.1.1.3232.18 1 27.0972 2508.641 26.9312 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.0100002288818 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.000200544993276708 1257.52624511719 629.7704 1257.52624511719 629.770385742188 2 11 1.1.1.3250.10 1 27.5354 7524.876 27.2981 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.17999958992 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.00041588899330236 1229.53088378906 410.8509 1229.53125 410.851043701172 3 8 1.1.1.3321.3 1 29.2725 2391.26 29.4647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.279999256134 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.0018807000014931 1229.52941894531 410.8504 1229.53125 410.851043701172 3 10 1.1.1.3258.3 1 27.7195 2949.773 27.7381 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.3200008869171 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term -0.00119105004705489 1241.53002929688 621.7723 1241.53125 621.772888183594 2 8 1.1.1.3239.12 1 27.2668 1195.406 27.2736 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.3200008869171 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term 0.00320336990989745 1241.53442382813 621.7745 1241.53125 621.772888183594 2 10 1.1.1.3258.8 1 27.7303 1019.405 27.7381 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.290002822876 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term -0.00668408023193479 1241.52465820313 621.7696 1241.53125 621.772888183594 2 10 1.1.1.3183.13 1 25.8961 2744.183 25.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.1899991035461 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00529247988015413 1257.52087402344 629.7677 1257.52624511719 629.770385742188 2 10 1.1.1.3129.5 1 24.5983 659.0595 24.6312 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term -0.00167932000476867 1241.52966308594 621.7721 1241.53125 621.772888183594 2 7 1.1.1.3019.7 1 21.9367 211.3385 21.8933 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.00260271993465722 1229.52868652344 615.7716 1229.53125 615.772888183594 2 10 1.1.1.3176.6 1 25.743 10222.26 25.9063 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term 0.00649918988347054 1241.53784179688 621.7762 1241.53125 621.772888183594 2 8 1.1.1.3290.13 1 28.518 736.2551 28.5004 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.7600011825562 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term -0.00167932000476867 1241.52966308594 621.7721 1241.53125 621.772888183594 2 8 1.1.1.3265.12 1 27.8991 1070.07 27.9338 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00602489011362195 1257.52001953125 629.7673 1257.52624511719 629.770385742188 2 8 1.1.1.3049.7 1 22.6814 620.7901 22.6891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term -0.00260700006037951 1257.5234375 629.769 1257.52624511719 629.770385742188 2 8 1.1.1.3087.16 1 23.543 1603.531 23.4287 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term -0.00119105004705489 1241.53002929688 621.7723 1241.53125 621.772888183594 2 10 1.1.1.3154.10 1 25.2066 2704.071 25.1892 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 DEPPQSPWDR Trp->Hydroxykynurenin(W)@8 cleaved Q-D@N-term 0.00281846988946199 1245.52905273438 623.7718 1245.52624511719 623.770385742188 2 10 1.1.1.3161.10 1 25.3782 1533.857 25.3591 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.00565440021455288 1229.52563476563 615.7701 1229.53125 615.772888183594 2 10 1.1.1.3240.10 1 27.2928 2242.47 27.2981 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 DEPPQSPWDR Pro->pyro-Glu(P)@7 cleaved Q-D@N-term -0.00538833998143673 1239.51025390625 620.7624 1239.515625 620.765075683594 2 8 1.1.1.3326.11 1 29.4071 999.4893 29.4647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 DEPPQSPWDR Carbamidomethyl@N-term cleaved Q-D@N-term -0.0041059497743845 1282.5537109375 642.2841 1282.55786132813 642.286193847656 2 8 1.1.1.3564.17 1 35.2928 949.7144 35.4843 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.4699985980988 DEPPQSPWDR Acetyl@N-term cleaved Q-D@N-term -0.000643445993773639 1267.54626464844 634.7804 1267.546875 634.78076171875 2 8 1.1.1.3577.15 1 35.6314 2197.599 35.4581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.529999256134 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.0024806500878185 1229.52893066406 615.7717 1229.53125 615.772888183594 2 8 1.1.1.3145.7 1 24.9874 2246.984 25.1407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.6799993515015 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.00235608010552824 1241.53356933594 414.8518 1241.53125 414.851043701172 3 6 1.1.1.3088.3 1 23.5562 611.6346 23.5515 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3900007009506 DEPPQSPWDR Carbamidomethyl@N-term cleaved Q-D@N-term -0.00105426996015012 1282.556640625 642.2856 1282.55786132813 642.286193847656 2 7 1.1.1.3587.9 1 35.885 790.5293 35.8752 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.7500007152557 DEPPQSPWDR Acetyl@N-term cleaved Q-D@N-term -0.000277245009783655 1267.54663085938 634.7806 1267.546875 634.78076171875 2 8 1.1.1.3563.17 1 35.2669 2142.586 35.3796 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.1199994087219 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term -0.00279621011577547 1229.52844238281 410.8501 1229.53125 410.851043701172 3 9 1.1.1.3225.3 1 26.911 9686.308 26.9312 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.9199995994568 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term -0.00130596000235528 1241.52990722656 414.8506 1241.53125 414.851043701172 3 7 1.1.1.3346.2 1 29.887 967.908 29.8828 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.000459270988358185 1452.7001953125 485.2407 1452.69970703125 485.240509033203 3 12 1.1.1.3424.10 1 31.8186 67453.24 31.9087 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.000184618998900987 1452.69995117188 485.2406 1452.69970703125 485.240509033203 3 11 1.1.1.3473.2 1 33.0322 4214.929 32.8072 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.000184618998900987 1452.69995117188 485.2406 1452.69970703125 485.240509033203 3 11 1.1.1.3389.5 1 30.9526 43453.59 31.0453 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 DEPPQSPWDRVK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10 0.0021806200966239 1456.69689941406 729.3557 1456.69470214844 729.354614257813 2 9 1.1.1.3239.13 1 27.2684 864.3044 27.2249 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 DEPPQSPWDRVK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 0.0055541698820889 1484.6953125 743.3549 1484.68957519531 743.35205078125 2 10 1.1.1.3197.8 1 26.2383 1525.84 26.1997 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 DEPPQSPWDRVK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 -0.00467940978705883 1484.68505859375 495.9023 1484.68957519531 495.90380859375 3 9 1.1.1.3100.8 1 23.8595 1234.057 23.8507 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7000026702881 DEPPQSPWDRVK Acetyl@N-term cleaved Q-D@N-term; missed R-V@10 0.00274307001382113 1494.71301269531 748.3638 1494.71032714844 748.362426757813 2 10 1.1.1.3601.20 1 36.2504 2584.685 36.0257 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 DEPPQSPWDRVK Oxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 0.00118661997839808 1468.69592285156 490.5726 1468.69470214844 490.572174072266 3 10 1.1.1.3054.9 1 22.7977 1083.135 22.7854 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 DEPPQSPWDRVK Oxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 0.000637319986708462 1468.6953125 490.5724 1468.69470214844 490.572174072266 3 8 1.1.1.3109.8 1 24.0873 620.059 24.1033 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 -0.000456236011814326 1452.69934082031 485.2404 1452.69970703125 485.240509033203 3 10 1.1.1.3382.6 1 30.7805 39768.98 30.9712 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7899985313416 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.000459270988358185 1452.7001953125 485.2407 1452.69970703125 485.240509033203 3 10 1.1.1.3445.4 1 32.3433 9755.28 32.3877 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7899985313416 DEPPQSPWDRVK Acetyl@N-term cleaved Q-D@N-term; missed R-V@10 0.00274307001382113 1494.71301269531 748.3638 1494.71032714844 748.362426757813 2 9 1.1.1.3594.20 1 36.0704 2584.685 36.0257 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.0100002288818 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 -0.000456236011814326 1452.69934082031 485.2404 1452.69970703125 485.240509033203 3 10 1.1.1.3410.4 1 31.4693 43094.8 31.6841 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.0100002288818 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.000184618998900987 1452.69995117188 485.2406 1452.69970703125 485.240509033203 3 10 1.1.1.3452.3 1 32.5183 10084.02 32.2639 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.17999958992 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.000459270988358185 1452.7001953125 485.2407 1452.69970703125 485.240509033203 3 10 1.1.1.3431.12 1 31.9978 67453.24 31.9087 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 DEPPQSPWDRVK Oxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 -0.00238385004922748 1468.6923828125 490.5714 1468.69470214844 490.572174072266 3 11 1.1.1.3273.11 1 28.0931 8646.283 28.057 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.00257088011130691 1452.70251464844 727.3585 1452.69970703125 727.357177734375 2 8 1.1.1.3448.21 1 32.433 2687.361 32.1647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.4699985980988 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.000459270988358185 1452.7001953125 485.2407 1452.69970703125 485.240509033203 3 9 1.1.1.3459.3 1 32.6887 7790.521 32.4382 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.8700013160706 DEPPQSPWDRVK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10 0.00181441998574883 1456.69653320313 729.3555 1456.69470214844 729.354614257813 2 8 1.1.1.3268.8 1 27.9751 646.171 27.9583 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.4699971675873 DEPPQSPWDRVK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 -0.00193289003800601 1484.68774414063 495.9032 1484.68957519531 495.90380859375 3 8 1.1.1.3115.14 1 24.2476 3161.71 24.384 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.3199980258942 DEPPQSPWDRVK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 -0.00138359004631639 1484.68835449219 495.9034 1484.68957519531 495.90380859375 3 8 1.1.1.3108.8 1 24.0655 823.0134 24.0265 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.3899984359741 DEPPQSPWDRVK Oxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 0.00512330001220107 1468.69995117188 490.5739 1468.69470214844 490.572174072266 3 8 1.1.1.3081.7 1 23.3942 473.6667 23.3319 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 DEPPQSPWDRVK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 -0.00193289003800601 1484.68774414063 495.9032 1484.68957519531 495.90380859375 3 8 1.1.1.3122.15 1 24.4243 3161.71 24.384 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.000184618998900987 1452.69995117188 485.2406 1452.69970703125 485.240509033203 3 9 1.1.1.3375.7 1 30.6086 21355.93 30.8478 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.000459270988358185 1452.7001953125 485.2407 1452.69970703125 485.240509033203 3 9 1.1.1.3396.5 1 31.1255 42274.53 31.1194 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.889999628067 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.000459270988358185 1452.7001953125 485.2407 1452.69970703125 485.240509033203 3 9 1.1.1.3403.4 1 31.2967 42274.53 31.1194 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.889999628067 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.000184618998900987 1452.69995117188 485.2406 1452.69970703125 485.240509033203 3 9 1.1.1.3417.4 1 31.6402 63543.89 31.8834 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 DEPPQSPWDRVK Oxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 0.00274298992007971 1468.69738769531 490.5731 1468.69470214844 490.572174072266 3 8 1.1.1.3295.10 1 28.6342 1394.084 28.5991 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.000825472990982234 1452.70056152344 485.2408 1452.69970703125 485.240509033203 3 8 1.1.1.3466.2 1 32.8598 4729.576 32.6106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.7500007152557 DEPPQSPWDRVK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 -0.000742734991945326 1484.68896484375 495.9036 1484.68957519531 495.90380859375 3 10 1.1.1.3213.5 1 26.6234 10060.45 26.6143 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.7500007152557 DEPPQSPWDRVK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 0.00282774004153907 1484.69250488281 495.9048 1484.68957519531 495.90380859375 3 10 1.1.1.3249.5 1 27.5051 3031.389 27.4447 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 DEPPQSPWDRVK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 -0.004404759965837 1484.68505859375 495.9023 1484.68957519531 495.90380859375 3 9 1.1.1.3241.7 1 27.3089 3441.823 27.2981 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 DEPPQSPWDRVK Oxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 -0.00238385004922748 1468.6923828125 490.5714 1468.69470214844 490.572174072266 3 9 1.1.1.3266.5 1 27.9152 8646.283 28.057 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00475814985111356 2669.375 668.351 2669.3701171875 668.349792480469 4 14 1.1.1.4610.6 1 62.137 157583.5 62.332 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000271614990197122 2669.36962890625 890.7972 2669.3701171875 890.797302246094 3 16 1.1.1.4610.10 1 62.1403 77891.1 62.332 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00393360992893577 2669.3662109375 890.796 2669.3701171875 890.797302246094 3 14 1.1.1.4639.6 1 62.869 57779.6 62.6095 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000856924976687878 2669.36938476563 668.3496 2669.3701171875 668.349792480469 4 15 1.1.1.4645.2 1 63.0167 59448.11 62.761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00411670980975032 2669.3662109375 890.796 2669.3701171875 890.797302246094 3 14 1.1.1.4646.9 1 63.0477 13396.13 63.0378 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00411670980975032 2669.3662109375 890.796 2669.3701171875 890.797302246094 3 16 1.1.1.4647.3 1 63.0678 13396.13 63.0378 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00411670980975032 2669.3662109375 890.796 2669.3701171875 890.797302246094 3 18 1.1.1.4648.7 1 63.0962 13295.05 63.0629 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00155937997624278 2669.37182617188 890.7979 2669.3701171875 890.797302246094 3 15 1.1.1.4667.4 1 63.5742 8070.636 63.3142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00539840990677476 2669.36450195313 890.7955 2669.3701171875 890.797302246094 3 17 1.1.1.4676.2 1 63.7947 6753.661 63.8882 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00631996989250183 2669.37622070313 890.7994 2669.3701171875 890.797302246094 3 15 1.1.1.4683.2 1 63.9692 7324.737 64.0129 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00631996989250183 2669.37622070313 890.7994 2669.3701171875 890.797302246094 3 13 1.1.1.4693.10 1 64.2247 7324.737 64.0129 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00301811005920172 2669.3671875 890.7963 2669.3701171875 890.797302246094 3 13 1.1.1.4706.12 1 64.5559 3714.848 64.4921 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.0041123297996819 2673.36889648438 669.3495 2673.36499023438 669.348510742188 4 14 1.1.1.4502.12 1 59.3326 45796.34 59.1351 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00475814985111356 2669.375 668.351 2669.3701171875 668.349792480469 4 13 1.1.1.4617.3 1 62.3117 163492.7 62.3571 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00475814985111356 2669.375 668.351 2669.3701171875 668.349792480469 4 13 1.1.1.4624.3 1 62.4886 163492.7 62.3571 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00598372984677553 2669.3642578125 668.3483 2669.3701171875 668.349792480469 4 13 1.1.1.4631.6 1 62.6676 157008.4 62.4077 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00426987977698445 2669.37451171875 668.3509 2669.3701171875 668.349792480469 4 13 1.1.1.4638.3 1 62.8415 109136.7 62.5844 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00411670980975032 2669.3662109375 890.796 2669.3701171875 890.797302246094 3 13 1.1.1.4650.7 1 63.1465 13295.05 63.0629 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000368657987564802 2669.36962890625 668.3497 2669.3701171875 668.349792480469 4 13 1.1.1.4652.2 1 63.1925 22953.13 63.2136 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000368657987564802 2669.36962890625 668.3497 2669.3701171875 668.349792480469 4 13 1.1.1.4659.3 1 63.369 22953.13 63.2136 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00426987977698445 2669.37451171875 668.3509 2669.3701171875 668.349792480469 4 13 1.1.1.4666.2 1 63.5444 14783.3 63.4395 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00158933002967387 2669.36865234375 668.3494 2669.3701171875 668.349792480469 4 13 1.1.1.4680.4 1 63.8939 11974.89 63.8882 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000856924976687878 2669.36938476563 668.3496 2669.3701171875 668.349792480469 4 13 1.1.1.4694.6 1 64.2472 14927.21 63.9879 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00265191006474197 2669.36743164063 890.7964 2669.3701171875 890.797302246094 3 12 1.1.1.4698.7 1 64.349 4683.216 64.366 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000124525002320297 2669.3701171875 668.3498 2669.3701171875 668.349792480469 4 13 1.1.1.4701.3 1 64.424 8728.873 64.366 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.0041123297996819 2673.36889648438 669.3495 2673.36499023438 669.348510742188 4 13 1.1.1.4495.11 1 59.1476 45796.34 59.1351 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000630819995421916 2685.36450195313 672.3484 2685.36499023438 672.348510742188 4 13 1.1.1.4573.5 1 61.1965 8408.603 61.1894 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000856924976687878 2669.36938476563 668.3496 2669.3701171875 668.349792480469 4 12 1.1.1.4687.4 1 64.0684 14433.53 64.0129 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00265191006474197 2669.36743164063 890.7964 2669.3701171875 890.797302246094 3 12 1.1.1.4699.10 1 64.3772 4683.216 64.366 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000405664992285892 2701.35986328125 676.3472 2701.35986328125 676.347229003906 4 13 1.1.1.4451.8 1 57.9889 64644.65 57.7185 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00411670980975032 2669.3662109375 890.796 2669.3701171875 890.797302246094 3 12 1.1.1.4651.8 1 63.1725 13295.05 63.0629 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00647199992090464 2669.36376953125 668.3482 2669.3701171875 668.349792480469 4 12 1.1.1.4715.3 1 64.7848 7365.093 64.6737 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK MDA adduct +62(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.0151399001479149 2731.37060546875 683.8499 2731.3857421875 683.853698730469 4 10 1.1.1.4562.10 1 60.9155 2228.635 60.93 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000368657987564802 2669.36962890625 668.3497 2669.3701171875 668.349792480469 4 11 1.1.1.4673.2 1 63.7185 8990.081 63.714 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000856924976687878 2669.36938476563 668.3496 2669.3701171875 668.349792480469 4 11 1.1.1.4708.5 1 64.6022 7392.377 64.5687 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00646708020940423 2669.37646484375 668.3514 2669.3701171875 668.349792480469 4 9 1.1.1.4753.8 1 65.7772 1436.696 65.7426 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00573959993198514 2669.36450195313 668.3484 2669.3701171875 668.349792480469 4 9 1.1.1.4722.5 1 64.9693 6328.845 64.7261 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00287734996527433 2701.36303710938 676.348 2701.35986328125 676.347229003906 4 13 1.1.1.4436.14 1 57.6031 62993.19 57.7185 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00524641014635563 2669.37524414063 668.3511 2669.3701171875 668.349792480469 4 9 1.1.1.4738.3 1 65.3858 2425.872 65.406 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.0135469995439053 2669.3837890625 668.3532 2669.3701171875 668.349792480469 4 8 1.1.1.4760.6 1 65.9547 1331.783 65.947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00149272999260575 2701.3583984375 901.4601 2701.35986328125 901.460571289063 3 11 1.1.1.4456.20 1 58.1299 15970.52 57.8487 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00785022042691708 2673.357421875 669.3466 2673.36499023438 669.348510742188 4 9 1.1.1.4482.8 1 58.8024 24683.79 59.0556 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Arg->GluSA(R)@10; acrolein addition +56(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.0157296992838383 2682.35864257813 671.5969 2682.3427734375 671.593017578125 4 12 1.1.1.4482.9 1 58.8032 4800.942 58.7921 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.0100221000611782 2673.35498046875 892.1256 2673.36499023438 892.128967285156 3 11 1.1.1.4507.20 1 59.4708 18450.03 59.2136 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00614127982407808 2673.35888671875 669.347 2673.36499023438 669.348510742188 4 11 1.1.1.4509.11 1 59.5166 36665.92 59.24 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000405664992285892 2701.35986328125 676.3472 2701.35986328125 676.347229003906 4 11 1.1.1.4444.14 1 57.8115 62993.19 57.7185 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00180305994581431 2701.36181640625 901.4612 2701.35986328125 901.460571289063 3 11 1.1.1.4453.18 1 58.0494 19293.16 57.7708 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 DEPPQSPWDRVKDLATVYVDVLK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.0122338999062777 2685.35278320313 896.1249 2685.36499023438 896.128967285156 3 11 1.1.1.4559.13 1 60.8391 4785.99 60.7977 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00915747042745352 2669.36083984375 668.3475 2669.3701171875 668.349792480469 4 8 1.1.1.4781.10 1 66.5053 754.5737 66.4933 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 DEPPQSPWDRVKDLATVYVDVLK Deamidated(Q)@5; acrolein addition +56(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.0148393996059895 2726.39526367188 682.6061 2726.38037109375 682.602355957031 4 8 1.1.1.4613.7 1 62.2141 1565.589 62.0788 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4699974060059 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00793679989874363 2669.36206054688 668.3478 2669.3701171875 668.349792480469 4 7 1.1.1.4767.9 1 66.1385 1131.495 66.0498 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4699974060059 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000124525002320297 2669.3701171875 668.3498 2669.3701171875 668.349792480469 4 7 1.1.1.4774.8 1 66.3209 1031.513 66.337 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.079998254776 DEPPQSPWDRVKDLATVYVDVLK MDA adduct +62(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.0151399001479149 2731.37060546875 683.8499 2731.3857421875 683.853698730469 4 7 1.1.1.4494.13 1 59.1231 1506.603 59.1082 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.079998254776 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00711781997233629 2673.35766601563 669.3467 2673.36499023438 669.348510742188 4 10 1.1.1.4516.9 1 59.7022 20566.38 59.4244 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.1000025272369 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00471219979226589 2673.3603515625 892.1274 2673.36499023438 892.128967285156 3 9 1.1.1.4513.21 1 59.6312 12969.51 59.3453 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7700023651123 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00626487005501986 2701.35375976563 676.3457 2701.35986328125 676.347229003906 4 10 1.1.1.4458.12 1 58.1754 37126.66 57.9006 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.7200012207031 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8; MDA adduct +54(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.0286062005907297 2755.39892578125 919.4736 2755.37036132813 919.464111328125 3 10 1.1.1.5071.15 1 74.2281 7349.749 74.3467 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.1000006198883 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8; acrolein addition +38(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.0124180996790528 2711.39306640625 678.8555 2711.38061523438 678.852416992188 4 8 1.1.1.4856.11 1 68.5105 483.9409 68.5241 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.8599984645844 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8; MDA adduct +54(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.0286062005907297 2755.39892578125 919.4736 2755.37036132813 919.464111328125 3 11 1.1.1.5078.14 1 74.4163 7349.749 74.3467 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 DEPPQSPWDRVKDLATVYVDVLK Carbamidomethyl@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.00338176009245217 2726.38818359375 682.6043 2726.3916015625 682.605163574219 4 7 1.1.1.5016.13 1 72.7445 441.7624 72.7565 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 DEPPQSPWDRVKDLATVYVDVLK acrolein addition +38(K)@12; Dehydrated(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.0145423002541065 2689.36059570313 673.3474 2689.37524414063 673.35107421875 4 11 1.1.1.4416.16 1 57.0868 6355.773 57.0444 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 38.1399989128113 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00524641014635563 2669.37524414063 668.3511 2669.3701171875 668.349792480469 4 6 1.1.1.4746.7 1 65.5971 2426.712 65.4327 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.480001449585 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00999153032898903 2669.38012695313 668.3523 2669.3701171875 668.349792480469 4 5 1.1.1.4867.4 1 68.8023 444.301 68.8756 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 22.4999994039536 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 -0.000368657987564802 2669.36962890625 668.3497 2669.3701171875 668.349792480469 4 6 1.1.1.4826.7 1 67.7035 628.8688 67.6931 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.4399996399879 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.00793187972158194 2669.37817382813 668.3518 2669.3701171875 668.349792480469 4 6 1.1.1.4840.9 1 68.0774 565.5394 68.0393 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.0021860699634999 3116.54370117188 780.1432 3116.54150390625 780.142639160156 4 17 1.1.1.4520.19 1 59.8175 6629.736 59.8504 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00617319019511342 3084.5576171875 617.9188 3084.55151367188 617.917602539063 5 13 1.1.1.4716.3 1 64.8107 16207.84 65.066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00831014011055231 3084.56005859375 1029.194 3084.55151367188 1029.19116210938 3 14 1.1.1.4726.18 1 65.085 4717.696 65.066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00373213994316757 3084.55541992188 772.1461 3084.55151367188 772.145202636719 4 17 1.1.1.4733.8 1 65.2586 19767.76 65.066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00373213994316757 3084.55541992188 772.1461 3084.55151367188 772.145202636719 4 11 1.1.1.4761.8 1 65.9821 1246.84 65.9725 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00446452992036939 3084.55615234375 772.1463 3084.55151367188 772.145202636719 4 12 1.1.1.4768.11 1 66.1666 1606.214 66.2062 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 -0.00302257994189858 3088.54345703125 773.1431 3088.54663085938 773.143920898438 4 13 1.1.1.4544.14 1 60.4465 5210.319 60.5374 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 -0.00302257994189858 3088.54345703125 773.1431 3088.54663085938 773.143920898438 4 13 1.1.1.4552.13 1 60.6561 5210.319 60.5374 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00617319019511342 3084.5576171875 617.9188 3084.55151367188 617.917602539063 5 13 1.1.1.4726.4 1 65.0733 16093.99 65.066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00373213994316757 3084.55541992188 772.1461 3084.55151367188 772.145202636719 4 12 1.1.1.4740.8 1 65.4423 4523.951 65.3797 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00152347004041076 3116.54321289063 624.3159 3116.54150390625 624.315551757813 5 12 1.1.1.4527.6 1 59.9907 7889.901 59.8504 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.0062019401229918 3088.55249023438 618.7178 3088.54663085938 618.716613769531 5 12 1.1.1.4546.8 1 60.4948 4629.744 60.5374 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00373213994316757 3084.55541992188 772.1461 3084.55151367188 772.145202636719 4 9 1.1.1.4714.9 1 64.7634 15232.49 64.9621 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00617319019511342 3084.5576171875 617.9188 3084.55151367188 617.917602539063 5 11 1.1.1.4718.3 1 64.8624 15952.98 65.066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00464814994484186 3084.55712890625 1029.193 3084.55151367188 1029.19116210938 3 9 1.1.1.4719.17 1 64.9004 4167.018 64.9621 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00373213994316757 3084.55541992188 772.1461 3084.55151367188 772.145202636719 4 9 1.1.1.4747.9 1 65.6249 4522.134 65.3797 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.0131919998675585 3084.56469726563 617.9202 3084.55151367188 617.917602539063 5 10 1.1.1.4737.2 1 65.3586 13302.8 65.0927 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.0108120003715158 3084.5625 772.1479 3084.55151367188 772.145202636719 4 8 1.1.1.4754.6 1 65.801 1141.106 65.8701 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5400021076202 DEPPQSPWDRVKDLATVYVDVLKDSGR Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00152347004041076 3116.54321289063 624.3159 3116.54150390625 624.315551757813 5 11 1.1.1.4520.10 1 59.8099 7889.901 59.8504 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.079998254776 DEPPQSPWDRVKDLATVYVDVLKDSGR Deamidated(Q)@5 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.0569794997572899 3085.59252929688 618.1258 3085.53564453125 618.114379882813 5 5 1.1.1.4823.8 1 67.6234 176.507 67.5869 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.4699981212616 DEPPQSPWDRVKDLATVYVDVLKDSGR Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.00349854002706707 3088.55029296875 1030.524 3088.54663085938 1030.52282714844 3 8 1.1.1.4546.19 1 60.504 1600.767 60.5636 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0213163997977972 4482.21923828125 748.0438 4482.19775390625 748.040283203125 6 16 1.1.1.4483.14 1 58.8339 8721.842 58.8974 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0135907996445894 4498.20654296875 750.7084 4498.19287109375 750.706115722656 6 22 1.1.1.4718.7 1 64.8658 35594.54 64.936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0135907996445894 4498.20654296875 750.7084 4498.19287109375 750.706115722656 6 19 1.1.1.4725.6 1 65.0482 39782.02 65.066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0135907996445894 4498.20654296875 750.7084 4498.19287109375 750.706115722656 6 18 1.1.1.4732.8 1 65.2323 39782.02 65.066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0220133997499943 4498.21484375 750.7098 4498.19287109375 750.706115722656 6 18 1.1.1.4739.7 1 65.4158 25450.78 65.3534 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0316949002444744 4498.224609375 900.6522 4498.19287109375 900.645874023438 5 15 1.1.1.4742.11 1 65.4979 38437.45 65.2225 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0194805003702641 4470.21728515625 746.0435 4470.19775390625 746.040283203125 6 19 1.1.1.4766.5 1 66.1091 24169.81 66.3107 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0103254998102784 4470.20849609375 746.042 4470.19775390625 746.040283203125 6 20 1.1.1.4773.2 1 66.2896 25249.73 66.3632 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0103254998102784 4470.20849609375 746.042 4470.19775390625 746.040283203125 6 18 1.1.1.4780.3 1 66.473 25249.73 66.3632 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7; Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.017306299880147 4486.21044921875 898.2493 4486.19287109375 898.245849609375 5 15 1.1.1.4702.4 1 64.4497 7413.276 64.3916 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0313896983861923 4498.22412109375 900.6521 4498.19287109375 900.645874023438 5 14 1.1.1.4728.10 1 65.1301 52642.07 65.0927 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0181610994040966 4470.2158203125 895.0505 4470.19775390625 895.046875 5 14 1.1.1.4758.11 1 65.9079 28072.96 66.1537 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00362546998076141 4466.20703125 745.3751 4466.203125 745.374450683594 6 21 1.1.1.4890.5 1 69.4265 105941.6 69.5696 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0192453991621733 4466.22216796875 894.2517 4466.203125 894.247863769531 5 16 1.1.1.4895.2 1 69.556 186802.7 69.5943 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00362546998076141 4466.20703125 745.3751 4466.203125 745.374450683594 6 21 1.1.1.4897.2 1 69.598 105941.6 69.5696 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00282260007224977 4466.20654296875 1117.559 4466.203125 1117.55798339844 4 16 1.1.1.4901.4 1 69.7127 53653.25 69.5696 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0192453991621733 4466.22216796875 894.2517 4466.203125 894.247863769531 5 18 1.1.1.4902.2 1 69.7241 186802.7 69.5943 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00282260007224977 4466.20654296875 1117.559 4466.203125 1117.55798339844 4 19 1.1.1.4903.5 1 69.7622 53653.25 69.5696 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00362546998076141 4466.20703125 745.3751 4466.203125 745.374450683594 6 22 1.1.1.4904.2 1 69.7752 105941.6 69.5696 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; Dehydrated(S)@6; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.000648125016596168 4507.21875 902.451 4507.21826171875 902.450927734375 5 24 1.1.1.4905.2 1 69.8116 4365.171 69.8168 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00233434000983834 4466.20654296875 1117.559 4466.203125 1117.55798339844 4 17 1.1.1.4906.4 1 69.8362 54446.34 69.5696 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00331085990183055 4466.20654296875 1117.559 4466.203125 1117.55798339844 4 17 1.1.1.4907.6 1 69.8576 52803.45 69.5943 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0265692993998528 4466.2294921875 894.2532 4466.203125 894.247863769531 5 17 1.1.1.4909.3 1 69.9042 183351.1 69.6437 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0190057996660471 4466.22216796875 745.3776 4466.203125 745.374450683594 6 23 1.1.1.4911.4 1 69.9504 94683.31 69.6932 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0120479995384812 4466.21533203125 745.3765 4466.203125 745.374450683594 6 17 1.1.1.4918.3 1 70.1231 66152.6 69.8662 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0180246997624636 4466.22119140625 894.2515 4466.203125 894.247863769531 5 17 1.1.1.4923.10 1 70.2496 90979.66 69.9896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.011315600015223 4466.2138671875 745.3763 4466.203125 745.374450683594 6 18 1.1.1.4925.8 1 70.299 44840.54 70.039 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0164988990873098 4466.2197265625 894.2512 4466.203125 894.247863769531 5 16 1.1.1.4930.14 1 70.433 56436.31 70.1635 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00106208003126085 4466.20361328125 745.3746 4466.203125 745.374450683594 6 17 1.1.1.4939.11 1 70.6695 15712.6 70.3921 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00282260007224977 4466.20654296875 1117.559 4466.203125 1117.55798339844 4 16 1.1.1.4908.4 1 69.8855 50148.08 69.619 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0313896983861923 4498.22412109375 900.6521 4498.19287109375 900.645874023438 5 13 1.1.1.4718.13 1 64.8708 51199.65 64.936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0227457992732525 4498.2158203125 750.7099 4498.19287109375 750.706115722656 6 13 1.1.1.4746.8 1 65.598 25696.55 65.327 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0184662993997335 4470.2158203125 895.0505 4470.19775390625 895.046875 5 13 1.1.1.4792.13 1 66.7987 25948.41 66.5197 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00922688003629446 4470.20703125 746.0418 4470.19775390625 746.040283203125 6 13 1.1.1.4794.3 1 66.8433 11895.02 66.7308 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Hydroxykynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0205441005527973 4486.21337890625 748.7095 4486.19287109375 748.706115722656 6 13 1.1.1.4699.5 1 64.373 4839.327 64.366 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0169791001826525 4498.2109375 1125.56 4498.19287109375 1125.55554199219 4 12 1.1.1.4732.20 1 65.2423 13873.02 65.066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7; Oxidation(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0301690995693207 4498.22314453125 900.6519 4498.19287109375 900.645874023438 5 14 1.1.1.4711.11 1 64.6868 49032.71 64.936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0136297000572085 4482.21142578125 897.4496 4482.19775390625 897.446838378906 5 12 1.1.1.4852.12 1 68.4024 6075.218 68.2008 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0282316002994776 4470.22607421875 895.0525 4470.19775390625 895.046875 5 12 1.1.1.4765.9 1 66.0865 37951.21 66.2325 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0136901000514627 4498.20654296875 900.6486 4498.19287109375 900.645874023438 5 12 1.1.1.4785.11 1 66.6113 3830.068 66.337 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +62(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0110336001962423 4528.2294921875 755.7122 4528.21875 755.710388183594 6 9 1.1.1.4842.10 1 68.1312 1629.353 68.1729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5400021076202 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7; Oxidation(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0313896983861923 4498.22412109375 900.6521 4498.19287109375 900.645874023438 5 13 1.1.1.4735.11 1 65.3133 52642.07 65.0927 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.4899997711182 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0192453991621733 4466.22216796875 894.2517 4466.203125 894.247863769531 5 15 1.1.1.4888.9 1 69.3767 184525.5 69.5696 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.4899997711182 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.00955766998231411 4466.19384765625 745.3729 4466.203125 745.374450683594 6 15 1.1.1.4946.9 1 70.8532 9466.395 70.5762 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0799973011017 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0143232000991702 4498.20751953125 750.7085 4498.19287109375 750.706115722656 6 11 1.1.1.4753.9 1 65.7781 14200.6 65.5114 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0799973011017 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0227457992732525 4498.2158203125 750.7099 4498.19287109375 750.706115722656 6 11 1.1.1.4760.7 1 65.9555 4823.512 65.8445 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0799973011017 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@3; Oxidation(P)@4 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00297100003808737 4498.19580078125 750.7066 4498.19287109375 750.706115722656 6 11 1.1.1.4776.5 1 66.3708 2988.84 66.2325 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4699974060059 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@4; Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.017467400059104 4498.2109375 1125.56 4498.19287109375 1125.55554199219 4 11 1.1.1.4740.19 1 65.4514 7994.443 65.3797 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1000015735626 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.00547786010429263 4466.19873046875 1117.557 4466.203125 1117.55798339844 4 15 1.1.1.4914.7 1 70.0338 38011.01 69.7675 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.079998254776 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00523839984089136 4466.2080078125 745.3753 4466.203125 745.374450683594 6 8 1.1.1.4678.6 1 63.8456 1653.616 63.8133 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.079998254776 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.016490900889039 4498.2109375 1125.56 4498.19287109375 1125.55554199219 4 10 1.1.1.4720.18 1 64.9283 13229.61 64.936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6300029754639 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00282260007224977 4466.20654296875 1117.559 4466.203125 1117.55798339844 4 14 1.1.1.4899.6 1 69.6582 53653.25 69.5696 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6300029754639 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00282260007224977 4466.20654296875 1117.559 4466.203125 1117.55798339844 4 14 1.1.1.4900.6 1 69.6846 53653.25 69.5696 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6300029754639 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00948012992739677 4466.212890625 894.2498 4466.203125 894.247863769531 5 14 1.1.1.4916.2 1 70.0701 137994.5 69.8168 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6300029754639 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00179448002018034 4466.205078125 745.3748 4466.203125 745.374450683594 6 14 1.1.1.4932.8 1 70.4806 28002.87 70.2137 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6300029754639 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trimethyl(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.0327932015061378 4508.21728515625 902.6507 4508.25 902.657287597656 5 16 1.1.1.5084.12 1 74.5771 6109.309 74.5898 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8900003433228 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +62(K)@12; Dehydrated(T)@16 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00789915025234222 4510.2158203125 903.0505 4510.2080078125 903.048889160156 5 15 1.1.1.5083.13 1 74.5512 10629 74.5898 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.4699981212616 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0238797999918461 4482.22216796875 748.0443 4482.19775390625 748.040283203125 6 10 1.1.1.4515.12 1 59.6778 6770.716 59.7709 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.4699981212616 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.00779274012893438 4466.19482421875 894.2463 4466.203125 894.247863769531 5 9 1.1.1.4675.4 1 63.7716 2340.23 63.7886 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2599990367889 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00282260007224977 4466.20654296875 1117.559 4466.203125 1117.55798339844 4 13 1.1.1.4891.9 1 69.4599 53653.25 69.5696 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2599990367889 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; Dehydrated(S)@6; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0192632004618645 4507.2373046875 902.4548 4507.21826171875 902.450927734375 5 15 1.1.1.4912.5 1 69.981 4500.333 69.7179 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2599990367889 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00673364987596869 4466.20947265625 894.2492 4466.203125 894.247863769531 5 13 1.1.1.4943.13 1 70.7769 20225.52 70.4967 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2599990367889 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.00181096000596881 4466.201171875 894.2475 4466.203125 894.247863769531 5 13 1.1.1.4951.16 1 70.9925 12546.86 70.7096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.9299988746643 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.00590089010074735 4482.19189453125 897.4457 4482.19775390625 897.446838378906 5 10 1.1.1.4485.17 1 58.8888 14917.45 58.8974 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1599972248077 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0118591003119946 4498.20458984375 900.6482 4498.19287109375 900.645874023438 5 9 1.1.1.4849.12 1 68.3222 2477.764 68.2542 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.7200016975403 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; reduced acrolein addition +58(K)@12; Dehydrated(T)@16 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00278428010642529 4507.22119140625 902.4515 4507.21826171875 902.450927734375 5 14 1.1.1.4923.11 1 70.2504 2318.682 70.2137 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.1400017738342 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.016490900889039 4498.2109375 1125.56 4498.19287109375 1125.55554199219 4 10 1.1.1.4721.20 1 64.956 13229.61 64.936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.9300026893616 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +76(K)@12; Lys->Allysine(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00216376991011202 4541.20458984375 909.2482 4541.20263671875 909.247802734375 5 14 1.1.1.4966.16 1 71.396 2374.99 71.4054 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.0200006961823 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; reduced acrolein addition +58(K)@12; Oxidation(Y)@18 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.00889516994357109 4541.21435546875 909.2502 4541.2236328125 909.252014160156 5 14 1.1.1.4875.12 1 69.0257 2481.903 69.0384 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.2799999713898 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.00498959003016353 4466.19873046875 1117.557 4466.203125 1117.55798339844 4 11 1.1.1.4915.7 1 70.0585 34413.03 69.7922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.2799999713898 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.00242128991521895 4466.20068359375 894.2474 4466.203125 894.247863769531 5 11 1.1.1.4958.17 1 71.1817 9447.301 70.8952 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.319997549057 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; Methyl(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0159754995256662 4481.21826171875 897.251 4481.20263671875 897.247802734375 5 13 1.1.1.4913.3 1 69.9991 1267.03 69.9896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.319997549057 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0061233201995492 4466.208984375 894.2491 4466.203125 894.247863769531 5 10 1.1.1.4995.19 1 72.1806 1987.743 72.1334 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.2499997615814 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0164988990873098 4466.2197265625 894.2512 4466.203125 894.247863769531 5 9 1.1.1.4919.11 1 70.1499 119995.6 69.8907 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.1000006198883 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.009262690320611 4498.20166015625 750.7076 4498.19287109375 750.706115722656 6 11 1.1.1.4860.6 1 68.6142 1023.304 68.6037 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.8599984645844 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0123036000877619 4482.2099609375 748.0423 4482.19775390625 748.040283203125 6 12 1.1.1.4869.7 1 68.8586 5913.79 68.8487 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.7000026702881 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0149731002748013 4466.21826171875 894.2509 4466.203125 894.247863769531 5 10 1.1.1.4937.12 1 70.617 35272.55 70.3406 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.7000026702881 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00551299005746841 4466.20849609375 894.249 4466.203125 894.247863769531 5 10 1.1.1.4944.12 1 70.8023 18949.89 70.5231 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.7000026702881 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.00113511004019529 4466.2021484375 745.3743 4466.203125 745.374450683594 6 10 1.1.1.4953.11 1 71.0416 5118.979 70.7622 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.7000026702881 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -3.65152991435025E-05 4466.20361328125 745.3745 4466.203125 745.374450683594 6 10 1.1.1.4961.14 1 71.26 3868.227 70.9751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.0700023174286 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.0154208997264504 4524.22900390625 905.8531 4524.2451171875 905.856262207031 5 10 1.1.1.4916.4 1 70.0768 1017.652 70.0637 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK FormaldehydeAdduct(W)@8; MDA adduct +62(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.0053000901825726 4540.21337890625 909.0499 4540.21875 909.051025390625 5 11 1.1.1.4969.15 1 71.4758 2580.092 71.4054 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.2099995613098 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; acrolein addition +56(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0207019001245499 4523.23388671875 754.8796 4523.21337890625 754.876159667969 6 10 1.1.1.4886.6 1 69.32 4835.354 69.3919 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 53.7599980831146 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0131420996040106 4466.2158203125 894.2505 4466.203125 894.247863769531 5 8 1.1.1.4979.13 1 71.7425 3476.509 71.6206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.2599995136261 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK FormaldehydeAdduct(W)@8; acrolein addition +56(K)@12; acrolein addition +94(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.01995600014925 4628.291015625 772.3891 4628.27099609375 772.385803222656 6 9 1.1.1.4885.9 1 69.2951 1317.5 69.3104 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 47.6099997758865 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00233434000983834 4466.20654296875 1117.559 4466.203125 1117.55798339844 4 8 1.1.1.4927.20 1 70.3601 16157.28 70.0887 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.739999294281 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +56(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.037848599255085 4522.19140625 754.7059 4522.22900390625 754.712158203125 6 9 1.1.1.4899.4 1 69.6532 1807.253 69.6437 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.739999294281 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.000768912024796009 4466.2021484375 745.3743 4466.203125 745.374450683594 6 8 1.1.1.4975.10 1 71.6329 1922.106 71.5668 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.739999294281 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +62(K)@12; acrolein addition +56(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.0302684996277094 4584.27490234375 917.8623 4584.2451171875 917.856262207031 5 7 1.1.1.5093.14 1 74.8172 971.7972 74.7767 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.140000462532 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.00399166019633412 4466.20703125 745.3751 4466.203125 745.374450683594 6 7 1.1.1.5033.14 1 73.2049 588.606 73.0284 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.5300004482269 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.0714941024780273 4520.14208984375 905.0357 4520.21337890625 905.049987792969 5 9 1.1.1.4914.3 1 70.0221 2182.736 69.7675 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6300029754639 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.00992233958095312 5062.57763671875 844.7702 5062.5673828125 844.7685546875 6 14 1.1.1.4935.13 1 70.5642 20750.16 70.7096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.7699973583221 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.00992233958095312 5062.57763671875 844.7702 5062.5673828125 844.7685546875 6 14 1.1.1.4949.15 1 70.9384 20750.16 70.7096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2599990367889 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.00662400992587209 5062.57421875 724.2322 5062.5673828125 724.231201171875 7 13 1.1.1.4939.9 1 70.6678 7328.478 70.7359 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5900027751923 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.0161582008004189 5094.57373046875 850.1029 5094.5576171875 850.100158691406 6 10 1.1.1.4795.11 1 66.8766 7021.625 66.9433 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.5100018978119 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.000708144973032176 5062.568359375 1013.521 5062.5673828125 1013.52081298828 5 10 1.1.1.4939.18 1 70.6753 11137.18 70.7096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.3099994659424 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.00662400992587209 5062.57421875 724.2322 5062.5673828125 724.231201171875 7 10 1.1.1.4946.8 1 70.8524 7328.478 70.7359 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5999977588654 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.0271441992372274 5094.58447265625 850.1047 5094.5576171875 850.100158691406 6 9 1.1.1.4809.9 1 67.2503 6910.387 67.0503 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.2299976348877 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.000708144973032176 5062.568359375 1013.521 5062.5673828125 1013.52081298828 5 9 1.1.1.4946.19 1 70.8616 11137.18 70.7096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLK -0.000401625002268702 1234.68041992188 618.3475 1234.68090820313 618.347717285156 2 15 1.1.1.4151.11 1 50.3035 61227.98 50.3936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLK -0.000401625002268702 1234.68041992188 618.3475 1234.68090820313 618.347717285156 2 18 1.1.1.4158.12 1 50.4825 61227.98 50.3936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLK -0.000279556988971308 1234.6806640625 618.3476 1234.68090820313 618.347717285156 2 15 1.1.1.4165.10 1 50.6592 62359.46 50.3936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLK -0.00125610001850873 1234.6796875 618.3471 1234.68090820313 618.347717285156 2 16 1.1.1.4172.10 1 50.837 31919.61 50.5715 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLK -0.000889895018190145 1234.68005371094 618.3473 1234.68090820313 618.347717285156 2 13 1.1.1.4179.9 1 51.0154 14862.99 50.7496 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLK 0.0111948000267148 1234.69201660156 618.3533 1234.68090820313 618.347717285156 2 10 1.1.1.4193.7 1 51.3731 2381.916 51.3389 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLK 0.00716655980795622 1234.68811035156 618.3513 1234.68090820313 618.347717285156 2 9 1.1.1.4200.7 1 51.5512 1785.562 51.5173 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLK 0.00692242989316583 1234.68786621094 618.3512 1234.68090820313 618.347717285156 2 8 1.1.1.4215.7 1 51.9339 1453.133 51.9508 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLK 0.0266973990947008 1234.70764160156 618.3611 1234.68090820313 618.347717285156 2 8 1.1.1.4224.10 1 52.165 1520.496 52.2298 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLK 0.017298199236393 1234.6982421875 618.3564 1234.68090820313 618.347717285156 2 7 1.1.1.4231.10 1 52.3425 1843.601 52.4079 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLK 0.0115609997883439 1234.69250488281 618.3535 1234.68090820313 618.347717285156 2 7 1.1.1.4238.4 1 52.5164 1664.566 52.5358 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 DLATVYVDVLK Delta:H(2)C(2)@N-term -0.00968034006655216 1260.68688964844 631.3507 1260.69653320313 631.355529785156 2 8 1.1.1.4222.10 1 52.1143 1565.75 52.1287 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGR missed K-D@11 0.00223232991993427 1649.86486816406 550.9622 1649.86242675781 550.96142578125 3 16 1.1.1.4210.4 1 51.8037 11617.44 51.7976 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@11; missed R-D@15 0.00479369983077049 3031.51904296875 758.887 3031.51391601563 758.8857421875 4 16 1.1.1.4520.17 1 59.8158 155762.8 60.0085 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@11; missed R-D@15 -0.00441097002476454 3031.50830078125 1011.51 3031.51391601563 1011.51190185547 3 13 1.1.1.4520.20 1 59.8183 71605.85 60.0085 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@11; missed R-D@15 0.00479369983077049 3031.51904296875 758.887 3031.51391601563 758.8857421875 4 17 1.1.1.4527.13 1 59.9966 156016.3 60.0085 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@11; missed R-D@15 0.00479369983077049 3031.51904296875 758.887 3031.51391601563 758.8857421875 4 21 1.1.1.4534.18 1 60.1818 156016.3 60.0085 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK Trimethyl(K)@11 missed K-D@11; missed R-D@15 -0.0362611003220081 3073.52612304688 1025.516 3073.56079101563 1025.52758789063 3 15 1.1.1.4804.13 1 67.1199 3881.536 67.1318 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK Acetyl(S)@13 missed K-D@11; missed R-D@15 0.00525123020634055 3073.52905273438 1025.517 3073.5244140625 1025.51538085938 3 15 1.1.1.4810.17 1 67.2842 3885.57 67.2109 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK Acetyl(S)@13 missed K-D@11; missed R-D@15 0.00525123020634055 3073.52905273438 1025.517 3073.5244140625 1025.51538085938 3 16 1.1.1.4811.17 1 67.3101 3885.57 67.2109 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK Trimethyl(K)@11 missed K-D@11; missed R-D@15 -0.0507539995014668 3073.51025390625 769.3848 3073.56079101563 769.3974609375 4 12 1.1.1.4818.10 1 67.4919 1157.452 67.4791 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK Acetyl(S)@13 missed K-D@11; missed R-D@15 0.00561742018908262 3073.52905273438 1025.517 3073.5244140625 1025.51538085938 3 12 1.1.1.4818.19 1 67.4994 3955.852 67.2109 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK Amino(Y)@6; Delta:H(2)C(2)(K)@11 missed K-D@11; missed R-D@15 -0.00224723992869258 3072.5380859375 769.1418 3072.54028320313 769.142395019531 4 14 1.1.1.4544.13 1 60.4457 15303.56 60.3241 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK Acetyl(S)@13 missed K-D@11; missed R-D@15 0.00488502997905016 3073.52905273438 1025.517 3073.5244140625 1025.51538085938 3 8 1.1.1.4797.16 1 66.934 3777.011 67.1318 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7900018692017 DLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@11; Dioxidation(Y)@17 missed K-D@11; missed R-D@15 0.0417879000306129 3117.55615234375 780.3963 3117.51416015625 780.385864257813 4 15 1.1.1.5033.15 1 73.2057 1609.356 73.1358 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0799973011017 DLATVYVDVLKDSGRDYVSQFEGSALGK Dehydrated(T)@4; reduced acrolein addition +58(K)@11; Deamidated(Q)@20 missed K-D@11; missed R-D@15 0.00898616015911102 3072.5380859375 769.1418 3072.52905273438 769.139587402344 4 11 1.1.1.4537.14 1 60.259 15303.56 60.3241 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4699974060059 DLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl(K)@11 missed K-D@11; missed R-D@15 0.0023516200017184 3088.53784179688 773.1417 3088.53540039063 773.14111328125 4 10 1.1.1.4520.18 1 59.8166 3736.856 59.8244 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.0200006961823 DLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@11; Methyl(D)@16 missed K-D@11; missed R-D@15 -0.031927801668644 3103.53979492188 776.8922 3103.5712890625 776.900146484375 4 9 1.1.1.4954.13 1 71.0701 265.5956 71.0552 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.2799999713898 DLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@11; Dimethyl(R)@15 missed K-D@11; missed R-D@15 -0.0309830997139215 3117.55615234375 780.3963 3117.5869140625 780.404052734375 4 9 1.1.1.5026.9 1 73.0132 1609.356 73.1358 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK missed K-D@11; missed R-D@15; missed K-Q@28 0.00859836023300886 3627.88720703125 726.5847 3627.87841796875 726.582946777344 5 11 1.1.1.4560.6 1 60.86 5934.847 60.8509 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLEEVKAK missed K-A@6 -0.000324641005136073 930.501892089844 466.2582 930.502197265625 466.258392333984 2 10 1.1.1.2962.5 1 20.6941 6889.791 20.8542 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLEEVKAK missed K-A@6 -0.00233876006677747 930.499877929688 466.2572 930.502197265625 466.258392333984 2 12 1.1.1.2972.5 1 20.874 6821.257 20.829 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 DLEEVKAK Formyl(K)@6 missed K-A@6 -0.000682820973452181 958.496459960938 480.2555 958.497131347656 480.255828857422 2 11 1.1.1.3151.9 1 25.1254 2821.819 25.0921 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 DLEEVKAK Formyl@N-term missed K-A@6 -0.00709136994555593 958.490051269531 480.2523 958.497131347656 480.255828857422 2 9 1.1.1.3161.5 1 25.3682 1040.053 25.3834 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 DLEEVKAK Acetyl(K)@6 missed K-A@6 -0.00407399004325271 972.508666992188 487.2616 972.512756347656 487.263671875 2 11 1.1.1.3172.6 1 25.6453 15935.29 25.5568 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.3799986839294 DLEEVKAK missed K-A@6 -0.00276599009521306 930.499450683594 466.257 930.502197265625 466.258392333984 2 6 1.1.1.2989.6 1 21.236 1966.133 20.957 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 21.4900001883507 DLEEVKAK Carbamidomethyl(K)@8 missed K-A@6 -0.00548534980043769 987.518249511719 494.7664 987.523681640625 494.769104003906 2 6 1.1.1.2970.3 1 20.8237 276.8676 20.8793 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6799974441528 DLEEVKAKVQPYLDDFQKKWQEEMELYR ONE addition +154(K)@6; ONE addition +154(K)@8; Oxidation(M)@24 missed K-A@6; missed K-V@8; missed K-K@18; missed K-W@19 0.0210894998162985 3880.9697265625 971.2497 3880.94848632813 971.244384765625 4 11 1.1.1.4089.20 1 48.7282 8977.864 48.6069 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 DLEEVKAKVQPYLDDFQKKWQEEMELYR Methyl(D)@1; reduced acrolein addition +96(K)@6; ONE addition +154(K)@8; Oxidation(M)@24 missed K-A@6; missed K-V@8; missed K-K@18; missed K-W@19 0.0206013005226851 3836.94287109375 960.243 3836.92236328125 960.237854003906 4 12 1.1.1.4074.21 1 48.3475 12480.54 48.1748 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 DLEEVKAKVQPYLDDFQKKWQEEMELYR ONE addition +154(K)@6; ONE addition +154(K)@8; Oxidation(M)@24 missed K-A@6; missed K-V@8; missed K-K@18; missed K-W@19 0.0218219999223948 3880.97045898438 971.2499 3880.94848632813 971.244384765625 4 10 1.1.1.4082.21 1 48.5509 8954.524 48.5561 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 61.6199970245361 DLEEVKAKVQPYLDDFQKKWQEEMELYR acrolein addition +94(K)@6; Delta:H(4)C(2)(K)@8; hexanoyl addition +98(K)@18; Oxidation(M)@24 missed K-A@6; missed K-V@8; missed K-K@18; missed K-W@19 0.0240160003304482 3792.92016601563 949.2373 3792.89599609375 949.231323242188 4 11 1.1.1.4079.21 1 48.4747 8744.88 48.3781 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.000264434987911955 1814.84326171875 605.955 1814.84350585938 605.955139160156 3 11 1.1.1.3591.16 1 35.9912 2255.316 35.9003 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.0037871899548918 1814.84729003906 908.4309 1814.84350585938 908.429016113281 2 21 1.1.1.3617.9 1 36.6532 1683.854 36.6855 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.00172923994250596 1814.841796875 605.9545 1814.84350585938 605.955139160156 3 14 1.1.1.3624.8 1 36.8177 7290.874 36.6855 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Oxidation(Y)@6 missed R-D@4 -0.0121131995692849 1830.82629394531 611.2827 1830.83837890625 611.286743164063 3 17 1.1.1.3625.4 1 36.8423 3497.918 36.8083 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Oxidation(F)@10 missed R-D@4 -0.00818338990211487 1830.83020019531 611.284 1830.83837890625 611.286743164063 3 12 1.1.1.3711.17 1 39.0344 1906.707 39.1718 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Oxidation(F)@10 missed R-D@4 -0.00818338990211487 1830.83020019531 611.284 1830.83837890625 611.286743164063 3 16 1.1.1.3718.11 1 39.2099 1906.707 39.1718 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00547072011977434 1814.84887695313 605.9569 1814.84350585938 605.955139160156 3 23 1.1.1.3765.6 1 40.4229 476352.4 40.5901 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00104491994716227 1814.8447265625 908.4296 1814.84350585938 908.429016113281 2 24 1.1.1.3766.12 1 40.4604 306188.4 40.6399 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00547072011977434 1814.84887695313 605.9569 1814.84350585938 605.955139160156 3 24 1.1.1.3772.5 1 40.5997 476352.4 40.5901 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.000800787005573511 1814.84423828125 908.4294 1814.84350585938 908.429016113281 2 25 1.1.1.3773.12 1 40.6296 312670.1 40.6897 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Cation:Na(E)@11 missed R-D@4 -0.00139416998717934 1836.82409667969 613.282 1836.82543945313 613.282409667969 3 20 1.1.1.3776.4 1 40.6978 6783.172 40.6649 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00547072011977434 1814.84887695313 605.9569 1814.84350585938 605.955139160156 3 24 1.1.1.3779.7 1 40.7725 476417.2 40.7396 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.000800787005573511 1814.84423828125 908.4294 1814.84350585938 908.429016113281 2 24 1.1.1.3781.9 1 40.8338 312670.1 40.6897 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00547072011977434 1814.84887695313 605.9569 1814.84350585938 605.955139160156 3 22 1.1.1.3786.5 1 40.9501 476417.2 40.7396 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00309041002765298 1814.84655761719 605.9561 1814.84350585938 605.955139160156 3 22 1.1.1.3793.6 1 41.1221 342727.7 40.9876 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00785103999078274 1814.85131835938 605.9577 1814.84350585938 605.955139160156 3 22 1.1.1.3800.7 1 41.2927 262359.1 41.0369 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00675242999568582 1814.84997558594 605.9573 1814.84350585938 605.955139160156 3 21 1.1.1.3807.16 1 41.478 178796.2 41.2099 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00254109990783036 1814.84582519531 605.9559 1814.84350585938 605.955139160156 3 20 1.1.1.3814.14 1 41.661 59982.75 41.5403 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00254109990783036 1814.84582519531 605.9559 1814.84350585938 605.955139160156 3 18 1.1.1.3821.11 1 41.842 58939.38 41.5667 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.000710090971551836 1814.84411621094 605.9553 1814.84350585938 605.955139160156 3 17 1.1.1.3828.12 1 42.0258 29272.21 41.7516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 -0.00430883979424834 1840.85461425781 614.6255 1840.85913085938 614.627014160156 3 18 1.1.1.3831.11 1 42.1047 14930.78 42.0386 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.00734636001288891 1814.8359375 605.9526 1814.84350585938 605.955139160156 3 18 1.1.1.3835.14 1 42.2133 22060.31 41.9327 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.0029519300442189 1814.84045410156 605.9541 1814.84350585938 605.955139160156 3 18 1.1.1.3864.10 1 42.9635 6516.219 42.9269 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Formyl@N-term missed R-D@4 -0.00362704996950924 1842.83483886719 922.4247 1842.83837890625 922.426513671875 2 22 1.1.1.3865.20 1 42.9976 5768.727 43.0298 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00107629003468901 1814.84436035156 605.9554 1814.84350585938 605.955139160156 3 15 1.1.1.3751.11 1 40.0611 24525.95 40.3117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00821723975241184 1814.85168457031 605.9578 1814.84350585938 605.955139160156 3 16 1.1.1.3758.15 1 40.249 325875.5 40.4905 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Cation:Na(E)@11 missed R-D@4 -0.00139416998717934 1836.82409667969 613.282 1836.82543945313 613.282409667969 3 16 1.1.1.3769.7 1 40.525 6783.172 40.6649 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Cation:Na(E)@11 missed R-D@4 -0.00194347999058664 1836.82360839844 613.2818 1836.82543945313 613.282409667969 3 16 1.1.1.3783.5 1 40.8717 6704.589 40.6897 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00547072011977434 1814.84887695313 605.9569 1814.84350585938 605.955139160156 3 16 1.1.1.3785.8 1 40.9228 476417.2 40.7396 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.00734636001288891 1814.8359375 605.9526 1814.84350585938 605.955139160156 3 17 1.1.1.3850.16 1 42.6119 11744.45 42.3306 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 -0.00467504002153873 1840.8544921875 614.6254 1840.85913085938 614.627014160156 3 16 1.1.1.3852.6 1 42.6559 13177.93 42.5685 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.0029519300442189 1814.84045410156 605.9541 1814.84350585938 605.955139160156 3 16 1.1.1.3857.7 1 42.7837 6516.219 42.9269 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00522956997156143 1814.84899902344 454.7195 1814.84350585938 454.718139648438 4 13 1.1.1.3796.4 1 41.1905 5026.877 40.9381 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.000835133017972112 1814.84460449219 454.7184 1814.84350585938 454.718139648438 4 15 1.1.1.3767.3 1 40.4719 8251.514 40.6649 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.00771257001906633 1814.83569335938 605.9525 1814.84350585938 605.955139160156 3 15 1.1.1.3842.12 1 42.3974 17894.9 42.1718 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.000710090971551836 1814.84411621094 605.9553 1814.84350585938 605.955139160156 3 15 1.1.1.3900.8 1 43.8864 3672.49 43.9024 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.00441674003377557 1814.83898925781 605.9536 1814.84350585938 605.955139160156 3 12 1.1.1.3970.11 1 45.6629 1363.302 45.7787 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Nitro(Y)@6 missed R-D@4 -0.000970366003457457 1859.82763671875 620.9498 1859.82861328125 620.950134277344 3 16 1.1.1.3874.11 1 43.2245 8970.316 43.2645 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.000835133017972112 1814.84460449219 454.7184 1814.84350585938 454.718139648438 4 14 1.1.1.3789.2 1 41.0167 7075.478 40.7646 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Oxidation(Y)@6 missed R-D@4 -0.00397206004709005 1830.83435058594 611.2854 1830.83837890625 611.286743164063 3 13 1.1.1.3726.13 1 39.4193 3242.511 39.484 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Oxidation(F)@10 missed R-D@4 0.00894343014806509 1830.84716796875 611.2897 1830.83837890625 611.286743164063 3 12 1.1.1.3555.17 1 35.0646 1381.462 35.0241 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.0072213402017951 1814.83618164063 454.7163 1814.84350585938 454.718139648438 4 10 1.1.1.3811.5 1 41.5745 575.6666 41.5403 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.00547072011977434 1814.84887695313 605.9569 1814.84350585938 605.955139160156 3 12 1.1.1.3765.5 1 40.422 476352.4 40.5901 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.00405053980648518 1814.83923339844 605.9537 1814.84350585938 605.955139160156 3 14 1.1.1.3871.7 1 43.1426 6013.625 43.0557 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.00807876978069544 1814.83532714844 605.9524 1814.84350585938 605.955139160156 3 14 1.1.1.3888.15 1 43.5887 3477.607 43.5735 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.00807876978069544 1814.83532714844 605.9524 1814.84350585938 605.955139160156 3 13 1.1.1.3886.9 1 43.5328 3477.607 43.5735 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Cation:Na(E)@11 missed R-D@4 -0.00102796999271959 1836.82446289063 613.2821 1836.82543945313 613.282409667969 3 14 1.1.1.3790.5 1 41.0488 4146.235 41.0122 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Cation:Na(E)@11 missed R-D@4 -0.00102796999271959 1836.82446289063 613.2821 1836.82543945313 613.282409667969 3 12 1.1.1.3797.6 1 41.217 2395.627 41.1852 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 -0.00430883979424834 1840.85461425781 614.6255 1840.85913085938 614.627014160156 3 14 1.1.1.3824.11 1 41.9191 14930.78 42.0386 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Formyl@N-term missed R-D@4 -0.00809413008391857 1842.83056640625 615.2841 1842.83837890625 615.286743164063 3 14 1.1.1.3803.12 1 41.3719 3414.163 41.3344 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 -0.00826186966150999 1814.8349609375 605.9523 1814.84350585938 605.955139160156 3 13 1.1.1.3878.11 1 43.3295 5970.38 43.0557 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 -0.00467504002153873 1840.8544921875 614.6254 1840.85913085938 614.627014160156 3 12 1.1.1.3844.11 1 42.4493 13177.93 42.5685 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6599981784821 DSGRDYVSQFEGSALGK Oxidation(Y)@6 missed R-D@4 0.00305480998940766 1830.84143066406 916.428 1830.83837890625 916.426513671875 2 10 1.1.1.3624.13 1 36.826 759.7148 36.8083 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 DSGRDYVSQFEGSALGK Cation:Na(E)@11 missed R-D@4 -0.00527177983894944 1836.8203125 919.4174 1836.82543945313 919.419982910156 2 13 1.1.1.3773.13 1 40.6313 890.9387 40.615 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 DSGRDYVSQFEGSALGK Iodo(Y)@6 missed R-D@4 0.000615691998973489 1940.74047851563 647.9208 1940.74011230469 647.920654296875 3 13 1.1.1.3961.13 1 45.4355 2563.085 45.4219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2100009918213 DSGRDYVSQFEGSALGK Oxidation(Y)@6 missed R-D@4 -0.00397206004709005 1830.83435058594 611.2854 1830.83837890625 611.286743164063 3 10 1.1.1.3734.13 1 39.6299 3242.511 39.484 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 DSGRDYVSQFEGSALGK Methyl(E)@11 missed R-D@4 -0.00677852006629109 1828.85266113281 610.6248 1828.85913085938 610.627014160156 3 11 1.1.1.3950.14 1 45.1545 1509.325 45.1401 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9600012302399 DSGRDYVSQFEGSALGK missed R-D@4 0.00193278002552688 1814.84521484375 605.9557 1814.84350585938 605.955139160156 3 9 1.1.1.3631.13 1 36.9948 4278.708 36.7346 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 DSGRDYVSQFEGSALGK Dehydrated(S)@2 missed R-D@4 -0.00625611981377006 1796.82678222656 599.9495 1796.83288574219 599.951599121094 3 12 1.1.1.3734.11 1 39.6283 3805.768 39.6155 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 DSGRDYVSQFEGSALGK Carbamidomethyl(S)@13; Hypusine(K)@17 missed R-D@4 -0.00133561005350202 1958.93200683594 653.9846 1958.93334960938 653.985046386719 3 15 1.1.1.3826.16 1 41.9761 11126.67 41.9327 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6200003623962 DSGRDYVSQFEGSALGK Deamidated(Q)@9 missed R-D@4 -0.0256859008222818 1815.80163574219 606.2745 1815.82751464844 606.283142089844 3 11 1.1.1.3980.8 1 45.9167 2227.909 45.9066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.1500008106232 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 -0.00477991998195648 1840.85424804688 921.4344 1840.85913085938 921.436828613281 2 10 1.1.1.3845.21 1 42.4842 4346.259 42.595 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2399988174438 DSGRDYVSQFEGSALGK Cation:Na(E)@11 missed R-D@4 -0.00560550019145012 1836.81994628906 613.2806 1836.82543945313 613.282409667969 3 9 1.1.1.3762.14 1 40.3535 5981.716 40.5901 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.739999294281 DSGRDYVSQFEGSALGK Formyl(K)@17 missed R-D@4 0.00197643996216357 1842.84045410156 615.2874 1842.83837890625 615.286743164063 3 11 1.1.1.3855.10 1 42.7357 2597.483 42.6995 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 DSGRDYVSQFEGSALGK Carbamidomethyl@N-term; Deamidated(R)@4 missed R-D@4 -0.0217340998351574 1872.82727050781 625.283 1872.84899902344 625.290283203125 3 12 1.1.1.3765.8 1 40.4254 1153.885 40.4407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 DSGRDYVSQFEGSALGK Dehydrated(S)@8 missed R-D@4 -0.016143599525094 1796.81689453125 599.9462 1796.83288574219 599.951599121094 3 11 1.1.1.3771.6 1 40.5774 1139.421 40.5154 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1800026893616 DSGRDYVSQFEGSALGK Dioxidation(Y)@6 missed R-D@4 -0.00272345007397234 1846.83068847656 616.6175 1846.83337402344 616.618408203125 3 11 1.1.1.3643.16 1 37.3047 1992.42 37.34 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0299973487854 DSGRDYVSQFEGSALGK Deamidated(Q)@9 missed R-D@4 -0.0379537008702755 1815.78930664063 606.2704 1815.82751464844 606.283142089844 3 10 1.1.1.3944.9 1 44.9982 13184.88 44.7612 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.8400025367737 DSGRDYVSQFEGSALGK Deamidated(Q)@9 missed R-D@4 -0.0386861003935337 1815.78881835938 606.2702 1815.82751464844 606.283142089844 3 10 1.1.1.3923.8 1 44.4675 29351.92 44.2053 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.4400000572205 DSGRDYVSQFEGSALGK Formyl@N-term missed R-D@4 -0.00369970011524856 1842.83471679688 615.2855 1842.83837890625 615.286743164063 3 10 1.1.1.3760.10 1 40.2973 3099.034 40.3117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.6100022792816 DSGRDYVSQFEGSALGK Dehydrated(S)@2 missed R-D@4 -0.0192562993615866 1796.81372070313 599.9452 1796.83288574219 599.951599121094 3 10 1.1.1.3778.5 1 40.7518 1189.782 40.6897 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.5800001621246 DSGRDYVSQFEGSALGK missed R-D@4 -0.00881117023527622 1814.83447265625 605.9521 1814.84350585938 605.955139160156 3 9 1.1.1.3996.12 1 46.3366 1211.282 46.3234 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.6899974346161 DSGRDYVSQFEGSALGK Carbamidomethyl(S)@13; reduced acrolein addition +58(K)@17 missed R-D@4 0.000566271017305553 1929.90759277344 644.3098 1929.90686035156 644.3095703125 3 10 1.1.1.3816.14 1 41.7141 2348.872 41.672 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.889999628067 DSGRDYVSQFEGSALGK Methyl+Deamidated(Q)@9 missed R-D@4 -0.0215390995144844 1829.82165527344 610.9478 1829.84313964844 610.955017089844 3 10 1.1.1.3617.6 1 36.6474 918.274 36.6364 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.7799991369247 DSGRDYVSQFEGSALGK Deamidated(Q)@9 missed R-D@4 -0.0350240990519524 1815.79248046875 606.2714 1815.82751464844 606.283142089844 3 9 1.1.1.3909.8 1 44.1136 27869.61 44.0793 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.8399990797043 DSGRDYVSQFEGSALGK Deamidated(Q)@9 missed R-D@4 -0.0379537008702755 1815.78930664063 606.2704 1815.82751464844 606.283142089844 3 9 1.1.1.3937.11 1 44.8235 12955.99 44.7612 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 35.5800002813339 DSGRDYVSQFEGSALGK acrolein addition +38(K)@17 missed R-D@4 -0.0657420977950096 1852.79345703125 618.6051 1852.85913085938 618.627014160156 3 9 1.1.1.3781.5 1 40.8238 2435.315 40.8887 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.4899996519089 DSGRDYVSQFEGSALGK missed R-D@4 -0.000264434987911955 1814.84326171875 605.955 1814.84350585938 605.955139160156 3 8 1.1.1.3582.17 1 35.7645 2255.316 35.9003 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 17.5200000405312 DSGRDYVSQFEGSALGK missed R-D@4 0.000468929996713996 1814.84411621094 454.7183 1814.84350585938 454.718139648438 4 7 1.1.1.3803.5 1 41.3661 2611.04 41.111 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 DSGRDYVSQFEGSALGKQL acrolein addition +56(K)@17; Deamidated(Q)@18 cleaved L-N@C-term; missed R-D@4; missed K-Q@17 -0.00654119020327926 2112.98974609375 705.3372 2112.99633789063 705.339416503906 3 12 1.1.1.3786.8 1 40.9576 3944.904 40.6897 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 DSGRDYVSQFEGSALGKQL acrolein addition +56(K)@17; Deamidated(Q)@18 cleaved L-N@C-term; missed R-D@4; missed K-Q@17 -0.00471018021926284 2112.99169921875 705.3378 2112.99633789063 705.339416503906 3 10 1.1.1.3801.4 1 41.32 997.6378 41.2099 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.2699990272522 DSGRDYVSQFEGSALGKQL acrolein addition +56(K)@17; Deamidated(Q)@18 cleaved L-N@C-term; missed R-D@4; missed K-Q@17 -0.00599189009517431 2112.99047851563 705.3374 2112.99633789063 705.339416503906 3 10 1.1.1.3779.8 1 40.7742 3945.356 40.6649 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 71.6099977493286 DSGRDYVSQFEGSALGKQL acrolein addition +56(K)@17; Deamidated(Q)@18 cleaved L-N@C-term; missed R-D@4; missed K-Q@17 -0.0149638000875711 2112.9814453125 705.3344 2112.99633789063 705.339416503906 3 10 1.1.1.3793.8 1 41.1254 2330.936 40.9876 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.4400000572205 DSGRDYVSQFEGSALGKQL acrolein addition +56(K)@17; Deamidated(Q)@18 cleaved L-N@C-term; missed R-D@4; missed K-Q@17 -0.0153299998492002 2112.98095703125 705.3343 2112.99633789063 705.339416503906 3 10 1.1.1.3772.8 1 40.6048 3978.149 40.5403 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK acrolein addition +56(K)@17; Deamidated(Q)@18 missed R-D@4; missed K-Q@17 0.0164420995861292 2468.23486328125 618.066 2468.21826171875 618.061889648438 4 16 1.1.1.4003.12 1 46.5191 11133.42 46.584 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@17; Ammonia-loss(N)@20 missed R-D@4; missed K-Q@17 0.00928517989814281 2452.23266601563 614.0654 2452.22338867188 614.063110351563 4 20 1.1.1.4015.13 1 46.8323 40978.81 46.8442 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.00113137997686863 2411.20922851563 603.8096 2411.2080078125 603.809326171875 4 22 1.1.1.4016.10 1 46.8555 89975.67 46.6101 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Formyl(K)@17 missed R-D@4; missed K-Q@17 0.00464534014463425 2439.20751953125 814.0765 2439.203125 814.074951171875 3 21 1.1.1.4100.17 1 49.0065 2976.805 49.0659 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Acetyl(K)@17 missed R-D@4; missed K-Q@17 -0.00183007004670799 2453.21704101563 614.3115 2453.21875 614.311950683594 4 17 1.1.1.4103.10 1 49.077 9455.11 49.1932 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Acetyl(K)@17 missed R-D@4; missed K-Q@17 0.000980630982667208 2453.21948242188 818.7471 2453.21875 818.746826171875 3 25 1.1.1.4103.19 1 49.0845 19672.02 49.1932 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Acetyl(K)@17 missed R-D@4; missed K-Q@17 0.000980630982667208 2453.21948242188 818.7471 2453.21875 818.746826171875 3 14 1.1.1.4115.20 1 49.3915 19672.02 49.1932 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Formyl(K)@17; reduced acrolein addition +58(K)@22 missed R-D@4; missed K-Q@17 0.00615281984210014 2497.25122070313 833.4243 2497.24487304688 833.422241210938 3 20 1.1.1.4283.14 1 53.6723 5173.997 53.6833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.00113137997686863 2411.20922851563 603.8096 2411.2080078125 603.809326171875 4 16 1.1.1.4002.15 1 46.4957 86869.16 46.6101 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.00235205003991723 2411.21044921875 603.8099 2411.2080078125 603.809326171875 4 15 1.1.1.4023.16 1 47.0409 2240.981 47.076 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Acetyl(K)@17 missed R-D@4; missed K-Q@17 0.00404393998906016 2453.22338867188 1227.619 2453.21875 1227.61657714844 2 10 1.1.1.4107.21 1 49.188 5542.542 49.1932 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Acetyl(K)@17 missed R-D@4; missed K-Q@17 -0.00183007004670799 2453.21704101563 614.3115 2453.21875 614.311950683594 4 13 1.1.1.4114.9 1 49.3569 9455.11 49.1932 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Acetyl(K)@17 missed R-D@4; missed K-Q@17 0.00404393998906016 2453.22338867188 1227.619 2453.21875 1227.61657714844 2 12 1.1.1.4106.21 1 49.1627 5542.542 49.1932 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Deamidated(N)@20; acrolein addition +56(K)@22 missed R-D@4; missed K-Q@17 0.0164420995861292 2468.23486328125 618.066 2468.21826171875 618.061889648438 4 14 1.1.1.4010.14 1 46.7031 11133.42 46.584 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 DSGRDYVSQFEGSALGKQLNLK acrolein addition +76(K)@17; Deamidated(Q)@18; Deamidated(N)@20 missed R-D@4; missed K-Q@17 0.0109018003568053 2489.21826171875 830.7467 2489.20751953125 830.743103027344 3 13 1.1.1.3769.12 1 40.5334 16964.32 40.4407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5899984836578 DSGRDYVSQFEGSALGKQLNLK MDA adduct +62(K)@17; Deamidated(Q)@18; Deamidated(N)@20; reduced acrolein addition +58(K)@22 missed R-D@4; missed K-Q@17 0.00853655021637678 2533.2421875 845.4213 2533.23364257813 845.418518066406 3 13 1.1.1.3771.7 1 40.5799 3730.678 40.5403 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2100009918213 DSGRDYVSQFEGSALGKQLNLK Ammonia-loss(N)@20; reduced acrolein addition +58(K)@22 missed R-D@4; missed K-Q@17 0.00928517989814281 2452.23266601563 614.0654 2452.22338867188 614.063110351563 4 13 1.1.1.4022.9 1 47.0095 40978.81 46.8442 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1300005912781 DSGRDYVSQFEGSALGKQLNLK acrolein addition +38(K)@22 missed R-D@4; missed K-Q@17 0.000961682002525777 2449.22485351563 817.4155 2449.2236328125 817.415222167969 3 12 1.1.1.3781.6 1 40.8263 8094.762 40.8142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 DSGRDYVSQFEGSALGKQLNLK Deamidated(Q)@18; Deamidated(N)@20; acrolein addition +76(K)@22 missed R-D@4; missed K-Q@17 0.0109018003568053 2489.21826171875 830.7467 2489.20751953125 830.743103027344 3 11 1.1.1.3762.19 1 40.3577 16964.32 40.4407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 DSGRDYVSQFEGSALGKQLNLK Ammonia-loss(N)@20; reduced acrolein addition +58(K)@22 missed R-D@4; missed K-Q@17 0.0105058997869492 2452.23364257813 614.0657 2452.22338867188 614.063110351563 4 11 1.1.1.4037.11 1 47.3954 2912.017 47.179 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 DSGRDYVSQFEGSALGKQLNLK Deamidated(Q)@18; Deamidated(N)@20; acrolein addition +76(K)@22 missed R-D@4; missed K-Q@17 0.0105355996638536 2489.21801757813 830.7466 2489.20751953125 830.743103027344 3 11 1.1.1.3776.9 1 40.7069 17422.86 40.4407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.3100020885468 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.010729200206697 2411.21875 804.7469 2411.2080078125 804.743286132813 3 9 1.1.1.4026.19 1 47.1211 1236.024 47.076 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.3899972438812 DSGRDYVSQFEGSALGKQLNLK Deamidated(N)@20 missed R-D@4; missed K-Q@17 0.0200225003063679 2412.21215820313 604.0603 2412.19213867188 604.055297851563 4 11 1.1.1.3984.10 1 46.0206 986.0345 46.035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 71.6099977493286 DSGRDYVSQFEGSALGKQLNLK MDA adduct +62(K)@17; Deamidated(Q)@18; Deamidated(N)@20; reduced acrolein addition +58(K)@22 missed R-D@4; missed K-Q@17 0.00890276022255421 2533.24243164063 845.4214 2533.23364257813 845.418518066406 3 9 1.1.1.3779.11 1 40.7792 3826.288 40.5154 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.6100022792816 DSGRDYVSQFEGSALGKQLNLK Dehydrated(S)@13; reduced acrolein addition +58(K)@17; Deamidated(Q)@18 missed R-D@4; missed K-Q@17 0.0118404002860188 2452.23510742188 818.419 2452.22338867188 818.415100097656 3 9 1.1.1.4024.20 1 47.0699 18653.18 46.7922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 0.011680300347507 4036.97705078125 808.4027 4036.96533203125 808.400390625 5 20 1.1.1.4457.18 1 58.154 9708.027 58.2141 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 -0.00101358001120389 4036.962890625 1010.248 4036.96533203125 1010.24865722656 4 21 1.1.1.4459.20 1 58.208 6190.841 58.2141 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 0.011680300347507 4036.97705078125 808.4027 4036.96533203125 808.400390625 5 19 1.1.1.4464.18 1 58.3372 9708.027 58.2141 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 -0.00218566996045411 4008.96875 802.801 4008.97045898438 802.801391601563 5 20 1.1.1.4494.15 1 59.1248 6620.409 59.1351 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed R-D@4; missed K-Q@17; missed K-L@22 0.011833400465548 4004.98779296875 802.0048 4004.9755859375 802.002380371094 5 17 1.1.1.4547.14 1 60.5263 11603.47 60.4577 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Ammonia-loss(N)@20; reduced acrolein addition +58(K)@22 missed R-D@4; missed K-Q@17; missed K-L@22 0.0383437015116215 4046.02905273438 810.2131 4045.99096679688 810.205444335938 5 18 1.1.1.4547.15 1 60.5272 2185.293 60.4845 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed R-D@4; missed K-Q@17; missed K-L@22 0.011833400465548 4004.98779296875 802.0048 4004.9755859375 802.002380371094 5 14 1.1.1.4548.13 1 60.5517 11603.47 60.4577 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Acetyl(K)@22; Trp->Kynurenin(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 0.0192531999200583 4050.9990234375 1013.757 4050.98095703125 1013.75256347656 4 17 1.1.1.4552.19 1 60.6611 1697.432 60.6681 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Acetyl(K)@17 missed R-D@4; missed K-Q@17; missed K-L@22 0.00380128994584084 4046.99096679688 1012.755 4046.98608398438 1012.75384521484 4 29 1.1.1.4676.5 1 63.8047 1506.102 63.8381 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Formyl(K)@17; reduced acrolein addition +58(K)@22 missed R-D@4; missed K-Q@17; missed K-L@22 0.0134944003075361 4091.02685546875 1023.764 4091.01245117188 1023.76037597656 4 22 1.1.1.4818.18 1 67.4986 1368.885 67.5063 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Deamidated(N)@20; Dioxidation(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 0.0569907985627651 4038.00659179688 808.6086 4037.94946289063 808.59716796875 5 14 1.1.1.4462.16 1 58.283 5404.429 58.2141 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 -0.00218566996045411 4008.96875 802.801 4008.97045898438 802.801391601563 5 14 1.1.1.4497.17 1 59.2051 6620.409 59.1351 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 0.0192309003323317 4008.99096679688 1003.255 4008.97045898438 1003.24987792969 4 10 1.1.1.4497.21 1 59.2084 3229.218 59.1082 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.4699981212616 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK acrolein addition +38(K)@22; Trp->Kynurenin(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 -0.0232973992824554 4046.962890625 1012.748 4046.98608398438 1012.75384521484 4 9 1.1.1.4685.16 1 64.0311 608.3558 63.9879 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 DSVTSTFSK cleaved W-D@N-term -0.00198010005988181 970.458862304688 486.2367 970.460754394531 486.237640380859 2 8 1.1.1.3164.13 1 25.4454 21272.09 25.3106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.00132191996090114 1399.66333007813 700.8389 1399.66198730469 700.838256835938 2 18 1.1.1.3846.12 1 42.5029 414209.9 42.7501 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK -0.00111942004878074 1399.66088867188 700.8377 1399.66198730469 700.838256835938 2 22 1.1.1.3853.13 1 42.6876 428854.6 42.7501 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK Cation:Na(E)@7 -0.00471256021410227 1421.63903808594 711.8268 1421.64392089844 711.829223632813 2 15 1.1.1.3859.11 1 42.8391 3092.482 42.7501 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK -0.00111942004878074 1399.66088867188 700.8377 1399.66198730469 700.838256835938 2 22 1.1.1.3860.13 1 42.866 428854.6 42.7501 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK -0.00172975996974856 1399.66027832031 700.8374 1399.66198730469 700.838256835938 2 22 1.1.1.3867.15 1 43.0455 390863.4 42.7754 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK Deamidated(Q)@5 0.0164278000593185 1400.66247558594 701.3385 1400.64599609375 701.330261230469 2 15 1.1.1.3869.12 1 43.095 86224.25 42.8259 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK -0.00185183004941791 1399.66003417969 700.8373 1399.66198730469 700.838256835938 2 19 1.1.1.3874.17 1 43.2295 79908.2 42.9523 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK -0.00246217008680105 1399.65942382813 700.837 1399.66198730469 700.838256835938 2 20 1.1.1.3881.16 1 43.4119 9790.527 43.5228 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK -0.0023401000071317 1399.65966796875 700.8371 1399.66198730469 700.838256835938 2 19 1.1.1.3888.17 1 43.5904 9656.062 43.5481 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK -0.00148563005495816 1399.66052246094 700.8375 1399.66198730469 700.838256835938 2 18 1.1.1.3895.16 1 43.7666 8188.344 43.6751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK -0.00209596008062363 1399.65991210938 700.8372 1399.66198730469 700.838256835938 2 17 1.1.1.3902.12 1 43.9405 5619.732 43.9024 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK -0.00209596008062363 1399.65991210938 700.8372 1399.66198730469 700.838256835938 2 17 1.1.1.3927.15 1 44.5742 4844.79 44.5341 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK Nitro(Y)@2 0.0107608996331692 1444.65783691406 723.3362 1444.64709472656 723.330810546875 2 16 1.1.1.4003.16 1 46.5224 1702.145 46.5319 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK Delta:H(2)C(2)@N-term 0.00201162998564541 1425.6796875 713.8471 1425.67761230469 713.846069335938 2 19 1.1.1.4009.18 1 46.6802 8189.214 46.584 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.00132191996090114 1399.66333007813 700.8389 1399.66198730469 700.838256835938 2 12 1.1.1.3675.17 1 38.1064 1295.584 38.0652 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK -0.00111942004878074 1399.66088867188 700.8377 1399.66198730469 700.838256835938 2 13 1.1.1.3941.13 1 44.9258 1805.039 44.9629 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK Cation:Na(E)@7 -0.00471256021410227 1421.63903808594 711.8268 1421.64392089844 711.829223632813 2 12 1.1.1.3852.13 1 42.6617 3092.482 42.7501 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK -0.00209596008062363 1399.65991210938 700.8372 1399.66198730469 700.838256835938 2 13 1.1.1.3934.14 1 44.7502 4844.79 44.5341 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK Lys-add@N-term; Oxidation(Y)@2 -0.00491661997511983 1543.74682617188 772.8807 1543.75183105469 772.883178710938 2 15 1.1.1.3811.19 1 41.5862 6433.501 41.5138 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.00132191996090114 1399.66333007813 700.8389 1399.66198730469 700.838256835938 2 11 1.1.1.3668.13 1 37.9312 1295.584 38.0652 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.00657082023099065 1399.66870117188 700.8416 1399.66198730469 700.838256835938 2 10 1.1.1.3728.18 1 39.4763 1457.971 39.6418 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.00229846010915935 1399.66430664063 700.8394 1399.66198730469 700.838256835938 2 10 1.1.1.3955.12 1 45.2807 1665.107 45.2164 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 DYVSQFEGSALGK Oxidation(Y)@2 -0.00362182990647852 1415.6533203125 708.8339 1415.65686035156 708.835693359375 2 10 1.1.1.3693.19 1 38.5677 846.3204 38.5746 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7299997806549 DYVSQFEGSALGK Delta:H(2)C(2)@N-term; Deamidated(Q)@5 0.00796233024448156 1426.66943359375 714.342 1426.66162109375 714.338073730469 2 12 1.1.1.3988.19 1 46.1328 4518.826 46.297 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.739999294281 DYVSQFEGSALGK Delta:H(2)C(2)@N-term 0.00201162998564541 1425.6796875 713.8471 1425.67761230469 713.846069335938 2 11 1.1.1.4008.16 1 46.6527 8189.214 46.584 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 71.6099977493286 DYVSQFEGSALGK Formyl@N-term 0.00951538980007172 1427.66650390625 714.8405 1427.65686035156 714.835693359375 2 8 1.1.1.3988.20 1 46.1336 1724.869 46.1922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGKQLNLK missed K-Q@13 0.00392427016049623 1996.03051757813 999.0225 1996.02661132813 999.020568847656 2 16 1.1.1.4109.21 1 49.2392 3944.052 49.27 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 DYVSQFEGSALGKQLNLK Ammonia-loss(N)@16; reduced acrolein addition +58(K)@18 missed K-Q@13 0.0122517002746463 2037.05419921875 680.0253 2037.04187011719 680.021240234375 3 10 1.1.1.4124.16 1 49.6193 6385.808 49.5516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0799973011017 DYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@23 missed K-Q@13; missed K-L@18 0.0042552100494504 3621.7880859375 906.4543 3621.78393554688 906.453247070313 4 10 1.1.1.4528.18 1 60.027 2610.446 60.0863 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EALKENGGAR Deamidated(N)@6 cleaved L-E@N-term; missed K-E@4 -0.00530171999707818 1044.5146484375 523.2646 1044.52001953125 523.267272949219 2 10 1.1.1.3041.8 1 22.4856 2056.226 22.4193 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 EALKENGGAR cleaved L-E@N-term; missed K-E@4 -0.000877663027495146 1043.53503417969 522.7748 1043.53601074219 522.775268554688 2 9 1.1.1.3012.6 1 21.7664 2338.921 21.6733 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 EALKENGGAR cleaved L-E@N-term; missed K-E@4 -0.000877663027495146 1043.53503417969 522.7748 1043.53601074219 522.775268554688 2 7 1.1.1.3005.6 1 21.588 2338.921 21.6733 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.529999256134 EALKENGGAR acrolein addition +112(K)@4 cleaved L-E@N-term; missed K-E@4 -0.00151910004206002 1155.5869140625 578.8007 1155.58837890625 578.801452636719 2 9 1.1.1.3613.5 1 36.5473 5987.418 36.5131 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.220002412796 EALKENGGAR acrolein addition +112(K)@4; Deamidated(N)@6 cleaved L-E@N-term; missed K-E@4 -0.00488989008590579 1156.56750488281 579.291 1156.57238769531 579.29345703125 2 7 1.1.1.3674.8 1 38.074 2807.185 38.1399 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.9199995994568 EALKENGGAR ONE addition +154(K)@4; Deamidated(N)@6 cleaved L-E@N-term; missed K-E@4 0.00731759006157517 1198.62670898438 400.5495 1198.61938476563 400.547058105469 3 7 1.1.1.3084.2 1 23.4572 9465.896 23.2114 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EHLSTLSEK cleaved T-E@N-term -0.003771279938519 1042.52563476563 522.2701 1042.52954101563 522.272033691406 2 12 1.1.1.3071.4 1 23.1538 4800.184 22.9358 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.1899991035461 EHLSTLSEK cleaved T-E@N-term -0.00340507994405925 1042.52612304688 522.2703 1042.52954101563 522.272033691406 2 6 1.1.1.3079.3 1 23.3407 2939.022 23.0911 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.1899991035461 EHLSTLSEK cleaved T-E@N-term -0.000597528996877372 1042.52893066406 522.2717 1042.52954101563 522.272033691406 2 5 1.1.1.3093.8 1 23.6913 212.9558 23.6265 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 EHLSTLSEK Glu->pyro-Glu@N-term cleaved T-E@N-term -0.0029222599696368 1024.51611328125 513.2653 1024.51892089844 513.266723632813 2 7 1.1.1.3056.4 1 22.8462 410.0095 22.8581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.4699985980988 EHLSTLSEK cleaved T-E@N-term -0.00352715002372861 1042.52612304688 522.2703 1042.52954101563 522.272033691406 2 5 1.1.1.3054.10 1 22.7993 4917.344 22.8877 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.529999256134 EHLSTLSEK cleaved T-E@N-term -0.000597528996877372 1042.52893066406 522.2717 1042.52954101563 522.272033691406 2 5 1.1.1.3086.4 1 23.5148 212.9558 23.6265 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.2799999713898 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +76(K)@11; Deamidated(Q)@19; hexanoyl addition +98(K)@29 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29 0.0220868997275829 4790.58935546875 959.1252 4790.5673828125 959.120727539063 5 12 1.1.1.5082.15 1 74.5257 2862.892 74.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1900026798248 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@9; reduced acrolein addition +58(K)@11; Deamidated(Q)@19 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29 -0.00464642979204655 4828.599609375 966.7272 4828.60400390625 966.728088378906 5 11 1.1.1.5084.18 1 74.5821 10038.81 74.6433 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl@N-term; reduced acrolein addition +58(K)@9; hexanoyl addition +98(K)@11 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41; missed K-L@42 0.00184861000161618 5412.94580078125 903.1649 5412.94384765625 903.16455078125 6 19 1.1.1.5097.17 1 74.9236 26355.66 74.9586 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.3000011444092 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@9; Deamidated(Q)@19; ONE addition +154(K)@29 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41; missed K-L@42 0.00364890997298062 5412.93359375 1083.594 5412.9326171875 1083.59375 5 9 1.1.1.5092.20 1 74.7965 6695.074 74.9586 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.0400007963181 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK MDA adduct +62(K)@4; Deamidated(Q)@12; acrolein addition +94(K)@22 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34 0.0352699011564255 4133.26904296875 827.6611 4133.23388671875 827.654113769531 5 9 1.1.1.5099.9 1 74.9698 11784.04 74.7767 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(Q)@12; HPNE addition +172(K)@22 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 -0.0261666998267174 4605.49365234375 922.106 4605.51953125 922.111206054688 5 11 1.1.1.5104.12 1 75.1055 8967.399 75.1947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.2099995613098 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +96(K)@4 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 -0.0214741993695498 4528.46142578125 906.6996 4528.4833984375 906.703918457031 5 10 1.1.1.5108.9 1 75.2049 1545.348 75.2456 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.2599995136261 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +94(K)@2; reduced acrolein addition +96(K)@4 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 -0.0661438032984734 4622.458984375 771.4171 4622.52490234375 771.428161621094 6 10 1.1.1.5106.6 1 75.1516 3391.741 75.2201 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0799973011017 EPPQSPWDRVKDLATVYVDVLK cleaved D-E@N-term; missed R-V@9; missed K-D@11 0.0237834993749857 2554.36694335938 639.599 2554.34301757813 639.593078613281 4 9 1.1.1.4569.6 1 61.0934 2167.514 61.1112 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.85999751091 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@11; acrolein addition +76(K)@22 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 -0.00940253958106041 4481.208984375 747.8754 4481.2177734375 747.876953125 6 10 1.1.1.4841.15 1 68.1088 2312.704 68.065 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.2599995136261 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +62(K)@11; acrolein addition +94(K)@22 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.00400702003389597 4507.2373046875 902.4548 4507.2333984375 902.453979492188 5 10 1.1.1.4912.5 1 69.981 4500.333 69.7179 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.5699999332428 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@11; acrolein addition +76(K)@22 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 -0.0165794994682074 4481.20068359375 747.8741 4481.2177734375 747.876953125 6 8 1.1.1.4891.3 1 69.4499 1045.612 69.619 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.5300004482269 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +62(K)@11; acrolein addition +94(K)@22 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 -0.00286452006548643 4507.23095703125 752.2124 4507.2333984375 752.212890625 6 9 1.1.1.4894.2 1 69.5278 2738.485 69.5448 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 19.9000000953674 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +62(K)@11; acrolein addition +94(K)@22 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 -0.0124719003215432 4507.22119140625 902.4515 4507.2333984375 902.453979492188 5 9 1.1.1.4923.11 1 70.2504 2318.682 70.2137 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Trp->Hydroxykynurenin(W)@11 0.00456314999610186 1951.9208984375 976.9677 1951.91638183594 976.965454101563 2 17 1.1.1.4077.21 1 48.4237 2639.463 48.48 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Dioxidation(W)@11 -0.000357392011210322 1963.91577148438 655.6459 1963.91638183594 655.646057128906 3 16 1.1.1.4084.17 1 48.5983 28279.57 48.7342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Dioxidation(W)@11 0.00120265001896769 1963.91772460938 982.9661 1963.91638183594 982.965454101563 2 20 1.1.1.4084.21 1 48.6017 44382.46 48.7342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Dioxidation(W)@11 0.00120265001896769 1963.91772460938 982.9661 1963.91638183594 982.965454101563 2 25 1.1.1.4091.21 1 48.78 44382.46 48.7342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Dioxidation(W)@11 -0.000357392011210322 1963.91577148438 655.6459 1963.91638183594 655.646057128906 3 19 1.1.1.4096.12 1 48.9006 28279.57 48.7342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Dioxidation(W)@11 0.00120265001896769 1963.91772460938 982.9661 1963.91638183594 982.965454101563 2 20 1.1.1.4098.21 1 48.9589 44382.46 48.7342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Dioxidation(W)@11 0.000924316991586238 1963.91748046875 655.6464 1963.91638183594 655.646057128906 3 14 1.1.1.4103.14 1 49.0803 21643.54 48.8108 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Dioxidation(W)@11 0.000958511023782194 1963.91723632813 982.9659 1963.91638183594 982.965454101563 2 20 1.1.1.4105.21 1 49.1373 24238.62 48.8622 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Dioxidation(W)@11 0.0056849499233067 1963.921875 655.6479 1963.91638183594 655.646057128906 3 14 1.1.1.4110.10 1 49.2556 5361.815 49.2444 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Dioxidation(W)@11 0.0056849499233067 1963.921875 655.6479 1963.91638183594 655.646057128906 3 21 1.1.1.4110.11 1 49.2564 5361.815 49.2444 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Dioxidation(W)@11 0.000348175002727658 1963.91662597656 982.9656 1963.91638183594 982.965454101563 2 15 1.1.1.4112.21 1 49.316 8167.659 49.2189 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Trp->Kynurenin(W)@11 -0.00199463008902967 1935.91955566406 646.3138 1935.92138671875 646.314392089844 3 19 1.1.1.4117.11 1 49.4354 22796.95 49.6544 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Trp->Kynurenin(W)@11 -0.00217772996984422 1935.91931152344 646.3137 1935.92138671875 646.314392089844 3 20 1.1.1.4124.11 1 49.6152 23610.37 49.6544 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Trp->Kynurenin(W)@11 -0.00217772996984422 1935.91931152344 646.3137 1935.92138671875 646.314392089844 3 21 1.1.1.4131.11 1 49.7939 23610.37 49.6544 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Oxidation(W)@11 -0.000528252974618226 1947.92102050781 650.3143 1947.92138671875 650.314392089844 3 14 1.1.1.3862.12 1 42.9141 4667.133 43.0557 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK 0.0031428299844265 1931.9296875 644.9838 1931.92651367188 644.982788085938 3 20 1.1.1.4251.10 1 52.8529 18807.01 53.02 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK -0.000333322008373216 1931.92602539063 966.9703 1931.92651367188 966.970520019531 2 25 1.1.1.4258.19 1 53.0384 45548.77 52.9947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK -0.00716907996684313 1931.91931152344 966.9669 1931.92651367188 966.970520019531 2 13 1.1.1.4268.15 1 53.291 43738.22 53.02 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK FormaldehydeAdduct(W)@11; Deamidated(N)@13 0.0213328003883362 1944.93176269531 649.3179 1944.91052246094 649.310791015625 3 12 1.1.1.4076.10 1 48.3891 1629.697 48.4544 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 EQLGPVTQEFWDNLEK Deamidated(N)@13; Lys->Allysine(K)@16 0.0113230003044009 1931.89025878906 966.9524 1931.87890625 966.946716308594 2 9 1.1.1.3837.21 1 42.2724 3372.604 42.1718 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.1500008106232 EQLGPVTQEFWDNLEK Deamidated(N)@13; Lys->Allysine(K)@16 0.0113230003044009 1931.89025878906 966.9524 1931.87890625 966.946716308594 2 11 1.1.1.3830.21 1 42.0865 3372.604 42.1718 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.619998216629 EQLGPVTQEFWDNLEK Trp->Kynurenin(W)@11 0.00781020009890199 1935.92919921875 646.317 1935.92138671875 646.314392089844 3 8 1.1.1.3985.15 1 46.0507 753.7222 46.061 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 EQLGPVTQEFWDNLEK Dioxidation(W)@11 0.00584119977429509 1963.92224121094 982.9684 1963.91638183594 982.965454101563 2 9 1.1.1.4128.20 1 49.7252 1376.993 49.7056 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.2899980545044 EQLGPVTQEFWDNLEK Deamidated(Q)@8; Dioxidation(W)@11 0.0217998996376991 1964.92211914063 983.4683 1964.900390625 983.457458496094 2 9 1.1.1.4081.21 1 48.5255 19280.1 48.7598 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.7799991369247 EQLGPVTQEFWDNLEK Trp->Kynurenin(W)@11; acrolein addition +38(K)@16 0.0109181003645062 1973.94799804688 658.9899 1973.93701171875 658.986328125 3 9 1.1.1.3817.14 1 41.7406 4155.789 41.6991 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.2199988365173 EQLGPVTQEFWDNLEK Oxidation(W)@11 -0.000528252974618226 1947.92102050781 650.3143 1947.92138671875 650.314392089844 3 7 1.1.1.3876.14 1 43.2793 4667.133 43.0557 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLR Dioxidation(W)@11 missed K-E@16 0.00300960009917617 2649.25903320313 884.0936 2649.255859375 884.092529296875 3 15 1.1.1.4366.18 1 55.7974 14524.36 55.9854 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLR Dioxidation(W)@11 missed K-E@16 0.00172788999043405 2649.25732421875 884.0931 2649.255859375 884.092529296875 3 18 1.1.1.4373.19 1 55.9785 14812.14 56.0368 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLR Dioxidation(W)@11 missed K-E@16 0.00172788999043405 2649.25732421875 884.0931 2649.255859375 884.092529296875 3 15 1.1.1.4380.20 1 56.1596 14812.14 56.0368 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@11 missed K-E@16 0.0131511995568871 2621.27416992188 874.7653 2621.26098632813 874.760925292969 3 15 1.1.1.4403.18 1 56.7522 7635.578 56.6304 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLR missed K-E@16 -0.00820009037852287 2617.2578125 873.4266 2617.26611328125 873.429260253906 3 12 1.1.1.4544.17 1 60.4491 35561.26 60.6158 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLR missed K-E@16 -0.00820009037852287 2617.2578125 873.4266 2617.26611328125 873.429260253906 3 14 1.1.1.4551.12 1 60.6291 35561.26 60.6158 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLR Dioxidation(W)@11 missed K-E@16 0.00154478999320418 2649.25732421875 884.0931 2649.255859375 884.092529296875 3 14 1.1.1.4387.19 1 56.3391 13641.46 56.0627 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.1200008392334 EQLGPVTQEFWDNLEKETEGLR Oxidation(P)@5 missed K-E@16 0.0119738997891545 2633.27294921875 878.7649 2633.26098632813 878.760925292969 3 11 1.1.1.4012.21 1 46.7609 2653.236 46.7922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@25 missed K-E@16; missed R-Q@22 0.001843860023655 3236.53125 810.1401 3236.52954101563 810.1396484375 4 14 1.1.1.4489.19 1 58.9962 16819.2 59.1872 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.6299974918365 EQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@11; Oxidation(M)@25 missed K-E@16; missed R-Q@22 0.00903575029224157 3268.52856445313 818.1394 3268.51928710938 818.137145996094 4 11 1.1.1.4310.17 1 54.3635 15859.77 54.3466 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 18.639999628067 EQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@11; Oxidation(M)@25 missed K-E@16; missed R-Q@22 0.0141626000404358 3268.53369140625 818.1407 3268.51928710938 818.137145996094 4 9 1.1.1.4296.16 1 54.0054 12176.38 54.2194 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.8699994683266 EQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@11; Oxidation(M)@25 missed K-E@16; missed R-Q@22 0.013918399810791 3268.53344726563 818.1406 3268.51928710938 818.137145996094 4 9 1.1.1.4303.18 1 54.186 12573.48 54.1937 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@25 missed K-E@16; missed R-Q@22; missed K-D@27; missed K-A@33 0.0134920002892613 4149.03515625 692.5131 4149.02099609375 692.510803222656 6 12 1.1.1.4480.12 1 58.7528 3971.389 58.6339 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@13; Oxidation(M)@25 missed K-E@16; missed R-Q@22; missed K-D@27; missed K-A@33 0.0442170985043049 4150.04931640625 692.6822 4150.00537109375 692.6748046875 6 12 1.1.1.4477.12 1 58.6735 2988.772 58.6862 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@13; Oxidation(D)@28 missed K-E@16; missed R-Q@22; missed K-D@27; missed K-A@33 0.0357945002615452 4150.041015625 692.6808 4150.00537109375 692.6748046875 6 12 1.1.1.4498.10 1 59.2256 3699.01 59.1872 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSK Glu->pyro-Glu@N-term; Oxidation(M)@9 missed R-Q@6 -0.00326580996625125 1304.59985351563 653.3072 1304.60302734375 653.308837890625 2 14 1.1.1.3036.5 1 22.3644 1973.564 22.4193 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSK Oxidation(M)@9 missed R-Q@6 0.00169509998522699 1322.61547851563 441.8791 1322.61364746094 441.878479003906 3 12 1.1.1.2794.2 1 18.0399 6652.153 18.1466 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSK Oxidation(M)@9 missed R-Q@6 0.00132889999076724 1322.61486816406 441.8789 1322.61364746094 441.878479003906 3 12 1.1.1.2808.2 1 18.2108 15310.27 18.3037 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSK Oxidation(M)@9 missed R-Q@6 0.000779589987359941 1322.61462402344 441.8788 1322.61364746094 441.878479003906 3 12 1.1.1.2825.2 1 18.5533 13227.46 18.3285 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSK Oxidation(M)@9 missed R-Q@6 0.000504938012454659 1322.6142578125 441.8787 1322.61364746094 441.878479003906 3 12 1.1.1.2832.2 1 18.7226 4455.992 18.4616 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSK Glu->pyro-Glu@N-term; Oxidation(M)@9 missed R-Q@6 -0.00350994989275932 1304.59973144531 653.3071 1304.60302734375 653.308837890625 2 13 1.1.1.3029.3 1 22.1871 713.6035 22.243 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 ETEGLRQEMSK Dioxidation(M)@9 missed R-Q@6 -0.00213976996019483 1338.6064453125 447.2094 1338.60852050781 447.210113525391 3 9 1.1.1.2840.3 1 18.8425 307.7394 18.8969 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.00627540983259678 2035.9794921875 679.6671 2035.97314453125 679.6650390625 3 20 1.1.1.3176.8 1 25.748 15556.2 25.8323 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.00261340010911226 2035.97583007813 679.6659 2035.97314453125 679.6650390625 3 24 1.1.1.3193.7 1 26.1456 12566.33 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.00894508976489306 2035.9814453125 1018.998 2035.97314453125 1018.99389648438 2 12 1.1.1.3194.9 1 26.17 2588.491 26.2729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.00894508976489306 2035.9814453125 1018.998 2035.97314453125 1018.99389648438 2 12 1.1.1.3195.12 1 26.1894 2588.491 26.2729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVK Glu->pyro-Glu@N-term; Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.0107084000483155 2017.97314453125 673.665 2017.96264648438 673.661499023438 3 16 1.1.1.3411.8 1 31.5072 2951.893 31.4143 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.0100002288818 ETEGLRQEMSKDLEEVK Glu->pyro-Glu@N-term; acrolein addition +76(K)@11 missed R-Q@6; missed K-D@11 -0.00231384998187423 2077.99682617188 693.6729 2077.9990234375 693.673645019531 3 9 1.1.1.3392.11 1 31.0384 934.4819 31.0699 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.6300014257431 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.00894508976489306 2035.9814453125 1018.998 2035.97314453125 1018.99389648438 2 7 1.1.1.3205.11 1 26.4384 2588.491 26.2729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.6799997091293 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.00576006015762687 2035.97900390625 510.002 2035.97314453125 510.000579833984 4 11 1.1.1.3184.5 1 25.9181 27275.96 25.8323 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.6799997091293 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.00136562995612621 2035.97448730469 510.0009 2035.97314453125 510.000579833984 4 11 1.1.1.3191.4 1 26.0969 17422.44 26.2729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.0000001192093 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.00719091994687915 2035.98046875 679.6674 2035.97314453125 679.6650390625 3 11 1.1.1.3209.10 1 26.5326 12021.56 26.2729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.7700006961823 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.000999424024485052 2035.97412109375 510.0008 2035.97314453125 510.000579833984 4 11 1.1.1.3202.5 1 26.3553 17467.36 26.3218 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVKAK Oxidation(M)@9 missed R-Q@6; missed K-D@11; missed K-A@17 0.00586062017828226 2235.11083984375 559.785 2235.10522460938 559.783569335938 4 13 1.1.1.3162.14 1 25.3977 31712.74 25.4324 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVKAK Glu->pyro-Glu@N-term; Oxidation(M)@9 missed R-Q@6; missed K-D@11; missed K-A@17 0.00879757013171911 2217.10327148438 555.2831 2217.0947265625 555.280944824219 4 13 1.1.1.3349.8 1 29.9673 1579.753 30.079 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 ETEGLRQEMSKDLEEVKAK Glu->pyro-Glu@N-term; Oxidation(M)@9 missed R-Q@6; missed K-D@11; missed K-A@17 0.00879757013171911 2217.10327148438 555.2831 2217.0947265625 555.280944824219 4 12 1.1.1.3356.6 1 30.139 1579.753 30.079 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.3000018596649 ETEGLRQEMSKDLEEVKAK Glu->pyro-Glu@N-term; Oxidation(M)@9 missed R-Q@6; missed K-D@11; missed K-A@17 0.00171765999402851 2217.09643554688 555.2814 2217.0947265625 555.280944824219 4 11 1.1.1.3397.8 1 31.1526 2736.489 31.0946 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.7899980545044 ETEGLRQEMSKDLEEVKAK Oxidation(M)@9 missed R-Q@6; missed K-D@11; missed K-A@17 0.00244622002355754 2235.10791015625 746.0432 2235.10522460938 746.042358398438 3 12 1.1.1.3179.7 1 25.8025 4308.88 25.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4299976825714 EYHAKATEHLSTLSEK Glu->pyro-Glu@N-term; Delta:H(2)C(2)(H)@3; ONE addition +154(K)@5 cleaved A-E@N-term; missed K-A@5 -0.0113431997597218 2005.00415039063 669.342 2005.015625 669.345825195313 3 13 1.1.1.3465.20 1 32.8511 2341.21 32.881 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 EYHAKATEHLSTLSEK Oxidation(Y)@2; reduced HNE(H)@3; ONE addition +154(K)@5 cleaved A-E@N-term; missed K-A@5 -0.00910678971558809 2171.12744140625 543.7891 2171.13623046875 543.791320800781 4 13 1.1.1.3275.8 1 28.1462 4921.846 28.1068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0200028419495 EYHAKATEHLSTLSEK reduced HNE(H)@3; acrolein addition +112(K)@5 cleaved A-E@N-term; missed K-A@5 -0.0255916994065046 2113.06884765625 529.2745 2113.09423828125 529.280822753906 4 11 1.1.1.3702.10 1 38.7938 46347.73 38.7305 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 FEGSALGKQLNLKLLDNWDSVTSTFSK acrolein addition +112(K)@8; Deamidated(Q)@9; Deamidated(N)@11; acrolein addition +112(K)@13 cleaved Q-F@N-term; missed K-Q@8; missed K-L@13 -0.0505511984229088 3223.568359375 1075.53 3223.61767578125 1075.54650878906 3 12 1.1.1.4043.21 1 47.5583 11282.51 47.6144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2100009918213 GRDYVSQFEGSALGK cleaved S-G@N-term; missed R-D@2 -0.00162285997066647 1612.78308105469 538.6016 1612.78454589844 538.602111816406 3 8 1.1.1.3697.10 1 38.6642 2179.792 38.5225 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.3899989128113 HAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@3; reduced acrolein addition +96(K)@14; HPNE addition +172(K)@16; acrolein addition +112(K)@34 cleaved Y-H@N-term; missed K-A@3; missed K-A@14; missed R-Q@23; missed K-V@34 0.0177264008671045 5616.04443359375 937.0147 5616.02685546875 937.011779785156 6 8 1.1.1.5086.14 1 74.6322 650.31 74.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 71.450001001358 HELQEKLSPLGEEMR Dethiomethyl(M)@14 cleaved L-H@N-term; missed K-L@6 0.0531035996973515 1746.943359375 583.3217 1746.89001464844 583.303955078125 3 9 1.1.1.3572.14 1 35.4994 28073.25 35.5104 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4999992847443 HVDALRTHLAPYSDELRQR Carbamidomethyl(T)@7; reduced HNE(H)@8 cleaved A-H@N-term; missed R-T@6; missed R-Q@17 -0.0200948007404804 2491.3095703125 499.2692 2491.32958984375 499.273193359375 5 13 1.1.1.3573.8 1 35.5206 38571.52 35.4581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.7799991369247 HVDALRTHLAPYSDELRQRLAARLEALKENGGAR reduced HNE(H)@1; Deamidated(R)@6 cleaved A-H@N-term; missed R-T@6; missed R-Q@17; missed R-L@19; missed R-L@23; missed K-E@28 0.0125610996037722 3985.17358398438 665.2029 3985.16088867188 665.200744628906 6 11 1.1.1.3977.10 1 45.8412 4019.023 45.7277 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.1799986362457 HVDALRTHLAPYSDELRQRLAARLEALKENGGAR reduced HNE(H)@1; Deamidated(R)@6 cleaved A-H@N-term; missed R-T@6; missed R-Q@17; missed R-L@19; missed R-L@23; missed K-E@28 0.00428031012415886 3985.1650390625 798.0403 3985.16088867188 798.039489746094 5 9 1.1.1.3970.17 1 45.6679 2891.009 45.651 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.2499997615814 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +54(K)@1; acrolein addition +112(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.0327685996890068 3885.15063476563 778.0374 3885.11791992188 778.030883789063 5 11 1.1.1.5105.9 1 75.1288 3677.127 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1900026798248 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK hexanoyl addition +98(K)@3; acrolein addition +76(K)@21 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.000353228009771556 3893.15966796875 779.6392 3893.15942382813 779.63916015625 5 11 1.1.1.5103.5 1 75.0738 1383.572 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.8599984645844 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +76(K)@1; acrolein addition +76(K)@3; Deamidated(Q)@11 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 -0.00573984021320939 3872.09619140625 969.0313 3872.1015625 969.032653808594 4 11 1.1.1.5103.15 1 75.0822 2304.759 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.480001449585 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced acrolein addition +96(K)@3; MDA adduct +54(K)@21 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.0148999998345971 3869.1376953125 968.2917 3869.123046875 968.288024902344 4 9 1.1.1.5104.14 1 75.1071 3043.4 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.2499997615814 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Oxidation(P)@4 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.0303137991577387 4319.40869140625 720.9087 4319.3779296875 720.903625488281 6 12 1.1.1.5105.4 1 75.1246 5688.19 75.2713 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.5300004482269 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@3; acrolein addition +76(K)@21 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.00819167029112577 4533.52197265625 907.7117 4533.513671875 907.710021972656 5 9 1.1.1.5108.10 1 75.2057 956.8611 75.1947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.5300004482269 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@3; acrolein addition +94(K)@21 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.00475449999794364 4453.45556640625 743.2499 4453.451171875 743.249145507813 6 9 1.1.1.5112.4 1 75.303 6112.25 75.1947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7000026702881 KATEHLSTLSEK Oxidation(K)@1 cleaved A-K@N-term; missed K-A@1 -0.00236563989892602 1358.70190429688 453.9079 1358.7041015625 453.908660888672 3 13 1.1.1.3121.8 1 24.393 68062.12 24.4601 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KDSGRDYVSQFEGSALGK Deamidated(R)@5; Oxidation(D)@6 cleaved L-K@N-term; missed K-D@1; missed R-D@5 0.00229643005877733 1959.91955566406 654.3138 1959.91735839844 654.313049316406 3 16 1.1.1.3751.18 1 40.067 39901.86 40.154 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0200028419495 KDSGRDYVSQFEGSALGK Oxidation(D)@2 cleaved L-K@N-term; missed K-D@1; missed R-D@5 -0.000969410000834614 1958.93225097656 653.9847 1958.93334960938 653.985046386719 3 12 1.1.1.3798.11 1 41.246 17037.46 41.1852 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KLLDNWDSVTSTFSK Oxidation(K)@1; Deamidated(N)@5 cleaved L-K@N-term; missed K-L@1 -0.00373034994117916 1756.84826660156 879.4314 1756.85192871094 879.433227539063 2 16 1.1.1.4196.19 1 51.4595 10841.59 51.4918 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KLLDNWDSVTSTFSK Oxidation(K)@1; Dioxidation(W)@6 cleaved L-K@N-term; missed K-L@1 -0.000549665011931211 1787.85729980469 894.9359 1787.85778808594 894.936157226563 2 17 1.1.1.4008.20 1 46.6561 10166.09 46.7142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 KLLDNWDSVTSTFSK Oxidation(K)@1 cleaved L-K@N-term; missed K-L@1 -0.000525179028045386 1755.86743164063 878.941 1755.86791992188 878.941223144531 2 12 1.1.1.4141.20 1 50.0562 11020.27 50.164 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2100005149841 KLLDNWDSVTSTFSK Deamidated(N)@5; Trp->Kynurenin(W)@6 cleaved L-K@N-term; missed K-L@1 0.0101509997621179 1744.8623046875 873.4384 1744.85192871094 873.433227539063 2 9 1.1.1.3934.17 1 44.7527 528.1166 44.7865 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KLREQLGPVTQEFWDNLEKETEGLR Oxidation(R)@3; Deamidated(Q)@5 cleaved S-K@N-term; missed K-L@1; missed R-E@3; missed K-E@19 -0.00570729980245233 3031.51928710938 758.8871 3031.52514648438 758.888549804688 4 13 1.1.1.4541.14 1 60.3669 102737.7 60.0863 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.7200016975403 KPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19 0.0157156009227037 3631.99096679688 909.005 3631.97534179688 909.001098632813 4 12 1.1.1.5105.18 1 75.1363 4019.709 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.2099995613098 KPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@19 cleaved A-K@N-term; missed R-Q@8; missed K-V@19 0.0275155007839203 3632.00244140625 727.4078 3631.97534179688 727.40234375 5 8 1.1.1.5127.11 1 75.698 4513.753 75.4239 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.5300004482269 KPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@19 cleaved A-K@N-term; missed R-Q@8; missed K-V@19 0.0281258001923561 3632.00366210938 727.408 3631.97534179688 727.40234375 5 10 1.1.1.5113.4 1 75.3284 4301.136 75.4494 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.4899973869324 KPALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31 0.00915715005248785 3760.07885742188 753.0231 3760.0703125 753.021301269531 5 11 1.1.1.5093.8 1 74.8122 3495.442 74.9058 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.2499997615814 KPALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31 0.0242926999926567 3760.09448242188 627.6897 3760.0703125 627.685668945313 6 8 1.1.1.5092.5 1 74.784 2016.347 74.8799 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.2299976348877 KPALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31 0.015870800241828 3760.0859375 753.0245 3760.0703125 753.021301269531 5 9 1.1.1.5101.10 1 75.024 5466.318 75.0384 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6300029754639 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.0284550990909338 4216.33154296875 703.7292 4216.3037109375 703.724548339844 6 17 1.1.1.5119.4 1 75.4813 16467.86 75.4751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6300029754639 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +54(K)@1; Oxidation(P)@2 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.0269914008677006 4174.28271484375 1044.578 4174.25634765625 1044.57141113281 4 13 1.1.1.5140.21 1 76.0515 3340.408 76.0567 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.3099999427795 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.0284550990909338 4216.33154296875 703.7292 4216.3037109375 703.724548339844 6 11 1.1.1.5126.7 1 75.6681 16467.86 75.4751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.3099999427795 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.0230973996222019 4216.32666015625 844.2726 4216.3037109375 844.268005371094 5 11 1.1.1.5130.18 1 75.7838 24789.99 75.5008 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.0700023174286 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.0133320996537805 4216.31689453125 844.2706 4216.3037109375 844.268005371094 5 10 1.1.1.5104.8 1 75.1021 13500.48 75.2201 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.2099995613098 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.00868035014718771 4216.3125 703.726 4216.3037109375 703.724548339844 6 9 1.1.1.5112.2 1 75.3013 9324.122 75.2456 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3900007009506 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@1; acrolein addition +56(K)@19 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.0221819002181292 4216.32568359375 844.2724 4216.3037109375 844.268005371094 5 9 1.1.1.5116.9 1 75.4086 27826.26 75.4751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KQLNLKLLDNWDSVTSTFSK Oxidation(K)@1; Dioxidation(W)@11 cleaved G-K@N-term; missed K-Q@1; missed K-L@6 0.00209225993603468 2384.224609375 795.7488 2384.22241210938 795.748046875 3 18 1.1.1.4239.18 1 52.5536 13733.22 52.6127 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KQLNLKLLDNWDSVTSTFSK Oxidation(K)@1; Deamidated(Q)@2 cleaved G-K@N-term; missed K-Q@1; missed K-L@6 0.00597399985417724 2353.22265625 785.4148 2353.21655273438 785.412780761719 3 17 1.1.1.4359.12 1 55.6134 9403.15 55.5491 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KQLNLKLLDNWDSVTSTFSK Oxidation(N)@4 cleaved G-K@N-term; missed K-Q@1; missed K-L@6 -0.000586971000302583 2352.23193359375 785.0846 2352.232421875 785.084777832031 3 13 1.1.1.4375.11 1 56.0232 12386.57 56.1657 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5899970531464 KQLNLKLLDNWDSVTSTFSK MDA adduct +54(K)@1; MDA adduct +54(K)@6; Dioxidation(W)@11 cleaved G-K@N-term; missed K-Q@1; missed K-L@6 -0.0151976002380252 2476.2333984375 826.4184 2476.24853515625 826.423461914063 3 12 1.1.1.3920.17 1 44.3991 11831.5 44.4836 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.410001039505 KVEPLRAELQEGAR Oxidation(K)@1 cleaved Q-K@N-term; missed K-V@1; missed R-A@6 -0.0141524001955986 1610.85986328125 537.9606 1610.8740234375 537.965270996094 3 13 1.1.1.3455.7 1 32.5987 17167.56 32.5615 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQK Oxidation(K)@1 cleaved A-K@N-term; missed K-V@1 -0.00270011997781694 1395.70092773438 698.8577 1395.70349121094 698.859008789063 2 16 1.1.1.3717.19 1 39.1908 9970.268 39.0946 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1 0.0100589003413916 1491.77111816406 498.2643 1491.76098632813 498.260925292969 3 13 1.1.1.3517.8 1 34.1244 13587.43 34.165 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1 0.0100589003413916 1491.77111816406 498.2643 1491.76098632813 498.260925292969 3 11 1.1.1.3510.8 1 33.9517 12840.09 34.1404 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1 0.0100589003413916 1491.77111816406 498.2643 1491.76098632813 498.260925292969 3 13 1.1.1.3524.6 1 34.2991 13587.43 34.165 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 KVQPYLDDFQK Oxidation(K)@1 cleaved A-K@N-term; missed K-V@1 -0.00282218004576862 1395.70068359375 698.8576 1395.70349121094 698.859008789063 2 11 1.1.1.3724.18 1 39.3712 9989.958 39.0946 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 KVQPYLDDFQK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1 0.00264325994066894 1491.76354980469 498.2618 1491.76098632813 498.260925292969 3 10 1.1.1.3538.5 1 34.6437 757.8675 34.5828 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3900007009506 KVQPYLDDFQK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1 0.0154603002592921 1491.77648925781 498.2661 1491.76098632813 498.260925292969 3 6 1.1.1.3562.9 1 35.2344 800.4011 35.1479 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 KVQPYLDDFQKK Oxidation(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11 0.00169496994931251 1523.80004882813 508.9406 1523.79833984375 508.940063476563 3 13 1.1.1.3559.8 1 35.157 5174.642 34.9751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7600028514862 KVQPYLDDFQKK Oxidation(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11 0.00169496994931251 1523.80004882813 508.9406 1523.79833984375 508.940063476563 3 15 1.1.1.3545.7 1 34.8162 5174.642 34.9751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 KVQPYLDDFQKK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11 0.0133643997833133 1619.86938476563 405.9746 1619.85595703125 405.971252441406 4 10 1.1.1.3372.2 1 30.5299 8837.43 30.4265 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.7600011825562 KVQPYLDDFQKK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11 0.0133643997833133 1619.86938476563 405.9746 1619.85595703125 405.971252441406 4 8 1.1.1.3365.2 1 30.3555 8837.43 30.4265 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Dioxidation(W)@13; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0159178003668785 2932.41137695313 734.1101 2932.39526367188 734.106079101563 4 23 1.1.1.3886.13 1 43.5361 11320.39 43.5481 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Dioxidation(W)@13; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0159178003668785 2932.41137695313 734.1101 2932.39526367188 734.106079101563 4 18 1.1.1.3893.12 1 43.7128 11320.39 43.5481 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR Oxidation(K)@1; Dioxidation(W)@13; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 -0.000650183006655425 2836.33740234375 710.0916 2836.337890625 710.091735839844 4 20 1.1.1.3962.14 1 45.4618 17414.36 45.4729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0106768999248743 2900.41625976563 726.1113 2900.40551757813 726.108642578125 4 17 1.1.1.4021.13 1 46.9875 6156.019 46.948 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0126299997791648 2900.41821289063 726.1118 2900.40551757813 726.108642578125 4 17 1.1.1.4024.14 1 47.0649 6420.846 47.076 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0126299997791648 2900.41821289063 726.1118 2900.40551757813 726.108642578125 4 18 1.1.1.4025.16 1 47.0926 6420.846 47.076 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR MDA adduct +62(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0462668016552925 2850.4150390625 713.611 2850.36865234375 713.599426269531 4 17 1.1.1.4083.16 1 48.5721 3276.535 48.48 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR Oxidation(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.00973557960242033 2804.35766601563 702.0967 2804.34790039063 702.09423828125 4 17 1.1.1.4104.14 1 49.1059 20752.57 49.117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR Oxidation(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.00973557960242033 2804.35766601563 702.0967 2804.34790039063 702.09423828125 4 18 1.1.1.4107.17 1 49.1846 20752.57 49.117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR Oxidation(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0031439398881048 2804.35083007813 702.095 2804.34790039063 702.09423828125 4 18 1.1.1.4114.17 1 49.3635 15168.34 49.4747 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR Oxidation(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0031439398881048 2804.35083007813 702.095 2804.34790039063 702.09423828125 4 25 1.1.1.4121.15 1 49.5414 15168.34 49.4747 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0170243997126818 2900.42260742188 726.1129 2900.40551757813 726.108642578125 4 18 1.1.1.4004.15 1 46.5479 13592.76 46.6366 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0170243997126818 2900.42260742188 726.1129 2900.40551757813 726.108642578125 4 16 1.1.1.4013.19 1 46.7854 13592.76 46.6366 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR Oxidation(K)@1; Deamidated(Q)@3; Deamidated(Q)@10; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0187088008970022 2806.33447265625 702.5909 2806.31591796875 702.586303710938 4 16 1.1.1.4167.17 1 50.7159 8715.375 50.8005 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0106768999248743 2900.41625976563 726.1113 2900.40551757813 726.108642578125 4 16 1.1.1.4020.18 1 46.9663 6156.019 46.948 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0121417995542288 2900.41772460938 726.1117 2900.40551757813 726.108642578125 4 13 1.1.1.4022.18 1 47.017 6137.777 47.0247 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0126299997791648 2900.41821289063 726.1118 2900.40551757813 726.108642578125 4 13 1.1.1.4032.20 1 47.2757 6420.846 47.076 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3399987220764 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0106292003765702 2900.41625976563 581.0905 2900.40551757813 581.08837890625 5 13 1.1.1.4006.11 1 46.5965 10967.57 46.6366 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2100009918213 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Dioxidation(W)@13; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.0153128001838923 2932.41040039063 587.4894 2932.39526367188 587.486328125 5 14 1.1.1.3888.12 1 43.5862 9271.809 43.5481 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 KVQPYLDDFQKKWQEEMELYR Oxidation(K)@1; Dioxidation(W)@13; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 -0.000650183006655425 2836.33740234375 710.0916 2836.337890625 710.091735839844 4 16 1.1.1.3960.16 1 45.4125 17414.36 45.4729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR Dioxidation(W)@2; Dioxidation(M)@6 missed K-W@1 -0.0051226899959147 1474.63464355469 738.3246 1474.63989257813 738.327209472656 2 17 1.1.1.3287.16 1 28.4461 3510.118 28.4759 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR Oxidation(M)@6 missed K-W@1 -0.000244935014052317 1426.65490722656 476.5589 1426.65515136719 476.558990478516 3 14 1.1.1.3288.5 1 28.4606 128776.2 28.3042 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 -0.000144959005410783 1458.64489746094 730.3297 1458.64489746094 730.329711914063 2 14 1.1.1.3242.8 1 27.3392 15725.64 27.469 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR Trp->Kynurenin(W)@2; Oxidation(M)@6 missed K-W@1 0.00102819001767784 1430.65112304688 477.891 1430.65002441406 477.890625 3 14 1.1.1.3261.4 1 27.7995 14139.75 27.7136 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR Trp->Kynurenin(W)@2; Oxidation(M)@6 missed K-W@1 -0.00645222002640367 1430.64343261719 716.329 1430.65002441406 716.332275390625 2 11 1.1.1.3254.10 1 27.6349 4189.99 27.7381 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.000847573974169791 1458.64562988281 487.2225 1458.64489746094 487.222259521484 3 14 1.1.1.3256.8 1 27.6788 55660.01 27.4935 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.000847573974169791 1458.64562988281 487.2225 1458.64489746094 487.222259521484 3 14 1.1.1.3249.4 1 27.5026 55660.01 27.4935 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR Acetyl@N-term; Oxidation(M)@6 missed K-W@1 -0.00576215982437134 1468.65991210938 735.3372 1468.66564941406 735.340087890625 2 12 1.1.1.3571.20 1 35.4783 1827.676 35.5631 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 KWQEEMELYR Carbamidomethyl@N-term; Oxidation(W)@2; Oxidation(M)@6 missed K-W@1 -0.00285732001066208 1499.66857910156 500.8968 1499.67150878906 500.897766113281 3 12 1.1.1.3269.11 1 27.9938 2308.331 28.0074 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 KWQEEMELYR Dioxidation(W)@2; Dioxidation(M)@6 missed K-W@1 -0.000165186997037381 1474.63952636719 492.5538 1474.63989257813 492.553894042969 3 14 1.1.1.3288.7 1 28.4639 14158.17 28.4514 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.0125660998746753 1458.65734863281 487.2264 1458.64489746094 487.222259521484 3 12 1.1.1.3283.11 1 28.3415 3220.208 28.2795 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 KWQEEMELYR Oxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.00434307008981705 1442.65441894531 722.3345 1442.65002441406 722.332275390625 2 10 1.1.1.3209.11 1 26.5342 795.5356 26.6386 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 KWQEEMELYR Oxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.00973192974925041 1442.65979003906 481.8939 1442.65002441406 481.890625 3 10 1.1.1.3154.5 1 25.1982 1021.324 25.165 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 KWQEEMELYR Dioxidation(W)@2; Dioxidation(M)@6 missed K-W@1 -0.000165186997037381 1474.63952636719 492.5538 1474.63989257813 492.553894042969 3 12 1.1.1.3295.11 1 28.6351 14158.17 28.4514 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.2199976444244 KWQEEMELYR Oxidation(W)@2; Oxidation(M)@6 missed K-W@1 -0.00345136993564665 1442.64660644531 481.8895 1442.65002441406 481.890625 3 12 1.1.1.3135.10 1 24.7391 1810.267 24.7527 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0099985599518 KWQEEMELYR Oxidation(W)@2; Oxidation(M)@6 missed K-W@1 -0.000430193991633132 1442.64965820313 481.8905 1442.65002441406 481.890625 3 11 1.1.1.3206.5 1 26.4527 1357.307 26.4193 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.9099998474121 KWQEEMELYR Oxidation(M)@6 missed K-W@1 -0.000244935014052317 1426.65490722656 476.5589 1426.65515136719 476.558990478516 3 9 1.1.1.3322.10 1 29.3037 1284.914 29.3172 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 -0.00336375995539129 1458.64147949219 487.2211 1458.64489746094 487.222259521484 3 11 1.1.1.3264.6 1 27.8671 27824 27.6157 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 KWQEEMELYR Carbamidomethyl@N-term; Oxidation(M)@6 missed K-W@1 -0.00715178996324539 1483.66955566406 495.5638 1483.67651367188 495.566131591797 3 10 1.1.1.3282.8 1 28.3186 1136.756 28.2795 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 KWQEEMELYR Trp->Hydroxykynurenin(W)@2; Oxidation(M)@6 missed K-W@1 -0.00217867991887033 1446.64270019531 483.2215 1446.64489746094 483.222259521484 3 12 1.1.1.3304.11 1 28.8598 6800.52 28.8734 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0200011730194 KWQEEMELYR Oxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.000119110001833178 1442.65026855469 481.8907 1442.65002441406 481.890625 3 11 1.1.1.3218.3 1 26.742 2533.094 26.6386 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0200011730194 KWQEEMELYR Trp->Kynurenin(W)@2; Oxidation(M)@6 missed K-W@1 0.00249299989081919 1430.65234375 477.8914 1430.65002441406 477.890625 3 11 1.1.1.3268.4 1 27.9659 1855.674 27.9828 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 -0.00234217010438442 1458.64270019531 730.3286 1458.64489746094 730.329711914063 2 10 1.1.1.3263.13 1 27.8552 9832.253 27.5912 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 KWQEEMELYR Oxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.000119110001833178 1442.65026855469 481.8907 1442.65002441406 481.890625 3 9 1.1.1.3162.8 1 25.3918 2782.48 25.4573 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 -0.00363841000944376 1458.64123535156 487.221 1458.64489746094 487.222259521484 3 11 1.1.1.3145.5 1 24.9824 2920.492 25.0194 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.000847573974169791 1458.64562988281 487.2225 1458.64489746094 487.222259521484 3 11 1.1.1.3241.6 1 27.3073 55216.52 27.4935 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.290002822876 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.0161364991217852 1458.66101074219 487.2276 1458.64489746094 487.222259521484 3 10 1.1.1.3290.8 1 28.5097 3269.426 28.2549 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.00597441010177135 1458.65075683594 487.2242 1458.64489746094 487.222259521484 3 8 1.1.1.3297.8 1 28.6821 1180.743 28.6734 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 -0.000617237004917115 1458.64416503906 487.222 1458.64489746094 487.222259521484 3 9 1.1.1.3159.6 1 25.317 3247.151 25.2863 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 KWQEEMELYR HPNE addition +172(K)@1; Trp->Kynurenin(W)@2; Oxidation(M)@6 missed K-W@1 -0.00579932983964682 1602.75439453125 535.2587 1602.76000976563 535.260620117188 3 8 1.1.1.3291.10 1 28.536 619.27 28.5497 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.4300000667572 KWQEEMELYR Oxidation(M)@6 missed K-W@1 -0.000611138006206602 1426.65454101563 476.5588 1426.65515136719 476.558990478516 3 11 1.1.1.3295.8 1 28.6326 74518.14 28.3779 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.6300014257431 KWQEEMELYR Oxidation(M)@6 missed K-W@1 0.000304368993965909 1426.65551757813 476.5591 1426.65515136719 476.558990478516 3 9 1.1.1.3310.5 1 29.0067 2030.574 28.9729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.9199995994568 KWQEEMELYR Deamidated(Q)@3; Oxidation(M)@6 missed K-W@1 0.0152899995446205 1427.65441894531 476.8921 1427.63916015625 476.886993408203 3 6 1.1.1.3314.9 1 29.1051 1231.069 28.9974 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3900007009506 KWQEEMELYRQK Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1; missed R-Q@10 0.00826495978981256 1714.806640625 572.6095 1714.79846191406 572.606750488281 3 9 1.1.1.3159.12 1 25.322 2166.059 25.3106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYRQKVEPLRAELQEGAR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1; missed R-Q@10; missed K-V@12; missed R-A@17 0.017637500539422 3163.58959960938 633.7252 3163.57202148438 633.7216796875 5 17 1.1.1.3775.4 1 40.6728 2034.754 40.6399 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@6 missed K-W@1; missed R-Q@10; missed K-V@12; missed R-A@17 0.0148035995662212 3131.59716796875 627.3267 3131.58227539063 627.32373046875 5 17 1.1.1.3789.7 1 41.025 12709.46 41.2099 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.7099993228912 KWQEEMELYRQKVEPLRAELQEGAR Dioxidation(W)@2; Dioxidation(M)@6 missed K-W@1; missed R-Q@10; missed K-V@12; missed R-A@17 0.00379503006115556 3179.57055664063 636.9214 3179.56689453125 636.920654296875 5 12 1.1.1.3796.15 1 41.1997 1477.934 41.1852 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.1999987363815 LAARLEALK missed R-L@4 -0.00226254994049668 983.610473632813 492.8125 983.61279296875 492.813659667969 2 10 1.1.1.3281.14 1 28.2939 11546.11 28.4024 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.00218329997733235 1567.88171386719 523.6345 1567.87939453125 523.633728027344 3 20 1.1.1.3192.7 1 26.1163 341936.3 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(R)@4; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.0358145982027054 1569.88330078125 524.3017 1569.84741210938 524.289794921875 3 18 1.1.1.3198.4 1 26.2585 32438.86 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.00218329997733235 1567.88171386719 523.6345 1567.87939453125 523.633728027344 3 20 1.1.1.3199.6 1 26.2837 341936.3 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.00218329997733235 1567.88171386719 523.6345 1567.87939453125 523.633728027344 3 16 1.1.1.3203.8 1 26.3813 341936.3 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.00218329997733235 1567.88171386719 523.6345 1567.87939453125 523.633728027344 3 20 1.1.1.3206.8 1 26.4602 341936.3 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.00218329997733235 1567.88171386719 523.6345 1567.87939453125 523.633728027344 3 19 1.1.1.3213.7 1 26.6267 249640.5 26.3705 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.0020002000965178 1567.88134765625 523.6344 1567.87939453125 523.633728027344 3 19 1.1.1.3220.8 1 26.799 122183.6 26.5411 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.00218329997733235 1567.88171386719 523.6345 1567.87939453125 523.633728027344 3 20 1.1.1.3227.13 1 26.9697 136950.6 27.0289 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.98616898059845 1568.86572265625 523.9625 1567.87939453125 523.633728027344 3 21 1.1.1.3234.10 1 27.1395 110066.4 27.3713 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.0016775099793449 1568.86511230469 785.4398 1568.86340332031 785.439025878906 2 19 1.1.1.3235.6 1 27.1656 11146.39 27.3958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00490017980337143 1568.86828613281 523.9634 1568.86340332031 523.961730957031 3 19 1.1.1.3242.4 1 27.3301 144371.1 27.5179 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00118924002163112 1568.86462402344 785.4396 1568.86340332031 785.439025878906 2 10 1.1.1.3248.13 1 27.4882 12793.33 27.4203 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00160435005091131 1568.86499023438 523.9623 1568.86340332031 523.961730957031 3 18 1.1.1.3249.6 1 27.5076 146225.5 27.5179 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00160435005091131 1568.86499023438 523.9623 1568.86340332031 523.961730957031 3 18 1.1.1.3256.10 1 27.6821 146225.5 27.5179 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00215365993790329 1568.86572265625 523.9625 1568.86340332031 523.961730957031 3 18 1.1.1.3263.10 1 27.8502 140949.7 27.5912 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00123815005645156 1568.86486816406 523.9622 1568.86340332031 523.961730957031 3 19 1.1.1.3270.16 1 28.0228 191997.6 28.1316 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00123815005645156 1568.86486816406 523.9622 1568.86340332031 523.961730957031 3 20 1.1.1.3277.8 1 28.1937 191997.6 28.1316 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00123815005645156 1568.86486816406 523.9622 1568.86340332031 523.961730957031 3 20 1.1.1.3284.9 1 28.366 200988.3 28.1068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00490017980337143 1568.86828613281 523.9634 1568.86340332031 523.961730957031 3 15 1.1.1.3291.9 1 28.5344 5993.738 28.5991 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00490017980337143 1568.86828613281 523.9634 1568.86340332031 523.961730957031 3 15 1.1.1.3298.13 1 28.711 5993.738 28.5991 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00581568013876677 1568.86926269531 523.9637 1568.86340332031 523.961730957031 3 18 1.1.1.3305.12 1 28.886 5598.298 28.6238 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.00492980983108282 1567.88427734375 523.6354 1567.87939453125 523.633728027344 3 16 1.1.1.3315.15 1 29.1364 3415.295 29.145 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00160435005091131 1568.86499023438 523.9623 1568.86340332031 523.961730957031 3 14 1.1.1.3346.8 1 29.8971 1776.219 30.0054 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.00712702982127666 1567.88647460938 523.6361 1567.87939453125 523.633728027344 3 12 1.1.1.3416.4 1 31.6182 641.3696 31.586 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term missed R-L@4; missed K-E@9 0.00265073007903993 1593.89770507813 532.3065 1593.89514160156 532.3056640625 3 17 1.1.1.3496.8 1 33.6062 17346.5 33.7206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Formyl(K)@9 missed R-L@4; missed K-E@9 0.00710442988201976 1595.88146972656 532.9678 1595.87438964844 532.965393066406 3 19 1.1.1.3500.6 1 33.7029 11685.08 33.7454 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term missed R-L@4; missed K-E@9 0.00265073007903993 1593.89770507813 532.3065 1593.89514160156 532.3056640625 3 22 1.1.1.3503.7 1 33.7797 17346.5 33.7206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Formyl(K)@9 missed R-L@4; missed K-E@9 -0.00176796002779156 1595.87243652344 798.9435 1595.87438964844 798.944458007813 2 14 1.1.1.3505.19 1 33.8375 1711.522 33.8691 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00408574007451534 1594.88317871094 532.635 1594.87915039063 532.633666992188 3 19 1.1.1.3510.9 1 33.9526 12074.61 33.9678 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Acetyl(K)@9 missed R-L@4; missed K-E@9 0.00180723995435983 1609.89184570313 537.6379 1609.89001464844 537.637268066406 3 21 1.1.1.3547.7 1 34.8652 31738.76 34.9261 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Acetyl(K)@9 missed R-L@4; missed K-E@9 0.00180723995435983 1609.89184570313 537.6379 1609.89001464844 537.637268066406 3 22 1.1.1.3554.10 1 35.0342 31738.76 34.9261 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Acetyl(K)@9 missed R-L@4; missed K-E@9 0.0021734400652349 1609.89221191406 537.638 1609.89001464844 537.637268066406 3 20 1.1.1.3561.12 1 35.2112 30750 34.9506 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term missed R-L@4; missed K-E@9 -0.00210989988408983 1593.89282226563 532.3049 1593.89514160156 532.3056640625 3 17 1.1.1.3563.10 1 35.261 5460.874 35.1984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Acetyl(K)@9 missed R-L@4; missed K-E@9 0.00144103995990008 1609.8916015625 537.6378 1609.89001464844 537.637268066406 3 18 1.1.1.3568.12 1 35.393 27899.39 35.5367 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.00287210009992123 1594.87622070313 532.6327 1594.87915039063 532.633666992188 3 16 1.1.1.3573.12 1 35.5239 5794.112 35.6417 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Acetyl(K)@9 missed R-L@4; missed K-E@9 0.00144103995990008 1609.8916015625 537.6378 1609.89001464844 537.637268066406 3 23 1.1.1.3575.11 1 35.5758 27899.39 35.5367 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.00287210009992123 1594.87622070313 532.6327 1594.87915039063 532.633666992188 3 16 1.1.1.3580.9 1 35.7051 5794.112 35.6417 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Carboxyethyl(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00311483000405133 1640.88757324219 547.9698 1640.88464355469 547.968811035156 3 17 1.1.1.3783.4 1 40.8701 4784.5 40.9876 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Carboxyethyl(K)@9 missed R-L@4; missed K-E@9 -0.000701682001817971 1639.90002441406 547.6406 1639.90051269531 547.640808105469 3 21 1.1.1.3790.3 1 41.0438 10075.13 41.1852 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Carboxyethyl(K)@9 missed R-L@4; missed K-E@9 -0.000701682001817971 1639.90002441406 547.6406 1639.90051269531 547.640808105469 3 18 1.1.1.3797.3 1 41.2145 10075.13 41.1852 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Formyl@N-term missed R-L@4; missed K-E@9 0.00060590700013563 1595.87487792969 532.9656 1595.87438964844 532.965393066406 3 13 1.1.1.3866.5 1 43.0112 6807.691 42.8763 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR reduced acrolein addition +58(K)@9 missed R-L@4; missed K-E@9 -0.0358362011611462 1625.88549804688 542.9691 1625.92126464844 542.981018066406 3 13 1.1.1.3697.11 1 38.665 4820.991 38.8082 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR acrolein addition +56(K)@9; Hydroxymethyl(N)@11 missed R-L@4; missed K-E@9 0.000609777984209359 1653.9169921875 552.3129 1653.91625976563 552.312683105469 3 17 1.1.1.3891.9 1 43.6598 90134.91 43.5989 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.985620021820068 1568.86499023438 523.9623 1567.87939453125 523.633728027344 3 16 1.1.1.3252.7 1 27.5793 146225.5 27.5179 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(R)@4; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.0358145982027054 1569.88330078125 524.3017 1569.84741210938 524.289794921875 3 16 1.1.1.3207.4 1 26.4805 32796.76 26.2241 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00408574007451534 1594.88317871094 532.635 1594.87915039063 532.633666992188 3 14 1.1.1.3517.9 1 34.1252 12074.61 33.9678 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Acetyl(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00438753981143236 1610.87841796875 806.4465 1610.8740234375 806.444274902344 2 14 1.1.1.3535.8 1 34.5775 1939.116 34.7054 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.0103112002834678 1594.88940429688 532.6371 1594.87915039063 532.633666992188 3 16 1.1.1.3549.8 1 34.9158 3202.095 35.0979 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Acetyl(K)@9 missed R-L@4; missed K-E@9 -0.006076879799366 1609.88391113281 805.9492 1609.89001464844 805.952270507813 2 16 1.1.1.3550.7 1 34.9453 3505.243 34.9261 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term missed R-L@4; missed K-E@9 -0.00210989988408983 1593.89282226563 532.3049 1593.89514160156 532.3056640625 3 14 1.1.1.3556.8 1 35.0818 5460.874 35.1984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Acetyl@N-term; Arg->GluSA(R)@4; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00853893999010324 1567.82922363281 523.617 1567.82055664063 523.614135742188 3 15 1.1.1.3908.6 1 44.0867 27044.71 43.9786 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR reduced acrolein addition +58(K)@9 missed R-L@4; missed K-E@9 -0.0358362011611462 1625.88549804688 542.9691 1625.92126464844 542.981018066406 3 14 1.1.1.3704.14 1 38.8494 4820.991 38.8082 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00105504994280636 1568.86450195313 523.9621 1568.86340332031 523.961730957031 3 10 1.1.1.3426.10 1 31.8691 839.2383 31.8582 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term missed R-L@4; missed K-E@9 -0.00577192986384034 1593.88928222656 532.3037 1593.89514160156 532.3056640625 3 14 1.1.1.3570.9 1 35.4429 5636.892 35.1731 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(R)@4; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.0363638997077942 1569.8837890625 524.3019 1569.84741210938 524.289794921875 3 15 1.1.1.3214.5 1 26.6511 21143.09 26.3949 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.981774985790253 1568.86120605469 523.961 1567.87939453125 523.633728027344 3 11 1.1.1.3289.8 1 28.4902 71910.17 28.2303 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Acetyl(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 -5.3659900004277E-05 1610.8740234375 537.9653 1610.8740234375 537.965270996094 3 16 1.1.1.3604.9 1 36.3178 6710.855 36.3845 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Acetyl@N-term; Arg->GluSA(R)@4 missed R-L@4; missed K-E@9 0.0067361700348556 1566.84338378906 523.2884 1566.83654785156 523.2861328125 3 16 1.1.1.3893.6 1 43.7078 47205.52 43.6751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.985620021820068 1568.86499023438 523.9623 1567.87939453125 523.633728027344 3 13 1.1.1.3351.7 1 30.018 1776.219 30.0054 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.00218329997733235 1567.88171386719 523.6345 1567.87939453125 523.633728027344 3 11 1.1.1.3198.3 1 26.256 341936.3 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Ammonia-loss(N)@11 missed R-L@4; missed K-E@9 -0.00352684990502894 1550.84948730469 517.9571 1550.85290527344 517.958251953125 3 13 1.1.1.3272.11 1 28.0683 26235.94 28.2057 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Formyl(K)@9 missed R-L@4; missed K-E@9 -0.000547286996152252 1595.87390136719 798.9442 1595.87438964844 798.944458007813 2 12 1.1.1.3498.14 1 33.6657 1965.06 33.7454 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Carbamidomethyl(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.00471389992162585 1625.88000488281 542.9673 1625.88488769531 542.968933105469 3 12 1.1.1.3248.11 1 27.4849 998.0703 27.4935 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9000022411346 LAARLEALKENGGAR Cation:Na(E)@6; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.0015944599872455 1590.84704589844 531.2896 1590.84545898438 531.2890625 3 13 1.1.1.3876.5 1 43.2718 4806.206 43.186 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7999975681305 LAARLEALKENGGAR Acetyl@N-term; Arg->GluSA(R)@4 missed R-L@4; missed K-E@9 0.0067361700348556 1566.84338378906 523.2884 1566.83654785156 523.2861328125 3 12 1.1.1.3886.7 1 43.5311 47205.52 43.6751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.985253989696503 1568.86486816406 523.9622 1567.87939453125 523.633728027344 3 11 1.1.1.3271.15 1 28.0468 191997.6 28.1316 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 LAARLEALKENGGAR Formyl(K)@9 missed R-L@4; missed K-E@9 0.00234379991889 1595.87670898438 532.9662 1595.87438964844 532.965393066406 3 12 1.1.1.3531.11 1 34.476 1290.973 34.4355 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 LAARLEALKENGGAR Carbamyl(K)@9 missed R-L@4; missed K-E@9 -0.00652643013745546 1610.87890625 537.9669 1610.88525390625 537.969055175781 3 13 1.1.1.3540.9 1 34.6902 19793.3 34.73 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 LAARLEALKENGGAR MDA adduct +62(K)@9; Carbamidomethyl(E)@10; Ammonia-loss(N)@11 missed R-L@4; missed K-E@9 -0.022316100075841 1669.86767578125 557.6298 1669.89001464844 557.637268066406 3 12 1.1.1.3640.12 1 37.2237 1645.164 37.2623 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 LAARLEALKENGGAR reduced acrolein addition +58(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.0392984002828598 1626.8662109375 543.296 1626.9052734375 543.309020996094 3 12 1.1.1.3234.12 1 27.1429 3569.909 27.0779 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 LAARLEALKENGGAR Ammonia-loss(N)@11 missed R-L@4; missed K-E@9 -0.00352684990502894 1550.84948730469 517.9571 1550.85290527344 517.958251953125 3 12 1.1.1.3283.12 1 28.3432 26235.94 28.2057 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.2199976444244 LAARLEALKENGGAR Carbamyl(K)@9 missed R-L@4; missed K-E@9 -0.00707572977989912 1610.87817382813 537.9667 1610.88525390625 537.969055175781 3 11 1.1.1.3529.4 1 34.4186 15170.8 34.6564 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 LAARLEALKENGGAR Formyl(K)@9 missed R-L@4; missed K-E@9 0.000429248990258202 1595.87463378906 798.9446 1595.87438964844 798.944458007813 2 9 1.1.1.3512.12 1 34.0119 1634.863 33.9185 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 LAARLEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00317023997195065 1594.88232421875 532.6347 1594.87915039063 532.633666992188 3 12 1.1.1.3524.7 1 34.3007 1204.147 34.3372 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 LAARLEALKENGGAR Formyl(K)@9 missed R-L@4; missed K-E@9 0.00142830004915595 1595.87585449219 532.9659 1595.87438964844 532.965393066406 3 12 1.1.1.3539.10 1 34.6707 1313.047 34.4109 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 LAARLEALKENGGAR reduced acrolein addition +58(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.0441043004393578 1626.861328125 543.2944 1626.9052734375 543.309020996094 3 8 1.1.1.3682.6 1 38.2722 1340.222 38.3666 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 LAARLEALKENGGAR Cation:Na(E)@6; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.0015944599872455 1590.84704589844 531.2896 1590.84545898438 531.2890625 3 10 1.1.1.3869.6 1 43.09 4806.206 43.186 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 LAARLEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.000789919984526932 1594.8798828125 532.6339 1594.87915039063 532.633666992188 3 10 1.1.1.3587.6 1 35.8825 2796.377 35.8502 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 LAARLEALKENGGAR acrolein addition +56(K)@9; Hydroxymethyl(N)@11 missed R-L@4; missed K-E@9 0.000609777984209359 1653.9169921875 552.3129 1653.91625976563 552.312683105469 3 10 1.1.1.3884.9 1 43.4823 90134.91 43.5989 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 LAARLEALKENGGAR acrolein addition +56(K)@9; Hydroxymethyl(N)@11 missed R-L@4; missed K-E@9 0.000609777984209359 1653.9169921875 552.3129 1653.91625976563 552.312683105469 3 11 1.1.1.3898.7 1 43.8348 97122.84 43.5989 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LAARLEALKENGGAR Carbamidomethyl(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.00258463993668556 1625.88256835938 407.4779 1625.88488769531 407.478515625 4 9 1.1.1.3245.3 1 27.4 2258.188 27.4447 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LAARLEALKENGGAR Carbamidomethyl(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.00734528992325068 1625.87780761719 407.4767 1625.88488769531 407.478515625 4 11 1.1.1.3254.3 1 27.6216 2113.635 27.5667 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LAARLEALKENGGAR Cation:Na(E)@6; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.00160419999156147 1590.84375 531.2885 1590.84545898438 531.2890625 3 12 1.1.1.3257.4 1 27.6966 1540.817 27.6891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LAARLEALKENGGAR Carbamyl(K)@9 missed R-L@4; missed K-E@9 -0.000117889001558069 1610.88513183594 537.969 1610.88525390625 537.969055175781 3 11 1.1.1.3483.7 1 33.283 4254.693 33.3492 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 LAARLEALKENGGAR reduced acrolein addition +58(K)@9 missed R-L@4; missed K-E@9 -0.0476910993456841 1625.87341308594 542.9651 1625.92126464844 542.981018066406 3 8 1.1.1.3241.10 0 27.3139 1005.308 27.4935 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 LAARLEALKENGGAR Acetyl(K)@9 missed R-L@4; missed K-E@9 -0.00862952973693609 1609.88134765625 537.6344 1609.89001464844 537.637268066406 3 10 1.1.1.3597.12 1 36.1411 1458.209 36.0006 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.7099993228912 LAARLEALKENGGAR reduced acrolein addition +58(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.0441043004393578 1626.861328125 543.2944 1626.9052734375 543.309020996094 3 9 1.1.1.3689.12 1 38.4577 1340.222 38.3666 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2399988174438 LAARLEALKENGGAR Acetyl@N-term; Arg->GluSA(R)@4 missed R-L@4; missed K-E@9 0.000876926991622895 1566.83728027344 523.2864 1566.83654785156 523.2861328125 3 10 1.1.1.3922.7 1 44.4414 1792.979 44.4582 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 LAARLEALKENGGAR Carbamidomethyl(K)@9 missed R-L@4; missed K-E@9 -0.0373468995094299 1624.86376953125 407.2232 1624.90087890625 407.232513427734 4 11 1.1.1.3219.3 1 26.7713 1324.318 26.7849 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.0100002288818 LAARLEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.00470311986282468 1594.87438964844 532.6321 1594.87915039063 532.633666992188 3 11 1.1.1.3531.10 1 34.4744 809.8654 34.46 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.279999256134 LAARLEALKENGGAR Dehydrated(E)@10 missed R-L@4; missed K-E@9 -0.00422972999513149 1549.86450195313 517.6288 1549.86889648438 517.630249023438 3 11 1.1.1.3485.5 1 33.3339 3984.046 33.3988 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.279999256134 LAARLEALKENGGAR Carbamyl(K)@9 missed R-L@4; missed K-E@9 -0.00158269994426519 1610.88366699219 537.9685 1610.88525390625 537.969055175781 3 11 1.1.1.3582.14 1 35.762 16076.45 35.5104 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1500015258789 LAARLEALKENGGAR Cation:Na(E)@6; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.002326870104298 1590.84790039063 531.2899 1590.84545898438 531.2890625 3 8 1.1.1.3903.8 1 43.9625 1147.921 43.9533 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.3200008869171 LAARLEALKENGGAR dHex(N)@11 missed R-L@4; missed K-E@9 0.000761458999477327 1713.93811035156 429.4918 1713.93737792969 429.491607666016 4 10 1.1.1.3594.3 1 36.0562 4569.792 36.1538 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 LAARLEALKENGGAR Cation:Na(E)@10; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.00105489999987185 1590.84423828125 531.2887 1590.84545898438 531.2890625 3 9 1.1.1.3273.13 1 28.0948 1838.019 28.1068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 LAARLEALKENGGAR Lys->Allysine(K)@9 missed R-L@4; missed K-E@9 -0.0071126502007246 1566.84057617188 523.2875 1566.84777832031 523.289855957031 3 10 1.1.1.3547.5 1 34.8619 1143.338 34.8771 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.9900004863739 LAARLEALKENGGAR Carbamidomethyl(K)@9 missed R-L@4; missed K-E@9 -0.00206929002888501 1624.89892578125 407.232 1624.90087890625 407.232513427734 4 10 1.1.1.3196.3 1 26.2039 7235.731 26.1753 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.4699985980988 LAARLEALKENGGAR reduced acrolein addition +58(K)@9; Carbamidomethyl(E)@10 missed R-L@4; missed K-E@9 -0.00241736997850239 1682.94055175781 421.7424 1682.94274902344 421.742980957031 4 9 1.1.1.3299.4 1 28.7283 5036.467 28.6238 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.4400000572205 LAARLEALKENGGAR Cation:Na(E)@6; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.00737750995904207 1590.83801269531 531.2866 1590.84545898438 531.2890625 3 7 1.1.1.3884.8 1 43.4814 1257.775 43.4975 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.3199980258942 LAARLEALKENGGAR acrolein addition +38(K)@9 missed R-L@4; missed K-E@9 -0.0576874017715454 1605.83728027344 536.2864 1605.89514160156 536.3056640625 3 9 1.1.1.3199.7 1 26.2854 1126.786 26.2974 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.3899984359741 LAARLEALKENGGAR Carbamidomethyl(K)@9 missed R-L@4; missed K-E@9 -0.00328997010365129 1624.89770507813 407.2317 1624.90087890625 407.232513427734 4 9 1.1.1.3228.3 1 26.9842 2138.277 27.0044 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.3899984359741 LAARLEALKENGGAR Cation:Na(E)@10; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.00828326027840376 1590.85363769531 531.2918 1590.84545898438 531.2890625 3 10 1.1.1.3236.5 1 27.1876 1252.147 27.3713 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 LAARLEALKENGGAR Carbamidomethyl(K)@9 missed R-L@4; missed K-E@9 -0.003768420079723 1624.89697265625 542.6396 1624.90087890625 542.640930175781 3 7 1.1.1.3557.12 1 35.1101 523.9463 35.1479 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.9199993610382 LAARLEALKENGGAR hexanoyl addition +98(K)@9 missed R-L@4; missed K-E@9 -0.0406205989420414 1665.91198730469 556.3113 1665.95263671875 556.324829101563 3 6 1.1.1.3648.9 1 37.429 292.6502 37.4182 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 LAARLEALKENGGAR Carbamyl(K)@9 missed R-L@4; missed K-E@9 -0.000117889001558069 1610.88513183594 537.969 1610.88525390625 537.969055175781 3 10 1.1.1.3490.8 1 33.4576 4254.693 33.3492 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.1799986362457 LAARLEALKENGGAR reduced acrolein addition +58(K)@9 missed R-L@4; missed K-E@9 -0.0358362011611462 1625.88549804688 542.9691 1625.92126464844 542.981018066406 3 6 1.1.1.3711.11 1 39.0294 4820.991 38.8082 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 35.5800002813339 LAARLEALKENGGAR missed R-L@4; missed K-E@9 -0.0503133982419968 1567.82922363281 523.617 1567.87939453125 523.633728027344 3 8 1.1.1.3901.6 1 43.9101 27044.71 43.9786 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 LAARLEALKENGGAR Carbamidomethyl(K)@9 missed R-L@4; missed K-E@9 -0.00206929002888501 1624.89892578125 407.232 1624.90087890625 407.232513427734 4 8 1.1.1.3203.5 1 26.3763 7235.731 26.1753 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.9400011301041 LAARLEALKENGGAR reduced acrolein addition +58(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.0392984002828598 1626.8662109375 543.296 1626.9052734375 543.309020996094 3 8 1.1.1.3227.14 1 26.9714 3569.909 27.0779 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.7700006961823 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.000718487019184977 1567.88012695313 523.634 1567.87939453125 523.633728027344 3 9 1.1.1.3308.13 1 28.9643 1871.65 28.6981 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.9199995994568 LAARLEALKENGGAR Formyl(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.0070746298879385 1596.86547851563 533.2958 1596.8583984375 533.293395996094 3 8 1.1.1.3493.9 1 33.5318 5386.72 33.671 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.2299998402596 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 -0.00626900000497699 1568.85729980469 523.9597 1568.86340332031 523.961730957031 3 7 1.1.1.3337.13 1 29.674 1558.762 29.6859 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 19.7699993848801 LAARLEALKENGGAR MDA adduct +54(K)@9 missed R-L@4; missed K-E@9 -0.00964402034878731 1621.88012695313 541.634 1621.89001464844 541.637268066406 3 10 1.1.1.3282.9 1 28.3211 1100.436 28.2549 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9600012302399 LAEYHAK -0.00200927001424134 830.426696777344 416.2206 830.428649902344 416.221588134766 2 11 1.1.1.2695.2 1 17.2773 18646.07 17.2994 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9600012302399 LAEYHAK -0.00225340994074941 830.426452636719 416.2205 830.428649902344 416.221588134766 2 9 1.1.1.2823.2 1 18.4965 1775.783 18.278 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 LAEYHAK Delta:H(2)C(2)@N-term -0.0018488799687475 856.442443847656 429.2285 856.444274902344 429.229431152344 2 11 1.1.1.3027.3 1 22.1307 2644.881 22.0407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 LAEYHAK Delta:H(2)C(2)@N-term -0.00361885991878808 856.440673828125 429.2276 856.444274902344 429.229431152344 2 11 1.1.1.3052.4 1 22.7518 2484.73 22.7854 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 LAEYHAK Formyl@N-term 0.000228831995627843 858.423889160156 430.2192 858.423583984375 430.219055175781 2 10 1.1.1.3165.5 1 25.4638 5026.054 25.4573 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 LAEYHAK Delta:H(2)C(2)@N-term -0.0018488799687475 856.442443847656 429.2285 856.444274902344 429.229431152344 2 6 1.1.1.3020.3 1 21.9495 2644.881 22.0407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.3900010585785 LAEYHAK -0.00200927001424134 830.426696777344 416.2206 830.428649902344 416.221588134766 2 10 1.1.1.2814.2 1 18.3232 2404.104 18.1586 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.2400007247925 LAEYHAK -0.00200927001424134 830.426696777344 416.2206 830.428649902344 416.221588134766 2 9 1.1.1.2830.2 1 18.6658 1354.768 18.5101 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.4199994802475 LAEYHAK -0.0024365100543946 830.42626953125 416.2204 830.428649902344 416.221588134766 2 10 1.1.1.2802.2 1 18.1346 3237.095 17.9878 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.6300014257431 LAEYHAK -0.00261960993520916 830.426086425781 416.2203 830.428649902344 416.221588134766 2 7 1.1.1.2877.2 1 19.4043 102.9541 19.3846 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.3799986839294 LAEYHAK -0.00225340994074941 830.426452636719 416.2205 830.428649902344 416.221588134766 2 10 1.1.1.2718.2 1 17.4454 17915.34 17.381 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.3799986839294 LAEYHAK -0.0024365100543946 830.42626953125 416.2204 830.428649902344 416.221588134766 2 10 1.1.1.2744.2 1 17.6161 11132.39 17.549 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.3799986839294 LAEYHAK -0.00200927001424134 830.426696777344 416.2206 830.428649902344 416.221588134766 2 10 1.1.1.2768.2 1 17.7861 6514.081 17.7138 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.3799986839294 LAEYHAK -0.00225340994074941 830.426452636719 416.2205 830.428649902344 416.221588134766 2 10 1.1.1.2790.2 1 17.9571 4177.408 17.8795 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 24.1300001740456 LAEYHAK -0.00261960993520916 830.426086425781 416.2203 830.428649902344 416.221588134766 2 7 1.1.1.2957.2 1 20.5655 295.7513 20.6225 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Carbamidomethyl(K)@7 missed K-A@7 0.00808569043874741 2084.06201171875 695.6946 2084.05395507813 695.69189453125 3 21 1.1.1.3168.12 1 25.5515 6037.403 25.6311 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK missed K-A@7 0.00418872991576791 2027.03662109375 406.4146 2027.03234863281 406.413757324219 5 13 1.1.1.3173.3 1 25.6622 123568.9 25.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK missed K-A@7 0.00368009996600449 2027.0361328125 507.7663 2027.03234863281 507.765380859375 4 15 1.1.1.3174.6 1 25.6909 175147.3 25.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Carbamidomethyl(K)@7 missed K-A@7 0.00324067007750273 2084.05688476563 522.0215 2084.05395507813 522.020751953125 4 19 1.1.1.3175.8 1 25.7187 33204.5 25.6311 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK missed K-A@7 0.00757585978135467 2027.04016113281 676.6873 2027.03234863281 676.684753417969 3 25 1.1.1.3176.7 1 25.7455 52153.32 25.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK missed K-A@7 0.00368009996600449 2027.0361328125 507.7663 2027.03234863281 507.765380859375 4 16 1.1.1.3182.9 1 25.8663 180498.9 25.6311 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK missed K-A@7 0.00368009996600449 2027.0361328125 507.7663 2027.03234863281 507.765380859375 4 12 1.1.1.3189.8 1 26.0415 46043.17 25.7834 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Formyl(K)@7 missed K-A@7 -0.00166641001123935 2055.02563476563 686.0158 2055.02734375 686.016357421875 3 19 1.1.1.3384.8 1 30.8425 4781.085 30.9959 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Formyl(K)@7 missed K-A@7 0.00726744020357728 2055.03466796875 514.7659 2055.02734375 514.764099121094 4 18 1.1.1.3391.8 1 31.0128 13426.95 31.0206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Acetyl(K)@7 missed K-A@7 0.00765122985467315 2069.05053710938 518.2699 2069.04296875 518.268005371094 4 17 1.1.1.3418.6 1 31.6706 92681.18 31.6841 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Carbamidomethyl(K)@7 missed K-A@7 0.00808569043874741 2084.06201171875 695.6946 2084.05395507813 695.69189453125 3 15 1.1.1.3177.7 1 25.7724 6037.403 25.6311 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Formyl(K)@7 missed K-A@7 0.00726744020357728 2055.03466796875 514.7659 2055.02734375 514.764099121094 4 14 1.1.1.3405.8 1 31.3516 11150.16 31.0946 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 LAEYHAKATEHLSTLSEK reduced acrolein addition +58(K)@7 missed K-A@7 -0.0347405001521111 2085.03930664063 696.0204 2085.07421875 696.032043457031 3 12 1.1.1.3419.9 1 31.7035 659.3401 31.6841 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7500011920929 LAEYHAKATEHLSTLSEK Methyl(E)@3; Oxidation(H)@5; acrolein addition +56(K)@7 missed K-A@7 -0.000439550000010058 2113.06884765625 529.2745 2113.06909179688 529.274536132813 4 15 1.1.1.3702.10 1 38.7938 46347.73 38.7305 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 LAEYHAKATEHLSTLSEK Hex(Y)@4 missed K-A@7 -0.00128262001089752 2189.08422851563 548.2783 2189.08520507813 548.278564453125 4 14 1.1.1.3174.10 1 25.6976 13848.6 25.6311 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 LAEYHAKATEHLSTLSEK Amino(Y)@4; Delta:H(2)C(2)(K)@7 missed K-A@7 0.00780283007770777 2068.06689453125 518.024 2068.05883789063 518.022033691406 4 14 1.1.1.3189.9 1 26.0432 95284.45 25.9555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 LAEYHAKATEHLSTLSEK Oxidation(H)@5; acrolein addition +56(K)@7 missed K-A@7 5.29343997186515E-05 2099.0537109375 525.7707 2099.05346679688 525.770629882813 4 12 1.1.1.3594.12 1 36.0637 9492.27 36.1281 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 LAEYHAKATEHLSTLSEK Delta:H(2)C(2)(H)@5 missed K-A@7 0.000249645003350452 2053.04809570313 514.2693 2053.04809570313 514.269287109375 4 11 1.1.1.3343.10 1 29.8252 2005.149 29.8582 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 LAEYHAKATEHLSTLSEK Hex(1)HexNAc(1)NeuAc(1)(S)@13 missed K-A@7 0.0204998999834061 2683.28051757813 671.8274 2683.26000976563 671.822265625 4 13 1.1.1.3160.14 1 25.3522 1373.131 25.3591 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.1899991035461 LAEYHAKATEHLSTLSEK Formyl(K)@7 missed K-A@7 0.00726744020357728 2055.03466796875 514.7659 2055.02734375 514.764099121094 4 11 1.1.1.3398.11 1 31.1813 13426.95 31.0206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 LAEYHAKATEHLSTLSEK Acetyl(K)@7 missed K-A@7 0.00765122985467315 2069.05053710938 518.2699 2069.04296875 518.268005371094 4 12 1.1.1.3425.9 1 31.843 92681.18 31.6841 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 LAEYHAKATEHLSTLSEK Formyl(K)@7 missed K-A@7 0.0116857998073101 2055.03930664063 1028.527 2055.02734375 1028.52087402344 2 7 1.1.1.3394.11 1 31.0894 563.0925 31.0946 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1699993610382 LAEYHAKATEHLSTLSEK acrolein addition +76(K)@7; Cation:Na(E)@10 missed K-A@7 -0.0425549000501633 2125.0029296875 709.3416 2125.04565429688 709.355834960938 3 7 1.1.1.3170.20 1 25.6002 752.0242 25.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.529999256134 LAEYHAKATEHLSTLSEK Trimethyl(K)@7 missed K-A@7 -0.0287343002855778 2069.05053710938 518.2699 2069.07934570313 518.277099609375 4 11 1.1.1.3411.6 1 31.5022 92418.67 31.6841 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 LAEYHAKATEHLSTLSEK Oxidation(H)@5; acrolein addition +56(K)@7 missed K-A@7 5.29343997186515E-05 2099.0537109375 525.7707 2099.05346679688 525.770629882813 4 10 1.1.1.3594.11 1 36.0629 9492.27 36.1281 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.4100006222725 LAEYHAKATEHLSTLSEK missed K-A@7 0.00418872991576791 2027.03662109375 406.4146 2027.03234863281 406.413757324219 5 10 1.1.1.3185.2 1 25.936 74553.47 25.7045 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.0280779004096985 6184.33740234375 884.4841 6184.31005859375 884.480163574219 7 24 1.1.1.5071.13 1 74.2264 13276.68 74.1842 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.0301488004624844 6184.34228515625 1031.731 6184.31005859375 1031.7255859375 6 15 1.1.1.5072.21 1 74.26 6529.035 74.2117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@20 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.00991792976856232 6226.3671875 890.4883 6226.35693359375 890.48681640625 7 17 1.1.1.5080.18 1 74.4737 3071.968 74.4814 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.1799993515015 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +76(K)@7; HexNAc(S)@16; reduced acrolein addition +96(K)@18 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.0411318987607956 6559.51953125 938.0815 6559.47802734375 938.075561523438 7 17 1.1.1.5109.14 0 75.2345 8271.906 75.2456 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.2799999713898 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(Q)@28; reduced acrolein addition +58(K)@38; Dehydrated(S)@43 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.033288698643446 6225.3583984375 890.3442 6225.3251953125 890.339477539063 7 13 1.1.1.5080.17 1 74.4728 3735.403 74.4274 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.5000028610229 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl@N-term; acrolein addition +94(K)@7; reduced acrolein addition +96(K)@18 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.0206713993102312 6431.45166015625 919.7861 6431.4306640625 919.783081054688 7 10 1.1.1.5115.14 0 75.3874 2439.413 75.3478 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 LAPYSDELRQR cleaved H-L@N-term; missed R-Q@9 9.32508010009769E-06 1346.6943359375 449.9054 1346.69421386719 449.905364990234 3 10 1.1.1.3253.7 1 27.602 4258.816 27.6891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.4500024318695 LDDFQKKWQEEMELYR MDA adduct +62(K)@6; MDA adduct +62(K)@7; Dethiomethyl(M)@12 cleaved Y-L@N-term; missed K-K@6; missed K-W@7 0.0502246990799904 2233.09838867188 745.3734 2233.04809570313 745.356628417969 3 11 1.1.1.4059.15 1 47.9611 32653.66 47.8184 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 LDNWDSVTSTFSK Methyl(D)@5 cleaved L-L@N-term 0.0197810996323824 1512.7294921875 757.372 1512.70959472656 757.362121582031 2 10 1.1.1.3595.21 1 36.097 4560.9 36.0765 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.290002822876 LDNWDSVTSTFSK Acetyl@N-term cleaved L-L@N-term 0.0210710000246763 1540.72570800781 771.3701 1540.70458984375 771.359558105469 2 8 1.1.1.3639.20 1 37.2046 799.4467 37.1335 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.2200009822845 LDNWDSVTSTFSK cleaved L-L@N-term 0.0270652994513512 1498.72106933594 750.3678 1498.69396972656 750.354248046875 2 7 1.1.1.3868.19 1 43.0754 580.3385 43.0298 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.9900004863739 LDNWDSVTSTFSK Acetyl@N-term cleaved L-L@N-term 0.0180192999541759 1540.72265625 771.3686 1540.70458984375 771.359558105469 2 11 1.1.1.3611.10 1 36.5062 5094.901 36.5625 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.8700013160706 LDNWDSVTSTFSK Methyl(D)@5 cleaved L-L@N-term 0.0197810996323824 1512.7294921875 757.372 1512.70959472656 757.362121582031 2 9 1.1.1.3602.21 1 36.2768 4560.9 36.0765 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.4999983310699 LDNWDSVTSTFSK Acetyl@N-term cleaved L-L@N-term 0.0147235002368689 1540.71923828125 771.3669 1540.70458984375 771.359558105469 2 10 1.1.1.3604.21 1 36.3278 7997.848 36.3331 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.3199980258942 LDNWDSVTSTFSK Acetyl@N-term cleaved L-L@N-term 0.0185075998306274 1540.72302246094 771.3688 1540.70458984375 771.359558105469 2 10 1.1.1.3625.7 1 36.8498 4548.825 36.5871 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR missed K-E@5 -0.000829897995572537 1156.61926269531 579.3169 1156.61999511719 579.317321777344 2 16 1.1.1.3010.6 1 21.7172 19779.3 21.6733 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR missed K-E@5 -0.000829897995572537 1156.61926269531 579.3169 1156.61999511719 579.317321777344 2 13 1.1.1.3017.7 1 21.8881 19779.3 21.6733 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR missed K-E@5 0.000146641003084369 1156.62023925781 579.3174 1156.61999511719 579.317321777344 2 9 1.1.1.3024.6 1 22.0606 3667.532 21.7962 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Deamidated(N)@7 missed K-E@5 -0.00183702004142106 1157.60229492188 579.8084 1157.60400390625 579.809326171875 2 13 1.1.1.3033.5 1 22.2884 19934.97 22.4193 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Deamidated(N)@7 missed K-E@5 -0.00183702004142106 1157.60229492188 579.8084 1157.60400390625 579.809326171875 2 18 1.1.1.3040.6 1 22.4634 19934.97 22.4193 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Deamidated(N)@7 missed K-E@5 -0.00183702004142106 1157.60229492188 579.8084 1157.60400390625 579.809326171875 2 15 1.1.1.3047.8 1 22.6328 19934.97 22.4193 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.00377807999029756 1157.60791015625 579.8112 1157.60400390625 579.809326171875 2 9 1.1.1.3054.12 1 22.8027 426.3455 22.7854 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Formyl(K)@5 missed K-E@5 -0.00496920989826322 1184.61010742188 593.3123 1184.61499023438 593.314758300781 2 14 1.1.1.3159.13 1 25.3229 3872.972 25.3591 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Acetyl(K)@5 missed K-E@5 -0.00265143997967243 1198.6279296875 600.3212 1198.63061523438 600.322570800781 2 13 1.1.1.3177.5 1 25.7658 14678.63 25.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@7 missed K-E@5 0.00190054997801781 1183.62170410156 592.8181 1183.61975097656 592.817138671875 2 12 1.1.1.3182.18 1 25.8746 719.7021 25.9063 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@7 missed K-E@5 0.00324328988790512 1183.62292480469 592.8187 1183.61975097656 592.817138671875 2 12 1.1.1.3173.8 1 25.6747 1335.298 25.7045 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Formyl(K)@5; Deamidated(N)@7 missed K-E@5 -0.00109386001713574 1185.59790039063 593.8062 1185.59899902344 593.806762695313 2 10 1.1.1.3166.20 1 25.5013 1674.255 25.5815 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Acetyl(K)@5 missed K-E@5 -0.00265143997967243 1198.6279296875 600.3212 1198.63061523438 600.322570800781 2 12 1.1.1.3170.18 1 25.5986 14678.63 25.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Acetyl(K)@5; Deamidated(N)@7 missed K-E@5 3.14022008751635E-06 1199.61462402344 600.8146 1199.61462402344 600.814575195313 2 15 1.1.1.3186.7 1 25.968 5358.147 26.0045 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 LEALKENGGAR Delta:H(2)C(2)@N-term missed K-E@5 0.00156512996181846 1182.63732910156 592.3259 1182.6357421875 592.325134277344 2 10 1.1.1.3151.15 1 25.1337 519.4901 25.1892 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 LEALKENGGAR Acetyl(K)@5 missed K-E@5 -0.000894628989044577 1198.62963867188 400.5505 1198.63061523438 400.550811767578 3 12 1.1.1.3173.2 1 25.6597 3832.471 25.6555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.409999370575 LEALKENGGAR Carbamidomethyl(K)@5 missed K-E@5 0.00108209997415543 1213.642578125 405.5548 1213.64147949219 405.554443359375 3 9 1.1.1.3008.2 1 21.6547 946.6589 21.7471 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.2199976444244 LEALKENGGAR Formyl@N-term missed K-E@5 -0.00838709995150566 1184.6064453125 593.3105 1184.61499023438 593.314758300781 2 8 1.1.1.3445.7 1 32.3458 1158.298 32.4382 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 LEALKENGGAR Delta:H(2)C(2)@N-term missed K-E@5 -0.0039278999902308 1182.6318359375 592.3232 1182.6357421875 592.325134277344 2 7 1.1.1.3169.14 1 25.5704 521.7685 25.5321 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 LEALKENGGAR Formyl@N-term missed K-E@5 -0.00838709995150566 1184.6064453125 593.3105 1184.61499023438 593.314758300781 2 9 1.1.1.3459.7 1 32.6954 757.7632 32.7581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 LEALKENGGAR acrolein addition +56(K)@5; Hydroxymethyl(N)@7 missed K-E@5 -0.00431725988164544 1242.65246582031 622.3335 1242.65686035156 622.335693359375 2 12 1.1.1.3622.9 1 36.7752 5539.312 36.7346 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 LEALKENGGAR Formyl@N-term missed K-E@5 -0.0108284000307322 1184.60412597656 593.3093 1184.61499023438 593.314758300781 2 7 1.1.1.3466.7 1 32.864 757.7632 32.7581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.3899984359741 LEALKENGGAR Carbamyl(K)@5 missed K-E@5 -0.011230300180614 1199.61462402344 600.8146 1199.62585449219 600.820190429688 2 10 1.1.1.3193.5 1 26.139 5358.147 26.0045 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 LEALKENGGAR Cation:Na(E)@6 missed K-E@5 -0.00674524996429682 1178.59521484375 590.3049 1178.60192871094 590.308288574219 2 7 1.1.1.3008.4 1 21.6614 124.7423 21.6733 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 LEALKENGGAR reduced acrolein addition +58(K)@5; Ammonia-loss(N)@7 missed K-E@5 0.0076191402040422 1197.64294433594 400.2216 1197.63537597656 400.219055175781 3 10 1.1.1.3040.2 1 22.4501 11232.72 22.444 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 LEALKENGGAR Formyl@N-term missed K-E@5 -0.00863123033195734 1184.60632324219 593.3104 1184.61499023438 593.314758300781 2 7 1.1.1.3473.9 1 33.0414 694.8349 33.0287 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 18.5599997639656 LEALKENGGAR acrolein addition +56(K)@5; Deamidated(N)@7 missed K-E@5 0.0123154995962977 1213.642578125 405.5548 1213.63024902344 405.550689697266 3 8 1.1.1.3015.2 1 21.827 946.6589 21.7471 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEK -0.00328051997348666 895.473083496094 448.7438 895.476318359375 448.745452880859 2 11 1.1.1.2838.4 1 18.8125 2843.42 18.6068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEK -0.00291430996730924 895.473449707031 448.744 895.476318359375 448.745452880859 2 10 1.1.1.2848.3 1 18.9835 818.0637 18.7934 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.5300009250641 LHELQEK -0.00309742009267211 895.473266601563 448.7439 895.476318359375 448.745452880859 2 11 1.1.1.2828.3 1 18.6257 2872.11 18.6068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.700000166893 LHELQEK -0.00309742009267211 895.473266601563 448.7439 895.476318359375 448.745452880859 2 7 1.1.1.2821.3 1 18.4563 2872.11 18.6068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMR Oxidation(M)@15 missed K-L@7 -0.000290035997750238 1923.97204589844 642.3313 1923.97241210938 642.331420898438 3 15 1.1.1.3465.19 1 32.8494 13707.76 33.0287 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMR Oxidation(M)@15 missed K-L@7 0.00591458985581994 1923.978515625 482.0019 1923.97241210938 482.000366210938 4 17 1.1.1.3472.4 1 33.0118 22257.69 33.0533 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMR Formyl(K)@7; Oxidation(M)@15 missed K-L@7 -0.00868581980466843 1951.95886230469 651.6602 1951.96728515625 651.663024902344 3 13 1.1.1.3758.18 1 40.2515 1058.77 40.2328 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMR Acetyl(K)@7; Oxidation(M)@15 missed K-L@7 -0.00979780964553356 1965.97302246094 983.9938 1965.98303222656 983.998779296875 2 13 1.1.1.3773.15 1 40.6346 657.0179 40.5901 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9000022411346 LHELQEKLSPLGEEMR Acetyl(K)@7; Oxidation(M)@15 missed K-L@7 -0.0068439501337707 1965.97595214844 656.3326 1965.98303222656 656.3349609375 3 15 1.1.1.3769.10 1 40.53 3261.256 40.5901 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.00415831012651324 2195.1044921875 732.7088 2195.1005859375 732.707458496094 3 15 1.1.1.3364.19 1 30.3447 67769.73 30.3766 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.004053870216012 2195.1044921875 549.7834 2195.1005859375 549.782409667969 4 16 1.1.1.3365.11 1 30.363 236452.6 30.3516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.004053870216012 2195.1044921875 549.7834 2195.1005859375 549.782409667969 4 15 1.1.1.3372.15 1 30.5408 236452.6 30.3516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.00844829995185137 2195.10888671875 549.7845 2195.1005859375 549.782409667969 4 15 1.1.1.3379.11 1 30.7173 140513.9 30.4514 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.00429800990968943 2195.1044921875 549.7834 2195.1005859375 549.782409667969 4 16 1.1.1.3393.4 1 31.053 10409.42 31.0699 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.00332146999426186 2195.10375976563 549.7832 2195.1005859375 549.782409667969 4 13 1.1.1.3407.3 1 31.3973 8392.104 31.3898 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.004053870216012 2195.1044921875 549.7834 2195.1005859375 549.782409667969 4 15 1.1.1.3414.4 1 31.5691 8339.461 31.6106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Acetyl(K)@7; Oxidation(M)@15 missed K-L@7; missed R-D@16 -0.0042957398109138 2237.1064453125 560.2839 2237.11108398438 560.285034179688 4 15 1.1.1.3705.12 1 38.8739 9700.247 38.8082 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 LHELQEKLSPLGEEMRDR Carbamidomethyl@N-term; Oxidation(P)@10 missed K-L@7; missed R-D@16 0.00759971980005503 2252.12963867188 564.0397 2252.12182617188 564.037780761719 4 12 1.1.1.3374.11 1 30.5872 1433.82 30.5759 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4100012779236 LHELQEKLSPLGEEMRDR Carbamidomethyl@N-term; Oxidation(M)@15 missed K-L@7; missed R-D@16 -0.00558356009423733 2252.11645507813 564.0364 2252.12182617188 564.037780761719 4 11 1.1.1.3357.11 1 30.1654 6664.826 30.2766 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 LHELQEKLSPLGEEMRDR Pro->pyro-Glu(P)@10; Oxidation(M)@15 missed K-L@7; missed R-D@16 0.00321756000630558 2209.0830078125 553.278 2209.07983398438 553.277221679688 4 12 1.1.1.3362.13 1 30.2897 4138.534 30.3516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.9799978733063 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.00415831012651324 2195.1044921875 732.7088 2195.1005859375 732.707458496094 3 12 1.1.1.3363.20 1 30.3206 67769.73 30.3766 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.9799978733063 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.00918070040643215 2195.10986328125 549.7847 2195.1005859375 549.782409667969 4 12 1.1.1.3400.6 1 31.2289 8491.12 31.2425 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.3900010585785 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.00869243033230305 2195.10888671875 549.7845 2195.1005859375 549.782409667969 4 12 1.1.1.3428.13 1 31.9221 7748.597 31.6841 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 29.1500002145767 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.0100888004526496 2179.11572265625 545.7862 2179.10546875 545.78369140625 4 9 1.1.1.3581.9 1 35.7313 1164.898 35.7203 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.2699991464615 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.004053870216012 2195.1044921875 549.7834 2195.1005859375 549.782409667969 4 11 1.1.1.3421.10 1 31.7437 8339.461 31.6106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.0599999427795 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.00811875984072685 2195.10864257813 440.029 2195.1005859375 440.027374267578 5 9 1.1.1.3375.3 1 30.6053 149345.2 30.3516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDRAR Oxidation(M)@15 missed K-L@7; missed R-D@16; missed R-A@18 0.00983066018670797 2422.24853515625 485.457 2422.23876953125 485.455017089844 5 13 1.1.1.3300.12 1 28.76 43480.2 28.823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDRAR Oxidation(M)@15 missed K-L@7; missed R-D@16; missed R-A@18 0.00983066018670797 2422.24853515625 485.457 2422.23876953125 485.455017089844 5 16 1.1.1.3304.12 1 28.8606 43480.2 28.823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.0699996948242 LHELQEKLSPLGEEMRDRAR Oxidation(M)@15 missed K-L@7; missed R-D@16; missed R-A@18 0.00293541001155972 2422.24145507813 404.7142 2422.23876953125 404.713714599609 6 11 1.1.1.3304.2 1 28.8523 10255.85 28.823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.9199995994568 LKENGGAR Deamidated(N)@4 cleaved A-L@N-term; missed K-E@2 -0.00453063985332847 844.435852050781 423.2252 844.440307617188 423.227416992188 2 5 1.1.1.3035.3 1 22.3333 303.5794 22.3945 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00465956004336476 1643.76330566406 822.8889 1643.76782226563 822.891235351563 2 21 1.1.1.3765.12 1 40.432 8571.93 40.4905 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00465956004336476 1643.76330566406 822.8889 1643.76782226563 822.891235351563 2 18 1.1.1.3772.10 1 40.6098 8571.93 40.4905 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Ammonia-loss(N)@4; Dioxidation(W)@5 0.0105985999107361 1626.75183105469 814.3832 1626.74133300781 814.3779296875 2 18 1.1.1.3784.7 1 40.9081 13589.28 41.1356 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Ammonia-loss(N)@4; Dioxidation(W)@5 0.0105985999107361 1626.75183105469 814.3832 1626.74133300781 814.3779296875 2 20 1.1.1.3791.11 1 41.0777 13887.67 41.111 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Ammonia-loss(N)@4; Dioxidation(W)@5 0.00998825021088123 1626.75122070313 814.3829 1626.74133300781 814.3779296875 2 19 1.1.1.3798.20 1 41.2535 13400.34 41.2099 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00856570992618799 1643.75952148438 822.887 1643.76782226563 822.891235351563 2 19 1.1.1.3801.6 1 41.3259 7280.1 41.5667 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Ammonia-loss(N)@4; Dioxidation(W)@5 0.00217593996785581 1626.74353027344 814.379 1626.74133300781 814.3779296875 2 18 1.1.1.3805.21 1 41.4304 12119.45 41.3847 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00856570992618799 1643.75952148438 822.887 1643.76782226563 822.891235351563 2 18 1.1.1.3811.20 1 41.587 7798.252 41.5931 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Ammonia-loss(N)@4; Dioxidation(W)@5 0.00217593996785581 1626.74353027344 814.379 1626.74133300781 814.3779296875 2 16 1.1.1.3813.20 1 41.6398 12223.67 41.3847 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00856570992618799 1643.75952148438 822.887 1643.76782226563 822.891235351563 2 14 1.1.1.3819.20 1 41.7981 7761.891 41.5667 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 -0.00660012010484934 1615.76623535156 808.8904 1615.77294921875 808.893737792969 2 15 1.1.1.3839.19 1 42.3238 14383.84 42.4365 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00478162989020348 1643.76330566406 822.8889 1643.76782226563 822.891235351563 2 17 1.1.1.3843.17 1 42.428 16181.06 42.542 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 -0.00660012010484934 1615.76623535156 808.8904 1615.77294921875 808.893737792969 2 20 1.1.1.3846.17 1 42.5071 14383.84 42.4365 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00478162989020348 1643.76330566406 822.8889 1643.76782226563 822.891235351563 2 21 1.1.1.3850.21 1 42.616 16181.06 42.542 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@5 -0.000329458998749033 1631.76770019531 816.8911 1631.76782226563 816.891235351563 2 16 1.1.1.3856.13 1 42.7652 74766.9 42.9523 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00502575980499387 1643.76281738281 822.8887 1643.76782226563 822.891235351563 2 17 1.1.1.3858.19 1 42.819 7186.102 42.9269 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@5 -8.53246965561993E-05 1631.76782226563 816.8912 1631.76782226563 816.891235351563 2 25 1.1.1.3863.19 1 42.9454 78755.71 42.9779 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00502575980499387 1643.76281738281 822.8887 1643.76782226563 822.891235351563 2 19 1.1.1.3865.17 1 42.9951 7186.102 42.9269 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@5 -8.53246965561993E-05 1631.76782226563 816.8912 1631.76782226563 816.891235351563 2 23 1.1.1.3870.18 1 43.1259 78755.71 42.9779 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00783331040292978 1643.76013183594 822.8873 1643.76782226563 822.891235351563 2 17 1.1.1.3872.17 1 43.1774 7347.754 42.9015 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@5 -0.000329458998749033 1631.76770019531 816.8911 1631.76782226563 816.891235351563 2 16 1.1.1.3877.16 1 43.3073 69326.72 43.0298 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00250678998418152 1627.7705078125 814.8925 1627.77294921875 814.893737792969 2 18 1.1.1.3878.19 1 43.3362 36648.87 43.4468 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00404922990128398 1643.76391601563 822.8892 1643.76782226563 822.891235351563 2 22 1.1.1.3884.15 1 43.4873 14185.74 43.5228 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00250678998418152 1627.7705078125 814.8925 1627.77294921875 814.893737792969 2 22 1.1.1.3885.11 1 43.5092 36648.87 43.4468 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00441543012857437 1643.76342773438 822.889 1643.76782226563 822.891235351563 2 20 1.1.1.3891.15 1 43.6648 7531.089 43.7004 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.00225382996723056 1627.77526855469 814.8949 1627.77294921875 814.893737792969 2 16 1.1.1.3893.16 1 43.7161 2256.711 43.7004 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.000997544964775443 1643.76684570313 822.8907 1643.76782226563 822.891235351563 2 19 1.1.1.3898.15 1 43.8415 6777.234 43.8264 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.000911088020075113 1627.77392578125 814.8942 1627.77294921875 814.893737792969 2 18 1.1.1.3904.17 1 43.9952 2595.793 43.8517 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00319476006552577 1643.7646484375 822.8896 1643.76782226563 822.891235351563 2 17 1.1.1.3906.10 1 44.0397 94817.25 44.2811 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.00278653996065259 1643.77062988281 822.8926 1643.76782226563 822.891235351563 2 24 1.1.1.3913.12 1 44.2178 369562.4 44.4329 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.00127729005180299 1627.77429199219 814.8944 1627.77294921875 814.893737792969 2 14 1.1.1.3914.14 1 44.2447 2170.312 44.2305 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4; Dioxidation(W)@5 0.0105926999822259 1644.76245117188 549.2614 1644.751953125 549.257934570313 3 17 1.1.1.3918.8 1 44.341 22176.58 44.4582 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4; Trp->Hydroxykynurenin(W)@5 0.00879405997693539 1632.76062011719 817.3876 1632.751953125 817.383239746094 2 15 1.1.1.3920.15 1 44.3974 2917.597 44.4077 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.000387209001928568 1643.76770019531 822.8911 1643.76782226563 822.891235351563 2 25 1.1.1.3920.16 1 44.3983 391045.3 44.4836 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.000387209001928568 1643.76770019531 822.8911 1643.76782226563 822.891235351563 2 25 1.1.1.3927.17 1 44.5759 391045.3 44.4836 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.000875478028319776 1643.76708984375 822.8908 1643.76782226563 822.891235351563 2 25 1.1.1.3934.16 1 44.7518 395228.5 44.4836 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 -0.00379256997257471 1615.76904296875 808.8918 1615.77294921875 808.893737792969 2 14 1.1.1.3939.17 1 44.8788 2285.59 44.8873 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00404922990128398 1643.76391601563 822.8892 1643.76782226563 822.891235351563 2 22 1.1.1.3941.16 1 44.9283 162201.3 44.6601 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00441543012857437 1643.76342773438 822.889 1643.76782226563 822.891235351563 2 23 1.1.1.3948.19 1 45.1078 24988.39 45.1147 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00189645995851606 1627.77111816406 814.8928 1627.77294921875 814.893737792969 2 20 1.1.1.3953.17 1 45.2336 11176.58 45.4729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00380508997477591 1643.76403808594 822.8893 1643.76782226563 822.891235351563 2 23 1.1.1.3955.18 1 45.2857 25994.53 45.2164 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.00523774977773428 1611.77282714844 806.8937 1611.77807617188 806.896301269531 2 22 1.1.1.3957.17 1 45.3361 17984.66 45.3705 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00214058998972178 1627.77087402344 814.8927 1627.77294921875 814.893737792969 2 19 1.1.1.3960.18 1 45.4141 11955.1 45.4729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00368301989510655 1643.76428222656 822.8894 1643.76782226563 822.891235351563 2 23 1.1.1.3962.17 1 45.4644 26287.48 45.2164 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.000174357002833858 1615.77319335938 539.5983 1615.77294921875 539.598266601563 3 18 1.1.1.3967.9 1 45.5851 167691.6 45.575 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00214058998972178 1627.77087402344 814.8927 1627.77294921875 814.893737792969 2 18 1.1.1.3967.18 1 45.5926 11955.1 45.4729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00380508997477591 1643.76403808594 822.8893 1643.76782226563 822.891235351563 2 18 1.1.1.3970.18 1 45.6687 6876.147 45.6765 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.000174357002833858 1615.77319335938 539.5983 1615.77294921875 539.598266601563 3 18 1.1.1.3974.9 1 45.7634 167691.6 45.575 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00250678998418152 1627.7705078125 814.8925 1627.77294921875 814.893737792969 2 24 1.1.1.3974.19 1 45.7717 33406.96 45.83 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.00132172997109592 1643.76928710938 822.8919 1643.76782226563 822.891235351563 2 19 1.1.1.3977.19 1 45.8487 9487.632 45.9066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 -0.000374947005184367 1615.7724609375 539.5981 1615.77294921875 539.598266601563 3 16 1.1.1.3981.7 1 45.941 108723.9 45.6765 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00807743985205889 1643.75988769531 822.8872 1643.76782226563 822.891235351563 2 17 1.1.1.3984.18 1 46.0273 5576.542 46.0091 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 -0.00367076997645199 1615.76916503906 539.597 1615.77294921875 539.598266601563 3 17 1.1.1.3988.12 1 46.127 34043.88 45.8557 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4; Trp->Kynurenin(W)@5 0.011315000243485 1616.7685546875 539.9301 1616.75695800781 539.92626953125 3 15 1.1.1.3990.4 1 46.1728 5973.333 46.1922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.00181986996904016 1611.77624511719 806.8954 1611.77807617188 806.896301269531 2 19 1.1.1.3997.18 1 46.3678 12489.03 46.4538 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.00181986996904016 1611.77624511719 806.8954 1611.77807617188 806.896301269531 2 21 1.1.1.4004.17 1 46.5495 12489.03 46.4538 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.000223127004574053 1643.76831054688 822.8914 1643.76782226563 822.891235351563 2 17 1.1.1.4011.17 1 46.7315 2565.902 46.6879 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4; Trp->Kynurenin(W)@5 -0.00248128990642726 1616.75451660156 809.3845 1616.75695800781 809.3857421875 2 20 1.1.1.4014.18 1 46.8104 7436.692 46.8181 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.00474948016926646 1611.77331542969 806.8939 1611.77807617188 806.896301269531 2 17 1.1.1.4023.21 1 47.045 10268.46 46.948 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.0024524899199605 1611.78051757813 806.8975 1611.77807617188 806.896301269531 2 16 1.1.1.4037.18 1 47.4013 570727.1 47.6398 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00189645995851606 1627.77111816406 814.8928 1627.77294921875 814.893737792969 2 22 1.1.1.4042.19 1 47.5308 13357.44 47.6398 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.0024524899199605 1611.78051757813 806.8975 1611.77807617188 806.896301269531 2 24 1.1.1.4044.13 1 47.577 563650.7 47.6144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00189645995851606 1627.77111816406 814.8928 1627.77294921875 814.893737792969 2 21 1.1.1.4049.17 1 47.7076 13357.44 47.6398 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trioxidation(W)@5 0.00160928000696003 1659.76452636719 830.8895 1659.76281738281 830.888671875 2 14 1.1.1.4049.19 1 47.7093 3032.393 47.6653 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.0024524899199605 1611.78051757813 806.8975 1611.77807617188 806.896301269531 2 25 1.1.1.4051.16 1 47.7578 563650.7 47.6144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00189645995851606 1627.77111816406 814.8928 1627.77294921875 814.893737792969 2 18 1.1.1.4056.17 1 47.8865 13551.87 47.6398 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.00220834999345243 1611.7802734375 806.8974 1611.77807617188 806.896301269531 2 25 1.1.1.4058.17 1 47.9374 460302 47.6653 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 7.79663023422472E-05 1627.77307128906 814.8938 1627.77294921875 814.893737792969 2 14 1.1.1.4063.18 1 48.0652 8264.816 47.7928 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.00452637020498514 1643.7724609375 822.8935 1643.76782226563 822.891235351563 2 15 1.1.1.4093.16 1 48.827 2058.053 48.8364 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term; Dioxidation(W)@5 -0.0019989600405097 1669.78161621094 835.8981 1669.78356933594 835.899047851563 2 16 1.1.1.4124.21 1 49.6235 6643.388 49.7313 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term; Dioxidation(W)@5 -0.0019989600405097 1669.78161621094 835.8981 1669.78356933594 835.899047851563 2 18 1.1.1.4131.20 1 49.8014 6643.388 49.7313 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term; Dioxidation(W)@5 -0.00212102988734841 1669.78149414063 835.898 1669.78356933594 835.899047851563 2 15 1.1.1.4138.19 1 49.9792 7101.446 49.7056 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term; Dioxidation(W)@5 0.00166306004393846 1669.78527832031 835.8999 1669.78356933594 835.899047851563 2 18 1.1.1.4149.17 1 50.2573 4215.177 50.3171 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term; Dioxidation(W)@5 0.00166306004393846 1669.78527832031 835.8999 1669.78356933594 835.899047851563 2 14 1.1.1.4156.19 1 50.4374 4215.177 50.3171 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Acetyl@N-term 0.00270941993221641 1653.79150390625 827.903 1653.78857421875 827.901611328125 2 14 1.1.1.4261.11 1 53.1085 1698.966 53.1221 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term -0.00515619991347194 1637.78869628906 819.9016 1637.79370117188 819.904113769531 2 15 1.1.1.4280.20 1 53.6007 12233.13 53.7596 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term -0.00515619991347194 1637.78869628906 819.9016 1637.79370117188 819.904113769531 2 19 1.1.1.4287.18 1 53.7774 12233.13 53.7596 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term -0.0019824500195682 1637.79162597656 819.9031 1637.79370117188 819.904113769531 2 16 1.1.1.4295.18 1 53.9817 5447.84 54.117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term -0.00234865001402795 1637.79150390625 819.903 1637.79370117188 819.904113769531 2 17 1.1.1.4302.15 1 54.1579 5357.925 54.1427 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(N)@4 0.000824758026283234 1627.77368164063 543.5985 1627.77294921875 543.598266601563 3 16 1.1.1.3799.5 1 41.266 10765.96 41.2347 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trioxidation(W)@5 -0.00595889007672668 1659.7568359375 830.8857 1659.76281738281 830.888671875 2 14 1.1.1.3807.21 1 41.4822 1835.113 41.5138 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.006046739872545 1627.76684570313 814.8907 1627.77294921875 814.893737792969 2 13 1.1.1.3827.19 1 42.0051 4283.672 41.7252 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.0137369995936751 1627.75927734375 814.8869 1627.77294921875 814.893737792969 2 13 1.1.1.3852.16 1 42.6643 1188.094 42.6213 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4; Dioxidation(W)@5 0.0193560998886824 1644.77124023438 823.3929 1644.751953125 823.383239746094 2 16 1.1.1.3928.17 1 44.601 136112.8 44.4582 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 -0.00684425001963973 1615.76611328125 808.8903 1615.77294921875 808.893737792969 2 13 1.1.1.3946.19 1 45.0572 2354.886 45.0894 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.000733872991986573 1643.76867675781 548.9302 1643.76782226563 548.929931640625 3 15 1.1.1.3954.10 1 45.2535 4262.776 45.2422 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@5; Dehydrated(D)@6 0.00385117996484041 1613.76123046875 807.8879 1613.75732421875 807.885925292969 2 17 1.1.1.3963.18 1 45.4908 10778.11 45.4475 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00807743985205889 1643.75988769531 822.8872 1643.76782226563 822.891235351563 2 14 1.1.1.3991.17 1 46.21 5576.542 46.0091 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 -0.000374947005184367 1615.7724609375 539.5981 1615.77294921875 539.598266601563 3 14 1.1.1.3995.4 1 46.3039 13313.41 46.035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.00023565000446979 1615.77331542969 808.8939 1615.77294921875 808.893737792969 2 12 1.1.1.4007.19 1 46.6297 2522.343 46.6366 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.00474948016926646 1611.77331542969 806.8939 1611.77807617188 806.896301269531 2 15 1.1.1.4016.19 1 46.863 10268.46 46.948 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.00368491001427174 1611.78161621094 806.8981 1611.77807617188 806.896301269531 2 23 1.1.1.4064.15 1 48.0882 311725.6 47.8184 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.000504514027852565 1611.77758789063 538.2665 1611.77807617188 538.2666015625 3 14 1.1.1.4065.5 1 48.1052 38849.83 47.8441 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.000511161983013153 1611.77844238281 806.8965 1611.77807617188 806.896301269531 2 21 1.1.1.4072.18 1 48.2942 137327.9 48.0476 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.00171881995629519 1643.76965332031 822.8921 1643.76782226563 822.891235351563 2 11 1.1.1.4074.20 1 48.3466 1663.159 48.1239 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.000831578974612057 1611.77722167969 806.8959 1611.77807617188 806.896301269531 2 22 1.1.1.4079.17 1 48.4714 26564.88 48.4544 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.000504514027852565 1611.77758789063 538.2665 1611.77807617188 538.2666015625 3 10 1.1.1.4083.4 1 48.5621 3869.098 48.48 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.000831578974612057 1611.77722167969 806.8959 1611.77807617188 806.896301269531 2 20 1.1.1.4086.15 1 48.6476 26564.88 48.4544 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Carbamidomethyl(S)@13; Hypusine(K)@14 0.000695494003593922 1755.86865234375 878.9416 1755.86791992188 878.941223144531 2 15 1.1.1.4086.17 1 48.6492 3177.071 48.6324 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.00705701019614935 1611.77111816406 806.8928 1611.77807617188 806.896301269531 2 21 1.1.1.4093.15 1 48.8262 21718.56 48.5561 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.00424946006387472 1611.77392578125 806.8942 1611.77807617188 806.896301269531 2 20 1.1.1.4100.16 1 49.0057 10385.54 49.0151 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.00424946006387472 1611.77392578125 806.8942 1611.77807617188 806.896301269531 2 17 1.1.1.4107.19 1 49.1863 10385.54 49.0151 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.000709511979948729 1611.77722167969 806.8959 1611.77807617188 806.896301269531 2 16 1.1.1.4114.20 1 49.3661 4830.361 49.2956 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.000511161983013153 1611.77844238281 806.8965 1611.77807617188 806.896301269531 2 19 1.1.1.4121.18 1 49.5439 5445.123 49.5772 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -9.91751003311947E-05 1611.77783203125 806.8962 1611.77807617188 806.896301269531 2 17 1.1.1.4129.16 1 49.7473 5235.342 49.7313 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.000144959994941019 1611.7783203125 806.8964 1611.77807617188 806.896301269531 2 15 1.1.1.4138.18 1 49.9783 5336.325 49.7056 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.000221241993131116 1611.77783203125 806.8962 1611.77807617188 806.896301269531 2 10 1.1.1.4143.20 1 50.1069 3959.125 49.833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4 0.0029216599650681 1612.76501464844 807.3898 1612.76208496094 807.388305664063 2 15 1.1.1.4154.19 1 50.3866 5014.358 50.4443 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.00698073022067547 1611.78503417969 806.8998 1611.77807617188 806.896301269531 2 10 1.1.1.4161.20 1 50.5655 2286.656 50.4953 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.00356283993460238 1611.78161621094 806.8981 1611.77807617188 806.896301269531 2 9 1.1.1.4170.19 1 50.7936 1334.539 50.7751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.0148692997172475 1611.76330566406 806.8889 1611.77807617188 806.896301269531 2 11 1.1.1.4190.13 1 51.3013 1541.273 51.1342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.00669080996885896 1611.77124023438 806.8929 1611.77807617188 806.896301269531 2 14 1.1.1.4228.19 1 52.2738 2584.15 52.3824 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK -0.00705701019614935 1611.77111816406 806.8928 1611.77807617188 806.896301269531 2 12 1.1.1.4236.16 1 52.4752 2644.961 52.3569 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dehydrated(D)@3 0.00773118995130062 1593.77526855469 797.8949 1593.76745605469 797.890991210938 2 11 1.1.1.4145.20 1 50.1579 1700.124 50.164 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(D)@3; Ammonia-loss(N)@4 -0.00147387001197785 1610.7451171875 806.3798 1610.74645996094 806.380493164063 2 13 1.1.1.4714.11 1 64.765 1397.405 64.7522 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.000174357002833858 1615.77319335938 539.5983 1615.77294921875 539.598266601563 3 15 1.1.1.3976.9 1 45.8148 171557.8 45.575 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5; Dehydrated(D)@6 0.00355018000118434 1625.76086425781 813.8877 1625.75732421875 813.885925292969 2 13 1.1.1.3990.20 1 46.1861 2894.724 46.0091 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trioxidation(W)@5; Methyl(D)@6 0.00176693999674171 1673.7802734375 837.8974 1673.77844238281 837.896484375 2 13 1.1.1.4102.18 1 49.0582 1748.176 49.0659 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.000875478028319776 1643.76708984375 822.8908 1643.76782226563 822.891235351563 2 12 1.1.1.4000.20 1 46.4477 4417.541 46.1659 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term; Trp->Kynurenin(W)@5 -0.000542457972187549 1641.78820800781 548.27 1641.78857421875 548.270141601563 3 12 1.1.1.4181.4 1 51.0631 2749.694 51.1342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term; Trp->Kynurenin(W)@5 -0.0027325099799782 1641.78588867188 821.9002 1641.78857421875 821.901611328125 2 13 1.1.1.4203.18 1 51.6369 1216.436 51.5936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00404922990128398 1643.76391601563 822.8892 1643.76782226563 822.891235351563 2 13 1.1.1.3836.18 1 42.2431 4601.288 42.3306 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trioxidation(W)@5 0.00160928000696003 1659.76452636719 830.8895 1659.76281738281 830.888671875 2 13 1.1.1.3848.19 1 42.5616 1248.627 42.542 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4; Dioxidation(W)@5 0.0105926999822259 1644.76245117188 549.2614 1644.751953125 549.257934570313 3 15 1.1.1.3925.7 1 44.5172 22176.58 44.4582 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00380508997477591 1643.76403808594 822.8893 1643.76782226563 822.891235351563 2 13 1.1.1.3940.16 1 44.9031 187860.5 44.635 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.000166167999850586 1627.77282714844 814.8937 1627.77294921875 814.893737792969 2 10 1.1.1.4071.20 1 48.2704 3219.655 48.073 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term; Trp->Hydroxykynurenin(W)@5 0.0125788999721408 1657.79602050781 829.9053 1657.78356933594 829.899047851563 2 11 1.1.1.4085.17 1 48.6238 982.2448 48.6578 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.0144694000482559 1627.75842285156 814.8865 1627.77294921875 814.893737792969 2 11 1.1.1.3933.19 1 44.7291 1170.119 44.7107 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00275092991068959 1627.77026367188 814.8924 1627.77294921875 814.893737792969 2 11 1.1.1.3738.19 1 39.7371 939.2147 39.7187 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00026514200726524 1643.76770019531 822.8911 1643.76782226563 822.891235351563 2 13 1.1.1.4041.21 1 47.5069 5440.1 47.6144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00629088003188372 1627.76672363281 814.8906 1627.77294921875 814.893737792969 2 9 1.1.1.3724.21 1 39.3737 611.2532 39.4312 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@5 3.67426000593696E-05 1631.76782226563 816.8912 1631.76782226563 816.891235351563 2 12 1.1.1.3887.15 1 43.5633 3186.673 43.4213 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5; Cation:Na(D)@6 -0.00373362004756927 1665.74609375 556.256 1665.74987792969 556.257202148438 3 16 1.1.1.3924.7 1 44.492 6280.436 44.4329 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00118936004582793 1627.771484375 543.5978 1627.77294921875 543.598266601563 3 12 1.1.1.3956.8 1 45.3029 5647.083 45.4219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.017119200900197 1627.75573730469 543.5925 1627.77294921875 543.598266601563 3 11 1.1.1.3837.11 1 42.2641 944.2858 42.3041 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 -0.0105632003396749 1627.76245117188 814.8885 1627.77294921875 814.893737792969 2 11 1.1.1.3926.17 1 44.5507 1408.912 44.5089 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5; Dehydrated(D)@6 0.00355018000118434 1625.76086425781 813.8877 1625.75732421875 813.885925292969 2 14 1.1.1.3982.21 1 45.9781 2894.724 46.0091 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.000174357002833858 1615.77319335938 539.5983 1615.77294921875 539.598266601563 3 13 1.1.1.3983.10 1 45.9947 87277.13 45.7277 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00026514200726524 1643.76770019531 822.8911 1643.76782226563 822.891235351563 2 13 1.1.1.4051.17 1 47.7587 5440.1 47.6144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 -0.000618821009993553 1615.77221679688 808.8934 1615.77294921875 808.893737792969 2 11 1.1.1.4003.20 1 46.5258 6209.449 46.2445 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9799976348877 LLDNWDSVTSTFSK Deamidated(N)@4; FormaldehydeAdduct(W)@5 0.0103737004101276 1624.7724609375 542.5981 1624.76208496094 542.594604492188 3 14 1.1.1.3431.16 1 32.0011 13155.7 32.0363 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00465956004336476 1643.76330566406 822.8889 1643.76782226563 822.891235351563 2 10 1.1.1.4021.19 1 46.9925 1990.373 46.9219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 LLDNWDSVTSTFSK Trioxidation(W)@5 0.00160928000696003 1659.76452636719 830.8895 1659.76281738281 830.888671875 2 11 1.1.1.4042.20 1 47.5317 3032.393 47.6653 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 LLDNWDSVTSTFSK Trioxidation(W)@5 0.00160928000696003 1659.76452636719 830.8895 1659.76281738281 830.888671875 2 11 1.1.1.4056.18 1 47.8873 3032.393 47.6653 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5; Dehydrated(D)@6 -0.00181032996624708 1597.76062011719 799.8876 1597.76245117188 799.888488769531 2 11 1.1.1.3763.19 1 40.3838 1239.928 40.3906 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2100009918213 LLDNWDSVTSTFSK Deamidated(N)@4; FormaldehydeAdduct(W)@5 0.0070295101031661 1624.76916503906 542.597 1624.76208496094 542.594604492188 3 13 1.1.1.3883.4 1 43.4527 16483.91 43.4468 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2100009918213 LLDNWDSVTSTFSK Deamidated(N)@4; Trp->Hydroxykynurenin(W)@5 0.0136767998337746 1632.765625 817.3901 1632.751953125 817.383239746094 2 10 1.1.1.3913.11 1 44.217 914.9812 44.2053 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2100009918213 LLDNWDSVTSTFSK Deamidated(N)@4; Trp->Kynurenin(W)@5 -0.00248128990642726 1616.75451660156 809.3845 1616.75695800781 809.3857421875 2 9 1.1.1.4021.17 1 46.9909 7436.692 46.8181 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.000174357002833858 1615.77319335938 539.5983 1615.77294921875 539.598266601563 3 12 1.1.1.3962.6 1 45.4552 167691.6 45.575 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 LLDNWDSVTSTFSK Acetyl@N-term 0.0099268602207303 1653.79833984375 552.2734 1653.78857421875 552.270141601563 3 12 1.1.1.3668.8 1 37.9254 14359.05 37.9662 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 LLDNWDSVTSTFSK Acetyl@N-term 0.0099268602207303 1653.79833984375 552.2734 1653.78857421875 552.270141601563 3 12 1.1.1.3675.9 1 38.0998 14359.05 37.9662 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 LLDNWDSVTSTFSK Oxidation(W)@5 -0.0127603998407722 1627.76025390625 814.8874 1627.77294921875 814.893737792969 2 12 1.1.1.3860.14 1 42.8676 1581.549 42.8007 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.00640708021819592 1643.76159667969 548.9278 1643.76782226563 548.929931640625 3 9 1.1.1.3887.8 1 43.5575 1782.868 43.5228 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 LLDNWDSVTSTFSK Oxidation(W)@5 -0.0044598700478673 1627.76843261719 814.8915 1627.77294921875 814.893737792969 2 10 1.1.1.3941.15 1 44.9275 2403.961 45.1147 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.7400004863739 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00118936004582793 1627.771484375 543.5978 1627.77294921875 543.598266601563 3 11 1.1.1.3966.6 1 45.5572 5647.083 45.4219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1300005912781 LLDNWDSVTSTFSK Deamidated(N)@4 0.00852441042661667 1612.77062988281 807.3926 1612.76208496094 807.388305664063 2 11 1.1.1.3975.18 1 45.7964 1965.645 45.8041 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 LLDNWDSVTSTFSK Quinone(W)@5 -0.000677598989568651 1641.75170898438 821.8831 1641.75219726563 821.883361816406 2 8 1.1.1.3698.20 1 38.6985 784.3987 38.6786 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 LLDNWDSVTSTFSK Dioxidation(W)@5; Oxidation(F)@12 -0.00119827000889927 1659.76171875 830.8881 1659.76281738281 830.888671875 2 11 1.1.1.3878.20 1 43.337 1131.913 43.3167 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 -0.000924250984098762 1615.77221679688 539.598 1615.77294921875 539.598266601563 3 10 1.1.1.3944.6 1 44.9957 2573.296 44.8873 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.000174357002833858 1615.77319335938 539.5983 1615.77294921875 539.598266601563 3 11 1.1.1.3960.8 1 45.4058 167691.6 45.575 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 LLDNWDSVTSTFSK Deamidated(N)@4; Oxidation(W)@5 0.0196556001901627 1628.77661132813 543.9328 1628.75695800781 543.92626953125 3 11 1.1.1.3966.7 1 45.558 3227.853 45.4985 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6200003623962 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.00987873040139675 1615.78308105469 539.6016 1615.77294921875 539.598266601563 3 9 1.1.1.3948.5 1 45.0961 2453.837 45.0894 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.5599973201752 LLDNWDSVTSTFSK -0.0413696989417076 1611.73669433594 806.8756 1611.77807617188 806.896301269531 2 11 1.1.1.3776.7 1 40.7028 5040.728 40.615 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.1500008106232 LLDNWDSVTSTFSK Dioxidation(W)@5 0.0012831799685955 1643.76940917969 548.9304 1643.76782226563 548.929931640625 3 8 1.1.1.3840.8 1 42.341 1107.331 42.3306 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.1500008106232 LLDNWDSVTSTFSK Dioxidation(W)@5 -0.01161739975214 1643.75622558594 822.8854 1643.76782226563 822.891235351563 2 9 1.1.1.4031.17 1 47.2475 1141.896 47.2305 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.1500008106232 LLDNWDSVTSTFSK Cation:Na(D)@6 0.00445315986871719 1633.76452636719 817.8895 1633.76000976563 817.887268066406 2 11 1.1.1.4043.17 1 47.555 2509.393 47.5889 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2399988174438 LLDNWDSVTSTFSK Dioxidation(W)@5 0.00732551980763674 1643.77526855469 548.9324 1643.76782226563 548.929931640625 3 7 1.1.1.3868.8 1 43.0662 1114.075 43.0557 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2399988174438 LLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@5 -0.00814175978302956 1631.75964355469 816.8871 1631.76782226563 816.891235351563 2 8 1.1.1.3904.18 1 43.9961 892.2736 44.0542 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 LLDNWDSVTSTFSK Deamidated(N)@4; Dioxidation(W)@5 0.011909999884665 1644.76391601563 823.3892 1644.751953125 823.383239746094 2 9 1.1.1.3837.20 1 42.2716 2240.546 42.3571 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.619998216629 LLDNWDSVTSTFSK Deamidated(N)@4; Dioxidation(W)@5 0.00458597997203469 1644.75646972656 823.3855 1644.751953125 823.383239746094 2 9 1.1.1.3802.20 1 41.3534 4765.227 41.5403 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.619998216629 LLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@5 -0.00467621022835374 1631.76306152344 544.9283 1631.76782226563 544.929931640625 3 11 1.1.1.3868.7 1 43.0654 15614.79 42.9779 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.9900009632111 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5; Cation:Na(D)@6 -0.00410699006170034 1637.75073242188 546.9242 1637.7548828125 546.925598144531 3 11 1.1.1.3964.12 1 45.5113 2157.853 45.575 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.8400018215179 LLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@5 -0.00350320991128683 1631.76452636719 816.8895 1631.76782226563 816.891235351563 2 9 1.1.1.3896.14 1 43.7902 1239.329 43.877 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0200028419495 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00629088003188372 1627.76672363281 814.8906 1627.77294921875 814.893737792969 2 6 1.1.1.3731.21 1 39.5575 611.2532 39.4312 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0200028419495 LLDNWDSVTSTFSK Carbamyl@N-term; Dehydrated(D)@3 -0.00270116003230214 1636.77062988281 819.3926 1636.77331542969 819.393920898438 2 12 1.1.1.4038.18 1 47.4272 10887.27 47.5121 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1500015258789 LLDNWDSVTSTFSK Carbamidomethyl@N-term; Deamidated(N)@4; Trp->Kynurenin(W)@5 -0.00292028998956084 1673.77551269531 837.895 1673.77844238281 837.896484375 2 10 1.1.1.3973.21 1 45.7476 8239.013 45.4729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.3200008869171 LLDNWDSVTSTFSK Methyl(D)@3; Deamidated(N)@4 0.0130476001650095 1626.79077148438 543.2709 1626.77770996094 543.266540527344 3 11 1.1.1.3639.6 1 37.1929 5914.873 37.0573 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2100005149841 LLDNWDSVTSTFSK Deamidated(N)@4; Methyl(D)@6 -0.0292942002415657 1626.74853515625 543.2568 1626.77770996094 543.266540527344 3 9 1.1.1.3803.9 1 41.3694 3711.828 41.3847 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2100005149841 LLDNWDSVTSTFSK Methyl(D)@3; Deamidated(N)@4 -0.0195898003876209 1626.75817871094 543.26 1626.77770996094 543.266540527344 3 9 1.1.1.3810.6 1 41.549 3440.238 41.5138 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2100005149841 LLDNWDSVTSTFSK Dioxidation(W)@5 0.00164937996305525 1643.76965332031 548.9305 1643.76782226563 548.929931640625 3 9 1.1.1.3848.9 1 42.5532 3049.539 42.542 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0299973487854 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5; Dehydrated(S)@7 -0.00498407986015081 1597.75744628906 799.886 1597.76245117188 799.888488769531 2 10 1.1.1.3834.19 1 42.1911 3744.55 42.1718 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0299973487854 LLDNWDSVTSTFSK Acetyl@N-term -0.00941208004951477 1653.779296875 827.8969 1653.78857421875 827.901611328125 2 11 1.1.1.3870.19 0 43.1267 1466.679 43.1595 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.8400025367737 LLDNWDSVTSTFSK Oxidation(W)@5 -0.0105632003396749 1627.76245117188 814.8885 1627.77294921875 814.893737792969 2 8 1.1.1.3834.20 1 42.1919 1766.204 42.0651 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 LLDNWDSVTSTFSK Acetyl@N-term 0.0102931000292301 1653.79907226563 552.2736 1653.78857421875 552.270141601563 3 10 1.1.1.3682.7 1 38.2731 12988.33 38.0156 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 LLDNWDSVTSTFSK Cation:Na(D)@6 0.00445315986871719 1633.76452636719 817.8895 1633.76000976563 817.887268066406 2 10 1.1.1.4050.17 1 47.7332 2509.393 47.5889 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.8799977302551 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term 0.0128293000161648 1637.806640625 546.9428 1637.79370117188 546.938537597656 3 8 1.1.1.4299.9 1 54.0762 1556.452 54.117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.6100022792816 LLDNWDSVTSTFSK Quinone(W)@5 -6.72624009894207E-05 1641.75231933594 821.8834 1641.75219726563 821.883361816406 2 7 1.1.1.3714.21 1 39.115 712.8809 39.146 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 -0.00660012010484934 1615.76623535156 808.8904 1615.77294921875 808.893737792969 2 7 1.1.1.3854.17 1 42.7163 15167.4 42.4365 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.6699981689453 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00302036991342902 1627.76989746094 543.5972 1627.77294921875 543.598266601563 3 9 1.1.1.3973.10 1 45.7384 5541.819 45.8041 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.6899974346161 LLDNWDSVTSTFSK -0.0413696989417076 1611.73669433594 806.8756 1611.77807617188 806.896301269531 2 7 1.1.1.3769.11 1 40.5317 5040.728 40.615 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.6899974346161 LLDNWDSVTSTFSK Oxidation(W)@5 -0.00338656990788877 1627.76953125 543.5971 1627.77294921875 543.598266601563 3 6 1.1.1.3828.6 1 42.0208 2109.474 41.7516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.6799993515015 LLDNWDSVTSTFSK Deamidated(N)@4; FormaldehydeAdduct(W)@5 0.0103737004101276 1624.7724609375 542.5981 1624.76208496094 542.594604492188 3 7 1.1.1.3438.12 1 32.1769 13155.7 32.0363 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.7500007152557 LLDNWDSVTSTFSK Deamidated(N)@4; FormaldehydeAdduct(W)@5 0.0157427005469799 1624.77783203125 813.3962 1624.76208496094 813.388305664063 2 10 1.1.1.3490.14 1 33.4676 1103.152 33.4729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.3499999046326 LLDNWDSVTSTFSK Deamidated(N)@4 0.0162663999944925 1612.77807617188 538.6 1612.76208496094 538.594604492188 3 9 1.1.1.4002.8 1 46.4898 1491.35 46.4797 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.1199994087219 LLDNWDSVTSTFSK Deamidated(N)@4; FormaldehydeAdduct(W)@5 0.011472299695015 1624.77331542969 542.5984 1624.76208496094 542.594604492188 3 10 1.1.1.3487.11 1 33.3852 8823.385 33.4482 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 21.170000731945 LLDNWDSVTSTFSK Dioxidation(W)@5 0.0133678996935487 1643.78137207031 548.9344 1643.76782226563 548.929931640625 3 5 1.1.1.3804.8 1 41.394 592.3606 41.3595 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR Dioxidation(W)@5 missed K-L@14 0.0037549699191004 1912.95690917969 957.4857 1912.95300292969 957.483825683594 2 13 1.1.1.4076.20 1 48.3975 4194.267 48.4544 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR Carbamidomethyl(K)@14 missed K-L@14 0.00799228996038437 1937.99267578125 647.0048 1937.98474121094 647.002197265625 3 12 1.1.1.4203.13 1 51.6327 2389.136 51.6191 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR missed K-L@14 -0.00184126000385731 1880.96130371094 627.9944 1880.96325683594 627.994995117188 3 16 1.1.1.4205.11 1 51.6818 44013.99 51.8489 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR missed K-L@14 -0.00184126000385731 1880.96130371094 627.9944 1880.96325683594 627.994995117188 3 19 1.1.1.4212.8 1 51.8582 44013.99 51.8489 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR Oxidation(W)@5 missed K-L@14 -0.00254598003812134 1896.95556640625 633.3258 1896.95812988281 633.32666015625 3 15 1.1.1.3959.7 1 45.3793 1869.295 45.3961 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR missed K-L@14 0.983793020248413 1881.94677734375 628.3229 1880.96325683594 627.994995117188 3 10 1.1.1.4236.7 1 52.4677 1177.055 52.5103 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR Methyl(T)@11; Oxidation(F)@12; acrolein addition +56(K)@14 missed K-L@14 -0.00574652990326285 1966.99426269531 984.5044 1967 984.507263183594 2 14 1.1.1.4573.18 1 61.2074 1870.413 61.2409 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR Acetyl(S)@13 missed K-L@14 0.0102286003530025 1922.98413085938 962.4993 1922.97375488281 962.494201660156 2 12 1.1.1.4354.20 1 55.4917 1933.709 55.4978 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.0600001811981 LLDNWDSVTSTFSKLR Dioxidation(W)@5 missed K-L@14 -0.000208062992896885 1912.95275878906 638.6582 1912.95300292969 638.658325195313 3 10 1.1.1.4074.11 1 48.3391 28073.16 48.4544 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.4400000572205 LLDNWDSVTSTFSKLR Trp->Hydroxykynurenin(W)@5 missed K-L@14 0.000187828001799062 1900.95336914063 634.6584 1900.95300292969 634.658325195313 3 10 1.1.1.4032.16 1 47.2723 3132.238 47.2561 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.0100018978119 LLDNWDSVTSTFSKLR Trp->Kynurenin(W)@5 missed K-L@14 0.00963841006159782 1884.96765136719 943.4911 1884.95812988281 943.486328125 2 7 1.1.1.4132.20 1 49.8269 853.6316 49.833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.0999970436096 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(K)@32 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.013090499676764 5099.49365234375 1020.906 5099.482421875 1020.90374755859 5 11 1.1.1.5074.20 1 74.3133 3739.536 74.3467 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEF cleaved F-W@C-term; missed R-E@2 -0.000226011994527653 1415.74072265625 708.8776 1415.74084472656 708.877685546875 2 14 1.1.1.3802.17 1 41.3509 2696.58 41.3344 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 LREQLGPVTQEF cleaved F-W@C-term; missed R-E@2 -0.0103575997054577 1415.73071289063 708.8726 1415.74084472656 708.877685546875 2 9 1.1.1.3816.17 1 41.7166 839.9631 41.672 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFW Trp->Hydroxykynurenin(W)@13 cleaved W-D@C-term; missed R-E@2 -0.00645224004983902 1621.8037109375 811.9091 1621.81005859375 811.912292480469 2 19 1.1.1.3973.20 1 45.7468 5029.243 45.6765 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFW Trp->Hydroxykynurenin(W)@13 cleaved W-D@C-term; missed R-E@2 -0.0065743001177907 1621.80346679688 811.909 1621.81005859375 811.912292480469 2 14 1.1.1.3980.19 1 45.9258 5189.01 45.651 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 71.6099977493286 LREQLGPVTQEFW Trp->Hydroxykynurenin(W)@13 cleaved W-D@C-term; missed R-E@2 -0.003400560002774 1621.806640625 811.9106 1621.81005859375 811.912292480469 2 9 1.1.1.4025.20 1 47.0959 1762.08 47.1279 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 -0.0403647981584072 2201.0712890625 734.6977 2201.11157226563 734.711181640625 3 16 1.1.1.3811.17 1 41.5845 26672.18 41.6991 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 -0.00222388003021479 2217.1044921875 740.0421 2217.10668945313 740.042785644531 3 18 1.1.1.3839.18 1 42.3229 26809.8 42.4629 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 -0.00222388003021479 2217.1044921875 740.0421 2217.10668945313 740.042785644531 3 24 1.1.1.3846.14 1 42.5046 26809.8 42.4629 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13; Ammonia-loss(N)@15 missed R-E@2 0.00935497973114252 2216.08422851563 739.702 2216.07495117188 739.698913574219 3 21 1.1.1.3878.17 1 43.3345 19309.31 43.3167 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.00930972024798393 2233.09204101563 745.3713 2233.1015625 745.374450683594 3 19 1.1.1.3935.16 1 44.7771 3750.656 44.7612 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.0105932001024485 2217.1171875 740.0463 2217.10668945313 740.042785644531 3 16 1.1.1.3952.20 1 45.2103 1151.194 45.1909 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 -0.00368869001977146 2217.10302734375 740.0416 2217.10668945313 740.042785644531 3 16 1.1.1.3966.14 1 45.5638 4658.074 45.524 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 -0.00259008002467453 2217.10375976563 740.0419 2217.10668945313 740.042785644531 3 21 1.1.1.3973.16 1 45.7434 4523.361 45.7528 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 -0.00790000986307859 2217.09887695313 740.0402 2217.10668945313 740.042785644531 3 19 1.1.1.3980.16 1 45.9233 4423.188 45.9066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.00253498996607959 2233.09887695313 745.3736 2233.1015625 745.374450683594 3 16 1.1.1.3986.17 1 46.0786 1825.251 46.0091 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Hydroxykynurenin(W)@13 missed R-E@2 0.00178709998726845 2221.103515625 741.3751 2221.1015625 741.374450683594 3 17 1.1.1.4018.16 1 46.9125 16878.87 47.076 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 0.00259183999150991 2233.10400390625 745.3753 2233.1015625 745.374450683594 3 22 1.1.1.4024.17 1 47.0674 132624.5 47.2561 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Hydroxykynurenin(W)@13 missed R-E@2 0.00178709998726845 2221.103515625 741.3751 2221.1015625 741.374450683594 3 25 1.1.1.4025.17 1 47.0934 16878.87 47.076 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 0.00262706005014479 2233.10424804688 559.2833 2233.1015625 559.282653808594 4 19 1.1.1.4030.8 1 47.2145 7095.158 47.2561 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.000703978992532939 2233.10083007813 745.3742 2233.1015625 745.374450683594 3 26 1.1.1.4031.14 1 47.245 134086.6 47.2561 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.000703978992532939 2233.10083007813 745.3742 2233.1015625 745.374450683594 3 24 1.1.1.4038.17 1 47.4263 134086.6 47.2561 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.0012532799737528 2233.10034179688 745.374 2233.1015625 745.374450683594 3 23 1.1.1.4045.17 1 47.6058 118925 47.3325 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.00326738995499909 2233.09838867188 745.3734 2233.1015625 745.374450683594 3 24 1.1.1.4052.14 1 47.7817 32653.66 47.8184 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.000815897015854716 2205.107421875 736.0431 2205.10668945313 736.042785644531 3 21 1.1.1.4053.19 1 47.8114 55134.59 48.0223 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.00326738995499909 2233.09838867188 745.3734 2233.1015625 745.374450683594 3 21 1.1.1.4059.16 1 47.962 32653.66 47.8184 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.00381658994592726 2205.11059570313 736.0441 2205.10668945313 736.042785644531 3 27 1.1.1.4062.18 1 48.0399 61941.72 48.0984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Hydroxykynurenin(W)@13 missed R-E@2 0.00150190002750605 2221.10278320313 741.3749 2221.1015625 741.374450683594 3 18 1.1.1.4062.19 1 48.0407 1400.003 48.1494 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.00381658994592726 2205.11059570313 736.0441 2205.10668945313 736.042785644531 3 24 1.1.1.4069.16 1 48.2163 61941.72 48.0984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.000463906006189063 2205.107421875 552.2841 2205.10668945313 552.283935546875 4 18 1.1.1.4074.5 1 48.3341 35384.27 48.073 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.00418278994038701 2205.11083984375 736.0442 2205.10668945313 736.042785644531 3 16 1.1.1.4075.17 1 48.3695 60989.31 48.0984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.00345038995146751 2205.10986328125 736.0439 2205.10668945313 736.042785644531 3 17 1.1.1.4076.13 1 48.3916 55623.02 48.1239 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.00607901997864246 2205.11303710938 552.2855 2205.10668945313 552.283935546875 4 12 1.1.1.4082.6 1 48.5384 1875.069 48.5053 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Deamidated(Q)@10; Deamidated(N)@15 missed R-E@2 0.0158553998917341 2203.09521484375 735.3724 2203.07983398438 735.3671875 3 17 1.1.1.4088.18 1 48.701 6275.519 48.6578 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.00629168003797531 2233.09521484375 745.3724 2233.1015625 745.374450683594 3 18 1.1.1.4092.17 1 48.8023 3556.238 48.8108 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.00629168003797531 2233.09521484375 745.3724 2233.1015625 745.374450683594 3 16 1.1.1.4102.17 1 49.0573 3606.663 48.7853 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.00153105997014791 2233.10034179688 745.374 2233.1015625 745.374450683594 3 13 1.1.1.4109.18 1 49.2367 2659.255 49.27 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.00462938006967306 2217.111328125 740.0444 2217.10668945313 740.042785644531 3 18 1.1.1.4153.20 1 50.362 6057.528 50.5206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.00462938006967306 2217.111328125 740.0444 2217.10668945313 740.042785644531 3 22 1.1.1.4160.21 1 50.541 6057.528 50.5206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Delta:H(2)C(2)@N-term; Dioxidation(W)@13 missed R-E@2 0.00789184961467981 2259.12524414063 754.049 2259.1171875 754.046325683594 3 15 1.1.1.4177.18 1 50.9716 2356.982 51.005 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.00499557983130217 2217.11157226563 740.0445 2217.10668945313 740.042785644531 3 18 1.1.1.4182.12 1 51.0955 3856.513 51.1342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.00499557983130217 2217.11157226563 740.0445 2217.10668945313 740.042785644531 3 14 1.1.1.4191.13 1 51.327 3856.513 51.1342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 1.00776994228363 2202.11962890625 735.0471 2201.11157226563 734.711181640625 3 16 1.1.1.4202.15 1 51.6088 2932.419 51.5427 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 1.00082004070282 2202.11254882813 735.0448 2201.11157226563 734.711181640625 3 17 1.1.1.4228.15 1 52.2704 2348.996 52.2552 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13; Amidated@C-term missed R-E@2 -0.00232097995467484 2232.115234375 745.0457 2232.11743164063 745.046447753906 3 17 1.1.1.4009.20 1 46.6818 3581.453 46.6879 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.000829912023618817 2205.107421875 1103.561 2205.10668945313 1103.560546875 2 11 1.1.1.4055.21 1 47.8643 14881.88 48.0984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 1.98389005661011 2203.09521484375 735.3724 2201.11157226563 734.711181640625 3 13 1.1.1.4081.19 1 48.5238 6275.519 48.6578 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.00345038995146751 2205.10986328125 736.0439 2205.10668945313 736.042785644531 3 14 1.1.1.4092.15 1 48.8006 9990.413 49.0407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 0.00108459999319166 2201.11254882813 734.7115 2201.11157226563 734.711181640625 3 15 1.1.1.4180.9 1 51.0413 128912.3 51.1599 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Deamidated(Q)@10 missed R-E@2 0.0153363002464175 2202.11108398438 735.0443 2202.095703125 735.039184570313 3 22 1.1.1.4181.12 1 51.0698 82953.92 51.1855 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 -0.00160664995200932 2201.109375 1101.562 2201.11157226563 1101.56311035156 2 17 1.1.1.4181.20 1 51.0765 42165.3 51.1599 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 0.00303288991563022 2201.11450195313 551.2859 2201.11157226563 551.285217285156 4 15 1.1.1.4182.7 1 51.0913 4808.481 51.1855 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 0.00108459999319166 2201.11254882813 734.7115 2201.11157226563 734.711181640625 3 25 1.1.1.4188.13 1 51.2505 128912.3 51.1599 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 0.00108459999319166 2201.11254882813 734.7115 2201.11157226563 734.711181640625 3 24 1.1.1.4195.16 1 51.4314 132090.7 51.1599 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 0.000169099002960138 2201.11181640625 734.7112 2201.11157226563 734.711181640625 3 12 1.1.1.4208.12 1 51.7594 4001.941 51.7976 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Methyl(E)@11; Dioxidation(W)@13 missed R-E@2 -0.0272563006728888 2247.08959960938 750.0372 2247.1171875 750.046325683594 3 17 1.1.1.4031.15 1 47.2458 1344.328 47.2818 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.0182105004787445 2205.12475585938 736.0489 2205.10668945313 736.042785644531 3 15 1.1.1.3948.15 1 45.1044 2290.384 45.1656 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK FormaldehydeAdduct(W)@13; Deamidated(N)@15 missed R-E@2 0.0215655993670225 2214.11743164063 739.0464 2214.095703125 739.039184570313 3 16 1.1.1.4021.14 1 46.9884 5500.519 47.076 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 -0.00368869001977146 2217.10302734375 740.0416 2217.10668945313 740.042785644531 3 15 1.1.1.3959.17 1 45.3876 4658.074 45.524 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -6.62476013530977E-05 2233.10180664063 745.3745 2233.1015625 745.374450683594 3 13 1.1.1.4118.15 1 49.4645 2230.237 49.4747 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.011052300222218 2233.09057617188 745.3708 2233.1015625 745.374450683594 3 11 1.1.1.4135.19 1 49.9026 1643.948 49.884 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.0133378002792597 2205.11962890625 736.0472 2205.10668945313 736.042785644531 3 12 1.1.1.4113.18 1 49.3388 2702.384 49.5772 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.00930972024798393 2233.09204101563 745.3713 2233.1015625 745.374450683594 3 14 1.1.1.3928.14 1 44.5985 3750.656 44.7612 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.00363358994945884 2233.09790039063 745.3732 2233.1015625 745.374450683594 3 13 1.1.1.3945.16 1 45.0293 3223.503 45.1909 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 -0.00112528004683554 2217.10546875 740.0424 2217.10668945313 740.042785644531 3 14 1.1.1.3987.16 1 46.1039 6604.85 46.1659 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.00499557983130217 2217.11157226563 740.0445 2217.10668945313 740.042785644531 3 12 1.1.1.4189.14 1 51.2768 3856.513 51.1342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK FormaldehydeAdduct(W)@13; Deamidated(N)@15 missed R-E@2 0.0129597997292876 2214.10864257813 739.0435 2214.095703125 739.039184570313 3 13 1.1.1.3761.18 1 40.3305 3183.892 40.3646 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 0.00625385995954275 2233.10766601563 745.3765 2233.1015625 745.374450683594 3 14 1.1.1.4016.17 1 46.8613 4766.588 46.7142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dehydrated(D)@14; Dehydrated(E)@17; MDA adduct +54(K)@18 missed R-E@2 -0.0108311995863914 2219.09008789063 740.704 2219.10107421875 740.707641601563 3 16 1.1.1.3872.15 1 43.1758 5867.03 43.186 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.00363358994945884 2233.09790039063 745.3732 2233.1015625 745.374450683594 3 14 1.1.1.3953.16 1 45.2328 3223.503 45.1909 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 2.00879001617432 2203.1201171875 735.3807 2201.11157226563 734.711181640625 3 12 1.1.1.4250.16 1 52.8324 9054.637 52.6382 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13; Dehydrated(D)@14 missed R-E@2 0.00101666001137346 2187.09692382813 730.0396 2187.09594726563 730.039306640625 3 15 1.1.1.3868.18 1 43.0745 2894.702 43.0557 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.00426951982080936 2205.11083984375 552.285 2205.10668945313 552.283935546875 4 13 1.1.1.3950.11 1 45.152 2305.447 45.1656 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13; Dehydrated(D)@14 missed R-E@2 -0.000265048001892865 2187.095703125 730.0392 2187.09594726563 730.039306640625 3 15 1.1.1.3883.10 1 43.4578 6579.125 43.4722 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 1.99962997436523 2203.111328125 735.3777 2201.11157226563 734.711181640625 3 12 1.1.1.4239.12 1 52.5486 16938.81 52.3824 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13; Ammonia-loss(N)@15; acrolein addition +38(K)@18 missed R-E@2 0.0210889000445604 2226.11669921875 743.0462 2226.095703125 743.039184570313 3 15 1.1.1.3976.17 1 45.8215 2870.469 45.8557 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK FormaldehydeAdduct(W)@13; Deamidated(N)@15 missed R-E@2 0.0125935999676585 2214.1083984375 739.0434 2214.095703125 739.039184570313 3 12 1.1.1.3738.18 1 39.7363 1697.502 39.7948 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.00784492027014494 2233.09375 745.3718 2233.1015625 745.374450683594 3 12 1.1.1.3976.18 1 45.8223 1824.167 45.9327 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 LREQLGPVTQEFWDNLEK Trp->Hydroxykynurenin(W)@13 missed R-E@2 0.000871598022058606 2221.1025390625 741.3748 2221.1015625 741.374450683594 3 12 1.1.1.4048.16 1 47.6814 1618.848 47.7672 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2100009918213 LREQLGPVTQEFWDNLEK Trp->Hydroxykynurenin(W)@13 missed R-E@2 0.00325190997682512 2221.10473632813 741.3755 2221.1015625 741.374450683594 3 10 1.1.1.4041.18 1 47.5044 1084.757 47.4349 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13; acrolein addition +38(K)@18 missed R-E@2 0.0136495996266603 2243.13623046875 561.7913 2243.12231445313 561.787841796875 4 12 1.1.1.3799.6 1 41.2668 5208.007 41.3096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.7400004863739 LREQLGPVTQEFWDNLEK Dioxidation(W)@13; hexanoyl addition +98(K)@18 missed R-E@2 0.0156315006315708 2331.1904296875 583.8049 2331.17456054688 583.800964355469 4 12 1.1.1.3770.3 1 40.5466 3157.382 40.5403 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7299997806549 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13; acrolein addition +38(K)@18 missed R-E@2 0.0116964997723699 2243.13403320313 561.7908 2243.12231445313 561.787841796875 4 9 1.1.1.3785.7 1 40.9212 2304.059 41.0369 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13; acrolein addition +38(K)@18 missed R-E@2 0.0143820000812411 2243.13647460938 561.7914 2243.12231445313 561.787841796875 4 11 1.1.1.3792.5 1 41.0957 5058.65 41.2846 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13; Dehydrated(D)@14 missed R-E@2 -0.00594118004664779 2187.09008789063 730.0373 2187.09594726563 730.039306640625 3 12 1.1.1.3876.18 1 43.2827 3251.01 43.1595 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2399988174438 LREQLGPVTQEFWDNLEK Trimethyl(K)@18 missed R-E@2 -0.0227358993142843 2243.13623046875 561.7913 2243.15869140625 561.796936035156 4 11 1.1.1.3806.6 1 41.4437 5208.007 41.3096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 LREQLGPVTQEFWDNLEK FormaldehydeAdduct(W)@13; Deamidated(N)@15 missed R-E@2 0.0159447006881237 2214.11181640625 554.5352 2214.095703125 554.531188964844 4 11 1.1.1.3743.4 1 39.8518 4616.314 39.7948 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 LREQLGPVTQEFWDNLEK FormaldehydeAdduct(W)@13; Deamidated(N)@15 missed R-E@2 0.0108179003000259 2214.1064453125 554.5339 2214.095703125 554.531188964844 4 11 1.1.1.3765.3 1 40.4204 6443.892 40.3646 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.619998216629 LREQLGPVTQEFWDNLEK Dioxidation(W)@13; Dehydrated(D)@14 missed R-E@2 0.0035266000777483 2215.09448242188 739.3721 2215.09106445313 739.370910644531 3 12 1.1.1.4010.19 1 46.7072 2525.854 46.7401 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.3199970722198 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13; acrolein addition +38(K)@18 missed R-E@2 0.0143251996487379 2243.13671875 748.7195 2243.12231445313 748.714721679688 3 8 1.1.1.3798.19 1 41.2527 2049.343 41.2347 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.3199970722198 LREQLGPVTQEFWDNLEK Deamidated(Q)@10; FormaldehydeAdduct(W)@13; Deamidated(N)@15 missed R-E@2 0.0321546010673046 2215.11206054688 739.3779 2215.07983398438 739.3671875 3 12 1.1.1.4019.16 1 46.9386 2339.598 46.948 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.2399985790253 LREQLGPVTQEFWDNLEK Dioxidation(K)@18 missed R-E@2 -0.00665789004415274 2233.09521484375 745.3723 2233.1015625 745.374450683594 3 12 1.1.1.4127.16 1 49.6961 1772.095 49.6288 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.1600000858307 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.00649202987551689 2205.11303710938 736.045 2205.10668945313 736.042785644531 3 10 1.1.1.4001.17 1 46.4711 6638.6 46.297 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 LREQLGPVTQEFWDNLEK Deamidated(Q)@10; Dioxidation(W)@13 missed R-E@2 0.0297488998621702 2234.11499023438 745.7123 2234.08544921875 745.702453613281 3 10 1.1.1.4128.17 1 49.7227 1892.086 49.449 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 -0.000615551020018756 2233.10107421875 745.3743 2233.1015625 745.374450683594 3 10 1.1.1.4185.19 0 51.1786 5621.646 51.2623 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.2699990272522 LREQLGPVTQEFWDNLEK Trp->Hydroxykynurenin(W)@13 missed R-E@2 0.00178709998726845 2221.103515625 741.3751 2221.1015625 741.374450683594 3 8 1.1.1.4032.21 1 47.2765 16878.87 47.076 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.1799988746643 LREQLGPVTQEFWDNLEK MDA adduct +62(K)@18 missed R-E@2 -0.0107822995632887 2263.11669921875 755.3795 2263.12744140625 755.383056640625 3 11 1.1.1.4024.18 1 47.0683 3060.37 47.102 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1000003814697 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.00957311037927866 2217.1162109375 740.046 2217.10668945313 740.042785644531 3 9 1.1.1.4117.18 1 49.4413 2915.437 49.1679 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1000003814697 LREQLGPVTQEFWDNLEK Trioxidation(W)@13 missed R-E@2 0.0201389994472265 2249.11669921875 750.7128 2249.09643554688 750.706115722656 3 10 1.1.1.4186.18 1 51.2033 1906.423 51.1342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.6100022792816 LREQLGPVTQEFWDNLEK FormaldehydeAdduct(W)@13; Deamidated(N)@15 missed R-E@2 0.0159447006881237 2214.11181640625 554.5352 2214.095703125 554.531188964844 4 7 1.1.1.3736.7 1 39.6765 4616.314 39.7948 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.7599983215332 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 -0.000760936993174255 2205.10571289063 736.0425 2205.10668945313 736.042785644531 3 7 1.1.1.4140.18 1 50.029 2222.716 49.8586 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.0072973701171577 2217.11376953125 740.0452 2217.10668945313 740.042785644531 3 9 1.1.1.4021.15 1 46.9892 2042.507 46.8957 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.0100018978119 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 0.00121546001173556 2233.10278320313 745.3749 2233.1015625 745.374450683594 3 7 1.1.1.4147.18 1 50.2072 1186.885 50.2917 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.6899974346161 LREQLGPVTQEFWDNLEK Deamidated(N)@15; Methyl(E)@17 missed R-E@2 0.0107479002326727 2216.1220703125 555.0378 2216.111328125 555.035095214844 4 9 1.1.1.3831.7 1 42.1014 2045.788 42.1718 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Oxidation(W)@13 missed R-E@2; missed K-E@18 0.00760577013716102 2902.45385742188 726.6207 2902.44604492188 726.618774414063 4 24 1.1.1.3981.15 1 45.9477 11796.01 46.0872 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Oxidation(W)@13 missed R-E@2; missed K-E@18 0.00760577013716102 2902.45385742188 726.6207 2902.44604492188 726.618774414063 4 20 1.1.1.3986.15 1 46.0769 11796.01 46.0872 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Dioxidation(W)@13 missed R-E@2; missed K-E@18 0.00823254976421595 2918.44946289063 730.6196 2918.44091796875 730.617553710938 4 24 1.1.1.4298.11 1 54.0523 48140.86 53.9381 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18 0.000393149006413296 2890.44653320313 723.6189 2890.44604492188 723.618774414063 4 19 1.1.1.4309.11 1 54.3331 24502.43 54.5761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18 0.0123819997534156 2890.45849609375 964.4934 2890.44604492188 964.489318847656 3 18 1.1.1.4312.16 1 54.4137 7716.52 54.5761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18 0.00551998009905219 2890.45166015625 723.6202 2890.44604492188 723.618774414063 4 22 1.1.1.4319.11 1 54.5882 25798.54 54.5761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18 0.00551998009905219 2890.45166015625 723.6202 2890.44604492188 723.618774414063 4 20 1.1.1.4326.12 1 54.7689 25798.54 54.5761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 -0.00436207978054881 2886.44702148438 722.619 2886.451171875 722.620056152344 4 21 1.1.1.4479.13 1 58.7276 78406.21 58.9503 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Ammonia-loss(N)@15; reduced acrolein addition +58(K)@18 missed R-E@2; missed K-E@18 0.00326716993004084 2927.4697265625 732.8747 2927.46655273438 732.873901367188 4 18 1.1.1.4481.13 1 58.7801 2702.185 58.845 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 -0.0116713996976614 2886.43969726563 963.1538 2886.451171875 963.157653808594 3 22 1.1.1.4482.20 1 58.8124 28237.63 58.9764 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 -0.0116713996976614 2886.43969726563 963.1538 2886.451171875 963.157653808594 3 20 1.1.1.4483.19 1 58.838 28237.63 58.9764 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 -0.0116713996976614 2886.43969726563 963.1538 2886.451171875 963.157653808594 3 24 1.1.1.4484.20 1 58.8648 28237.63 58.9764 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 -0.0116713996976614 2886.43969726563 963.1538 2886.451171875 963.157653808594 3 24 1.1.1.4485.19 1 58.8905 28237.63 58.9764 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 -0.00436207978054881 2886.44702148438 722.619 2886.451171875 722.620056152344 4 23 1.1.1.4486.12 1 58.9113 79239.4 58.9503 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 -0.00436207978054881 2886.44702148438 722.619 2886.451171875 722.620056152344 4 21 1.1.1.4493.16 1 59.0989 79239.4 58.9503 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 -0.00460621016100049 2886.44653320313 722.6189 2886.451171875 722.620056152344 4 23 1.1.1.4500.13 1 59.2807 70335.48 59.003 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 0.000962460006121546 2886.4521484375 963.158 2886.451171875 963.157653808594 3 15 1.1.1.4505.19 1 59.4175 11430.03 59.1351 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 -0.00460621016100049 2886.44653320313 722.6189 2886.451171875 722.620056152344 4 21 1.1.1.4507.11 1 59.4632 21547.1 59.1872 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Deamidated(Q)@10 missed R-E@2; missed K-E@18 0.0233110003173351 2887.45849609375 722.8719 2887.43530273438 722.866088867188 4 17 1.1.1.4507.12 1 59.4641 5336.887 59.3717 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 -0.00434743007645011 2886.44702148438 963.1563 2886.451171875 963.157653808594 3 9 1.1.1.4509.21 1 59.525 4993.221 59.24 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Oxidation(W)@13 missed R-E@2; missed K-E@18 0.00793111976236105 2902.45385742188 968.4919 2902.44604492188 968.489318847656 3 13 1.1.1.3986.21 1 46.0819 2321.813 46.0872 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Methyl(D)@14; Deamidated(N)@15 missed R-E@2; missed K-E@18 -0.00266535999253392 2901.4482421875 726.3693 2901.45092773438 726.369995117188 4 14 1.1.1.4107.18 1 49.1855 1620.263 49.1932 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Deamidated(N)@15 missed R-E@2; missed K-E@18 -0.00725291017442942 2887.42822265625 722.8643 2887.43530273438 722.866088867188 4 15 1.1.1.4010.17 1 46.7056 2900.972 46.7142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 LREQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@13; acrolein addition +38(K)@18 missed R-E@2; missed K-E@18 0.00963243003934622 2928.47143554688 733.1251 2928.46166992188 733.122741699219 4 13 1.1.1.3995.15 1 46.3131 3070.421 46.3493 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 LREQLGPVTQEFWDNLEKETEGLR FormaldehydeAdduct(W)@13; Deamidated(N)@15 missed R-E@2; missed K-E@18 0.0141834001988173 2899.44946289063 725.8696 2899.43530273438 725.866088867188 4 11 1.1.1.3837.18 1 42.2699 1235.906 42.3041 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 -4.03824996948242 2882.41284179688 721.6105 2886.451171875 722.620056152344 4 11 1.1.1.3906.6 1 44.0364 3778.615 44.1297 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 LREQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@13; acrolein addition +38(K)@18 missed R-E@2; missed K-E@18 0.0253170002251863 2928.48706054688 586.7047 2928.46166992188 586.699645996094 5 11 1.1.1.3998.5 1 46.3827 2139.59 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.8400018215179 LREQLGPVTQEFWDNLEKETEGLR Deamidated(Q)@10; FormaldehydeAdduct(W)@13 missed R-E@2; missed K-E@18 0.0144391003996134 2899.44970703125 580.8972 2899.43530273438 580.894287109375 5 11 1.1.1.3844.9 1 42.4477 1610.315 42.4629 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 LREQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18 0.0116496002301574 2890.45776367188 964.4932 2890.44604492188 964.489318847656 3 10 1.1.1.4328.20 1 54.8267 8128.991 54.5761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.6899974346161 LREQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@13; Deamidated(N)@15; acrolein addition +38(K)@18 missed R-E@2; missed K-E@18 0.0263864006847143 2929.47192382813 586.9017 2929.44580078125 586.896423339844 5 10 1.1.1.3995.9 1 46.3081 2224.946 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00811858009546995 3521.7177734375 705.3508 3521.70971679688 705.349182128906 5 18 1.1.1.4012.17 1 46.7576 7217.006 46.7142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00811858009546995 3521.7177734375 705.3508 3521.70971679688 705.349182128906 5 19 1.1.1.4014.16 1 46.8087 7217.006 46.7142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0132245002314448 3537.7177734375 885.4367 3537.70458984375 885.433410644531 4 19 1.1.1.4247.10 1 52.7516 47145.33 52.7405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0107751004397869 3537.71557617188 708.5504 3537.70458984375 708.548217773438 5 23 1.1.1.4252.10 1 52.8784 89434.99 52.9438 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13; Arg->Orn(R)@24; Deamidated(Q)@25; reduced acrolein addition +58(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24 -0.000491272017825395 3538.712890625 708.7499 3538.71362304688 708.75 5 22 1.1.1.4254.5 1 52.9252 54776.3 52.9438 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00565632013604045 3537.71020507813 885.4348 3537.70458984375 885.433410644531 4 19 1.1.1.4254.10 1 52.9294 64803.46 52.9438 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0107751004397869 3537.71557617188 708.5504 3537.70458984375 708.548217773438 5 21 1.1.1.4259.13 1 53.0592 89434.99 52.9438 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.022512199357152 3509.73217773438 878.4403 3509.70971679688 878.434692382813 4 16 1.1.1.4266.16 1 53.2405 20053.89 53.2756 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00524881016463041 3509.71508789063 702.9503 3509.70971679688 702.94921875 5 16 1.1.1.4267.10 1 53.2612 34400.67 53.3012 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.022512199357152 3509.73217773438 878.4403 3509.70971679688 878.434692382813 4 20 1.1.1.4270.19 1 53.3454 20053.89 53.2756 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0139675000682473 3509.7236328125 878.4382 3509.70971679688 878.434692382813 4 18 1.1.1.4273.18 1 53.4209 24768.08 53.4542 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00616431003436446 3509.71557617188 702.9504 3509.70971679688 702.94921875 5 18 1.1.1.4274.12 1 53.4414 42498.18 53.4542 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0122677003964782 3509.72216796875 702.9517 3509.70971679688 702.94921875 5 19 1.1.1.4281.12 1 53.6194 42132.89 53.4796 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(N)@15; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0242746993899345 3506.72314453125 702.3519 3506.69873046875 702.347045898438 5 16 1.1.1.4414.8 1 57.0284 59528.58 57.0444 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.00151013000868261 3505.71313476563 702.1499 3505.71484375 702.150207519531 5 13 1.1.1.4445.13 1 57.8368 21464.53 57.5626 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.00273080007173121 3505.71215820313 702.1497 3505.71484375 702.150207519531 5 14 1.1.1.4453.12 1 58.0444 5713.022 57.9789 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.00570137007161975 3505.708984375 877.4345 3505.71484375 877.435974121094 4 12 1.1.1.4458.19 1 58.1812 3940.93 58.0572 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.0123516004532576 3521.697265625 881.4316 3521.70971679688 881.434692382813 4 17 1.1.1.4481.19 1 58.7852 2972.712 58.7655 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00873803999274969 3505.7236328125 877.4382 3505.71484375 877.435974121094 4 15 1.1.1.4401.17 1 56.6996 56668.79 56.9409 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0128301996737719 3505.7275390625 702.1528 3505.71484375 702.150207519531 5 25 1.1.1.4408.11 1 56.8755 112750.1 57.0444 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00947044044733047 3505.724609375 877.4384 3505.71484375 877.435974121094 4 23 1.1.1.4412.17 1 56.9839 57581.77 56.9409 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0128301996737719 3505.7275390625 702.1528 3505.71484375 702.150207519531 5 24 1.1.1.4415.12 1 57.0576 112750.1 57.0444 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.012219900265336 3505.7265625 702.1526 3505.71484375 702.150207519531 5 21 1.1.1.4424.12 1 57.2905 116313.7 57.0182 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00385534996166825 3505.71899414063 877.437 3505.71484375 877.435974121094 4 17 1.1.1.4424.19 1 57.2964 76603.41 57.0182 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0119147002696991 3505.7265625 702.1526 3505.71484375 702.150207519531 5 15 1.1.1.4431.15 1 57.4743 38446.3 57.4587 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00947044044733047 3505.724609375 877.4384 3505.71484375 877.435974121094 4 17 1.1.1.4431.20 1 57.4785 24750.48 57.4587 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00947044044733047 3505.724609375 877.4384 3505.71484375 877.435974121094 4 14 1.1.1.4438.18 1 57.6589 24750.48 57.4587 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Hydroxykynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.000559358973987401 3525.705078125 706.1483 3525.70458984375 706.148193359375 5 15 1.1.1.4253.9 1 52.903 5487.363 53.0453 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(N)@15; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0221385005861521 3506.72045898438 702.3514 3506.69873046875 702.347045898438 5 14 1.1.1.4431.16 1 57.4752 19738.49 57.4587 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.0205038990825415 3505.69409179688 877.4308 3505.71484375 877.435974121094 4 15 1.1.1.3991.19 1 46.2117 6061.516 46.2707 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0132245002314448 3537.7177734375 885.4367 3537.70458984375 885.433410644531 4 14 1.1.1.4240.16 1 52.5776 47145.33 52.7405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00524881016463041 3509.71508789063 702.9503 3509.70971679688 702.94921875 5 14 1.1.1.4260.11 1 53.0829 33607 53.2756 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(N)@15; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0190868005156517 3506.7177734375 702.3508 3506.69873046875 702.347045898438 5 13 1.1.1.4401.10 1 56.6938 46488.34 56.9409 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00565632013604045 3537.71020507813 885.4348 3537.70458984375 885.433410644531 4 13 1.1.1.4261.12 1 53.1094 64803.46 52.9438 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; acrolein addition +76(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.0166565999388695 3521.72607421875 705.3525 3521.74267578125 705.355834960938 5 16 1.1.1.3954.14 1 45.2568 14991.99 45.1147 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00811858009546995 3521.7177734375 705.3508 3521.70971679688 705.349182128906 5 15 1.1.1.4015.17 1 46.8356 7217.006 46.7142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0163580998778343 3521.72607421875 705.3525 3521.70971679688 705.349182128906 5 15 1.1.1.3947.11 1 45.0759 14991.99 45.1147 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Hydroxykynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.000559358973987401 3525.705078125 706.1483 3525.70458984375 706.148193359375 5 13 1.1.1.4262.14 1 53.1365 5487.363 53.0453 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0148876998573542 3521.724609375 881.4384 3521.70971679688 881.434692382813 4 11 1.1.1.4359.14 1 55.6151 1309.566 55.6004 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; MDA adduct +62(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00245713000185788 3507.72973632813 702.5532 3507.72705078125 702.552673339844 5 13 1.1.1.4424.13 1 57.2913 25233.83 57.0704 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7999975681305 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.0286848992109299 3505.68603515625 702.1445 3505.71484375 702.150207519531 5 13 1.1.1.3998.16 1 46.3919 11410.61 46.2707 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 LREQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(N)@15; acrolein addition +76(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.0131922997534275 3518.71850585938 704.751 3518.73168945313 704.753662109375 5 14 1.1.1.3813.17 1 41.6373 5391.095 41.5403 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5000014305115 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.022512199357152 3509.73217773438 878.4403 3509.70971679688 878.434692382813 4 12 1.1.1.4271.19 1 53.3709 20053.89 53.2756 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5000014305115 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0171412006020546 3509.72705078125 878.439 3509.70971679688 878.434692382813 4 12 1.1.1.4297.16 1 54.0311 2595.234 54.0148 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3699977397919 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.00570137007161975 3505.708984375 877.4345 3505.71484375 877.435974121094 4 11 1.1.1.4454.17 1 58.075 3940.93 58.0572 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3699977397919 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00113434996455908 3505.7158203125 877.4362 3505.71484375 877.435974121094 4 11 1.1.1.4478.17 1 58.7039 1617.594 58.7125 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2100009918213 LREQLGPVTQEFWDNLEKETEGLRQEMSK FormaldehydeAdduct(W)@13; Deamidated(N)@15; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0198224000632763 3518.71850585938 704.751 3518.69873046875 704.747009277344 5 14 1.1.1.3806.17 1 41.4529 5391.095 41.5403 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0163580998778343 3521.72607421875 705.3525 3521.70971679688 705.349182128906 5 13 1.1.1.3942.20 1 44.9568 14991.99 45.1147 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0168856997042894 3521.7265625 881.4389 3521.70971679688 881.434692382813 4 13 1.1.1.3947.18 1 45.0817 9910.931 45.1147 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1700012683868 LREQLGPVTQEFWDNLEKETEGLRQEMSK FormaldehydeAdduct(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.0188581999391317 3517.69604492188 880.4313 3517.71484375 880.435974121094 4 13 1.1.1.3993.19 1 46.2639 2709.659 46.297 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 LREQLGPVTQEFWDNLEKETEGLRQEMSK Cation:Na(E)@17; acrolein addition +38(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.027836799621582 3501.68603515625 701.3445 3501.71411132813 701.35009765625 5 14 1.1.1.3832.18 1 42.1369 8463.836 42.0917 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6200003623962 LREQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(Q)@10; Deamidated(N)@15; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0228880997747183 3507.70581054688 877.9337 3507.68286132813 877.927978515625 4 12 1.1.1.3991.20 1 46.2125 3447.605 46.2186 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.2199971675873 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0142002003267407 3521.7236328125 881.4382 3521.70971679688 881.434692382813 4 11 1.1.1.4008.19 1 46.6553 5076.332 46.7142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6700012683868 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.022512199357152 3509.73217773438 878.4403 3509.70971679688 878.434692382813 4 11 1.1.1.4259.19 1 53.0642 19687.74 53.2756 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.4100005626678 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0127362003549933 3537.71728515625 885.4366 3537.70458984375 885.433410644531 4 11 1.1.1.4268.10 1 53.2868 40649.16 53.02 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 LREQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(N)@15; acrolein addition +76(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.00920470990240574 3518.72241210938 704.7518 3518.73168945313 704.753662109375 5 11 1.1.1.4254.4 1 52.9244 3296.432 53.0453 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Deamidated(N)@15; MDA adduct +62(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00291552999988198 3508.71411132813 702.7501 3508.7109375 702.74951171875 5 12 1.1.1.4291.13 1 53.8752 3108.176 53.8361 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6399977207184 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dethiomethyl(M)@27; acrolein addition +112(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24 0.114763997495174 3553.8837890625 889.4782 3553.76879882813 889.449523925781 4 12 1.1.1.4182.16 1 51.0989 8613.606 51.2623 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.8799977302551 LREQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(Q)@10; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.0221385005861521 3506.72045898438 702.3514 3506.69873046875 702.347045898438 5 10 1.1.1.4439.14 1 57.6814 19738.49 57.4587 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.6899974346161 LREQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(N)@15; acrolein addition +56(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24 0.0240393001586199 3546.75415039063 710.3581 3546.72998046875 710.353271484375 5 9 1.1.1.3985.18 1 46.0532 7140.576 46.061 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.6899974346161 LREQLGPVTQEFWDNLEKETEGLRQEMSK Formyl(K)@18; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.0354227013885975 3533.67407226563 884.4258 3533.70971679688 884.434692382813 4 11 1.1.1.4045.20 1 47.6083 2180.403 47.6398 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.6200013160706 LREQLGPVTQEFWDNLEKETEGLRQEMSK reduced acrolein addition +96(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.00949648022651672 3537.78344726563 885.4531 3537.77392578125 885.450744628906 4 9 1.1.1.4275.14 1 53.4686 2194.654 53.4031 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 40.8199995756149 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Hydroxykynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.000559358973987401 3525.705078125 706.1483 3525.70458984375 706.148193359375 5 10 1.1.1.4261.8 1 53.106 5487.363 53.0453 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0260471999645233 4251.08984375 709.5223 4251.06396484375 709.517944335938 6 22 1.1.1.4318.14 1 54.5651 14901.77 54.6018 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK hexanoyl addition +98(K)@18; Deamidated(Q)@25; reduced acrolein addition +58(K)@29; reduced acrolein addition +58(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.00130051001906395 4418.22216796875 737.3776 4418.22021484375 737.377319335938 6 15 1.1.1.4416.21 1 57.0909 47334.17 56.8891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0115526998415589 4219.08544921875 704.1882 4219.07421875 704.186340332031 6 20 1.1.1.4474.11 1 58.594 15144.4 58.6862 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.00253629009239376 4219.07666015625 844.8226 4219.07421875 844.822143554688 5 18 1.1.1.4477.21 1 58.681 17632.8 58.7125 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0115526998415589 4219.08544921875 704.1882 4219.07421875 704.186340332031 6 23 1.1.1.4481.10 1 58.7776 15144.4 58.6862 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.00253629009239376 4219.07666015625 844.8226 4219.07421875 844.822143554688 5 14 1.1.1.4484.19 1 58.864 17632.8 58.7125 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0126513000577688 4219.0869140625 704.1884 4219.07421875 704.186340332031 6 22 1.1.1.4488.11 1 58.9629 19667.82 59.1082 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.00375695992261171 4219.078125 844.8229 4219.07421875 844.822143554688 5 16 1.1.1.4491.21 1 59.0503 25777.53 59.1082 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0126513000577688 4219.0869140625 704.1884 4219.07421875 704.186340332031 6 27 1.1.1.4495.12 1 59.1485 19667.82 59.1082 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.00375695992261171 4219.078125 844.8229 4219.07421875 844.822143554688 5 23 1.1.1.4498.19 1 59.2331 25777.53 59.1082 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0126513000577688 4219.0869140625 704.1884 4219.07421875 704.186340332031 6 17 1.1.1.4502.15 1 59.3351 19667.82 59.1082 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK hexanoyl addition +98(K)@18; reduced acrolein addition +58(K)@29; acrolein addition +76(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0103679997846484 4435.236328125 740.2133 4435.2255859375 740.211547851563 6 12 1.1.1.4085.14 1 48.6213 2551.201 48.6578 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0260471999645233 4251.08984375 709.5223 4251.06396484375 709.517944335938 6 15 1.1.1.4325.11 1 54.7423 14901.77 54.6018 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Deamidated(N)@15; MDA adduct +62(K)@18; acrolein addition +94(K)@29; reduced acrolein addition +58(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0474631004035473 4418.21044921875 737.3757 4418.16259765625 737.367736816406 6 13 1.1.1.4083.17 1 48.5729 3195.819 48.5053 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0238349996507168 4251.08837890625 851.2249 4251.06396484375 851.220092773438 5 14 1.1.1.4315.19 1 54.4927 16740.34 54.6018 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0167373009026051 4223.0859375 704.8549 4223.0693359375 704.852172851563 6 14 1.1.1.4365.11 1 55.7659 7335.093 55.703 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK hexanoyl addition +98(K)@18; Deamidated(Q)@25; reduced acrolein addition +58(K)@29; reduced acrolein addition +58(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.00156063004396856 4418.22216796875 884.6517 4418.22021484375 884.6513671875 5 13 1.1.1.4412.18 1 56.9847 20599.72 56.8633 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0405404008924961 4223.10986328125 704.8589 4223.0693359375 704.852172851563 6 13 1.1.1.4346.13 1 55.2807 2541.335 55.267 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0104109002277255 4223.07958984375 845.6232 4223.0693359375 845.62109375 5 13 1.1.1.4361.17 1 55.6688 7231.881 55.6774 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.028455700725317 4223.09765625 704.8569 4223.0693359375 704.852172851563 6 13 1.1.1.4374.14 1 56.0001 4706.974 55.8823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0152903003618121 4251.0791015625 851.2231 4251.06396484375 851.220092773438 5 13 1.1.1.4330.17 1 54.8755 7516.908 54.9096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0242161992937326 4251.08837890625 709.522 4251.06396484375 709.517944335938 6 13 1.1.1.4332.8 1 54.9191 6788.612 54.9096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Met->Hcy(M)@27; MDA adduct +62(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0171236004680395 4251.0966796875 851.2266 4251.07958984375 851.22314453125 5 13 1.1.1.4355.18 1 55.5157 6867.984 55.2415 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Trp->Kynurenin(W)@13; acrolein addition +76(K)@18; acrolein addition +94(K)@29; reduced acrolein addition +58(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0326801016926765 4435.2216796875 740.2109 4435.189453125 740.205505371094 6 14 1.1.1.3988.21 1 46.1345 7747.063 46.1922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5000014305115 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dethiomethyl(M)@27; reduced acrolein addition +96(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 -0.0456436015665531 4251.0869140625 1063.779 4251.1337890625 1063.79064941406 4 11 1.1.1.4319.21 1 54.5965 2471.333 54.5761 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5000014305115 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dethiomethyl(M)@27; reduced acrolein addition +96(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 -0.0320006981492043 4251.1015625 709.5242 4251.1337890625 709.529541015625 6 12 1.1.1.4354.15 1 55.4876 5892.39 55.216 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.6199984550476 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK acrolein addition +38(K)@18; acrolein addition +38(K)@29; ONE addition +154(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.00808743014931679 4433.21826171875 739.877 4433.2099609375 739.875610351563 6 13 1.1.1.3995.16 1 46.3139 7957.124 46.1922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2399988174438 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK reduced acrolein addition +58(K)@18; Dethiomethyl(M)@27; acrolein addition +38(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 -0.0433529987931252 4251.08984375 709.5223 4251.1337890625 709.529541015625 6 12 1.1.1.4339.11 1 55.1001 6505.983 55.1904 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Deamidated(N)@15; hexanoyl addition +98(K)@18; MDA adduct +54(K)@29; acrolein addition +94(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.019972899928689 4450.208984375 891.0491 4450.18896484375 891.045104980469 5 11 1.1.1.4298.17 1 54.0574 15778.51 53.7852 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.0600001811981 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0167373009026051 4223.0859375 704.8549 4223.0693359375 704.852172851563 6 11 1.1.1.4358.11 1 55.5869 7335.093 55.703 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0716675966978073 4223.140625 704.8641 4223.0693359375 704.852172851563 6 11 1.1.1.4335.9 1 54.9965 1840.619 54.9609 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0213936995714903 4251.0859375 851.2244 4251.06396484375 851.220092773438 5 11 1.1.1.4339.14 1 55.1026 7666.261 55.1904 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.8799977302551 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Deamidated(N)@15; reduced acrolein addition +96(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 -0.0243404004722834 4252.09326171875 709.6895 4252.11767578125 709.693542480469 6 11 1.1.1.4325.12 1 54.7431 9868.541 54.6018 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dioxidation(W)@13; Deamidated(Q)@25; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.047623198479414 4252.095703125 709.6899 4252.04833984375 709.681945800781 6 11 1.1.1.4343.13 1 55.2041 4779.782 55.216 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Trp->Kynurenin(W)@13; Deamidated(N)@15; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.086285799741745 4224.1396484375 705.0305 4224.05322265625 705.016174316406 6 11 1.1.1.4365.12 1 55.7668 4218.439 55.703 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.0100018978119 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK reduced acrolein addition +96(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 -0.0480065010488033 4251.0859375 851.2244 4251.1337890625 851.234008789063 5 10 1.1.1.4347.20 1 55.3124 7666.261 55.1904 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.429998755455 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dehydrated(E)@26; acrolein addition +38(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0337068997323513 4223.1181640625 704.8603 4223.08447265625 704.854675292969 6 10 1.1.1.4325.10 1 54.7415 2400.673 54.7816 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.7099996805191 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Deamidated(N)@15; MDA adduct +62(K)@18; hexanoyl addition +98(K)@29; reduced acrolein addition +58(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0329807996749878 4422.22705078125 632.754 4422.1943359375 632.749267578125 7 7 1.1.1.4281.8 1 53.6161 15916.08 53.6833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.0799994468689 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Deamidated(N)@15; reduced acrolein addition +58(K)@18; HPNE addition +172(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.0175547990947962 4434.23291015625 740.0461 4434.21533203125 740.043151855469 6 8 1.1.1.4499.10 1 59.2521 2604.232 59.3717 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.1099994778633 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dethiomethyl(M)@27; reduced acrolein addition +96(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 -0.0433529987931252 4251.08984375 709.5223 4251.1337890625 709.529541015625 6 9 1.1.1.4346.14 1 55.2815 6505.983 55.1904 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.031096700578928 4450.22802734375 742.7119 4450.1962890625 742.706665039063 6 20 1.1.1.4263.9 1 53.1579 29227.07 53.1475 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0306477006524801 4450.22705078125 636.754 4450.1962890625 636.749572753906 7 23 1.1.1.4267.7 1 53.2587 43272.38 53.2499 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0188656002283096 4450.21484375 891.0503 4450.1962890625 891.046508789063 5 17 1.1.1.4268.11 1 53.2877 19136.89 53.2499 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0306477006524801 4450.22705078125 636.754 4450.1962890625 636.749572753906 7 20 1.1.1.4274.8 1 53.4381 43272.38 53.2499 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0206966996192932 4450.21728515625 891.0507 4450.1962890625 891.046508789063 5 16 1.1.1.4282.15 1 53.6474 18961.02 53.6833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0186850000172853 4450.21533203125 636.7523 4450.1962890625 636.749572753906 7 22 1.1.1.4285.12 1 53.7215 46683.48 53.6833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0299980994313955 4450.2265625 742.7117 4450.1962890625 742.706665039063 6 22 1.1.1.4285.17 1 53.7257 33887.65 53.7087 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0257700998336077 4422.22705078125 632.754 4422.201171875 632.750305175781 7 17 1.1.1.4287.10 1 53.7707 15916.08 53.6833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0270518008619547 4422.228515625 632.7542 4422.201171875 632.750305175781 7 16 1.1.1.4295.11 1 53.9758 15448.81 53.7087 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0216757003217936 4450.2177734375 636.7527 4450.1962890625 636.749572753906 7 20 1.1.1.4297.5 1 54.0219 39121.45 53.7596 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.013739800080657 4422.21484375 738.0431 4422.201171875 738.040832519531 6 25 1.1.1.4306.13 1 54.2583 23853.06 54.3721 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; Deamidated(N)@15; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0221321992576122 4423.20751953125 738.2085 4423.185546875 738.204833984375 6 16 1.1.1.4311.12 1 54.385 16342.43 54.3721 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.013739800080657 4422.21484375 738.0431 4422.201171875 738.040832519531 6 24 1.1.1.4313.13 1 54.4366 23853.06 54.3721 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0155707998201251 4422.216796875 738.0434 4422.201171875 738.040832519531 6 20 1.1.1.4320.11 1 54.614 22996.73 54.4995 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0145637998357415 4418.22119140625 884.6515 4418.20654296875 884.648559570313 5 18 1.1.1.4439.19 1 57.6856 27586.51 57.6143 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.015692200511694 4418.22216796875 632.1819 4418.20654296875 632.179626464844 7 21 1.1.1.4442.9 1 57.7556 55939.87 57.5626 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.015692200511694 4418.22216796875 632.1819 4418.20654296875 632.179626464844 7 15 1.1.1.4442.10 1 57.7564 55939.87 57.5626 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.00990093965083361 4418.2158203125 737.3766 4418.20654296875 737.375 6 24 1.1.1.4444.20 1 57.8165 65931.42 57.5364 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.00390704022720456 4418.21044921875 884.6494 4418.20654296875 884.648559570313 5 12 1.1.1.4446.19 1 57.8679 28181.95 57.5885 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0148376999422908 4418.2216796875 632.1818 4418.20654296875 632.179626464844 7 19 1.1.1.4449.8 1 57.9368 47231.68 57.6924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0091685401275754 4418.21533203125 737.3765 4418.20654296875 737.375 6 19 1.1.1.4451.14 1 57.9939 50461.19 57.7185 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0169738996773958 4418.22412109375 632.1821 4418.20654296875 632.179626464844 7 16 1.1.1.4456.12 1 58.1232 20815.88 57.8487 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(R)@24 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.00147834001109004 4418.20751953125 737.3752 4418.20654296875 737.375 6 18 1.1.1.4458.16 1 58.1787 19465.44 57.9006 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0197930000722408 4422.22119140625 885.4515 4422.201171875 885.447509765625 5 15 1.1.1.4283.16 1 53.6739 7020.813 53.6833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0206966996192932 4450.21728515625 891.0507 4450.1962890625 891.046508789063 5 15 1.1.1.4289.18 1 53.8284 18961.02 53.6833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0187612995505333 4418.22509765625 632.1823 4418.20654296875 632.179626464844 7 17 1.1.1.4398.5 1 56.6118 37772.47 56.8118 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0144867999479175 4418.220703125 737.3774 4418.20654296875 737.375 6 23 1.1.1.4402.18 1 56.7262 47457.5 56.8118 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0187612995505333 4418.22509765625 632.1823 4418.20654296875 632.179626464844 7 17 1.1.1.4405.4 1 56.7924 42131.07 56.8891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0154793001711369 4418.22216796875 884.6517 4418.20654296875 884.648559570313 5 16 1.1.1.4408.19 1 56.8822 20599.72 56.8633 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0152192004024982 4418.22216796875 737.3776 4418.20654296875 737.375 6 26 1.1.1.4409.19 1 56.9081 47334.17 56.8891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0187612995505333 4418.22509765625 632.1823 4418.20654296875 632.179626464844 7 23 1.1.1.4412.6 1 56.9747 42131.07 56.8891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0200430005788803 4418.2265625 632.1825 4418.20654296875 632.179626464844 7 15 1.1.1.4420.8 1 57.184 36431.7 56.915 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0170501992106438 4418.22412109375 737.3779 4418.20654296875 737.375 6 21 1.1.1.4423.15 1 57.2671 51356.8 57.5106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0187612995505333 4418.22509765625 632.1823 4418.20654296875 632.179626464844 7 18 1.1.1.4427.11 1 57.3672 55225.7 57.5626 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0163177996873856 4418.22265625 737.3777 4418.20654296875 737.375 6 21 1.1.1.4430.15 1 57.4485 64717.86 57.5626 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0145637998357415 4418.22119140625 884.6515 4418.20654296875 884.648559570313 5 21 1.1.1.4432.18 1 57.5029 27586.51 57.6143 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.019615700468421 4418.2255859375 632.1824 4418.20654296875 632.179626464844 7 19 1.1.1.4434.12 1 57.5499 55939.87 57.5626 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.019615700468421 4418.2255859375 632.1824 4418.20654296875 632.179626464844 7 20 1.1.1.4434.13 1 57.5507 55939.87 57.5626 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0163177996873856 4418.22265625 737.3777 4418.20654296875 737.375 6 26 1.1.1.4437.18 1 57.6329 64717.86 57.5626 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK acrolein addition +38(K)@18; Dehydrated(S)@28 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.000166921003255993 4422.216796875 632.7525 4422.216796875 632.752502441406 7 15 1.1.1.4307.7 1 54.2786 24593.23 54.3721 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(Q)@25; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0306337997317314 4419.22119140625 632.3246 4419.1904296875 632.320190429688 7 14 1.1.1.4400.8 1 56.6663 23128.54 56.8891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0394541993737221 4434.24072265625 740.0474 4434.201171875 740.040832519531 6 14 1.1.1.4092.16 1 48.8014 3772.968 48.7853 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; acrolein addition +94(K)@18; Phospho(S)@28; ONE addition +154(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.0262446999549866 4731.27685546875 789.5534 4731.30322265625 789.557800292969 6 15 1.1.1.4434.21 1 57.5574 2033.76 57.5364 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0348200015723705 4434.236328125 634.4696 4434.201171875 634.464599609375 7 16 1.1.1.3991.8 1 46.2025 8077.89 46.1922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0115534998476505 4422.212890625 885.4498 4422.201171875 885.447509765625 5 14 1.1.1.4309.18 1 54.3389 9528.565 54.3466 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(Q)@10; Deamidated(Q)@25; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0531871989369392 4420.2275390625 632.4684 4420.17431640625 632.460754394531 7 14 1.1.1.4407.5 1 56.8447 14454.39 56.8891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0241410005837679 4419.21533203125 632.3237 4419.1904296875 632.320190429688 7 11 1.1.1.4460.11 1 58.2269 9306.135 57.9529 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3399987220764 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0261138007044792 4434.2275390625 740.0452 4434.201171875 740.040832519531 6 13 1.1.1.4002.21 1 46.5007 6788.044 46.5581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.079998254776 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; Deamidated(Q)@25; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0381438992917538 4420.21240234375 632.4662 4420.17431640625 632.460754394531 7 10 1.1.1.4449.9 1 57.9376 8369.533 57.9006 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2399988174438 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0188656002283096 4450.21484375 891.0503 4450.1962890625 891.046508789063 5 12 1.1.1.4260.16 1 53.0871 19136.89 53.2499 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2399988174438 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0188656002283096 4450.21484375 891.0503 4450.1962890625 891.046508789063 5 12 1.1.1.4275.15 1 53.4694 19136.89 53.2499 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0346935987472534 4434.23583984375 740.0466 4434.201171875 740.040832519531 6 11 1.1.1.4071.18 1 48.2687 1893.218 48.2765 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0306337997317314 4419.22119140625 632.3246 4419.1904296875 632.320190429688 7 11 1.1.1.4427.12 1 57.368 35887.2 57.5626 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0200028419495 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0117491995915771 4434.21337890625 634.4663 4434.201171875 634.464599609375 7 11 1.1.1.4005.14 1 46.573 5838.39 46.6101 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.4100005626678 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0115534998476505 4422.212890625 885.4498 4422.201171875 885.447509765625 5 11 1.1.1.4302.18 1 54.1604 9439.437 54.3466 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0225684996694326 4434.2236328125 634.4678 4434.201171875 634.464599609375 7 11 1.1.1.4087.12 1 48.6705 3284.099 48.7853 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dethiomethyl(M)@27; reduced acrolein addition +96(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.0609688013792038 4450.20458984375 636.7508 4450.265625 636.759521484375 7 11 1.1.1.4311.4 1 54.3783 2821.361 54.3466 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.0100018978119 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Hydroxykynurenin(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0124690001830459 4422.2138671875 885.45 4422.201171875 885.447509765625 5 10 1.1.1.4317.19 1 54.5437 9284.087 54.4995 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.8699994683266 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.0204034000635147 4422.2216796875 885.4516 4422.201171875 885.447509765625 5 9 1.1.1.4291.19 1 53.8802 5543.488 53.8361 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1000003814697 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQK MDA adduct +54(K)@37; Deamidated(Q)@46; HPNE addition +172(K)@47 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35; missed K-V@37 0.15361399948597 5863.07275390625 838.5891 5862.9189453125 838.567138671875 7 11 1.1.1.4283.15 1 53.6731 2677.667 53.6577 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LSPLGEEMR Oxidation(M)@8 -0.00140546995680779 1046.50524902344 524.2599 1046.50659179688 524.260620117188 2 12 1.1.1.3187.8 1 25.9942 155542 25.8816 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.3199980258942 LSPLGEEMR Dioxidation(M)@8 -0.000110834997030906 1062.50146484375 532.258 1062.50158691406 532.258056640625 2 8 1.1.1.3213.8 1 26.6284 1146.71 26.663 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 NWDSVTSTFSK Dioxidation(W)@2 cleaved D-N@N-term 0.00482273008674383 1302.57763671875 652.2961 1302.57275390625 652.293701171875 2 9 1.1.1.3570.19 1 35.4512 901.618 35.5104 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.7000002861023 NWDSVTSTFSK cleaved D-N@N-term -0.00208628992550075 1270.58093261719 636.2977 1270.5830078125 636.298767089844 2 7 1.1.1.3715.16 1 39.1366 1282.229 39.0946 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 35.5800002813339 NWDSVTSTFSK cleaved D-N@N-term -0.00208628992550075 1270.58093261719 636.2977 1270.5830078125 636.298767089844 2 6 1.1.1.3708.15 1 38.9549 1282.229 39.0946 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 17.679999768734 PALEDLR cleaved K-P@N-term -0.00164181995205581 812.437683105469 407.2261 812.439208984375 407.226898193359 2 7 1.1.1.3279.4 1 28.2355 6664.782 28.3289 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4799990653992 PALEDLRQGLLPVLESFKVSFLSALEEYTK dHex(S)@16; acrolein addition +94(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18 0.075744703412056 3632.00366210938 727.408 3631.927734375 727.392822265625 5 16 1.1.1.5113.4 1 75.3284 4301.136 75.4494 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.3100016117096 PALEDLRQGLLPVLESFKVSFLSALEEYTK GlnThrGlyGly(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18 0.0818402990698814 3735.05859375 748.019 3734.97705078125 748.002685546875 5 16 1.1.1.5104.4 1 75.0988 4615.468 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.9300026893616 PALEDLRQGLLPVLESFKVSFLSALEEYTK GlnThrGlyGly(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18 0.0501371994614601 3735.02734375 934.7641 3734.97705078125 934.751525878906 4 13 1.1.1.5103.13 1 75.0805 2139.313 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.7799983024597 PALEDLRQGLLPVLESFKVSFLSALEEYTKK MDA adduct +54(K)@30; Amidated@C-term cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30 0.00788616016507149 3572.95727539063 894.2466 3572.94946289063 894.24462890625 4 12 1.1.1.5102.16 0 75.0565 73120.88 75.0659 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.2099995613098 PALEDLRQGLLPVLESFKVSFLSALEEYTKK cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30 -0.0263592004776001 3519.896484375 880.9814 3519.9228515625 880.987976074219 4 8 1.1.1.5092.13 1 74.7906 337.071 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.480001449585 PALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +56(K)@18; acrolein addition +56(K)@30 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30 0.00790342967957258 3631.9833984375 909.0031 3631.97534179688 909.001098632813 4 8 1.1.1.5118.15 1 75.4649 4209.662 75.4494 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.140000462532 PALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +38(K)@18; acrolein addition +56(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30 -0.0150448996573687 3613.94970703125 904.4947 3613.96484375 904.498474121094 4 8 1.1.1.5105.17 1 75.1355 5761.178 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.8100011348724 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLN reduced acrolein addition +58(K)@18; MDA adduct +54(K)@30; MDA adduct +54(K)@31 cleaved K-P@N-term; cleaved N-T@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.106380000710487 3913.00659179688 783.6086 3913.11279296875 783.629821777344 5 10 1.1.1.5105.10 1 75.1296 6328.447 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.2599995732307 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLN reduced acrolein addition +96(K)@30; ONE addition +154(K)@31 cleaved K-P@N-term; cleaved N-T@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0197510998696089 3997.2265625 800.4526 3997.20678710938 800.448608398438 5 7 1.1.1.5093.10 1 74.8139 1643.451 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.2499997615814 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +76(K)@30; reduced acrolein addition +96(K)@31; Deamidated(N)@33 cleaved K-P@N-term; cleaved T-Q@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.0203728992491961 4021.15087890625 1006.295 4021.17041015625 1006.29986572266 4 11 1.1.1.5103.19 1 75.0855 7306.415 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1900026798248 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT MDA adduct +62(K)@30; acrolein addition +94(K)@31; Deamidated(N)@33 cleaved K-P@N-term; cleaved T-Q@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0183710008859634 4005.15893554688 1002.297 4005.13916015625 1002.29205322266 4 10 1.1.1.5106.14 1 75.1582 11016.88 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.2299976348877 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT MDA adduct +54(K)@18; acrolein addition +94(K)@30; acrolein addition +76(K)@31; Deamidated(N)@33 cleaved K-P@N-term; cleaved T-Q@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.0832170993089676 4073.08227539063 679.8543 4073.16528320313 679.8681640625 6 10 1.1.1.5090.2 1 74.7295 5048.199 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.2299976348877 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT HPNE addition +172(K)@18; hexanoyl addition +98(K)@30; hexanoyl addition +98(K)@31 cleaved K-P@N-term; cleaved T-Q@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.0229477994143963 4216.3310546875 703.7291 4216.35400390625 703.73291015625 6 9 1.1.1.5133.13 1 75.8597 9887.795 75.579 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.7000005245209 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Ser->LacticAcid(S)@16; HPNE addition +172(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0141404997557402 4133.26904296875 827.6611 4133.25537109375 827.658325195313 5 15 1.1.1.5092.12 1 74.7898 11784.04 74.7767 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.1099987030029 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@30; acrolein addition +112(K)@31; Deamidated(N)@33 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0586604997515678 4201.3037109375 841.268 4201.2451171875 841.256286621094 5 12 1.1.1.5127.17 1 75.703 6160.1 75.7116 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.2799999713898 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ GlnThrGlyGly(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.103084996342659 4319.40869140625 720.9087 4319.30517578125 720.891479492188 6 13 1.1.1.5112.3 1 75.3021 5688.19 75.2713 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1900026798248 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Methyl(E)@26; reduced acrolein addition +58(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.031037300825119 4048.24291992188 1013.068 4048.21362304688 1013.06066894531 4 12 1.1.1.5104.21 1 75.113 8197.92 75.2713 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.7000026702881 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@18; MDA adduct +54(K)@30; MDA adduct +62(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0276740994304419 4190.283203125 699.3878 4190.25537109375 699.383178710938 6 10 1.1.1.5102.3 1 75.0456 2062.996 75.0659 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.7000026702881 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@18; MDA adduct +62(K)@30; acrolein addition +94(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0176704004406929 4190.27294921875 839.0619 4190.25537109375 839.058349609375 5 10 1.1.1.5102.15 1 75.0556 4697.543 75.0659 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.5100018978119 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@18; Carboxy(E)@27; HPNE addition +172(K)@30; hexanoyl addition +98(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0459734015166759 4444.474609375 889.9022 4444.42822265625 889.892944335938 5 11 1.1.1.5118.12 1 75.4624 1806.917 75.4239 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@18; ONE addition +154(K)@31; Deamidated(N)@33 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.012211199849844 4189.2939453125 838.866 4189.28125 838.863525390625 5 10 1.1.1.5102.14 1 75.0548 3171.041 75.0659 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@18; HPNE addition +172(K)@30; hexanoyl addition +98(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.00934807956218719 4418.45849609375 884.699 4418.44921875 884.697082519531 5 9 1.1.1.5104.9 1 75.103 1524.753 75.1947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.2099995613098 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +62(K)@18; reduced acrolein addition +96(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0440131016075611 4134.27294921875 827.8619 4134.2294921875 827.853149414063 5 9 1.1.1.5101.13 1 75.0265 8027.881 74.7506 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.2099995613098 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0663406029343605 4088.2744140625 818.6622 4088.20849609375 818.648986816406 5 8 1.1.1.5119.13 1 75.4888 3662.891 75.579 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.0999970436096 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +62(K)@18; reduced acrolein addition +96(K)@30; hexanoyl addition +98(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0163173992186785 4232.31884765625 847.471 4232.30224609375 847.4677734375 5 9 1.1.1.5101.14 1 75.0274 20695.48 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.0999970436096 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@18; acrolein addition +94(K)@30; HPNE addition +172(K)@31; Carbamidomethyl(T)@34 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0272212997078896 4453.45556640625 743.2499 4453.4287109375 743.245422363281 6 11 1.1.1.5105.6 1 75.1263 6112.25 75.1947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.2299976348877 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@18; HPNE addition +172(K)@30; hexanoyl addition +98(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.0281360000371933 4400.466796875 734.4184 4400.4384765625 734.413696289063 6 9 1.1.1.5106.2 1 75.1482 4473.654 75.1947 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 PLGEEMRDR Oxidation(M)@6 cleaved S-P@N-term; missed R-D@7 -0.00246608001179993 1117.51611328125 559.7653 1117.5185546875 559.7666015625 2 9 1.1.1.3130.7 1 24.6234 16334.03 24.7527 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 -0.00186049996409565 1238.67126464844 620.3429 1238.67309570313 620.343872070313 2 15 1.1.1.3345.9 1 29.8725 6365.733 30.0545 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 -0.00454598013311625 1238.66870117188 620.3416 1238.67309570313 620.343872070313 2 11 1.1.1.3338.16 1 29.7012 5083.347 29.9318 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 -0.00186049996409565 1238.67126464844 620.3429 1238.67309570313 620.343872070313 2 13 1.1.1.3359.18 1 30.219 6752.46 30.1035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 0.00412078993394971 1238.67724609375 620.3459 1238.67309570313 620.343872070313 2 9 1.1.1.3232.17 1 27.0955 573.7145 27.1025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.3200008869171 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 -0.00051776401232928 1238.67272949219 620.3436 1238.67309570313 620.343872070313 2 8 1.1.1.3494.10 1 33.5615 831.8896 33.5966 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.2999994158745 PPQSPWDR Trp->Kynurenin(W)@6 cleaved E-P@N-term -0.000880256004165858 985.460876464844 493.7377 985.461730957031 493.738159179688 2 6 1.1.1.3187.7 1 25.9926 1548.986 25.9063 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 PPQSPWDRVK cleaved E-P@N-term; missed R-V@8 -0.00103808997664601 1208.62902832031 605.3218 1208.63024902344 605.322387695313 2 7 1.1.1.3419.7 1 31.6985 1257.4 31.7088 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0799973011017 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +76(K)@10; HPNE addition +172(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 -0.0586327016353607 4470.2158203125 895.0505 4470.27490234375 895.062194824219 5 11 1.1.1.4758.11 1 65.9079 28072.96 66.1537 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.8299970626831 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +94(K)@10; Cation:K(D)@11; ONE addition +154(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 -0.0134332999587059 4508.21728515625 902.6507 4508.23046875 902.653381347656 5 15 1.1.1.5084.12 1 74.5771 6109.309 74.5898 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.7999999523163 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; MDA adduct +62(K)@10; ONE addition +154(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 -0.0210717990994453 4495.2490234375 900.0571 4495.27001953125 900.061279296875 5 9 1.1.1.5080.19 1 74.4745 702.9778 74.5085 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.0999970436096 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@3; acrolein addition +112(K)@10; HPNE addition +172(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 -0.0341318994760513 4507.24560546875 752.2149 4507.27978515625 752.220581054688 6 10 1.1.1.4932.9 1 70.4815 4999.694 70.6563 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.2299976348877 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@3; acrolein addition +112(K)@10; HPNE addition +172(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 -0.0454839989542961 4507.234375 752.213 4507.27978515625 752.220581054688 6 10 1.1.1.4904.3 1 69.781 2959.332 69.7179 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.8000013828278 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +76(K)@10; HPNE addition +172(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 -0.0536512993276119 4470.22119140625 746.0441 4470.27490234375 746.053039550781 6 9 1.1.1.4801.5 1 67.0317 3955.252 67.0503 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 35.1000010967255 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +76(K)@10; HPNE addition +172(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 -0.0546654984354973 4470.2197265625 895.0513 4470.27490234375 895.062194824219 5 9 1.1.1.4776.10 1 66.375 38160.23 66.337 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKK cleaved Q-P@N-term; missed K-K@8 -0.000185431999852881 1152.58142089844 577.298 1152.58154296875 577.298034667969 2 12 1.1.1.3441.10 1 32.2536 6595.204 32.1647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 PYLDDFQKK cleaved Q-P@N-term; missed K-K@8 -0.000185431999852881 1152.58142089844 577.298 1152.58154296875 577.298034667969 2 9 1.1.1.3434.15 1 32.0779 6595.204 32.1647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.199999332428 PYLDDFQKK cleaved Q-P@N-term; missed K-K@8 -0.00238264002837241 1152.57922363281 577.2969 1152.58154296875 577.298034667969 2 11 1.1.1.3455.8 1 32.6003 2463.633 32.338 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 PYLDDFQKK cleaved Q-P@N-term; missed K-K@8 -0.00824187975376844 1152.5732421875 577.2939 1152.58154296875 577.298034667969 2 8 1.1.1.3359.17 1 30.2182 929.3816 30.202 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYR Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 -0.00165545998606831 2433.12939453125 812.0504 2433.13110351563 812.050964355469 3 12 1.1.1.4073.19 1 48.3204 2725.234 48.4035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYR Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.00987990014255047 2433.14111328125 812.0543 2433.13110351563 812.050964355469 3 11 1.1.1.4087.18 1 48.6756 2581.436 48.6324 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYR Deamidated(Q)@7; reduced acrolein addition +96(K)@8; HPNE addition +172(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 -0.00906382035464048 2702.2734375 901.7651 2702.28247070313 901.768127441406 3 13 1.1.1.4148.19 1 50.2336 11997.39 50.2405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYR Deamidated(Q)@7; reduced acrolein addition +96(K)@8; HPNE addition +172(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 -0.00906382035464048 2702.2734375 901.7651 2702.28247070313 901.768127441406 3 13 1.1.1.4155.20 1 50.413 10698.17 50.4699 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYR acrolein addition +112(K)@8; acrolein addition +112(K)@9; Oxidation(W)@10; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.0286379996687174 2673.25927734375 669.3221 2673.23095703125 669.315002441406 4 15 1.1.1.3943.12 1 44.9754 39958.94 45.0894 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@8; HPNE addition +172(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 -0.00925256032496691 2701.28930664063 676.3296 2701.29858398438 676.331909179688 4 12 1.1.1.4106.15 1 49.1577 24841.67 49.0914 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 PYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@8; HPNE addition +172(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 -0.0128584997728467 2701.28564453125 676.3287 2701.29858398438 676.331909179688 4 13 1.1.1.4054.13 1 47.8322 16744.07 47.6653 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7299997806549 PYLDDFQKKWQEEMELYR MDA adduct +54(K)@8; HPNE addition +172(K)@9; Deamidated(Q)@11; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 -0.00851870980113745 2660.22705078125 666.064 2660.23559570313 666.066162109375 4 13 1.1.1.3729.17 1 39.5018 9025.376 39.5104 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 PYLDDFQKKWQEEMELYR Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.0029220599681139 2433.1337890625 812.0519 2433.13110351563 812.050964355469 3 10 1.1.1.4080.20 1 48.4993 2715.709 48.429 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.5600028038025 PYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@8; HPNE addition +172(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 -0.0146235004067421 2701.28369140625 676.3282 2701.29858398438 676.331909179688 4 11 1.1.1.4120.15 1 49.5157 18073.55 49.449 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.8400025367737 PYLDDFQKKWQEEMELYR acrolein addition +112(K)@8; HPNE addition +172(K)@9; Oxidation(W)@10; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 -0.0129723995923996 2733.275390625 684.3261 2733.28833007813 684.329345703125 4 12 1.1.1.3919.15 1 44.3721 21059.21 44.3064 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.7399988174438 PYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@8; HPNE addition +172(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 -0.0146235004067421 2701.28369140625 676.3282 2701.29858398438 676.331909179688 4 11 1.1.1.4113.14 1 49.3355 18073.55 49.449 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.7799991369247 PYLDDFQKKWQEEMELYR acrolein addition +94(K)@8; ONE addition +154(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 -0.0105814998969436 2681.26171875 671.3227 2681.2724609375 671.325378417969 4 10 1.1.1.4058.11 1 47.9324 2357.438 47.9459 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.1799986362457 PYLDDFQKKWQEEMELYR reduced acrolein addition +58(K)@8; hexanoyl addition +98(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 -0.0349259003996849 2589.21142578125 648.3101 2589.24609375 648.318786621094 4 10 1.1.1.3710.13 1 39.0051 4351.66 39.0946 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +62(K)@8; reduced acrolein addition +58(K)@9; Deamidated(Q)@19; ONE addition +154(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.00378558994270861 4397.20068359375 629.1788 4397.2041015625 629.179321289063 7 14 1.1.1.4094.10 1 48.8478 47287.09 49.0151 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +62(K)@8; hexanoyl addition +98(K)@9; Deamidated(Q)@19; hexanoyl addition +98(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.00559980003163219 4381.20361328125 731.2079 4381.20947265625 731.208801269531 6 14 1.1.1.4160.19 1 50.5394 15160.07 50.3681 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.3100004196167 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +62(K)@8; hexanoyl addition +98(K)@9; Deamidated(Q)@19; hexanoyl addition +98(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.000230876001296565 4381.208984375 731.2088 4381.20947265625 731.208801269531 6 12 1.1.1.3895.18 1 43.7682 8409.584 43.9024 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@7; acrolein addition +94(K)@8; acrolein addition +56(K)@9; acrolein addition +112(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.0263768993318081 4385.1943359375 731.873 4385.16796875 731.868591308594 6 12 1.1.1.4126.18 1 49.6721 12647.91 49.4747 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +62(K)@8; hexanoyl addition +98(K)@9; Deamidated(Q)@19; hexanoyl addition +98(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.0137678999453783 4381.22314453125 626.8963 4381.20947265625 626.894348144531 7 12 1.1.1.4144.10 1 50.1239 3342.769 50.113 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.2399985790253 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR acrolein addition +94(K)@8; ONE addition +154(K)@9 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.00589036988094449 4370.19873046875 625.3214 4370.20458984375 625.322204589844 7 11 1.1.1.4131.10 1 49.7931 4078.157 49.7313 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.5600028038025 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +62(K)@8; reduced acrolein addition +96(K)@9; hexanoyl addition +98(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.00769393006339669 4378.20166015625 730.7076 4378.20947265625 730.708862304688 6 11 1.1.1.4114.19 1 49.3652 5041.393 49.449 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1000003814697 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR acrolein addition +38(K)@8; reduced acrolein addition +96(K)@9; Deamidated(Q)@19; acrolein addition +112(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.0270594004541636 4369.2001953125 874.8473 4369.1728515625 874.841857910156 5 11 1.1.1.4125.20 1 49.6483 9583.271 49.7313 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1000003814697 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +58(K)@8; acrolein addition +112(K)@9; Deamidated(Q)@19; acrolein addition +76(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.0270594004541636 4369.2001953125 874.8473 4369.1728515625 874.841857910156 5 11 1.1.1.4132.19 1 49.826 10089.04 49.9351 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.4400000572205 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +62(K)@8; hexanoyl addition +98(K)@9; Deamidated(Q)@19; hexanoyl addition +98(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.00119631004054099 4381.2080078125 877.2489 4381.20947265625 877.249145507813 5 11 1.1.1.3983.19 1 46.0022 5526.389 45.9833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR HPNE addition +172(K)@8; acrolein addition +76(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.000336299010086805 4370.20361328125 625.3221 4370.20458984375 625.322204589844 7 10 1.1.1.4138.8 1 49.97 4362.148 49.9861 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR acrolein addition +112(K)@9; HPNE addition +172(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.0155223999172449 4406.21044921875 882.2493 4406.2255859375 882.25244140625 5 10 1.1.1.4245.18 1 52.7072 5637.717 52.6639 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.889997959137 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +62(K)@8; HPNE addition +172(K)@9; hexanoyl addition +98(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.0388182997703552 4454.22314453125 637.3249 4454.26220703125 637.330444335938 7 10 1.1.1.4092.12 1 48.7981 2670.607 48.7853 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 40.8199995756149 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR acrolein addition +38(K)@8; reduced acrolein addition +96(K)@9; Deamidated(Q)@19; acrolein addition +112(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.0282800998538733 4369.201171875 874.8475 4369.1728515625 874.841857910156 5 10 1.1.1.4139.20 1 50.0053 10156.61 49.9606 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.1099994778633 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +54(K)@8; acrolein addition +94(K)@9; acrolein addition +112(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.0447901003062725 4382.212890625 731.3761 4382.16796875 731.36865234375 6 9 1.1.1.4195.15 1 51.4305 1981.426 51.4663 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 -0.00480491993948817 1162.56823730469 582.2914 1162.57312011719 582.293823242188 2 14 1.1.1.3217.9 1 26.7284 2127.217 26.5655 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 -0.00504906009882689 1162.56811523438 582.2913 1162.57312011719 582.293823242188 2 13 1.1.1.3210.10 1 26.5602 2158.846 26.4924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6599981784821 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 -0.00138704001437873 1162.57189941406 582.2932 1162.57312011719 582.293823242188 2 12 1.1.1.3224.6 1 26.9016 1340.566 26.9069 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.00142051000148058 1162.57470703125 582.2946 1162.57312011719 582.293823242188 2 11 1.1.1.3510.10 1 33.9542 3127.343 33.8444 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.00178670999594033 1162.57482910156 582.2947 1162.57312011719 582.293823242188 2 11 1.1.1.3531.12 1 34.4777 2634.656 34.46 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.00215292000211775 1162.57531738281 582.2949 1162.57312011719 582.293823242188 2 10 1.1.1.3196.11 1 26.2156 1704.506 26.3705 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 -0.00443872017785907 1162.56872558594 582.2916 1162.57312011719 582.293823242188 2 10 1.1.1.3517.11 1 34.1286 3302.042 34.0911 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.00142051000148058 1162.57470703125 582.2946 1162.57312011719 582.293823242188 2 10 1.1.1.3503.8 1 33.7814 3127.343 33.8444 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 -0.00163117004558444 1162.57153320313 582.293 1162.57312011719 582.293823242188 2 10 1.1.1.3524.8 1 34.3024 3229.147 34.2634 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.00593699980527163 1162.5791015625 582.2968 1162.57312011719 582.293823242188 2 9 1.1.1.3496.9 1 33.6079 2819.443 33.6959 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.00081017502816394 1162.57409667969 582.2943 1162.57312011719 582.293823242188 2 9 1.1.1.3544.7 1 34.7958 2315.603 34.6809 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.880001783371 QEEMELYR Formyl@N-term; Oxidation(M)@4 cleaved W-Q@N-term -0.00311676994897425 1140.47265625 571.2436 1140.47570800781 571.2451171875 2 10 1.1.1.3273.16 1 28.0973 1762.23 28.1564 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 QEEMELYR Oxidation(M)@4 cleaved W-Q@N-term -0.00374803994782269 1112.47705078125 557.2458 1112.48083496094 557.247680664063 2 7 1.1.1.3098.6 1 23.8173 3711.73 23.9509 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.9900004863739 QEEMELYR Gln->pyro-Glu@N-term; Oxidation(M)@4 cleaved W-Q@N-term -0.00340604991652071 1095.45092773438 548.7327 1095.45422363281 548.734436035156 2 7 1.1.1.3297.10 1 28.6837 911.0956 28.7478 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 QEEMELYR Oxidation(M)@4 cleaved W-Q@N-term -0.00374803994782269 1112.47705078125 557.2458 1112.48083496094 557.247680664063 2 7 1.1.1.3105.17 1 23.9927 3711.73 23.9509 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVK Gln->pyro-Glu@N-term; Oxidation(M)@3 missed K-D@5 -0.00185775000136346 1333.60522460938 667.8099 1333.60717773438 667.810852050781 2 17 1.1.1.3147.8 1 25.0383 14599.88 25.1407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVK Oxidation(M)@3; Acetyl(S)@4 missed K-D@5 0.00285031995736063 1392.64709472656 697.3308 1392.64428710938 697.329406738281 2 14 1.1.1.3181.18 1 25.8517 1989.582 25.9063 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVK Gln->pyro-Glu@N-term; Oxidation(M)@3; Carbamidomethyl(K)@5 missed K-D@5 0.00756593979895115 1390.63623046875 696.3254 1390.62866210938 696.321594238281 2 11 1.1.1.3150.8 1 25.1111 637.7137 25.1163 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QEMSKDLEEVK Gln->pyro-Glu@N-term; Carbamidomethyl(K)@5 missed K-D@5 0.00313666998408735 1374.63684082031 688.3257 1374.63366699219 688.324096679688 2 12 1.1.1.3177.6 1 25.7691 1530.35 25.7834 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVKAK Oxidation(M)@3 missed K-D@5; missed K-A@11 -0.00146881002001464 1549.76440429688 517.5954 1549.76574707031 517.595886230469 3 13 1.1.1.2994.2 1 21.3654 1631.206 21.2672 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 QEMSKDLEEVKAK Gln->pyro-Glu@N-term; Oxidation(M)@3 missed K-D@5; missed K-A@11 0.000967108004260808 1532.740234375 511.9207 1532.7392578125 511.920349121094 3 6 1.1.1.3109.10 1 24.0898 8080.88 24.2072 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.0000001192093 QEMSKDLEEVKAK Oxidation(M)@3 missed K-D@5; missed K-A@11 -0.00146881002001464 1549.76440429688 517.5954 1549.76574707031 517.595886230469 3 9 1.1.1.2987.3 1 21.1785 1631.206 21.2672 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFK Gln->pyro-Glu@N-term -0.00332074007019401 1212.67211914063 607.3433 1212.67541503906 607.344970703125 2 9 1.1.1.4643.3 1 62.9673 4169.343 63.1384 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFK Gln->pyro-Glu@N-term -0.00332074007019401 1212.67211914063 607.3433 1212.67541503906 607.344970703125 2 11 1.1.1.4657.3 1 63.3205 4169.343 63.1384 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFK -0.0058565498329699 1229.69604492188 615.8553 1229.70202636719 615.858276367188 2 14 1.1.1.4281.6 1 53.6144 19923.9 53.7596 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFK -0.0058565498329699 1229.69604492188 615.8553 1229.70202636719 615.858276367188 2 13 1.1.1.4288.7 1 53.7936 19923.9 53.7596 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFK -0.0058565498329699 1229.69604492188 615.8553 1229.70202636719 615.858276367188 2 12 1.1.1.4295.8 1 53.9733 19923.9 53.7596 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 -0.00192753004375845 2597.3974609375 866.8064 2597.39916992188 866.807006835938 3 13 1.1.1.5110.11 1 75.2577 31192.91 75.3224 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 0.000797108979895711 2597.40014648438 650.3573 2597.39916992188 650.357116699219 4 16 1.1.1.5111.2 1 75.2758 9224.605 75.3224 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 -0.00192753004375845 2597.3974609375 866.8064 2597.39916992188 866.807006835938 3 16 1.1.1.5117.10 1 75.435 31192.91 75.3224 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 -0.00192753004375845 2597.3974609375 866.8064 2597.39916992188 866.807006835938 3 15 1.1.1.5118.11 1 75.4616 31192.91 75.3224 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 0.000797108979895711 2597.40014648438 650.3573 2597.39916992188 650.357116699219 4 10 1.1.1.5122.8 1 75.5629 10060.05 75.2969 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 -0.00668809982016683 2597.392578125 866.8048 2597.39916992188 866.807006835938 3 14 1.1.1.5125.15 1 75.6483 17561.75 75.3731 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.0199990272522 QGLLPVLESFKVSFLSALEEYTKK missed K-V@11; missed K-K@23 -10.1062002182007 2715.38818359375 679.8543 2725.494140625 682.380859375 4 15 1.1.1.5097.3 1 74.9119 5048.199 74.8025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.0101025002077222 3181.73754882813 637.3548 3181.7275390625 637.352783203125 5 11 1.1.1.5110.2 1 75.2502 2297.731 75.2969 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.00841328967362642 3181.73583984375 796.4412 3181.7275390625 796.439147949219 4 23 1.1.1.5114.8 1 75.3571 40249.07 75.3478 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.00841328967362642 3181.73583984375 796.4412 3181.7275390625 796.439147949219 4 11 1.1.1.5121.11 1 75.5392 40249.07 75.3478 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.00841328967362642 3181.73583984375 796.4412 3181.7275390625 796.439147949219 4 11 1.1.1.5122.13 1 75.5671 40249.07 75.3478 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.0037434499245137 3181.73022460938 1061.584 3181.7275390625 1061.58312988281 3 10 1.1.1.5110.18 1 75.2636 7870.319 75.2969 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEK missed K-L@2 -0.000291867996565998 1151.62963867188 576.8221 1151.6298828125 576.822204589844 2 15 1.1.1.2824.2 1 18.5291 3080.54 18.6068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEK missed K-L@2 -0.000291867996565998 1151.62963867188 576.8221 1151.6298828125 576.822204589844 2 15 1.1.1.2831.2 1 18.6984 3080.54 18.6068 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEK missed K-L@2 -0.00370975001715124 1151.62622070313 576.8204 1151.6298828125 576.822204589844 2 10 1.1.1.2851.3 1 19.0393 585.7781 18.8477 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEK Gln->pyro-Glu@N-term missed K-L@2 -0.00201947009190917 1134.60131835938 568.3079 1134.60327148438 568.308959960938 2 14 1.1.1.3070.5 1 23.1307 22608.31 23.356 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEK Gln->pyro-Glu@N-term missed K-L@2 -0.00214153993874788 1134.60131835938 568.3079 1134.60327148438 568.308959960938 2 14 1.1.1.3077.8 1 23.2999 23658.43 23.356 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEK Gln->pyro-Glu@N-term missed K-L@2 -0.00214153993874788 1134.60131835938 568.3079 1134.60327148438 568.308959960938 2 14 1.1.1.3084.7 1 23.4655 23658.43 23.356 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEK Gln->pyro-Glu@N-term; Formyl(K)@2 missed K-L@2 -0.00114913994912058 1162.59704589844 582.3058 1162.59826660156 582.306396484375 2 12 1.1.1.3279.11 1 28.2413 3103.904 28.3042 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEK Acetyl@N-term missed K-L@2 -0.00565173011273146 1193.63464355469 597.8246 1193.64038085938 597.827514648438 2 14 1.1.1.3097.14 1 23.7909 3388.677 23.7763 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEK Gln->pyro-Glu@N-term; Formyl(K)@2 missed K-L@2 -0.00114913994912058 1162.59704589844 582.3058 1162.59826660156 582.306396484375 2 11 1.1.1.3286.10 1 28.4183 3103.904 28.3042 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 QKLHELQEK Gln->pyro-Glu@N-term; Acetyl(K)@2 missed K-L@2 -0.00273513002321124 1176.611328125 589.3129 1176.61389160156 589.314208984375 2 14 1.1.1.3323.8 1 29.334 16753.32 29.1203 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 QKLHELQEK Gln->pyro-Glu@N-term; Acetyl(K)@2 missed K-L@2 -0.00273513002321124 1176.611328125 589.3129 1176.61389160156 589.314208984375 2 14 1.1.1.3309.12 1 28.9889 16753.32 29.1203 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 QKLHELQEK Lys->Allysine(K)@2 missed K-L@2 -0.00281211989931762 1150.59545898438 576.305 1150.59826660156 576.306396484375 2 10 1.1.1.3046.8 1 22.611 418.9273 22.6405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 QKLHELQEK Methyl+Deamidated(Q)@1; MDA adduct +54(K)@2 missed K-L@2 -0.00702264020219445 1220.63305664063 611.3238 1220.64013671875 611.327331542969 2 12 1.1.1.3802.13 1 41.3476 7812.054 41.5403 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8299975395203 QKLHELQEK Methyl+Deamidated(Q)@1; MDA adduct +54(K)@2 missed K-L@2 -0.00702264020219445 1220.63305664063 611.3238 1220.64013671875 611.327331542969 2 13 1.1.1.3809.11 1 41.5267 7872.714 41.5403 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKLHELQEK Gln->pyro-Glu@N-term; Acetyl(K)@2 missed K-L@2 -0.00273513002321124 1176.611328125 589.3129 1176.61389160156 589.314208984375 2 14 1.1.1.3316.15 1 29.161 16753.32 29.1203 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 QKLHELQEK Carbamidomethyl@N-term; reduced acrolein addition +58(K)@2 missed K-L@2 -0.0042375298216939 1266.68884277344 423.2369 1266.69323730469 423.238342285156 3 11 1.1.1.2901.2 1 19.8112 230.0388 19.8164 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.1899991035461 QKLHELQEK Gln->pyro-Glu@N-term; Acetyl(K)@2 missed K-L@2 0.00202548992820084 1176.61584472656 589.3152 1176.61389160156 589.314208984375 2 10 1.1.1.3331.7 1 29.5263 964.0434 29.5137 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.8400025367737 QKLHELQEK Methyl+Deamidated(Q)@1; MDA adduct +54(K)@2 missed K-L@2 -0.00702264020219445 1220.63305664063 611.3238 1220.64013671875 611.327331542969 2 10 1.1.1.3816.11 1 41.7116 7872.714 41.5403 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.4999983310699 QKLHELQEK Gln->pyro-Glu@N-term; Delta:H(2)C(2)(H)@4 missed K-L@2 -0.00999561976641417 1160.60913085938 581.3118 1160.61901855469 581.316772460938 2 7 1.1.1.3273.17 1 28.0981 1140.625 28.1316 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3900007009506 QKLHELQEK Lys->Allysine(K)@2 missed K-L@2 -0.00586380017921329 1150.59252929688 576.3035 1150.59826660156 576.306396484375 2 6 1.1.1.3093.10 1 23.6947 617.1202 23.6014 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.1200001239777 QKLHELQEK missed K-L@2 -0.000536002975422889 1151.62951660156 576.822 1151.6298828125 576.822204589844 2 9 1.1.1.2841.3 1 18.8671 1770.568 18.6794 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Oxidation(M)@17 missed K-L@2; missed K-L@9 0.00602116994559765 2180.13208007813 546.0403 2180.1259765625 546.038757324219 4 20 1.1.1.3459.5 1 32.6921 73905.85 32.6352 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Oxidation(M)@17 missed K-L@2; missed K-L@9 0.00602116994559765 2180.13208007813 546.0403 2180.1259765625 546.038757324219 4 17 1.1.1.3466.6 1 32.8632 74878.78 32.6106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9 -0.000854904996231198 2163.09838867188 722.0401 2163.09936523438 722.040405273438 3 14 1.1.1.3723.18 1 39.3452 20133.61 39.5104 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9 -5.62280984013341E-05 2163.09936523438 541.7821 2163.09936523438 541.782104492188 4 22 1.1.1.3730.6 1 39.5189 37163.64 39.5104 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9 -0.000854904996231198 2163.09838867188 722.0401 2163.09936523438 722.040405273438 3 16 1.1.1.3737.20 1 39.7126 20133.61 39.5104 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.0148793002590537 2221.15625 556.2963 2221.14135742188 556.292602539063 4 15 1.1.1.3484.8 1 33.3126 5996.442 33.374 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Acetyl(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.00312120001763105 2205.11303710938 736.045 2205.10986328125 736.0439453125 3 17 1.1.1.3994.18 1 46.2893 6638.6 46.297 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7999975681305 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; acrolein addition +56(K)@9; Ser->LacticAcid(S)@11; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.00813254993408918 2204.123046875 552.038 2204.11474609375 552.035949707031 4 15 1.1.1.3768.5 1 40.4968 4613.723 40.4905 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.0141468998044729 2221.1552734375 556.2961 2221.14135742188 556.292602539063 4 11 1.1.1.3505.11 1 33.8308 5666.374 33.6959 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0200011730194 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.00902003981173038 2221.15063476563 556.2949 2221.14135742188 556.292602539063 4 11 1.1.1.3519.5 1 34.1768 1724.858 34.3127 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0200011730194 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.00950830988585949 2221.15087890625 556.295 2221.14135742188 556.292602539063 4 11 1.1.1.3540.11 1 34.6935 1833.36 34.5092 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.0141468998044729 2221.1552734375 556.2961 2221.14135742188 556.292602539063 4 11 1.1.1.3498.8 1 33.6557 5666.374 33.6959 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +96(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9 -0.0438592992722988 2195.11450195313 549.7859 2195.15869140625 549.796936035156 4 12 1.1.1.3451.3 1 32.4954 2394.351 32.586 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.5599973201752 QKLHELQEKLSPLGEEMR Acetyl@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9 -0.0028363699093461 2222.1337890625 556.5407 2222.13647460938 556.541381835938 4 12 1.1.1.3729.8 1 39.4943 10628.77 39.5891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2100005149841 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Oxidation(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9 -0.00775488978251815 2179.08642578125 727.3694 2179.09423828125 727.3720703125 3 9 1.1.1.3728.20 1 39.478 912.9788 39.5891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.019029600545764 2221.16064453125 556.2974 2221.14135742188 556.292602539063 4 10 1.1.1.3491.4 1 33.4807 5720.799 33.7206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 QKLHELQEKLSPLGEEMR Formyl@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.00707216002047062 2266.16967773438 567.5497 2266.16284179688 567.547973632813 4 11 1.1.1.3974.14 1 45.7676 3775.545 45.7528 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.3999998569489 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Deamidated(Q)@7; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.00790875963866711 2222.13330078125 556.5406 2222.12524414063 556.53857421875 4 10 1.1.1.3743.5 1 39.8526 10761.94 39.5891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.3999998569489 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Deamidated(Q)@7; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.0108879003673792 2222.13647460938 741.7194 2222.12524414063 741.715698242188 3 9 1.1.1.3743.20 1 39.8651 4469.615 39.7694 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.2699990272522 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Deamidated(Q)@7; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.00839702971279621 2222.1337890625 556.5407 2222.12524414063 556.53857421875 4 10 1.1.1.3736.8 1 39.6773 10628.77 39.5891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.5400006771088 QKLHELQEKLSPLGEEMR Lys->Allysine(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9 -0.000207553006475791 2179.09423828125 545.7808 2179.09423828125 545.780883789063 4 10 1.1.1.3731.9 1 39.5475 1652.342 39.5628 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +96(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9 -0.0438592992722988 2195.11450195313 549.7859 2195.15869140625 549.796936035156 4 10 1.1.1.3458.5 1 32.6691 2394.351 32.586 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.0146351000294089 2221.15625 556.2963 2221.14135742188 556.292602539063 4 9 1.1.1.3512.9 1 34.0069 4763.533 33.7454 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.00902003981173038 2221.15063476563 556.2949 2221.14135742188 556.292602539063 4 9 1.1.1.3526.4 1 34.3466 1724.858 34.3127 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.00950830988585949 2221.15087890625 556.295 2221.14135742188 556.292602539063 4 9 1.1.1.3533.8 1 34.5235 1833.36 34.5092 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRD Oxidation(M)@17 cleaved D-R@C-term; missed K-L@2; missed K-L@9; missed R-D@18 -0.0114227999001741 2295.14135742188 766.0544 2295.15283203125 766.058227539063 3 13 1.1.1.3469.11 1 32.9496 1255.106 32.9548 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.8400018215179 QKLHELQEKLSPLGEEMRD Gln->pyro-Glu@N-term; Oxidation(M)@17 cleaved D-R@C-term; missed K-L@2; missed K-L@9; missed R-D@18 0.000454427005024627 2278.12670898438 760.3829 2278.12646484375 760.382751464844 3 8 1.1.1.3734.19 1 39.6349 1495.463 39.7187 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00861894991248846 2451.26245117188 613.8229 2451.25390625 613.82080078125 4 14 1.1.1.3371.15 1 30.5159 263662.7 30.5262 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00837481021881104 2451.26245117188 613.8229 2451.25390625 613.82080078125 4 14 1.1.1.3385.7 1 30.8572 250127 30.9219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00837481021881104 2451.26245117188 613.8229 2451.25390625 613.82080078125 4 15 1.1.1.3399.9 1 31.2101 281865.5 31.0699 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00910721998661757 2451.26342773438 613.8231 2451.25390625 613.82080078125 4 13 1.1.1.3407.4 1 31.3998 249708.8 31.144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0164567995816469 2492.28564453125 624.0787 2492.26928710938 624.074584960938 4 18 1.1.1.3439.10 1 32.2075 53521.5 32.0882 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0140490997582674 2434.24145507813 487.8556 2434.2275390625 487.852752685547 5 17 1.1.1.3651.4 1 37.5005 145576.3 37.6191 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00614898977801204 2434.23364257813 609.5657 2434.2275390625 609.564147949219 4 19 1.1.1.3658.8 1 37.6859 320092.8 37.6191 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00614898977801204 2434.23364257813 609.5657 2434.2275390625 609.564147949219 4 18 1.1.1.3665.4 1 37.8502 323595.4 37.6191 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(H)@4; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.00329436990432441 2450.21923828125 613.5621 2450.22241210938 613.562866210938 4 21 1.1.1.3671.8 1 38.0079 14365.69 37.9909 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Acetyl(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.000258957006735727 2476.23779296875 620.0667 2476.23803710938 620.066772460938 4 21 1.1.1.3918.11 1 44.3435 51034.58 44.4836 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Acetyl(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.000258957006735727 2476.23779296875 620.0667 2476.23803710938 620.066772460938 4 18 1.1.1.3925.9 1 44.5189 51034.58 44.4836 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0147478003054857 2492.2841796875 624.0783 2492.26928710938 624.074584960938 4 16 1.1.1.3446.19 1 32.3808 36122.61 32.5122 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Methyl+Deamidated(Q)@1; MDA adduct +54(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.000405658996896818 2520.2646484375 631.0734 2520.26416015625 631.073364257813 4 16 1.1.1.4186.13 1 51.1992 10755.27 51.1855 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0180513001978397 2492.28759765625 499.4648 2492.26928710938 499.461151123047 5 16 1.1.1.3437.12 1 32.1519 84192.31 32.0882 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00639312015846372 2434.23364257813 609.5657 2434.2275390625 609.564147949219 4 15 1.1.1.3646.11 1 37.3786 303208.7 37.6191 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Acetyl@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00453526992350817 2493.26904296875 624.3245 2493.2646484375 624.323425292969 4 16 1.1.1.3670.4 1 37.9756 100843 38.0652 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Formyl(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00178109004627913 2479.25048828125 620.8199 2479.2490234375 620.819519042969 4 16 1.1.1.3640.15 1 37.2262 18552.77 37.34 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Carbamidomethyl(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00216576992534101 2491.25146484375 623.8201 2491.2490234375 623.819519042969 4 16 1.1.1.3652.13 1 37.5328 16886.91 37.3922 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Acetyl(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.000229312005103566 2476.23803710938 620.0668 2476.23803710938 620.066772460938 4 17 1.1.1.3877.11 1 43.3031 34303.48 43.3431 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Dioxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00232072989456356 2450.22485351563 613.5635 2450.22241210938 613.562866210938 4 15 1.1.1.3698.11 1 38.691 25979.52 38.6267 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0044400398619473 2434.23168945313 609.5652 2434.2275390625 609.564147949219 4 14 1.1.1.3672.9 1 38.0252 277794.2 37.768 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(H)@4; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00268171005882323 2450.22509765625 491.0523 2450.22241210938 491.0517578125 5 15 1.1.1.3671.4 1 37.9987 6646.254 37.9167 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Lys-add@N-term; Oxidation(H)@4; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00718626985326409 2595.35083007813 649.845 2595.34399414063 649.84326171875 4 16 1.1.1.3449.9 1 32.4552 17312.19 32.4129 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Acetyl@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00453526992350817 2493.26904296875 624.3245 2493.2646484375 624.323425292969 4 14 1.1.1.3677.10 1 38.1505 100843 38.0652 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0044400398619473 2434.23168945313 609.5652 2434.2275390625 609.564147949219 4 13 1.1.1.3679.7 1 38.1978 164454.5 37.9414 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.00141919997986406 2434.22607421875 609.5638 2434.2275390625 609.564147949219 4 13 1.1.1.3695.15 1 38.6165 15720.77 38.3407 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; acrolein addition +76(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0073321801610291 2510.26611328125 503.0605 2510.2587890625 503.059020996094 5 13 1.1.1.3388.6 1 30.933 2552.553 30.9219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +96(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.0376931987702847 2466.24926757813 494.2571 2466.28662109375 494.264617919922 5 14 1.1.1.3410.6 1 31.4727 5469.49 31.4634 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +96(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.0376931987702847 2466.24926757813 494.2571 2466.28662109375 494.264617919922 5 14 1.1.1.3412.4 1 31.5201 5469.49 31.4634 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7999975681305 QKLHELQEKLSPLGEEMRDR Formyl@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00244201999157667 2537.29345703125 635.3306 2537.29077148438 635.329956054688 4 14 1.1.1.3912.9 1 44.19 25849.71 44.2305 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +96(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.0670022964477539 2466.2197265625 617.5622 2466.28662109375 617.578918457031 4 14 1.1.1.3654.9 1 37.5824 5356.739 37.644 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2100009918213 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00370764010585845 2434.2314453125 609.5651 2434.2275390625 609.564147949219 4 12 1.1.1.3714.16 1 39.1109 3136.933 38.8605 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00199494999833405 2434.22973632813 487.8532 2434.2275390625 487.852752685547 5 12 1.1.1.3686.5 1 38.374 30124.1 38.115 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00297523010522127 2434.23046875 609.5649 2434.2275390625 609.564147949219 4 12 1.1.1.3686.14 1 38.3815 67363.09 38.115 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Delta:H(2)C(2)(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.00643893983215094 2460.23706054688 616.0665 2460.2431640625 616.068054199219 4 13 1.1.1.3849.12 1 42.5822 13492.94 42.5156 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +96(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.0441017001867294 2466.24267578125 494.2558 2466.28662109375 494.264617919922 5 13 1.1.1.3394.4 1 31.0777 9060.23 30.9959 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0226287990808487 2492.2919921875 499.4657 2492.26928710938 499.461151123047 5 12 1.1.1.3455.6 1 32.597 49411.69 32.6844 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(P)@12; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00253988988697529 2386.2265625 597.5639 2386.22412109375 597.563293457031 4 12 1.1.1.3645.15 1 37.3558 1737.166 37.34 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.7400004863739 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +96(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.0687113031744957 2466.21826171875 617.5618 2466.28662109375 617.578918457031 4 13 1.1.1.3662.7 1 37.7792 5486.367 37.768 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.7400004863739 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@7; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0108859995380044 2493.26416015625 624.3233 2493.25341796875 624.320617675781 4 12 1.1.1.3684.15 1 38.3305 101302.6 38.0652 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@7; acrolein addition +112(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.0238029006868601 2483.24169921875 621.8177 2483.265625 621.823669433594 4 13 1.1.1.3418.9 1 31.6756 3574.054 31.537 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.409999370575 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@7; acrolein addition +94(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.00701258983463049 2465.248046875 494.0569 2465.25512695313 494.058288574219 5 13 1.1.1.3379.8 1 30.7123 5332.563 30.7243 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.409999370575 QKLHELQEKLSPLGEEMRDR Dioxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00500806979835033 2467.25366210938 617.8207 2467.2490234375 617.819519042969 4 12 1.1.1.3427.14 1 31.8976 38168.31 31.9594 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.409999370575 QKLHELQEKLSPLGEEMRDR Dioxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0106391999870539 2467.25952148438 494.4592 2467.2490234375 494.457061767578 5 12 1.1.1.3430.9 1 31.9697 38921.87 31.9594 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 QKLHELQEKLSPLGEEMRDR Acetyl@N-term; Dehydrated(E)@5; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00759244011715055 2475.26171875 496.0596 2475.25390625 496.058074951172 5 14 1.1.1.3711.7 1 39.026 20938.62 38.9652 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00614898977801204 2434.23364257813 609.5657 2434.2275390625 609.564147949219 4 11 1.1.1.3654.7 1 37.579 320092.8 37.6191 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.00117506005335599 2434.22607421875 609.5638 2434.2275390625 609.564147949219 4 11 1.1.1.3707.12 1 38.9263 4642.413 38.6527 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00370764010585845 2434.2314453125 609.5651 2434.2275390625 609.564147949219 4 11 1.1.1.3721.16 1 39.2917 3419.207 39.2235 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 QKLHELQEKLSPLGEEMRDR Carbamidomethyl@N-term; MDA adduct +62(K)@2; Delta:H(2)C(2)(H)@4; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0303383991122246 2596.33715820313 520.2747 2596.30688476563 520.268615722656 5 13 1.1.1.3491.3 1 33.479 50337.16 33.374 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6200003623962 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00297523010522127 2434.23046875 609.5649 2434.2275390625 609.564147949219 4 11 1.1.1.3686.13 1 38.3806 67363.09 38.115 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4100012779236 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0226287990808487 2492.2919921875 499.4657 2492.26928710938 499.461151123047 5 11 1.1.1.3448.9 1 32.423 46287.19 32.6598 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00775610003620386 2434.2353515625 609.5661 2434.2275390625 609.564147949219 4 10 1.1.1.3378.10 1 30.686 1431.875 30.6996 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.739999294281 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 -0.0317633002996445 2534.28466796875 634.5784 2534.31616210938 634.586364746094 4 10 1.1.1.3712.16 1 39.0594 2348.057 39.0946 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@7; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0103976996615529 2493.263671875 624.3232 2493.25341796875 624.320617675781 4 11 1.1.1.3694.15 1 38.5904 35539.42 38.3153 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Formyl(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00570554984733462 2462.22802734375 616.5643 2462.22241210938 616.562866210938 4 12 1.1.1.3873.11 1 43.1983 9369.457 43.2645 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 QKLHELQEKLSPLGEEMRDR Formyl@N-term; reduced acrolein addition +58(K)@2; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.00244201999157667 2537.29345703125 635.3306 2537.29077148438 635.329956054688 4 13 1.1.1.3905.13 1 44.0171 24848.86 44.2053 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.7999982833862 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; hexanoyl addition +98(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.060028500854969 2532.24047851563 634.0674 2532.30053710938 634.082458496094 4 11 1.1.1.3372.19 1 30.5441 749.3789 30.4764 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.619998216629 QKLHELQEKLSPLGEEMRDR Lys->Allysine(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00134018005337566 2450.2236328125 817.7485 2450.22241210938 817.748046875 3 12 1.1.1.3669.8 1 37.9609 2072.748 37.9414 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.619998216629 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Dioxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00232072989456356 2450.22485351563 613.5635 2450.22241210938 613.562866210938 4 11 1.1.1.3691.13 1 38.5106 25979.52 38.6267 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.619998216629 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00291046011261642 2434.23046875 487.8534 2434.2275390625 487.852752685547 5 8 1.1.1.3701.4 1 38.7628 3996.171 38.4966 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.9900009632111 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00370764010585845 2434.2314453125 609.5651 2434.2275390625 609.564147949219 4 9 1.1.1.3722.12 1 39.3143 3419.207 39.2235 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.5300009250641 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00861894991248846 2451.26245117188 613.8229 2451.25390625 613.82080078125 4 12 1.1.1.3378.11 1 30.6877 236435.7 30.7983 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.5300009250641 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00910721998661757 2451.26342773438 613.8231 2451.25390625 613.82080078125 4 12 1.1.1.3414.5 1 31.5707 234010.9 31.3161 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.290002822876 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Carbamidomethyl(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0815955027937889 2491.33056640625 499.2734 2491.2490234375 499.257049560547 5 12 1.1.1.3469.5 1 32.9395 21616.85 32.6844 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.290002822876 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Dioxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0194352008402348 2508.28369140625 628.0782 2508.26416015625 628.073364257813 4 11 1.1.1.3477.16 1 33.1435 2555.656 33.1521 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.290002822876 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Hex(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.056827999651432 2596.33715820313 520.2747 2596.2802734375 520.263305664063 5 13 1.1.1.3484.7 1 33.3109 50337.16 33.374 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.1600000858307 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Phospho(S)@11; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0365702994167805 2450.23217773438 491.0537 2450.19555664063 491.04638671875 5 12 1.1.1.3652.4 1 37.5253 4187.271 37.6936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.1600000858307 QKLHELQEKLSPLGEEMRDR Acetyl@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.00208753999322653 2493.26245117188 832.0948 2493.2646484375 832.095458984375 3 11 1.1.1.3663.6 1 37.8124 12698.12 38.0404 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.8400025367737 QKLHELQEKLSPLGEEMRDR Formyl(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.000485563010443002 2479.24853515625 620.8194 2479.2490234375 620.819519042969 4 11 1.1.1.3653.3 1 37.5542 18552.77 37.34 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.8400025367737 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Carbamidomethyl(E)@8; MDA adduct +62(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.00931395031511784 2553.25537109375 639.3211 2553.2646484375 639.323425292969 4 11 1.1.1.3748.12 1 39.986 2420.844 39.9727 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.5800020694733 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Lys->Hydroxyallysine(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0225039999932051 2449.21337890625 613.3106 2449.19067382813 613.304931640625 4 12 1.1.1.3650.4 1 37.4807 6500.819 37.7184 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +96(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.0436439998447895 2466.2431640625 494.2559 2466.28662109375 494.264617919922 5 11 1.1.1.3401.5 1 31.2518 9119.419 30.9959 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; acrolein addition +76(K)@2; MDA adduct +62(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00850643962621689 2508.28466796875 502.6642 2508.27612304688 502.662506103516 5 11 1.1.1.3422.6 1 31.7651 17582.72 31.7334 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4199993610382 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0147478003054857 2492.2841796875 624.0783 2492.26928710938 624.074584960938 4 10 1.1.1.3460.5 1 32.7283 40522.82 32.6844 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Met->Hcy(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.009835010394454 2404.22705078125 602.064 2404.216796875 602.0615234375 4 11 1.1.1.3661.5 1 37.7527 2604.037 37.7432 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(H)@4; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00680149020627141 2450.22900390625 491.0531 2450.22241210938 491.0517578125 5 11 1.1.1.3678.4 1 38.1703 6387.575 37.9662 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00794576015323401 2434.23559570313 487.8544 2434.2275390625 487.852752685547 5 7 1.1.1.3711.6 1 39.0252 1419.004 38.9129 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; MDA adduct +62(K)@9; Dehydrated(D)@19 missed K-L@2; missed K-L@9; missed R-D@18 -0.0147671001031995 2462.22290039063 821.7482 2462.23754882813 821.753173828125 3 11 1.1.1.3875.18 1 43.2568 3570.923 43.2645 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.9900004863739 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0226287990808487 2492.2919921875 499.4657 2492.26928710938 499.461151123047 5 10 1.1.1.3462.4 1 32.7657 49411.69 32.6844 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.9900004863739 QKLHELQEKLSPLGEEMRDR Delta:H(2)C(2)(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.00279187993146479 2477.26684570313 620.324 2477.26977539063 620.32470703125 4 11 1.1.1.3616.2 1 36.6226 2277.146 36.5625 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.3899972438812 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.00878394953906536 2418.24096679688 484.6555 2418.232421875 484.653778076172 5 10 1.1.1.3818.6 1 41.7604 1222.742 41.7516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.2699990272522 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00639312015846372 2434.23364257813 609.5657 2434.2275390625 609.564147949219 4 9 1.1.1.3646.10 1 37.3778 303208.7 37.6191 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 71.6099977493286 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Formyl(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00643794983625412 2462.22900390625 616.5645 2462.22241210938 616.562866210938 4 10 1.1.1.3885.6 1 43.505 3396.602 43.5481 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.9000000953674 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Dioxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.00329436990432441 2450.21923828125 613.5621 2450.22241210938 613.562866210938 4 10 1.1.1.3664.7 1 37.8322 14365.69 37.9909 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.9000000953674 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Carbamyl(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.000562741013709456 2477.23364257813 620.3157 2477.23315429688 620.315612792969 4 11 1.1.1.3816.12 1 41.7125 13719.76 41.6458 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.2400007247925 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0133314002305269 2451.26708984375 491.2607 2451.25390625 491.258087158203 5 12 1.1.1.3396.6 1 31.1263 344985.6 31.0699 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.2400007247925 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0128736002370715 2451.26708984375 491.2607 2451.25390625 491.258087158203 5 12 1.1.1.3410.5 1 31.471 294816.8 31.2179 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.5400006771088 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0137171996757388 2434.24145507813 609.5676 2434.2275390625 609.564147949219 4 9 1.1.1.3733.12 1 39.6027 3369.569 39.6418 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.3899984359741 QKLHELQEKLSPLGEEMRDR Oxidation(P)@12; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0080443499609828 2403.25903320313 601.822 2403.25073242188 601.819946289063 4 11 1.1.1.3395.6 1 31.1091 2871.407 31.1194 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0262566991150379 2434.25366210938 487.858 2434.2275390625 487.852752685547 5 9 1.1.1.3404.3 1 31.3221 2741.03 31.3161 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@7; acrolein addition +112(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.0289296992123127 2483.23706054688 621.8165 2483.265625 621.823669433594 4 11 1.1.1.3406.10 1 31.3812 6990.86 31.1194 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@7; acrolein addition +112(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.00849478971213102 2483.25708007813 497.6587 2483.265625 497.660400390625 5 11 1.1.1.3411.5 1 31.4997 4424.243 31.4634 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +96(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0663693994283676 2466.35302734375 494.2779 2466.28662109375 494.264617919922 5 9 1.1.1.3422.4 1 31.7634 11199.45 32.0106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.700001001358 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Delta:H(2)C(2)(H)@4; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.00249635009095073 2460.24072265625 821.0875 2460.2431640625 821.088317871094 3 8 1.1.1.3848.18 1 42.5607 2052.16 42.5156 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.4399995803833 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@7; acrolein addition +112(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.0199385993182659 2483.24560546875 497.6564 2483.265625 497.660400390625 5 11 1.1.1.3379.9 1 30.714 7318.831 30.8231 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.8399990797043 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0044400398619473 2434.23168945313 609.5652 2434.2275390625 609.564147949219 4 7 1.1.1.3675.11 1 38.1014 229088.1 37.8424 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.9199993610382 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(H)@4; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.00353851006366313 2450.21899414063 613.562 2450.22241210938 613.562866210938 4 10 1.1.1.3679.9 1 38.1995 14265.2 38.0156 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.9199993610382 QKLHELQEKLSPLGEEMRDR Formyl@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00200299010612071 2479.25122070313 496.8575 2479.2490234375 496.857055664063 5 10 1.1.1.3717.7 1 39.1808 3621.298 39.1718 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.0400003194809 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Dioxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00207659997977316 2450.224609375 613.5634 2450.22241210938 613.562866210938 4 8 1.1.1.3646.12 1 37.3794 7094.464 37.5943 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3900007009506 QKLHELQEKLSPLGEEMRDR Deamidated(Q)@7; acrolein addition +56(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0139504000544548 2508.27807617188 837.1 2508.26416015625 837.095336914063 3 8 1.1.1.3366.20 1 30.3955 3555.85 30.3516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3900007009506 QKLHELQEKLSPLGEEMRDR acrolein addition +112(K)@2; reduced acrolein addition +96(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.0111998999491334 2595.3544921875 520.0782 2595.36572265625 520.080383300781 5 10 1.1.1.3450.3 1 32.4707 28840.09 32.4129 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3900007009506 QKLHELQEKLSPLGEEMRDR Deamidated(Q)@1; Deamidated(Q)@7; MDA adduct +62(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0204590000212193 2451.25952148438 491.2592 2451.23950195313 491.255157470703 5 11 1.1.1.3481.4 1 33.2362 24052.42 32.9795 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.1799986362457 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +96(K)@9; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.0649645030498505 2466.22143554688 494.2516 2466.28662109375 494.264617919922 5 10 1.1.1.3657.4 1 37.6502 2254.471 37.7184 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 35.5800002813339 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Delta:H(2)C(2)(H)@4; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.000348709989339113 2460.24365234375 493.056 2460.2431640625 493.055908203125 5 8 1.1.1.3844.4 1 42.4435 8211.754 42.5156 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.1199994087219 QKLHELQEKLSPLGEEMRDR reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.0278488006442785 2509.26806640625 628.3243 2509.2958984375 628.331237792969 4 9 1.1.1.3364.17 1 30.3431 12328.95 30.3016 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00779394013807178 2434.23510742188 487.8543 2434.2275390625 487.852752685547 5 9 1.1.1.3400.5 1 31.2272 3172.89 31.0453 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0147478003054857 2492.2841796875 624.0783 2492.26928710938 624.074584960938 4 9 1.1.1.3453.8 1 32.5562 36122.61 32.5122 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.8199990987778 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0015371999470517 2434.22900390625 487.8531 2434.2275390625 487.852752685547 5 7 1.1.1.3694.6 1 38.5829 8376.361 38.3153 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.7700006961823 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00861894991248846 2451.26245117188 613.8229 2451.25390625 613.82080078125 4 11 1.1.1.3423.18 1 31.8 161329.8 31.537 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.2199988365173 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@7; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0147730000317097 2493.26806640625 499.6609 2493.25341796875 499.657958984375 5 9 1.1.1.3663.2 1 37.799 45764.33 38.0404 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.690000295639 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00861894991248846 2451.26245117188 613.8229 2451.25390625 613.82080078125 4 11 1.1.1.3364.16 1 30.3422 261151.8 30.5262 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.0699987411499 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0133314002305269 2451.26708984375 491.2607 2451.25390625 491.258087158203 5 11 1.1.1.3403.5 1 31.2975 348537.6 31.0453 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.0699987411499 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00631250999867916 2451.26025390625 491.2593 2451.25390625 491.258087158203 5 11 1.1.1.3431.13 1 31.9986 54392.26 31.7334 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.9199995994568 QKLHELQEKLSPLGEEMRDR Met->Hcy(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.00966935977339745 2421.25341796875 606.3206 2421.24340820313 606.318115234375 4 10 1.1.1.3404.5 1 31.3254 2827.276 31.2179 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.9199995994568 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.0163199994713068 2492.28588867188 831.7692 2492.26928710938 831.763732910156 3 9 1.1.1.3450.7 1 32.4824 3955.602 32.4877 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 19.1200003027916 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.022061999887228 2492.29150390625 416.3892 2492.26928710938 416.385498046875 6 9 1.1.1.3439.2 1 32.1942 8903.153 32.0882 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDRAR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0155496001243591 2678.40771484375 893.8099 2678.39233398438 893.8046875 3 12 1.1.1.3334.12 1 29.6066 4067.45 29.3418 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0128736002370715 2661.37866210938 444.5704 2661.36572265625 444.568237304688 6 16 1.1.1.3602.4 1 36.2626 19246.17 36.1796 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; Oxidation(D)@19 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0159940999001265 2661.3818359375 533.2836 2661.36572265625 533.280395507813 5 17 1.1.1.3606.11 1 36.3709 81097.01 36.1796 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0128736002370715 2661.37866210938 444.5704 2661.36572265625 444.568237304688 6 14 1.1.1.3595.7 1 36.0853 19246.17 36.1796 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5599994659424 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; Oxidation(D)@19 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0159940999001265 2661.3818359375 533.2836 2661.36572265625 533.280395507813 5 14 1.1.1.3599.7 1 36.1883 81097.01 36.1796 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4100012779236 QKLHELQEKLSPLGEEMRDRAR Acetyl@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.00637590000405908 2720.40942382813 681.1096 2720.40283203125 681.107971191406 4 12 1.1.1.3610.16 1 36.479 4187.55 36.4884 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0126213999465108 2719.42016601563 544.8913 2719.40747070313 544.888793945313 5 11 1.1.1.3370.6 1 30.4885 2487.103 30.5013 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7000026702881 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0202507004141808 2719.427734375 544.8928 2719.40747070313 544.888793945313 5 11 1.1.1.3359.15 1 30.2165 7502.528 30.2516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; Oxidation(D)@19 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.00500804977491498 2661.37036132813 533.2814 2661.36572265625 533.280395507813 5 12 1.1.1.3613.4 1 36.5456 61298.69 36.282 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.4400010108948 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; Carbamyl(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 -0.0155584001913667 2704.35620117188 677.0963 2704.37158203125 677.100158691406 4 11 1.1.1.3834.14 1 42.1869 2487.729 42.2777 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.3200008869171 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Deamidated(Q)@7; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0372267998754978 2720.42895507813 454.4121 2720.3916015625 454.405883789063 6 11 1.1.1.3361.8 1 30.2605 3241.361 30.2516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.9799978733063 QKLHELQEKLSPLGEEMRDRAR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0138875003904104 2678.40600585938 536.6885 2678.39233398438 536.685729980469 5 12 1.1.1.3326.8 1 29.4021 90992.55 29.4647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.2400007247925 QKLHELQEKLSPLGEEMRDRAR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0144979003816843 2678.40649414063 536.6886 2678.39233398438 536.685729980469 5 12 1.1.1.3341.7 1 29.7728 85194.92 29.5137 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; Oxidation(D)@19 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0159940999001265 2661.3818359375 533.2836 2661.36572265625 533.280395507813 5 11 1.1.1.3592.3 1 36.0055 81097.01 36.1796 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 QKLHELQEKLSPLGEEMRDRAR Deamidated(Q)@1; Oxidation(M)@17; Deamidated(R)@18 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0437952987849712 2680.40405273438 537.0881 2680.3603515625 537.079345703125 5 11 1.1.1.3315.17 1 29.1397 15749.92 29.3172 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0204096995294094 2719.42822265625 454.2453 2719.40747070313 454.241882324219 6 9 1.1.1.3359.6 1 30.209 5169.971 30.2516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; Deamidated(Q)@7; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0155210001394153 2720.40698242188 545.0887 2720.3916015625 545.085571289063 5 10 1.1.1.3611.6 1 36.4995 12598.86 36.4363 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.8599996566772 QKLHELQEKLSPLGEEMRDRAR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.0144979003816843 2678.40649414063 536.6886 2678.39233398438 536.685729980469 5 11 1.1.1.3316.12 1 29.1568 84369.7 29.3418 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.6599992513657 QKLHELQEKLSPLGEEMRDRAR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.00360949011519551 2678.39624023438 670.6063 2678.39233398438 670.605346679688 4 11 1.1.1.3317.14 0 29.189 28287.06 29.3665 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 QKLHELQEKLSPLGEEMRDRARA Gln->pyro-Glu@N-term; Oxidation(M)@17 cleaved A-H@C-term; missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20; missed R-A@22 -0.0343432985246181 2732.36865234375 684.0994 2732.40283203125 684.107971191406 4 11 1.1.1.3669.6 1 37.9559 7779.577 37.6936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 QKLHELQEKLSPLGEEMRDRARA Gln->pyro-Glu@N-term; Oxidation(M)@17 cleaved A-H@C-term; missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20; missed R-A@22 -0.0258252006024122 2732.37719726563 547.4827 2732.40283203125 547.487854003906 5 9 1.1.1.3668.7 1 37.9245 2902.877 37.6688 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.9199993610382 QKLHELQEKLSPLGEEMRDRARA Gln->pyro-Glu@N-term; Oxidation(M)@17 cleaved A-H@C-term; missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20; missed R-A@22 -0.0275075007230043 2732.37524414063 684.1011 2732.40283203125 684.107971191406 4 10 1.1.1.3662.9 1 37.7826 8266.101 37.6688 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLR Gln->pyro-Glu@N-term missed K-V@2 -0.000730281986761838 851.485900878906 426.7502 851.486511230469 426.750518798828 2 7 1.1.1.3151.2 1 25.1195 1421.52 25.1892 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLR Gln->pyro-Glu@N-term missed K-V@2 -0.00353783997707069 851.482849121094 426.7487 851.486511230469 426.750518798828 2 9 1.1.1.2883.2 1 19.5152 1015.52 19.6188 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLR Gln->pyro-Glu@N-term missed K-V@2 -0.00353783997707069 851.482849121094 426.7487 851.486511230469 426.750518798828 2 10 1.1.1.2893.2 1 19.6877 1021.728 19.6188 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.2400007247925 QKVEPLR Gln->pyro-Glu@N-term missed K-V@2 -0.00311059993691742 851.483459472656 426.749 851.486511230469 426.750518798828 2 11 1.1.1.3129.3 1 24.5917 121745.3 24.6069 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.2400007247925 QKVEPLR Gln->pyro-Glu@N-term missed K-V@2 -0.00311059993691742 851.483459472656 426.749 851.486511230469 426.750518798828 2 10 1.1.1.3136.3 1 24.7659 121745.3 24.6069 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 QKVEPLR Gln->pyro-Glu@N-term; Carbamidomethyl(K)@2 missed K-V@2 -0.00120172998867929 908.506896972656 455.2607 908.507995605469 455.261260986328 2 8 1.1.1.3130.5 1 24.6184 1336.478 24.6069 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.5500003099442 QKVEPLR Gln->pyro-Glu@N-term missed K-V@2 -0.00311059993691742 851.483459472656 426.749 851.486511230469 426.750518798828 2 8 1.1.1.2903.2 1 19.8609 761.1765 19.6683 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 18.299999833107 QKVEPLR missed K-V@2 -0.00463058007881045 868.508483886719 435.2615 868.513061523438 435.263793945313 2 8 1.1.1.2935.2 1 20.2132 408.8012 20.1039 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.5199995040894 QKVEPLR missed K-V@2 -0.00463058007881045 868.508483886719 435.2615 868.513061523438 435.263793945313 2 7 1.1.1.2917.2 1 20.0146 994.176 19.8841 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.6700000166893 QKVEPLR missed K-V@2 -0.00383714004419744 868.50927734375 435.2619 868.513061523438 435.263793945313 2 9 1.1.1.2892.2 1 19.6546 5684.101 19.6188 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.529999256134 QKVEPLRAELQ Dehydrated(E)@9 cleaved Q-E@C-term; missed K-V@2; missed R-A@7 0.00626992015168071 1291.73107910156 646.8728 1291.72485351563 646.869689941406 2 11 1.1.1.3250.11 1 27.5371 1367.376 27.5179 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00734659004956484 1722.94519042969 575.3223 1722.93762207031 575.31982421875 3 13 1.1.1.3236.6 1 27.1901 310938.3 27.1269 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00734659004956484 1722.94519042969 575.3223 1722.93762207031 575.31982421875 3 14 1.1.1.3243.6 1 27.3586 241547 27.3958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00734659004956484 1722.94519042969 575.3223 1722.93762207031 575.31982421875 3 14 1.1.1.3264.12 1 27.8721 220735.8 27.6646 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00267744995653629 1722.94055175781 431.7424 1722.93762207031 431.74169921875 4 14 1.1.1.3271.5 1 28.0384 140551.9 27.8604 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00218918011523783 1722.93969726563 431.7422 1722.93762207031 431.74169921875 4 13 1.1.1.3278.5 1 28.2116 106394.6 27.9583 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 0.0144387995824218 1763.96740722656 441.9991 1763.95300292969 441.995513916016 4 17 1.1.1.3280.4 1 28.2601 100235.7 28.2549 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 0.0144387995824218 1763.96740722656 441.9991 1763.95300292969 441.995513916016 4 13 1.1.1.3287.6 1 28.4336 100235.7 28.2549 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00203665997833014 1722.93969726563 575.3205 1722.93762207031 575.31982421875 3 11 1.1.1.3355.11 1 30.1162 1579.783 30.1527 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00275037996470928 1705.91418457031 569.6453 1705.9111328125 569.644348144531 3 20 1.1.1.3490.9 1 33.4593 544260.8 33.6461 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00179693999234587 1705.91284179688 853.9637 1705.9111328125 853.962829589844 2 22 1.1.1.3495.11 1 33.5864 108484.1 33.6214 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00275037996470928 1705.91418457031 569.6453 1705.9111328125 569.644348144531 3 21 1.1.1.3497.11 1 33.6326 548530.4 33.6461 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00309823988936841 1705.91418457031 427.4858 1705.9111328125 427.485046386719 4 13 1.1.1.3499.2 1 33.6747 11273.81 33.6461 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00275037996470928 1705.91418457031 569.6453 1705.9111328125 569.644348144531 3 21 1.1.1.3504.7 1 33.8078 548530.4 33.6461 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00309823988936841 1705.91418457031 427.4858 1705.9111328125 427.485046386719 4 13 1.1.1.3506.2 1 33.8488 11273.81 33.6461 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00696170004084706 1705.91833496094 569.6467 1705.9111328125 569.644348144531 3 19 1.1.1.3511.6 1 33.9789 411058.2 33.7206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00622930005192757 1705.91748046875 569.6464 1705.9111328125 569.644348144531 3 17 1.1.1.3518.6 1 34.1514 130426.4 33.8938 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00238417997024953 1705.91345214844 569.6451 1705.9111328125 569.644348144531 3 17 1.1.1.3525.7 1 34.322 34795.78 34.2634 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00238417997024953 1705.91345214844 569.6451 1705.9111328125 569.644348144531 3 18 1.1.1.3532.6 1 34.4956 34289.22 34.4847 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 -0.00146095000673085 1705.90991210938 569.6439 1705.9111328125 569.644348144531 3 16 1.1.1.3539.12 1 34.674 31455.91 34.7054 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 -0.00146095000673085 1705.90991210938 569.6439 1705.9111328125 569.644348144531 3 19 1.1.1.3546.6 1 34.844 31455.91 34.7054 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 -0.00201024999842048 1705.9091796875 569.6437 1705.9111328125 569.644348144531 3 15 1.1.1.3553.5 1 35.0113 27175.14 34.9751 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00604620017111301 1705.91748046875 569.6464 1705.9111328125 569.644348144531 3 16 1.1.1.3560.9 1 35.1832 37892.79 35.1731 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00604620017111301 1705.91748046875 569.6464 1705.9111328125 569.644348144531 3 13 1.1.1.3567.12 1 35.3668 37892.79 35.1731 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 -0.00146095000673085 1705.90991210938 569.6439 1705.9111328125 569.644348144531 3 14 1.1.1.3574.11 1 35.5495 27553.28 35.2754 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 -0.00237644999288023 1705.90905761719 569.6436 1705.9111328125 569.644348144531 3 12 1.1.1.3581.11 1 35.733 12969.93 35.4581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 -0.00274264998733997 1705.90832519531 569.6434 1705.9111328125 569.644348144531 3 11 1.1.1.3595.15 1 36.092 4443.695 35.9003 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Delta:H(2)C(2)(K)@2 missed K-V@2; missed R-A@7 -0.00126829999499023 1731.92553710938 578.3158 1731.9267578125 578.316223144531 3 20 1.1.1.3742.16 1 39.8363 11605.18 39.8457 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00734659004956484 1722.94519042969 575.3223 1722.93762207031 575.31982421875 3 12 1.1.1.3250.7 1 27.5304 241547 27.3958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Lys->Allysine(K)@2 missed K-V@2; missed R-A@7 0.00244598998688161 1721.908203125 574.9767 1721.90600585938 574.975952148438 3 16 1.1.1.3508.8 1 33.9049 7369.219 33.9432 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Carbamidomethyl@N-term; Hypusine(K)@2 missed K-V@2; missed R-A@7 0.00440242979675531 1867.03210449219 467.7653 1867.02758789063 467.76416015625 4 17 1.1.1.3302.4 1 28.8036 55945.73 28.823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Formyl(K)@2 missed K-V@2; missed R-A@7 -0.0036311699077487 1733.90246582031 867.9585 1733.90600585938 867.960327148438 2 14 1.1.1.3770.9 1 40.56 3447.991 40.6399 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Acetyl(K)@2 missed K-V@2; missed R-A@7 -0.000474480009870604 1747.92126464844 874.9679 1747.92175292969 874.968139648438 2 15 1.1.1.3792.11 1 41.1058 6953.46 41.0616 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Lys->Allysine(K)@2 missed K-V@2; missed R-A@7 0.00281219999305904 1721.90893554688 574.9769 1721.90600585938 574.975952148438 3 15 1.1.1.3473.8 1 33.0397 11770.45 33.0533 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Acetyl(K)@2 missed K-V@2; missed R-A@7 -0.000474480009870604 1747.92126464844 874.9679 1747.92175292969 874.968139648438 2 14 1.1.1.3785.13 1 40.9312 6953.46 41.0616 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Pro->pyro-Glu(P)@5 missed K-V@2; missed R-A@7 -0.00681851990520954 1719.88366699219 574.3018 1719.89038085938 574.304077148438 3 15 1.1.1.3493.11 1 33.5351 5047.751 33.671 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 -0.00504853017628193 1808.96936035156 603.9971 1808.97448730469 603.998779296875 3 14 1.1.1.3840.11 1 42.3435 21300.54 42.3571 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Pro->pyro-Glu(P)@5 missed K-V@2; missed R-A@7 -0.00681851990520954 1719.88366699219 574.3018 1719.89038085938 574.304077148438 3 14 1.1.1.3500.8 1 33.7046 5047.751 33.671 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 QKVEPLRAELQEGAR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-V@2; missed R-A@7 0.0158744994550943 1779.96398925781 594.3286 1779.94787597656 594.3232421875 3 12 1.1.1.3257.7 1 27.7016 3291.367 27.469 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9600012302399 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 0.0150851998478174 1763.96789550781 588.9966 1763.95300292969 588.991638183594 3 12 1.1.1.3273.18 1 28.099 69133.63 28.2549 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 QKVEPLRAELQEGAR Pro->pyro-Glu(P)@5 missed K-V@2; missed R-A@7 -0.00313909002579749 1736.91369628906 579.9785 1736.9169921875 579.979614257813 3 13 1.1.1.3231.3 1 27.0643 1867.286 27.1269 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 QKVEPLRAELQEGAR Formyl(K)@2; Deamidated(R)@7 missed K-V@2; missed R-A@7 0.0193533003330231 1751.93591308594 584.9859 1751.91662597656 584.9794921875 3 14 1.1.1.3486.13 1 33.3621 5506.791 33.4235 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Delta:H(2)C(2)(K)@2 missed K-V@2; missed R-A@7 -0.00126829999499023 1731.92553710938 578.3158 1731.9267578125 578.316223144531 3 10 1.1.1.3749.12 1 40.0106 11605.18 39.8457 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00267743994481862 1722.94055175781 431.7424 1722.93762207031 431.74169921875 4 13 1.1.1.3232.4 1 27.083 285447.2 27.1269 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00218917010352016 1722.93969726563 431.7422 1722.93762207031 431.74169921875 4 13 1.1.1.3239.6 1 27.2568 211219.1 27.3958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00182296999264508 1722.93969726563 431.7422 1722.93762207031 431.74169921875 4 13 1.1.1.3253.4 1 27.597 187093.2 27.5423 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKVEPLRAELQEGAR Carbamidomethyl@N-term; Hypusine(K)@2 missed K-V@2; missed R-A@7 0.00440242979675531 1867.03210449219 467.7653 1867.02758789063 467.76416015625 4 14 1.1.1.3295.7 1 28.6317 55928.23 28.823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKVEPLRAELQEGAR Carbamidomethyl@N-term; Hypusine(K)@2 missed K-V@2; missed R-A@7 0.00440242979675531 1867.03210449219 467.7653 1867.02758789063 467.76416015625 4 14 1.1.1.3309.8 1 28.9822 55945.73 28.823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKVEPLRAELQEGAR Lys->Allysine(K)@2 missed K-V@2; missed R-A@7 0.00317839998751879 1721.9091796875 574.977 1721.90600585938 574.975952148438 3 13 1.1.1.3465.16 1 32.8469 11591.29 33.0533 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Oxidation(R)@7 missed K-V@2; missed R-A@7 0.00665732007473707 1721.91247558594 574.9781 1721.90600585938 574.975952148438 3 13 1.1.1.3488.7 1 33.4099 4615.03 33.5718 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKVEPLRAELQEGAR Acetyl@N-term missed K-V@2; missed R-A@7 0.00144070002716035 1764.94995117188 589.3239 1764.9482421875 589.323364257813 3 12 1.1.1.3506.8 1 33.8589 26833.15 34.0419 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKVEPLRAELQEGAR Acetyl@N-term; Dehydrated(E)@4 missed K-V@2; missed R-A@7 0.00145645998418331 1746.93908691406 583.3203 1746.93762207031 583.31982421875 3 14 1.1.1.3549.9 1 34.9175 20060.88 34.9016 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 QKVEPLRAELQEGAR Acetyl@N-term; Dehydrated(E)@4 missed K-V@2; missed R-A@7 0.00548468017950654 1746.943359375 583.3217 1746.93762207031 583.31982421875 3 14 1.1.1.3570.14 1 35.4471 28073.25 35.5104 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.2199976444244 QKVEPLRAELQEGAR acrolein addition +56(K)@2; Deamidated(R)@7 missed K-V@2; missed R-A@7 0.0131981000304222 1779.96130371094 445.9976 1779.94787597656 445.994262695313 4 12 1.1.1.3234.5 1 27.1328 7762.075 27.1025 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 QKVEPLRAELQEGAR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-V@2; missed R-A@7 0.00355472997762263 1779.95129394531 445.9951 1779.94787597656 445.994262695313 4 11 1.1.1.3241.4 1 27.3039 5932.799 27.3958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 QKVEPLRAELQEGAR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-V@2; missed R-A@7 0.0128319002687931 1779.9609375 445.9975 1779.94787597656 445.994262695313 4 11 1.1.1.3248.7 1 27.4782 5357.971 27.469 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 QKVEPLRAELQEGAR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-V@2; missed R-A@7 0.0131981000304222 1779.96130371094 445.9976 1779.94787597656 445.994262695313 4 11 1.1.1.3255.5 1 27.6493 5325.09 27.6157 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00218917010352016 1722.93969726563 431.7422 1722.93762207031 431.74169921875 4 12 1.1.1.3246.5 1 27.4261 211219.1 27.3958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00218917010352016 1722.93969726563 431.7422 1722.93762207031 431.74169921875 4 12 1.1.1.3260.5 1 27.7684 188283.6 27.6891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4100012779236 QKVEPLRAELQEGAR Acetyl@N-term; Dehydrated(E)@4 missed K-V@2; missed R-A@7 0.00109024997800589 1746.93872070313 583.3202 1746.93762207031 583.31982421875 3 13 1.1.1.3556.9 1 35.0826 21180.18 34.9996 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 QKVEPLRAELQEGAR HPNE addition +172(K)@2; Oxidation(P)@5 missed K-V@2; missed R-A@7 0.0128573002293706 1911.05529785156 478.7711 1911.04248046875 478.767913818359 4 10 1.1.1.3304.10 1 28.8589 3461.23 28.8987 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7000026702881 QKVEPLRAELQEGAR Deamidated(Q)@1; Formyl(K)@2 missed K-V@2; missed R-A@7 -0.0150696998462081 1751.90161132813 584.9745 1751.91662597656 584.9794921875 3 12 1.1.1.3504.9 1 33.8111 2278.719 33.547 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7000026702881 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Deamidated(R)@7; Dehydrated(E)@9 missed K-V@2; missed R-A@7 0.0126898996531963 1746.93908691406 583.3203 1746.92639160156 583.316101074219 3 13 1.1.1.3542.10 1 34.7426 20060.88 34.9016 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7000026702881 QKVEPLRAELQEGAR Lys->Allysine(K)@2 missed K-V@2; missed R-A@7 -0.00194842997007072 1721.90405273438 574.9753 1721.90600585938 574.975952148438 3 9 1.1.1.3559.14 1 35.162 1259.421 35.1479 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 QKVEPLRAELQEGAR Deamidated(Q)@1; Carbamidomethyl(K)@2 missed K-V@2; missed R-A@7 -0.00331226992420852 1780.93969726563 446.2422 1780.94311523438 446.243072509766 4 10 1.1.1.3205.4 1 26.4267 969.4284 26.4924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 QKVEPLRAELQEGAR Delta:H(2)C(2)(K)@2 missed K-V@2; missed R-A@7 0.00197537010535598 1748.95532226563 438.2461 1748.95336914063 438.24560546875 4 11 1.1.1.3443.3 1 32.2948 6679.089 32.2391 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.7999982833862 QKVEPLRAELQEGAR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-V@2; missed R-A@7 0.0158744994550943 1779.96398925781 594.3286 1779.94787597656 594.3232421875 3 9 1.1.1.3264.16 1 27.8755 2768.729 27.8115 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Dioxidation(R)@7 missed K-V@2; missed R-A@7 -0.006099299993366 1737.89465332031 580.3055 1737.90100097656 580.3076171875 3 12 1.1.1.3508.9 1 33.9066 5691.063 33.6461 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 QKVEPLRAELQEGAR acrolein addition +56(K)@2; Oxidation(P)@5 missed K-V@2; missed R-A@7 -0.0112936999648809 1794.94750976563 599.3231 1794.95886230469 599.326904296875 3 9 1.1.1.3735.13 1 39.6562 6200.803 39.6155 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.9900004863739 QKVEPLRAELQEGAR Lys->Allysine(K)@2 missed K-V@2; missed R-A@7 0.00244598998688161 1721.908203125 574.9767 1721.90600585938 574.975952148438 3 11 1.1.1.3516.5 1 34.103 7369.219 33.9432 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.3199980258942 QKVEPLRAELQEGAR Deamidated(Q)@1; Formyl(K)@2 missed K-V@2; missed R-A@7 -0.0201964993029833 1751.896484375 584.9728 1751.91662597656 584.9794921875 3 11 1.1.1.3497.12 1 33.6334 2216.156 33.5966 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.889999628067 QKVEPLRAELQEGAR Methyl+Deamidated(Q)@1; acrolein addition +112(K)@2 missed K-V@2; missed R-A@7 0.00866478960961103 1849.99841308594 617.6734 1849.98974609375 617.670532226563 3 11 1.1.1.3582.18 1 35.7653 6712.546 35.7466 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Oxidation(P)@5 missed K-V@2; missed R-A@7 0.00244598998688161 1721.908203125 574.9767 1721.90600585938 574.975952148438 3 8 1.1.1.3507.7 1 33.8769 7369.219 33.9432 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 40.3299987316132 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00734659004956484 1722.94519042969 575.3223 1722.93762207031 575.31982421875 3 11 1.1.1.3257.6 1 27.6999 220735.8 27.6646 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.7500007152557 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Cation:Na(E)@12 missed K-V@2; missed R-A@7 -0.00230647996068001 1727.89086914063 576.9709 1727.89306640625 576.971618652344 3 10 1.1.1.3499.6 1 33.6806 4725.151 33.6461 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.5500003099442 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.00734659004956484 1722.94519042969 575.3223 1722.93762207031 575.31982421875 3 11 1.1.1.3229.10 1 27.017 310938.3 27.1269 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 35.4099988937378 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 -0.0022052600979805 1722.93530273438 431.7411 1722.93762207031 431.74169921875 4 11 1.1.1.3285.3 1 28.3838 37569.16 28.1316 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.1199994087219 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Carbamidomethyl(K)@2 missed K-V@2; missed R-A@7 -0.000974308990407735 1762.931640625 882.4731 1762.9326171875 882.473571777344 2 7 1.1.1.3502.12 1 33.7649 996.179 33.7206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.710000872612 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 -0.00486763007938862 1705.90625 569.6427 1705.9111328125 569.644348144531 3 8 1.1.1.3649.10 1 37.4559 782.1656 37.4703 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 QKVEPLRAELQEGAR MDA adduct +62(K)@2; Cation:Na(E)@4 missed K-V@2; missed R-A@7 -0.000165278004715219 1806.93505859375 603.319 1806.93530273438 603.319030761719 3 10 1.1.1.3620.3 1 36.7193 773.1108 36.71 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 29.1500002145767 QKVEPLRAELQEGAR MDA adduct +54(K)@2 missed K-V@2; missed R-A@7 -0.00361227011308074 1776.94445800781 593.3221 1776.9482421875 593.323364257813 3 10 1.1.1.3576.11 1 35.6019 3194.996 35.5893 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.4800012111664 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 0.0140725998207927 1763.96740722656 441.9991 1763.95300292969 441.995513916016 4 10 1.1.1.3294.6 1 28.6061 2808.422 28.5991 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 19.7699993848801 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 -0.00135078001767397 1722.9365234375 431.7414 1722.93762207031 431.74169921875 4 10 1.1.1.3292.3 1 28.5541 10736.01 28.5743 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 18.0500000715256 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.0146947000175714 1705.92578125 427.4887 1705.9111328125 427.485046386719 4 6 1.1.1.3558.2 1 35.1268 576.175 35.224 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 17.8000003099442 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 -0.00292576011270285 1705.90832519531 569.6434 1705.9111328125 569.644348144531 3 9 1.1.1.3626.6 1 36.8695 1547.596 36.7837 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.5199995040894 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.00366588006727397 1705.9150390625 569.6456 1705.9111328125 569.644348144531 3 10 1.1.1.3249.7 1 27.5101 1809.258 27.4447 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.0100018978119 QKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@32 missed K-V@2; missed R-A@7; missed R-Q@15; missed K-L@17; missed K-L@24; missed R-D@33 0.0267430990934372 4139.18115234375 690.8708 4139.15478515625 690.866394042969 6 9 1.1.1.4107.16 1 49.1838 3785.742 49.27 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.0139439003542066 2223.11962890625 742.0472 2223.10595703125 742.042602539063 3 18 1.1.1.4123.18 1 49.5955 13621.39 49.6033 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 -0.00417095981538296 2224.13330078125 1113.074 2224.13745117188 1113.07604980469 2 17 1.1.1.4129.21 1 49.7515 4583.187 49.7056 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 -0.00221191998571157 2224.13525390625 742.3857 2224.13745117188 742.386474609375 3 24 1.1.1.4130.17 1 49.7736 20805.88 49.7313 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.00444435980170965 2240.13696289063 747.7196 2240.13256835938 747.718078613281 3 18 1.1.1.4150.15 1 50.2815 5742.154 50.2917 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.000599231978412718 2240.13305664063 747.7183 2240.13256835938 747.718078613281 3 16 1.1.1.4165.17 1 50.6651 10580.38 50.6736 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@10 missed K-L@5 -0.00149437005165964 2228.130859375 743.7176 2228.13256835938 743.718078613281 3 24 1.1.1.4175.18 1 50.9204 39655.3 50.9026 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; Trp->Hydroxykynurenin(W)@10 missed K-L@5 0.00588948978111148 2269.15356445313 757.3918 2269.14770507813 757.389892578125 3 16 1.1.1.4182.13 1 51.0964 3829.744 51.0566 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 -0.00998228043317795 2212.12744140625 738.3831 2212.13745117188 738.386474609375 3 14 1.1.1.4184.14 1 51.1488 7460.216 51.1342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 -0.00221191998571157 2224.13525390625 742.3857 2224.13745117188 742.386474609375 3 20 1.1.1.4184.15 1 51.1497 17296.71 51.1599 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 -0.00544309988617897 2240.12719726563 747.7163 2240.13256835938 747.718078613281 3 18 1.1.1.4184.16 1 51.1505 9908.805 51.1599 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; FormaldehydeAdduct(W)@10 missed K-L@5 0.0144347995519638 2221.14086914063 741.3876 2221.12670898438 741.3828125 3 18 1.1.1.4197.11 1 51.4782 6589.895 51.4918 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; FormaldehydeAdduct(W)@10 missed K-L@5 0.0144347995519638 2221.14086914063 741.3876 2221.12670898438 741.3828125 3 16 1.1.1.4198.15 1 51.507 6589.895 51.4918 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; FormaldehydeAdduct(W)@10 missed K-L@5 0.0144347995519638 2221.14086914063 741.3876 2221.12670898438 741.3828125 3 17 1.1.1.4199.17 1 51.5341 6589.895 51.4918 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 -0.00121906003914773 2240.13134765625 1121.073 2240.13256835938 1121.07348632813 2 22 1.1.1.4201.20 1 51.5875 77573.77 51.6953 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carbamidomethyl(K)@5; Dioxidation(W)@10 missed K-L@5 0.00303529994562268 2297.1572265625 766.7263 2297.15405273438 766.725280761719 3 17 1.1.1.4204.16 1 51.6605 4698.275 51.6953 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.00426125014200807 2240.13671875 747.7195 2240.13256835938 747.718078613281 3 26 1.1.1.4208.14 1 51.7611 168711.3 51.7211 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 -0.0205636005848646 2298.15356445313 767.0585 2298.17431640625 767.065368652344 3 15 1.1.1.4209.12 1 51.7849 3117.272 51.7722 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 0.01109420042485 2281.15893554688 761.3936 2281.14770507813 761.389892578125 3 20 1.1.1.4214.20 1 51.9191 16529.14 52.0019 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.00426125014200807 2240.13671875 747.7195 2240.13256835938 747.718078613281 3 23 1.1.1.4215.14 1 51.9397 168711.3 51.7211 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 -0.00166261999402195 2224.13598632813 742.3859 2224.13745117188 742.386474609375 3 19 1.1.1.4218.15 1 52.017 6417.838 51.9762 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 0.01109420042485 2281.15893554688 761.3936 2281.14770507813 761.389892578125 3 21 1.1.1.4221.21 1 52.0981 16529.14 52.0019 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 4.99291018059012E-05 2240.13232421875 747.7181 2240.13256835938 747.718078613281 3 18 1.1.1.4222.18 1 52.121 11624.88 52.1287 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 -0.000682474987115711 2240.1318359375 747.7179 2240.13256835938 747.718078613281 3 18 1.1.1.4229.17 1 52.2975 13082.99 52.0272 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 -0.00507690012454987 2240.12719726563 747.7164 2240.13256835938 747.718078613281 3 19 1.1.1.4236.14 1 52.4735 10949.65 52.4846 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 -0.00306553998962045 2212.13452148438 554.0409 2212.13745117188 554.041687011719 4 17 1.1.1.4245.4 1 52.6955 66760.84 52.8673 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 -0.00221191998571157 2224.13525390625 742.3857 2224.13745117188 742.386474609375 3 17 1.1.1.4245.12 1 52.7022 14285.07 52.7405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 -0.000923392013646662 2212.13745117188 1107.076 2212.13745117188 1107.07604980469 2 21 1.1.1.4247.19 1 52.7591 24093.24 52.766 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 -0.00392682990059257 2224.13330078125 1113.074 2224.13745117188 1113.07604980469 2 20 1.1.1.4247.20 1 52.76 3083.024 52.7405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 -0.000923392013646662 2212.13745117188 1107.076 2212.13745117188 1107.07604980469 2 22 1.1.1.4248.18 1 52.7837 24093.24 52.766 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 0.00503200991079211 2212.142578125 738.3881 2212.13745117188 738.386474609375 3 26 1.1.1.4249.15 1 52.8064 50509.05 52.766 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 -0.000923392013646662 2212.13745117188 1107.076 2212.13745117188 1107.07604980469 2 24 1.1.1.4249.19 1 52.8098 24093.24 52.766 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 -0.000679258024320006 2212.13745117188 1107.076 2212.13745117188 1107.07604980469 2 22 1.1.1.4250.21 1 52.8366 29693.11 52.8928 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 -0.000679258024320006 2212.13745117188 1107.076 2212.13745117188 1107.07604980469 2 23 1.1.1.4251.21 1 52.8621 29693.11 52.8928 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 -0.00306553998962045 2212.13452148438 554.0409 2212.13745117188 554.041687011719 4 18 1.1.1.4252.6 1 52.875 66760.84 52.8673 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 -0.0026965900324285 2240.1298828125 747.7172 2240.13256835938 747.718078613281 3 15 1.1.1.4254.6 1 52.9261 3865.446 52.9438 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 -0.000461018993519247 2212.13696289063 738.3863 2212.13745117188 738.386474609375 3 23 1.1.1.4257.9 1 53.0047 68259.7 52.8928 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 -0.00306553998962045 2212.13452148438 554.0409 2212.13745117188 554.041687011719 4 16 1.1.1.4259.5 1 53.0525 66760.84 52.8673 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; Trp->Kynurenin(W)@10 missed K-L@5 0.00972354039549828 2213.13134765625 554.2901 2213.12158203125 554.287658691406 4 14 1.1.1.4277.12 1 53.5178 2845.586 53.4286 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; Deamidated(N)@9 missed K-L@5 0.0360228009521961 2250.17797851563 751.0666 2250.14208984375 751.054626464844 3 17 1.1.1.4349.17 1 55.3608 11232.94 55.5491 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@3; reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 0.0317541994154453 2282.16381835938 761.7285 2282.1318359375 761.717895507813 3 17 1.1.1.4392.17 1 56.4667 3242.226 56.4492 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@3; reduced acrolein addition +58(K)@5; Trp->Kynurenin(W)@10 missed K-L@5 0.0125620998442173 2254.1494140625 752.3904 2254.13696289063 752.38623046875 3 15 1.1.1.4444.21 1 57.8173 2646.388 57.8748 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 -0.00721932994201779 2223.09936523438 1112.557 2223.10595703125 1112.56018066406 2 14 1.1.1.4455.21 1 58.1045 36599.86 58.2405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 -0.0107738999649882 2223.09521484375 742.039 2223.10595703125 742.042602539063 3 27 1.1.1.4462.13 1 58.2805 32845.05 58.2665 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 -0.0107738999649882 2223.09521484375 742.039 2223.10595703125 742.042602539063 3 18 1.1.1.4462.14 1 58.2813 32845.05 58.2665 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 -0.0107738999649882 2223.09521484375 742.039 2223.10595703125 742.042602539063 3 23 1.1.1.4469.15 1 58.4658 32845.05 58.2665 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 -0.00770758977159858 2223.09741210938 1112.556 2223.10595703125 1112.56018066406 2 17 1.1.1.4476.21 1 58.6548 27281.22 58.371 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 -0.0025808101054281 2223.10327148438 1112.559 2223.10595703125 1112.56018066406 2 15 1.1.1.4483.21 1 58.8397 4558.66 58.7655 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 -0.00599867012351751 2223.09936523438 1112.557 2223.10595703125 1112.56018066406 2 10 1.1.1.4490.20 1 59.0231 4627.853 58.7655 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Trp->Kynurenin(W)@10 missed K-L@5 0.00170348002575338 2195.11254882813 732.7115 2195.11108398438 732.7109375 3 17 1.1.1.4513.17 1 59.6279 35343.96 59.7974 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Delta:H(2)C(2)@N-term missed K-L@5 0.00122076994739473 2234.15942382813 745.7271 2234.158203125 745.726684570313 3 15 1.1.1.4517.10 1 59.7297 4566.348 59.7709 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Trp->Kynurenin(W)@10 missed K-L@5 0.00170348002575338 2195.11254882813 732.7115 2195.11108398438 732.7109375 3 23 1.1.1.4520.15 1 59.8141 35343.96 59.7974 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Trp->Kynurenin(W)@10 missed K-L@5 0.00170348002575338 2195.11254882813 732.7115 2195.11108398438 732.7109375 3 22 1.1.1.4527.10 1 59.9941 35343.96 59.7974 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Trp->Kynurenin(W)@10 missed K-L@5 -0.0111231002956629 2195.09936523438 1098.557 2195.11108398438 1098.56274414063 2 13 1.1.1.4527.21 1 60.0033 18258.03 59.7709 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.000271602009888738 2191.11572265625 731.3792 2191.1162109375 731.379333496094 3 15 1.1.1.4531.19 1 60.1047 1659.673 60.1895 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Delta:H(2)C(2)@N-term missed K-L@5 -0.00775113003328443 2234.15063476563 745.7241 2234.158203125 745.726684570313 3 19 1.1.1.4534.17 1 60.181 4798.22 60.2429 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Trp->Kynurenin(W)@10 missed K-L@5 0.00756268016993999 2195.11840820313 732.7134 2195.11108398438 732.7109375 3 12 1.1.1.4539.12 1 60.3114 1236.246 60.3241 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.0119244996458292 2191.10327148438 1096.559 2191.1162109375 1096.56530761719 2 10 1.1.1.4546.20 1 60.5048 2378.295 60.59 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.0103420997038484 2191.10595703125 731.3759 2191.1162109375 731.379333496094 3 16 1.1.1.4550.11 1 60.6022 1616.503 60.59 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@3; reduced acrolein addition +58(K)@5 missed K-L@5 0.00912319961935282 2250.15112304688 751.0576 2250.14208984375 751.054626464844 3 15 1.1.1.4552.12 1 60.6553 7728.946 60.7457 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@3; reduced acrolein addition +58(K)@5 missed K-L@5 0.000987414037808776 2250.14331054688 1126.079 2250.14208984375 1126.07824707031 2 17 1.1.1.4555.21 1 60.7405 6841.766 60.72 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 0.000720299023669213 2326.169921875 776.3973 2326.16918945313 776.397033691406 3 15 1.1.1.4559.8 1 60.8349 5466.906 60.93 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 -0.0100570004433393 2326.15942382813 1164.087 2326.16918945313 1164.09191894531 2 17 1.1.1.4563.20 1 60.9494 4569.213 60.9555 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00649699987843633 2191.109375 731.3771 2191.1162109375 731.379333496094 3 26 1.1.1.4580.7 1 61.3769 57112.96 61.4448 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00313574005849659 2191.11328125 1096.564 2191.1162109375 1096.56530761719 2 25 1.1.1.4582.17 1 61.4362 83756.94 61.4448 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00649699987843633 2191.109375 731.3771 2191.1162109375 731.379333496094 3 21 1.1.1.4589.11 1 61.6087 57112.96 61.4448 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00313574005849659 2191.11328125 1096.564 2191.1162109375 1096.56530761719 2 22 1.1.1.4590.19 1 61.6406 83756.94 61.4448 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00313574005849659 2191.11328125 1096.564 2191.1162109375 1096.56530761719 2 22 1.1.1.4591.14 1 61.6676 83756.94 61.4448 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5; Trp->Kynurenin(W)@10 missed K-L@5 0.00680116005241871 2298.18115234375 767.0677 2298.17431640625 767.065368652344 3 14 1.1.1.4592.3 1 61.678 1362.821 61.6729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00313574005849659 2191.11328125 1096.564 2191.1162109375 1096.56530761719 2 17 1.1.1.4592.17 1 61.6897 86519.47 61.4448 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00264746998436749 2191.11328125 1096.564 2191.1162109375 1096.56530761719 2 18 1.1.1.4594.19 1 61.7423 79506.98 61.4701 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Ammonia-loss(N)@3; reduced acrolein addition +58(K)@5 missed K-L@5 0.00668067997321486 2232.13793945313 745.0533 2232.13134765625 745.051086425781 3 15 1.1.1.4595.5 1 61.7559 3451.604 61.8504 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.0067977299913764 2191.109375 1096.562 2191.1162109375 1096.56530761719 2 20 1.1.1.4596.8 1 61.7845 52567.96 61.5211 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5; Trp->Kynurenin(W)@10 missed K-L@5 0.00167436001356691 2298.17602539063 767.066 2298.17431640625 767.065368652344 3 14 1.1.1.4599.5 1 61.8572 2553.262 61.7745 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.00632000016048551 2191.12231445313 731.3814 2191.1162109375 731.379333496094 3 12 1.1.1.4601.5 1 61.9076 1961.385 61.9261 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Ammonia-loss(N)@3; reduced acrolein addition +58(K)@5 missed K-L@5 0.00668067997321486 2232.13793945313 745.0533 2232.13134765625 745.051086425781 3 14 1.1.1.4602.5 1 61.933 3451.604 61.8504 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.0063094599172473 2191.109375 1096.562 2191.1162109375 1096.56530761719 2 14 1.1.1.4603.15 1 61.967 2430.714 61.9516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00777869997546077 2191.1083984375 731.3767 2191.1162109375 731.379333496094 3 15 1.1.1.4610.8 1 62.1387 1833.322 62.1041 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00533293001353741 2191.111328125 1096.563 2191.1162109375 1096.56530761719 2 8 1.1.1.4618.18 1 62.3494 2105.454 62.1548 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00503219990059733 2191.11108398438 731.3776 2191.1162109375 731.379333496094 3 11 1.1.1.4622.8 1 62.4421 1238.426 62.4581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00215920992195606 2191.11328125 1096.564 2191.1162109375 1096.56530761719 2 11 1.1.1.4627.17 1 62.5758 1740.067 62.6349 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.0125393001362681 2191.103515625 731.3751 2191.1162109375 731.379333496094 3 14 1.1.1.4629.5 1 62.6163 1449.069 62.5844 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00215920992195606 2191.11328125 1096.564 2191.1162109375 1096.56530761719 2 10 1.1.1.4634.13 1 62.7491 1740.067 62.6349 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00728598982095718 2191.109375 1096.562 2191.1162109375 1096.56530761719 2 12 1.1.1.4641.15 1 62.9269 1770.938 62.8363 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.0109479995444417 2191.10546875 1096.56 2191.1162109375 1096.56530761719 2 14 1.1.1.4649.13 1 63.1281 1477.975 62.8617 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carboxyethyl(K)@5 missed K-L@5 -0.00839366018772125 2280.1552734375 1141.085 2280.16381835938 1141.08911132813 2 16 1.1.1.4652.10 1 63.205 966.1447 63.2136 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.00247490010224283 2191.11865234375 731.3801 2191.1162109375 731.379333496094 3 14 1.1.1.4671.3 1 63.6712 713.2155 63.689 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00228570005856454 2191.11352539063 731.3785 2191.1162109375 731.379333496094 3 10 1.1.1.4672.3 1 63.6938 780.3631 63.714 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00228570005856454 2191.11352539063 731.3785 2191.1162109375 731.379333496094 3 11 1.1.1.4673.4 1 63.7219 780.3631 63.714 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.000385282008210197 2294.17944335938 1148.097 2294.17944335938 1148.09704589844 2 11 1.1.1.4740.21 1 65.4531 3960.275 65.5629 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 -0.00707367993891239 2294.17236328125 765.7314 2294.17944335938 765.733764648438 3 14 1.1.1.4743.8 1 65.5211 4787.62 65.5629 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.000385282008210197 2294.17944335938 1148.097 2294.17944335938 1148.09704589844 2 16 1.1.1.4747.21 1 65.6349 3960.275 65.5629 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.0033148699440062 2294.18334960938 1148.099 2294.17944335938 1148.09704589844 2 14 1.1.1.4754.14 1 65.8135 4120.389 65.5371 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; FormaldehydeAdduct(W)@10 missed K-L@5 0.0144347995519638 2221.14086914063 741.3876 2221.12670898438 741.3828125 3 15 1.1.1.4196.16 1 51.4569 6589.895 51.4918 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 -0.0103339003399014 2208.13232421875 737.0514 2208.142578125 737.054809570313 3 13 1.1.1.4225.17 1 52.196 3216.018 52.1541 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK MDA adduct +62(K)@5 missed K-L@5 -0.0145880999043584 2270.14404296875 757.7219 2270.158203125 757.726684570313 3 11 1.1.1.4239.16 1 52.552 6647.81 52.5613 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 -0.00614702003076673 2208.13745117188 1105.076 2208.142578125 1105.07861328125 2 12 1.1.1.4260.19 1 53.0896 3085.098 53.1221 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.00156771996989846 2208.14453125 737.0554 2208.142578125 737.054809570313 3 16 1.1.1.4264.15 1 53.1882 11219.92 53.1221 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.00577904004603624 2208.14868164063 737.0568 2208.142578125 737.054809570313 3 16 1.1.1.4279.13 1 53.5695 5876.012 53.6577 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.00577904004603624 2208.14868164063 737.0568 2208.142578125 737.054809570313 3 12 1.1.1.4286.12 1 53.7468 5876.012 53.6577 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.00248322007246315 2208.14526367188 737.0557 2208.142578125 737.054809570313 3 20 1.1.1.4332.9 1 54.92 170197.9 55.0118 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3; acrolein addition +56(K)@5 missed K-L@5 0.00883445981889963 2265.16186523438 756.0612 2265.15283203125 756.058227539063 3 14 1.1.1.4333.13 1 54.949 3618.322 55.0118 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 -0.00184571999125183 2224.13598632813 742.3859 2224.13745117188 742.386474609375 3 13 1.1.1.4336.14 1 55.0262 4577.137 55.0373 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.00248322007246315 2208.14526367188 737.0557 2208.142578125 737.054809570313 3 26 1.1.1.4339.12 1 55.101 167953.7 55.0881 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3; acrolein addition +56(K)@5 missed K-L@5 0.00883445981889963 2265.16186523438 756.0612 2265.15283203125 756.058227539063 3 14 1.1.1.4340.14 1 55.1281 3618.322 55.0118 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 -0.000380909012164921 2224.13745117188 742.3864 2224.13745117188 742.386474609375 3 14 1.1.1.4344.18 1 55.2337 4657.113 55.1647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.00248322007246315 2208.14526367188 737.0557 2208.142578125 737.054809570313 3 26 1.1.1.4346.15 1 55.2824 167953.7 55.0881 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.0124330995604396 2249.17041015625 750.7307 2249.15795898438 750.726623535156 3 21 1.1.1.4351.16 1 55.4113 22563.78 55.5748 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.00211702007800341 2208.14453125 737.0555 2208.142578125 737.054809570313 3 23 1.1.1.4353.17 1 55.4634 157652.5 55.1904 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.0124330995604396 2249.17041015625 750.7307 2249.15795898438 750.726623535156 3 24 1.1.1.4358.15 1 55.5902 22563.78 55.5748 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 -0.00224087992683053 2208.14135742188 1105.078 2208.142578125 1105.07861328125 2 21 1.1.1.4359.21 1 55.6209 37140.64 55.344 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.00211702007800341 2208.14453125 737.0555 2208.142578125 737.054809570313 3 24 1.1.1.4360.13 1 55.6398 101875.4 55.3694 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.0124330995604396 2249.17041015625 750.7307 2249.15795898438 750.726623535156 3 11 1.1.1.4364.17 1 55.7456 22563.78 55.5748 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.00193391996435821 2208.14453125 737.0555 2208.142578125 737.054809570313 3 20 1.1.1.4367.15 1 55.8208 55510.98 55.5491 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 -0.00740423984825611 2208.13549804688 737.0524 2208.142578125 737.054809570313 3 23 1.1.1.4374.18 1 56.0034 19752.26 56.0627 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 -0.00740423984825611 2208.13549804688 737.0524 2208.142578125 737.054809570313 3 19 1.1.1.4381.16 1 56.1818 19752.26 56.0627 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.00193391996435821 2208.14453125 737.0555 2208.142578125 737.054809570313 3 22 1.1.1.4388.18 1 56.3641 13355.85 56.346 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 -0.00199674000032246 2208.14135742188 1105.078 2208.142578125 1105.07861328125 2 11 1.1.1.4389.21 1 56.3924 3126.033 56.3718 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9 missed K-L@5 0.00776294013485312 2209.13427734375 737.3854 2209.12670898438 737.3828125 3 12 1.1.1.4391.16 1 56.4397 6182.432 56.4234 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.00193391996435821 2208.14453125 737.0555 2208.142578125 737.054809570313 3 19 1.1.1.4395.17 1 56.5443 13355.85 56.346 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9 missed K-L@5 -0.00532539002597332 2209.12133789063 1105.568 2209.12670898438 1105.57055664063 2 11 1.1.1.4403.21 1 56.7547 3328.118 56.7858 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; Trp->Kynurenin(W)@10 missed K-L@5 0.0149096995592117 2253.16772460938 564.2992 2253.15283203125 564.295471191406 4 14 1.1.1.4259.7 1 53.0542 3812.748 53.0711 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 -0.00707367993891239 2294.17236328125 765.7314 2294.17944335938 765.733764648438 3 13 1.1.1.4744.6 1 65.5451 4787.62 65.5629 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.029874300584197 2223.13598632813 742.0526 2223.10595703125 742.042602539063 3 12 1.1.1.4515.11 1 59.677 2990.383 59.7974 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@9; Methyl(D)@11 missed K-L@5 -0.00397111987695098 2206.11206054688 736.3779 2206.11572265625 736.379211425781 3 13 1.1.1.4330.15 1 54.8738 1996.305 54.9609 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(Q)@1; acrolein addition +56(K)@5 missed K-L@5 0.00956687983125448 2265.16235351563 756.0614 2265.15283203125 756.058227539063 3 12 1.1.1.4347.14 1 55.3074 2165.473 55.2926 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 0.000825514027383178 2224.13842773438 557.0419 2224.13745117188 557.041687011719 4 11 1.1.1.4126.9 1 49.6646 2853.44 49.7313 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.0564069002866745 2223.16259765625 556.7979 2223.10595703125 556.783752441406 4 10 1.1.1.4132.4 1 49.8135 1822.121 49.7567 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.000599231978412718 2240.13305664063 747.7183 2240.13256835938 747.718078613281 3 13 1.1.1.4173.17 1 50.8685 10580.38 50.6736 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 -0.00166261999402195 2224.13598632813 742.3859 2224.13745117188 742.386474609375 3 13 1.1.1.4211.12 1 51.8362 6417.838 51.9762 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3; acrolein addition +56(K)@5; Dioxidation(W)@10 missed K-L@5 0.0142687000334263 2297.1572265625 766.7263 2297.14282226563 766.721496582031 3 12 1.1.1.4211.15 1 51.8387 4698.275 51.6953 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 -0.0089399004355073 2224.12866210938 557.0394 2224.13745117188 557.041687011719 4 12 1.1.1.4215.4 1 51.9314 2249.374 51.9508 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.00389504991471767 2240.13647460938 747.7194 2240.13256835938 747.718078613281 3 13 1.1.1.4243.17 1 52.6554 9380.595 52.4336 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 -0.00544309988617897 2240.12719726563 747.7163 2240.13256835938 747.718078613281 3 13 1.1.1.4252.13 1 52.8809 3879.846 52.8928 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carbamidomethyl@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 -0.00873513985425234 2323.197265625 775.4064 2323.2060546875 775.409240722656 3 11 1.1.1.4359.10 1 55.6117 3587.868 55.6774 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@3; reduced acrolein addition +58(K)@5 missed K-L@5 0.00912319961935282 2250.15112304688 751.0576 2250.14208984375 751.054626464844 3 11 1.1.1.4555.11 1 60.7322 7728.946 60.7457 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Formyl@N-term missed K-L@5 -0.00166284001898021 2236.13598632813 746.3859 2236.13745117188 746.386474609375 3 9 1.1.1.4561.8 1 60.888 1007.621 60.8778 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Cation:Na(D)@8 missed K-L@5 -0.00966890994459391 2213.08837890625 738.7034 2213.09814453125 738.706604003906 3 11 1.1.1.4586.9 1 61.5343 3670.324 61.4448 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@3; reduced acrolein addition +58(K)@5 missed K-L@5 0.000987414037808776 2250.14331054688 1126.079 2250.14208984375 1126.07824707031 2 9 1.1.1.4554.18 1 60.7123 6841.766 60.72 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Cation:Na(D)@11 missed K-L@5 0.0469297990202904 2213.14501953125 554.2935 2213.09814453125 554.281799316406 4 11 1.1.1.4303.6 1 54.176 744.742 54.117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3; acrolein addition +56(K)@5; Deamidated(N)@9 missed K-L@5 0.0111843999475241 2266.14819335938 756.39 2266.13696289063 756.38623046875 3 11 1.1.1.4360.14 1 55.6407 2832.193 55.6774 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; FormaldehydeAdduct(W)@10 missed K-L@5 0.00757905980572104 2221.13427734375 741.3854 2221.12670898438 741.3828125 3 15 1.1.1.3882.12 1 43.434 3432.718 43.4722 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Oxidation(W)@10 missed K-L@5 -0.00493294978514314 2207.10546875 1104.56 2207.11108398438 1104.56274414063 2 8 1.1.1.4507.21 1 59.4716 1445.633 59.4244 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@3; reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 0.0317541994154453 2282.16381835938 761.7285 2282.1318359375 761.717895507813 3 13 1.1.1.4390.14 1 56.4123 3242.226 56.4492 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Hydroxymethyl(N)@9 missed K-L@5 0.0161838997155428 2221.14306640625 556.293 2221.12670898438 556.288940429688 4 11 1.1.1.4194.2 1 51.3943 4489.644 51.4918 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Methyl+Deamidated(Q)@1; MDA adduct +54(K)@5 missed K-L@5 -0.0167660992592573 2277.13525390625 1139.575 2277.15283203125 1139.58374023438 2 12 1.1.1.5061.20 1 73.9617 613.5942 73.9949 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.00535986013710499 2240.13793945313 747.7199 2240.13256835938 747.718078613281 3 11 1.1.1.4108.18 1 49.2112 2542.752 49.27 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 -0.00257726991549134 2212.13500976563 554.041 2212.13745117188 554.041687011719 4 11 1.1.1.4185.6 1 51.1677 4205.038 51.1599 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.032803300768137 2223.138671875 742.0535 2223.10595703125 742.042602539063 3 12 1.1.1.4195.17 1 51.4322 3350.631 51.4663 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; MDA adduct +62(K)@5; Oxidation(W)@10 missed K-L@5 0.0268357992172241 2269.15356445313 757.3918 2269.12670898438 757.3828125 3 11 1.1.1.4248.14 1 52.7804 1365.013 52.766 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 0.0040135201998055 2224.1416015625 742.3878 2224.13745117188 742.386474609375 3 11 1.1.1.4351.15 1 55.4105 4291.742 55.267 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Hydroxymethyl(N)@9 missed K-L@5 0.00850396044552326 2221.13525390625 556.2911 2221.12670898438 556.288940429688 4 11 1.1.1.3908.7 1 44.0876 2285.87 44.1549 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.00481056002900004 2240.13745117188 747.7197 2240.13256835938 747.718078613281 3 11 1.1.1.4141.18 1 50.0545 5705.563 50.2405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; MDA adduct +62(K)@5; Deamidated(N)@9 missed K-L@5 0.0146575998514891 2254.13037109375 752.3841 2254.11572265625 752.379211425781 3 11 1.1.1.4208.15 1 51.7619 1412.264 51.7211 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; acrolein addition +38(K)@5 missed K-L@5 -0.012020199559629 2229.11962890625 744.0472 2229.1318359375 744.051208496094 3 10 1.1.1.4199.18 1 51.5349 3107.334 51.5936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.079998254776 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; Deamidated(N)@9 missed K-L@5 0.00912319961935282 2250.15112304688 751.0576 2250.14208984375 751.054626464844 3 8 1.1.1.4560.7 1 60.8609 7728.946 60.7457 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7199990749359 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Hydroxymethyl(N)@9 missed K-L@5 0.0161838997155428 2221.14306640625 556.293 2221.12670898438 556.288940429688 4 10 1.1.1.4201.4 1 51.5741 4489.644 51.4918 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6200003623962 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Quinone(W)@10 missed K-L@5 0.0453777015209198 2221.1357421875 556.2912 2221.09033203125 556.279846191406 4 13 1.1.1.3915.5 1 44.2625 2791.333 44.2558 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2399988174438 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@9; Trioxidation(W)@10 missed K-L@5 0.0416265018284321 2240.12646484375 747.7161 2240.0849609375 747.702209472656 3 12 1.1.1.4115.18 1 49.3898 2163.058 49.449 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2399988174438 QLNLKLLDNWDSVTSTFSK Methyl(D)@8; Deamidated(N)@9 missed K-L@5 -0.0224415995180607 2223.11962890625 742.0472 2223.14233398438 742.0546875 3 12 1.1.1.4116.19 1 49.4164 13529.49 49.6033 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@9; Dioxidation(W)@10 missed K-L@5 0.049252100288868 2224.13916015625 742.387 2224.08984375 742.37060546875 3 9 1.1.1.4164.18 1 50.6403 1084.294 50.6225 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 QLNLKLLDNWDSVTSTFSK Carbamidomethyl(K)@5; Dioxidation(W)@10 missed K-L@5 0.0065602702088654 2297.16137695313 1149.588 2297.15405273438 1149.58422851563 2 8 1.1.1.4206.20 1 51.7151 1128.196 51.6953 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.2399985790253 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.0166903994977474 2223.12280273438 742.0482 2223.10595703125 742.042602539063 3 10 1.1.1.4204.14 1 51.6588 1993.148 51.5936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.5600028038025 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.0176059007644653 2223.12377929688 742.0485 2223.10595703125 742.042602539063 3 10 1.1.1.4138.16 1 49.9767 7030.781 49.7056 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 -0.000753085012547672 2224.13745117188 1113.076 2224.13745117188 1113.07604980469 2 7 1.1.1.4188.17 1 51.2538 4223.396 51.1599 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6399977207184 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.00444435980170965 2240.13696289063 747.7196 2240.13256835938 747.718078613281 3 9 1.1.1.4198.16 1 51.5078 167191.1 51.7211 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.8799977302551 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.00444435980170965 2240.13696289063 747.7196 2240.13256835938 747.718078613281 3 8 1.1.1.4158.20 1 50.4892 5742.154 50.2917 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.8799977302551 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; Oxidation(W)@10 missed K-L@5 0.014236900024116 2225.1357421875 742.7192 2225.12158203125 742.714477539063 3 10 1.1.1.4214.19 1 51.9183 4132.549 51.9508 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.8799977302551 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 -0.00452760001644492 2240.1279296875 747.7166 2240.13256835938 747.718078613281 3 8 1.1.1.4354.16 1 55.4884 1732.546 55.4978 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1000003814697 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.00535986013710499 2240.13793945313 747.7199 2240.13256835938 747.718078613281 3 8 1.1.1.4337.16 1 55.0533 2390.221 55.0373 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.4400000572205 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; Deamidated(N)@9 missed K-L@5 0.0237891003489494 2250.16577148438 563.5487 2250.14208984375 563.542785644531 4 8 1.1.1.4011.6 1 46.7223 21293.4 46.5581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5999977588654 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.0289587993174791 2223.134765625 742.0522 2223.10595703125 742.042602539063 3 8 1.1.1.4538.13 1 60.2857 1453.366 60.2976 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; hexanoyl addition +98(K)@5; Trp->Hydroxykynurenin(W)@10 missed K-L@5 -0.0394910015165806 2309.1396484375 770.7205 2309.17919921875 770.733642578125 3 9 1.1.1.4868.8 1 68.8327 742.3705 68.7675 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 -0.00221191998571157 2224.13525390625 742.3857 2224.13745117188 742.386474609375 3 9 1.1.1.4131.19 1 49.8006 20805.88 49.7313 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 QLNLKLLDNWDSVTSTFSK Carbamidomethyl@N-term; reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 0.00584843009710312 2355.20166015625 786.0745 2355.19580078125 786.072570800781 3 9 1.1.1.4220.15 1 52.0679 1677.495 52.1287 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 QLNLKLLDNWDSVTSTFSK HPNE addition +172(K)@5; Deamidated(N)@9; Trp->Kynurenin(W)@10 missed K-L@5 -0.0271188002079725 2385.20434570313 796.0754 2385.2314453125 796.08447265625 3 10 1.1.1.4220.16 1 52.0688 7135.043 51.9762 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3 missed K-L@5 -0.0449701994657516 2209.08203125 737.3679 2209.12670898438 737.3828125 3 10 1.1.1.4234.16 0 52.4242 14335.97 52.4846 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.0100018978119 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; Trp->Kynurenin(W)@10 missed K-L@5 0.0115933995693922 2213.13305664063 738.7183 2213.12158203125 738.714477539063 3 9 1.1.1.4167.19 1 50.7175 4323.138 50.8005 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.7799991369247 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; FormaldehydeAdduct(W)@10 missed K-L@5 0.0290112998336554 2221.15576171875 556.2962 2221.12670898438 556.288940429688 4 8 1.1.1.3899.6 1 43.8593 1680.228 43.9024 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.0099995136261 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; acrolein addition +38(K)@5; Trp->Kynurenin(W)@10 missed K-L@5 -0.00905765034258366 2233.11767578125 745.3798 2233.12670898438 745.3828125 3 6 1.1.1.4855.6 1 68.4782 996.1573 68.4959 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.739999294281 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; MDA adduct +54(K)@5; Dioxidation(W)@10 missed K-L@5 0.034791998565197 2277.15112304688 760.0577 2277.11645507813 760.046081542969 3 7 1.1.1.5059.10 1 73.8995 1145.402 73.9678 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.7199989557266 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; Dioxidation(W)@10 missed K-L@5 0.0164986997842789 2241.1328125 748.0516 2241.11645507813 748.046081542969 3 9 1.1.1.4220.13 1 52.0663 85317.63 51.7976 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 40.8199995756149 QLNLKLLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@10 missed K-L@5 -0.00149437005165964 2228.130859375 743.7176 2228.13256835938 743.718078613281 3 9 1.1.1.4168.20 1 50.7436 39655.3 50.9026 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.5399992465973 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 -0.00753012020140886 2191.109375 1096.562 2191.1162109375 1096.56530761719 2 8 1.1.1.4666.7 1 63.5528 904.4877 63.5147 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.5399992465973 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.00247490010224283 2191.11865234375 731.3801 2191.1162109375 731.379333496094 3 7 1.1.1.4703.2 1 64.471 407.9482 64.4921 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 18.3699995279312 QLNLKLLDNWDSVTSTFSK MDA adduct +54(K)@5; Dioxidation(W)@10 missed K-L@5 0.0293118003755808 2294.17236328125 765.7314 2294.14306640625 765.721618652344 3 7 1.1.1.4751.5 1 65.724 4787.62 65.5629 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.9100001454353 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.00492062978446484 2191.12133789063 1096.568 2191.1162109375 1096.56530761719 2 7 1.1.1.4659.10 1 63.3757 594.9011 63.3893 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 -0.00270615005865693 2477.32495117188 826.7823 2477.32788085938 826.783203125 3 17 1.1.1.4462.17 1 58.2838 8957.469 58.4496 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 -0.00509760994464159 2477.32299804688 620.338 2477.32788085938 620.339233398438 4 17 1.1.1.4464.8 1 58.3288 19091.27 58.4496 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 -0.00509760994464159 2477.32299804688 620.338 2477.32788085938 620.339233398438 4 19 1.1.1.4465.7 1 58.3541 19091.27 58.4496 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 -0.00509760994464159 2477.32299804688 620.338 2477.32788085938 620.339233398438 4 19 1.1.1.4469.10 1 58.4616 19091.27 58.4496 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 -0.00509760994464159 2477.32299804688 620.338 2477.32788085938 620.339233398438 4 17 1.1.1.4476.12 1 58.6473 19091.27 58.4496 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5 missed K-L@5; missed K-L@19 0.0116266002878547 2518.3544921875 630.5959 2518.34301757813 630.593078613281 4 12 1.1.1.4479.9 1 58.7242 7144.884 58.8185 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 0.00100573000963777 2477.32885742188 620.3395 2477.32788085938 620.339233398438 4 18 1.1.1.4483.8 1 58.8289 12342.8 58.5548 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 -0.00783294998109341 2477.31982421875 826.7806 2477.32788085938 826.783203125 3 10 1.1.1.4483.17 1 58.8364 3492.417 58.7125 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5; missed K-L@19 -0.00691743986681104 2492.2841796875 831.7687 2492.291015625 831.77099609375 3 19 1.1.1.4539.14 1 60.3131 6918.809 60.3241 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Acetyl(K)@19 missed K-L@5; missed K-L@19 -0.00432437006384134 2519.333984375 840.7853 2519.33837890625 840.786743164063 3 16 1.1.1.4556.13 1 60.7596 1175.031 60.7457 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term; Trp->Kynurenin(W)@10 missed K-L@5; missed K-L@19 -0.00228360993787646 2464.2939453125 822.4386 2464.29614257813 822.439331054688 3 18 1.1.1.4566.7 1 61.0163 1889.259 61.0332 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term missed K-L@5; missed K-L@19 0.00178789999336004 2460.30297851563 821.1083 2460.30126953125 821.107727050781 3 14 1.1.1.4680.6 1 63.8956 4658.074 64.0878 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term missed K-L@5; missed K-L@19 0.00178789999336004 2460.30297851563 821.1083 2460.30126953125 821.107727050781 3 19 1.1.1.4687.6 1 64.0701 4687.408 64.0878 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term missed K-L@5; missed K-L@19 0.00178789999336004 2460.30297851563 821.1083 2460.30126953125 821.107727050781 3 17 1.1.1.4694.8 1 64.2488 4687.408 64.0878 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term missed K-L@5; missed K-L@19 0.016252800822258 2460.3173828125 821.1131 2460.30126953125 821.107727050781 3 9 1.1.1.4703.6 1 64.4743 702.0883 64.4921 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term missed K-L@5; missed K-L@19 -0.00773329008370638 2460.29345703125 821.1051 2460.30126953125 821.107727050781 3 9 1.1.1.4712.7 1 64.7092 796.1145 64.6737 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term; acrolein addition +38(K)@5; Deamidated(N)@9; Dehydrated(D)@11 missed K-L@5; missed K-L@19 0.0315429009497166 2481.322265625 621.3378 2481.29028320313 621.329895019531 4 13 1.1.1.4338.9 1 55.0729 2634.344 55.0373 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Dioxidation(W)@10 missed K-L@5; missed K-L@19 0.00558699993416667 2509.3232421875 628.3381 2509.31762695313 628.336669921875 4 13 1.1.1.4293.8 1 53.9221 11797.1 54.0404 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Dioxidation(W)@10 missed K-L@5; missed K-L@19 -0.00777286989614367 2509.30981445313 837.4439 2509.31762695313 837.446472167969 3 13 1.1.1.4297.15 1 54.0302 4247.174 54.0148 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 QLNLKLLDNWDSVTSTFSKLR MDA adduct +54(K)@5; Dioxidation(W)@10 missed K-L@5; missed K-L@19 0.0285174008458853 2563.35668945313 855.4595 2563.328125 855.450012207031 3 9 1.1.1.4847.15 1 68.2714 627.5582 68.2542 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.4899973869324 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@10; hexanoyl addition +98(K)@14 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 -0.00555155007168651 4852.37744140625 971.4828 4852.38330078125 971.48388671875 5 14 1.1.1.4907.5 1 69.8542 12537.26 69.9401 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.4899973869324 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@10; hexanoyl addition +98(K)@14 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 0.0177290998399258 4852.40087890625 809.7408 4852.38330078125 809.73779296875 6 14 1.1.1.4914.2 1 70.0196 3609.1 69.9153 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.9300026893616 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trioxidation(W)@10; hexanoyl addition +98(K)@14 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 0.0108933001756668 4868.38916015625 974.6851 4868.3779296875 974.682922363281 5 14 1.1.1.4896.5 1 69.5824 5426.796 69.619 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.1099987030029 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamyl@N-term cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 0.0340251997113228 4765.35986328125 954.0793 4765.326171875 954.072448730469 5 13 1.1.1.4898.3 1 69.6301 977.4332 69.619 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.2499997615814 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@10; hexanoyl addition +98(K)@14 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 -0.00555155007168651 4852.37744140625 971.4828 4852.38330078125 971.48388671875 5 12 1.1.1.4914.6 1 70.0305 12537.26 69.9401 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trioxidation(W)@10; hexanoyl addition +98(K)@14 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 0.0108933001756668 4868.38916015625 974.6851 4868.3779296875 974.682922363281 5 12 1.1.1.4903.4 1 69.758 5426.796 69.619 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@10; hexanoyl addition +98(K)@14 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 -0.00114305003080517 4852.3828125 1214.103 4852.38330078125 1214.10302734375 4 11 1.1.1.4904.4 1 69.7869 2700.993 69.8415 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.2299997806549 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@14; acrolein addition +76(K)@25 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 0.0250378996133804 4852.38720703125 971.4847 4852.36181640625 971.479675292969 5 9 1.1.1.4921.9 1 70.2085 12331.16 69.9401 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.9099986553192 QRLAARLEALKENGGAR Deamidated(Q)@1; reduced acrolein addition +96(K)@11 missed R-L@2; missed R-L@6; missed K-E@11 -0.0323356986045837 1949.04809570313 488.2693 1949.08068847656 488.277435302734 4 10 1.1.1.4021.5 1 46.9809 31913.54 46.9219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.2699990272522 QRLAARLEALKENGGAR Deamidated(Q)@1; reduced acrolein addition +96(K)@11 missed R-L@2; missed R-L@6; missed K-E@11 -0.0323356986045837 1949.04809570313 488.2693 1949.08068847656 488.277435302734 4 9 1.1.1.4014.5 1 46.7995 31913.54 46.9219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.2699990272522 QRLAARLEALKENGGAR Deamidated(Q)@1; reduced acrolein addition +96(K)@11 missed R-L@2; missed R-L@6; missed K-E@11 -0.0263544004410505 1949.05419921875 488.2708 1949.08068847656 488.277435302734 4 9 1.1.1.4052.5 1 47.7742 7919.412 47.7928 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.3800020217896 QRLAARLEALKENGGAR Deamidated(Q)@1; reduced acrolein addition +96(K)@11 missed R-L@2; missed R-L@6; missed K-E@11 -0.0221643000841141 1949.05859375 488.2719 1949.08068847656 488.277435302734 4 8 1.1.1.4072.3 1 48.2817 1092.94 48.3527 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDR Dioxidation(W)@14 cleaved A-R@N-term; missed R-H@1 0.00469639012590051 2139.9560546875 714.3259 2139.951171875 714.324279785156 3 14 1.1.1.3555.20 1 35.0671 940.9775 35.0486 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDR cleaved A-R@N-term; missed R-H@1 0.00491584977135062 2107.96606445313 527.9988 2107.96118164063 527.997619628906 4 15 1.1.1.3641.9 1 37.247 2223.155 37.314 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDR cleaved A-R@N-term; missed R-H@1 0.00491584977135062 2107.96606445313 527.9988 2107.96118164063 527.997619628906 4 15 1.1.1.3643.9 1 37.2988 2223.155 37.314 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDR cleaved A-R@N-term; missed R-H@1 0.00491584977135062 2107.96606445313 527.9988 2107.96118164063 527.997619628906 4 13 1.1.1.3645.12 1 37.3533 2223.155 37.314 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDR cleaved A-R@N-term; missed R-H@1 0.00491584977135062 2107.96606445313 527.9988 2107.96118164063 527.997619628906 4 14 1.1.1.3640.9 1 37.2212 2223.155 37.314 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDR cleaved A-R@N-term; missed R-H@1 0.00491584977135062 2107.96606445313 527.9988 2107.96118164063 527.997619628906 4 13 1.1.1.3644.8 1 37.3239 2223.155 37.314 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDR Dioxidation(W)@14 cleaved A-R@N-term; missed R-H@1 0.00457334006205201 2139.95581054688 535.9962 2139.951171875 535.995056152344 4 14 1.1.1.3554.9 1 35.0333 1664.428 35.0486 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDR Dioxidation(W)@14 cleaved A-R@N-term; missed R-H@1 0.00457334006205201 2139.95581054688 535.9962 2139.951171875 535.995056152344 4 12 1.1.1.3562.11 1 35.2361 1664.428 35.0486 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDR cleaved A-R@N-term; missed R-H@1 0.0089179202914238 2107.97021484375 527.9998 2107.96118164063 527.997619628906 4 11 1.1.1.3668.6 1 37.9237 665.2828 37.9662 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDR cleaved A-R@N-term; missed R-H@1 0.0023262700997293 2107.9638671875 527.9982 2107.96118164063 527.997619628906 4 10 1.1.1.3685.7 1 38.3497 547.0472 38.29 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0099985599518 RHFWQQDEPPQSPWDR Trp->Kynurenin(W)@14 cleaved A-R@N-term; missed R-H@1 0.0167437996715307 2111.97290039063 529.0005 2111.95629882813 528.996337890625 4 11 1.1.1.3567.10 1 35.3652 815.5972 35.3796 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0099985599518 RHFWQQDEPPQSPWDR cleaved A-R@N-term; missed R-H@1 -0.000493753992486745 2107.9609375 703.6609 2107.96118164063 703.661010742188 3 10 1.1.1.3645.20 1 37.36 1504.595 37.2881 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6200003623962 RHFWQQDEPPQSPWDR cleaved A-R@N-term; missed R-H@1 0.00794138014316559 2107.96923828125 527.9996 2107.96118164063 527.997619628906 4 11 1.1.1.3655.8 1 37.6031 1206.457 37.5943 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 RHFWQQDEPPQSPWDRVK cleaved A-R@N-term; missed R-H@1; missed R-V@16 0.0111827999353409 2335.13623046875 584.7913 2335.12475585938 584.788452148438 4 7 1.1.1.3635.10 1 37.0936 1351.867 36.9566 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.409999370575 RLAARLEALKENGGAR cleaved Q-R@N-term; missed R-L@1; missed R-L@5; missed K-E@10 -11.0296001434326 1712.95092773438 429.245 1723.98059082031 432.002410888672 4 11 1.1.1.3559.4 1 35.1537 7470.98 35.3535 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 RLAARLEALKENGGAR cleaved Q-R@N-term; missed R-L@1; missed R-L@5; missed K-E@10 -10.0340003967285 1713.94653320313 429.4939 1723.98059082031 432.002410888672 4 12 1.1.1.3511.2 1 33.9722 15081.54 33.9432 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 RLAARLEALKENGGAR cleaved Q-R@N-term; missed R-L@1; missed R-L@5; missed K-E@10 -11.0289001464844 1712.95178222656 429.2452 1723.98059082031 432.002410888672 4 11 1.1.1.3535.3 1 34.565 6151.531 34.3127 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SALGKQLNLKLLDNWDSVTSTFSK MDA adduct +62(K)@5; MDA adduct +62(K)@10 cleaved G-S@N-term; missed K-Q@5; missed K-L@10 0.00811553001403809 2788.45141601563 930.4911 2788.44360351563 930.488464355469 3 11 1.1.1.4045.21 1 47.6091 2580.873 47.6398 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.7099993228912 SALGKQLNLKLLDNWDSVTSTFSK MDA adduct +62(K)@5; MDA adduct +62(K)@10 cleaved G-S@N-term; missed K-Q@5; missed K-L@10 0.0130593003705144 2788.45654296875 930.4928 2788.44360351563 930.488464355469 3 10 1.1.1.4058.20 1 47.9399 2616.359 47.6653 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.3199980258942 SDELRQR cleaved Y-S@N-term; missed R-Q@5 -0.00411307998001575 902.452880859375 452.2337 902.456970214844 452.235778808594 2 8 1.1.1.3209.3 1 26.5209 28767.07 26.5168 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 SDELRQR cleaved Y-S@N-term; missed R-Q@5 -0.00429617986083031 902.452697753906 452.2336 902.456970214844 452.235778808594 2 8 1.1.1.3216.3 1 26.6965 27774.19 26.6386 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.7600021362305 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Acetyl@N-term; MDA adduct +62(K)@5 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23 -0.0440663993358612 4039.11083984375 1010.785 4039.15576171875 1010.79620361328 4 13 1.1.1.5104.20 1 75.1121 14977.38 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Acetyl@N-term; MDA adduct +62(K)@5 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23 -0.0440663993358612 4039.11083984375 1010.785 4039.15576171875 1010.79620361328 4 10 1.1.1.5111.16 1 75.2875 14977.38 75.0924 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.2599995732307 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +54(K)@3; MDA adduct +62(K)@5; acrolein addition +38(K)@23 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23 -0.0817554965615273 4089.08959960938 818.8252 4089.17138671875 818.841552734375 5 9 1.1.1.5103.6 1 75.0747 525.4939 75.0659 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6499998569489 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl@N-term; MDA adduct +62(K)@5 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 -0.0421252995729446 4623.44287109375 1156.868 4623.48388671875 1156.87829589844 4 13 1.1.1.5105.21 1 75.1388 12457.72 75.144 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.1000006198883 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl@N-term; MDA adduct +62(K)@23 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 -0.0397620014846325 4623.4443359375 925.6961 4623.48388671875 925.7041015625 5 12 1.1.1.5104.13 1 75.1063 49283.6 75.2201 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.5100018978119 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +54(K)@5; Oxidation(P)@6 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 0.0250861998647451 4589.48828125 765.922 4589.46337890625 765.917846679688 6 11 1.1.1.5109.6 1 75.2279 10892.82 75.1693 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.5200023651123 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl@N-term; MDA adduct +62(K)@5 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 -0.0212584007531405 4623.462890625 771.5844 4623.48388671875 771.587951660156 6 11 1.1.1.5110.5 1 75.2527 4895.953 75.2201 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SGRDYVSQFEGSALGK cleaved D-S@N-term; missed R-D@3 -0.00171431002672762 1699.81469726563 567.6122 1699.81652832031 567.61279296875 3 15 1.1.1.3712.10 1 39.0544 10110.75 38.9652 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 24.1300001740456 SGRDYVSQFEGSALGK cleaved D-S@N-term; missed R-D@3 -0.00134810002055019 1699.8154296875 567.6124 1699.81652832031 567.61279296875 3 6 1.1.1.3720.15 1 39.2649 8842.229 38.9911 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 TEHLSTLSEK cleaved A-T@N-term -0.000860275002196431 1143.57629394531 572.7954 1143.5771484375 572.795837402344 2 17 1.1.1.3064.6 1 23.0033 5595.609 22.9653 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 TEHLSTLSEK cleaved A-T@N-term -0.000860275002196431 1143.57629394531 572.7954 1143.5771484375 572.795837402344 2 16 1.1.1.3072.7 1 23.1771 5599.286 22.9653 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 TEHLSTLSEK cleaved A-T@N-term -0.00427816016599536 1143.57287597656 572.7937 1143.5771484375 572.795837402344 2 8 1.1.1.3079.4 1 23.3441 3539.675 23.0911 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 TEHLSTLSEKAKPALEDLR MDA adduct +54(K)@10; reduced acrolein addition +58(K)@12 cleaved A-T@N-term; missed K-A@10 0.0185001995414495 2249.20849609375 450.849 2249.1904296875 450.845336914063 5 7 1.1.1.3634.5 1 37.064 7690.12 36.8822 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.0200006961823 TEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@12 cleaved A-T@N-term; missed K-A@10; missed R-Q@19; missed K-V@30 0.0278111007064581 4828.60693359375 805.7751 4828.5791015625 805.770446777344 6 12 1.1.1.5090.10 1 74.7362 16954.52 74.6433 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.7099997997284 TEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +62(K)@12; acrolein addition +94(K)@30 cleaved A-T@N-term; missed K-A@10; missed R-Q@19; missed K-V@30 -0.0221807006746531 4872.5625 813.101 4872.583984375 813.104614257813 6 7 1.1.1.5087.13 1 74.6583 412.3478 74.6702 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 18.0800005793571 TEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@30 cleaved A-T@N-term; missed K-A@10; missed R-Q@19; missed K-V@30 0.0278111007064581 4828.60693359375 805.7751 4828.5791015625 805.770446777344 6 7 1.1.1.5084.8 1 74.5738 16954.52 74.6433 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR -0.00110479001887143 1300.64001464844 651.3273 1300.64111328125 651.327880859375 2 13 1.1.1.3284.12 1 28.371 47177.6 28.5991 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR 0.000783741008490324 1300.64196777344 434.5546 1300.64111328125 434.554321289063 3 14 1.1.1.3285.5 1 28.3871 178987.4 28.6238 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR -0.0013489299453795 1300.63989257813 651.3272 1300.64111328125 651.327880859375 2 17 1.1.1.3291.13 1 28.541 53139.97 28.6238 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR 0.000509087985847145 1300.64172363281 434.5545 1300.64111328125 434.554321289063 3 16 1.1.1.3292.4 1 28.5549 188719.9 28.6487 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR -0.0013489299453795 1300.63989257813 651.3272 1300.64111328125 651.327880859375 2 16 1.1.1.3298.17 1 28.7143 53139.97 28.6238 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR 0.000509087985847145 1300.64172363281 434.5545 1300.64111328125 434.554321289063 3 15 1.1.1.3299.7 1 28.7308 188719.9 28.6487 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR -0.0013489299453795 1300.63989257813 651.3272 1300.64111328125 651.327880859375 2 11 1.1.1.3305.19 1 28.8918 53499.16 28.6238 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR 0.00206896010786295 1300.64331054688 651.3289 1300.64111328125 651.327880859375 2 13 1.1.1.3319.10 1 29.2365 3398.638 28.9729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR -0.0013489299453795 1300.63989257813 651.3272 1300.64111328125 651.327880859375 2 11 1.1.1.3333.11 1 29.5821 924.9044 29.4401 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR Carbamidomethyl@N-term 0.00299353990703821 1357.66564941406 453.5625 1357.66259765625 453.561492919922 3 10 1.1.1.3283.8 1 28.3373 782.7692 28.3534 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR Carbamidomethyl@N-term -0.00689393980428576 1357.65576171875 453.5592 1357.66259765625 453.561492919922 3 12 1.1.1.3299.8 1 28.7317 2588.174 28.7229 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR 0.999786019325256 1301.64099121094 434.8876 1300.64111328125 434.554321289063 3 12 1.1.1.3313.5 1 29.0772 10735.1 28.823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR Dehydrated(D)@8 -0.00502294022589922 1282.62548828125 428.5491 1282.63061523438 428.550811767578 3 10 1.1.1.3293.6 1 28.5814 9359.3 28.6238 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR Trioxidation(Y)@6 0.00365494005382061 1348.62963867188 450.5505 1348.62585449219 450.549255371094 3 9 1.1.1.3292.7 1 28.5574 799.5171 28.6734 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELR Oxidation(P)@5 -0.00240516010671854 1316.63366699219 659.3241 1316.63610839844 659.325317382813 2 10 1.1.1.3294.20 1 28.6178 1640.3 28.6487 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 THLAPYSDELR Formyl@N-term -0.000146190999657847 1328.63610839844 665.3253 1328.63610839844 665.325317382813 2 13 1.1.1.3585.5 1 35.8416 2443.936 35.7992 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.4499990940094 THLAPYSDELR Oxidation(Y)@6 -0.00652723992243409 1316.62951660156 439.8838 1316.63610839844 439.885955810547 3 8 1.1.1.3287.5 1 28.4328 5870.301 28.6238 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 THLAPYSDELR Pro->pyro-Glu(P)@5 -0.00233917008154094 1314.61804199219 439.2133 1314.62048339844 439.214080810547 3 9 1.1.1.3300.7 1 28.7558 3363.096 28.6238 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 THLAPYSDELR Formyl@N-term 0.000220009998884052 1328.63623046875 665.3254 1328.63610839844 665.325317382813 2 10 1.1.1.3578.16 1 35.6584 3036.494 35.5893 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 THLAPYSDELR Formyl@N-term 0.0196286998689175 1328.65563964844 665.3351 1328.63610839844 665.325317382813 2 10 1.1.1.3592.16 1 36.0205 664.0632 35.9754 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 THLAPYSDELR Pro->pyro-Glu(P)@5 -0.00867655035108328 1314.61181640625 658.3132 1314.62048339844 658.317504882813 2 9 1.1.1.3295.19 1 28.6417 771.8078 28.6238 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 THLAPYSDELR 1.00757002830505 1301.64880371094 434.8902 1300.64111328125 434.554321289063 3 10 1.1.1.3320.7 1 29.2512 1734.782 29.2435 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 THLAPYSDELR 1.0072900056839 1301.6484375 434.8901 1300.64111328125 434.554321289063 3 11 1.1.1.3327.6 1 29.4274 1624.065 29.4401 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 THLAPYSDELR Oxidation(Y)@6 -0.00652723992243409 1316.62951660156 439.8838 1316.63610839844 439.885955810547 3 10 1.1.1.3301.6 1 28.78 5924.876 28.6238 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2999999523163 THLAPYSDELR Dioxidation(Y)@6 -0.00102315994445235 1332.63000488281 445.2173 1332.63098144531 445.217620849609 3 10 1.1.1.3179.4 1 25.7933 1062.887 25.8816 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0200011730194 THLAPYSDELR Dehydrated(E)@9 -0.00502294022589922 1282.62548828125 428.5491 1282.63061523438 428.550811767578 3 9 1.1.1.3286.7 1 28.4133 9240.041 28.6487 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 THLAPYSDELR Pro->pyro-Glu(P)@5 -0.00233917008154094 1314.61804199219 439.2133 1314.62048339844 439.214080810547 3 8 1.1.1.3288.3 1 28.4573 3363.096 28.6238 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.4699985980988 THLAPYSDELR Nitro(Y)@6 0.0168436001986265 1345.64318847656 449.555 1345.62622070313 449.549346923828 3 8 1.1.1.3294.8 1 28.6077 942.3539 28.5991 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1699993610382 THLAPYSDELR Cation:Na(D)@8 0.0107789002358913 1322.63391113281 662.3242 1322.62316894531 662.31884765625 2 8 1.1.1.3293.12 1 28.5872 310.2048 28.5743 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.4300000667572 THLAPYSDELR 0.000509087985847145 1300.64172363281 434.5545 1300.64111328125 434.554321289063 3 7 1.1.1.3293.7 1 28.5822 188719.9 28.6487 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.0051788198761642 1584.80578613281 529.2759 1584.80090332031 529.274230957031 3 18 1.1.1.3188.11 1 26.0204 287013.6 26.2485 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.00499571999534965 1584.80578613281 529.2759 1584.80090332031 529.274230957031 3 17 1.1.1.3195.9 1 26.1844 374792.8 26.3705 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.0012282399693504 1584.80212402344 793.4083 1584.80090332031 793.40771484375 2 12 1.1.1.3197.9 1 26.24 65488.8 26.3705 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.00224919989705086 1584.80322265625 529.275 1584.80090332031 529.274230957031 3 18 1.1.1.3202.7 1 26.3586 390172.5 26.4436 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.00224919989705086 1584.80322265625 529.275 1584.80090332031 529.274230957031 3 18 1.1.1.3209.7 1 26.5276 403011.3 26.5411 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR Carbamidomethyl@N-term missed R-Q@11 -0.000229350000154227 1641.82214355469 548.2813 1641.822265625 548.281372070313 3 17 1.1.1.3214.6 1 26.6544 7295.986 26.7605 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.00224919989705086 1584.80322265625 529.275 1584.80090332031 529.274230957031 3 17 1.1.1.3216.5 1 26.7032 403011.3 26.5411 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR Carbamidomethyl@N-term missed R-Q@11 -0.000229350000154227 1641.82214355469 548.2813 1641.822265625 548.281372070313 3 18 1.1.1.3221.5 1 26.8285 7295.986 26.7605 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.00224919989705086 1584.80322265625 529.275 1584.80090332031 529.274230957031 3 18 1.1.1.3223.6 1 26.8739 391294.4 26.6143 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.00279851001687348 1584.80346679688 529.2751 1584.80090332031 529.274230957031 3 15 1.1.1.3230.11 1 27.0448 298554.1 26.7849 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.00261539989151061 1584.80346679688 529.2751 1584.80090332031 529.274230957031 3 14 1.1.1.3237.10 1 27.2179 175142.2 26.9556 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.00133370002731681 1584.80236816406 529.2747 1584.80090332031 529.274230957031 3 17 1.1.1.3251.6 1 27.5615 17378.15 27.5423 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.000967493979260325 1584.80163574219 529.2745 1584.80090332031 529.274230957031 3 13 1.1.1.3258.7 1 27.7278 16982.99 27.6891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.000967493979260325 1584.80163574219 529.2745 1584.80090332031 529.274230957031 3 14 1.1.1.3265.10 1 27.8957 16982.99 27.6891 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.00169990002177656 1584.80249023438 529.2748 1584.80090332031 529.274230957031 3 13 1.1.1.3279.9 1 28.2397 11457.39 27.9828 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.00554502010345459 1584.80651855469 529.2761 1584.80090332031 529.274230957031 3 12 1.1.1.3322.13 1 29.3087 1451.618 29.2435 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 -0.00379313994199038 1584.796875 529.2729 1584.80090332031 529.274230957031 3 9 1.1.1.3337.14 1 29.6748 1403.623 29.6611 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.00224919989705086 1584.80322265625 529.275 1584.80090332031 529.274230957031 3 12 1.1.1.3286.9 1 28.4166 7205.158 28.1564 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR Carbamidomethyl@N-term missed R-Q@11 -0.000412450986914337 1641.82214355469 548.2813 1641.822265625 548.281372070313 3 15 1.1.1.3207.6 1 26.4871 6428.471 26.7118 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.00499571999534965 1584.80578613281 529.2759 1584.80090332031 529.274230957031 3 11 1.1.1.3293.10 1 28.5847 3368.404 28.6734 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR Carbamidomethyl@N-term missed R-Q@11 -0.000778653018642217 1641.82153320313 548.2811 1641.822265625 548.281372070313 3 13 1.1.1.3228.15 1 26.9992 6393.571 26.8825 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5599994659424 THLAPYSDELRQR Delta:H(2)C(2)(H)@2 missed R-Q@11 0.0433624014258385 1610.85986328125 537.9606 1610.81652832031 537.946105957031 3 13 1.1.1.3462.7 1 32.7707 17167.56 32.5615 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 THLAPYSDELRQR Carbamidomethyl@N-term missed R-Q@11 -0.00975061021745205 1641.81237792969 548.2781 1641.822265625 548.281372070313 3 12 1.1.1.3199.10 1 26.2921 2533.365 26.5168 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 THLAPYSDELRQR Formyl@N-term missed R-Q@11 0.00568164978176355 1612.80151367188 807.408 1612.79577636719 807.405151367188 2 13 1.1.1.3449.10 1 32.4577 2607.11 32.4877 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 THLAPYSDELRQR Delta:H(2)C(2)(H)@2 missed R-Q@11 0.00693497993052006 1610.82336425781 403.7131 1610.81652832031 403.711395263672 4 12 1.1.1.3453.2 1 32.5412 4519.876 32.586 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 THLAPYSDELRQR Nitro(Y)@6 missed R-Q@11 0.00494625978171825 1629.79077148438 544.2709 1629.78588867188 544.269226074219 3 13 1.1.1.3402.4 1 31.2762 2304.261 31.2425 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5499997138977 THLAPYSDELRQR Iodo(Y)@6 missed R-Q@11 0.00264345994219184 1710.7001953125 428.6823 1710.69750976563 428.681640625 4 10 1.1.1.3465.3 1 32.836 3400.684 32.881 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0200011730194 THLAPYSDELRQR Carbamidomethyl@N-term missed R-Q@11 -0.000738782982807606 1641.82177734375 411.4627 1641.822265625 411.462860107422 4 11 1.1.1.3189.4 1 26.0349 3601.886 26.029 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 THLAPYSDELRQR Formyl@N-term missed R-Q@11 0.00478716008365154 1612.80065917969 538.6075 1612.79577636719 538.605895996094 3 11 1.1.1.3465.11 1 32.8427 15255.15 32.586 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4099972248077 THLAPYSDELRQR Delta:H(2)C(2)(H)@2 missed R-Q@11 0.0433624014258385 1610.85986328125 537.9606 1610.81652832031 537.946105957031 3 11 1.1.1.3455.7 1 32.5987 17167.56 32.5615 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.7999982833862 THLAPYSDELRQR Iodo(Y)@6 missed R-Q@11 0.00191564997658134 1710.69946289063 571.2404 1710.69750976563 571.23974609375 3 11 1.1.1.3463.4 1 32.7919 2259.876 32.8563 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.7999982833862 THLAPYSDELRQR Formyl@N-term; Delta:H(2)C(2)(H)@2 missed R-Q@11 0.011106800287962 1638.822265625 547.2814 1638.81140136719 547.277770996094 3 11 1.1.1.3508.7 1 33.9032 1425.304 33.8691 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.5099987983704 THLAPYSDELRQR Oxidation(Y)@6 missed R-Q@11 0.00415309984236956 1600.79968261719 534.6072 1600.79577636719 534.605895996094 3 11 1.1.1.3212.5 1 26.599 2379.327 26.5899 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.279999256134 THLAPYSDELRQR Carbamidomethyl@N-term missed R-Q@11 -0.00352517003193498 1641.81884765625 548.2802 1641.822265625 548.281372070313 3 10 1.1.1.3190.9 1 26.0676 3002.598 26.029 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.1899991035461 THLAPYSDELRQR Oxidation(P)@5 missed R-Q@11 0.01129399985075 1600.80700683594 534.6096 1600.79577636719 534.605895996094 3 10 1.1.1.3222.8 1 26.8478 1862.862 26.8337 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 THLAPYSDELRQR Carbamidomethyl@N-term missed R-Q@11 -0.00147119001485407 1641.82092285156 411.4625 1641.822265625 411.462860107422 4 10 1.1.1.3226.3 1 26.9387 8472.487 26.8825 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.9900004863739 THLAPYSDELRQR Nitro(Y)@6 missed R-Q@11 0.00550012988969684 1629.79138183594 408.4551 1629.78588867188 408.453765869141 4 7 1.1.1.3431.5 1 31.9919 1007.859 31.934 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.0800018310547 THLAPYSDELRQR Oxidation(P)@5 missed R-Q@11 0.0155464997515082 1600.81140136719 401.2101 1600.79577636719 401.206207275391 4 8 1.1.1.3218.2 1 26.7403 2430.7 26.663 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.3899984359741 THLAPYSDELRQR Iodo(Y)@6 missed R-Q@11 0.00191564997658134 1710.69946289063 571.2404 1710.69750976563 571.23974609375 3 10 1.1.1.3471.5 1 32.9913 2259.876 32.8563 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 THLAPYSDELRQR Acetyl@N-term missed R-Q@11 0.00131537998095155 1626.8125 407.7104 1626.81140136719 407.710144042969 4 7 1.1.1.3431.4 1 31.9911 1970.97 32.0363 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 THLAPYSDELRQR Nitro(Y)@6 missed R-Q@11 0.00494625978171825 1629.79077148438 544.2709 1629.78588867188 544.269226074219 3 9 1.1.1.3409.4 1 31.4465 2304.261 31.2425 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.1199994087219 THLAPYSDELRQR Carbamidomethyl@N-term missed R-Q@11 -0.000738782982807606 1641.82177734375 411.4627 1641.822265625 411.462860107422 4 9 1.1.1.3217.3 1 26.7176 9158.234 26.7605 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 THLAPYSDELRQR Carbamidomethyl@N-term; Deamidated(Q)@12 missed R-Q@11 0.000820906017906964 1642.80737304688 411.7091 1642.80627441406 411.708862304688 4 8 1.1.1.3188.3 1 26.0088 5966.97 25.9308 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 THLAPYSDELRQR Nitro(Y)@6 missed R-Q@11 0.00494625978171825 1629.79077148438 544.2709 1629.78588867188 544.269226074219 3 10 1.1.1.3395.5 1 31.1066 2304.261 31.2425 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.129998922348 THLAPYSDELRQR missed R-Q@11 0.00682672997936606 1584.8076171875 529.2765 1584.80090332031 529.274230957031 3 10 1.1.1.3315.16 1 29.1381 1850.528 29.022 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 24.1300001740456 THLAPYSDELRQR missed R-Q@11 0.000784392992500216 1584.80163574219 529.2745 1584.80090332031 529.274230957031 3 9 1.1.1.3181.15 1 25.8467 3441.545 25.8816 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 21.7199996113777 THLAPYSDELRQR missed R-Q@11 0.0051788198761642 1584.80578613281 529.2759 1584.80090332031 529.274230957031 3 10 1.1.1.3272.12 1 28.0691 11388.52 27.9828 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 21.7199996113777 THLAPYSDELRQR missed R-Q@11 0.00499571999534965 1584.80578613281 529.2759 1584.80090332031 529.274230957031 3 9 1.1.1.3300.15 1 28.7625 3368.404 28.6734 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 19.1200003027916 THLAPYSDELRQR HexNAc(T)@1 missed R-Q@11 0.00466259988024831 1787.88488769531 447.9785 1787.88024902344 447.977325439453 4 9 1.1.1.3271.10 1 28.0426 5115.854 28.0818 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.6700000166893 THLAPYSDELRQR missed R-Q@11 0.000784392992500216 1584.80163574219 529.2745 1584.80090332031 529.274230957031 3 8 1.1.1.3171.11 1 25.6175 3106.291 25.6311 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.997938990592957 3135.66772460938 628.1408 3134.66967773438 627.941223144531 5 20 1.1.1.3964.16 1 45.5146 148381.1 45.4475 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.0136903999373317 3134.68359375 523.4545 3134.66967773438 523.452209472656 6 21 1.1.1.3971.8 1 45.686 164566.8 45.7787 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.00797160994261503 3134.677734375 627.9428 3134.66967773438 627.941223144531 5 18 1.1.1.3971.14 1 45.691 174072.1 45.6765 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.0136903999373317 3134.68359375 523.4545 3134.66967773438 523.452209472656 6 18 1.1.1.3978.5 1 45.8623 164566.8 45.7787 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.00797160994261503 3134.677734375 627.9428 3134.66967773438 627.941223144531 5 19 1.1.1.3978.13 1 45.869 178191.3 45.7787 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@24 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.0120922001078725 3135.66552734375 628.1404 3135.65380859375 628.138000488281 5 20 1.1.1.3992.14 1 46.2335 49005.37 46.2707 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 -0.00127422995865345 3134.66845703125 784.6744 3134.66967773438 784.674682617188 4 16 1.1.1.3969.17 1 45.6424 46528.56 45.702 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@24 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.0139231998473406 3135.66772460938 628.1408 3135.65380859375 628.138000488281 5 14 1.1.1.3957.11 1 45.3311 148381.1 45.4475 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@24 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.017324099317193 3135.6708984375 523.6191 3135.65380859375 523.6162109375 6 14 1.1.1.3964.7 1 45.5071 136384.6 45.4475 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.00263191992416978 3134.67260742188 784.6754 3134.66967773438 784.674682617188 4 14 1.1.1.3987.19 1 46.1064 39069.21 45.83 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3699977397919 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.00336431991308928 3134.6728515625 784.6755 3134.66967773438 784.674682617188 4 13 1.1.1.3984.17 1 46.0264 47316.02 45.8041 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1300005912781 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 -0.00127422995865345 3134.66845703125 784.6744 3134.66967773438 784.674682617188 4 12 1.1.1.3965.19 1 45.5426 46528.56 45.702 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1300005912781 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 -0.00127422995865345 3134.66845703125 784.6744 3134.66967773438 784.674682617188 4 12 1.1.1.3967.17 1 45.5918 46528.56 45.702 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1300005912781 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 -0.00127422995865345 3134.66845703125 784.6744 3134.66967773438 784.674682617188 4 12 1.1.1.3968.19 1 45.6188 46528.56 45.702 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1300005912781 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.00336431991308928 3134.6728515625 784.6755 3134.66967773438 784.674682617188 4 12 1.1.1.3975.17 1 45.7956 48024.38 45.7787 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1300005912781 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.0136745003983378 3134.68359375 448.8192 3134.66967773438 448.817230224609 7 12 1.1.1.3987.3 1 46.093 31438.51 45.83 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 THLAPYSDELRQRLAARLEALKENGGAR Oxidation(P)@5 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.0196470990777016 3150.68408203125 526.1213 3150.66455078125 526.118041992188 6 10 1.1.1.3972.7 1 45.7108 2741.852 45.7787 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.6099982261658 THLAPYSDELRQRLAARLEALKENGGAR Arg->Orn(R)@17; acrolein addition +76(K)@22; Deamidated(N)@24 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 -0.0399210005998611 3169.6220703125 1057.548 3169.66333007813 1057.56164550781 3 9 1.1.1.3209.12 1 26.5359 1480.06 26.3705 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.8400025367737 THLAPYSDELRQRLAARLEALKENGGAR Ammonia-loss(N)@24 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.015463899821043 3117.6591796875 520.6171 3117.64306640625 520.614501953125 6 11 1.1.1.3992.4 1 46.2251 8395.616 46.297 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.2400012016296 THLAPYSDELRQRLAARLEALKENGGAR Acetyl(K)@22 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.00123252999037504 3176.681640625 636.3436 3176.68017578125 636.343322753906 5 12 1.1.1.4141.12 1 50.0495 3474.662 50.0622 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.3999998569489 THLAPYSDELRQRLAARLEALKENGGAR Oxidation(P)@5 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.0093934303149581 3150.67407226563 526.1196 3150.66455078125 526.118041992188 6 9 1.1.1.3965.9 1 45.5343 2449.454 45.4985 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 THLAPYSDELRQRLAARLEALKENGGAR Deamidated(Q)@12; Ammonia-loss(N)@24 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.0480277985334396 3118.67529296875 520.7865 3118.62719726563 520.778503417969 6 11 1.1.1.3996.9 1 46.3341 5166.532 46.297 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.5800001621246 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.0136745003983378 3134.68359375 448.8192 3134.66967773438 448.817230224609 7 11 1.1.1.3976.3 1 45.8098 41170.23 45.7787 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.5800001621246 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.0136903999373317 3134.68359375 523.4545 3134.66967773438 523.452209472656 6 11 1.1.1.3985.4 1 46.0416 165113.8 45.7787 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.6899974346161 THLAPYSDELRQRLAARLEALKENGGAR Dioxidation(R)@17 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 -0.0102847004309297 3166.64965820313 528.7822 3166.65966796875 528.783874511719 6 10 1.1.1.3965.10 1 45.5351 1789.109 45.4985 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 35.5800002813339 THLAPYSDELRQRLAARLEALKENGGAR Carbamidomethyl@N-term; Deamidated(N)@24 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.0202469993382692 3192.69580078125 533.1232 3192.67529296875 533.119812011719 6 8 1.1.1.3983.8 1 45.993 1655.466 45.9327 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 38.2699996232986 VDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; MDA adduct +62(K)@5 cleaved Y-V@N-term; missed K-D@5; missed R-D@9 0.0201705005019903 2488.24365234375 623.0682 2488.22338867188 623.063110351563 4 10 1.1.1.3800.8 1 41.2935 4814.057 41.2846 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 -0.00161449995357543 1466.78259277344 489.9348 1466.7841796875 489.935333251953 3 14 1.1.1.3333.7 1 29.5754 169616.5 29.8093 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 0.00195596995763481 1466.7861328125 489.936 1466.7841796875 489.935333251953 3 15 1.1.1.3340.8 1 29.744 335644.1 29.9809 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 -0.00133985001593828 1466.78283691406 489.9349 1466.7841796875 489.935333251953 3 17 1.1.1.3347.5 1 29.9149 403791 30.1035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 -0.00133985001593828 1466.78283691406 489.9349 1466.7841796875 489.935333251953 3 16 1.1.1.3354.6 1 30.0858 408842.9 30.1035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 -0.00133985001593828 1466.78283691406 489.9349 1466.7841796875 489.935333251953 3 16 1.1.1.3361.13 1 30.2647 408842.9 30.1035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 0.00223062001168728 1466.78649902344 489.9361 1466.7841796875 489.935333251953 3 15 1.1.1.3368.7 1 30.4346 388206.1 30.1773 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 -0.00225535989739001 1466.78198242188 489.9346 1466.7841796875 489.935333251953 3 13 1.1.1.3383.9 1 30.8078 7052.643 30.7243 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 -0.00188916001934558 1466.7822265625 489.9347 1466.7841796875 489.935333251953 3 13 1.1.1.3390.8 1 30.9798 7325.22 31.0699 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 -0.00188916001934558 1466.7822265625 489.9347 1466.7841796875 489.935333251953 3 13 1.1.1.3404.4 1 31.3237 6535.212 31.2915 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 -0.00133985001593828 1466.78283691406 489.9349 1466.7841796875 489.935333251953 3 14 1.1.1.3411.4 1 31.4972 6336.073 31.4143 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 0.00104046997148544 1466.78527832031 489.9357 1466.7841796875 489.935333251953 3 12 1.1.1.3425.8 1 31.8421 7522.672 31.7334 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 -0.00280466000549495 1466.78137207031 489.9344 1466.7841796875 489.935333251953 3 13 1.1.1.3439.7 1 32.2025 4950.768 31.934 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 -0.00280466000549495 1466.78137207031 489.9344 1466.7841796875 489.935333251953 3 13 1.1.1.3446.8 1 32.3717 2832.616 32.3133 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9600012302399 VEPLRAELQEGAR missed R-A@5 -0.00253000995144248 1466.78173828125 489.9345 1466.7841796875 489.935333251953 3 11 1.1.1.3432.9 1 32.021 6273.547 31.8582 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9200005531311 VEPLRAELQEGAR Pro->pyro-Glu(P)@3 missed R-A@5 -0.00155036000069231 1480.76196289063 494.5946 1480.76342773438 494.595092773438 3 13 1.1.1.3350.8 1 29.9952 6169.655 30.128 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.4699985980988 VEPLRAELQEGAR Dioxidation(R)@5 missed R-A@5 -0.00227025989443064 1498.77160644531 500.5978 1498.77392578125 500.598602294922 3 11 1.1.1.3359.11 1 30.2132 8076.283 30.1527 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.4999983310699 VEPLRAELQEGAR Methyl(E)@2 missed R-A@5 -0.0379359014332294 1480.76196289063 494.5946 1480.7998046875 494.607208251953 3 11 1.1.1.3357.9 1 30.162 6169.655 30.128 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.3899984359741 VEPLRAELQEGAR Oxidation(P)@3 missed R-A@5 -0.00418451987206936 1482.77490234375 495.2656 1482.77905273438 495.266967773438 3 9 1.1.1.3361.14 1 30.2655 4250.355 30.1527 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 47.4999994039536 VEPLRAELQEGAR missed R-A@5 -0.00188916001934558 1466.7822265625 489.9347 1466.7841796875 489.935333251953 3 11 1.1.1.3375.8 1 30.6094 19487.98 30.3516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 40.3299987316132 VEPLRAELQEGAR missed R-A@5 -0.00188916001934558 1466.7822265625 489.9347 1466.7841796875 489.935333251953 3 11 1.1.1.3397.6 1 31.1509 7325.22 31.0699 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.1199994087219 VEPLRAELQEGAR Oxidation(P)@3 missed R-A@5 -0.00482536992058158 1482.7744140625 495.2654 1482.77905273438 495.266967773438 3 9 1.1.1.3354.7 1 30.0866 4342.329 30.0545 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5100014209747 VEPLRAELQEGAR Oxidation(P)@3 missed R-A@5 -0.000614041986409575 1482.77856445313 495.2668 1482.77905273438 495.266967773438 3 7 1.1.1.3339.9 1 29.7201 3615.071 29.9563 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.9400011301041 VEPLRAELQEGAR Cation:Na(E)@2 missed R-A@5 -0.000963522994425148 1488.76501464844 497.2623 1488.76611328125 497.262634277344 3 8 1.1.1.3354.8 1 30.0875 2576.034 30.079 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.00137028994504362 1461.8427734375 488.2882 1461.84423828125 488.288696289063 3 18 1.1.1.3936.4 1 44.7923 203256.6 45.0387 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.00100408995058388 1461.84338378906 488.2884 1461.84423828125 488.288696289063 3 20 1.1.1.3943.5 1 44.9696 236147.1 45.1656 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.00100408995058388 1461.84338378906 488.2884 1461.84423828125 488.288696289063 3 21 1.1.1.3950.4 1 45.1462 239469.2 45.1656 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.000729437975678593 1461.84375 488.2885 1461.84423828125 488.288696289063 3 21 1.1.1.3957.3 1 45.3244 269417.5 45.2934 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.000729437975678593 1461.84375 488.2885 1461.84423828125 488.288696289063 3 21 1.1.1.3964.5 1 45.5054 269417.5 45.2934 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.00100408995058388 1461.84338378906 488.2884 1461.84423828125 488.288696289063 3 21 1.1.1.3971.6 1 45.6843 197093.2 45.4219 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK Delta:H(2)C(2)(K)@2 missed K-D@2 0.00249381992034614 1487.8623046875 496.9614 1487.85998535156 496.960601806641 3 12 1.1.1.4121.4 1 49.5322 2314.91 49.5516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK Formyl@N-term missed K-D@2 -0.00311864004470408 1489.83605957031 745.9253 1489.83923339844 745.926879882813 2 14 1.1.1.4210.17 1 51.8145 2648.073 51.8489 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-D@2 -0.00394160998985171 1547.87731933594 774.9459 1547.88110351563 774.947814941406 2 11 1.1.1.4535.16 0 60.2066 2629.179 60.0348 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.00494077010080218 1461.83911132813 488.287 1461.84423828125 488.288696289063 3 16 1.1.1.3985.2 1 46.0399 32745.17 45.958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.00494077010080218 1461.83911132813 488.287 1461.84423828125 488.288696289063 3 15 1.1.1.3999.3 1 46.4075 9565.375 46.3493 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.00403119996190071 1461.84814453125 488.29 1461.84423828125 488.288696289063 3 15 1.1.1.4007.5 1 46.618 3355.199 46.6879 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.01083580031991 1461.85510253906 488.2923 1461.84423828125 488.288696289063 3 8 1.1.1.4097.3 1 48.9184 738.8519 48.8877 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.00164495001081377 1461.84240722656 488.2881 1461.84423828125 488.288696289063 3 15 1.1.1.3992.3 1 46.2243 32639.02 45.958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.00494077010080218 1461.83911132813 488.287 1461.84423828125 488.288696289063 3 15 1.1.1.3978.2 1 45.8598 32745.17 45.958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-D@2 -0.00394160998985171 1547.87731933594 774.9459 1547.88110351563 774.947814941406 2 12 1.1.1.4527.14 0 59.9974 2629.179 60.0348 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK Carbamidomethyl@N-term missed K-D@2 -0.00391189008951187 1518.86193847656 507.2946 1518.86572265625 507.295867919922 3 11 1.1.1.3938.5 1 44.8436 2927.498 44.9125 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2 -0.003739990061149 1502.8671875 501.963 1502.87084960938 501.964233398438 3 14 1.1.1.4005.7 1 46.5672 24417.51 46.297 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK Acetyl@N-term missed K-D@2 0.000182938994839787 1503.85510253906 752.9348 1503.85485839844 752.934692382813 2 12 1.1.1.4230.17 1 52.3228 4250.013 52.3569 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK Nitro(Y)@8 missed K-D@2 0.00230798008851707 1506.83166503906 503.2845 1506.82934570313 503.283721923828 3 10 1.1.1.4202.3 1 51.5988 1188.106 51.5936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK Oxidation(Y)@8 missed K-D@2 -0.00721460022032261 1477.83215332031 493.618 1477.83923339844 493.620330810547 3 12 1.1.1.3951.6 1 45.1732 2487.758 45.2934 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.00330676999874413 1461.8408203125 731.9277 1461.84423828125 731.929443359375 2 12 1.1.1.3947.13 1 45.0775 60183.18 45.0894 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 -0.00306264008395374 1461.84130859375 731.9279 1461.84423828125 731.929443359375 2 12 1.1.1.3955.14 1 45.2824 69949.63 45.319 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK Carbamidomethyl@N-term missed K-D@2 -0.00839786976575851 1518.857421875 507.2931 1518.86572265625 507.295867919922 3 9 1.1.1.3952.9 1 45.2011 1671.847 45.1401 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 VKDLATVYVDVLK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2 -0.003739990061149 1502.8671875 501.963 1502.87084960938 501.964233398438 3 14 1.1.1.3997.3 1 46.3553 27063.1 46.2707 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 VKDLATVYVDVLK Carbamidomethyl@N-term; reduced acrolein addition +58(K)@2 missed K-D@2 -0.00122976000420749 1576.90661621094 526.6428 1576.90759277344 526.643127441406 3 9 1.1.1.4007.7 1 46.6197 2216.519 46.6101 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6200003623962 VKDLATVYVDVLK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2 -0.00302811991423368 1502.86791992188 752.4412 1502.87084960938 752.442687988281 2 13 1.1.1.3990.19 1 46.1853 6431.939 46.297 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.8400008678436 VKDLATVYVDVLK missed K-D@2 -0.00489364983513951 1461.83923339844 731.9269 1461.84423828125 731.929443359375 2 10 1.1.1.3982.18 1 45.9756 8028.316 45.958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 -0.00207949988543987 1877.02380371094 626.6819 1877.02587890625 626.682556152344 3 23 1.1.1.4007.12 1 46.6239 43469.34 46.5581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 0.0104606002569199 1877.03649902344 470.2664 1877.02587890625 470.263732910156 4 17 1.1.1.4007.4 1 46.6172 60074.81 46.584 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 -0.00039371001184918 1877.02551269531 939.52 1877.02587890625 939.520202636719 2 14 1.1.1.4009.21 1 46.6827 4027.464 46.584 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 -0.00199026009067893 1877.02380371094 470.2632 1877.02587890625 470.263732910156 4 12 1.1.1.3998.3 1 46.3811 56774.93 46.5581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 -0.00039371001184918 1877.02551269531 939.52 1877.02587890625 939.520202636719 2 13 1.1.1.4008.21 1 46.6569 4027.464 46.584 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7999975681305 VKDLATVYVDVLKDSGR Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2; missed K-D@13 -0.0018756800564006 1918.05041503906 640.3574 1918.05236816406 640.358093261719 3 15 1.1.1.4019.8 1 46.9319 3389.119 46.974 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0199971199036 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 0.0143667999655008 1877.04016113281 470.2673 1877.02587890625 470.263732910156 4 8 1.1.1.3859.2 1 42.8299 767.2913 42.8259 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2399988174438 VKDLATVYVDVLKDSGR Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2; missed K-D@13 0.0018493999959901 1918.05419921875 480.5208 1918.05236816406 480.520385742188 4 13 1.1.1.4023.8 1 47.0342 3950.24 46.974 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)(K)@2 missed K-D@2; missed K-D@13; missed R-D@17 0.00355743989348412 3284.69653320313 822.1814 3284.69287109375 822.180480957031 4 16 1.1.1.4480.20 1 58.7594 4996.21 58.8185 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Formyl(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 0.00225891009904444 3286.67456054688 822.6759 3286.67211914063 822.67529296875 4 21 1.1.1.4545.16 1 60.475 3964.178 60.5108 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Acetyl(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 -0.0099193099886179 3300.67822265625 826.1768 3300.68774414063 826.17919921875 4 23 1.1.1.4553.13 1 60.682 25482.39 60.6418 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Acetyl(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 -0.0099193099886179 3300.67822265625 826.1768 3300.68774414063 826.17919921875 4 24 1.1.1.4554.9 1 60.7047 25482.39 60.6418 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@13; Dimethyl(R)@17 missed K-D@2; missed K-D@13; missed R-D@17 -0.0336060002446175 3344.71704101563 837.1865 3344.75048828125 837.194885253906 4 18 1.1.1.4823.12 1 67.6267 10010.98 67.5063 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@13; Dioxidation(Y)@19 missed K-D@2; missed K-D@13; missed R-D@17 0.0396533012390137 3344.71728515625 837.1866 3344.677734375 837.176696777344 4 14 1.1.1.4830.11 1 67.8129 8839.678 67.5333 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.0125887002795935 3258.68969726563 815.6797 3258.67724609375 815.676574707031 4 21 1.1.1.4177.20 1 50.9732 2984.611 50.9282 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.00697360001504421 3258.68408203125 815.6783 3258.67724609375 815.676574707031 4 18 1.1.1.4234.17 1 52.4251 2480.209 52.4336 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 -0.012079400010407 3316.70703125 664.3487 3316.71899414063 664.35107421875 5 15 1.1.1.4324.8 1 54.7141 3993.825 54.7559 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.003552749985829 3258.68017578125 1087.234 3258.67724609375 1087.23303222656 3 12 1.1.1.4325.17 1 54.7473 40743.24 54.9352 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.0118562998250127 3258.689453125 815.6796 3258.67724609375 815.676574707031 4 22 1.1.1.4326.17 1 54.7731 142884.5 54.9352 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.0118562998250127 3258.689453125 815.6796 3258.67724609375 815.676574707031 4 24 1.1.1.4333.16 1 54.9515 142884.5 54.9352 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.0113679999485612 3258.6884765625 815.6794 3258.67724609375 815.676574707031 4 21 1.1.1.4340.16 1 55.1297 143208.3 55.1647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.00743641005828977 3258.6845703125 652.7442 3258.67724609375 652.742736816406 5 13 1.1.1.4343.12 1 55.2033 117239 55.1904 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.0113679999485612 3258.6884765625 815.6794 3258.67724609375 815.676574707031 4 24 1.1.1.4347.17 1 55.3099 143208.3 55.1647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.00804674997925758 3258.68530273438 652.7443 3258.67724609375 652.742736816406 5 22 1.1.1.4354.11 1 55.4842 101684.5 55.216 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.0113679999485612 3258.6884765625 815.6794 3258.67724609375 815.676574707031 4 22 1.1.1.4354.18 1 55.4901 119763.3 55.216 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.00941197015345097 3258.68603515625 1087.236 3258.67724609375 1087.23303222656 3 12 1.1.1.4355.21 1 55.5182 27045.08 55.2415 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.0001123589972849 3258.67700195313 652.7427 3258.67724609375 652.742736816406 5 17 1.1.1.4362.9 1 55.6878 44728.36 55.4462 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.0125887002795935 3258.68969726563 815.6797 3258.67724609375 815.676574707031 4 14 1.1.1.4372.15 1 55.9495 16014.96 55.6774 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.017959700897336 3258.6953125 815.6811 3258.67724609375 815.676574707031 4 12 1.1.1.4379.13 1 56.128 9172.784 55.8565 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 -0.00181524001527578 3258.67529296875 815.6761 3258.67724609375 815.676574707031 4 13 1.1.1.4386.13 1 56.3084 4599.822 56.1913 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.0343166999518871 3258.71166992188 815.6852 3258.67724609375 815.676574707031 4 15 1.1.1.4404.14 1 56.7747 1549.192 56.7858 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)(K)@2 missed K-D@2; missed K-D@13; missed R-D@17 0.00258090998977423 3284.69580078125 822.1812 3284.69287109375 822.180480957031 4 14 1.1.1.4518.17 1 59.7624 4160.066 59.7974 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Acetyl(S)@15 missed K-D@2; missed K-D@13; missed R-D@17 -0.00465071015059948 3300.68310546875 1101.235 3300.68774414063 1101.23657226563 3 14 1.1.1.4549.18 1 60.5822 9822.679 60.6681 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Formyl(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 0.00225891009904444 3286.67456054688 822.6759 3286.67211914063 822.67529296875 4 14 1.1.1.4550.14 1 60.6047 3964.178 60.5108 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Trimethyl(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 -0.0463047996163368 3300.67822265625 826.1768 3300.72412109375 826.188293457031 4 15 1.1.1.4556.12 1 60.7588 25482.39 60.6418 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2; missed K-D@13; missed R-D@17 0.029220599681139 3299.7333984375 825.9406 3299.70385742188 825.933227539063 4 16 1.1.1.4358.19 1 55.5936 14425.48 55.703 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Trimethyl(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 -0.0463047996163368 3300.67822265625 826.1768 3300.72412109375 826.188293457031 4 13 1.1.1.4546.13 1 60.499 25482.39 60.6418 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@13; Dehydrated(S)@21; Deamidated(Q)@22 missed K-D@2; missed K-D@13; missed R-D@17 0.0184009000658989 3299.71118164063 660.9495 3299.69262695313 660.94580078125 5 14 1.1.1.4364.13 1 55.7422 13454.85 55.6774 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-D@2; missed K-D@13; missed R-D@17 0.00400019017979503 3344.71826171875 837.1868 3344.71411132813 837.185791015625 4 12 1.1.1.4691.10 1 64.1737 3291.469 64.1379 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK MolybdopterinGD(D)@10 missed K-D@2; missed K-D@13; missed R-D@17 -0.0736187994480133 4831.5888671875 967.3251 4831.6630859375 967.339904785156 5 15 1.1.1.4340.17 1 55.1306 5286.778 55.1137 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@13; Deamidated(R)@17 missed K-D@2; missed K-D@13; missed R-D@17 0.0228544007986784 3317.72607421875 830.4388 3317.703125 830.433044433594 4 12 1.1.1.4333.17 1 54.9523 4803.117 54.7816 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5400021076202 VKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@13; Dimethyl(R)@17 missed K-D@2; missed K-D@13; missed R-D@17 -0.0300555992871523 3344.720703125 669.9514 3344.75048828125 669.957336425781 5 9 1.1.1.4821.4 1 67.5675 997.536 67.4791 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.7999985218048 VKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@13; Dioxidation(R)@17 missed K-D@2; missed K-D@13; missed R-D@17 0.0389209017157555 3344.71655273438 837.1864 3344.677734375 837.176696777344 4 10 1.1.1.4810.9 1 67.2776 10018.88 67.5063 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.079998254776 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Acetyl@N-term missed K-D@2; missed K-D@13; missed R-D@17 0.00375214009545743 3300.69165039063 826.1802 3300.68774414063 826.17919921875 4 10 1.1.1.4531.21 1 60.1064 4882.177 60.0348 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.6599998474121 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; acrolein addition +76(K)@2; Iodo(Y)@8; acrolein addition +112(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 0.0184685997664928 3629.6962890625 1210.906 3629.67895507813 1210.90026855469 3 12 1.1.1.3771.9 1 40.5849 7647.526 40.5653 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.4699981212616 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(4)C(2)@N-term; reduced acrolein addition +58(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 -0.0336060002446175 3344.71704101563 837.1865 3344.75048828125 837.194885253906 4 8 1.1.1.4837.6 1 67.9935 802.7046 67.8788 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 VKDLATVYVDVLKDSGRDYVSQFEGSALGK MolybdopterinGD(D)@14 missed K-D@2; missed K-D@13; missed R-D@17 -0.0577500984072685 4831.60498046875 967.3283 4831.6630859375 967.339904785156 5 13 1.1.1.4331.19 1 54.9026 8401.585 54.9096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2; missed K-D@13; missed R-D@17 0.00808302965015173 3299.71142578125 660.9496 3299.70385742188 660.948059082031 5 13 1.1.1.4357.12 1 55.562 10013.04 55.5235 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.8400015830994 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)(K)@2 missed K-D@2; missed K-D@13; missed R-D@17 0.00355743989348412 3284.69653320313 822.1814 3284.69287109375 822.180480957031 4 8 1.1.1.4487.16 1 58.9408 4996.21 58.8185 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.0176238995045424 3855.05981445313 964.7722 3855.04174804688 964.767761230469 4 14 1.1.1.4458.20 1 58.1821 7656.334 58.2405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.0211980007588863 3855.06323242188 643.5178 3855.04174804688 643.514221191406 6 18 1.1.1.4462.9 1 58.2771 9341.234 58.2405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.00420816009864211 3855.0458984375 772.0165 3855.04174804688 772.015625 5 19 1.1.1.4465.15 1 58.3608 23378.84 58.2405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Acetyl(K)@30 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 -0.00748600997030735 3897.044921875 975.2685 3897.05249023438 975.270385742188 4 13 1.1.1.4499.20 1 59.2604 3441.956 59.3453 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Ammonia-loss(N)@33; reduced acrolein addition +58(K)@35 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.0157795995473862 3896.0732421875 780.2219 3896.05712890625 780.218688964844 5 12 1.1.1.4466.17 1 58.3885 9312.154 58.4234 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@30; Ammonia-loss(N)@33 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.0250909999012947 3896.08227539063 650.3543 3896.05712890625 650.350158691406 6 12 1.1.1.4467.9 1 58.4082 4394.621 58.4496 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3299970626831 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Acetyl(K)@30 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 -0.00748600997030735 3897.044921875 975.2685 3897.05249023438 975.270385742188 4 10 1.1.1.4506.21 1 59.4454 3441.956 59.3453 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 22.409999370575 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Deamidated(Q)@22 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.0293781999498606 3856.05517578125 772.2183 3856.02587890625 772.212463378906 5 11 1.1.1.4459.15 1 58.2038 13390.91 58.2405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 22.409999370575 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Deamidated(Q)@31 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.0293781999498606 3856.05517578125 772.2183 3856.02587890625 772.212463378906 5 11 1.1.1.4466.16 1 58.3877 13390.91 58.2405 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.6899976730347 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNW acrolein addition +56(K)@13; HPNE addition +172(K)@30; MDA adduct +62(K)@35; Deamidated(N)@39 cleaved W-D@C-term; missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.097136102616787 4787.59228515625 958.5257 4787.4951171875 958.506286621094 5 11 1.1.1.4346.19 1 55.2857 11141.72 55.1647 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@40 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.0188500992953777 5480.81787109375 914.4769 5480.79931640625 914.473815917969 6 13 1.1.1.4706.14 1 64.5576 2526.401 64.5687 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@40 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.0188500992953777 5480.81787109375 914.4769 5480.79931640625 914.473815917969 6 11 1.1.1.4713.10 1 64.7378 2526.401 64.5687 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@40 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.0540856011211872 5452.8583984375 909.817 5452.80419921875 909.807983398438 6 11 1.1.1.4741.9 1 65.4693 1442.826 65.406 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.5399992465973 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK acrolein addition +94(K)@2 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.00657426984980702 5542.8583984375 1109.579 5542.85107421875 1109.57751464844 5 11 1.1.1.4582.18 0 61.4371 7516.751 61.4193 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQK -0.00363649008795619 1251.61010742188 626.8123 1251.61352539063 626.814025878906 2 15 1.1.1.3609.17 1 36.454 380088.7 36.5625 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQK -0.00363649008795619 1251.61010742188 626.8123 1251.61352539063 626.814025878906 2 16 1.1.1.3616.3 1 36.631 380088.7 36.5625 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQK -0.00363649008795619 1251.61010742188 626.8123 1251.61352539063 626.814025878906 2 17 1.1.1.3623.6 1 36.7997 386317.9 36.5379 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQK -0.00400268984958529 1251.60961914063 626.8121 1251.61352539063 626.814025878906 2 14 1.1.1.3630.14 1 36.9714 283124.3 36.71 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1500015258789 VQPYLDDFQK Delta:H(2)C(2)@N-term -0.00403930991888046 1277.62524414063 639.8199 1277.62915039063 639.821899414063 2 7 1.1.1.3853.9 1 42.6842 3081.092 42.7754 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.529999256134 VQPYLDDFQK Oxidation(Y)@4 -0.00236809998750687 1267.60607910156 634.8103 1267.60852050781 634.8115234375 2 10 1.1.1.3614.5 1 36.5752 3172.186 36.6117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.7800016403198 VQPYLDDFQK -0.00560466991737485 1251.60803222656 626.8113 1251.61352539063 626.814025878906 2 10 1.1.1.3679.11 1 38.2028 6791.814 38.3153 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 VQPYLDDFQK Delta:H(2)C(2)@N-term -0.0069689298979938 1277.62231445313 639.8184 1277.62915039063 639.821899414063 2 8 1.1.1.3783.8 1 40.8767 3741.427 41.0122 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 53.1499981880188 VQPYLDDFQK -0.00536054000258446 1251.60827636719 626.8114 1251.61352539063 626.814025878906 2 8 1.1.1.3649.16 1 37.4609 55288.88 37.314 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 53.1499981880188 VQPYLDDFQK -0.00560466991737485 1251.60803222656 626.8113 1251.61352539063 626.814025878906 2 10 1.1.1.3658.9 1 37.6884 31385.53 37.4182 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.7899980545044 VQPYLDDFQK -0.00424683000892401 1251.60949707031 626.812 1251.61352539063 626.814025878906 2 11 1.1.1.3644.18 1 37.3323 55288.88 37.314 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 37.3600006103516 VQPYLDDFQK Deamidated(Q)@2 0.0171923004090786 1252.61462402344 627.3146 1252.59753417969 627.306030273438 2 7 1.1.1.3671.9 1 38.0104 4726.016 37.9909 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.7500007152557 VQPYLDDFQK Dioxidation(P)@3 -0.00305456994101405 1283.60021972656 642.8074 1283.60339355469 642.808959960938 2 8 1.1.1.3617.8 1 36.6507 1575.611 36.6364 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.9999996423721 VQPYLDDFQK -0.00560466991737485 1251.60803222656 626.8113 1251.61352539063 626.814025878906 2 8 1.1.1.3672.13 1 38.0285 6622.135 37.768 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.7599997520447 VQPYLDDFQKK Delta:H(2)C(2)@N-term missed K-K@10 -0.00400546006858349 1405.72021484375 469.5807 1405.72412109375 469.582000732422 3 8 1.1.1.3661.3 1 37.7494 2896.31 37.6936 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 47.4999994039536 VQPYLDDFQKK missed K-K@10 0.0017901899991557 1379.71032714844 460.9107 1379.70849609375 460.910125732422 3 11 1.1.1.3454.5 1 32.5732 121799.2 32.3133 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 47.4999994039536 VQPYLDDFQKK missed K-K@10 0.0012408799957484 1379.70959472656 460.9105 1379.70849609375 460.910125732422 3 11 1.1.1.3461.4 1 32.7437 73963.7 32.4877 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 47.4999994039536 VQPYLDDFQKK missed K-K@10 -0.00297045009210706 1379.70544433594 460.9091 1379.70849609375 460.910125732422 3 11 1.1.1.3468.2 1 32.9116 23188.87 33.0287 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.0000001192093 VQPYLDDFQKK missed K-K@10 -0.00297045009210706 1379.70544433594 460.9091 1379.70849609375 460.910125732422 3 10 1.1.1.3475.5 1 33.084 23188.87 33.0287 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.0699987411499 VQPYLDDFQKK missed K-K@10 -0.00269580003805459 1379.70581054688 460.9092 1379.70849609375 460.910125732422 3 9 1.1.1.3484.3 1 33.3042 6280.355 33.3492 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.0699996948242 VQPYLDDFQKK missed K-K@10 0.00151553994510323 1379.7099609375 460.9106 1379.70849609375 460.910125732422 3 10 1.1.1.3447.6 1 32.3952 351614.6 32.1394 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.759999871254 VQPYLDDFQKK missed K-K@10 0.00600151997059584 1379.71447753906 460.9121 1379.70849609375 460.910125732422 3 7 1.1.1.3555.2 1 35.0521 1662.492 34.9996 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.2299998402596 VQPYLDDFQKK missed K-K@10 0.000600030005443841 1379.70910644531 460.9103 1379.70849609375 460.910125732422 3 7 1.1.1.3304.8 1 28.8573 1403.7 28.823 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.3500002622604 VQPYLDDFQKK missed K-K@10 -0.00269580003805459 1379.70581054688 460.9092 1379.70849609375 460.910125732422 3 7 1.1.1.3492.3 1 33.5021 6280.355 33.3492 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 18.299999833107 VQPYLDDFQKK missed K-K@10 0.00966355018317699 1379.71801757813 460.9133 1379.70849609375 460.910125732422 3 8 1.1.1.3512.4 1 33.9986 1415.268 34.0172 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00448129000142217 2676.2578125 670.0717 2676.2529296875 670.070556640625 4 16 1.1.1.3831.14 1 42.1072 62950.51 42.0917 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.0133777996525168 2680.26123046875 671.0726 2680.24780273438 671.069274902344 4 17 1.1.1.3992.17 1 46.236 31829.88 46.3234 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0104347998276353 2660.2685546875 666.0744 2660.25805664063 666.07177734375 4 12 1.1.1.4065.17 1 48.1152 499040.8 48.0984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0104347998276353 2660.2685546875 666.0744 2660.25805664063 666.07177734375 4 11 1.1.1.4067.14 1 48.1637 499040.8 48.0984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0104347998276353 2660.2685546875 666.0744 2660.25805664063 666.07177734375 4 13 1.1.1.4072.15 1 48.2917 499040.8 48.0984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0109230997040868 2660.26904296875 666.0745 2660.25805664063 666.07177734375 4 12 1.1.1.4079.14 1 48.4689 497691.6 48.4544 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0178705006837845 2660.275390625 533.0624 2660.25805664063 533.058898925781 5 12 1.1.1.4082.3 1 48.5359 3914.155 48.4035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0109230997040868 2660.26904296875 666.0745 2660.25805664063 666.07177734375 4 14 1.1.1.4086.10 1 48.6434 501879.8 48.5053 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.007137690205127 2660.26513671875 887.7623 2660.25805664063 887.759948730469 3 17 1.1.1.4087.20 1 48.6772 139053.5 48.5053 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0109230997040868 2660.26904296875 666.0745 2660.25805664063 666.07177734375 4 13 1.1.1.4093.12 1 48.8237 476652.2 48.5815 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR MDA adduct +62(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.00469696987420321 2722.26904296875 681.5745 2722.27368164063 681.57568359375 4 11 1.1.1.4099.18 1 48.9818 7251.218 49.117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0104347998276353 2660.2685546875 666.0744 2660.25805664063 666.07177734375 4 11 1.1.1.4100.13 1 49.0032 349401.6 48.7342 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0021342399995774 2660.26025390625 666.0723 2660.25805664063 666.07177734375 4 12 1.1.1.4107.14 1 49.1821 17816.81 49.1425 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00774934003129601 2660.26586914063 666.0737 2660.25805664063 666.07177734375 4 12 1.1.1.4114.12 1 49.3594 16695.05 49.3213 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00774934003129601 2660.26586914063 666.0737 2660.25805664063 666.07177734375 4 12 1.1.1.4121.13 1 49.5397 16695.05 49.3213 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0101907001808286 2660.26806640625 666.0743 2660.25805664063 666.07177734375 4 12 1.1.1.4128.13 1 49.7193 11678.04 49.449 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.00123529997654259 2676.25463867188 670.0709 2676.2529296875 670.070556640625 4 14 1.1.1.4116.18 1 49.4155 22000.81 49.449 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR MDA adduct +62(K)@11; Dioxidation(M)@16 missed K-K@10; missed K-W@11 1.64211996889208E-05 2738.26904296875 685.5745 2738.2685546875 685.574462890625 4 13 1.1.1.4142.13 1 50.0758 3601.122 50.164 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR MDA adduct +62(K)@11; FormaldehydeAdduct(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.0112308003008366 2734.26245117188 912.4281 2734.27368164063 912.431884765625 3 14 1.1.1.4142.16 1 50.0783 12403.53 50.0113 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.00339303002692759 2708.24609375 678.0688 2708.24291992188 678.067993164063 4 16 1.1.1.3979.13 1 45.8946 229074.6 45.8041 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@2; Deamidated(Q)@9; reduced acrolein addition +58(K)@10; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.018681300804019 2720.28662109375 681.0789 2720.26806640625 681.074279785156 4 13 1.1.1.4072.16 1 48.2925 3895.153 48.2765 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00196770997717977 2676.2548828125 670.071 2676.2529296875 670.070556640625 4 13 1.1.1.4079.15 1 48.4697 13054.1 48.4035 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Carbamidomethyl(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.00229217996820807 2717.27734375 680.3266 2717.27954101563 680.3271484375 4 15 1.1.1.4059.10 1 47.957 6324.539 48.0223 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR acrolein addition +56(K)@11; Deamidated(Q)@13; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0130457002669573 2717.28125 680.3276 2717.26831054688 680.324340820313 4 12 1.1.1.4068.15 1 48.19 7225.646 48.2002 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.00436956994235516 2708.24731445313 678.0691 2708.24291992188 678.067993164063 4 15 1.1.1.3965.15 1 45.5393 199225.1 45.7787 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; acrolein addition +56(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0157769992947578 2717.2841796875 680.3283 2717.26831054688 680.324340820313 4 14 1.1.1.4048.13 1 47.6789 21350.07 47.7417 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.00113381003029644 2676.25219726563 670.0703 2676.2529296875 670.070556640625 4 14 1.1.1.3982.14 1 45.9722 31252.23 45.9833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00650091981515288 2692.25463867188 674.0709 2692.24780273438 674.069274902344 4 14 1.1.1.3998.12 1 46.3886 6399.579 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00374889001250267 2676.2568359375 670.0715 2676.2529296875 670.070556640625 4 14 1.1.1.4002.17 1 46.4973 55968.72 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7999975681305 VQPYLDDFQKKWQEEMELYR Trp->Hydroxykynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.003856569994241 2680.25170898438 671.0702 2680.24780273438 671.069274902344 4 14 1.1.1.3941.10 1 44.9233 172241.3 45.0894 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6999988555908 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.00339303002692759 2708.24609375 678.0688 2708.24291992188 678.067993164063 4 14 1.1.1.3972.13 1 45.7158 229074.6 45.8041 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 VQPYLDDFQKKWQEEMELYR MDA adduct +62(K)@10; Oxidation(W)@12; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.0243101995438337 2674.24609375 669.5688 2674.27026367188 669.574890136719 4 14 1.1.1.3933.13 1 44.7241 8053.301 44.4582 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 VQPYLDDFQKKWQEEMELYR FormaldehydeAdduct(W)@12; Deamidated(Q)@13; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0174045991152525 2673.25927734375 669.3221 2673.2421875 669.317810058594 4 14 1.1.1.3950.16 1 45.1562 39958.94 45.0894 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00208054995164275 2664.2548828125 667.071 2664.2529296875 667.070556640625 4 13 1.1.1.3967.13 1 45.5884 149762.6 45.575 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00208054995164275 2664.2548828125 667.071 2664.2529296875 667.070556640625 4 13 1.1.1.3974.15 1 45.7684 149762.6 45.575 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3399987220764 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00552438013255596 2692.25341796875 674.0706 2692.24780273438 674.069274902344 4 13 1.1.1.3931.14 1 44.6745 592316.3 44.6601 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3399987220764 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0067450599744916 2692.25463867188 674.0709 2692.24780273438 674.069274902344 4 13 1.1.1.3952.13 1 45.2044 249572.1 44.9377 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3399987220764 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.00113381003029644 2676.25219726563 670.0703 2676.2529296875 670.070556640625 4 13 1.1.1.3975.13 1 45.7922 30870.54 45.9833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3399987220764 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00390033004805446 2676.2568359375 893.0929 2676.2529296875 893.091613769531 3 13 1.1.1.3995.21 1 46.3181 19311.12 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2100009918213 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00448129000142217 2676.2578125 670.0717 2676.2529296875 670.070556640625 4 13 1.1.1.3759.19 1 40.2786 43856.62 39.998 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0300009250641 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00734368013218045 2660.26538085938 666.0736 2660.25805664063 666.07177734375 4 13 1.1.1.4058.10 1 47.9315 499040.8 48.0984 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; acrolein addition +56(K)@11; Oxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.0127320997416973 2749.27099609375 688.325 2749.25805664063 688.321838378906 4 14 1.1.1.3956.13 1 45.3071 4052.201 45.319 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7299997806549 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.00827572029083967 2708.25146484375 678.0701 2708.24291992188 678.067993164063 4 13 1.1.1.3986.10 1 46.0727 232374.6 45.8041 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0052136997692287 2676.25805664063 670.0718 2676.2529296875 670.070556640625 4 12 1.1.1.3745.16 1 39.9129 115035.4 39.897 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00448129000142217 2676.2578125 670.0717 2676.2529296875 670.070556640625 4 12 1.1.1.3824.17 1 41.9241 62950.51 42.0917 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00448129000142217 2676.2578125 670.0717 2676.2529296875 670.070556640625 4 12 1.1.1.3838.13 1 42.2922 62950.51 42.0917 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00650091981515288 2692.25463867188 674.0709 2692.24780273438 674.069274902344 4 12 1.1.1.3917.12 1 44.3189 500976.1 44.5592 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00552438013255596 2692.25341796875 674.0706 2692.24780273438 674.069274902344 4 12 1.1.1.3924.11 1 44.4953 592316.3 44.6601 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00208054995164275 2664.2548828125 667.071 2664.2529296875 667.070556640625 4 12 1.1.1.3960.13 1 45.4099 149762.6 45.575 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00390033004805446 2676.2568359375 893.0929 2676.2529296875 893.091613769531 3 12 1.1.1.3987.21 1 46.1081 15946.53 46.1397 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00374889001250267 2676.2568359375 670.0715 2676.2529296875 670.070556640625 4 12 1.1.1.4012.14 1 46.7551 15571.35 46.4797 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7199990749359 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; reduced acrolein addition +58(K)@10; acrolein addition +56(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.010844400152564 2775.32104492188 694.8375 2775.31030273438 694.834838867188 4 10 1.1.1.4115.17 1 49.389 4102.052 49.5004 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.7099993228912 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@2; MDA adduct +62(K)@11; Trp->Kynurenin(W)@12; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.00536262989044189 2663.259765625 666.8222 2663.25439453125 666.820861816406 4 13 1.1.1.3953.14 1 45.2311 4651.909 45.319 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.739999294281 VQPYLDDFQKKWQEEMELYR Trp->Hydroxykynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.003856569994241 2680.25170898438 671.0702 2680.24780273438 671.069274902344 4 12 1.1.1.3949.15 1 45.1299 172241.3 45.0894 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.1999990940094 VQPYLDDFQKKWQEEMELYR MDA adduct +62(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.0270629990845919 2658.24853515625 665.5694 2658.275390625 665.576110839844 4 10 1.1.1.3756.16 1 40.1972 1620.394 40.1803 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.619998216629 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00647498015314341 2664.25927734375 667.0721 2664.2529296875 667.070556640625 4 11 1.1.1.3981.13 1 45.946 91627.63 45.6765 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.619998216629 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@2; Cation:K(D)@7; hexanoyl addition +98(K)@10; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.00233494001440704 2733.2705078125 684.3249 2733.27294921875 684.325500488281 4 13 1.1.1.3982.15 1 45.9731 4335.984 45.9066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.8500015735626 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.126093998551369 2661.3681640625 666.3493 2661.2421875 666.317810058594 4 10 1.1.1.3605.17 1 36.3501 34727.28 36.1796 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.3199970722198 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0067450599744916 2692.25463867188 674.0709 2692.24780273438 674.069274902344 4 11 1.1.1.3945.11 1 45.0251 544607.6 44.7612 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 VQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@10; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.0616643987596035 2708.25048828125 678.0699 2708.31225585938 678.085327148438 4 10 1.1.1.4074.17 1 48.3441 8551.696 48.3781 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.6099984645844 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.00155553000513464 2692.24609375 674.0688 2692.24780273438 674.069274902344 4 11 1.1.1.3959.9 1 45.3809 38771.85 45.1147 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.8400018215179 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0052136997692287 2676.25805664063 670.0718 2676.2529296875 670.070556640625 4 11 1.1.1.3752.18 1 40.0931 115035.4 39.897 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.8400018215179 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00552438013255596 2692.25341796875 674.0706 2692.24780273438 674.069274902344 4 11 1.1.1.3938.12 1 44.852 592316.3 44.6601 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1500015258789 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.00305750011466444 2676.25 893.0906 2676.2529296875 893.091613769531 3 11 1.1.1.3828.20 1 42.0325 13982.78 42.1183 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2100005149841 VQPYLDDFQKKWQEEMELYR acrolein addition +56(K)@11; Deamidated(Q)@13; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0165094006806612 2717.28491210938 680.3285 2717.26831054688 680.324340820313 4 10 1.1.1.3995.10 1 46.3089 2488.431 46.4013 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2599976062775 VQPYLDDFQKKWQEEMELYR Cation:K(D)@7; reduced acrolein addition +58(K)@10; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.0080137699842453 2692.24926757813 674.0696 2692.25756835938 674.071655273438 4 12 1.1.1.4058.12 1 47.9332 6335.585 47.9459 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.3899972438812 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +58(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.0234494991600513 2718.27661132813 680.5764 2718.30004882813 680.582275390625 4 11 1.1.1.4006.16 1 46.6006 2047.832 46.5581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.8700022697449 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.0102866003289819 2680.25830078125 894.4267 2680.24780273438 894.423278808594 3 11 1.1.1.3993.21 1 46.2655 8969.239 46.3234 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 VQPYLDDFQKKWQEEMELYR Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.00123529997654259 2676.25463867188 670.0709 2676.2529296875 670.070556640625 4 10 1.1.1.4109.14 1 49.2333 22170.97 49.4747 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.2699990272522 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; acrolein addition +56(K)@11; Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0121798003092408 2733.275390625 684.3261 2733.26318359375 684.323059082031 4 11 1.1.1.3918.15 1 44.3469 21059.21 44.3064 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.3800003528595 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; acrolein addition +56(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0130457002669573 2717.28125 680.3276 2717.26831054688 680.324340820313 4 10 1.1.1.4076.11 1 48.39 7225.646 48.2002 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6399977207184 VQPYLDDFQKKWQEEMELYR Formyl(K)@10; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0180500000715256 2688.27124023438 897.0977 2688.2529296875 897.091613769531 3 10 1.1.1.4154.20 1 50.3875 1399.772 50.4953 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6399977207184 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@2; reduced acrolein addition +96(K)@10; acrolein addition +112(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.0229396000504494 2805.3310546875 702.34 2805.35375976563 702.345703125 4 11 1.1.1.4184.10 1 51.1455 18276.44 51.005 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1000003814697 VQPYLDDFQKKWQEEMELYR Oxidation(P)@3; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00147944001946598 2676.25463867188 670.0709 2676.2529296875 670.070556640625 4 10 1.1.1.4068.14 1 48.1892 11375.52 48.2002 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1000003814697 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@2; acrolein addition +38(K)@10; acrolein addition +76(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0412508994340897 2775.330078125 694.8398 2775.2890625 694.829528808594 4 8 1.1.1.4101.15 1 49.0305 4388.75 49.117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1000003814697 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12 missed K-K@10; missed K-W@11 0.00758280977606773 2676.26049804688 670.0724 2676.2529296875 670.070556640625 4 9 1.1.1.4102.15 1 49.0557 3459.892 49.0914 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1000003814697 VQPYLDDFQKKWQEEMELYR Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.00123529997654259 2676.25463867188 670.0709 2676.2529296875 670.070556640625 4 9 1.1.1.4124.14 1 49.6177 22000.81 49.449 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1000003814697 VQPYLDDFQKKWQEEMELYR acrolein addition +38(K)@11; Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00522108981385827 2702.27416992188 901.7653 2702.2685546875 901.763488769531 3 10 1.1.1.4287.19 1 53.7783 6589.39 53.8617 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.2899980545044 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00196770997717977 2676.2548828125 670.071 2676.2529296875 670.070556640625 4 10 1.1.1.4082.15 1 48.5459 12303.14 48.5307 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.4400000572205 VQPYLDDFQKKWQEEMELYR MDA adduct +62(K)@11; Deamidated(Q)@13; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.0123229995369911 2659.24731445313 665.8191 2659.25952148438 665.822143554688 4 9 1.1.1.3754.15 1 40.1438 1546.088 40.2066 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.4400000572205 VQPYLDDFQKKWQEEMELYR Oxidation(P)@3; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00374889001250267 2676.2568359375 670.0715 2676.2529296875 670.070556640625 4 10 1.1.1.3993.13 1 46.2589 55968.72 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 VQPYLDDFQKKWQEEMELYR Carbamidomethyl@N-term; reduced acrolein addition +58(K)@10; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.000388990010833368 2775.32104492188 694.8375 2775.32153320313 694.837646484375 4 9 1.1.1.4122.17 1 49.5687 4102.052 49.5004 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.6100022792816 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0140690999105573 2692.26220703125 674.0728 2692.24780273438 674.069274902344 4 10 1.1.1.3778.8 1 40.7593 2431.427 40.6897 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.6100022792816 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00601265020668507 2692.25366210938 674.0707 2692.24780273438 674.069274902344 4 10 1.1.1.3922.11 1 44.4447 583019.9 44.635 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.6100022792816 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; Deamidated(Q)@13; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0209550000727177 2662.24682617188 666.569 2662.22607421875 666.563781738281 4 10 1.1.1.3997.12 1 46.3628 7607.473 46.3234 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.6100022792816 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00552438013255596 2692.25341796875 674.0706 2692.24780273438 674.069274902344 4 10 1.1.1.4008.12 1 46.6494 4931.221 46.5581 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.7599983215332 VQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@10; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.0550726987421513 2708.25732421875 678.0716 2708.31225585938 678.085327148438 4 10 1.1.1.4065.18 1 48.1161 7328.17 48.1494 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.00162207998801023 2676.25146484375 670.0701 2676.2529296875 670.070556640625 4 10 1.1.1.3782.8 1 40.8503 1828.696 40.8142 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.00668236007913947 2692.24145507813 674.0676 2692.24780273438 674.069274902344 4 10 1.1.1.3984.13 1 46.0231 6416.434 46.061 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.6699981689453 VQPYLDDFQKKWQEEMELYR acrolein addition +76(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.0340662002563477 2736.25537109375 685.0711 2736.28930664063 685.079650878906 4 9 1.1.1.3999.15 1 46.4175 4132.053 46.4538 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.0100018978119 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; reduced acrolein addition +58(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.000767042976804078 2719.28466796875 680.8284 2719.28393554688 680.828247070313 4 8 1.1.1.4088.17 1 48.7002 2064.065 48.6833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.0100018978119 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; MDA adduct +62(K)@10; Deamidated(Q)@13 missed K-K@10; missed K-W@11 0.00249239010736346 2708.24926757813 678.0696 2708.24682617188 678.068969726563 4 9 1.1.1.4090.11 1 48.7463 7901.79 48.6069 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 50.7099986076355 VQPYLDDFQKKWQEEMELYR acrolein addition +76(K)@10; reduced acrolein addition +96(K)@11; Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.00467291986569762 2836.33740234375 710.0916 2836.341796875 710.092712402344 4 10 1.1.1.3958.16 1 45.3611 17414.36 45.4729 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 50.330001115799 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@2; Deamidated(Q)@9; acrolein addition +38(K)@11 missed K-K@10; missed K-W@11 -0.0157503001391888 2684.2314453125 672.0651 2684.24682617188 672.068969726563 4 9 1.1.1.4061.13 1 48.0103 4872.006 48.1239 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.429998755455 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@2; Deamidated(Q)@9; reduced acrolein addition +58(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0228316001594067 2720.291015625 681.08 2720.26806640625 681.074279785156 4 9 1.1.1.4080.16 1 48.496 3702.461 48.3527 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.429998755455 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; acrolein addition +38(K)@10; acrolein addition +76(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.022936699911952 2711.26782226563 678.8242 2711.29077148438 678.829956054688 4 9 1.1.1.4124.15 1 49.6185 2335.777 49.6033 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.7799991369247 VQPYLDDFQKKWQEEMELYR Trp->Hydroxykynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.003856569994241 2680.25170898438 671.0702 2680.24780273438 671.069274902344 4 10 1.1.1.3957.14 1 45.3336 181378.1 45.0641 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.6200013160706 VQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.0619084984064102 2708.25048828125 678.0699 2708.31225585938 678.085327148438 4 8 1.1.1.4089.12 1 48.7215 8150.822 48.48 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.9199993610382 VQPYLDDFQKKWQEEMELYR MDA adduct +62(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.029992600902915 2658.24584960938 665.5687 2658.275390625 665.576110839844 4 8 1.1.1.3798.13 1 41.2477 1894.35 41.3344 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.9199993610382 VQPYLDDFQKKWQEEMELYR MDA adduct +62(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.0287718996405602 2658.24682617188 665.569 2658.275390625 665.576110839844 4 9 1.1.1.3830.16 1 42.0823 3578.378 42.0917 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.1799986362457 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; MDA adduct +62(K)@10; MDA adduct +62(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.0079636899754405 2721.26684570313 681.324 2721.27514648438 681.326049804688 4 10 1.1.1.3975.14 1 45.7931 3872.872 45.83 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 37.3600006103516 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@2; acrolein addition +56(K)@10; MDA adduct +54(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.0201890002936125 2707.26049804688 677.8224 2707.28051757813 677.827453613281 4 10 1.1.1.3745.17 1 39.9137 803.1926 39.897 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.2800000905991 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +58(K)@10; acrolein addition +56(K)@11; Deamidated(Q)@13; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.0201214998960495 2775.330078125 694.8398 2775.31030273438 694.834838867188 4 8 1.1.1.4108.17 1 49.2104 4388.75 49.117 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 21.170000731945 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00405956991016865 2692.25219726563 674.0703 2692.24780273438 674.069274902344 4 8 1.1.1.3852.10 1 42.6592 30209.81 42.5156 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 21.170000731945 VQPYLDDFQKKWQEEMELYR Oxidation(P)@3; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.00252820993773639 2676.255859375 670.0712 2676.2529296875 670.070556640625 4 9 1.1.1.3916.13 1 44.2945 3441.172 44.4582 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.8699994683266 VQPYLDDFQKKWQEEMELYR acrolein addition +56(K)@10; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.0466157011687756 2716.23779296875 680.0667 2716.28442382813 680.078369140625 4 8 1.1.1.4086.11 1 48.6442 2585.387 48.6324 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.8699994683266 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@2; MDA adduct +62(K)@11 missed K-K@10; missed K-W@11 -0.0298616997897625 2707.23291015625 903.4183 2707.26293945313 903.42822265625 3 8 1.1.1.4148.20 1 50.2344 1893.376 50.1895 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.0121136996895075 2916.42407226563 584.2921 2916.41162109375 584.289611816406 5 15 1.1.1.3999.12 1 46.415 108790.8 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQK Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.00346372998319566 2932.41015625 734.1098 2932.40649414063 734.10888671875 4 14 1.1.1.3650.7 1 37.4898 1129.784 37.5199 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0300009250641 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.00658077001571655 2916.41821289063 730.1118 2916.41162109375 730.110168457031 4 13 1.1.1.3993.16 1 46.2614 88208.97 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0300009250641 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.00658077001571655 2916.41821289063 730.1118 2916.41162109375 730.110168457031 4 13 1.1.1.3997.16 1 46.3661 88208.97 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0300009250641 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.00570514984428883 2916.41748046875 584.2908 2916.41162109375 584.289611816406 5 13 1.1.1.4006.12 1 46.5973 96452.61 46.6366 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 VQPYLDDFQKKWQEEMELYRQK Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.00692937988787889 2964.40307617188 593.8879 2964.396484375 593.886535644531 5 13 1.1.1.3898.8 1 43.8356 20674.15 43.9533 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 VQPYLDDFQKKWQEEMELYRQK Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.00631903996691108 2964.40258789063 593.8878 2964.396484375 593.886535644531 5 13 1.1.1.3906.5 1 44.0356 20505.39 43.9786 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.4800000190735 VQPYLDDFQKKWQEEMELYRQK Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.0042446400038898 2920.41088867188 731.11 2920.40649414063 731.10888671875 4 12 1.1.1.3910.10 1 44.1446 10526.56 44.1297 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6200003623962 VQPYLDDFQKKWQEEMELYRQK Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 -0.00417573982849717 2948.3974609375 983.8064 2948.4013671875 983.807739257813 3 12 1.1.1.3860.16 1 42.871 10755.29 42.8007 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0100004673004 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.00658077001571655 2916.41821289063 730.1118 2916.41162109375 730.110168457031 4 12 1.1.1.3998.18 1 46.3936 88208.97 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0199971199036 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.0121136996895075 2916.42407226563 584.2921 2916.41162109375 584.289611816406 5 12 1.1.1.3992.11 1 46.231 108790.8 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0199971199036 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.00658077001571655 2916.41821289063 730.1118 2916.41162109375 730.110168457031 4 12 1.1.1.3996.17 1 46.3408 88208.97 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.619998216629 VQPYLDDFQKKWQEEMELYRQK Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 -0.00417573982849717 2948.3974609375 983.8064 2948.4013671875 983.807739257813 3 9 1.1.1.3852.21 1 42.6684 10755.29 42.8007 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.8400018215179 VQPYLDDFQKKWQEEMELYRQK Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.00484046014025807 2920.41088867188 585.0895 2920.40649414063 585.088562011719 5 11 1.1.1.3907.8 1 44.0632 12856.15 44.1297 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.4400000572205 VQPYLDDFQKKWQEEMELYRQK Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.000645701016765088 2964.39697265625 742.1065 2964.396484375 742.106384277344 4 11 1.1.1.3901.15 1 43.9176 17296.84 43.9533 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 VQPYLDDFQKKWQEEMELYRQK Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.00519957998767495 2948.40649414063 590.6886 2948.4013671875 590.687561035156 5 10 1.1.1.3859.5 1 42.8325 88736.51 42.8007 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.700001001358 VQPYLDDFQKKWQEEMELYRQK MDA adduct +54(K)@10; acrolein addition +38(K)@11; Trp->Kynurenin(W)@12; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 -0.0278150998055935 2948.40649414063 590.6886 2948.4345703125 590.694152832031 5 11 1.1.1.3866.8 1 43.0137 88736.51 42.8007 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.0400003194809 VQPYLDDFQKKWQEEMELYRQK Deamidated(Q)@13; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.0269352998584509 2917.42260742188 730.3629 2917.39575195313 730.356201171875 4 9 1.1.1.4016.16 1 46.8605 42673.87 46.6366 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.9999996423721 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.00570514984428883 2916.41748046875 584.2908 2916.41162109375 584.289611816406 5 11 1.1.1.4013.9 1 46.777 96452.61 46.6366 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR Deamidated(Q)@9; acrolein addition +94(K)@11; Deamidated(Q)@13; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 -0.00961992982774973 3542.7626953125 591.4677 3542.77221679688 591.469299316406 6 17 1.1.1.3985.11 1 46.0474 41348.94 45.958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.0196107998490334 3510.7802734375 586.1373 3510.76049804688 586.134033203125 6 14 1.1.1.4111.9 1 49.2803 16529.06 49.2956 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.0196107998490334 3510.7802734375 586.1373 3510.76049804688 586.134033203125 6 18 1.1.1.4125.8 1 49.6383 32739.87 49.7056 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.0178481005132198 3510.77880859375 703.163 3510.76049804688 703.159362792969 5 17 1.1.1.4127.14 1 49.6945 45110.36 49.7056 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.0196107998490334 3510.7802734375 586.1373 3510.76049804688 586.134033203125 6 18 1.1.1.4132.7 1 49.816 32739.87 49.7056 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.00812782999128103 3542.7587890625 709.559 3542.75048828125 709.557373046875 5 14 1.1.1.3978.16 1 45.8715 57034.27 45.958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.00812782999128103 3542.7587890625 709.559 3542.75048828125 709.557373046875 5 14 1.1.1.3980.14 1 45.9217 57034.27 45.958 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 VQPYLDDFQKKWQEEMELYRQKVEPLR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.0196107998490334 3510.7802734375 586.1373 3510.76049804688 586.134033203125 6 11 1.1.1.4118.7 1 49.4578 16529.06 49.2956 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2100028991699 VQPYLDDFQKKWQEEMELYRQKVEPLR Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.0162713993340731 3558.76171875 594.1342 3558.74536132813 594.131469726563 6 13 1.1.1.4000.10 1 46.4394 10531.5 46.3755 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Delta:H(4)C(2)(K)@11; Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.00432121008634567 4397.20703125 733.8751 4397.21142578125 733.875854492188 6 22 1.1.1.4097.18 1 48.9309 97736.52 48.9896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0253893006592989 4397.20068359375 629.1788 4397.1748046875 629.175109863281 7 20 1.1.1.4101.11 1 49.0271 47287.09 49.0151 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0320643000304699 4397.20703125 733.8751 4397.1748046875 733.869812011719 6 24 1.1.1.4104.15 1 49.1067 97736.52 48.9896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Trp->Hydroxykynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.019166199490428 4385.1943359375 731.873 4385.1748046875 731.869812011719 6 17 1.1.1.4119.17 1 49.4918 12647.91 49.4747 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0248064007610083 4413.1943359375 736.5397 4413.169921875 736.535583496094 6 23 1.1.1.4127.15 1 49.6953 38847.2 49.6033 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16; Carbamidomethyl(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0281544998288155 4422.23486328125 738.0464 4422.20654296875 738.041748046875 6 17 1.1.1.4206.14 1 51.71 9633.391 51.6953 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0313319005072117 4397.20654296875 733.875 4397.1748046875 733.869812011719 6 15 1.1.1.4111.15 1 49.2853 95152.86 49.0151 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.019845999777317 4365.20458984375 728.5414 4365.18505859375 728.538146972656 6 16 1.1.1.4184.12 1 51.1472 92379.87 51.3389 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0194812007248402 4365.205078125 624.608 4365.18505859375 624.605163574219 7 16 1.1.1.4186.12 1 51.1983 39537.02 51.3645 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0205783993005753 4365.2060546875 728.5416 4365.18505859375 728.538146972656 6 20 1.1.1.4191.12 1 51.3262 93985.32 51.3645 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0194812007248402 4365.205078125 624.608 4365.18505859375 624.605163574219 7 18 1.1.1.4193.8 1 51.3739 39537.02 51.3645 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0191136002540588 4365.2041015625 728.5413 4365.18505859375 728.538146972656 6 21 1.1.1.4198.14 1 51.5062 92541.41 51.4663 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0194812007248402 4365.205078125 624.608 4365.18505859375 624.605163574219 7 14 1.1.1.4201.6 1 51.5758 36537.11 51.4663 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.019845999777317 4365.20458984375 728.5414 4365.18505859375 728.538146972656 6 21 1.1.1.4205.15 1 51.6851 113009.5 51.8231 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0190539006143808 4365.20458984375 624.6079 4365.18505859375 624.605163574219 7 15 1.1.1.4209.3 1 51.7774 48956.38 51.8231 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.019845999777317 4365.20458984375 728.5414 4365.18505859375 728.538146972656 6 25 1.1.1.4212.15 1 51.864 113009.5 51.8231 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0194812007248402 4365.205078125 624.608 4365.18505859375 624.605163574219 7 17 1.1.1.4217.10 1 51.9875 47323.11 51.9508 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0205783993005753 4365.2060546875 728.5416 4365.18505859375 728.538146972656 6 20 1.1.1.4219.14 1 52.0417 106617 51.9508 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0205783993005753 4365.2060546875 728.5416 4365.18505859375 728.538146972656 6 16 1.1.1.4226.12 1 52.2171 106599.5 51.9508 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@21; acrolein addition +56(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0404205992817879 4406.240234375 735.3807 4406.20068359375 735.3740234375 6 14 1.1.1.4243.16 1 52.6545 9054.637 52.6382 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dehydrated(D)@7; acrolein addition +38(K)@11 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0103797996416688 4369.20556640625 625.1795 4369.1953125 625.178039550781 7 14 1.1.1.4129.5 1 49.7381 5768.4 49.7056 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@9; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0497248992323875 4366.2197265625 624.7529 4366.16943359375 624.745727539063 7 13 1.1.1.4216.4 1 51.9568 31018.54 51.9252 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.0440108999609947 4397.20068359375 629.1788 4397.24462890625 629.18505859375 7 13 1.1.1.4094.10 1 48.8478 47287.09 49.0151 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR acrolein addition +38(K)@11; Dethiomethyl(M)@16; Deamidated(Q)@21; hexanoyl addition +98(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.0369045995175838 4438.22314453125 740.7111 4438.259765625 740.717224121094 6 13 1.1.1.4137.16 1 49.9512 7873.094 49.9096 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7199990749359 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.0440108999609947 4397.20068359375 629.1788 4397.24462890625 629.18505859375 7 12 1.1.1.4108.12 1 49.2062 47287.09 49.0151 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2399988174438 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dehydrated(D)@7; acrolein addition +38(K)@11 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.00970240030437708 4369.205078125 729.2081 4369.1953125 729.206481933594 6 12 1.1.1.4129.14 1 49.7457 15368.74 49.7313 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@13; Deamidated(Q)@21; MDA adduct +62(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0328646004199982 4413.20703125 631.4654 4413.173828125 631.460693359375 7 11 1.1.1.4122.12 1 49.5645 14224.31 49.6033 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +62(K)@11; Trp->Kynurenin(W)@12; Dethiomethyl(M)@16; Deamidated(Q)@31 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0121277002617717 4368.19384765625 729.0396 4368.181640625 729.037536621094 6 13 1.1.1.4213.16 1 51.8904 17458.37 51.7976 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.0600001811981 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0179456993937492 4369.19775390625 625.1784 4369.18017578125 625.175842285156 7 11 1.1.1.4136.14 1 49.924 6551.284 49.9861 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(P)@3; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0385892987251282 4381.21875 731.2104 4381.18017578125 731.203979492188 6 11 1.1.1.4195.14 1 51.4297 2937.681 51.4408 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0800023078918 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@21; acrolein addition +56(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0295446999371052 4406.22998046875 630.4687 4406.20068359375 630.464477539063 7 10 1.1.1.4231.12 1 52.3442 6393.396 52.3824 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.8799977302551 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@2; MDA adduct +54(K)@10; acrolein addition +76(K)@11; MDA adduct +62(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0393161997199059 4542.271484375 758.0525 4542.23193359375 758.0458984375 6 10 1.1.1.4161.19 1 50.5646 3681.515 50.5206 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1000003814697 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@2; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0505793988704681 4366.22021484375 624.753 4366.16943359375 624.745727539063 7 10 1.1.1.4225.10 1 52.1901 31095.35 51.9508 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.2899980545044 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dioxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0246737003326416 4381.205078125 731.2081 4381.18017578125 731.203979492188 6 10 1.1.1.4146.16 1 50.1801 10251.93 50.164 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@13; Deamidated(Q)@21; MDA adduct +62(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0207837000489235 4413.1943359375 736.5397 4413.173828125 736.536254882813 6 10 1.1.1.4120.17 1 49.5174 38847.2 49.6033 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4599983692169 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@9; MDA adduct +62(K)@11; Deamidated(Q)@13 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0111017003655434 4413.18505859375 883.6443 4413.173828125 883.64208984375 5 10 1.1.1.4121.21 1 49.5464 25354.05 49.6033 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 61.5800023078918 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@9; Dioxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0918999016284943 4382.25634765625 731.3833 4382.1640625 731.367980957031 6 11 1.1.1.3984.15 1 46.0248 9119.786 46.0091 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.7599983215332 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(P)@3; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0235750004649162 4381.20361328125 731.2079 4381.18017578125 731.203979492188 6 10 1.1.1.4153.19 1 50.3611 15160.07 50.3681 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.6499989032745 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dioxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0289440006017685 4381.208984375 731.2088 4381.18017578125 731.203979492188 6 10 1.1.1.3895.18 1 43.7682 8409.584 43.9024 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.0100018978119 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.0407112017273903 4397.20361328125 880.448 4397.24462890625 880.456176757813 5 10 1.1.1.4105.17 1 49.134 73215.95 48.9896 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 38.9299988746643 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dioxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0246737003326416 4381.205078125 731.2081 4381.18017578125 731.203979492188 6 9 1.1.1.4139.18 1 50.0036 10251.93 50.164 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.2800000905991 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@2; ONE addition +154(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.0533917993307114 4456.216796875 743.7101 4456.2705078125 743.718994140625 6 10 1.1.1.4097.19 1 48.9317 4210.863 48.8108 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.2800000905991 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +62(K)@11; Deamidated(Q)@13; Deamidated(Q)@21 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0111017003655434 4413.18505859375 883.6443 4413.173828125 883.64208984375 5 9 1.1.1.4128.18 1 49.7235 25354.05 49.6033 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.2800000905991 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dioxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0429427996277809 4381.22314453125 626.8963 4381.18017578125 626.89013671875 7 9 1.1.1.4144.10 1 50.1239 3342.769 50.113 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.8699994683266 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.0249585006386042 4369.205078125 729.2081 4369.18017578125 729.203979492188 6 9 1.1.1.4122.19 1 49.5703 15368.74 49.7313 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTK -0.00224362988956273 1385.70568847656 693.8601 1385.70788574219 693.861206054688 2 18 1.1.1.4356.15 1 55.5388 89870.44 55.703 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTK -0.00224362988956273 1385.70568847656 693.8601 1385.70788574219 693.861206054688 2 21 1.1.1.4363.15 1 55.7183 89870.44 55.703 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTK -0.00224362988956273 1385.70568847656 693.8601 1385.70788574219 693.861206054688 2 19 1.1.1.4370.16 1 55.8987 89870.44 55.703 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTK -0.00468498002737761 1385.70324707031 693.8589 1385.70788574219 693.861206054688 2 17 1.1.1.4377.13 1 56.0767 8601.553 56.0886 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTK -0.00529531994834542 1385.70263671875 693.8586 1385.70788574219 693.861206054688 2 16 1.1.1.4391.13 1 56.4372 8417.7 56.1657 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTK -0.00126708997413516 1385.70666503906 693.8606 1385.70788574219 693.861206054688 2 15 1.1.1.4398.9 1 56.6151 4303.809 56.6304 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTK -0.00163328996859491 1385.70629882813 693.8604 1385.70788574219 693.861206054688 2 15 1.1.1.4406.14 1 56.8264 4303.681 56.6567 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTK 0.00630109012126923 1385.71423339844 693.8644 1385.70788574219 693.861206054688 2 14 1.1.1.4415.11 1 57.0568 2109.77 57.0444 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTKK missed K-K@12 -0.00531475991010666 1513.79736328125 505.6064 1513.80285644531 505.608215332031 3 11 1.1.1.4226.3 1 52.2096 12119.74 52.3569 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-K@12; missed K-L@13 -0.00378290005028248 1841.9736328125 614.9985 1841.9775390625 614.999755859375 3 14 1.1.1.4509.8 1 59.5141 5485.574 59.5037 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-K@12; missed K-L@13 -0.00378290005028248 1841.9736328125 614.9985 1841.9775390625 614.999755859375 3 10 1.1.1.4516.6 1 59.6997 5485.574 59.5037 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-K@12; missed K-L@13 -0.00250119995325804 1841.97521972656 614.999 1841.9775390625 614.999755859375 3 12 1.1.1.4523.9 1 59.8881 1302.229 59.8769 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTKKLNT reduced acrolein addition +58(K)@12; acrolein addition +112(K)@13 cleaved T-Q@C-term; missed K-K@12; missed K-L@13 0.0174129009246826 2012.08923339844 671.7037 2012.07177734375 671.697875976563 3 12 1.1.1.4543.10 1 60.4162 2115.727 60.4577 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTKKLNT Carbamidomethyl(K)@12; acrolein addition +112(K)@13 cleaved T-Q@C-term; missed K-K@12; missed K-L@13 0.0194109994918108 2011.07080078125 671.3642 2011.05139160156 671.357727050781 3 13 1.1.1.4544.10 1 60.4432 2650.789 60.4577 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTKKLNTQ missed K-K@12; missed K-L@13 -0.00369636993855238 1970.03259277344 657.6848 1970.03601074219 657.685974121094 3 18 1.1.1.4501.13 1 59.3069 43100.92 59.2665 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTKKLNTQ missed K-K@12; missed K-L@13 -0.00369636993855238 1970.03259277344 657.6848 1970.03601074219 657.685974121094 3 12 1.1.1.4508.12 1 59.491 43100.92 59.2665 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTKKLNTQ missed K-K@12; missed K-L@13 0.00454314006492496 1970.04064941406 657.6875 1970.03601074219 657.685974121094 3 16 1.1.1.4515.10 1 59.6762 13640.99 59.6636 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTKKLNTQ missed K-K@12; missed K-L@13 -0.000217466993490234 1970.03588867188 657.6859 1970.03601074219 657.685974121094 3 15 1.1.1.4522.14 1 59.8659 9877.144 59.8244 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTKKLNTQ Deamidated(N)@15 missed K-K@12; missed K-L@13 -0.00141294999048114 1971.01867675781 658.0135 1971.02001953125 658.013977050781 3 11 1.1.1.4434.15 1 57.5524 2844.848 57.5885 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 WQEEMELYR Oxidation(M)@5 -0.00181189004797488 1298.55822753906 650.2864 1298.56018066406 650.287353515625 2 15 1.1.1.3421.15 1 31.7495 141818.8 31.8582 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 WQEEMELYR Oxidation(M)@5 -0.00181189004797488 1298.55822753906 650.2864 1298.56018066406 650.287353515625 2 15 1.1.1.3428.19 1 31.9271 141818.8 31.8582 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 WQEEMELYR Oxidation(M)@5 -0.0049856398254633 1298.55529785156 650.2849 1298.56018066406 650.287353515625 2 11 1.1.1.3470.6 1 32.9742 2474.199 33.0041 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 WQEEMELYR Oxidation(M)@5 -0.00181189004797488 1298.55822753906 650.2864 1298.56018066406 650.287353515625 2 12 1.1.1.3435.18 1 32.1062 148480.2 31.833 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9400029182434 WQEEMELYR Dioxidation(W)@1; Oxidation(M)@5 -0.00502419983968139 1330.544921875 666.2797 1330.54992675781 666.282287597656 2 13 1.1.1.3344.10 1 29.8513 2624.519 29.9318 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.4099984169006 WQEEMELYR Dioxidation(W)@1; Deamidated(Q)@2; Dehydrated(E)@3; Oxidation(M)@5 -0.00310125993564725 1313.5205078125 657.7675 1313.5234375 657.768981933594 2 14 1.1.1.3757.15 1 40.2225 14621.52 40.0747 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9099988937378 WQEEMELYR Dioxidation(W)@1; Deamidated(Q)@2; Dehydrated(E)@3; Oxidation(M)@5 -0.00310125993564725 1313.5205078125 657.7675 1313.5234375 657.768981933594 2 14 1.1.1.3750.17 1 40.0404 14621.52 40.0747 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 WQEEMELYR Dioxidation(W)@1; Oxidation(M)@5 -0.00502419983968139 1330.544921875 666.2797 1330.54992675781 666.282287597656 2 12 1.1.1.3351.9 1 30.0222 2624.519 29.9318 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 WQEEMELYR Trp->Kynurenin(W)@1; Oxidation(M)@5 -0.000977701973170042 1302.55407714844 652.2843 1302.55505371094 652.284790039063 2 9 1.1.1.3372.20 1 30.545 5251.417 30.3516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.759997844696 WQEEMELYR FormaldehydeAdduct(W)@1; Oxidation(M)@5 -0.00272525008767843 1310.55749511719 656.286 1310.56018066406 656.287353515625 2 10 1.1.1.3542.14 1 34.7493 1215.886 34.8036 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 WQEEMELYR Oxidation(W)@1; Oxidation(M)@5 -0.000914831005502492 1314.55432128906 658.2844 1314.55505371094 658.284790039063 2 9 1.1.1.3273.20 1 28.1006 2069.355 28.181 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 WQEEMELYR Dioxidation(W)@1; Oxidation(M)@5 -1.94458007172216E-05 1330.54992675781 666.2822 1330.54992675781 666.282287597656 2 8 1.1.1.3266.12 1 27.9269 932.9847 27.9093 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 WQEEMELYR Trp->Kynurenin(W)@1; Oxidation(M)@5 -0.000977701973170042 1302.55407714844 652.2843 1302.55505371094 652.284790039063 2 10 1.1.1.3365.21 1 30.3713 5251.417 30.3516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 WQEEMELYR FormaldehydeAdduct(W)@1; Oxidation(M)@5 -0.00626520020887256 1310.55383300781 656.2842 1310.56018066406 656.287353515625 2 9 1.1.1.3563.19 1 35.2686 898.7665 35.3013 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9099977016449 WQEEMELYR Quinone(W)@1; Deamidated(Q)@2; Oxidation(M)@5 0.00014711800031364 1329.51843261719 665.7665 1329.51831054688 665.766418457031 2 12 1.1.1.3612.10 1 36.5326 1009.808 36.5131 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.7999982833862 WQEEMELYR Trp->Hydroxykynurenin(W)@1; Oxidation(M)@5 -0.00337686995044351 1318.54663085938 660.2806 1318.54992675781 660.282287597656 2 11 1.1.1.3495.10 1 33.5847 3672.529 33.4976 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 WQEEMELYR Dioxidation(M)@5 0.00225892011076212 1314.55725097656 658.2859 1314.55505371094 658.284790039063 2 9 1.1.1.3469.10 1 32.9479 1938.005 33.0287 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.3899984359741 WQEEMELYR Trp->Kynurenin(W)@1; Oxidation(M)@5 -0.000977701973170042 1302.55407714844 652.2843 1302.55505371094 652.284790039063 2 8 1.1.1.3358.20 1 30.1959 5251.417 30.3516 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9399971961975 WQEEMELYR Trp->Hydroxykynurenin(W)@1; Oxidation(M)@5 -0.00337686995044351 1318.54663085938 660.2806 1318.54992675781 660.282287597656 2 10 1.1.1.3488.12 1 33.4183 3672.529 33.4976 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 47.4999994039536 WQEEMELYR Oxidation(M)@5 -0.00266636000014842 1298.55749511719 650.286 1298.56018066406 650.287353515625 2 11 1.1.1.3407.7 1 31.409 10940.99 31.6351 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.0399993658066 WQEEMELYR FormaldehydeAdduct(W)@1; Oxidation(M)@5 -0.00174871005583555 1310.55847167969 656.2865 1310.56018066406 656.287353515625 2 8 1.1.1.3556.18 1 35.091 821.1694 35.0732 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3900007009506 WQEEMELYR Dioxidation(M)@5 0.00225892011076212 1314.55725097656 658.2859 1314.55505371094 658.284790039063 2 8 1.1.1.3476.17 1 33.1204 1938.005 33.0287 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.4199994802475 WQEEMELYR Oxidation(M)@5 -0.00522977020591497 1298.55493164063 650.2847 1298.56018066406 650.287353515625 2 10 1.1.1.3456.7 1 32.6249 3536.412 32.6106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.129998922348 WQEEMELYR Oxidation(M)@5 -0.00217808992601931 1298.55810546875 650.2863 1298.56018066406 650.287353515625 2 10 1.1.1.3442.13 1 32.2801 29100.98 32.0106 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.0099999904633 YSDELRQR cleaved P-Y@N-term; missed R-Q@6 -0.00112077000085264 1065.51928710938 533.7669 1065.52026367188 533.767456054688 2 9 1.1.1.3195.10 1 26.1861 7304.216 26.3949 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.529999256134 YSDELRQR cleaved P-Y@N-term; missed R-Q@6 -0.000876633974257857 1065.51953125 533.767 1065.52026367188 533.767456054688 2 9 1.1.1.3209.8 1 26.5292 8197.996 26.5411 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.0800018310547 YSDELRQR cleaved P-Y@N-term; missed R-Q@6 -0.000876633974257857 1065.51953125 533.767 1065.52026367188 533.767456054688 2 9 1.1.1.3224.4 1 26.8949 7586.958 26.6874 1 266.65 266.65 93.2600021362305 93.2600021362305 93.2600021362305 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0699985027313 YVSQFEGSALGK cleaved D-Y@N-term -0.00151186995208263 1284.63342285156 643.324 1284.63500976563 643.324768066406 2 8 1.1.1.3448.19 1 32.4313 5368.17 32.3133 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 AATVGSLAGQPLQER -0.00334099004976451 1496.79150390625 749.403 1496.79467773438 749.404602050781 2 19 1.1.1.3511.10 1 33.9856 1767.392 33.8938 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 AATVGSLAGQPLQERAQAWGER missed R-A@15 -0.00288649997673929 2295.16943359375 766.0637 2295.171875 766.064636230469 3 16 1.1.1.3761.20 1 40.3322 9337.778 40.3646 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 AKLEEQAQQIR missed K-L@2 -0.000381846009986475 1312.70947265625 438.5771 1312.7099609375 438.577239990234 3 14 1.1.1.3097.7 1 23.7842 22468.54 23.7514 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 AKLEEQAQQIRLQAEAFQAR missed K-L@2; missed R-L@11 0.00292539992369711 2327.23779296875 582.8167 2327.23461914063 582.81591796875 4 25 1.1.1.3822.6 1 41.8634 91567.35 41.8042 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 ARLSKELQAAQAR missed R-L@2; missed K-E@5 0.00108829000964761 1440.81726074219 481.2797 1440.81616210938 481.279327392578 3 13 1.1.1.3098.5 1 23.814 796.0605 23.8259 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 AYKSELEEQLTPVAEETR missed K-S@3 0.00222384999506176 2092.03466796875 698.3522 2092.03247070313 698.351440429688 3 21 1.1.1.3689.18 1 38.4627 34369.88 38.4184 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 AYKSELEEQLTPVAEETRAR missed K-S@3; missed R-A@18 0.000963298021815717 2319.17163085938 580.8002 2319.17065429688 580.799926757813 4 19 1.1.1.3642.12 1 37.2754 15780 37.2365 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 DRLDEVKEQVAEVR missed R-L@2; missed K-E@7 -0.000491916027385741 1684.87390136719 562.6319 1684.87438964844 562.632080078125 3 11 1.1.1.3580.10 1 35.706 20340 35.432 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 ELQAAQAR -0.00119168998207897 885.465698242188 443.7401 885.466857910156 443.740692138672 2 11 1.1.1.2828.2 1 18.6173 1259.515 18.5585 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 GEVQAMLGQSTEELR Oxidation(M)@6 0.00307861994951963 1662.79150390625 555.2711 1662.78833007813 555.27001953125 3 15 1.1.1.3481.5 1 33.2387 3512.086 33.1273 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 GEVQAMLGQSTEELRVR Oxidation(M)@6 missed R-V@15 -0.00258044991642237 1917.95520019531 640.3257 1917.95776367188 640.326538085938 3 16 1.1.1.3582.19 1 35.7661 8970.085 35.7203 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 GLSAIRER missed R-E@6 -0.00278118997812271 900.511291503906 451.2629 900.514099121094 451.264343261719 2 11 1.1.1.3048.2 1 22.6512 2128.662 22.5918 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 KLEEQAQQIRLQAEAFQAR acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-L@1; missed R-L@10 0.0176820997148752 2368.26782226563 593.0742 2368.25 593.069763183594 4 15 1.1.1.3833.12 1 42.1591 2520.996 42.0917 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 KVEQAVETEPEPELR cleaved A-K@N-term; missed K-V@1 0.00382329989224672 1752.89318847656 585.305 1752.88940429688 585.3037109375 3 19 1.1.1.3267.10 1 27.9497 38571.3 27.9583 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 KVEQAVETEPEPELRQQTEWQSGQR cleaved A-K@N-term; missed K-V@1; missed R-Q@15 0.0272466000169516 2981.47485351563 746.376 2981.44799804688 746.369262695313 4 18 1.1.1.3456.8 1 32.6274 4803.391 32.7336 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LAVYQAGAR -0.00319449999369681 947.515686035156 474.7651 947.518859863281 474.766723632813 2 12 1.1.1.3162.7 1 25.391 62711.86 25.4573 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LDEVKEQVAEVR missed K-E@5 -0.00381331006065011 1413.74255371094 472.2548 1413.74633789063 472.256072998047 3 17 1.1.1.3189.7 1 26.0399 1369.849 26.1753 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LEEQAQQIR -0.00654774997383356 1113.5712890625 557.7929 1113.57788085938 557.796203613281 2 15 1.1.1.3049.5 1 22.6764 1062.674 22.7131 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LEEQAQQIRLQAEAFQAR missed R-L@9 -0.00354573992080987 2128.09887695313 710.3736 2128.1025390625 710.374755859375 3 19 1.1.1.3762.17 1 40.356 9547.775 40.3906 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LGADMEDVCGR Carbamidomethyl(C)@9 -0.00099798000883311 1221.51086425781 611.7627 1221.51184082031 611.76318359375 2 9 1.1.1.3292.14 1 28.5633 510.6658 28.5743 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LGPLVEQGR -0.00403894996270537 967.541076660156 484.7778 967.545104980469 484.779815673828 2 10 1.1.1.3274.10 1 28.1172 5460.901 28.3042 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LGPLVEQGRVR missed R-V@9 0.000116388000606094 1222.71484375 408.5789 1222.71459960938 408.578796386719 3 12 1.1.1.3275.2 1 28.1361 12042.95 28.2549 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LKSWFEPLVEDMQR Oxidation(M)@12 missed K-S@2 -0.00315026007592678 1792.87866210938 598.6335 1792.8818359375 598.634521484375 3 15 1.1.1.4001.13 1 46.4678 8163.607 46.4277 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LLRDADDLQK missed R-D@3 -0.00281223002821207 1185.63244628906 593.8235 1185.63537597656 593.824951171875 2 8 1.1.1.3127.11 1 24.5513 719.3697 24.6069 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LLRDADDLQKR missed R-D@3; missed K-R@10 -0.00231795990839601 1341.73425292969 448.252 1341.73645019531 448.252777099609 3 9 1.1.1.3097.8 1 23.785 5460.352 23.8755 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LLRDADDLQKRLAVYQAGAR missed R-D@3; missed K-R@10; missed R-L@11 0.000855201971717179 2271.24584960938 568.8187 2271.24487304688 568.818481445313 4 22 1.1.1.3742.14 1 39.8346 19068.31 39.744 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LQAEAFQAR -0.0040450100786984 1032.53125 517.2729 1032.53527832031 517.27490234375 2 12 1.1.1.3193.3 1 26.134 13587.27 26.1997 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LSKELQAAQAR missed K-E@3 -0.00316904997453094 1213.67468261719 405.5655 1213.67785644531 405.566558837891 3 14 1.1.1.3046.2 1 22.5959 29230.17 22.5181 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LVQYRGEVQAMLGQSTEELR Oxidation(M)@11 missed R-G@5 -0.00286461994983256 2322.16088867188 775.0609 2322.16381835938 775.061889648438 3 17 1.1.1.3692.19 1 38.5417 4534.848 38.4704 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LVQYRGEVQAMLGQSTEELRVR Oxidation(M)@11 missed R-G@5; missed R-V@20 0.000963450991548598 2577.33422851563 645.3408 2577.33325195313 645.340576171875 4 20 1.1.1.3735.18 1 39.6604 79547.31 39.7187 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 QWAGLVEKVQAAVGTSAAPVPSDNH Dioxidation(W)@2 missed K-V@8 -0.00584818003699183 2563.26098632813 855.4276 2563.2666015625 855.429504394531 3 16 1.1.1.4024.21 1 47.0708 5332.022 46.948 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 SELEEQLTPVAEETR -0.0065256399102509 1729.83044433594 865.9225 1729.83703613281 865.92578125 2 20 1.1.1.3652.18 1 37.5369 8146.86 37.644 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 SELEEQLTPVAEETRAR missed R-A@15 -0.00121114996727556 1956.97412109375 653.332 1956.97521972656 653.332336425781 3 16 1.1.1.3625.6 1 36.8473 1408.636 36.833 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 TRDRLDEVKEQVAEVR missed R-D@2; missed R-L@4; missed K-E@9 -0.000447527010692284 1942.02282714844 648.3482 1942.02319335938 648.348327636719 3 19 1.1.1.3435.17 1 32.1053 15106.99 32.0106 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 TRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQAR missed R-D@2; missed R-L@4; missed K-E@9; missed R-A@16; missed K-L@18; missed R-L@27 0.0114182000979781 4251.2587890625 709.5504 4251.2470703125 709.548461914063 6 12 1.1.1.4439.15 1 57.6822 5483.135 57.6666 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 VEQAVETEPEPELR 0.00217828992754221 1624.79663085938 813.4056 1624.79443359375 813.404479980469 2 16 1.1.1.3356.11 1 30.1474 1091.916 30.1527 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 VQAAVGTSAAPVPSDNH -0.00118787004612386 1619.78918457031 540.937 1619.79040527344 540.937377929688 3 10 1.1.1.3233.10 1 27.12 3733.056 26.858 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 VRAATVGSLAGQPLQER Deamidated(Q)@12 missed R-A@2 0.00411263015121222 1752.95227050781 585.3247 1752.9482421875 585.323364257813 3 14 1.1.1.3444.8 1 32.3302 1154.126 32.338 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 1.67778015136719 98.989999294281 DADDLQKRLAVYQAGAR missed K-R@7; missed R-L@8 -0.00308350007981062 1888.97253417969 473.2504 1888.97546386719 473.251159667969 4 13 1.1.1.3647.6 1 37.4005 8799.604 37.314 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.903090000152588 99.0000009536743 SKELQAAQAR cleaved L-S@N-term; missed K-E@2 -0.00464549986645579 1100.58923339844 551.3019 1100.59387207031 551.30419921875 2 9 1.1.1.3041.9 1 22.4881 297.2042 22.5181 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.798602938652039 99.0000009536743 AGLVEKVQAAVGTSAAPVPSDNH cleaved W-A@N-term; missed K-V@6 -0.0181076005101204 2217.12060546875 740.0475 2217.13891601563 740.053588867188 3 11 1.1.1.3806.18 1 41.4538 1098.057 41.4874 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.420216411352158 99.0000009536743 ALMDETMKELK Oxidation(M)@3; Oxidation(M)@7 missed K-E@8 -0.000354637013515458 1339.63598632813 447.5526 1339.63635253906 447.552734375 3 13 1.1.1.3076.5 1 23.275 8695.418 23.3319 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.37675067782402 99.0000009536743 KLEEQAQQIR acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-L@1 0.00691562984138727 1353.73205566406 452.2513 1353.72521972656 452.2490234375 3 8 1.1.1.3109.5 1 24.0847 909.5192 24.1294 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.319664508104324 99.0000009536743 YKSELEEQLTPVAEETR acrolein addition +112(K)@2 cleaved A-Y@N-term; missed K-S@2 0.0112484004348516 2133.05883789063 712.0269 2133.0478515625 712.023193359375 3 12 1.1.1.3715.19 1 39.1391 1454.274 39.043 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.295849472284317 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH Dethiomethyl(M)@12; reduced acrolein addition +96(K)@22 missed K-S@2; missed R-Q@14; missed K-V@22 -0.0311932992190123 4338.1748046875 1085.551 4338.20751953125 1085.55908203125 4 10 1.1.1.4551.18 1 60.6341 950.5905 60.59 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.0867160931229591 31.8500012159348 AQAWGERLR missed R-L@7 0.00014717600424774 1085.5732421875 543.7939 1085.57299804688 543.793762207031 2 7 1.1.1.3169.11 1 25.5679 1358.004 25.6063 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.0362121723592281 15.5200004577637 EQVAEVR -0.00473082019016147 829.424682617188 415.7196 829.429382324219 415.721954345703 2 7 1.1.1.2894.2 1 19.7123 192.903 19.7236 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.0204516258090734 98.2800006866455 SWFEPLVEDMQR Dioxidation(W)@2; Oxidation(M)@10 -0.0003906239871867 1583.69226074219 792.8534 1583.69262695313 792.853576660156 2 10 1.1.1.3892.15 1 43.6902 1920.61 43.776 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.00174066168256104 44.6200013160706 RGLSAIRER cleaved E-R@N-term; missed R-G@1; missed R-E@7 -0.0110294995829463 1056.60424804688 529.3094 1056.615234375 529.314880371094 2 4 1.1.1.4153.5 1 50.3495 529.4172 50.3171 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.00130484171677381 39.3900007009506 AQAWGER Dioxidation(W)@4 -0.00164472998585552 848.376098632813 425.1953 848.377685546875 425.196105957031 2 6 1.1.1.2945.2 1 20.4016 184.9527 20.282 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.00130484171677381 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEK Dioxidation(W)@4; Oxidation(M)@12; Dioxidation(W)@16 missed K-S@2; missed R-Q@14 -0.00114038004539907 2768.34692382813 693.094 2768.34790039063 693.09423828125 4 12 1.1.1.4108.16 1 49.2095 1270.399 49.1932 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.000434511806815863 99.0000009536743 AKVEQAVETEPEPELR Methyl(E)@4; Deamidated(Q)@5 cleaved Q-A@N-term; missed K-V@2 -0.00167847995180637 1838.92443847656 920.4695 1838.92614746094 920.470336914063 2 10 1.1.1.3734.21 1 39.6366 661.1288 39.6682 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER -0.000899648002814502 1496.79382324219 749.4042 1496.79467773438 749.404602050781 2 13 1.1.1.3440.14 1 32.2339 637.9087 32.2144 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER -0.00175411999225616 1496.79284667969 749.4037 1496.79467773438 749.404602050781 2 23 1.1.1.3483.14 1 33.2947 77779.21 33.4482 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER -0.00175411999225616 1496.79284667969 749.4037 1496.79467773438 749.404602050781 2 12 1.1.1.3484.12 1 33.3193 77779.21 33.4482 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER -0.00175411999225616 1496.79284667969 749.4037 1496.79467773438 749.404602050781 2 25 1.1.1.3490.13 1 33.466 77779.21 33.4482 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER -0.00175411999225616 1496.79284667969 749.4037 1496.79467773438 749.404602050781 2 22 1.1.1.3497.16 1 33.6393 77779.21 33.4482 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER -0.00175411999225616 1496.79284667969 749.4037 1496.79467773438 749.404602050781 2 23 1.1.1.3504.10 1 33.8128 12884.63 33.547 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER -0.000899648002814502 1496.79382324219 749.4042 1496.79467773438 749.404602050781 2 17 1.1.1.3518.11 1 34.1598 1765.712 33.8938 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.00386097002774477 1496.79870605469 749.4066 1496.79467773438 749.404602050781 2 21 1.1.1.3526.8 1 34.3566 1030.656 34.3127 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.00923192035406828 1496.80383300781 749.4092 1496.79467773438 749.404602050781 2 16 1.1.1.3533.11 1 34.5285 918.156 34.5337 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.0170441996306181 1496.81164550781 749.4131 1496.79467773438 749.404602050781 2 15 1.1.1.3540.15 1 34.7002 1501.911 34.7054 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.00972019042819738 1496.80444335938 749.4095 1496.79467773438 749.404602050781 2 19 1.1.1.3550.6 1 34.942 1367.328 34.9016 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.00410509994253516 1496.798828125 749.4067 1496.79467773438 749.404602050781 2 9 1.1.1.3557.19 1 35.1159 892.8234 35.0979 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER -0.0023644499015063 1496.79223632813 749.4034 1496.79467773438 749.404602050781 2 8 1.1.1.3564.20 1 35.2953 610.5299 35.3535 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER Delta:H(2)C(2)@N-term -0.00478720013052225 1522.80541992188 762.41 1522.81030273438 762.412475585938 2 16 1.1.1.3594.21 1 36.0712 1347.945 36.1022 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 97.2199976444244 AATVGSLAGQPLQER Delta:H(2)C(2)@N-term -0.00478720013052225 1522.80541992188 762.41 1522.81030273438 762.412475585938 2 9 1.1.1.3605.20 1 36.3526 443.7194 36.3587 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 39.3900007009506 AATVGSLAGQPLQER Hex(1)HexNAc(1)NeuAc(1)(T)@3 -0.00668133003637195 2153.01538085938 718.6791 2153.02221679688 718.681396484375 3 11 1.1.1.3491.9 1 33.4899 5552.897 33.4235 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 20.6400007009506 AATVGSLAGQPLQER -0.00269694998860359 1496.79211425781 499.938 1496.79467773438 499.938842773438 3 10 1.1.1.3484.6 1 33.3093 39321.61 33.4482 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 17.9299995303154 AATVGSLAGQPLQER Deamidated(Q)@13 0.0162247996777296 1497.79467773438 500.2722 1497.77868652344 500.266845703125 3 10 1.1.1.3485.4 1 33.3323 12707.15 33.4482 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQERAQAWGER missed R-A@15 -0.00137569999787956 2295.17065429688 574.7999 2295.171875 574.80029296875 4 15 1.1.1.3763.11 1 40.3771 1515.335 40.3646 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 60.6100022792816 AATVGSLAGQPLQERAQAWGER Dioxidation(W)@19 missed R-A@15 0.00618722988292575 2327.16796875 776.7299 2327.16186523438 776.727905273438 3 8 1.1.1.3747.20 1 39.9667 5042.876 39.8711 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 52.700001001358 AATVGSLAGQPLQERAQAWGER Dioxidation(W)@19 missed R-A@15 0.00618722988292575 2327.16796875 776.7299 2327.16186523438 776.727905273438 3 8 1.1.1.3740.20 1 39.7887 5042.876 39.8711 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 16.5199995040894 AKLEEQAQQIR missed K-L@2 -0.000381846009986475 1312.70947265625 438.5771 1312.7099609375 438.577239990234 3 6 1.1.1.3090.4 1 23.6112 22468.54 23.7514 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AKLEEQAQQIRLQAEAFQAR missed K-L@2; missed R-L@11 0.00292539992369711 2327.23779296875 582.8167 2327.23461914063 582.81591796875 4 19 1.1.1.3815.8 1 41.683 91567.35 41.8042 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AKLEEQAQQIRLQAEAFQAR missed K-L@2; missed R-L@11 0.00292539992369711 2327.23779296875 582.8167 2327.23461914063 582.81591796875 4 20 1.1.1.3829.10 1 42.0507 96608.77 41.7781 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AKLEEQAQQIRLQAEAFQAR missed K-L@2; missed R-L@11 -0.00732827000319958 2327.22729492188 582.8141 2327.23461914063 582.81591796875 4 13 1.1.1.3836.9 1 42.2356 10073.5 41.9591 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 97.9099988937378 AKLEEQAQQIRLQAEAFQAR Acetyl@N-term; Deamidated(Q)@13 missed K-L@2; missed R-L@11 0.0466725006699562 2370.27563476563 593.5762 2370.22924804688 593.564575195313 4 12 1.1.1.3831.8 1 42.1022 1050.137 42.0917 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 97.9200005531311 ALMDETMKELK Oxidation(M)@3; Oxidation(M)@7 missed K-E@8 -0.000629290007054806 1339.63562011719 447.5525 1339.63635253906 447.552734375 3 12 1.1.1.3090.5 1 23.6137 11748.72 23.5515 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 96.5499997138977 ALMDETMKELK Oxidation(M)@3; Oxidation(M)@7 missed K-E@8 -0.000629290007054806 1339.63562011719 447.5525 1339.63635253906 447.552734375 3 11 1.1.1.3083.3 1 23.4394 11748.72 23.5515 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 19.42999958992 AQAWGER -0.004738740157336 816.383056640625 409.1988 816.387878417969 409.201202392578 2 6 1.1.1.3024.2 1 22.0473 635.2736 21.942 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 34.1199994087219 ARLSKELQAAQAR Acetyl@N-term missed R-L@2; missed K-E@5 -0.00438018003478646 1482.82238769531 495.2814 1482.82666015625 495.282836914063 3 7 1.1.1.3273.12 1 28.094 734.3063 28.1068 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AYKSELEEQLTPVAEETR missed K-S@3 0.00222384999506176 2092.03466796875 698.3522 2092.03247070313 698.351440429688 3 18 1.1.1.3682.18 1 38.2822 34369.88 38.4184 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AYKSELEEQLTPVAEETR missed K-S@3 0.00222384999506176 2092.03466796875 698.3522 2092.03247070313 698.351440429688 3 13 1.1.1.3696.18 1 38.6449 34369.88 38.4184 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AYKSELEEQLTPVAEETR missed K-S@3 0.00475770002231002 2092.03735351563 524.0166 2092.03247070313 524.015380859375 4 12 1.1.1.3690.9 1 38.4813 2446.782 38.4184 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 39.1799986362457 AYKSELEEQLTPVAEETR Carbamidomethyl@N-term missed K-S@3 -0.00248901988379657 2149.05126953125 717.3577 2149.05395507813 717.358581542969 3 7 1.1.1.3686.20 1 38.3865 810.5104 38.3407 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 46.5499997138977 AYKSELEEQLTPVAEETRAR missed K-S@3; missed R-A@18 -0.00155753002036363 2319.16943359375 580.7996 2319.17065429688 580.799926757813 4 8 1.1.1.3649.11 1 37.4567 15816.61 37.2365 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 38.1300002336502 AYKSELEEQLTPVAEETRAR missed K-S@3; missed R-A@18 0.000963298021815717 2319.17163085938 580.8002 2319.17065429688 580.799926757813 4 8 1.1.1.3635.9 1 37.0928 15780 37.2365 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 25.9600013494492 DADDLQKRLAVYQAGAR missed K-R@7; missed R-L@8 -0.00643193023279309 1888.96887207031 630.6636 1888.97546386719 630.665771484375 3 8 1.1.1.3641.15 1 37.2521 7432.509 37.314 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 DRLDEVKEQVAEVR missed R-L@2; missed K-E@7 5.73877005081158E-05 1684.87438964844 562.6321 1684.87438964844 562.632080078125 3 12 1.1.1.3563.12 1 35.2627 24258.57 35.4057 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 DRLDEVKEQVAEVR missed R-L@2; missed K-E@7 5.73877005081158E-05 1684.87438964844 562.6321 1684.87438964844 562.632080078125 3 19 1.1.1.3570.12 1 35.4454 24258.57 35.4057 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 30.3799986839294 ELQAAQAR -0.00119168998207897 885.465698242188 443.7401 885.466857910156 443.740692138672 2 8 1.1.1.2821.2 1 18.448 1259.515 18.5585 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 29.1500002145767 ELQAAQAR -0.00357200996950269 885.463256835938 443.7389 885.466857910156 443.740692138672 2 6 1.1.1.2838.3 1 18.8067 958.993 18.6068 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 29.1500002145767 ELQAAQAR -0.00338891008868814 885.463500976563 443.739 885.466857910156 443.740692138672 2 6 1.1.1.2848.2 1 18.9752 359.7631 18.8178 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 GEVQAMLGQSTEELR Oxidation(M)@6 0.00307861994951963 1662.79150390625 555.2711 1662.78833007813 555.27001953125 3 20 1.1.1.3474.7 1 33.066 3512.086 33.1273 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 27.3299992084503 GEVQAMLGQSTEELRVR Oxidation(M)@6 missed R-V@15 -0.00258044991642237 1917.95520019531 640.3257 1917.95776367188 640.326538085938 3 10 1.1.1.3589.16 1 35.941 8970.085 35.7203 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 84.7500026226044 IRERLGPLVEQGRVRAATVGSLAGQPLQER cleaved A-I@N-term; missed R-E@2; missed R-L@4; missed R-V@13; missed R-A@15 2.99899005889893 3258.82666015625 815.7139 3255.82763671875 814.964172363281 4 10 1.1.1.3567.21 1 35.3744 3656.231 35.3274 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 65.3800010681152 KAYKSELEEQLTPVAEETR Oxidation(Y)@3 cleaved L-K@N-term; missed K-A@1; missed K-S@4 0.00699122995138168 2236.12939453125 746.3837 2236.12231445313 746.381408691406 3 8 1.1.1.3716.21 1 39.1666 781.9724 39.1718 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 KVEQAVETEPEPELR Acetyl@N-term cleaved A-K@N-term; missed K-V@1 0.00431940983980894 1794.904296875 599.3087 1794.89990234375 599.307250976563 3 17 1.1.1.3468.4 1 32.9183 855.3625 32.9056 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 KVEQAVETEPEPELR cleaved A-K@N-term; missed K-V@1 0.00364020001143217 1752.89282226563 585.3049 1752.88940429688 585.3037109375 3 15 1.1.1.3260.17 1 27.7801 38511.73 27.9583 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 KVEQAVETEPEPELR cleaved A-K@N-term; missed K-V@1 0.00382329989224672 1752.89318847656 585.305 1752.88940429688 585.3037109375 3 12 1.1.1.3278.15 1 28.22 38857.08 27.9583 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 KVEQAVETEPEPELR acrolein addition +56(K)@1; Deamidated(Q)@4 cleaved A-K@N-term; missed K-V@1 0.00813104957342148 1809.90783691406 604.3099 1809.89965820313 604.30712890625 3 12 1.1.1.3272.20 1 28.0758 1014.078 28.1068 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 97.759997844696 KVEQAVETEPEPELR reduced acrolein addition +58(K)@1; Dehydrated(E)@3; Deamidated(Q)@4 cleaved A-K@N-term; missed K-V@1 0.00935825984925032 1793.91394042969 598.9786 1793.90466308594 598.975524902344 3 12 1.1.1.3279.13 1 28.243 1162.824 28.2549 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 78.9900004863739 KVEQAVETEPEPELR cleaved A-K@N-term; missed K-V@1 0.0135276997461915 1752.90283203125 585.3082 1752.88940429688 585.3037109375 3 7 1.1.1.3294.16 1 28.6144 511.7303 28.5991 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 KVEQAVETEPEPELRQQTEWQSGQR Dioxidation(W)@20 cleaved A-K@N-term; missed K-V@1; missed R-Q@15 0.00385814998298883 3013.44165039063 754.3677 3013.43774414063 754.36669921875 4 18 1.1.1.3420.17 1 31.7249 3269.377 31.7334 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 KVEQAVETEPEPELRQQTEWQSGQR cleaved A-K@N-term; missed K-V@1; missed R-Q@15 0.0272466000169516 2981.47485351563 746.376 2981.44799804688 746.369262695313 4 19 1.1.1.3463.7 1 32.7994 4803.391 32.7336 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LAVYQAGAR -0.00319449999369681 947.515686035156 474.7651 947.518859863281 474.766723632813 2 8 1.1.1.3169.4 1 25.5621 62711.86 25.4573 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LDEVKEQVAEVR missed K-E@5 -0.00024283499806188 1413.74621582031 472.256 1413.74633789063 472.256072998047 3 16 1.1.1.3196.7 1 26.2089 1436.218 26.2729 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Oxidation(M)@5; Carbamidomethyl(C)@9 -0.00192336004693061 1237.5048828125 619.7597 1237.50671386719 619.760620117188 2 18 1.1.1.3074.3 1 23.2243 50550.45 23.3319 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Oxidation(M)@5; Carbamidomethyl(C)@9 -0.00192336004693061 1237.5048828125 619.7597 1237.50671386719 619.760620117188 2 19 1.1.1.3081.9 1 23.3992 50550.45 23.3319 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Oxidation(M)@5; Carbamidomethyl(C)@9 -0.00192336004693061 1237.5048828125 619.7597 1237.50671386719 619.760620117188 2 17 1.1.1.3088.20 1 23.5712 53573.92 23.3077 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Oxidation(M)@5; Carbamidomethyl(C)@9 -0.0016792300157249 1237.50512695313 619.7598 1237.50671386719 619.760620117188 2 13 1.1.1.3095.18 1 23.7462 5146.041 23.4774 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Oxidation(M)@5; Carbamidomethyl(C)@9 -0.0016792300157249 1237.50512695313 619.7598 1237.50671386719 619.760620117188 2 10 1.1.1.3102.18 1 23.918 1370.791 23.6516 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Dioxidation(M)@5; Carbamidomethyl(C)@9 -0.00138578994665295 1253.50024414063 627.7574 1253.50158691406 627.758117675781 2 12 1.1.1.3105.20 1 23.996 1365.161 24.0518 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Oxidation(M)@5; Carbamidomethyl(C)@9 0.00454619992524385 1237.51123046875 619.7629 1237.50671386719 619.760620117188 2 11 1.1.1.3109.13 1 24.0948 541.5612 24.0265 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Delta:H(2)C(2)@N-term; Oxidation(M)@5; Carbamidomethyl(C)@9 -0.000520551984664053 1263.52185058594 632.7682 1263.52233886719 632.768432617188 2 14 1.1.1.3147.7 1 25.0358 1594.413 24.9225 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Delta:H(2)C(2)@N-term; Oxidation(M)@5; Carbamidomethyl(C)@9 -0.000520551984664053 1263.52185058594 632.7682 1263.52233886719 632.768432617188 2 14 1.1.1.3140.8 1 24.8688 1594.413 24.9225 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Dioxidation(M)@5; Carbamidomethyl(C)@9 -0.00138578994665295 1253.50024414063 627.7574 1253.50158691406 627.758117675781 2 9 1.1.1.3112.20 1 24.1761 1365.161 24.0518 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Delta:H(2)C(2)@N-term; Oxidation(M)@5; Carbamidomethyl(C)@9 -0.00381636992096901 1263.51843261719 632.7665 1263.52233886719 632.768432617188 2 12 1.1.1.3123.21 1 24.4549 1483.494 24.384 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Delta:H(2)C(2)@N-term; Oxidation(M)@5; Carbamidomethyl(C)@9 -0.00381636992096901 1263.51843261719 632.7665 1263.52233886719 632.768432617188 2 10 1.1.1.3116.16 1 24.2751 1483.494 24.384 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 52.7899980545044 LGADMEDVCGR Oxidation(M)@5; Carbamidomethyl(C)@9 -0.0016792300157249 1237.50512695313 619.7598 1237.50671386719 619.760620117188 2 5 1.1.1.3123.20 1 24.4541 302.4044 24.384 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGPLVEQGR -0.00361170992255211 967.54150390625 484.778 967.545104980469 484.779815673828 2 10 1.1.1.3246.10 1 27.4328 13692.45 27.6646 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGPLVEQGR -0.00226897001266479 967.542846679688 484.7787 967.545104980469 484.779815673828 2 14 1.1.1.3253.8 1 27.6037 21969.26 27.7625 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGPLVEQGR -0.00226897001266479 967.542846679688 484.7787 967.545104980469 484.779815673828 2 12 1.1.1.3260.9 1 27.7717 21969.26 27.7625 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGPLVEQGR -0.00226897001266479 967.542846679688 484.7787 967.545104980469 484.779815673828 2 13 1.1.1.3267.5 1 27.9414 21969.26 27.7625 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGPLVEQGR -0.00403894996270537 967.541076660156 484.7778 967.545104980469 484.779815673828 2 11 1.1.1.3281.12 1 28.2914 5512.366 28.3042 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 26.0699987411499 LGPLVEQGR -0.00403894996270537 967.541076660156 484.7778 967.545104980469 484.779815673828 2 8 1.1.1.3289.7 1 28.4885 5512.366 28.3042 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 52.7899980545044 LGPLVEQGRVR missed R-V@9 -0.00290478998795152 1222.7119140625 408.5779 1222.71459960938 408.578796386719 3 11 1.1.1.3268.2 1 27.9626 19526.58 27.8115 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 47.4999994039536 LGPLVEQGRVR missed R-V@9 -0.00290478998795152 1222.7119140625 408.5779 1222.71459960938 408.578796386719 3 11 1.1.1.3261.3 1 27.7962 19526.58 27.8115 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 29.1500002145767 LGPLVEQGRVR missed R-V@9 0.000116388000606094 1222.71484375 408.5789 1222.71459960938 408.578796386719 3 10 1.1.1.3282.2 1 28.3086 12042.95 28.2549 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 25.0699996948242 LGPLVEQGRVR missed R-V@9 -0.00533886021003127 1222.70922851563 612.3619 1222.71459960938 612.364562988281 2 8 1.1.1.3254.8 1 27.6299 2638.297 27.7625 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQR Dioxidation(W)@4; Oxidation(M)@12 missed K-S@2 -0.00647029979154468 1824.86535644531 609.2957 1824.87158203125 609.2978515625 3 14 1.1.1.3881.13 1 43.4094 15105.21 43.4468 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQR Dioxidation(M)@12 missed K-S@2 -0.00142236996907741 1808.87524414063 603.9657 1808.87670898438 603.966186523438 3 11 1.1.1.4033.9 1 47.2918 1098.966 47.307 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LLRDADDLQKR missed R-D@3; missed K-R@10 -0.00231795990839601 1341.73425292969 448.252 1341.73645019531 448.252777099609 3 14 1.1.1.3104.5 1 23.9591 5460.352 23.8755 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LLRDADDLQKRLAVYQAGAR missed R-D@3; missed K-R@10; missed R-L@11 0.000855201971717179 2271.24584960938 568.8187 2271.24487304688 568.818481445313 4 15 1.1.1.3735.11 1 39.6546 19068.31 39.744 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 94.0199971199036 LLRDADDLQKRLAVYQAGAR missed R-D@3; missed K-R@10; missed R-L@11 0.00440016016364098 2271.2490234375 758.0903 2271.24487304688 758.0888671875 3 9 1.1.1.3741.19 1 39.8132 2522.013 39.744 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 83.3100020885468 LLRDADDLQKRLAVYQAGAR missed R-D@3; missed K-R@10; missed R-L@11 0.000855201971717179 2271.24584960938 568.8187 2271.24487304688 568.818481445313 4 8 1.1.1.3749.10 1 40.009 19215.87 39.744 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LQAEAFQAR -0.0040450100786984 1032.53125 517.2729 1032.53527832031 517.27490234375 2 14 1.1.1.3200.4 1 26.3124 13587.27 26.1997 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LSKELQAAQAR missed K-E@3 -0.00220981007441878 1213.67565917969 607.8451 1213.67785644531 607.84619140625 2 18 1.1.1.3039.3 1 22.4387 3122.645 22.5181 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LSKELQAAQAR Acetyl(K)@3 missed K-E@3 -0.00404930021613836 1255.68444824219 628.8495 1255.6884765625 628.851501464844 2 18 1.1.1.3261.6 1 27.8062 2108.29 27.6402 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LSKELQAAQAR Acetyl@N-term missed K-E@3 -0.0034389600623399 1255.68505859375 628.8498 1255.6884765625 628.851501464844 2 15 1.1.1.3254.9 1 27.6324 2117.183 27.6157 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LVQYRGEVQAMLGQSTEELR Oxidation(M)@11 missed R-G@5 0.00189600000157952 2322.16577148438 775.0625 2322.16381835938 775.061889648438 3 17 1.1.1.3699.17 1 38.7219 5745.046 38.6527 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LVQYRGEVQAMLGQSTEELR Oxidation(M)@11 missed R-G@5 -0.00286461994983256 2322.16088867188 775.0609 2322.16381835938 775.061889648438 3 14 1.1.1.3685.21 1 38.3614 4534.848 38.4704 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 70.1799988746643 LVQYRGEVQAMLGQSTEELR Oxidation(M)@11 missed R-G@5 0.00474571995437145 2322.16845703125 581.5494 2322.16381835938 581.548217773438 4 9 1.1.1.3689.15 1 38.4602 1262.039 38.6267 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LVQYRGEVQAMLGQSTEELRVR Oxidation(M)@11 missed R-G@5; missed R-V@20 0.00560201006010175 2577.3388671875 645.342 2577.33325195313 645.340576171875 4 18 1.1.1.3728.16 1 39.4746 78854.96 39.7187 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LVQYRGEVQAMLGQSTEELRVR Oxidation(M)@11 missed R-G@5; missed R-V@20 0.000963450991548598 2577.33422851563 645.3408 2577.33325195313 645.340576171875 4 19 1.1.1.3742.19 1 39.8388 79547.31 39.7187 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LVQYRGEVQAMLGQSTEELRVR Oxidation(M)@11 missed R-G@5; missed R-V@20 0.000666822015773505 2577.33422851563 516.4741 2577.33325195313 516.473937988281 5 14 1.1.1.3740.7 1 39.7778 5245.744 39.6935 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 98.0300009250641 LVQYRGEVQAMLGQSTEELRVR Oxidation(M)@11 missed R-G@5; missed R-V@20 0.000963450991548598 2577.33422851563 645.3408 2577.33325195313 645.340576171875 4 13 1.1.1.3749.17 1 40.0148 73070.29 39.744 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 98.0300009250641 LVQYRGEVQAMLGQSTEELRVR Oxidation(M)@11 missed R-G@5; missed R-V@20 -0.0141728995367885 2577.31884765625 645.337 2577.33325195313 645.340576171875 4 13 1.1.1.3780.6 1 40.809 1107.509 40.7894 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 98.0300009250641 LVQYRGEVQAMLGQSTEELRVR Oxidation(M)@11 missed R-G@5; missed R-V@20 0.0148791000247002 2577.34814453125 645.3443 2577.33325195313 645.340576171875 4 13 1.1.1.3787.5 1 40.9748 1286.191 40.9134 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 97.1300005912781 LVQYRGEVQAMLGQSTEELRVR Oxidation(M)@11 missed R-G@5; missed R-V@20 -0.000257223000517115 2577.3330078125 645.3405 2577.33325195313 645.340576171875 4 12 1.1.1.3756.15 1 40.1963 7621.998 39.9223 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 15.9999996423721 LVQYRGEVQAMLGQSTEELRVR Oxidation(M)@11 missed R-G@5; missed R-V@20 0.00169585994444788 2577.3349609375 645.341 2577.33325195313 645.340576171875 4 11 1.1.1.3773.11 1 40.6279 1184.317 40.615 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 QWAGLVEKVQAAVGTSAAPVPSDNH Dioxidation(W)@2 missed K-V@8 -0.00584818003699183 2563.26098632813 855.4276 2563.2666015625 855.429504394531 3 16 1.1.1.4017.20 1 46.8897 5332.022 46.948 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 QWAGLVEKVQAAVGTSAAPVPSDNH missed K-V@8 0.0276634991168976 2531.3046875 844.7755 2531.27685546875 844.766235351563 3 19 1.1.1.4121.19 1 49.5448 2135.334 49.5772 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 SELEEQLTPVAEETR -0.0065256399102509 1729.83044433594 865.9225 1729.83703613281 865.92578125 2 25 1.1.1.3659.13 1 37.7132 8146.86 37.644 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 SELEEQLTPVAEETR -0.00432843016460538 1729.83264160156 865.9236 1729.83703613281 865.92578125 2 20 1.1.1.3667.17 1 37.9098 8140.841 37.644 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 SELEEQLTPVAEETR 0.000768886995501816 1729.83776855469 577.6199 1729.83703613281 577.61962890625 3 16 1.1.1.3658.6 1 37.6809 5292.387 37.644 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 17.5200000405312 SELEEQLTPVAEETR -0.00765377003699541 1729.82958984375 577.6171 1729.83703613281 577.61962890625 3 7 1.1.1.3680.7 1 38.2228 757.2535 38.2147 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 TRDRLDEVKEQVAEVR missed R-D@2; missed R-L@4; missed K-E@9 0.00232691993005574 1942.02575683594 486.5137 1942.02319335938 486.513092041016 4 14 1.1.1.3425.7 1 31.8413 61265.15 31.9594 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 TRDRLDEVKEQVAEVR missed R-D@2; missed R-L@4; missed K-E@9 0.00232691993005574 1942.02575683594 486.5137 1942.02319335938 486.513092041016 4 19 1.1.1.3432.8 1 32.0202 61265.15 31.9594 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 TRDRLDEVKEQVAEVR missed R-D@2; missed R-L@4; missed K-E@9 0.00232691993005574 1942.02575683594 486.5137 1942.02319335938 486.513092041016 4 16 1.1.1.3439.6 1 32.2008 62862.6 31.9594 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 85.7200026512146 TRDRLDEVKEQVAEVR Acetyl@N-term missed R-D@2; missed R-L@4; missed K-E@9 0.0146639999002218 1984.04858398438 497.0194 1984.03381347656 497.015716552734 4 8 1.1.1.3743.3 1 39.8509 1361.199 39.744 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 TRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQAR Deamidated(Q)@22 missed R-D@2; missed R-L@4; missed K-E@9; missed R-A@16; missed K-L@18; missed R-L@27 0.0187123008072376 4252.25 709.7156 4252.2314453125 709.712463378906 6 16 1.1.1.4436.15 1 57.604 3249.48 57.5885 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 TRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQAR missed R-D@2; missed R-L@4; missed K-E@9; missed R-A@16; missed K-L@18; missed R-L@27 0.0143371997401118 4251.26171875 608.3304 4251.2470703125 608.328308105469 7 11 1.1.1.4440.8 1 57.7024 1745.815 57.6924 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 47.4999994039536 VEQAVETEPEPELR 0.0190255995839834 1624.81359863281 542.6118 1624.79443359375 542.605407714844 3 11 1.1.1.3357.10 1 30.1637 725.9007 30.1527 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 VQAAVGTSAAPVPSDNH 0.00493100984022021 1619.79528808594 810.9049 1619.79040527344 810.902465820313 2 19 1.1.1.3206.9 1 26.4627 10431.4 26.6874 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 VQAAVGTSAAPVPSDNH 0.00480894977226853 1619.79504394531 810.9048 1619.79040527344 810.902465820313 2 29 1.1.1.3213.10 1 26.6334 11020.07 26.6874 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 VQAAVGTSAAPVPSDNH 0.00480894977226853 1619.79504394531 810.9048 1619.79040527344 810.902465820313 2 27 1.1.1.3220.11 1 26.804 11020.07 26.6874 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 VQAAVGTSAAPVPSDNH 0.00212346995249391 1619.79248046875 810.9035 1619.79040527344 810.902465820313 2 24 1.1.1.3227.16 1 26.9748 3144.95 26.98 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 47.4999994039536 VQAAVGTSAAPVPSDNH -0.00210337992757559 1619.78833007813 540.9367 1619.79040527344 540.937377929688 3 9 1.1.1.3234.11 1 27.1412 704.356 27.1514 2 80.99 80.99 84.5399975776672 74.7600018978119 74.7600018978119 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 98.7999975681305 YKSELEEQLTPVAEETR acrolein addition +112(K)@2 cleaved A-Y@N-term; missed K-S@2 0.0112484004348516 2133.05883789063 712.0269 2133.0478515625 712.023193359375 3 10 1.1.1.3708.20 1 38.9591 1454.274 39.043 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 DVLEGNEQFINAAK cleaved I-D@N-term 0.00534975016489625 1546.76806640625 774.3913 1546.7626953125 774.388671875 2 10 1.1.1.3745.19 1 39.9154 512.0485 39.897 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 GEHNIDVLEGNEQFINAAK cleaved L-G@N-term 0.000291038013529032 2097.01293945313 700.0116 2097.0126953125 700.011535644531 3 19 1.1.1.3828.16 1 42.0292 2565.299 42.0917 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@23; Delta:H(4)C(2)(K)@39 cleaved L-G@N-term; missed K-I@19; missed K-L@39 -0.000730858009774238 5573.8818359375 797.2761 5573.8828125 797.276245117188 7 20 1.1.1.4585.7 1 61.5041 4440.453 61.4701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 GNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@12 cleaved N-G@N-term; missed K-L@12 -0.00379784009419382 2400.2646484375 801.0955 2400.26831054688 801.0966796875 3 21 1.1.1.4237.18 1 52.5025 15594.91 52.4589 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@14 -0.00582720991224051 2283.15112304688 762.0576 2283.15698242188 762.0595703125 3 22 1.1.1.4030.20 1 47.2245 17170.04 47.2561 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Ammonia-loss(N)@10 missed K-L@20 0.0117317996919155 3291.70385742188 823.9332 3291.69213867188 823.930297851563 4 21 1.1.1.4298.15 1 54.0557 12104.99 54.117 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 IMLIKLSSPATLNSR cleaved D-I@N-term; missed K-L@5 -0.00374756008386612 1642.94055175781 548.6541 1642.94396972656 548.6552734375 3 16 1.1.1.3909.6 1 44.112 1953.75 44.1801 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAK missed R-L@4 -0.00192091998178512 2706.40673828125 903.1429 2706.40893554688 903.143615722656 3 22 1.1.1.4011.18 1 46.7323 42386.26 46.7922 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK missed R-L@4; missed K-I@24 -0.00782877020537853 4970.5634765625 829.4345 4970.5712890625 829.435791015625 6 21 1.1.1.4514.21 1 59.6584 1790.116 59.6636 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed R-L@4; missed K-I@24; missed K-L@44 -0.00894196983426809 5997.1083984375 1200.429 5997.1171875 1200.4306640625 5 21 1.1.1.4552.21 1 60.6628 8071.868 60.72 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 IVGGYTCAANSIPYQVSLNSG Carbamidomethyl(C)@7 cleaved G-S@C-term -0.00516636995598674 2170.03149414063 724.3511 2170.03637695313 724.352783203125 3 19 1.1.1.3990.15 1 46.182 30815.67 46.1922 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 0.050067700445652 4814.30712890625 963.8687 4814.2568359375 963.858642578125 5 16 1.1.1.4191.18 1 51.3312 91255.4 51.2367 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 KIITHPNFNGNTLDNDIMLIK Oxidation(K)@1 cleaved A-K@N-term; missed K-I@1 -0.00200561992824078 2426.26098632813 809.7609 2426.2626953125 809.761535644531 3 20 1.1.1.4164.20 1 50.642 11188.66 50.6991 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 KIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(K)@1 cleaved A-K@N-term; missed K-I@1; missed K-L@21 -0.00541219022125006 3452.80346679688 864.2081 3452.80859375 864.209411621094 4 19 1.1.1.4318.20 1 54.5701 9011.586 54.5251 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 LGEHNIDVLEGN cleaved N-E@C-term 0.000319242011755705 1308.63122558594 655.3229 1308.63098144531 655.32275390625 2 12 1.1.1.3589.17 1 35.9418 1836.126 36.0257 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQ cleaved Q-F@C-term -0.00244764005765319 1565.72961425781 783.8721 1565.73217773438 783.873352050781 2 15 1.1.1.3591.20 1 35.9946 3403.492 35.9254 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFINAAK Ammonia-loss(N)@17 -0.000590796989854425 2193.06982421875 732.0305 2193.0703125 732.030700683594 3 19 1.1.1.3923.12 1 44.4708 3349.17 44.4582 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNF hexanoyl addition +98(K)@20; Delta:H(2)C(2)(H)@24 cleaved F-N@C-term; missed K-I@20 -0.0138825001195073 3156.61059570313 790.1599 3156.62451171875 790.163391113281 4 18 1.1.1.4360.16 1 55.6423 10145.05 55.5748 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK missed K-I@20 0.00231922999955714 4474.2626953125 1119.573 4474.25927734375 1119.57202148438 4 13 1.1.1.4521.21 1 59.8452 2868.801 59.8769 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.0522157996892929 5199.70751953125 867.6252 5199.6552734375 867.616455078125 6 13 1.1.1.4778.10 1 66.4267 2671.052 66.3632 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Ammonia-loss(N)@34 missed K-I@20; missed K-L@40 -0.0263833999633789 5483.75146484375 914.9659 5483.7783203125 914.970336914063 6 15 1.1.1.4571.8 1 61.1477 1971.043 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 LSSPATLNSR -0.0087289996445179 1044.54772949219 523.2811 1044.55639648438 523.285461425781 2 8 1.1.1.3093.9 1 23.693 866.9204 23.7514 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN acrolein addition +56(K)@8; Carbamidomethyl(C)@10 missed K-V@8 0.0339525006711483 2736.4033203125 913.1417 2736.36938476563 913.13037109375 3 12 1.1.1.4418.18 1 57.1403 9863.287 57.1738 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; MDA adduct +62(K)@23; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 -0.0244046002626419 5975.03955078125 996.8472 5975.06396484375 996.851257324219 6 17 1.1.1.4591.12 1 61.6642 42016.14 61.4701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 TLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@10 cleaved N-T@N-term; missed K-L@10 -0.00339168007485569 2229.20043945313 744.0741 2229.20385742188 744.075256347656 3 19 1.1.1.4185.18 1 51.1778 10050.48 51.2623 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 VATVSLPR -0.00298639992251992 841.499267578125 421.7569 841.502136230469 421.758361816406 2 9 1.1.1.3498.4 1 33.6515 2293.906 33.671 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 2 99.0000009536743 VLEGNEQFINAAK cleaved D-V@N-term 0.0102795995771885 1431.74609375 716.8803 1431.73583984375 716.875183105469 2 17 1.1.1.3518.10 1 34.1581 1449.82 34.2142 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 1.88605630397797 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.0481412000954151 5313.74365234375 1063.756 5313.69775390625 1063.74682617188 5 12 1.1.1.4710.20 1 64.6676 11555.37 64.7786 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 1.36653172969818 99.0000009536743 IITHPNFNGNTLDND cleaved D-I@C-term 0.00705602997913957 1683.79223632813 842.9034 1683.78527832031 842.89990234375 2 13 1.1.1.3575.21 1 35.5841 1660.896 35.5893 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 1.07058119773865 99.0000009536743 LGEHNIDVLEGNEQF cleaved F-I@C-term 0.00532886013388634 1712.80590820313 857.4102 1712.80053710938 857.407592773438 2 13 1.1.1.3879.21 1 43.3641 2717.773 43.4213 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 1.0177286863327 99.0000009536743 LGEHNIDVLEGNEQFIN Deamidated(N)@17 cleaved N-A@C-term 0.00719769997522235 1940.91882324219 971.4667 1940.91162109375 971.463073730469 2 12 1.1.1.3978.20 1 45.8748 973.4619 45.83 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.647817432880402 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPN acrolein addition +94(K)@20 cleaved N-F@C-term; missed K-I@20 0.0184570997953415 2979.52758789063 994.1831 2979.50903320313 994.176940917969 3 10 1.1.1.4622.18 1 62.4504 848.2321 62.4077 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.578396081924438 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITH Deamidated(N)@17; MDA adduct +62(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 -0.0102842999622226 2895.49169921875 724.8802 2895.50170898438 724.882751464844 4 14 1.1.1.4243.15 1 52.6537 4136.069 52.6127 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.20273245871067 99.0000009536743 IDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@15; Deamidated(N)@29 cleaved N-I@N-term; missed K-I@15; missed K-L@35 0.0219042003154755 5007.5888671875 1002.525 5007.56494140625 1002.52032470703 5 11 1.1.1.4695.19 1 64.2835 1903.752 64.2649 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.134303942322731 94.5699989795685 YVNWIQQTIAAN cleaved N-Y@N-term 0.014189500361681 1419.72888183594 710.8717 1419.71472167969 710.864624023438 2 8 1.1.1.4150.14 1 50.2807 1061.302 50.3171 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.0438315682113171 77.1399974822998 SQWVVSAAHCYKSRIQVRLGEHNIDVLEGNEQFINAAK Carbamidomethyl(C)@10; MDA adduct +54(K)@12 cleaved N-S@N-term; missed K-S@12; missed R-I@14; missed R-L@18 -0.0131614999845624 4420.20068359375 885.0474 4420.21337890625 885.049987792969 5 10 1.1.1.3882.15 1 43.4365 3682.088 43.5228 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.0433514192700386 99.0000009536743 CAAAGTECLISGWGNTK Carbamidomethyl(C)@1; Cation:Na(E)@7; Carbamidomethyl(C)@8 cleaved S-C@N-term 0.000936741009354591 1816.78564453125 909.4001 1816.78479003906 909.399719238281 2 16 1.1.1.3893.20 1 43.7194 6070.694 43.6496 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.040481623262167 91.159999370575 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIML reduced acrolein addition +96(K)@20; reduced HNE(H)@24 cleaved L-I@C-term; missed K-I@20 -0.00386728998273611 4487.2626953125 1122.823 4487.26806640625 1122.82434082031 4 8 1.1.1.4525.20 1 59.9497 3584.63 60.0085 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.0362121723592281 94.3700015544891 FNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@14 cleaved N-F@N-term; missed K-L@14 0.0501703992486 2787.49780273438 697.8817 2787.44775390625 697.869201660156 4 9 1.1.1.4547.9 1 60.5221 2480.246 60.5636 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.0268721450120211 97.9900002479553 IITHPNFNGNTLD cleaved D-N@C-term -0.00544128008186817 1454.70983886719 728.3622 1454.71533203125 728.364990234375 2 10 1.1.1.3605.19 1 36.3518 1211.947 36.282 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.0254883076995611 99.0000009536743 INSQWVVSAAHCYKSR Carbamidomethyl(C)@12 cleaved L-I@N-term; missed K-S@14 3.97360992431641 1908.90502929688 955.4598 1904.93151855469 953.473022460938 2 12 1.1.1.4166.18 1 50.6913 11507.71 50.6991 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.0254883076995611 86.6900026798248 IVGGYTCAANSIPYQVSLNS Carbamidomethyl(C)@7 cleaved S-G@C-term 0.00394491013139486 2113.01904296875 705.3469 2113.01489257813 705.345581054688 3 10 1.1.1.3996.15 1 46.3391 9503.401 46.4013 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.0209070984274149 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFN ONE addition +154(K)@20; Delta:H(2)C(2)(H)@24; Deamidated(N)@28 cleaved N-G@C-term; missed K-I@20 0.00274476991035044 3327.6806640625 832.9274 3327.67749023438 832.926635742188 4 14 1.1.1.4303.19 1 54.1868 2842.218 54.1682 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.0150228748098016 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNT cleaved T-L@C-term; missed K-I@20 -1.03271996974945 3417.658203125 855.4218 3418.69067382813 855.679931640625 4 12 1.1.1.4653.6 1 63.2211 1036.734 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.0109953843057156 97.6400017738342 LGEHNIDVLEGNEQFINAAKIITHP reduced HNE(H)@24 cleaved P-N@C-term; missed K-I@20 -0.0427085012197495 2929.51245117188 977.5114 2929.55493164063 977.525573730469 3 10 1.1.1.4601.16 1 61.9176 706.196 61.901 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.00921730790287256 67.5100028514862 LGEHNIDVLEG cleaved G-N@C-term 0.00628944998607039 1194.59423828125 598.3044 1194.58801269531 598.301330566406 2 8 1.1.1.3623.3 1 36.7914 1143.268 36.5379 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.00833099242299795 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATL Delta:H(4)C(2)(K)@20 cleaved L-N@C-term; missed K-L@20 0.00628129998221993 2979.58032226563 994.2007 2979.57397460938 994.198608398438 3 12 1.1.1.4517.18 1 59.7363 3071.725 59.7175 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.00744648277759552 65.4799997806549 DNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@8 cleaved L-D@N-term; missed K-L@8 -0.00923885032534599 2085.10473632813 696.0422 2085.11401367188 696.045288085938 3 8 1.1.1.4525.10 1 59.9413 710.9182 59.8504 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.00700490176677704 86.1800014972687 IQVRLGEHNIDVLEGNEQFINAAKII Deamidated(N)@21; acrolein addition +94(K)@24 cleaved I-T@C-term; missed R-L@4; missed K-I@24 -0.00580831989645958 3027.59741210938 757.9066 3027.60302734375 757.908020019531 4 9 1.1.1.4627.8 1 62.5683 1302.78 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.00568284746259451 99.0000009536743 RLGEHNIDVLEGNEQFINAAK Methyl(H)@5; Deamidated(N)@6 cleaved V-R@N-term; missed R-L@1 -0.0110977003350854 2381.1865234375 794.7361 2381.19750976563 794.739807128906 3 15 1.1.1.3966.17 1 45.5663 1280.348 45.651 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.00436480529606342 95.8100020885468 DIMLIKLSSPATLNSR acrolein addition +94(K)@6 cleaved N-D@N-term; missed K-L@6 0.0511690005660057 1852.06384277344 618.3619 1852.01281738281 618.344909667969 3 8 1.1.1.4576.3 1 61.2719 2289.186 61.3176 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.00174066168256104 97.0700025558472 SRIQVRLGEHNIDVLEGNEQFINAAK Cation:Na(E)@9; Deamidated(N)@11 missed R-I@2; missed R-L@6 0.0182590000331402 2972.5263671875 991.8494 2972.50805664063 991.84326171875 3 13 1.1.1.3880.21 1 43.3902 11788.47 43.4468 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.00174066168256104 98.0400025844574 VGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSR Dehydrated(T)@5; Carbamidomethyl(C)@6; Deamidated(N)@18; Carbamidomethyl(C)@24; Carbamidomethyl(C)@40 cleaved I-V@N-term; missed K-S@42 0.0670301988720894 4772.2626953125 955.4598 4772.19580078125 955.446472167969 5 13 1.1.1.4166.18 1 50.6913 11507.71 50.6991 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.00130484171677381 57.6600015163422 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTL Deamidated(N)@30 cleaved L-D@C-term; missed K-I@20 0.0626031011343002 3532.82104492188 589.8108 3532.75854492188 589.800415039063 6 10 1.1.1.3830.14 1 42.0806 3754.712 42.0386 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.00130484171677381 99.0000009536743 PGVYTKVCNYVNWIQQTIAAN Octanoyl(T)@5; HPNE addition +172(K)@6; Carbamidomethyl(C)@8 cleaved K-P@N-term; missed K-V@6 -0.00130364997312427 2736.41845703125 685.1119 2736.41967773438 685.112182617188 4 14 1.1.1.4421.8 1 57.2098 2579.177 57.2001 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.000434511806815863 99.0000009536743 KLSSPATLNSR Oxidation(K)@1 cleaved I-K@N-term; missed K-L@1 -0.00218813004903495 1188.64404296875 595.3293 1188.64624023438 595.330383300781 2 16 1.1.1.3232.15 1 27.0922 12846.67 27.1025 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.000434511806815863 49.7200012207031 NDIMLIKLSSPATLNSR cleaved D-N@N-term; missed K-L@7 -0.00985443964600563 1872.00402832031 625.0086 1872.01391601563 625.011901855469 3 9 1.1.1.4005.12 1 46.5713 1067.555 46.584 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.000434511806815863 99.0000009536743 NFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@3; Oxidation(N)@5 cleaved P-N@N-term; missed K-L@15 0.0634294971823692 2764.43383789063 692.1157 2764.3701171875 692.099792480469 4 14 1.1.1.4569.9 1 61.0959 1895.837 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0.000434511806815863 98.2100009918213 PNFNGNTLDNDIMLIKLSSPATLNSR Met->Hcy(M)@13; reduced acrolein addition +96(K)@16 cleaved H-P@N-term; missed K-L@16 0.0156519003212452 2926.50170898438 976.5078 2926.48583984375 976.502563476563 3 11 1.1.1.4654.14 1 63.2554 957.7515 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 85.1400017738342 FNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; reduced acrolein addition +58(K)@14 cleaved N-F@N-term; missed K-L@14 -0.0236904993653297 2692.3505859375 674.0949 2692.37426757813 674.100830078125 4 8 1.1.1.4613.6 1 62.2133 988.6151 62.231 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@19; reduced acrolein addition +96(K)@39 cleaved L-G@N-term; missed K-I@19; missed K-L@39 0.0261991992592812 5579.86181640625 798.1304 5579.8359375 798.126708984375 7 15 1.1.1.4623.7 1 62.4666 5558.607 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@23; Delta:H(4)C(2)(K)@39 cleaved L-G@N-term; missed K-I@19; missed K-L@39 0.0368655994534492 5573.91943359375 797.2815 5573.8828125 797.276245117188 7 14 1.1.1.4685.5 1 64.0194 1331.911 64.0129 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.3299970626831 GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@23; Delta:H(4)C(2)(K)@39 cleaved L-G@N-term; missed K-I@19; missed K-L@39 -0.00201255991123617 5573.88037109375 797.2759 5573.8828125 797.276245117188 7 22 1.1.1.4615.10 1 62.2672 3865.141 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.4699981212616 GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@19; MDA adduct +54(K)@39 cleaved L-G@N-term; missed K-I@19; missed K-L@39 0.0143991997465491 5595.8447265625 933.6481 5595.83056640625 933.645751953125 6 7 1.1.1.4833.17 1 67.8972 443.699 67.8788 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 66.1899983882904 GGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@5; Carbamidomethyl(C)@23; Hex(N)@29; reduced HNE(H)@38; Carbamidomethyl(C)@39; acrolein addition +56(K)@41 cleaved V-G@N-term -0.00188672996591777 4823.228515625 965.653 4823.23046875 965.653381347656 5 11 1.1.1.4209.19 1 51.7907 14561.28 51.8998 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 GNTLDNDIMLIKLSSPATLNSR cleaved N-G@N-term; missed K-L@12 -0.00214937003329396 2372.23486328125 791.7522 2372.23706054688 791.7529296875 3 12 1.1.1.4207.16 1 51.7371 2139.017 51.7466 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 GNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@12 cleaved N-G@N-term; missed K-L@12 -0.00379784009419382 2400.2646484375 801.0955 2400.26831054688 801.0966796875 3 13 1.1.1.4230.18 1 52.3237 15594.91 52.4589 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.4399983882904 GNTLDNDIMLIKLSSPATLNSR Deamidated(N)@2; Delta:H(4)C(2)(K)@12 cleaved N-G@N-term; missed K-L@12 0.00624191015958786 2401.25854492188 801.4268 2401.25219726563 801.424682617188 3 11 1.1.1.4246.16 1 52.7311 8257.783 52.4589 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 23.9199995994568 IITHPNFNGNTLDND Deamidated(N)@10 cleaved D-I@C-term 0.00763267977163196 1684.77709960938 843.3958 1684.76928710938 843.391906738281 2 6 1.1.1.3598.21 1 36.1743 672.4946 36.2308 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@10; Oxidation(M)@17 0.0116191999986768 2299.16333007813 767.3951 2299.15185546875 767.391235351563 3 17 1.1.1.4011.16 1 46.7306 44866.05 46.974 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17 -0.00189912994392216 2298.166015625 767.0626 2298.16772460938 767.063232421875 3 26 1.1.1.4018.17 1 46.9134 75123.39 46.974 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17 -0.00189912994392216 2298.166015625 767.0626 2298.16772460938 767.063232421875 3 23 1.1.1.4025.19 1 47.0951 75123.39 46.974 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17 -0.00244843005202711 2298.16528320313 767.0624 2298.16772460938 767.063232421875 3 18 1.1.1.4033.14 1 47.2984 2837.504 47.3835 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8; Oxidation(M)@17 -0.00326602999120951 2299.1484375 767.3901 2299.15185546875 767.391235351563 3 20 1.1.1.4070.19 1 48.2441 25987.82 48.1239 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.986546993255615 2283.15942382813 762.0604 2282.1728515625 761.731567382813 3 23 1.1.1.4133.19 1 49.8517 53274.52 50.0368 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Ammonia-loss(N)@10 -0.000753274012822658 2265.1455078125 756.0558 2265.14624023438 756.056091308594 3 17 1.1.1.4144.18 1 50.1306 22904.21 50.1384 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.990575015544891 2283.16357421875 762.0618 2282.1728515625 761.731567382813 3 21 1.1.1.4159.19 1 50.5138 110703.2 50.2405 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8; Deamidated(N)@14 0.00549397012218833 2284.146484375 762.3894 2284.14086914063 762.387573242188 3 15 1.1.1.4059.19 1 47.9645 3327.561 48.0984 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@14 0.0137007003650069 2283.17041015625 762.0641 2283.15698242188 762.0595703125 3 14 1.1.1.4083.19 1 48.5746 2265.154 48.5307 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17 -0.0054327598772943 2298.16235351563 767.0614 2298.16772460938 767.063232421875 3 10 1.1.1.4085.15 1 48.6221 2301.934 48.6324 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.00768881989642978 2282.18041992188 761.7341 2282.1728515625 761.731567382813 3 22 1.1.1.4091.18 1 48.7775 142388.7 48.9896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17 0.000609572976827621 2298.16845703125 767.0634 2298.16772460938 767.063232421875 3 12 1.1.1.4092.18 1 48.8031 7382.838 48.8877 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.00768881989642978 2282.18041992188 761.7341 2282.1728515625 761.731567382813 3 26 1.1.1.4098.19 1 48.9572 144179.4 48.9896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17 -0.000855236023198813 2298.1669921875 767.0629 2298.16772460938 767.063232421875 3 22 1.1.1.4103.18 1 49.0836 7248.067 49.0914 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.00805502012372017 2282.18115234375 761.7343 2282.1728515625 761.731567382813 3 25 1.1.1.4105.16 1 49.1332 140936.7 49.117 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17 -0.00470035988837481 2298.16284179688 767.0616 2298.16772460938 767.063232421875 3 18 1.1.1.4110.15 1 49.2597 8339.119 48.9896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.00805502012372017 2282.18115234375 761.7343 2282.1728515625 761.731567382813 3 25 1.1.1.4112.16 1 49.3118 140936.7 49.117 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17 -0.0050665601156652 2298.16284179688 767.0615 2298.16772460938 767.063232421875 3 17 1.1.1.4118.18 1 49.467 5747.369 49.1932 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.00347750005312264 2282.17626953125 761.7327 2282.1728515625 761.731567382813 3 25 1.1.1.4119.19 1 49.4935 100143.7 49.2189 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.00621654978021979 2282.17944335938 571.5521 2282.1728515625 571.550476074219 4 17 1.1.1.4122.7 1 49.5603 9382.112 49.2956 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.00384370004758239 2282.17651367188 761.7328 2282.1728515625 761.731567382813 3 24 1.1.1.4126.19 1 49.673 63247.54 49.449 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8 -0.00199027010239661 2283.15502929688 571.796 2283.15698242188 571.796508789063 4 15 1.1.1.4137.7 1 49.9437 5512.494 50.0113 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8 0.00655975984409451 2283.16357421875 762.0618 2283.15698242188 762.0595703125 3 27 1.1.1.4144.19 1 50.1315 112901 50.2149 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8 0.00655975984409451 2283.16357421875 762.0618 2283.15698242188 762.0595703125 3 25 1.1.1.4151.20 1 50.311 112901 50.2149 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8 0.00151557999197394 2283.15942382813 1142.587 2283.15698242188 1142.58569335938 2 10 1.1.1.4154.21 1 50.3883 15835.03 50.2149 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8 0.0160809997469187 2283.1728515625 762.0649 2283.15698242188 762.0595703125 3 11 1.1.1.4210.18 1 51.8154 4042.413 52.0528 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@14; Oxidation(M)@17 -0.00577537016943097 2299.14599609375 767.3893 2299.15185546875 767.391235351563 3 14 1.1.1.3967.15 1 45.5901 3579.651 45.651 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8; Deamidated(N)@14 0.00799413956701756 2284.14916992188 762.3903 2284.14086914063 762.387573242188 3 12 1.1.1.4067.20 1 48.1687 3336.855 48.0984 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@10; Oxidation(M)@17 0.00466137984767556 2299.15673828125 767.3928 2299.15185546875 767.391235351563 3 14 1.1.1.4047.14 1 47.6543 4215.121 47.6144 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK -0.00909196957945824 2282.16381835938 761.7286 2282.1728515625 761.731567382813 3 12 1.1.1.4021.16 1 46.99 2824.574 47.102 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@6; Oxidation(M)@17 0.000945296022109687 2299.15258789063 767.3915 2299.15185546875 767.391235351563 3 11 1.1.1.4077.17 1 48.4204 23505.61 48.1494 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.3699977397919 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17 -0.000983624020591378 2298.1669921875 767.0629 2298.16772460938 767.063232421875 3 13 1.1.1.4040.19 1 47.4793 2611.133 47.4349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 88.0200028419495 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8; Oxidation(M)@17 -0.00577537016943097 2299.14599609375 767.3893 2299.15185546875 767.391235351563 3 10 1.1.1.4058.15 1 47.9357 25797.94 48.1239 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 38.9299988746643 IITHPNFNGNTLDNDIMLIK -0.00238172011449933 2282.17041015625 761.7308 2282.1728515625 761.731567382813 3 12 1.1.1.4166.12 0 50.6863 8981.11 50.6736 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 26.3799995183945 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17 0.00495770992711186 2298.17333984375 1150.094 2298.16772460938 1150.09118652344 2 10 1.1.1.4020.21 1 46.9688 4568.583 46.974 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17; Methyl(K)@20 missed K-L@20 0.022774999961257 3338.75219726563 835.6953 3338.72924804688 835.689575195313 4 18 1.1.1.4216.18 1 51.9685 3068.228 52.0272 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17; Delta:H(4)C(2)(K)@20 missed K-L@20 0.0263097994029522 3352.77124023438 839.2001 3352.74487304688 839.193481445313 4 17 1.1.1.4226.14 1 52.2188 2670.901 52.2552 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17; Methyl(K)@20 missed K-L@20 0.0178922992199659 3338.74731445313 835.6941 3338.72924804688 835.689575195313 4 16 1.1.1.4231.15 1 52.3467 3124.613 52.4079 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17; Delta:H(4)C(2)(K)@20 missed K-L@20 0.00751142017543316 3352.75244140625 839.1954 3352.74487304688 839.193481445313 4 21 1.1.1.4233.15 1 52.3976 5301.079 52.5358 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Oxidation(M)@17 missed K-L@20 0.0137157002463937 3325.71142578125 832.4351 3325.69775390625 832.431701660156 4 17 1.1.1.4241.18 1 52.6049 4524.331 52.587 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Oxidation(M)@17 missed K-L@20 0.00858884025365114 3325.7060546875 832.4338 3325.69775390625 832.431701660156 4 18 1.1.1.4252.16 1 52.8834 10334.83 53.1221 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Oxidation(M)@17 missed K-L@20 0.00907711032778025 3325.70703125 832.434 3325.69775390625 832.431701660156 4 25 1.1.1.4260.15 1 53.0862 10298.85 53.0965 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(D)@15 missed K-L@20 0.0123779000714421 3330.71313476563 667.1499 3330.70068359375 667.147399902344 5 16 1.1.1.4271.9 1 53.3626 4274.968 53.4286 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6; Deamidated(N)@14 missed K-L@20 0.0438417010009289 3310.73046875 663.1534 3310.68676757813 663.144653320313 5 19 1.1.1.4274.9 1 53.4389 9571.644 53.4286 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Methyl(K)@20 missed K-L@20 0.0235463995486498 3323.74169921875 831.9427 3323.71826171875 831.936889648438 4 17 1.1.1.4284.13 1 53.6968 32861.53 53.9127 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.00491832988336682 3322.7392578125 665.5551 3322.734375 665.554138183594 5 18 1.1.1.4289.9 1 53.8209 10213.05 53.9381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.0119810001924634 3322.74609375 831.6938 3322.734375 831.690856933594 4 24 1.1.1.4291.18 1 53.8794 64625.44 53.9637 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.0119810001924634 3322.74609375 831.6938 3322.734375 831.690856933594 4 22 1.1.1.4292.16 1 53.9033 64625.44 53.9637 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.0119810001924634 3322.74609375 831.6938 3322.734375 831.690856933594 4 24 1.1.1.4293.19 1 53.9313 64625.44 53.9637 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14; Oxidation(M)@17; Methyl(K)@20 missed K-L@20 0.0458145998418331 3339.75927734375 835.9471 3339.71337890625 835.935607910156 4 18 1.1.1.4293.20 1 53.9321 10844.38 54.1682 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.0119810001924634 3322.74609375 831.6938 3322.734375 831.690856933594 4 21 1.1.1.4294.21 1 53.9585 64625.44 53.9637 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 0.996457993984222 3309.71533203125 828.4361 3308.71875 828.186950683594 4 26 1.1.1.4295.19 1 53.9825 47843.02 53.7087 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.0119810001924634 3322.74609375 831.6938 3322.734375 831.690856933594 4 20 1.1.1.4295.20 1 53.9833 64625.44 53.9637 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.0119810001924634 3322.74609375 831.6938 3322.734375 831.690856933594 4 24 1.1.1.4296.17 1 54.0063 64625.44 53.9637 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.011854300275445 3336.76220703125 835.1978 3336.75 835.194763183594 4 23 1.1.1.4296.18 1 54.0071 103111.7 54.1682 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.00491832988336682 3322.7392578125 665.5551 3322.734375 665.554138183594 5 16 1.1.1.4298.9 1 54.0507 10213.05 53.9381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.0160444006323814 3336.76586914063 668.3605 3336.75 668.357299804688 5 21 1.1.1.4298.10 1 54.0515 18317.49 54.1427 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.0063369800336659 3336.75537109375 1113.259 3336.75 1113.25732421875 3 16 1.1.1.4299.21 1 54.0862 15998.8 54.1682 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.0160444006323814 3336.76586914063 668.3605 3336.75 668.357299804688 5 24 1.1.1.4300.7 1 54.1001 18317.49 54.1427 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.0160444006323814 3336.76586914063 668.3605 3336.75 668.357299804688 5 23 1.1.1.4301.11 1 54.1292 18317.49 54.1427 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.011854300275445 3336.76220703125 835.1978 3336.75 835.194763183594 4 26 1.1.1.4303.20 1 54.1877 103111.7 54.1682 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14; Delta:H(4)C(2)(K)@20 missed K-L@20 0.0223012994974852 3337.755859375 668.5585 3337.73413085938 668.554077148438 5 19 1.1.1.4304.8 1 54.2033 11700.78 54.1682 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.0160444006323814 3336.76586914063 668.3605 3336.75 668.357299804688 5 23 1.1.1.4305.7 1 54.2279 18317.49 54.1427 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.0160444006323814 3336.76586914063 668.3605 3336.75 668.357299804688 5 23 1.1.1.4306.10 1 54.2558 18317.49 54.1427 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Methyl(K)@20 missed K-L@20 0.0167105998843908 3323.73486328125 831.941 3323.71826171875 831.936889648438 4 23 1.1.1.4306.18 1 54.2625 29524.11 53.9894 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.0160444006323814 3336.76586914063 668.3605 3336.75 668.357299804688 5 23 1.1.1.4307.8 1 54.2795 18317.49 54.1427 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.011854300275445 3336.76220703125 835.1978 3336.75 835.194763183594 4 23 1.1.1.4310.19 1 54.3652 103111.7 54.1682 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14; Methyl(K)@20 missed K-L@20 0.0147575000301003 3323.7333984375 831.9406 3323.71826171875 831.936889648438 4 20 1.1.1.4313.19 1 54.4416 7963.223 54.1682 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.0128308003768325 3336.76293945313 835.198 3336.75 835.194763183594 4 24 1.1.1.4317.18 1 54.5429 8206.886 54.6787 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Ammonia-loss(N)@10; Delta:H(4)C(2)(K)@20 missed K-L@20 0.00488808983936906 3319.728515625 830.9394 3319.72338867188 830.938171386719 4 23 1.1.1.4322.17 1 54.6702 4472.323 54.7302 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.0135369002819061 3323.73168945313 831.9402 3323.71826171875 831.936889648438 4 29 1.1.1.4326.19 1 54.7747 11041.61 54.7302 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@14 missed K-L@20 0.0233954004943371 3310.7099609375 663.1493 3310.68676757813 663.144653320313 5 18 1.1.1.4327.8 1 54.7912 15796.09 54.8073 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.0143865998834372 3337.74853515625 835.4444 3337.73413085938 835.440795898438 4 25 1.1.1.4327.16 1 54.7978 14559.29 54.884 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.000841857981868088 3323.71923828125 831.9371 3323.71826171875 831.936889648438 4 26 1.1.1.4334.17 1 54.9777 19516.31 55.216 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.0143865998834372 3337.74853515625 835.4444 3337.73413085938 835.440795898438 4 20 1.1.1.4334.18 1 54.9785 14559.29 54.884 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.00108598999213427 3323.71923828125 831.9371 3323.71826171875 831.936889648438 4 24 1.1.1.4341.15 1 55.1544 20021.04 55.216 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Delta:H(4)C(2)(K)@20 missed K-L@20 0.00706257997080684 3337.74145507813 835.4426 3337.73413085938 835.440795898438 4 18 1.1.1.4346.18 1 55.2849 20675.69 55.5235 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.00108598999213427 3323.71923828125 831.9371 3323.71826171875 831.936889648438 4 23 1.1.1.4348.16 1 55.3345 20021.04 55.216 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.00828326027840376 3337.74243164063 835.4429 3337.73413085938 835.440795898438 4 24 1.1.1.4353.19 1 55.465 50589.71 55.6004 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.00279493001289666 3323.72143554688 831.9376 3323.71826171875 831.936889648438 4 23 1.1.1.4355.16 1 55.5141 19128.89 55.2415 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6; Deamidated(N)@14; Delta:H(4)C(2)(K)@20 missed K-L@20 0.0154360001906753 3338.73364257813 668.754 3338.71801757813 668.750854492188 5 20 1.1.1.4358.10 1 55.586 6416.444 55.6004 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.00828326027840376 3337.74243164063 835.4429 3337.73413085938 835.440795898438 4 25 1.1.1.4360.18 1 55.644 50589.71 55.6004 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.00828326027840376 3337.74243164063 835.4429 3337.73413085938 835.440795898438 4 21 1.1.1.4367.17 1 55.8224 50589.71 55.6004 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.0239078998565674 3337.75805664063 835.4468 3337.73413085938 835.440795898438 4 17 1.1.1.4376.18 1 56.055 5067.803 56.0886 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@14; Delta:H(4)C(2)(K)@20 missed K-L@20 0.0528067015111446 3338.77099609375 835.7 3338.71801757813 835.686767578125 4 17 1.1.1.4384.18 1 56.2609 3602.262 56.0627 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@6 missed K-L@20 0.00210379995405674 3335.72045898438 834.9374 3335.71826171875 834.936889648438 4 17 1.1.1.4537.15 1 60.2599 1883.276 60.2976 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14 missed K-L@20 0.00951290968805552 3309.71264648438 828.4354 3309.70263671875 828.432983398438 4 19 1.1.1.4202.18 1 51.6113 11572.23 51.6953 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17 missed K-L@20 0.00581231992691755 3324.71923828125 832.1871 3324.71362304688 832.185668945313 4 17 1.1.1.4204.18 1 51.6622 16724.1 51.8489 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14 missed K-L@20 0.022843400016427 3309.72534179688 1104.249 3309.70263671875 1104.24157714844 3 9 1.1.1.4206.19 1 51.7142 1407.212 51.6953 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14 missed K-L@20 0.00951290968805552 3309.71264648438 828.4354 3309.70263671875 828.432983398438 4 18 1.1.1.4209.15 1 51.7874 11572.23 51.6953 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17 missed K-L@20 0.00141789996996522 3324.71484375 832.186 3324.71362304688 832.185668945313 4 22 1.1.1.4211.17 1 51.8404 19248.14 51.9508 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17 missed K-L@20 0.000685496022924781 3324.71459960938 832.1859 3324.71362304688 832.185668945313 4 22 1.1.1.4218.17 1 52.0187 18823.78 52.0019 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17 missed K-L@20 0.000685496022924781 3324.71459960938 832.1859 3324.71362304688 832.185668945313 4 21 1.1.1.4225.20 1 52.1985 18823.78 52.0019 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17 missed K-L@20 0.0243666004389524 3324.73803710938 832.1918 3324.71362304688 832.185668945313 4 19 1.1.1.4233.14 1 52.3968 2662.539 52.5103 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 0.0135722002014518 3308.73266601563 828.1904 3308.71875 828.186950683594 4 28 1.1.1.4266.15 1 53.2397 280898.1 53.4286 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 0.00566479004919529 3308.72338867188 1103.915 3308.71875 1103.91357421875 3 21 1.1.1.4267.20 1 53.2695 52448.43 53.4286 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17 missed K-L@20 0.00556819001212716 3324.71923828125 832.1871 3324.71362304688 832.185668945313 4 23 1.1.1.4269.15 1 53.3165 5398.205 53.3523 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 0.0135722002014518 3308.73266601563 828.1904 3308.71875 828.186950683594 4 23 1.1.1.4274.18 1 53.4464 281649.4 53.4286 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17 missed K-L@20 0.0182632002979517 3324.73168945313 832.1902 3324.71362304688 832.185668945313 4 17 1.1.1.4276.15 1 53.495 5523.87 53.4542 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 0.0135722002014518 3308.73266601563 828.1904 3308.71875 828.186950683594 4 23 1.1.1.4281.18 1 53.6244 281649.4 53.4286 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 0.00325205991975963 3308.72143554688 662.7516 3308.71875 662.751037597656 5 13 1.1.1.4284.10 1 53.6943 43020.99 53.4286 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 0.0111307995393872 3308.73022460938 828.1898 3308.71875 828.186950683594 4 24 1.1.1.4288.19 1 53.8036 163960.2 53.5306 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 0.00676338979974389 3308.72631835938 1103.916 3308.71875 1103.91357421875 3 15 1.1.1.4289.20 1 53.8301 20533.96 53.5559 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17 missed K-L@20 0.0516690984368324 3324.76513671875 665.9603 3324.71362304688 665.950012207031 5 14 1.1.1.4297.8 1 54.0244 3340.442 53.9894 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14 missed K-L@20 0.0169842001050711 3309.71899414063 1104.247 3309.70263671875 1104.24157714844 3 10 1.1.1.4297.19 1 54.0336 4499.916 53.9637 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 0.0117968004196882 3308.73071289063 662.7534 3308.71875 662.751037597656 5 17 1.1.1.4298.8 1 54.0498 2199.583 54.0148 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10 missed K-L@20 0.00389781990088522 3309.70703125 828.434 3309.70263671875 828.432983398438 4 20 1.1.1.4302.17 1 54.1596 53887.36 54.2702 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6 missed K-L@20 0.00160374003462493 3309.7041015625 1104.242 3309.70263671875 1104.24157714844 3 16 1.1.1.4304.21 1 54.2142 7457.858 54.2448 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Ammonia-loss(N)@10 missed K-L@20 0.0117317996919155 3291.70385742188 823.9332 3291.69213867188 823.930297851563 4 15 1.1.1.4305.13 1 54.2329 12104.99 54.117 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6 missed K-L@20 0.0247674994170666 3309.72778320313 662.9528 3309.70263671875 662.947814941406 5 20 1.1.1.4310.12 1 54.3593 6559.867 54.2702 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6 missed K-L@20 0.00389781990088522 3309.70703125 828.434 3309.70263671875 828.432983398438 4 35 1.1.1.4310.18 1 54.3643 53887.36 54.2702 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8 missed K-L@20 0.00782916974276304 3309.71020507813 1104.244 3309.70263671875 1104.24157714844 3 13 1.1.1.4311.20 1 54.3916 7445.499 54.2956 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14 missed K-L@20 0.011221899650991 3309.71411132813 828.4358 3309.70263671875 828.432983398438 4 19 1.1.1.4320.18 1 54.6198 184117.6 54.7816 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10 missed K-L@20 0.00920393038541079 3309.71142578125 662.9496 3309.70263671875 662.947814941406 5 24 1.1.1.4324.7 1 54.7133 25606.39 54.7816 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17 missed K-L@20 0.00406272988766432 3324.71752929688 665.9508 3324.71362304688 665.950012207031 5 11 1.1.1.4326.10 1 54.7672 1629.139 54.7302 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8 missed K-L@20 0.011221899650991 3309.71411132813 828.4358 3309.70263671875 828.432983398438 4 23 1.1.1.4327.15 1 54.797 184117.6 54.7816 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8 missed K-L@20 0.00920393038541079 3309.71142578125 662.9496 3309.70263671875 662.947814941406 5 28 1.1.1.4333.7 1 54.944 25606.39 54.7816 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10 missed K-L@20 0.011221899650991 3309.71411132813 828.4358 3309.70263671875 828.432983398438 4 25 1.1.1.4334.16 1 54.9769 184117.6 54.7816 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8 missed K-L@20 0.0119543001055717 3309.71484375 828.436 3309.70263671875 828.432983398438 4 20 1.1.1.4341.14 1 55.1536 107114.9 54.884 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10 missed K-L@20 0.0107335997745395 3309.7138671875 828.4357 3309.70263671875 828.432983398438 4 17 1.1.1.4350.20 1 55.3891 6579.758 55.3184 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8 missed K-L@20 0.011221899650991 3309.71411132813 828.4358 3309.70263671875 828.432983398438 4 30 1.1.1.4357.17 1 55.5662 12016.46 55.5235 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10 missed K-L@20 0.0270905997604132 3309.73022460938 828.4398 3309.70263671875 828.432983398438 4 20 1.1.1.4370.20 1 55.902 4395.676 55.8565 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@8; Deamidated(N)@14 missed K-L@20 -0.056403499096632 3336.64624023438 835.1688 3336.70239257813 835.182861328125 4 14 1.1.1.4567.12 1 61.0464 1530.036 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(D)@15 missed K-L@20 0.00929688010364771 3322.7451171875 1108.589 3322.734375 1108.58544921875 3 13 1.1.1.4297.20 1 54.0344 8740.628 53.9637 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@14; Delta:H(4)C(2)(K)@20; Deamidated(N)@28 missed K-L@20 0.050212200731039 3339.75244140625 835.9454 3339.7021484375 835.932800292969 4 16 1.1.1.4373.16 1 55.976 2228.329 55.8823 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Deamidated(N)@14; Delta:H(4)C(2)(K)@20 missed K-L@20 0.0340083986520767 3338.75219726563 835.6953 3338.71801757813 835.686767578125 4 15 1.1.1.4224.16 1 52.17 3068.228 52.0272 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Dethiomethyl(M)@17; MDA adduct +62(K)@20 missed K-L@20 0.0432320013642311 3323.75805664063 665.7589 3323.71508789063 665.750305175781 5 14 1.1.1.4289.10 1 53.8217 6571.361 53.9381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6; Deamidated(N)@8; Deamidated(N)@14; Oxidation(M)@17 missed K-L@20 0.0685838013887405 3327.73461914063 832.9409 3327.66577148438 832.923706054688 4 14 1.1.1.4252.17 1 52.8842 2852.72 53.0711 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.4399983882904 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Oxidation(D)@13; Deamidated(N)@14 missed K-L@20 0.0301636997610331 3326.71166992188 832.6852 3326.681640625 832.677673339844 4 13 1.1.1.4328.15 1 54.8226 3803.108 54.8328 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 93.2399988174438 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Dethiomethyl(M)@17; hexanoyl addition +98(K)@20 missed K-L@20 -0.0306167006492615 3359.74169921875 672.9556 3359.7724609375 672.961791992188 5 12 1.1.1.4302.9 1 54.1529 1840.484 54.1427 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 74.0800023078918 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Cation:Na(D)@15 missed K-L@20 0.0138426003977656 3331.69848632813 833.9319 3331.6845703125 833.928466796875 4 12 1.1.1.4328.16 1 54.8234 1903.753 54.7816 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 70.6399977207184 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.00667029991745949 3337.7421875 1113.588 3337.73413085938 1113.58532714844 3 10 1.1.1.4361.21 1 55.6722 8270.073 55.6004 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 38.9299988746643 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@17; MDA adduct +54(K)@20 missed K-L@20 -0.012563600204885 3314.71362304688 663.95 3314.72583007813 663.952453613281 5 9 1.1.1.4335.6 1 54.994 4688.478 54.7816 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 16.8699994683266 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Dehydrated(T)@11; acrolein addition +38(K)@20 missed K-L@20 -0.00274813990108669 3328.72143554688 833.1876 3328.72387695313 833.188232421875 4 9 1.1.1.4276.16 1 53.4959 2095.954 53.4542 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 51.2799978256226 IITHPNFNGNTLDNDIMLIKLSSPATLNSRV acrolein addition +94(K)@20; Deamidated(N)@28 cleaved V-A@C-term; missed K-L@20; missed R-V@30 0.0609425008296967 3502.87426757813 876.7258 3502.81298828125 876.710510253906 4 10 1.1.1.4096.19 1 48.9064 3804.133 48.9896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IMLIKLSSPATLNSR Delta:H(4)C(2)(K)@5 cleaved D-I@N-term; missed K-L@5 -0.00185841997154057 1670.97338867188 557.9984 1670.97534179688 557.9990234375 3 19 1.1.1.3915.6 1 44.2633 8937.592 44.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IMLIKLSSPATLNSR Delta:H(4)C(2)(K)@5 cleaved D-I@N-term; missed K-L@5 -0.00185841997154057 1670.97338867188 557.9984 1670.97534179688 557.9990234375 3 15 1.1.1.3922.8 1 44.4422 8937.592 44.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAK missed R-L@4 0.00579915987327695 2706.4150390625 677.611 2706.40893554688 677.609497070313 4 24 1.1.1.4018.15 1 46.9117 170430.7 46.7922 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAK missed R-L@4 -0.00128075003158301 2706.40771484375 677.6092 2706.40893554688 677.609497070313 4 21 1.1.1.4026.16 1 47.1185 3785.578 47.076 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAK Deamidated(N)@21 missed R-L@4 -0.00729229021817446 2707.3857421875 677.8537 2707.39282226563 677.855529785156 4 16 1.1.1.4034.16 1 47.3231 2851.715 47.102 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAK Deamidated(N)@21 missed R-L@4 -0.0993311032652855 2707.29370117188 677.8307 2707.39282226563 677.855529785156 4 16 1.1.1.4006.15 1 46.5998 2754.183 46.584 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAK missed R-L@4 0.00517847016453743 2706.4140625 542.2901 2706.40893554688 542.2890625 5 16 1.1.1.4012.5 1 46.7476 3042.222 46.7922 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 88.0200028419495 IQVRLGEHNIDVLEGNEQFINAAK Oxidation(H)@8 missed R-L@4 -0.0263614002615213 2722.37744140625 681.6016 2722.40380859375 681.608215332031 4 11 1.1.1.4012.16 1 46.7568 2709.899 46.7922 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 62.5400006771088 IQVRLGEHNIDVLEGNEQFINAAK Deamidated(Q)@2 missed R-L@4 -0.076841302216053 2707.31616210938 903.446 2707.39282226563 903.471618652344 3 10 1.1.1.4053.20 1 47.8123 1783.318 47.8184 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Deamidated(N)@38; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0301415007561445 6054.1904296875 865.8916 6054.16015625 865.887329101563 7 23 1.1.1.4537.16 1 60.2607 6037.779 60.2976 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0669042989611626 6054.1962890625 1010.04 6054.12744140625 1010.02850341797 6 15 1.1.1.4537.20 1 60.2641 6423.479 60.2976 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24; Met->Hcy(M)@41; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0606404989957809 6069.1962890625 1012.54 6069.13818359375 1012.53033447266 6 20 1.1.1.4538.20 1 60.2915 20404.71 60.378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; Oxidation(M)@41; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0757943987846375 6070.19775390625 868.1784 6070.1220703125 868.167602539063 7 16 1.1.1.4539.15 1 60.3139 10854.86 60.378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Met->Hcy(M)@41; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0309629999101162 6069.20556640625 868.0366 6069.1748046875 868.0322265625 7 27 1.1.1.4540.17 1 60.343 14347.22 60.3516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0631560981273651 6054.1904296875 865.8916 6054.12744140625 865.882629394531 7 15 1.1.1.4544.16 1 60.4482 6037.779 60.2976 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; Oxidation(M)@41; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0471698008477688 6070.16943359375 868.1743 6070.1220703125 868.167602539063 7 15 1.1.1.4550.15 1 60.6056 5117.136 60.7716 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed R-L@4; missed K-I@24; missed K-L@44 0.0130840996280313 5997.13037109375 1000.529 5997.1171875 1000.52679443359 6 17 1.1.1.4550.20 1 60.6097 23487.24 60.72 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed R-L@4; missed K-I@24; missed K-L@44 0.0262896008789539 5997.14404296875 857.7421 5997.1171875 857.73828125 7 26 1.1.1.4551.10 1 60.6275 12728.42 60.72 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@24; Deamidated(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.0359579995274544 6036.15283203125 863.3148 6036.11669921875 863.309692382813 7 17 1.1.1.4551.11 1 60.6283 976.271 60.6158 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@28 missed R-L@4; missed K-I@24; missed K-L@44 0.0213895998895168 6011.15234375 1002.866 6011.1328125 1002.86273193359 6 19 1.1.1.4555.20 1 60.7397 8758.641 60.7977 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24 missed R-L@4; missed K-I@24; missed K-L@44 0.0557026006281376 6025.16748046875 861.7455 6025.11181640625 861.737548828125 7 28 1.1.1.4556.14 1 60.7605 22016.95 60.8242 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Pro->pyro-Glu(P)@29; Deamidated(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.0994637981057167 6012.1796875 859.8901 6012.08056640625 859.875915527344 7 27 1.1.1.4557.8 1 60.7816 4220.146 60.7977 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24; Methyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0703732967376709 6039.1982421875 863.7499 6039.12744140625 863.739807128906 7 22 1.1.1.4557.9 1 60.7824 6954.876 60.8509 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0234514996409416 6053.203125 865.7506 6053.1796875 865.747253417969 7 27 1.1.1.4557.10 1 60.7833 146646.5 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed R-L@4; missed K-I@24; missed K-L@44 0.0130840996280313 5997.13037109375 1000.529 5997.1171875 1000.52679443359 6 23 1.1.1.4557.18 1 60.79 23487.24 60.72 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@24; reduced HNE(H)@28; Oxidation(P)@29 missed R-L@4; missed K-I@24; missed K-L@44 0.0561093017458916 6269.3740234375 1045.903 6269.31591796875 1045.89318847656 6 18 1.1.1.4557.19 1 60.7908 2452.921 60.8242 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24 missed R-L@4; missed K-I@24; missed K-L@44 0.0469438992440701 6025.158203125 1206.039 6025.11181640625 1206.02966308594 5 22 1.1.1.4557.21 1 60.7925 11438.88 60.8242 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.0543881990015507 5998.15625 857.8867 5998.10107421875 857.878845214844 7 29 1.1.1.4558.9 1 60.809 9379.427 60.72 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; Oxidation(M)@41; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0471698008477688 6070.16943359375 868.1743 6070.1220703125 868.167602539063 7 16 1.1.1.4558.10 1 60.8098 5117.136 60.7716 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24; Methyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0630330964922905 6039.1904296875 1007.539 6039.12744140625 1007.52856445313 6 29 1.1.1.4558.18 1 60.8165 9947.731 60.8509 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@24; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.000151543004903942 6053.17822265625 1211.643 6053.1796875 1211.64318847656 5 24 1.1.1.4559.20 1 60.8449 77065.99 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; Oxidation(M)@41; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0249873008579016 6072.16259765625 868.4591 6072.1376953125 868.45556640625 7 18 1.1.1.4560.12 1 60.865 3187.529 60.8509 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@21; acrolein addition +112(K)@24; reduced HNE(H)@28; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.062874898314476 6296.380859375 1050.404 6296.3154296875 1050.39318847656 6 26 1.1.1.4560.19 1 60.8709 16499.4 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.00222987006418407 6025.150390625 1005.199 6025.1484375 1005.19866943359 6 26 1.1.1.4561.15 1 60.8939 33641.82 60.8242 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@24; Methyl(H)@28; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.00230629998259246 6077.18212890625 1013.871 6077.1796875 1013.87054443359 6 17 1.1.1.4561.17 1 60.8956 3248.067 60.93 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@18; ONE addition +154(K)@24; reduced HNE(H)@28; Hex(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 -0.0234402995556593 6472.3603515625 925.6302 6472.3837890625 925.633544921875 7 16 1.1.1.4562.15 1 60.9197 4629.738 60.9814 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0192057006061077 6053.20068359375 1009.874 6053.1796875 1009.87054443359 6 33 1.1.1.4563.16 1 60.9461 191661 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@24; Dehydrated(T)@27; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0237786006182432 6069.17822265625 1012.537 6069.1533203125 1012.53283691406 6 21 1.1.1.4563.17 1 60.9469 5241.223 60.8509 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0482701994478703 6026.1806640625 861.8902 6026.13232421875 861.883361816406 7 23 1.1.1.4564.10 1 60.9671 14418.72 60.8242 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0234514996409416 6053.203125 865.7506 6053.1796875 865.747253417969 7 28 1.1.1.4564.11 1 60.9679 146646.5 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; Oxidation(M)@41; MDA adduct +62(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0458271987736225 6076.15771484375 869.0298 6076.11181640625 869.023254394531 7 16 1.1.1.4564.12 1 60.9687 4110.215 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34 missed R-L@4; missed K-I@24; missed K-L@44 0.015510099940002 5998.11669921875 857.8811 5998.10107421875 857.878845214844 7 22 1.1.1.4565.10 1 60.993 5363.615 61.0592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@24; Deamidated(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.0688548982143402 6036.185546875 863.3195 6036.11669921875 863.309692382813 7 15 1.1.1.4565.11 1 60.9938 8013.375 61.0592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24 missed R-L@4; missed K-I@24; missed K-L@44 0.0598370991647244 6053.203125 865.7506 6053.14306640625 865.742004394531 7 13 1.1.1.4565.12 1 60.9947 146646.5 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@21; Delta:H(4)C(2)(K)@24; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0357206985354424 6054.1962890625 1010.04 6054.16015625 1010.03399658203 6 25 1.1.1.4565.18 1 60.9997 131787.9 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@24; Dehydrated(T)@35; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0303035005927086 6069.18359375 868.0335 6069.1533203125 868.029174804688 7 18 1.1.1.4566.10 1 61.0188 2733.581 60.9814 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0365370996296406 6053.17822265625 1211.643 6053.14306640625 1211.63598632813 5 22 1.1.1.4566.21 1 61.028 77065.99 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@21; acrolein addition +112(K)@24; reduced HNE(H)@28; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.062874898314476 6296.380859375 1050.404 6296.3154296875 1050.39318847656 6 20 1.1.1.4567.19 1 61.0523 16499.4 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34 missed R-L@4; missed K-I@24; missed K-L@44 0.0196366999298334 5998.1201171875 1000.694 5998.10107421875 1000.69079589844 6 20 1.1.1.4568.15 1 61.0749 8116.472 61.0592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@28; Deamidated(N)@30; Deamidated(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.0275106001645327 6025.12646484375 1005.195 6025.1005859375 1005.19073486328 6 20 1.1.1.4568.16 1 61.0757 5964.21 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0758612975478172 6036.1904296875 1007.039 6036.11669921875 1007.02673339844 6 15 1.1.1.4568.17 1 61.0766 9468.688 61.0592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@41; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0162393003702164 6071.17041015625 1012.869 6071.15380859375 1012.86627197266 6 14 1.1.1.4569.19 1 61.1042 2820.447 61.0074 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@28; Deamidated(N)@34 missed R-L@4; missed K-I@24; missed K-L@44 -0.00574810989201069 6012.1123046875 1003.026 6012.11669921875 1003.02673339844 6 18 1.1.1.4570.15 1 61.1276 2507.102 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0555911995470524 6053.20068359375 1009.874 6053.14306640625 1009.86450195313 6 35 1.1.1.4570.16 1 61.1284 191661 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24; Deamidated(N)@32; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0776349976658821 6054.201171875 865.8932 6054.1240234375 865.882141113281 7 27 1.1.1.4571.6 1 61.146 97710.68 60.9814 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Deamidated(N)@30; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0335234999656677 6054.1962890625 1010.04 6054.16015625 1010.03399658203 6 26 1.1.1.4577.17 1 61.309 96950.16 61.0332 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.00807117018848658 6053.18798828125 865.7484 6053.1796875 865.747253417969 7 29 1.1.1.4578.12 1 61.3303 75184.67 61.0592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@21; Delta:H(4)C(2)(H)@28; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0309600997716188 6054.1904296875 1010.039 6054.16015625 1010.03399658203 6 25 1.1.1.4584.17 1 61.4871 12974.57 61.4448 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0696633979678154 6053.21337890625 865.752 6053.14306640625 865.742004394531 7 24 1.1.1.4585.9 1 61.5058 9469.387 61.4448 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.0109922997653484 6026.12255859375 1005.361 6026.13232421875 1005.36267089844 6 17 1.1.1.4590.18 1 61.6398 2965.611 61.6983 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@21; Delta:H(4)C(2)(H)@28; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0203402992337942 6054.17822265625 1010.037 6054.16015625 1010.03399658203 6 28 1.1.1.4591.13 1 61.6659 21765.55 61.8758 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24; Deamidated(N)@34; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0643908008933067 6054.18798828125 865.8913 6054.1240234375 865.882141113281 7 24 1.1.1.4592.5 1 61.6797 13399.2 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24; Deamidated(N)@34; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0669794008135796 6054.1904296875 1010.039 6054.1240234375 1010.02795410156 6 23 1.1.1.4598.20 1 61.8451 41287.79 62.0026 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Deamidated(N)@34; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0391133986413479 6054.19921875 865.8929 6054.16015625 865.887329101563 7 25 1.1.1.4599.9 1 61.8605 32413.74 62.0026 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; Deamidated(N)@34 missed R-L@4; missed K-I@24; missed K-L@44 0.0491915009915829 6054.1787109375 1211.843 6054.12744140625 1211.83276367188 5 13 1.1.1.4603.21 1 61.972 11766.31 62.0026 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24; Deamidated(N)@34; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0669794008135796 6054.1904296875 1010.039 6054.1240234375 1010.02795410156 6 23 1.1.1.4605.17 1 62.0194 41287.79 62.0026 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Deamidated(N)@34; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0391133986413479 6054.19921875 865.8929 6054.16015625 865.887329101563 7 30 1.1.1.4606.9 1 62.0382 32413.74 62.0026 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Deamidated(N)@34; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0203402992337942 6054.17822265625 1010.037 6054.16015625 1010.03399658203 6 25 1.1.1.4612.18 1 62.1979 39592.02 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Deamidated(N)@34; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0305687002837658 6054.19091796875 865.8917 6054.16015625 865.887329101563 7 30 1.1.1.4613.10 1 62.2166 31139.65 62.1041 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@24; Deamidated(N)@34; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0203402992337942 6054.17822265625 1010.037 6054.16015625 1010.03399658203 6 27 1.1.1.4619.19 1 62.3756 39592.02 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Deamidated(N)@34; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0318504013121128 6054.19140625 865.8918 6054.16015625 865.887329101563 7 26 1.1.1.4620.5 1 62.3891 30721 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@18; Formyl(K)@24; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0662470012903214 6054.1904296875 1010.039 6054.1240234375 1010.02795410156 6 21 1.1.1.4626.19 1 62.5523 22685.65 62.2816 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0635833963751793 6054.19091796875 865.8917 6054.12744140625 865.882629394531 7 18 1.1.1.4627.10 1 62.5699 13782.26 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0544536001980305 6054.1845703125 1010.038 6054.12744140625 1010.02850341797 6 16 1.1.1.4633.18 1 62.728 14754.21 62.6095 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0648650974035263 6054.19140625 865.8918 6054.12744140625 865.882629394531 7 17 1.1.1.4634.7 1 62.7441 12927.89 62.4836 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@21; Formyl(K)@24; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0585567988455296 6054.1845703125 1010.038 6054.1240234375 1010.02795410156 6 19 1.1.1.4640.18 1 62.9042 11020.61 62.8363 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; Delta:H(4)C(2)(H)@28; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0425311997532845 6054.20263671875 865.8934 6054.16015625 865.887329101563 7 23 1.1.1.4641.8 1 62.9211 8919.381 62.8363 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0544536001980305 6054.1845703125 1010.038 6054.12744140625 1010.02850341797 6 17 1.1.1.4647.16 1 63.0794 11325.22 62.8111 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0648650974035263 6054.19140625 865.8918 6054.12744140625 865.882629394531 7 18 1.1.1.4648.6 1 63.0954 8825.185 62.8363 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24; Deamidated(N)@32; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0699089989066124 6054.1962890625 1010.04 6054.1240234375 1010.02795410156 6 22 1.1.1.4654.16 1 63.2588 6007.321 63.1885 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0768276005983353 6054.20458984375 865.8936 6054.12744140625 865.882629394531 7 16 1.1.1.4655.7 1 63.2724 4261.87 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@21; Formyl(K)@24; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0596554018557072 6054.1845703125 1010.038 6054.1240234375 1010.02795410156 6 17 1.1.1.4662.4 1 63.4499 4590.83 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Deamidated(N)@34; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0232698991894722 6054.1845703125 1010.038 6054.16015625 1010.03399658203 6 19 1.1.1.4669.6 1 63.6306 4590.83 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28; Deamidated(N)@30; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0357206985354424 6054.1962890625 1010.04 6054.16015625 1010.03399658203 6 23 1.1.1.4676.4 1 63.8014 3577.226 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0518901981413364 6054.17822265625 1010.037 6054.12744140625 1010.02850341797 6 15 1.1.1.4684.8 1 64.0026 2839.491 64.0129 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0461656004190445 6053.18994140625 865.7487 6053.14306640625 865.742004394531 7 20 1.1.1.4686.9 1 64.051 1554.312 63.9631 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0201044008135796 6053.1630859375 865.7449 6053.14306640625 865.742004394531 7 13 1.1.1.4695.8 1 64.2743 1383.727 64.2391 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0049163899384439 6169.234375 1029.213 6169.22705078125 1029.21179199219 6 12 1.1.1.4698.12 1 64.354 1480.872 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@24; Ammonia-loss(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.0778070017695427 6042.1845703125 1008.038 6042.10595703125 1008.02496337891 6 15 1.1.1.4538.19 1 60.2907 2562.373 60.3241 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0669042989611626 6054.1962890625 1010.04 6054.12744140625 1010.02850341797 6 14 1.1.1.4544.21 1 60.4524 6423.479 60.2976 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@41; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0606404989957809 6069.1962890625 1012.54 6069.13818359375 1012.53033447266 6 13 1.1.1.4545.20 1 60.4784 20404.71 60.378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@24 missed R-L@4; missed K-I@24; missed K-L@44 0.0386154018342495 6025.150390625 1005.199 6025.11181640625 1005.19262695313 6 14 1.1.1.4554.14 1 60.7089 33641.82 60.8242 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@24; reduced HNE(H)@28; Dioxidation(M)@41; HPNE addition +172(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.044480100274086 6471.3583984375 1079.567 6471.39990234375 1079.57397460938 6 15 1.1.1.4559.18 1 60.8432 15479.88 60.9814 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@24; Deamidated(N)@38; Formyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0154405003413558 6084.154296875 1015.033 6084.1376953125 1015.0302734375 6 15 1.1.1.4560.18 1 60.87 2282.745 60.8778 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@24; reduced HNE(H)@28; Dioxidation(M)@41; HPNE addition +172(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.044480100274086 6471.3583984375 1079.567 6471.39990234375 1079.57397460938 6 15 1.1.1.4566.17 1 61.0246 15479.88 60.9814 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0678557008504868 6054.19482421875 865.8923 6054.12744140625 865.882629394531 7 12 1.1.1.4663.7 1 63.4727 3248.466 63.4143 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; Oxidation(M)@41; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0799188986420631 6072.22021484375 1013.044 6072.1376953125 1013.0302734375 6 13 1.1.1.4560.17 1 60.8692 3791.229 60.7977 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@41; Delta:H(2)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.057303998619318 6039.18359375 1208.844 6039.12744140625 1208.83276367188 5 12 1.1.1.4561.21 1 60.8989 3866.301 60.8778 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; Oxidation(M)@41; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0534856989979744 6070.17333984375 1215.042 6070.1220703125 1215.03173828125 5 12 1.1.1.4559.21 1 60.8457 2895.354 60.7716 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.0201082993298769 6025.12646484375 1005.195 6025.1484375 1005.19866943359 6 12 1.1.1.4575.18 1 61.2588 5964.21 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@28; Oxidation(M)@41 missed R-L@4; missed K-I@24; missed K-L@44 0.0582724995911121 6039.1845703125 1007.538 6039.12744140625 1007.52856445313 6 12 1.1.1.4578.20 1 61.337 5177.598 61.0592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0665381029248238 6054.1962890625 1010.04 6054.12744140625 1010.02850341797 6 12 1.1.1.4655.16 1 63.2799 6007.321 63.1885 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0518901981413364 6054.17822265625 1010.037 6054.12744140625 1010.02850341797 6 12 1.1.1.4692.12 1 64.2064 2290.246 64.2391 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@24; reduced HNE(H)@28; HexNAc(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.0461313985288143 6434.404296875 1073.408 6434.3583984375 1073.400390625 6 13 1.1.1.4560.20 1 60.8717 2677.715 60.9041 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0577360987663269 6054.18359375 1211.844 6054.12744140625 1211.83276367188 5 10 1.1.1.4629.21 1 62.6296 5130.14 62.6095 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; MDA adduct +54(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.05417849868536 6052.16845703125 1009.702 6052.11181640625 1009.69256591797 6 9 1.1.1.4556.18 1 60.7638 81456.56 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.7299978733063 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@24; Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.0340676009654999 6108.103515625 873.5935 6108.1376953125 873.598388671875 7 10 1.1.1.4561.13 1 60.8922 1732.583 60.93 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.3299970626831 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.114239998161793 6035.2470703125 863.1854 6035.1328125 863.169067382813 7 10 1.1.1.4559.11 1 60.8374 5943.118 61.0332 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.3299970626831 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.114239998161793 6035.2470703125 863.1854 6035.1328125 863.169067382813 7 10 1.1.1.4566.9 1 61.0179 5844.113 61.0332 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.3299970626831 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@28; MDA adduct +62(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0269965995103121 6085.17431640625 1015.203 6085.1484375 1015.19866943359 6 10 1.1.1.4567.18 1 61.0514 1791.682 60.9814 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0491915009915829 6054.1787109375 1211.843 6054.12744140625 1211.83276367188 5 10 1.1.1.4595.18 1 61.7692 10331.32 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0636086016893387 6054.1904296875 1010.039 6054.12744140625 1010.02850341797 6 10 1.1.1.4604.18 1 61.9948 41287.79 62.0026 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.4699974060059 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@41; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0383898988366127 6069.1787109375 1214.843 6069.13818359375 1214.8349609375 5 8 1.1.1.4540.21 1 60.3463 4964.173 60.3516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; Oxidation(M)@41; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0477844998240471 6070.16845703125 1012.702 6070.1220703125 1012.6943359375 6 10 1.1.1.4556.19 1 60.7647 7215.634 60.7716 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0479708015918732 6054.173828125 1211.842 6054.12744140625 1211.83276367188 5 9 1.1.1.4625.17 1 62.5288 6402.655 62.3825 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0518901981413364 6054.17822265625 1010.037 6054.12744140625 1010.02850341797 6 9 1.1.1.4700.19 1 64.41 2290.246 64.2391 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@8; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0473893992602825 6079.20458984375 1014.208 6079.1591796875 1014.20043945313 6 10 1.1.1.4714.16 1 64.7692 1828.347 64.7522 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 96.1000025272369 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0644498020410538 6054.193359375 1211.846 6054.12744140625 1211.83276367188 5 8 1.1.1.4618.21 1 62.3519 11319.66 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 93.9300000667572 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0577360987663269 6054.18359375 1211.844 6054.12744140625 1211.83276367188 5 7 1.1.1.4634.21 1 62.7558 5130.14 62.6095 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 91.7999982833862 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; Deamidated(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.0636086016893387 6054.1904296875 1010.039 6054.12744140625 1010.02850341797 6 8 1.1.1.4624.16 1 62.4995 28303.95 62.231 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 29.5800000429153 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@24; Deamidated(N)@38; Dethiomethyl(M)@41 missed R-L@4; missed K-I@24; missed K-L@44 0.00849130004644394 6026.140625 1005.364 6026.12890625 1005.36212158203 6 9 1.1.1.4620.13 1 62.3957 1934.266 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 26.5399992465973 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0372272990643978 6055.19580078125 866.0353 6055.1591796875 866.029968261719 7 11 1.1.1.4559.12 1 60.8382 50258.7 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 26.5399992465973 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0854215025901794 6035.21826171875 1006.877 6035.1328125 1006.86273193359 6 11 1.1.1.4561.16 1 60.8947 6509.077 61.0592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 15.4100000858307 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.0481332987546921 6053.193359375 1211.646 6053.14306640625 1211.63598632813 5 10 1.1.1.4588.15 1 61.5918 3297.411 61.4957 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 95.770001411438 IVGGYTCAANSIPYQVSLN Carbamidomethyl(C)@7; Oxidation(P)@13; Carbamidomethyl(Y)@14 cleaved N-S@C-term 0.00154645997099578 2099.00146484375 1050.508 2098.99926757813 1050.50695800781 2 11 1.1.1.3913.19 1 44.2236 4587.245 44.3316 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.5899984836578 IVGGYTCAANSIPYQVSLNSG Carbamidomethyl(C)@7 cleaved G-S@C-term -0.000117992000014056 2170.03735351563 1086.026 2170.03637695313 1086.02551269531 2 11 1.1.1.3999.21 1 46.4225 16616.58 46.1922 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 94.1500008106232 IVGGYTCAANSIPYQVSLNSG Carbamidomethyl(C)@7 cleaved G-S@C-term -0.00516636995598674 2170.03149414063 724.3511 2170.03637695313 724.352783203125 3 11 1.1.1.3997.15 1 46.3653 30815.67 46.1922 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 0.0339531004428864 4814.29052734375 1204.58 4814.2568359375 1204.57141113281 4 12 1.1.1.4188.21 1 51.2572 24196.43 51.2367 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 0.050067700445652 4814.30712890625 963.8687 4814.2568359375 963.858642578125 5 14 1.1.1.4184.19 1 51.153 91255.4 51.2367 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Deamidated(Q)@15; Carbamidomethyl(C)@25; Delta:H(4)C(2)(H)@40; Carbamidomethyl(C)@41; hexanoyl addition +98(K)@43 0.00767552014440298 4786.26953125 958.2612 4786.26171875 958.259643554688 5 14 1.1.1.4182.19 1 51.1014 35616.64 51.1083 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 95.7199990749359 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Deamidated(Q)@33; Carbamidomethyl(C)@41; ONE addition +154(K)@43 0.0599840991199017 4815.30029296875 964.0674 4815.24072265625 964.055419921875 5 12 1.1.1.4199.19 1 51.5357 32757.94 51.6191 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.2300000190735 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; reduced HNE(H)@23; Carbamidomethyl(C)@25; Ammonia-loss(N)@31; Carbamidomethyl(C)@41 0.013578100129962 4800.291015625 961.0655 4800.27734375 961.062744140625 5 12 1.1.1.4156.20 1 50.4383 60340.18 50.3425 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.2300000190735 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; reduced HNE(H)@23; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; Tyr->Dha(Y)@42; MDA adduct +62(K)@43 -0.00122292002197355 4786.26025390625 798.7173 4786.26171875 798.717590332031 6 13 1.1.1.4182.14 1 51.0972 4895.794 51.1083 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 72.3800003528595 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 0.0439497008919716 4814.30029296875 803.3907 4814.2568359375 803.383422851563 6 10 1.1.1.4191.14 1 51.3278 13075.83 51.2367 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 70.6399977207184 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Deamidated(Q)@15; Carbamidomethyl(C)@25; Carbamidomethyl(C)@41; acrolein addition +112(K)@43 0.0436512008309364 4772.2529296875 955.4579 4772.2099609375 955.44921875 5 10 1.1.1.4142.18 1 50.08 19665.56 50.1384 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 63.4599983692169 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Methyl(H)@40; Carbamidomethyl(C)@41; acrolein addition +112(K)@43 0.0557544007897377 4786.28271484375 1197.578 4786.2255859375 1197.56359863281 4 11 1.1.1.4184.21 1 51.1547 7547.445 51.1083 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 56.0100018978119 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Deamidated(N)@19; Carbamidomethyl(C)@25; Carbamidomethyl(C)@41; ONE addition +154(K)@43 0.0439497008919716 4814.30029296875 803.3907 4814.2568359375 803.383422851563 6 9 1.1.1.4184.17 1 51.1513 13075.83 51.2367 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 48.429998755455 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Deamidated(Q)@15; Carbamidomethyl(C)@25; Carbamidomethyl(C)@41; acrolein addition +112(K)@43 0.051274199038744 4772.2626953125 1194.073 4772.2099609375 1194.05969238281 4 9 1.1.1.4142.21 1 50.0825 4690.796 50.1384 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 33.2800000905991 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Deamidated(N)@19; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 0.0465568006038666 4815.28759765625 964.0648 4815.24072265625 964.055419921875 5 9 1.1.1.4170.21 1 50.7953 10817.17 50.9282 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 45.5700010061264 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKS Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Carbamidomethyl(C)@41; MDA adduct +54(K)@43 cleaved S-R@C-term; missed K-S@43 0.0705676004290581 4800.287109375 801.0551 4800.2158203125 801.043273925781 6 10 1.1.1.4157.17 1 50.4613 7421.071 50.3681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 KIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(K)@1 cleaved A-K@N-term; missed K-I@1; missed K-L@21 -0.00541219022125006 3452.80346679688 864.2081 3452.80859375 864.209411621094 4 16 1.1.1.4311.17 1 54.3891 9011.586 54.5251 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 KIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(H)@5; Deamidated(N)@11 cleaved A-K@N-term; missed K-I@1; missed K-L@21 0.0205568000674248 3453.81323242188 864.4606 3453.79272460938 864.455444335938 4 14 1.1.1.4373.18 1 55.9776 3544.852 55.9081 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 80.7399988174438 KIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(H)@5; Deamidated(N)@15 cleaved A-K@N-term; missed K-I@1; missed K-L@21 0.00493222009390593 3453.7978515625 864.4567 3453.79272460938 864.455444335938 4 12 1.1.1.4327.17 1 54.7987 9374.661 54.5251 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 79.8900008201599 LEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@12; Oxidation(P)@17 cleaved V-L@N-term; missed K-I@12; missed K-L@32 0.12584100663662 4793.595703125 959.7264 4793.4697265625 959.701232910156 5 13 1.1.1.4275.16 1 53.4703 8995.912 53.4542 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGN cleaved N-E@C-term 0.000319242011755705 1308.63122558594 655.3229 1308.63098144531 655.32275390625 2 10 1.1.1.3596.14 1 36.117 1836.126 36.0257 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 59.7699999809265 LGEHNIDVLEGN Dehydrated(E)@10 cleaved N-E@C-term -0.00428675999864936 1290.61633300781 646.3154 1290.62048339844 646.317504882813 2 11 1.1.1.3611.8 1 36.5029 3363.011 36.5379 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQ cleaved Q-F@C-term 0.000237835993175395 1565.732421875 783.8735 1565.73217773438 783.873352050781 2 13 1.1.1.3598.20 1 36.1735 811.7209 36.1281 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQ Delta:H(4)C(2)@N-term cleaved Q-F@C-term -0.00202931999228895 1593.76147460938 797.888 1593.76342773438 797.889038085938 2 11 1.1.1.3644.21 1 37.3348 1040.25 37.3661 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQ cleaved Q-F@C-term -0.00244764005765319 1565.72961425781 783.8721 1565.73217773438 783.873352050781 2 12 1.1.1.3584.19 1 35.8185 3403.492 35.9254 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.9099988937378 LGEHNIDVLEGNEQFIN Dehydrated(E)@13 cleaved N-A@C-term -0.00211847992613912 1921.91491699219 961.9647 1921.9169921875 961.965759277344 2 12 1.1.1.3996.20 1 46.3433 3055.332 46.4013 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Oxidation(F)@15 0.00881563033908606 2226.1005859375 743.0408 2226.091796875 743.037841796875 3 19 1.1.1.3805.20 1 41.4295 2792.017 41.4356 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17 -5.9476700698724E-05 2211.08081054688 738.0342 2211.08081054688 738.0341796875 3 23 1.1.1.3869.13 1 43.0959 37500.02 43.0298 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17 -5.9476700698724E-05 2211.08081054688 738.0342 2211.08081054688 738.0341796875 3 22 1.1.1.3869.14 1 43.0967 37500.02 43.0298 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00546438992023468 2210.10229492188 737.708 2210.0966796875 737.706176757813 3 22 1.1.1.3878.16 1 43.3337 457477.6 43.5735 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@5; Deamidated(N)@17 0.0455017983913422 2212.1103515625 738.3774 2212.06469726563 738.362182617188 3 19 1.1.1.3879.20 1 43.3632 98480.8 43.5228 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@13 0.00186371000017971 2232.08056640625 745.0341 2232.07861328125 745.033508300781 3 22 1.1.1.3880.17 1 43.3869 13774.26 43.4975 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.000277704995824024 2210.09741210938 1106.056 2210.0966796875 1106.0556640625 2 25 1.1.1.3884.18 1 43.4923 142407.8 43.5228 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.000567211012821645 2210.09741210938 553.5316 2210.0966796875 553.531494140625 4 23 1.1.1.3885.4 1 43.5033 46575.82 43.5228 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00509819015860558 2210.10180664063 737.7079 2210.0966796875 737.706176757813 3 23 1.1.1.3885.10 1 43.5083 433403.1 43.4975 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@10 0.00186371000017971 2232.08056640625 745.0341 2232.07861328125 745.033508300781 3 23 1.1.1.3887.14 1 43.5625 13774.26 43.4975 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.000567211012821645 2210.09741210938 553.5316 2210.0966796875 553.531494140625 4 21 1.1.1.3892.5 1 43.6818 37587.81 43.7255 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00546438992023468 2210.10229492188 737.708 2210.0966796875 737.706176757813 3 20 1.1.1.3892.11 1 43.6868 419545.9 43.5735 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00320731010288 2210.09936523438 1106.057 2210.0966796875 1106.0556640625 2 24 1.1.1.3892.20 1 43.6952 128861.6 43.6751 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00747849978506565 2210.10424804688 737.7087 2210.0966796875 737.706176757813 3 24 1.1.1.3899.14 1 43.8659 201516.9 43.8264 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00320731010288 2210.09936523438 1106.057 2210.0966796875 1106.0556640625 2 25 1.1.1.3899.21 1 43.8718 128861.6 43.6751 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@10 0.00332851009443402 2232.08203125 745.0346 2232.07861328125 745.033508300781 3 17 1.1.1.3901.16 1 43.9185 10569.3 43.7255 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00253476994112134 2210.09912109375 737.707 2210.0966796875 737.706176757813 3 22 1.1.1.3906.7 1 44.0372 173973.4 44.0542 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 3.35711010848172E-05 2210.09741210938 1106.056 2210.0966796875 1106.0556640625 2 23 1.1.1.3906.16 1 44.0489 106571.3 43.776 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00253476994112134 2210.09912109375 737.707 2210.0966796875 737.706176757813 3 23 1.1.1.3913.9 1 44.2153 173973.4 44.0542 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.00402412982657552 2224.11743164063 1113.066 2224.1123046875 1113.0634765625 2 19 1.1.1.3913.20 1 44.2253 4222.374 44.3064 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00180236995220184 2210.0986328125 737.7068 2210.0966796875 737.706176757813 3 25 1.1.1.3920.12 1 44.3949 139409.8 44.1297 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 -0.0025937301106751 2224.10986328125 742.3772 2224.1123046875 742.378051757813 3 22 1.1.1.3920.13 1 44.3958 36602.78 44.3064 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)@N-term -0.000764987024012953 2238.12719726563 747.0497 2238.12817382813 747.049987792969 3 19 1.1.1.3921.15 1 44.4227 59333.04 44.5592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00033756101038307 2210.09716796875 737.7063 2210.0966796875 737.706176757813 3 25 1.1.1.3927.16 1 44.5751 76286.15 44.3064 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)@N-term -0.000764987024012953 2238.12719726563 747.0497 2238.12817382813 747.049987792969 3 26 1.1.1.3928.15 1 44.5994 59333.04 44.5592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(I)@16; Ammonia-loss(N)@17; MDA adduct +54(K)@20 0.00637945020571351 2261.10278320313 754.7082 2261.09643554688 754.706115722656 3 18 1.1.1.3932.15 1 44.7005 3649.595 44.6601 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK -0.0040568602271378 2210.09252929688 737.7048 2210.0966796875 737.706176757813 3 22 1.1.1.3934.15 1 44.751 21846.04 44.6856 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)@N-term -0.000764987024012953 2238.12719726563 747.0497 2238.12817382813 747.049987792969 3 22 1.1.1.3935.17 1 44.778 59333.04 44.5592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Lys-add@N-term; Oxidation(H)@4 -0.00520221004262567 2354.18139648438 785.7344 2354.1865234375 785.736145019531 3 24 1.1.1.3939.15 1 44.8771 33476 44.8118 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK -0.0040568602271378 2210.09252929688 737.7048 2210.0966796875 737.706176757813 3 23 1.1.1.3941.14 1 44.9266 22196.42 44.6601 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Lys-add@N-term; Oxidation(H)@4 -0.00483600981533527 2354.18212890625 785.7346 2354.1865234375 785.736145019531 3 20 1.1.1.3946.18 1 45.0564 33989.53 44.7865 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.000703762983903289 2210.09741210938 737.7064 2210.0966796875 737.706176757813 3 24 1.1.1.3948.16 1 45.1053 17406.31 45.0135 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@12 0.0224619004875422 2211.10327148438 738.0417 2211.08081054688 738.0341796875 3 21 1.1.1.3950.18 1 45.1579 7994.476 45.1909 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Dimethyl(N)@5 0.0045449398458004 2238.1328125 747.0515 2238.12817382813 747.049987792969 3 20 1.1.1.3951.19 1 45.184 2590.175 45.1401 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.000703762983903289 2210.09741210938 737.7064 2210.0966796875 737.706176757813 3 22 1.1.1.3955.16 1 45.2841 14276.62 45.2164 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Lys-add@N-term; Oxidation(H)@4; Deamidated(N)@5 0.00209056003950536 2355.1728515625 786.0649 2355.17065429688 786.064147949219 3 19 1.1.1.3955.17 1 45.2849 6141.488 45.0641 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00125306996051222 2210.09790039063 737.7066 2210.0966796875 737.706176757813 3 20 1.1.1.3962.15 1 45.4627 6029.568 45.4475 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@12 0.00256360997445881 2211.08325195313 1106.549 2211.08081054688 1106.54760742188 2 15 1.1.1.3967.21 1 45.5951 3410.225 45.6765 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@12 -0.00482010003179312 2211.07592773438 738.0326 2211.08081054688 738.0341796875 3 22 1.1.1.3974.17 1 45.7701 28652.75 45.6765 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK -0.00295826001092792 2210.09375 737.7052 2210.0966796875 737.706176757813 3 18 1.1.1.3984.16 1 46.0256 6595.785 46.0091 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.00407013017684221 2236.11669921875 746.3795 2236.1123046875 746.378051757813 3 22 1.1.1.3987.17 1 46.1047 88175.77 46.3493 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.000525693001691252 2236.11328125 1119.064 2236.1123046875 1119.0634765625 2 17 1.1.1.3989.21 1 46.1607 19089.72 46.4013 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.000886864028871059 2210.09765625 737.7065 2210.0966796875 737.706176757813 3 19 1.1.1.3993.17 1 46.2622 6710.431 45.9833 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 -3.84621998819057E-05 2236.11206054688 560.0353 2236.1123046875 560.035400390625 4 16 1.1.1.3996.10 1 46.3349 7288.128 46.4013 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.00461942981928587 2236.11694335938 746.3796 2236.1123046875 746.378051757813 3 25 1.1.1.3996.18 1 46.3416 108762.8 46.4013 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@5 -0.00243978993967175 2211.07836914063 738.0334 2211.08081054688 738.0341796875 3 21 1.1.1.4002.20 1 46.4998 6039.306 46.5059 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.00461942981928587 2236.11694335938 746.3796 2236.1123046875 746.378051757813 3 24 1.1.1.4003.18 1 46.5241 108762.8 46.4013 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.00461942981928587 2236.11694335938 746.3796 2236.1123046875 746.378051757813 3 19 1.1.1.4011.15 1 46.7298 76701.16 46.4538 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)@N-term; Delta:H(2)C(2)(H)@4 -0.00516664981842041 2264.13891601563 755.7202 2264.14379882813 755.721862792969 3 19 1.1.1.4151.19 1 50.3102 3090.043 50.2917 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@3 0.00491512008011341 2232.08325195313 1117.049 2232.07861328125 1117.04663085938 2 17 1.1.1.4186.21 1 51.2058 4938.834 51.2878 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@3 0.0175151005387306 2232.09643554688 745.0394 2232.07861328125 745.033508300781 3 20 1.1.1.4193.16 1 51.3806 6925.836 51.2878 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@3 0.00491512008011341 2232.08325195313 1117.049 2232.07861328125 1117.04663085938 2 11 1.1.1.4194.20 1 51.4093 4938.834 51.2878 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Oxidation(H)@4; Ammonia-loss(N)@5 0.00494406977668405 2209.0693359375 1105.542 2209.06518554688 1105.53979492188 2 14 1.1.1.4231.20 1 52.3508 12530.37 52.4846 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Oxidation(H)@4; Ammonia-loss(N)@5 0.00494406977668405 2209.0693359375 1105.542 2209.06518554688 1105.53979492188 2 21 1.1.1.4238.20 1 52.5297 12530.37 52.4846 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)(H)@4; Deamidated(N)@17 -0.00683824019506574 2239.10522460938 747.3757 2239.11206054688 747.377990722656 3 15 1.1.1.3880.18 1 43.3877 1854.707 43.3693 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@13 -0.00725835002958775 2232.0712890625 559.0251 2232.07861328125 559.026977539063 4 16 1.1.1.3894.8 1 43.7347 5142.199 43.7004 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00105547998100519 2210.09765625 553.5317 2210.0966796875 553.531494140625 4 16 1.1.1.3906.3 1 44.0339 35294.84 43.776 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.00993295013904572 2210.10668945313 737.7095 2210.0966796875 737.706176757813 3 10 1.1.1.4090.14 1 48.7488 2200.36 48.7088 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.0073695401661098 2210.10424804688 737.7087 2210.0966796875 737.706176757813 3 11 1.1.1.4109.16 1 49.235 1320.12 49.2189 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17 0.00183120998553932 2211.08325195313 1106.549 2211.08081054688 1106.54760742188 2 11 1.1.1.3862.21 1 42.9216 2812.915 43.0298 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Lys-add@N-term; Oxidation(H)@4 0.0112033998593688 2354.1982421875 589.5568 2354.1865234375 589.553955078125 4 17 1.1.1.3938.9 1 44.847 5119.9 44.7865 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Oxidation(H)@4; Ammonia-loss(N)@5 0.016567500308156 2209.08203125 737.3679 2209.06518554688 737.3623046875 3 15 1.1.1.4234.16 0 52.4242 14335.97 52.4846 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Dehydrated(E)@10 0.00511611020192504 2192.09130859375 731.7044 2192.08618164063 731.702697753906 3 14 1.1.1.3882.11 1 43.4332 1371.402 43.4213 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)(H)@4 0.0045449398458004 2238.1328125 747.0515 2238.12817382813 747.049987792969 3 14 1.1.1.3944.18 1 45.0057 2590.175 45.1401 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.000703762983903289 2210.09741210938 737.7064 2210.0966796875 737.706176757813 3 13 1.1.1.4022.20 1 47.0187 2681.897 46.9219 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Oxidation(F)@15; Deamidated(N)@17; hexanoyl addition +98(K)@20 0.01346439961344 2325.16235351563 776.0614 2325.14892578125 776.056884765625 3 15 1.1.1.3920.14 1 44.3966 7528.95 44.4582 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(N)@17 -0.00204443000257015 2224.1103515625 742.3774 2224.1123046875 742.378051757813 3 12 1.1.1.3929.14 1 44.6239 20423.09 44.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Formyl@N-term -0.000401786004658788 2238.09130859375 1120.053 2238.091796875 1120.05310058594 2 9 1.1.1.4122.21 1 49.572 1168.658 49.526 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@3; Deamidated(N)@12 0.0381751991808414 2233.10107421875 745.3743 2233.06274414063 745.361511230469 3 13 1.1.1.4185.19 0 51.1786 5621.646 51.2623 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@13 0.00186371000017971 2232.08056640625 745.0341 2232.07861328125 745.033508300781 3 14 1.1.1.3883.12 1 43.4594 13774.26 43.4975 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:K(E)@10 0.00916290003806353 2248.06176757813 750.3612 2248.052734375 750.358154296875 3 13 1.1.1.3883.13 1 43.4603 3230.136 43.5228 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)(H)@4 -0.00279409997165203 2238.12524414063 560.5386 2238.12817382813 560.539306640625 4 12 1.1.1.3923.7 1 44.4666 5989.197 44.5592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAK 0.00481540011242032 2210.1015625 443.0276 2210.0966796875 443.026641845703 5 12 1.1.1.3885.2 1 43.5016 2222.159 43.5228 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.6999988555908 LGEHNIDVLEGNEQFINAAK Oxidation(N)@5 -0.0162691995501518 2226.07543945313 743.0324 2226.091796875 743.037841796875 3 10 1.1.1.3716.20 1 39.1657 709.656 39.2235 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.6999988555908 LGEHNIDVLEGNEQFINAAK Deamidated(N)@12; Carbamidomethyl(E)@13 -0.0666823983192444 2268.03540039063 757.0191 2268.10229492188 757.041381835938 3 15 1.1.1.3899.15 1 43.8668 781.1485 43.8517 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.7400004863739 LGEHNIDVLEGNEQFINAAK -0.993718028068542 2209.10278320313 737.3749 2210.0966796875 737.706176757813 3 12 1.1.1.4052.13 0 47.7809 3045.786 47.7417 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.3800003528595 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@13 0.00699053006246686 2232.08569335938 745.0358 2232.07861328125 745.033508300781 3 12 1.1.1.3908.15 1 44.0942 9823.517 43.8264 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 96.2100028991699 LGEHNIDVLEGNEQFINAAK Ammonia-loss(N)@12 0.0169868990778923 2193.08715820313 732.0363 2193.0703125 732.030700683594 3 10 1.1.1.3893.11 1 43.7119 3181.031 43.877 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 95.9200024604797 LGEHNIDVLEGNEQFINAAK Cation:K(E)@13 -0.009140869602561 2248.04345703125 563.0181 2248.052734375 563.020446777344 4 12 1.1.1.3888.10 1 43.5845 3658.809 43.4722 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 93.7099993228912 LGEHNIDVLEGNEQFINAAK Methyl(N)@17 -0.00057961797574535 2224.11206054688 742.3779 2224.1123046875 742.378051757813 3 10 1.1.1.3936.13 1 44.7999 1251.089 44.6601 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 93.7099993228912 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 -3.84621998819057E-05 2236.11206054688 560.0353 2236.1123046875 560.035400390625 4 10 1.1.1.4004.7 1 46.5412 7288.128 46.4013 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 92.739999294281 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)(H)@4 -0.0124834002926946 2238.11547851563 747.0458 2238.12817382813 747.049987792969 3 10 1.1.1.3872.16 1 43.1766 845.2844 43.186 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 92.1999990940094 LGEHNIDVLEGNEQFINAAK Deamidated(N)@5; Deamidated(N)@12; Deamidated(Q)@14; Deamidated(N)@17 0.0595389008522034 2214.09252929688 739.0381 2214.03271484375 739.018188476563 3 12 1.1.1.3871.18 1 43.1517 5386.96 43.0822 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 92.1999990940094 LGEHNIDVLEGNEQFINAAK Cation:K(E)@10 -0.00084027397679165 2248.0517578125 563.0202 2248.052734375 563.020446777344 4 10 1.1.1.3895.6 1 43.7582 2449.591 43.776 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.9900009632111 LGEHNIDVLEGNEQFINAAK Acetyl@N-term 0.00558908004313707 2252.11303710938 751.7116 2252.107421875 751.709716796875 3 10 1.1.1.3917.13 1 44.3197 2696.041 44.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.9900009632111 LGEHNIDVLEGNEQFINAAK Lys-add@N-term; Oxidation(H)@4 0.0112033998593688 2354.1982421875 589.5568 2354.1865234375 589.553955078125 4 12 1.1.1.3941.7 1 44.9208 5119.9 44.7865 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.9900009632111 LGEHNIDVLEGNEQFINAAK Methyl(N)@17 -0.00973466970026493 2224.1025390625 742.3748 2224.1123046875 742.378051757813 3 11 1.1.1.3947.14 1 45.0784 847.5129 45.0641 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.9900009632111 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4; Deamidated(N)@5 0.0308158006519079 2237.12744140625 560.2891 2237.09643554688 560.281372070313 4 10 1.1.1.4002.10 1 46.4915 3678.005 46.4013 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.2300000190735 LGEHNIDVLEGNEQFINAAK Formyl@N-term; Delta:H(2)C(2)(H)@4; Deamidated(N)@12 0.045287199318409 2265.13647460938 756.0528 2265.09130859375 756.037719726563 3 12 1.1.1.4228.18 1 52.2729 1147.342 52.2552 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 87.1500015258789 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)@N-term 0.0045449398458004 2238.1328125 747.0515 2238.12817382813 747.049987792969 3 11 1.1.1.3958.20 1 45.3644 2590.175 45.1401 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 86.2100005149841 LGEHNIDVLEGNEQFINAAK Deamidated(N)@12; Cation:K(E)@13 0.0364140011370182 2249.07299804688 750.6983 2249.03662109375 750.686157226563 3 10 1.1.1.3881.17 1 43.4127 1835.604 43.4722 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 86.2100005149841 LGEHNIDVLEGNEQFINAAK Carbamidomethyl@N-term; Dicarbamidomethyl(D)@7 0.0252877995371819 2381.1865234375 794.7361 2381.1611328125 794.727661132813 3 13 1.1.1.3966.17 1 45.5663 1280.348 45.651 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 83.0299973487854 LGEHNIDVLEGNEQFINAAK Oxidation(N)@12 -0.00638175010681152 2226.08520507813 743.0357 2226.091796875 743.037841796875 3 10 1.1.1.3894.13 1 43.7389 2584.161 43.5989 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 81.8400025367737 LGEHNIDVLEGNEQFINAAK Deamidated(Q)@14; Deamidated(N)@17; reduced acrolein addition +58(K)@20 0.00251927995122969 2270.10913085938 757.7103 2270.10668945313 757.70947265625 3 10 1.1.1.3880.19 1 43.3886 4196.23 43.3693 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 79.2599976062775 LGEHNIDVLEGNEQFINAAK Carbamidomethyl@N-term; Deamidated(N)@5 -0.00570981996133924 2268.09643554688 757.0394 2268.10229492188 757.041381835938 3 9 1.1.1.3890.15 1 43.6393 2073.044 43.4722 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 73.9300012588501 LGEHNIDVLEGNEQFINAAK 0.00618231995031238 2210.10302734375 553.533 2210.0966796875 553.531494140625 4 10 1.1.1.3921.9 1 44.4177 7007.301 44.1549 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 68.8799977302551 LGEHNIDVLEGNEQFINAAK Deamidated(Q)@14 0.0390157997608185 2211.11962890625 738.0472 2211.08081054688 738.0341796875 3 8 1.1.1.4117.17 1 49.4404 1216.102 49.4747 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 62.5400006771088 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@13 -0.00252487999387085 2232.07543945313 1117.045 2232.07861328125 1117.04663085938 2 6 1.1.1.3889.20 1 43.6182 1443.141 43.5481 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 62.5400006771088 LGEHNIDVLEGNEQFINAAK Deamidated(N)@5; Deamidated(N)@12; Deamidated(Q)@14 0.046203400939703 2213.09497070313 738.7056 2213.048828125 738.690185546875 3 10 1.1.1.3960.17 1 45.4133 3056.386 45.3961 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 58.6499989032745 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@13 0.0177382007241249 2232.09741210938 1117.056 2232.07861328125 1117.04663085938 2 6 1.1.1.3898.21 1 43.8465 719.0333 43.8517 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 22.6400002837181 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@13 0.00332851009443402 2232.08203125 745.0346 2232.07861328125 745.033508300781 3 7 1.1.1.3892.13 1 43.6885 10569.3 43.7255 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 15.9999996423721 LGEHNIDVLEGNEQFINAAK 0.0180984009057283 2210.11474609375 737.7122 2210.0966796875 737.706176757813 3 10 1.1.1.4045.16 1 47.605 2384.652 47.7162 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.6400008201599 LGEHNIDVLEGNEQFINAAKIITH hexanoyl addition +98(K)@20; Oxidation(H)@24 cleaved H-P@C-term; missed K-I@20 0.0497182011604309 2788.4892578125 698.1296 2788.439453125 698.1171875 4 10 1.1.1.4624.7 1 62.492 930.434 62.5592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 96.6300010681152 LGEHNIDVLEGNEQFINAAKIITH acrolein addition +112(K)@20 cleaved H-P@C-term; missed K-I@20 -0.0153810000047088 2786.40844726563 697.6094 2786.423828125 697.61328125 4 9 1.1.1.4555.9 1 60.7305 2598.201 60.72 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 41.3700014352798 LGEHNIDVLEGNEQFINAAKIITH MDA adduct +54(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 3.07894988509361E-05 2886.51293945313 963.1782 2886.5126953125 963.178161621094 3 8 1.1.1.4637.8 1 62.8202 854.8702 62.8111 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 80.2600026130676 LGEHNIDVLEGNEQFINAAKIITHP HPNE addition +172(K)@20 cleaved P-N@C-term; missed K-I@20 0.0109569001942873 2943.54516601563 982.189 2943.5341796875 982.185363769531 3 8 1.1.1.4661.18 1 63.4317 1065.681 63.4143 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 27.0799994468689 LGEHNIDVLEGNEQFINAAKIITHP HPNE addition +172(K)@20 cleaved P-N@C-term; missed K-I@20 0.0270697008818388 2943.56103515625 982.1943 2943.5341796875 982.185363769531 3 8 1.1.1.4644.8 1 63.0023 908.8215 62.9875 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPN acrolein addition +94(K)@20 cleaved N-F@C-term; missed K-I@20 -0.000219056993955746 2979.5087890625 994.1769 2979.50903320313 994.176940917969 3 9 1.1.1.4595.12 1 61.7617 1571.722 61.6983 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 92.9499983787537 LGEHNIDVLEGNEQFINAAKIITHPN Delta:H(2)C(2)(H)@24 cleaved N-F@C-term; missed K-I@20 -0.0132333002984524 2911.46948242188 971.4971 2911.48291015625 971.501525878906 3 9 1.1.1.4658.7 1 63.3473 691.815 63.3142 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.4699981212616 LGEHNIDVLEGNEQFINAAKIITHPN MDA adduct +54(K)@20; reduced HNE(H)@24 cleaved N-F@C-term; missed K-I@20 -0.00447242986410856 3097.60424804688 1033.542 3097.6083984375 1033.54345703125 3 8 1.1.1.4572.19 1 61.1825 720.3536 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 87.1599972248077 LGEHNIDVLEGNEQFINAAKIITHPN MDA adduct +54(K)@20 cleaved N-F@C-term; missed K-I@20 0.0309804007411003 2939.5087890625 980.8435 2939.47778320313 980.833190917969 3 8 1.1.1.4658.10 1 63.3523 697.7376 63.3642 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 70.9100008010864 LGEHNIDVLEGNEQFINAAKIITHPN reduced acrolein addition +58(K)@20 cleaved N-F@C-term; missed K-I@20 -0.0107643995434046 2943.498046875 982.1733 2943.50903320313 982.176940917969 3 8 1.1.1.4634.12 1 62.7483 775.0897 62.7357 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 63.5999977588654 LGEHNIDVLEGNEQFINAAKIITHPN cleaved N-F@C-term; missed K-I@20 0.0220574997365475 2885.48901367188 962.837 2885.46728515625 962.829650878906 3 7 1.1.1.4672.8 1 63.698 680.2037 63.6641 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 41.3700014352798 LGEHNIDVLEGNEQFINAAKIITHPN ONE addition +154(K)@20; reduced HNE(H)@24; Deamidated(N)@26 cleaved N-F@C-term; missed K-I@20 0.0468919984996319 3198.72802734375 800.6893 3198.68115234375 800.677612304688 4 9 1.1.1.4623.8 1 62.4675 0 -1 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 41.3700014352798 LGEHNIDVLEGNEQFINAAKIITHPN reduced acrolein addition +58(K)@20 cleaved N-F@C-term; missed K-I@20 0.0264047998934984 2943.53540039063 982.1857 2943.50903320313 982.176940917969 3 8 1.1.1.4654.15 1 63.2571 1224.302 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 38.1399989128113 LGEHNIDVLEGNEQFINAAKIITHPN acrolein addition +94(K)@20 cleaved N-F@C-term; missed K-I@20 -0.00626133987680078 2979.5029296875 994.1749 2979.50903320313 994.176940917969 3 8 1.1.1.4588.10 1 61.5834 1207.418 61.5717 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 27.0799994468689 LGEHNIDVLEGNEQFINAAKIITHPN acrolein addition +94(K)@20 cleaved N-F@C-term; missed K-I@20 0.01387959998101 2979.52294921875 994.1816 2979.50903320313 994.176940917969 3 8 1.1.1.4610.13 1 62.1428 1261.577 62.0788 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.2300000190735 LGEHNIDVLEGNEQFINAAKIITHPNF hexanoyl addition +98(K)@20; Delta:H(2)C(2)(H)@24 cleaved F-N@C-term; missed K-I@20 -0.0138825001195073 3156.61059570313 790.1599 3156.62451171875 790.163391113281 4 12 1.1.1.4353.18 1 55.4642 10145.05 55.5748 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFN reduced acrolein addition +96(K)@20; Iodo(H)@24; Deamidated(N)@28 cleaved N-G@C-term; missed K-I@20 -0.0134685002267361 3369.50341796875 1124.175 3369.5166015625 1124.17956542969 3 13 1.1.1.4641.19 1 62.9303 0 -1 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.7299978733063 LGEHNIDVLEGNEQFINAAKIITHPNFN reduced acrolein addition +58(K)@20; reduced HNE(H)@24; Deamidated(N)@26; Deamidated(N)@28 cleaved N-G@C-term; missed K-I@20 0.0173215009272099 3364.736328125 1122.586 3364.71899414063 1122.58032226563 3 11 1.1.1.4606.17 1 62.0482 0 -1 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 27.0799994468689 LGEHNIDVLEGNEQFINAAKIITHPNFN MDA adduct +54(K)@20; reduced HNE(H)@24 cleaved N-G@C-term; missed K-I@20 -0.00218795007094741 3358.71801757813 1120.58 3358.7197265625 1120.58056640625 3 6 1.1.1.4587.19 1 61.5647 0 -1 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Formyl(K)@20; Oxidation(M)@37 missed K-I@20 0.0494439005851746 4518.2978515625 904.6669 4518.2490234375 904.657043457031 5 16 1.1.1.4495.16 1 59.1518 3305.723 59.1082 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK missed K-I@20 0.0114372996613383 4474.2705078125 895.8614 4474.25927734375 895.859069824219 5 22 1.1.1.4522.17 1 59.8684 8580.996 59.8769 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Methyl(H)@24 missed K-I@20 0.000164105003932491 4488.2744140625 898.6622 4488.27490234375 898.662231445313 5 20 1.1.1.4523.18 1 59.8956 27825.46 60.0085 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Formyl(K)@20 missed K-I@20 0.042060200124979 4502.2958984375 901.4665 4502.25390625 901.458068847656 5 22 1.1.1.4526.19 1 59.9751 27005.21 60.0348 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Methyl(H)@24 missed K-I@20 0.000164105003932491 4488.2744140625 898.6622 4488.27490234375 898.662231445313 5 14 1.1.1.4532.19 1 60.1304 27825.46 60.0085 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Delta:H(4)C(2)(H)@24 missed K-I@20 0.0056746699847281 4502.2958984375 901.4665 4502.29052734375 901.46533203125 5 24 1.1.1.4533.18 1 60.1555 27005.21 60.0348 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Methyl+Deamidated(Q)@14 missed K-I@20 0.01678810082376 4489.27587890625 898.8624 4489.2587890625 898.859008789063 5 20 1.1.1.4540.18 1 60.3438 7693.72 60.378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Delta:H(4)C(2)(H)@24; Deamidated(N)@28 missed K-I@20 0.0125332996249199 4503.287109375 901.6647 4503.2744140625 901.662170410156 5 18 1.1.1.4542.14 1 60.3936 7061.381 60.4306 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Formyl(K)@20 missed K-I@20 0.0388549007475376 4502.29296875 751.3894 4502.25390625 751.382934570313 6 11 1.1.1.4533.11 1 60.1497 2010.786 60.1117 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 94.7700023651123 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Formyl(K)@20 missed K-I@20 0.0377563014626503 4502.29150390625 751.3892 4502.25390625 751.382934570313 6 10 1.1.1.4527.12 1 59.9957 3024.095 60.0348 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 87.1599972248077 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Delta:H(4)C(2)(H)@24 missed K-I@20 0.0115807000547647 4502.302734375 1126.583 4502.29052734375 1126.57983398438 4 9 1.1.1.4532.20 1 60.1313 8362.834 60.0348 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.0585875995457172 5199.71337890625 1040.95 5199.6552734375 1040.93823242188 5 13 1.1.1.4778.17 1 66.4325 13568.67 66.337 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.0573669001460075 5199.71337890625 1040.95 5199.6552734375 1040.93823242188 5 11 1.1.1.4785.14 1 66.6138 14038 66.337 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL Delta:H(4)C(2)@N-term; acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.0518746003508568 5227.73876953125 1046.555 5227.6865234375 1046.54455566406 5 13 1.1.1.4783.18 1 66.5643 14555.17 66.5986 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL Delta:H(4)C(2)@N-term; acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.0518746003508568 5227.73876953125 1046.555 5227.6865234375 1046.54455566406 5 13 1.1.1.4790.16 1 66.7481 14514.68 66.7042 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL Oxidation(M)@37; acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.0677831992506981 5215.71875 1044.151 5215.64990234375 1044.13732910156 5 10 1.1.1.4698.13 1 64.3557 1525.003 64.3916 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.0585875995457172 5199.71337890625 1040.95 5199.6552734375 1040.93823242188 5 10 1.1.1.4771.14 1 66.2477 13568.67 66.337 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL Delta:H(4)C(2)@N-term; acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.0500436015427113 5227.73876953125 1046.555 5227.6865234375 1046.54455566406 5 11 1.1.1.4774.16 1 66.3276 12497.85 66.5197 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL Deamidated(N)@34; acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.0480506010353565 5200.6884765625 1041.145 5200.63916015625 1041.13513183594 5 10 1.1.1.4801.19 1 67.0434 2018.656 67.078 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 94.7700023651123 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.0795138999819756 5226.7333984375 1046.354 5226.65478515625 1046.33825683594 5 10 1.1.1.4841.18 1 68.1113 1097.162 68.1456 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.0481412000954151 5313.74365234375 1063.756 5313.69775390625 1063.74682617188 5 12 1.1.1.4717.19 1 64.8502 11555.37 64.7786 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.0562248006463051 5313.75439453125 886.633 5313.69775390625 886.623596191406 6 10 1.1.1.4711.9 1 64.6851 3138.601 64.7786 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN Delta:H(4)C(2)(H)@4; acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.0524092987179756 5341.78369140625 1069.364 5341.7294921875 1069.35314941406 5 11 1.1.1.4721.18 1 64.9543 1696.146 64.909 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +56(K)@40; Dehydrated(T)@46 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.0557629987597466 5295.74365234375 1060.156 5295.6875 1060.14477539063 5 11 1.1.1.4743.16 1 65.5277 4115.976 65.717 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 85.1400017738342 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +56(K)@40; Dehydrated(T)@46 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.0563732981681824 5295.74365234375 1060.156 5295.6875 1060.14477539063 5 9 1.1.1.4757.20 1 65.8897 4164.048 65.717 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@34; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0590468011796474 5587.884765625 932.3214 5587.82568359375 932.311584472656 6 17 1.1.1.4510.18 1 59.5493 1510.918 59.5571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; MDA adduct +62(K)@40; Dehydrated(S)@43 missed K-I@20; missed K-L@40 0.0529159009456635 5588.8681640625 932.4853 5588.81494140625 932.476440429688 6 20 1.1.1.4518.19 1 59.764 3332.867 59.7441 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0384438000619411 5557.853515625 1112.578 5557.81494140625 1112.5703125 5 17 1.1.1.4522.20 1 59.8709 6312.423 59.9296 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0489679984748363 5557.86376953125 927.3179 5557.81494140625 927.309814453125 6 17 1.1.1.4523.20 1 59.8973 13017.22 59.9034 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.039785198867321 5572.865234375 929.8182 5572.826171875 929.811645507813 6 15 1.1.1.4526.20 1 59.976 2125.018 59.982 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0489679984748363 5557.86376953125 927.3179 5557.81494140625 927.309814453125 6 16 1.1.1.4530.18 1 60.0786 13017.22 59.9034 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Delta:H(4)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0188829004764557 5557.86669921875 927.3184 5557.84814453125 927.315307617188 6 23 1.1.1.4537.19 1 60.2632 57410.36 60.5108 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0361966006457806 5572.86328125 1115.58 5572.826171875 1115.57250976563 5 13 1.1.1.4538.21 1 60.2923 47505.32 60.5374 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0078863799571991 5556.85986328125 927.1506 5556.86767578125 927.15185546875 6 24 1.1.1.4539.17 1 60.3156 25015.85 60.5108 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37 missed K-I@20; missed K-L@40 0.00822523981332779 5516.80810546875 920.4753 5516.7998046875 920.473937988281 6 20 1.1.1.4540.19 1 60.3446 3867.218 60.4046 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.010967000387609 5529.8310546875 922.6458 5529.8203125 922.643981933594 6 23 1.1.1.4541.17 1 60.3694 6669.502 60.4577 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0461347997188568 5572.88720703125 929.8218 5572.84130859375 929.814147949219 6 22 1.1.1.4541.18 1 60.3703 115516.5 60.5636 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; Met->Hcy(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0288568995893002 5588.865234375 932.4848 5588.83642578125 932.47998046875 6 21 1.1.1.4541.19 1 60.3711 5225.488 60.3516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0444923005998135 5572.8857421875 797.1338 5572.84130859375 797.12744140625 7 21 1.1.1.4542.11 1 60.3911 27946.73 60.6418 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0104299997910857 5588.8359375 799.4124 5588.84619140625 799.413879394531 7 16 1.1.1.4542.12 1 60.3919 1438.026 60.3516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.000154816007125191 5556.83349609375 1112.374 5556.8310546875 1112.37353515625 5 12 1.1.1.4542.20 1 60.3986 14021.14 60.5108 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0223184004426003 5556.853515625 794.8435 5556.8310546875 794.840270996094 7 25 1.1.1.4543.17 1 60.4221 7494.251 60.4845 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0623394995927811 5544.85693359375 925.1501 5544.794921875 925.139709472656 6 21 1.1.1.4543.18 1 60.4229 20116.08 60.4845 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0398848988115788 5590.85546875 932.8165 5590.8154296875 932.809875488281 6 16 1.1.1.4543.19 1 60.4237 3179.486 60.3516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@26; Formyl(K)@40 missed K-I@20; missed K-L@40 0.103749997913837 5701.99755859375 951.3402 5701.8935546875 951.322937011719 6 18 1.1.1.4544.20 1 60.4516 1877.199 60.4577 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0120959999039769 5801.046875 967.8484 5801.03515625 967.846435546875 6 21 1.1.1.4545.19 1 60.4775 4350.61 60.5108 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; Oxidation(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0509307011961937 5545.86865234375 1110.181 5545.81494140625 1110.17028808594 5 21 1.1.1.4545.21 1 60.4792 7151.598 60.4845 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@34; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0177842993289232 5557.865234375 927.3182 5557.84814453125 927.315307617188 6 28 1.1.1.4546.15 1 60.5006 58330.77 60.5108 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00416096998378634 5580.87158203125 931.1525 5580.86767578125 931.15185546875 6 19 1.1.1.4546.16 1 60.5015 2492.056 60.5108 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Met->Hcy(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.013238400220871 5572.87353515625 1115.582 5572.8623046875 1115.57971191406 5 19 1.1.1.4546.21 1 60.5056 84367.71 60.6681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0765274986624718 5544.87109375 793.1317 5544.794921875 793.120788574219 7 22 1.1.1.4547.12 1 60.5246 3795.05 60.4845 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.00766114005818963 5595.83837890625 800.4128 5595.83056640625 800.411682128906 7 13 1.1.1.4547.13 1 60.5255 2658.945 60.59 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0467890985310078 5545.8623046875 925.3176 5545.81494140625 925.309814453125 6 19 1.1.1.4547.19 1 60.5305 13418.24 60.4845 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0437786988914013 5576.8798828125 797.7044 5576.83642578125 797.698181152344 7 15 1.1.1.4548.12 1 60.5509 4195.034 60.5374 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Met->Hcy(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0162166003137827 5572.87841796875 929.8204 5572.8623046875 929.817687988281 6 33 1.1.1.4548.15 1 60.5534 141946.7 60.6681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0416653007268906 5588.8876953125 932.4886 5588.84619140625 932.481628417969 6 21 1.1.1.4548.16 1 60.5542 5306.877 60.4845 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Met->Hcy(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.059748400002718 5572.8857421875 797.1338 5572.826171875 797.125305175781 7 25 1.1.1.4549.9 1 60.5747 31846.29 60.6681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0335611999034882 5557.8486328125 1112.577 5557.81494140625 1112.5703125 5 13 1.1.1.4549.19 1 60.5831 32973.74 60.5108 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0259540006518364 5544.85693359375 925.1501 5544.8310546875 925.145812988281 6 18 1.1.1.4550.16 1 60.6064 20116.08 60.4845 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@30 missed K-I@20; missed K-L@40 0.0507990010082722 5557.865234375 927.3182 5557.81494140625 927.309814453125 6 16 1.1.1.4550.17 1 60.6072 58330.77 60.5108 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.00167513999622315 5594.8447265625 933.4814 5594.8466796875 933.481750488281 6 13 1.1.1.4550.18 1 60.6081 3828.583 60.59 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@30; Dethiomethyl(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0177842993289232 5557.865234375 927.3182 5557.84814453125 927.315307617188 6 22 1.1.1.4553.17 1 60.6854 58330.77 60.5108 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; Deamidated(N)@34; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.0178031995892525 5816.052734375 970.3494 5816.03466796875 970.346374511719 6 16 1.1.1.4553.20 1 60.6879 14434.56 60.6681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Oxidation(P)@25; Dethiomethyl(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0166091993451118 5572.87353515625 1115.582 5572.85888671875 1115.5791015625 5 21 1.1.1.4553.21 1 60.6887 84367.71 60.6681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0324406996369362 5595.86328125 800.4163 5595.83056640625 800.411682128906 7 17 1.1.1.4554.8 1 60.7039 2895.965 60.6681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0388801991939545 5800.04248046875 967.681 5800.00341796875 967.674499511719 6 16 1.1.1.4554.12 1 60.7072 2147.853 60.6418 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Met->Hcy(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0162166003137827 5572.87841796875 929.8204 5572.8623046875 929.817687988281 6 35 1.1.1.4555.16 1 60.7363 141946.7 60.6681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0189609006047249 5588.865234375 932.4848 5588.84619140625 932.481628417969 6 22 1.1.1.4555.17 1 60.7372 4527.234 60.7716 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Met->Hcy(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.059748400002718 5572.8857421875 797.1338 5572.826171875 797.125305175781 7 27 1.1.1.4556.11 1 60.758 31846.29 60.6681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0238959994167089 5574.865234375 797.4166 5574.841796875 797.413208007813 7 16 1.1.1.4557.7 1 60.7808 13440.94 60.694 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0211551003158093 5545.8369140625 925.3134 5545.81494140625 925.309814453125 6 20 1.1.1.4557.12 1 60.7849 6703.543 60.8242 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0564473010599613 5539.86083984375 924.3174 5539.8046875 924.308044433594 6 17 1.1.1.4558.15 1 60.814 12007.58 60.8778 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.00780765991657972 5595.83837890625 933.647 5595.83056640625 933.645751953125 6 13 1.1.1.4558.16 1 60.8148 4423.701 60.694 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.064647302031517 5539.869140625 792.4172 5539.8046875 792.407958984375 7 16 1.1.1.4559.9 1 60.8357 3004.466 60.8778 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-I@20; missed K-L@40 0.0130505999550223 5500.8173828125 917.8102 5500.8046875 917.80810546875 6 25 1.1.1.4559.14 1 60.8399 38501.74 61.0074 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.013896600343287 5529.833984375 922.6463 5529.8203125 922.643981933594 6 18 1.1.1.4559.16 1 60.8416 2942.782 60.8778 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0292314998805523 5556.8603515625 927.1507 5556.8310546875 927.145812988281 6 22 1.1.1.4560.15 1 60.8675 14601.11 60.59 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-I@20; missed K-L@40 0.0323053002357483 5500.83740234375 786.8412 5500.8046875 786.836547851563 7 20 1.1.1.4562.14 1 60.9189 7009.574 61.0074 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Ammonia-loss(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0241244994103909 5573.849609375 929.9822 5573.8251953125 929.978149414063 6 20 1.1.1.4562.16 1 60.9205 59439.77 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00101352005731314 5584.861328125 931.8175 5584.8623046875 931.817687988281 6 17 1.1.1.4562.17 1 60.9214 1982.544 60.7977 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-I@20; missed K-L@40 0.00651723984628916 5500.81396484375 1101.17 5500.8046875 1101.16821289063 5 21 1.1.1.4562.21 1 60.9247 24483.72 61.0074 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0326622985303402 5527.83740234375 922.3135 5527.8046875 922.308044433594 6 16 1.1.1.4563.15 1 60.9452 77039.03 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.053669098764658 5573.86376953125 797.2735 5573.81005859375 797.265869140625 7 18 1.1.1.4564.8 1 60.9654 12770.53 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Pro->pyro-Glu(P)@25 missed K-I@20; missed K-L@40 0.0416388995945454 5514.82568359375 920.1449 5514.7841796875 920.138000488281 6 20 1.1.1.4564.14 1 60.9704 31885.5 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; Delta:H(4)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0430519990622997 5557.890625 927.3224 5557.84814453125 927.315307617188 6 24 1.1.1.4564.15 1 60.9712 182375.7 61.2151 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR GlyGlyGln(K)@20 missed K-I@20; missed K-L@40 0.058501198887825 5743.97314453125 958.3361 5743.9140625 958.326293945313 6 20 1.1.1.4564.18 1 60.9737 3279.824 60.9814 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 0.00988228991627693 5514.82861328125 1103.973 5514.8173828125 1103.970703125 5 15 1.1.1.4564.19 1 60.9746 17461.6 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0386888012290001 5539.86083984375 924.3174 5539.822265625 924.310974121094 6 21 1.1.1.4565.13 1 60.9955 12007.58 60.8778 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Hex(N)@30 missed K-I@20; missed K-L@40 -0.0109010003507137 5919.05029296875 987.5157 5919.0615234375 987.517517089844 6 21 1.1.1.4565.16 1 60.998 2433.564 61.0074 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20 missed K-I@20; missed K-L@40 0.0519137009978294 5528.8525390625 790.8433 5528.7998046875 790.835815429688 7 19 1.1.1.4566.6 1 61.0154 37525.67 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-I@20; missed K-L@40 0.0130505999550223 5500.8173828125 917.8102 5500.8046875 917.80810546875 6 32 1.1.1.4566.14 1 61.0221 38501.74 61.0074 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Oxidation(P)@25; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0393805988132954 5573.849609375 929.9822 5573.81005859375 929.975646972656 6 20 1.1.1.4566.15 1 61.023 59439.77 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; PhosphoUridine(H)@24 missed K-I@20; missed K-L@40 0.0769099965691566 5918.95849609375 1184.799 5918.8828125 1184.78381347656 5 15 1.1.1.4566.19 1 61.0263 1878.987 61.0074 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24 missed K-I@20; missed K-L@40 0.00853651016950607 5514.8291015625 788.84 5514.8203125 788.838806152344 7 19 1.1.1.4567.10 1 61.0448 6175.363 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.0357168987393379 5817.04443359375 970.5147 5817.0087890625 970.508728027344 6 16 1.1.1.4567.17 1 61.0506 3300.475 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-I@20; missed K-L@40 0.0323053002357483 5500.83740234375 786.8412 5500.8046875 786.836547851563 7 13 1.1.1.4568.7 1 61.0682 7009.574 61.0074 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0909696966409683 5555.89013671875 794.7059 5555.79931640625 794.692932128906 7 18 1.1.1.4568.8 1 61.0691 35911.11 61.2409 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20 missed K-I@20; missed K-L@40 0.0407024994492531 5562.861328125 928.1508 5562.8203125 928.14404296875 6 15 1.1.1.4568.11 1 61.0716 7924.204 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0182083006948233 5580.84912109375 931.1488 5580.8310546875 931.145812988281 6 16 1.1.1.4568.12 1 61.0724 9579.374 61.2409 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; ONE addition +154(K)@20; NeuAc(T)@23 missed K-I@20; missed K-L@40 0.0416295006871223 5947.02587890625 992.1782 5946.98388671875 992.171203613281 6 23 1.1.1.4568.14 1 61.0741 11862.34 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24 missed K-I@20; missed K-L@40 0.0387654006481171 5772.0087890625 1155.409 5771.97216796875 1155.40173339844 5 14 1.1.1.4568.20 1 61.0791 6088.6 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.053669098764658 5573.86376953125 797.2735 5573.81005859375 797.265869140625 7 19 1.1.1.4569.12 1 61.0984 12770.53 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0436212010681629 5542.85888671875 924.8171 5542.8154296875 924.809875488281 6 34 1.1.1.4569.14 1 61.1001 59288.85 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 -0.0225782003253698 5550.85205078125 926.1493 5550.87451171875 926.153076171875 6 17 1.1.1.4569.15 1 61.1009 5121.162 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Deamidated(N)@26; MDA adduct +62(K)@40; Dehydrated(S)@42 missed K-I@20; missed K-L@40 0.0605099983513355 5573.849609375 929.9822 5573.7890625 929.972106933594 6 27 1.1.1.4569.16 1 61.1017 59439.77 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-I@20; missed K-L@40 0.00651723984628916 5500.81396484375 1101.17 5500.8046875 1101.16821289063 5 19 1.1.1.4569.20 1 61.1051 24483.72 61.0074 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0261591002345085 5516.8251953125 789.1252 5516.7998046875 789.121520996094 7 15 1.1.1.4570.7 1 61.1209 3043.875 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.0611965991556644 5556.89306640625 794.8491 5556.8310546875 794.840270996094 7 16 1.1.1.4570.8 1 61.1217 100833.9 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00734328990802169 5528.84375 922.4812 5528.83642578125 922.47998046875 6 30 1.1.1.4570.11 1 61.1242 159432.6 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.0173787008970976 5976.0654296875 997.0182 5976.0830078125 997.021118164063 6 17 1.1.1.4570.13 1 61.1259 22194.91 61.3684 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dimethyl(N)@34 missed K-I@20; missed K-L@40 0.00711573986336589 5528.84375 1106.776 5528.83642578125 1106.77453613281 5 26 1.1.1.4570.18 1 61.1301 92586.23 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0203370004892349 5586.85888671875 1118.379 5586.8779296875 1118.38293457031 5 16 1.1.1.4570.19 1 61.1309 3268.16 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0344923995435238 5557.88232421875 794.9905 5557.84814453125 794.985595703125 7 28 1.1.1.4571.4 1 61.1444 68821.63 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.053669098764658 5573.86376953125 797.2735 5573.81005859375 797.265869140625 7 17 1.1.1.4571.5 1 61.1452 12770.53 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24 missed K-I@20; missed K-L@40 0.00525340018793941 5514.82568359375 920.1449 5514.8203125 920.14404296875 6 24 1.1.1.4571.9 1 61.1485 31885.5 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0298321004956961 5556.89794921875 927.1569 5556.86767578125 927.15185546875 6 41 1.1.1.4571.10 1 61.1494 293612.7 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; reduced acrolein addition +58(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00874574016779661 5587.87109375 932.3191 5587.8623046875 932.317626953125 6 28 1.1.1.4571.11 1 61.1502 6466.438 61.1894 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@24; Deamidated(N)@34; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.0636411979794502 5772.03564453125 963.0132 5771.97216796875 963.002624511719 6 17 1.1.1.4571.17 1 61.1552 10474.7 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0100635001435876 5785.99755859375 965.3402 5785.98779296875 965.338562011719 6 26 1.1.1.4571.18 1 61.156 3398.257 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.018699100241065 5556.888671875 1112.385 5556.86767578125 1112.38073730469 5 26 1.1.1.4571.20 1 61.1577 176750.1 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.036413200199604 5610.80517578125 802.5509 5610.841796875 802.556091308594 7 14 1.1.1.4572.12 1 61.1767 2845.728 61.2151 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0436212010681629 5542.85888671875 924.8171 5542.8154296875 924.809875488281 6 28 1.1.1.4572.15 1 61.1792 59288.85 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 -0.0116907004266977 5597.83447265625 933.9797 5597.8466796875 933.981689453125 6 12 1.1.1.4572.16 1 61.18 3220.045 61.1894 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24 missed K-I@20; missed K-L@40 0.0241109002381563 5757.033203125 960.5128 5757.0087890625 960.508728027344 6 12 1.1.1.4572.17 1 61.1808 2402.782 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0656128004193306 5800.06884765625 967.6854 5800.00341796875 967.674499511719 6 28 1.1.1.4572.18 1 61.1817 18812.26 61.2409 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Deamidated(N)@34; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 0.000322984007652849 5512.8134765625 1103.57 5512.8115234375 1103.56958007813 5 16 1.1.1.4572.20 1 61.1833 4545.121 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0318985991179943 5542.8486328125 1109.577 5542.8154296875 1109.5703125 5 24 1.1.1.4572.21 1 61.1842 33042.84 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0155282001942396 5528.8525390625 790.8433 5528.83642578125 790.841003417969 7 28 1.1.1.4573.11 1 61.2015 37525.67 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0490732006728649 5560.86376953125 795.4164 5560.81494140625 795.409362792969 7 18 1.1.1.4573.12 1 61.2024 9167.624 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0159636996686459 5580.8515625 798.2718 5580.86767578125 798.274047851563 7 20 1.1.1.4573.13 1 61.2032 6780.266 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Oxidation(N)@30; Formyl(K)@40 missed K-I@20; missed K-L@40 0.00994763989001513 5602.84716796875 934.8151 5602.83642578125 934.813354492188 6 17 1.1.1.4573.14 1 61.204 2350.822 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0564428009092808 5800.05859375 1161.019 5800.00341796875 1161.00793457031 5 15 1.1.1.4573.20 1 61.2091 12884.34 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.0268466006964445 5594.81982421875 800.2673 5594.8466796875 800.271118164063 7 14 1.1.1.4574.12 1 61.2282 2228.251 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0368556007742882 5572.8623046875 929.8177 5572.826171875 929.811645507813 6 12 1.1.1.4574.15 1 61.2307 34539.47 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.0206946991384029 5608.8056640625 935.8082 5608.826171875 935.811645507813 6 15 1.1.1.4574.16 1 61.2315 3957.482 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0692545995116234 5610.80908203125 936.1421 5610.8779296875 936.153625488281 6 22 1.1.1.4575.12 1 61.2538 5108.405 61.2921 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0217709001153708 5614.87353515625 936.8195 5614.85205078125 936.81591796875 6 14 1.1.1.4575.13 1 61.2546 3455.999 61.2409 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0320964008569717 5773.03564453125 963.1799 5773.00390625 963.174560546875 6 14 1.1.1.4575.15 1 61.2563 8905.375 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Ammonia-loss(N)@34; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.0184940993785858 5579.85400390625 930.983 5579.8359375 930.979919433594 6 18 1.1.1.4576.9 1 61.2769 11520.08 61.2409 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0394665002822876 5785.00048828125 965.174 5785.0400390625 965.180603027344 6 19 1.1.1.4576.10 1 61.2778 2634.484 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0611965991556644 5556.89306640625 794.8491 5556.8310546875 794.840270996094 7 16 1.1.1.4577.6 1 61.2999 100833.9 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0673822984099388 5578.88232421875 797.9905 5578.8154296875 797.980895996094 7 15 1.1.1.4577.7 1 61.3007 8797.978 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00734328990802169 5528.84375 922.4812 5528.83642578125 922.47998046875 6 33 1.1.1.4577.9 1 61.3024 159432.6 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0215994007885456 5572.8623046875 929.8177 5572.84130859375 929.814147949219 6 29 1.1.1.4577.11 1 61.304 34539.47 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; Hex(N)@34; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.0366868004202843 5991.02490234375 999.5114 5991.0615234375 999.517517089844 6 16 1.1.1.4577.14 1 61.3065 2904.347 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@40 missed K-I@20; missed K-L@40 0.0435012988746166 5528.84375 1106.776 5528.7998046875 1106.76721191406 5 22 1.1.1.4577.19 1 61.3107 92586.23 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0248111002147198 5556.89306640625 794.8491 5556.86767578125 794.845520019531 7 35 1.1.1.4578.7 1 61.3261 100833.9 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0585910007357597 5572.89990234375 797.1358 5572.84130859375 797.12744140625 7 23 1.1.1.4578.8 1 61.327 4791.786 61.2409 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0349206998944283 5975.05224609375 854.5862 5975.087890625 854.591247558594 7 16 1.1.1.4578.11 1 61.3295 4785.546 61.4448 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0298321004956961 5556.89794921875 927.1569 5556.86767578125 927.15185546875 6 32 1.1.1.4578.15 1 61.3328 293612.7 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.025272399187088 5586.85302734375 932.1494 5586.8779296875 932.153625488281 6 25 1.1.1.4578.16 1 61.3337 6205.942 61.3176 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.0141259003430605 5594.83251953125 933.4794 5594.8466796875 933.481750488281 6 12 1.1.1.4578.17 1 61.3345 3488.119 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.018699100241065 5556.888671875 1112.385 5556.86767578125 1112.38073730469 5 28 1.1.1.4578.21 1 61.3378 176750.1 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; reduced acrolein addition +58(K)@20; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.0116907004266977 5597.83447265625 933.9797 5597.8466796875 933.981689453125 6 14 1.1.1.4579.10 1 61.354 3220.045 61.1894 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0656128004193306 5800.06884765625 967.6854 5800.00341796875 967.674499511719 6 27 1.1.1.4579.13 1 61.3565 18812.26 61.2409 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.0268466006964445 5594.81982421875 800.2673 5594.8466796875 800.271118164063 7 14 1.1.1.4580.9 1 61.3786 2228.251 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Dethiomethyl(M)@37; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0148689998313785 5574.85302734375 930.1495 5574.83837890625 930.14697265625 6 25 1.1.1.4580.10 1 61.3794 33487.59 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00581614999100566 5587.8681640625 932.3186 5587.8623046875 932.317626953125 6 17 1.1.1.4580.11 1 61.3803 6315.935 61.3176 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0564428009092808 5800.05859375 1161.019 5800.00341796875 1161.00793457031 5 17 1.1.1.4580.16 1 61.3853 12884.34 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0561762005090714 5579.85546875 798.1295 5579.79931640625 798.121459960938 7 16 1.1.1.4581.14 1 61.4082 9102.148 61.3938 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0273956004530191 5578.84375 1116.776 5578.8154296875 1116.77038574219 5 14 1.1.1.4581.17 1 61.4123 5149.522 61.4193 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.0268466006964445 5594.81982421875 800.2673 5594.8466796875 800.271118164063 7 13 1.1.1.4582.8 1 61.4287 2228.251 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0911595970392227 5541.86328125 924.6512 5541.7724609375 924.636047363281 6 18 1.1.1.4583.11 1 61.4565 13866.28 61.4701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0534147992730141 5579.85302734375 930.9828 5579.79931640625 930.973876953125 6 15 1.1.1.4583.12 1 61.4574 11220.64 61.4193 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.0210992991924286 5609.7890625 935.9721 5609.81005859375 935.975646972656 6 15 1.1.1.4583.14 1 61.459 4866.888 61.4193 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0309258997440338 5614.88232421875 936.821 5614.85205078125 936.81591796875 6 15 1.1.1.4583.15 1 61.4599 4160.883 61.1894 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0441308990120888 5572.86865234375 1115.581 5572.826171875 1115.57250976563 5 12 1.1.1.4583.20 1 61.4641 8232.438 61.1894 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-I@20; missed K-L@40 -0.00159739004448056 5500.80322265625 917.8078 5500.8046875 917.80810546875 6 16 1.1.1.4584.8 1 61.4796 2727 61.4448 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00551229016855359 5528.841796875 922.4809 5528.83642578125 922.47998046875 6 30 1.1.1.4584.9 1 61.4804 19296.91 61.3938 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@30; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0435407012701035 5541.86328125 924.6512 5541.8203125 924.643981933594 6 29 1.1.1.4584.10 1 61.4813 13866.28 61.4701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0344163998961449 5572.87548828125 929.8199 5572.84130859375 929.814147949219 6 25 1.1.1.4584.11 1 61.4821 13303.23 61.4701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0482192002236843 5975.03955078125 996.8472 5975.087890625 996.855224609375 6 16 1.1.1.4584.16 1 61.4863 42016.14 61.4701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0248111002147198 5556.89306640625 794.8491 5556.86767578125 794.845520019531 7 32 1.1.1.4585.6 1 61.5033 106635.6 61.4448 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Lys->Allysine(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0778871029615402 5513.86328125 919.9845 5513.78564453125 919.971557617188 6 17 1.1.1.4585.10 1 61.5066 3808.09 61.2409 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0305645000189543 5556.8984375 927.157 5556.86767578125 927.15185546875 6 41 1.1.1.4585.11 1 61.5075 293808 61.4193 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00325988000258803 5528.833984375 1106.774 5528.83642578125 1106.77453613281 5 13 1.1.1.4585.15 1 61.5108 10490.65 61.4193 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0199197996407747 5556.888671875 1112.385 5556.86767578125 1112.38073730469 5 31 1.1.1.4585.17 1 61.5125 176666.9 61.3938 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0324883013963699 5584.8935546875 1117.986 5584.8623046875 1117.97973632813 5 20 1.1.1.4585.18 1 61.5133 2386.498 61.3684 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0567014999687672 5578.8720703125 797.989 5578.8154296875 797.980895996094 7 20 1.1.1.4586.10 1 61.5359 9139.086 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@26; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0560915991663933 5800.05908203125 967.6838 5800.00341796875 967.674499511719 6 30 1.1.1.4586.11 1 61.5376 14259.62 61.4448 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.013506299816072 5587.87548828125 932.3199 5587.8623046875 932.317626953125 6 22 1.1.1.4587.10 1 61.5572 4505.214 61.5717 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 -0.00701989000663161 5599.85546875 934.3165 5599.8623046875 934.317626953125 6 16 1.1.1.4587.12 1 61.5589 3391.618 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@26; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0540014989674091 5800.05859375 1161.019 5800.00341796875 1161.00793457031 5 14 1.1.1.4587.21 1 61.5664 11866.22 61.2921 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20 missed K-I@20; missed K-L@40 0.015022199600935 5594.8623046875 800.2733 5594.8466796875 800.271118164063 7 17 1.1.1.4589.13 1 61.6104 2029.336 61.6729 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.015022199600935 5594.8623046875 800.2733 5594.8466796875 800.271118164063 7 14 1.1.1.4589.14 1 61.6112 2029.336 61.6729 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0349206998944283 5975.05224609375 854.5862 5975.087890625 854.591247558594 7 15 1.1.1.4590.12 1 61.6348 4785.546 61.4448 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@40 missed K-I@20; missed K-L@40 0.0418977998197079 5528.841796875 922.4809 5528.7998046875 922.473937988281 6 14 1.1.1.4590.13 1 61.6356 20341.93 61.6983 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0611695982515812 5540.849609375 924.4822 5540.78857421875 924.472045898438 6 17 1.1.1.4590.14 1 61.6365 20398.74 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0386865995824337 5572.865234375 929.8181 5572.826171875 929.811645507813 6 14 1.1.1.4590.15 1 61.6373 12706.51 61.597 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00755740003660321 5580.85986328125 931.1506 5580.86767578125 931.15185546875 6 23 1.1.1.4590.16 1 61.6381 9431.865 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00551229016855359 5528.841796875 922.4809 5528.83642578125 922.47998046875 6 29 1.1.1.4591.6 1 61.6551 20341.93 61.6983 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Dehydrated(D)@35; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0241627991199493 5572.865234375 929.8182 5572.84130859375 929.814147949219 6 29 1.1.1.4591.8 1 61.6576 13911.41 61.6983 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0109697002917528 5701.94140625 951.3308 5701.93017578125 951.328979492188 6 16 1.1.1.4591.9 1 61.6592 7993.242 61.901 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0239566005766392 5556.89111328125 794.8489 5556.86767578125 794.845520019531 7 31 1.1.1.4592.4 1 61.6789 104884.9 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.00822721980512142 5501.78076171875 917.9707 5501.7890625 917.972106933594 6 16 1.1.1.4592.6 1 61.6805 3169.042 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0305645000189543 5556.8984375 927.157 5556.86767578125 927.15185546875 6 30 1.1.1.4592.8 1 61.6822 294732.2 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0314240008592606 5539.83349609375 1108.974 5539.8046875 1108.96813964844 5 12 1.1.1.4592.19 1 61.6914 8255.21 61.7492 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0180888008326292 5556.8837890625 1112.384 5556.86767578125 1112.38073730469 5 28 1.1.1.4592.20 1 61.6922 169433 61.6983 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@30; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0479974001646042 5573.89111328125 797.2774 5573.84326171875 797.270568847656 7 19 1.1.1.4593.10 1 61.7093 4138.947 61.6983 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dehydrated(T)@31; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.0194614995270967 5578.87109375 797.9889 5578.85205078125 797.986083984375 7 18 1.1.1.4593.11 1 61.7102 9284.54 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0318509005010128 5609.814453125 935.9764 5609.8466796875 935.981689453125 6 23 1.1.1.4593.13 1 61.7118 4363.094 61.6729 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0579226016998291 5800.06103515625 967.6841 5800.00341796875 967.674499511719 6 24 1.1.1.4593.16 1 61.7143 13790.9 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@40 missed K-I@20; missed K-L@40 0.0410599000751972 5528.84375 1106.776 5528.7998046875 1106.76721191406 5 17 1.1.1.4593.19 1 61.7168 10605.56 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.065635196864605 5555.86376953125 1112.18 5555.79931640625 1112.16711425781 5 13 1.1.1.4593.20 1 61.7177 95376.75 61.6983 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0182668995112181 5587.88037109375 932.3207 5587.8623046875 932.317626953125 6 20 1.1.1.4594.9 1 61.7339 5182.717 61.6983 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.0243794992566109 5594.82275390625 933.4777 5594.8466796875 933.481750488281 6 14 1.1.1.4594.10 1 61.7348 3188.913 61.8251 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0326047986745834 5539.83740234375 792.4126 5539.8046875 792.407958984375 7 15 1.1.1.4595.7 1 61.7575 4220.15 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0363617986440659 5598.8779296875 934.1536 5598.841796875 934.147583007813 6 19 1.1.1.4595.10 1 61.76 3999.808 61.7998 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0368070006370544 5572.86328125 1115.58 5572.826171875 1115.57250976563 5 12 1.1.1.4596.9 1 61.7862 5267.903 61.8251 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0246552005410194 5575.88330078125 1116.184 5575.85888671875 1116.17907714844 5 19 1.1.1.4596.10 1 61.7878 4375.988 61.6983 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00779624981805682 5539.86669921875 924.3184 5539.85888671875 924.317077636719 6 21 1.1.1.4597.10 1 61.8107 24227.94 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0662176012992859 5556.89794921875 927.1569 5556.8310546875 927.145812988281 6 14 1.1.1.4597.11 1 61.8115 280916.6 61.8504 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0513177998363972 5529.8720703125 790.989 5529.8203125 790.981567382813 7 19 1.1.1.4598.8 1 61.8343 3750.606 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00624469015747309 5528.84228515625 922.481 5528.83642578125 922.47998046875 6 30 1.1.1.4598.12 1 61.8376 18387.37 61.7998 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; reduced acrolein addition +58(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.160859003663063 5561.95947265625 928.0005 5561.798828125 927.973754882813 6 17 1.1.1.4598.13 1 61.8384 14734.07 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Met->Hcy(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.051503598690033 5572.87744140625 929.8202 5572.826171875 929.811645507813 6 25 1.1.1.4598.14 1 61.8393 12237.22 61.8251 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0671684965491295 5700.97705078125 951.1701 5700.90966796875 951.158874511719 6 16 1.1.1.4598.15 1 61.8401 10681.02 62.028 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0336740016937256 5701.9638671875 951.3346 5701.93017578125 951.328979492188 6 17 1.1.1.4598.16 1 61.8409 14838.17 62.028 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 -0.0379657000303268 5975.0498046875 996.8489 5975.087890625 996.855224609375 6 18 1.1.1.4598.19 1 61.8434 30859.98 61.6983 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0629054978489876 5556.89404296875 794.8493 5556.8310546875 794.840270996094 7 17 1.1.1.4599.6 1 61.858 95111.82 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0100974999368191 5580.87744140625 798.2755 5580.86767578125 798.274047851563 7 21 1.1.1.4599.7 1 61.8589 6422.458 61.9261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0298321004956961 5556.89794921875 927.1569 5556.86767578125 927.15185546875 6 30 1.1.1.4599.10 1 61.8614 280916.6 61.8504 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0192074999213219 5614.87109375 936.8191 5614.85205078125 936.81591796875 6 15 1.1.1.4599.11 1 61.8622 2848.335 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0375273004174232 5539.84326171875 1108.976 5539.8046875 1108.96813964844 5 13 1.1.1.4599.17 1 61.8672 11490.44 61.9773 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.018699100241065 5556.888671875 1112.385 5556.86767578125 1112.38073730469 5 36 1.1.1.4599.19 1 61.8689 153407.3 61.8251 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0265200007706881 5556.89404296875 794.8493 5556.86767578125 794.845520019531 7 36 1.1.1.4600.6 1 61.8833 95111.82 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0942562967538834 5573.904296875 797.2793 5573.81005859375 797.265869140625 7 18 1.1.1.4600.7 1 61.8841 4522.433 61.8251 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0558470003306866 5578.87109375 797.9889 5578.8154296875 797.980895996094 7 16 1.1.1.4600.8 1 61.8849 9284.54 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24; Deamidated(N)@30; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.0068175601772964 5609.80322265625 935.9745 5609.81005859375 935.975646972656 6 21 1.1.1.4600.15 1 61.8908 4809.096 61.9261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0579226016998291 5800.06103515625 967.6841 5800.00341796875 967.674499511719 6 21 1.1.1.4600.18 1 61.8933 13790.9 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0579226016998291 5800.06103515625 967.6841 5800.00341796875 967.674499511719 6 30 1.1.1.4600.19 1 61.8941 13790.9 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.046289000660181 5528.88330078125 790.8477 5528.83642578125 790.841003417969 7 20 1.1.1.4601.9 1 61.9109 3611.04 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0261955000460148 5501.814453125 917.9764 5501.7890625 917.972106933594 6 18 1.1.1.4601.11 1 61.9126 6585.36 62.028 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00980595964938402 5588.85595703125 932.4833 5588.84619140625 932.481628417969 6 19 1.1.1.4601.12 1 61.9134 6225.217 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.0243794992566109 5594.82275390625 933.4777 5594.8466796875 933.481750488281 6 15 1.1.1.4601.13 1 61.9142 3188.913 61.8251 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@40 missed K-I@20; missed K-L@40 0.0349566005170345 5528.833984375 1106.774 5528.7998046875 1106.76721191406 5 21 1.1.1.4601.17 1 61.9192 9508.526 61.9261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0735320001840591 5800.078125 1161.023 5800.00341796875 1161.00793457031 5 19 1.1.1.4601.18 1 61.9209 6966.498 61.8504 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0407561995089054 5598.8828125 934.1544 5598.841796875 934.147583007813 6 20 1.1.1.4602.7 1 61.9346 5060.277 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0812114030122757 5540.8701171875 792.5601 5540.78857421875 792.548522949219 7 15 1.1.1.4604.11 1 61.989 5805.741 61.9773 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0619403012096882 5539.86669921875 924.3184 5539.8046875 924.308044433594 6 20 1.1.1.4604.12 1 61.9898 24227.94 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0622036010026932 5579.8623046875 930.9843 5579.79931640625 930.973876953125 6 16 1.1.1.4604.13 1 61.9907 10843.31 61.9261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Formyl(K)@40 missed K-I@20; missed K-L@40 0.034340001642704 5542.8486328125 1109.577 5542.8154296875 1109.5703125 5 17 1.1.1.4604.20 1 61.9965 8464.211 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.0223145000636578 5610.8193359375 802.5529 5610.841796875 802.556091308594 7 13 1.1.1.4605.6 1 62.0102 3252.006 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0220663007348776 5528.85498046875 922.4831 5528.8330078125 922.479431152344 6 13 1.1.1.4605.8 1 62.0119 19518.96 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0186954997479916 5528.85498046875 922.4831 5528.83642578125 922.47998046875 6 31 1.1.1.4605.9 1 62.0128 19518.96 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0680485963821411 5556.89990234375 927.1572 5556.8310546875 927.145812988281 6 15 1.1.1.4605.10 1 62.0136 278498.3 61.9261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0500387996435165 5572.87548828125 929.8199 5572.826171875 929.811645507813 6 15 1.1.1.4605.11 1 62.0144 14853.69 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0336740016937256 5701.9638671875 951.3346 5701.93017578125 951.328979492188 6 20 1.1.1.4605.13 1 62.0161 15117.85 62.028 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; Hex(N)@34; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 -0.0332050994038582 5975.05419921875 996.8497 5975.087890625 996.855224609375 6 16 1.1.1.4605.16 1 62.0186 17886.08 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0316631011664867 5556.89990234375 927.1572 5556.86767578125 927.15185546875 6 34 1.1.1.4606.11 1 62.0399 278498.3 61.9261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0437105000019073 5612.85009765625 936.4823 5612.8935546875 936.489562988281 6 25 1.1.1.4606.12 1 62.0407 3741.4 61.9773 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0375273004174232 5539.84326171875 1108.976 5539.8046875 1108.96813964844 5 14 1.1.1.4606.15 1 62.0449 11490.44 61.9773 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0193093996495008 5556.888671875 1112.385 5556.86767578125 1112.38073730469 5 28 1.1.1.4606.16 1 62.0465 159015.2 61.9773 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0265200007706881 5556.89404296875 794.8493 5556.86767578125 794.845520019531 7 33 1.1.1.4607.7 1 62.0618 95111.82 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.00680667022243142 5595.837890625 800.4127 5595.83056640625 800.411682128906 7 16 1.1.1.4607.8 1 62.0627 2272.165 61.9773 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.00680667022243142 5595.837890625 800.4127 5595.83056640625 800.411682128906 7 15 1.1.1.4607.9 1 62.0635 2272.165 61.9773 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24 missed K-I@20; missed K-L@40 0.00195760000497103 5514.822265625 920.1443 5514.8203125 920.14404296875 6 22 1.1.1.4607.12 1 62.0668 3301.116 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0432031005620956 5609.80322265625 935.9745 5609.8466796875 935.981689453125 6 20 1.1.1.4607.13 1 62.0685 4809.096 61.9261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0469366014003754 5800.05029296875 967.6823 5800.00341796875 967.674499511719 6 28 1.1.1.4607.14 1 62.0702 9691.689 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Ammonia-loss(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0555022992193699 5573.88037109375 797.2759 5573.8251953125 797.268005371094 7 25 1.1.1.4608.12 1 62.0913 3865.141 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0373440012335777 5579.8525390625 798.1291 5579.89013671875 798.134399414063 7 22 1.1.1.4608.13 1 62.0921 7534.378 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30 missed K-I@20; missed K-L@40 0.0386462993919849 5501.82763671875 917.9785 5501.7890625 917.972106933594 6 25 1.1.1.4608.15 1 62.0938 6644.455 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00988270994275808 5586.88818359375 932.1553 5586.8779296875 932.153625488281 6 22 1.1.1.4608.17 1 62.0955 5369.997 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0434962995350361 5588.8896484375 932.4889 5588.84619140625 932.481628417969 6 18 1.1.1.4608.18 1 62.0963 4635.846 62.1041 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Carbamidomethyl(T)@23; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0517255999147892 5802.08154296875 968.0209 5802.0302734375 968.012329101563 6 22 1.1.1.4608.19 1 62.0972 5648.15 61.9773 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; Deamidated(N)@34; Oxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0302901994436979 5844.02392578125 975.0112 5843.9931640625 975.006164550781 6 14 1.1.1.4608.20 1 62.098 2521.77 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20 missed K-I@20; missed K-L@40 0.0435012988746166 5528.84375 1106.776 5528.7998046875 1106.76721191406 5 16 1.1.1.4608.21 1 62.0988 9442.306 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0296187996864319 5700.9755859375 815.4324 5700.9462890625 815.428161621094 7 19 1.1.1.4609.7 1 62.1125 3143.655 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 -0.0361876003444195 5596.82568359375 933.8116 5596.8623046875 933.817687988281 6 12 1.1.1.4609.9 1 62.1142 3841.552 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0552221015095711 5800.05859375 1161.019 5800.00341796875 1161.00793457031 5 19 1.1.1.4609.18 1 62.1242 5671.394 62.028 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.037160899490118 5578.853515625 1116.778 5578.8154296875 1116.77038574219 5 12 1.1.1.4610.19 1 62.1479 3780.85 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00783802010118961 5528.8447265625 790.8422 5528.83642578125 790.841003417969 7 15 1.1.1.4611.9 1 62.165 3405.323 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0509543009102345 5539.85546875 924.3165 5539.8046875 924.308044433594 6 18 1.1.1.4611.10 1 62.1659 20627.68 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; reduced acrolein addition +96(K)@20; Dehydrated(T)@23 missed K-I@20; missed K-L@40 0.0221561007201672 5579.85791015625 930.9836 5579.8359375 930.979919433594 6 20 1.1.1.4611.11 1 62.1667 8967.899 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Delta:H(2)C(2)(K)@20 missed K-I@20; missed K-L@40 0.024379899725318 5527.82861328125 1106.573 5527.8046875 1106.56823730469 5 14 1.1.1.4611.18 1 62.1726 3719.19 62.2563 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.020728399977088 5540.853515625 792.5578 5540.8330078125 792.554809570313 7 21 1.1.1.4612.8 1 62.1896 4597.698 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0175969004631042 5528.85400390625 922.4829 5528.83642578125 922.47998046875 6 31 1.1.1.4612.11 1 62.1921 17479.8 62.1803 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.046867199242115 5572.888671875 929.822 5572.84130859375 929.814147949219 6 24 1.1.1.4612.12 1 62.1929 11413.43 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0344064012169838 5701.96484375 951.3347 5701.93017578125 951.328979492188 6 23 1.1.1.4612.13 1 62.1938 16406.58 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34 missed K-I@20; missed K-L@40 0.027717100456357 5501.818359375 1101.371 5501.7890625 1101.36511230469 5 14 1.1.1.4612.19 1 62.1988 3792.936 62.1803 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-I@20; missed K-L@40 0.000966005027294159 5500.8056640625 917.8082 5500.8046875 917.80810546875 6 12 1.1.1.4613.11 1 62.2175 4285.578 62.1803 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0287334993481636 5556.896484375 927.1567 5556.86767578125 927.15185546875 6 35 1.1.1.4613.12 1 62.2183 253935.1 62.1803 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@23; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0475995987653732 5572.888671875 929.8221 5572.84130859375 929.814147949219 6 26 1.1.1.4613.13 1 62.2191 10152.24 62.231 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.049567598849535 5810.037109375 969.3468 5809.98779296875 969.338562011719 6 15 1.1.1.4613.15 1 62.2208 3958.142 62.3825 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.00960021000355482 5811.02880859375 969.5121 5811.01953125 969.510498046875 6 18 1.1.1.4613.16 1 62.2216 6446.876 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0180888008326292 5556.8837890625 1112.384 5556.86767578125 1112.38073730469 5 29 1.1.1.4613.19 1 62.2241 143406.2 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.032285500317812 5811.02880859375 1163.213 5810.998046875 1163.20690917969 5 14 1.1.1.4613.20 1 62.225 2299.882 62.3825 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0603749006986618 5539.865234375 792.4166 5539.8046875 792.407958984375 7 15 1.1.1.4614.4 1 62.2377 5211.45 61.9773 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0248111002147198 5556.89306640625 794.8491 5556.86767578125 794.845520019531 7 31 1.1.1.4614.5 1 62.2394 75880.37 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Pro->pyro-Glu(P)@25 missed K-I@20; missed K-L@40 0.0482304990291595 5514.83251953125 920.146 5514.7841796875 920.138000488281 6 25 1.1.1.4614.6 1 62.241 3698.785 62.3068 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.06119329854846 5541.8779296875 924.6536 5541.81689453125 924.643432617188 6 23 1.1.1.4614.7 1 62.2427 19452.55 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0389252007007599 5598.880859375 934.1541 5598.841796875 934.147583007813 6 24 1.1.1.4614.8 1 62.2444 5060.644 62.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0307522993534803 5609.81591796875 935.9766 5609.8466796875 935.981689453125 6 22 1.1.1.4614.9 1 62.246 3962.483 62.1803 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0685423985123634 5800.07177734375 967.6859 5800.00341796875 967.674499511719 6 25 1.1.1.4614.10 1 62.2477 7546.819 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0611965991556644 5556.89306640625 794.8491 5556.8310546875 794.840270996094 7 28 1.1.1.4615.9 1 62.2664 75880.37 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Ammonia-loss(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0555022992193699 5573.88037109375 797.2759 5573.8251953125 797.268005371094 7 25 1.1.1.4615.10 1 62.2672 3865.141 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.024023400619626 5610.81787109375 802.5527 5610.841796875 802.556091308594 7 12 1.1.1.4615.12 1 62.2689 2710.303 62.0026 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@28 missed K-I@20; missed K-L@40 0.0386462993919849 5501.82763671875 917.9785 5501.7890625 917.972106933594 6 22 1.1.1.4615.15 1 62.2714 6644.455 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; Oxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0208078008145094 5843.02978515625 974.8456 5843.00927734375 974.842163085938 6 14 1.1.1.4615.19 1 62.2747 2575.515 62.4077 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Delta:H(2)C(2)(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.06144829839468 5528.8486328125 1106.777 5528.78857421875 1106.76501464844 5 18 1.1.1.4615.21 1 62.2764 9069.979 62.332 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0570307001471519 5579.85595703125 798.1296 5579.79931640625 798.121459960938 7 15 1.1.1.4616.5 1 62.2882 6380.755 62.2563 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00475591979920864 5586.8828125 932.1544 5586.8779296875 932.153625488281 6 20 1.1.1.4616.8 1 62.2907 4320.294 62.2563 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; GlyGly(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0229681003838778 5839.00244140625 974.1744 5839.025390625 974.178161621094 6 20 1.1.1.4616.12 1 62.2949 2495.234 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.054611798375845 5800.05859375 1161.019 5800.00341796875 1161.00793457031 5 19 1.1.1.4616.16 1 62.3016 5629.737 62.028 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.0238306000828743 5597.87060546875 933.9857 5597.8466796875 933.981689453125 6 13 1.1.1.4617.9 1 62.3167 4603.433 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.037160899490118 5578.853515625 1116.778 5578.8154296875 1116.77038574219 5 12 1.1.1.4617.15 1 62.325 3780.85 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0505881011486053 5539.85546875 924.3165 5539.8046875 924.308044433594 6 16 1.1.1.4618.11 1 62.3436 14088.11 62.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0563444010913372 5579.85595703125 930.9833 5579.79931640625 930.973876953125 6 16 1.1.1.4618.12 1 62.3444 6886.583 62.332 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0195048991590738 5528.8173828125 790.8383 5528.83642578125 790.841003417969 7 21 1.1.1.4619.10 1 62.3681 4128.629 62.4077 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@40 missed K-I@20; missed K-L@40 0.0605739988386631 5528.8603515625 922.484 5528.7998046875 922.473937988281 6 16 1.1.1.4619.11 1 62.3689 17660.77 62.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Delta:H(4)C(2)(H)@24 missed K-I@20; missed K-L@40 0.0234178006649017 5529.84375 922.6479 5529.8203125 922.643981933594 6 30 1.1.1.4619.12 1 62.3698 26789.38 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.0643867030739784 5556.89599609375 927.1566 5556.8310546875 927.145812988281 6 17 1.1.1.4619.13 1 62.3706 236355.1 62.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Met->Hcy(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.00156867003533989 5572.86376953125 929.8179 5572.8623046875 929.817687988281 6 22 1.1.1.4619.14 1 62.3714 10039.74 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0431951992213726 5701.9736328125 951.3362 5701.93017578125 951.328979492188 6 20 1.1.1.4619.15 1 62.3723 11708.7 62.3825 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0493908002972603 5544.880859375 925.1541 5544.8310546875 925.145812988281 6 20 1.1.1.4620.6 1 62.3899 6891.923 62.2563 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0280010998249054 5556.89599609375 927.1566 5556.86767578125 927.15185546875 6 35 1.1.1.4620.7 1 62.3907 236355.1 62.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@23; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0226980000734329 5572.86376953125 929.8179 5572.84130859375 929.814147949219 6 25 1.1.1.4620.8 1 62.3916 10039.74 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0289376992732286 5501.818359375 1101.371 5501.7890625 1101.36511230469 5 16 1.1.1.4620.15 1 62.3991 4121.66 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0168680995702744 5556.8837890625 1112.384 5556.86767578125 1112.38073730469 5 33 1.1.1.4620.17 1 62.4024 124291.2 62.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0236329007893801 5539.828125 792.4113 5539.8046875 792.407958984375 7 17 1.1.1.4621.2 1 62.4127 3317.454 62.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0389252007007599 5598.880859375 934.1541 5598.841796875 934.147583007813 6 21 1.1.1.4621.4 1 62.416 5060.644 62.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(2)C(2)(H)@24; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0415517017245293 5613.8369140625 936.6467 5613.8779296875 936.653564453125 6 21 1.1.1.4621.5 1 62.4177 3100.924 62.6095 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0531620010733604 5800.05615234375 967.6833 5800.00341796875 967.674499511719 6 27 1.1.1.4621.6 1 62.4202 7024.168 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0239566005766392 5556.89111328125 794.8489 5556.86767578125 794.845520019531 7 33 1.1.1.4622.10 1 62.4437 73907.33 62.1803 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Ammonia-loss(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0649013966321945 5573.89013671875 797.2773 5573.8251953125 797.268005371094 7 22 1.1.1.4622.11 1 62.4446 3048.835 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-I@20; missed K-L@40 -0.0338229015469551 5500.77099609375 917.8024 5500.8046875 917.80810546875 6 18 1.1.1.4622.13 1 62.4462 3173.688 62.3825 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; Methyl(H)@24 missed K-I@20; missed K-L@40 0.0367082990705967 5515.8408203125 920.3141 5515.8046875 920.308044433594 6 23 1.1.1.4622.14 1 62.4471 5336.207 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; acrolein addition +76(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00108636997174472 5778.994140625 964.173 5778.9931640625 964.172790527344 6 19 1.1.1.4622.16 1 62.4487 2044.071 62.5592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0288986004889011 5811.02685546875 969.5118 5810.998046875 969.506958007813 6 15 1.1.1.4622.17 1 62.4496 6963.073 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; Hex(N)@34; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 -0.0390642993152142 5975.04931640625 996.8488 5975.087890625 996.855224609375 6 16 1.1.1.4622.19 1 62.4512 8696.472 62.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0457808002829552 5529.82861328125 1106.973 5529.78369140625 1106.96398925781 5 18 1.1.1.4622.20 1 62.4521 13902.29 62.4836 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 -0.00963192991912365 5598.86865234375 1120.781 5598.8779296875 1120.78283691406 5 13 1.1.1.4622.21 1 62.4529 2561.563 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0470978990197182 5556.8779296875 794.847 5556.8310546875 794.840270996094 7 25 1.1.1.4623.6 1 62.4658 59296.19 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0118108000606298 5542.83837890625 1109.575 5542.85205078125 1109.57763671875 5 19 1.1.1.4623.18 1 62.4758 6737.243 62.4836 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Ammonia-loss(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0230336003005505 5541.84326171875 924.6478 5541.8203125 924.643981933594 6 18 1.1.1.4625.6 1 62.5162 16193.43 62.5088 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0611050017178059 5579.86083984375 930.9841 5579.79931640625 930.973876953125 6 17 1.1.1.4625.7 1 62.5171 7501.487 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0467242002487183 5584.87255859375 931.8194 5584.826171875 931.811645507813 6 15 1.1.1.4625.8 1 62.5179 4884.237 62.5592 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.0238306000828743 5597.87060546875 933.9857 5597.8466796875 933.981689453125 6 15 1.1.1.4625.9 1 62.5187 4603.433 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0148943001404405 5515.81884765625 1104.171 5515.8046875 1104.16821289063 5 13 1.1.1.4625.13 1 62.5221 2791.607 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0429103001952171 5572.86865234375 1115.581 5572.826171875 1115.57250976563 5 12 1.1.1.4625.15 1 62.5254 4038.647 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Deamidated(N)@28 missed K-I@20; missed K-L@40 0.0528455004096031 5529.8369140625 922.6467 5529.78369140625 922.637939453125 6 27 1.1.1.4626.12 1 62.5465 26054.13 62.6095 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28 missed K-I@20; missed K-L@40 0.0535176992416382 5539.8583984375 924.317 5539.8046875 924.308044433594 6 22 1.1.1.4626.13 1 62.5473 14229.07 62.4836 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.0555979013442993 5556.88671875 927.1551 5556.8310546875 927.145812988281 6 17 1.1.1.4626.14 1 62.5481 238036.2 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Met->Hcy(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.00156867003533989 5572.86376953125 929.8179 5572.8623046875 929.817687988281 6 23 1.1.1.4626.15 1 62.549 10039.74 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0711581036448479 5701.96484375 951.3348 5701.8935546875 951.322937011719 6 17 1.1.1.4626.17 1 62.5506 11578.1 62.4077 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0192124005407095 5556.88671875 927.1551 5556.86767578125 927.15185546875 6 38 1.1.1.4627.11 1 62.5708 238036.2 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Dethiomethyl(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00943197961896658 5574.865234375 930.1515 5574.87451171875 930.153076171875 6 25 1.1.1.4627.12 1 62.5716 7571.963 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.007713139988482 5556.87353515625 1112.382 5556.86767578125 1112.38073730469 5 33 1.1.1.4627.19 1 62.5774 122037.9 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0927466005086899 5540.8818359375 792.5618 5540.78857421875 792.548522949219 7 15 1.1.1.4628.8 1 62.5934 3168.065 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00370503007434309 5587.8583984375 932.317 5587.8623046875 932.317626953125 6 19 1.1.1.4628.10 1 62.5951 4421.729 62.5844 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0447393991053104 5800.0478515625 967.6819 5800.00341796875 967.674499511719 6 26 1.1.1.4628.11 1 62.5959 4676.307 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0573520995676517 5577.87744140625 797.8469 5577.8203125 797.838745117188 7 18 1.1.1.4629.6 1 62.6171 3448.098 62.7106 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34 missed K-I@20; missed K-L@40 0.00678694993257523 5501.79541015625 917.9732 5501.7890625 917.972106933594 6 17 1.1.1.4629.8 1 62.6188 3324.656 62.5088 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0308688003569841 5598.87255859375 934.1527 5598.841796875 934.147583007813 6 19 1.1.1.4629.11 1 62.6213 5092.419 62.6601 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.044557299464941 5975.04296875 996.8478 5975.087890625 996.855224609375 6 16 1.1.1.4629.19 1 62.628 8393.39 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0492340996861458 5556.880859375 794.8474 5556.8310546875 794.840270996094 7 26 1.1.1.4630.8 1 62.6441 49876.36 62.6095 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0366284996271133 5557.884765625 794.9908 5557.84814453125 794.985595703125 7 27 1.1.1.4630.9 1 62.6449 53709.71 62.6853 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; Deamidated(N)@17; acrolein addition +76(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0652733966708183 5579.853515625 798.1292 5579.7880859375 798.119873046875 7 19 1.1.1.4630.10 1 62.6457 5692.12 62.5844 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.0112065002322197 5610.83056640625 802.5545 5610.841796875 802.556091308594 7 15 1.1.1.4630.11 1 62.6466 2223.664 62.6853 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 -0.00919975992292166 5515.79345703125 1104.166 5515.80126953125 1104.16748046875 5 12 1.1.1.4630.19 1 62.6533 2158.909 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.00939526036381722 5529.82861328125 1106.973 5529.8203125 1106.97131347656 5 17 1.1.1.4630.20 1 62.6541 13930.44 62.6095 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Pro->pyro-Glu(P)@25 missed K-I@20; missed K-L@40 0.0628402009606361 5515.83056640625 920.3124 5515.76806640625 920.302001953125 6 19 1.1.1.4632.6 1 62.6928 4798.101 62.5844 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0170786008238792 5580.85009765625 931.149 5580.86767578125 931.15185546875 6 22 1.1.1.4632.7 1 62.6936 7362.654 62.7106 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0258210003376007 5572.853515625 1115.578 5572.826171875 1115.57250976563 5 11 1.1.1.4632.13 1 62.7037 3636.137 62.7357 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0312379002571106 5529.8515625 790.9861 5529.8203125 790.981567382813 7 20 1.1.1.4633.8 1 62.7196 8196.301 62.8617 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.010967000387609 5529.8310546875 922.6458 5529.8203125 922.643981933594 6 28 1.1.1.4633.9 1 62.7205 45537.14 62.8617 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0706908032298088 5540.859375 924.4838 5540.78857421875 924.472045898438 6 17 1.1.1.4633.10 1 62.7213 15735.17 62.6095 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00951487012207508 5572.8505859375 929.8157 5572.84130859375 929.814147949219 6 19 1.1.1.4633.11 1 62.7221 8091.113 62.7357 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0314619988203049 5811.02978515625 969.5122 5810.998046875 969.506958007813 6 18 1.1.1.4633.15 1 62.7255 6721.014 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(E)@13; acrolein addition +94(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0124284001067281 5838.01806640625 974.0103 5838.0302734375 974.012329101563 6 19 1.1.1.4633.16 1 62.7263 2566.412 62.9119 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0192124005407095 5556.88671875 927.1551 5556.86767578125 927.15185546875 6 43 1.1.1.4634.9 1 62.7458 238036.2 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0297050997614861 5610.8486328125 936.1487 5610.8779296875 936.153625488281 6 23 1.1.1.4634.10 1 62.7466 3902.258 62.6853 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0440987013280392 5556.87353515625 1112.382 5556.8310546875 1112.37353515625 5 27 1.1.1.4634.15 1 62.7508 122037.9 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00687636993825436 5588.85302734375 932.4828 5588.84619140625 932.481628417969 6 22 1.1.1.4635.5 1 62.7732 4582.758 62.8867 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0109107000753284 5616.8564453125 937.15 5616.86767578125 937.15185546875 6 21 1.1.1.4635.6 1 62.7757 2900.567 62.8867 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0721732974052429 5574.91357421875 797.4235 5574.841796875 797.413208007813 7 17 1.1.1.4636.5 1 62.7925 2629.776 62.8363 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.0190699994564056 5597.86572265625 933.9849 5597.8466796875 933.981689453125 6 13 1.1.1.4636.7 1 62.7942 3717.608 62.7106 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.000733417982701212 5612.85693359375 936.4834 5612.857421875 936.483520507813 6 16 1.1.1.4636.8 1 62.7959 3630.942 62.7106 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0293074008077383 5801.064453125 967.8513 5801.03515625 967.846435546875 6 24 1.1.1.4636.10 1 62.7992 3857.548 62.8111 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0216754004359245 5557.8701171875 794.9887 5557.84814453125 794.985595703125 7 27 1.1.1.4637.3 1 62.816 73638.63 63.0125 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34 missed K-I@20; missed K-L@40 0.050730898976326 5501.83935546875 917.9805 5501.7890625 917.972106933594 6 15 1.1.1.4637.4 1 62.8169 2346.042 62.786 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(N)@17; Oxidation(P)@25; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0266864001750946 5544.8583984375 925.1503 5544.8310546875 925.145812988281 6 20 1.1.1.4637.5 1 62.8177 15523.06 62.8867 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0601034015417099 5585.90673828125 931.9917 5585.8466796875 931.981689453125 6 21 1.1.1.4637.6 1 62.8185 4328.408 62.8111 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Hex(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.0343036986887455 5975.05322265625 996.8495 5975.087890625 996.855224609375 6 20 1.1.1.4637.14 1 62.826 8154.949 62.8363 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00939526036381722 5529.82861328125 1106.973 5529.8203125 1106.97131347656 5 22 1.1.1.4637.17 1 62.8311 19860.32 62.8617 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@28; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0486113987863064 5579.83642578125 798.1268 5579.7880859375 798.119873046875 7 17 1.1.1.4638.8 1 62.8456 7875.774 62.9623 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.021237900480628 5542.873046875 792.8463 5542.85205078125 792.84326171875 7 22 1.1.1.4639.5 1 62.8681 4625.869 62.8363 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.010967000387609 5529.8310546875 922.6458 5529.8203125 922.643981933594 6 16 1.1.1.4639.8 1 62.8715 45537.14 62.8617 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; MDA adduct +62(K)@20; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0548795983195305 5579.85400390625 930.983 5579.79931640625 930.973876953125 6 16 1.1.1.4639.9 1 62.8731 8518.209 62.9623 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0312379002571106 5529.8515625 790.9861 5529.8203125 790.981567382813 7 25 1.1.1.4640.4 1 62.8925 8196.301 62.8617 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0234124008566141 5580.8544921875 798.2722 5580.8310546875 798.268859863281 7 17 1.1.1.4640.5 1 62.8933 6740.105 62.9623 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.010967000387609 5529.8310546875 922.6458 5529.8203125 922.643981933594 6 32 1.1.1.4640.8 1 62.8958 45537.14 62.8617 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0732159018516541 5541.84619140625 924.6483 5541.7724609375 924.636047363281 6 16 1.1.1.4640.9 1 62.8967 17106.29 62.8617 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0223318003118038 5572.86376953125 929.8179 5572.84130859375 929.814147949219 6 22 1.1.1.4640.10 1 62.8975 8152.189 62.9119 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0344064012169838 5701.96484375 951.3347 5701.93017578125 951.328979492188 6 17 1.1.1.4640.12 1 62.8992 7553.033 62.8867 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; reduced acrolein addition +58(K)@20; reduced HNE(H)@24; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -5.08748016727623E-05 5779.97705078125 964.3368 5779.97705078125 964.336791992188 6 18 1.1.1.4640.14 1 62.9008 3671.439 62.9623 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0546901002526283 5557.8701171875 794.9887 5557.81494140625 794.980895996094 7 18 1.1.1.4641.6 1 62.9194 74443.68 63.0125 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00529679004102945 5556.873046875 927.1528 5556.86767578125 927.15185546875 6 32 1.1.1.4641.10 1 62.9228 217563.3 62.9119 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0769447982311249 5610.80126953125 936.1408 5610.8779296875 936.153625488281 6 26 1.1.1.4641.11 1 62.9236 4530.712 62.9372 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0281661991029978 5811.02685546875 969.5117 5810.998046875 969.506958007813 6 16 1.1.1.4641.14 1 62.9261 4023.556 62.9119 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00527181988582015 5556.87353515625 1112.382 5556.86767578125 1112.38073730469 5 29 1.1.1.4641.18 1 62.9294 94951 62.9372 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00529679004102945 5556.873046875 927.1528 5556.86767578125 927.15185546875 6 23 1.1.1.4642.6 1 62.9471 217563.3 62.9119 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@26; Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00687636993825436 5588.85302734375 932.4828 5588.84619140625 932.481628417969 6 24 1.1.1.4642.7 1 62.9487 4582.758 62.8867 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0191278997808695 5627.91259765625 938.9927 5627.8935546875 938.989501953125 6 18 1.1.1.4642.8 1 62.9504 2140.934 62.8867 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@28; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0127660995349288 5529.82861328125 1106.973 5529.81689453125 1106.970703125 5 27 1.1.1.4642.10 1 62.9537 19860.32 62.8617 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0439759008586407 5574.8857421875 797.4195 5574.841796875 797.413208007813 7 16 1.1.1.4643.5 1 62.969 3141.811 62.9875 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; GlyGly(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0405456982553005 5838.98486328125 974.1714 5839.025390625 974.178161621094 6 23 1.1.1.4643.7 1 62.9706 3039.298 62.9372 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@28; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0216754004359245 5557.8701171875 794.9887 5557.84814453125 794.985595703125 7 30 1.1.1.4644.3 1 62.9939 74443.68 63.0125 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0466153994202614 5598.88818359375 934.1553 5598.841796875 934.147583007813 6 22 1.1.1.4644.4 1 62.9956 4000.588 62.9372 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0418098010122776 5800.04541015625 967.6815 5800.00341796875 967.674499511719 6 22 1.1.1.4644.5 1 62.9973 4280.421 63.0378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0254747997969389 5616.8564453125 937.15 5616.8310546875 937.145812988281 6 13 1.1.1.4645.6 1 63.02 2900.567 62.8867 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Carbamidomethyl(T)@23; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00785984005779028 5838.02392578125 1168.612 5838.0302734375 1168.61328125 5 18 1.1.1.4645.16 1 63.0325 8651.784 63.0378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0216651000082493 5542.87353515625 792.8464 5542.85205078125 792.84326171875 7 19 1.1.1.4646.8 1 63.0468 4727.24 62.8617 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00416096998378634 5580.87158203125 931.1525 5580.86767578125 931.15185546875 6 27 1.1.1.4646.10 1 63.0485 9044.7 62.9623 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00734328990802169 5528.84375 922.4812 5528.83642578125 922.47998046875 6 27 1.1.1.4647.4 1 63.0686 21446.31 62.8617 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Oxidation(P)@25; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0266864001750946 5544.8583984375 925.1503 5544.8310546875 925.145812988281 6 26 1.1.1.4647.6 1 63.0703 15523.06 62.8867 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Ammonia-loss(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0376739017665386 5573.86279296875 929.9844 5573.8251953125 929.978149414063 6 26 1.1.1.4647.7 1 63.0711 8825.125 63.088 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; Deamidated(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.00517765991389751 5779.9716796875 964.3359 5779.97705078125 964.336791992188 6 15 1.1.1.4647.11 1 63.0744 3492.757 63.088 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0199944991618395 5580.85107421875 798.2717 5580.8310546875 798.268859863281 7 17 1.1.1.4648.5 1 63.0945 6859.366 63.0629 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.052573200315237 5557.900390625 927.324 5557.84814453125 927.315307617188 6 26 1.1.1.4648.9 1 63.0979 256489.6 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0744713023304939 5612.8193359375 936.4772 5612.8935546875 936.489562988281 6 24 1.1.1.4648.10 1 63.0987 3479.487 63.0629 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0238471999764442 5786.0478515625 965.3486 5786.02392578125 965.344604492188 6 21 1.1.1.4648.13 1 63.1012 2060.096 62.9119 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0142932003363967 5801.04931640625 967.8488 5801.03515625 967.846435546875 6 20 1.1.1.4648.14 1 63.102 4680.846 63.0378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0249419007450342 5812.02783203125 969.6786 5812.00341796875 969.674499511719 6 15 1.1.1.4648.15 1 63.1029 5380.289 63.0125 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0286216996610165 5557.87841796875 1112.583 5557.84814453125 1112.57690429688 5 23 1.1.1.4648.20 1 63.107 126805.4 63.1131 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.0339918993413448 5976.02880859375 1196.213 5976.06201171875 1196.21960449219 5 17 1.1.1.4648.21 1 63.1079 8471.023 63.088 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0441795997321606 5572.8701171875 929.819 5572.826171875 929.811645507813 6 15 1.1.1.4649.9 1 63.1231 7338.358 63.1131 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00943975988775492 5588.85546875 932.4832 5588.84619140625 932.481628417969 6 19 1.1.1.4649.10 1 63.1239 4132.348 63.1384 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Ammonia-loss(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0921972990036011 5573.9140625 797.2807 5573.82177734375 797.267578125 7 23 1.1.1.4650.6 1 63.1456 3037.706 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0154686998575926 5542.8369140625 924.8134 5542.85205078125 924.81591796875 6 25 1.1.1.4650.8 1 63.1481 11289.22 63.1131 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0681559965014458 5610.81005859375 936.1423 5610.8779296875 936.153625488281 6 24 1.1.1.4650.9 1 63.1498 4189.02 63.1384 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; Carbamidomethyl(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00990973971784115 5838.0400390625 974.014 5838.0302734375 974.012329101563 6 26 1.1.1.4650.10 1 63.1515 3724.323 63.264 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0675071030855179 5557.88232421875 794.9905 5557.81494140625 794.980895996094 7 18 1.1.1.4651.4 1 63.1692 80338.01 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0344923995435238 5557.88232421875 794.9905 5557.84814453125 794.985595703125 7 26 1.1.1.4651.5 1 63.17 80338.01 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0439759008586407 5574.8857421875 797.4195 5574.841796875 797.413208007813 7 14 1.1.1.4651.6 1 63.1708 3141.811 62.9875 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0537668988108635 5556.88525390625 927.1548 5556.8310546875 927.145812988281 6 15 1.1.1.4651.11 1 63.175 213061.7 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.00543088978156447 5599.8671875 934.3185 5599.8623046875 934.317626953125 6 12 1.1.1.4651.12 1 63.1758 3752.521 62.9372 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0692747980356216 5800.072265625 967.686 5800.00341796875 967.674499511719 6 19 1.1.1.4652.7 1 63.2 3843.518 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00203921995125711 5528.833984375 1106.774 5528.83642578125 1106.77453613281 5 18 1.1.1.4652.9 1 63.2034 5102.289 63.1131 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Carbamidomethyl(T)@23; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0103011997416615 5838.0185546875 1168.611 5838.0302734375 1168.61328125 5 17 1.1.1.4652.11 1 63.2067 11329.8 63.264 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00585749978199601 5542.85791015625 792.8441 5542.85205078125 792.84326171875 7 15 1.1.1.4653.4 1 63.2194 3200.912 62.9623 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.0146243004128337 5610.8271484375 802.554 5610.841796875 802.556091308594 7 11 1.1.1.4653.5 1 63.2203 2421.665 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HexNAc(N)@17; reduced acrolein addition +58(K)@20; reduced HNE(H)@24; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.0389843992888927 5976.0439453125 997.0146 5976.0830078125 997.021118164063 6 18 1.1.1.4653.13 1 63.2269 16669.46 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0344037003815174 5529.8544921875 922.6497 5529.8203125 922.643981933594 6 22 1.1.1.4654.4 1 63.2446 12383.33 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Ammonia-loss(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0626503974199295 5573.88427734375 929.988 5573.82177734375 929.977600097656 6 20 1.1.1.4654.6 1 63.2462 8533.698 63.1634 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0169302001595497 5584.87939453125 931.8205 5584.8623046875 931.817687988281 6 19 1.1.1.4654.7 1 63.2471 4394.316 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; Deamidated(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0142309004440904 5779.9912109375 964.3392 5779.97705078125 964.336791992188 6 17 1.1.1.4654.11 1 63.2504 2980.345 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0553217008709908 5579.85498046875 798.1294 5579.79931640625 798.121459960938 7 18 1.1.1.4655.6 1 63.2716 8321.757 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@26; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.052573200315237 5557.900390625 927.324 5557.84814453125 927.315307617188 6 26 1.1.1.4655.8 1 63.2732 256489.6 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0371664017438889 5557.88330078125 1112.584 5557.84814453125 1112.57690429688 5 24 1.1.1.4655.17 1 63.2807 135934.1 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.0146243004128337 5610.8271484375 802.554 5610.841796875 802.556091308594 7 13 1.1.1.4656.5 1 63.2989 2421.665 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; hexanoyl addition +98(K)@20; Dethiomethyl(M)@37; Formyl(K)@40 missed K-I@20; missed K-L@40 0.00915815029293299 5579.86279296875 930.9844 5579.853515625 930.98291015625 6 20 1.1.1.4656.6 1 63.3006 9216.204 63.1885 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0307295992970467 5811.02880859375 969.5121 5810.998046875 969.506958007813 6 17 1.1.1.4656.7 1 63.3022 4123.43 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; HexNAc(N)@26; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.00903960969299078 5975.060546875 996.8507 5975.05126953125 996.849182128906 6 17 1.1.1.4656.9 1 63.3064 12521.4 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0310455001890659 5588.87744140625 932.4868 5588.84619140625 932.481628417969 6 26 1.1.1.4657.5 1 63.3239 3626.845 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0476173013448715 5801.08251953125 967.8544 5801.03515625 967.846435546875 6 22 1.1.1.4657.6 1 63.3255 4435.455 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; Carbamidomethyl(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00148715998511761 5838.03173828125 974.0126 5838.0302734375 974.012329101563 6 23 1.1.1.4657.7 1 63.3272 3724.323 63.264 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HexNAc(N)@17; ONE addition +154(K)@20; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.043689701706171 5936.0380859375 990.3469 5935.994140625 990.339660644531 6 16 1.1.1.4657.9 1 63.3314 2122.809 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0344923995435238 5557.88232421875 794.9905 5557.84814453125 794.985595703125 7 29 1.1.1.4658.3 1 63.3439 80338.01 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.064391702413559 5578.8798828125 797.9901 5578.8154296875 797.980895996094 7 18 1.1.1.4658.4 1 63.3448 4483.328 63.3392 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0537668988108635 5556.88525390625 927.1548 5556.8310546875 927.145812988281 6 24 1.1.1.4658.5 1 63.3456 213061.7 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.028591200709343 5597.87548828125 933.9865 5597.8466796875 933.981689453125 6 12 1.1.1.4658.6 1 63.3464 2860.12 63.3893 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Cation:K(D)@33; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.037738598883152 5837.01318359375 973.8428 5836.97509765625 973.836486816406 6 19 1.1.1.4658.8 1 63.3489 2704.052 63.3642 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; Cation:K(D)@33; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 -0.0402207002043724 5912.9658203125 986.5016 5913.00634765625 986.508361816406 6 18 1.1.1.4658.12 1 63.3556 4402.02 63.5147 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.0101648001000285 5610.83154296875 936.1459 5610.841796875 936.147583007813 6 12 1.1.1.4659.6 1 63.3715 3557.832 63.3642 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 0.000721274991519749 5528.833984375 1106.774 5528.8330078125 1106.77380371094 5 16 1.1.1.4659.11 1 63.3774 4091.66 63.4143 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0163461994379759 5580.85107421875 931.1491 5580.86767578125 931.15185546875 6 25 1.1.1.4660.4 1 63.3999 7724.626 63.3642 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0150335002690554 5528.85107421875 922.4825 5528.83642578125 922.47998046875 6 25 1.1.1.4661.9 1 63.4242 7819.59 63.4143 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; reduced acrolein addition +58(K)@20; Dehydrated(T)@31 missed K-I@20; missed K-L@40 0.0585548989474773 5541.87841796875 924.6537 5541.8203125 924.643981933594 6 18 1.1.1.4661.10 1 63.425 7734.746 63.3642 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Ammonia-loss(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0399461016058922 5573.8623046875 929.9843 5573.82177734375 929.977600097656 6 19 1.1.1.4661.11 1 63.4259 7719.437 63.4395 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@24; Deamidated(N)@34; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.0574157983064651 5772.02978515625 963.0122 5771.97216796875 963.002624511719 6 14 1.1.1.4661.15 1 63.4292 2202.767 63.3642 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0656128004193306 5800.06884765625 967.6854 5800.00341796875 967.674499511719 6 15 1.1.1.4661.16 1 63.43 2936.889 63.4395 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@28; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.052573200315237 5557.900390625 927.324 5557.84814453125 927.315307617188 6 26 1.1.1.4662.2 1 63.4449 258258.8 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0377767011523247 5557.88330078125 1112.584 5557.84814453125 1112.57690429688 5 23 1.1.1.4662.5 1 63.4524 112205.1 63.3642 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@23; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0227715000510216 5572.86328125 1115.58 5572.84130859375 1115.57556152344 5 20 1.1.1.4662.6 1 63.4558 2910.16 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00924300029873848 5580.876953125 798.2754 5580.86767578125 798.274047851563 7 22 1.1.1.4663.6 1 63.4718 5335.491 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0534083992242813 5557.86865234375 794.9885 5557.81494140625 794.980895996094 7 14 1.1.1.4664.5 1 63.4961 56120.85 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0314501002430916 5587.8935546875 932.3229 5587.8623046875 932.317626953125 6 16 1.1.1.4664.6 1 63.497 4185.79 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0656128004193306 5800.06884765625 967.6854 5800.00341796875 967.674499511719 6 22 1.1.1.4664.7 1 63.4978 2936.889 63.4395 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; GlyGly(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0134469997137785 5839.0126953125 974.176 5839.025390625 974.178161621094 6 22 1.1.1.4664.9 1 63.4995 4397.968 63.4395 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0685660019516945 5579.8681640625 798.1313 5579.79931640625 798.121459960938 7 15 1.1.1.4665.2 1 63.5186 5197.881 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0446119010448456 5556.87646484375 927.1533 5556.8310546875 927.145812988281 6 12 1.1.1.4665.3 1 63.5194 149619 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.0274925995618105 5597.87451171875 933.9863 5597.8466796875 933.981689453125 6 14 1.1.1.4665.4 1 63.5211 2862.345 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0203936994075775 5557.86865234375 794.9885 5557.84814453125 794.985595703125 7 28 1.1.1.4666.3 1 63.5461 56120.85 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; Methyl(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0274784006178379 5855.109375 976.8588 5855.08203125 976.854248046875 6 24 1.1.1.4666.4 1 63.5478 1543.11 63.2893 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; HexNAc(N)@28; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.0804022029042244 5911.91357421875 986.3262 5911.994140625 986.339660644531 6 18 1.1.1.4666.6 1 63.5511 5829.207 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Carbamidomethyl(T)@23; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00541851995512843 5838.02392578125 1168.612 5838.0302734375 1168.61328125 5 22 1.1.1.4666.11 1 63.5595 10374.63 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0494799017906189 5610.82861328125 936.1454 5610.8779296875 936.153625488281 6 23 1.1.1.4667.6 1 63.5792 3379.755 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0347699001431465 5529.85498046875 922.6498 5529.8203125 922.643981933594 6 24 1.1.1.4668.6 1 63.5966 9244.746 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0119962999597192 5542.86376953125 924.8179 5542.85205078125 924.81591796875 6 21 1.1.1.4668.8 1 63.5983 8478.104 63.3893 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.0548655018210411 5556.88671875 927.155 5556.8310546875 927.145812988281 6 18 1.1.1.4668.9 1 63.5991 162735.8 63.3392 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0079236002638936 5580.859375 931.1505 5580.86767578125 931.15185546875 6 26 1.1.1.4668.10 1 63.6008 6964.652 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0450262017548084 5701.97509765625 951.3365 5701.93017578125 951.328979492188 6 20 1.1.1.4668.12 1 63.6041 8011.09 63.714 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0434181988239288 5557.8916015625 927.3225 5557.84814453125 927.315307617188 6 27 1.1.1.4669.4 1 63.6247 209378.8 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; hexanoyl addition +98(K)@20; Dethiomethyl(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.00152256002184004 5589.873046875 932.6528 5589.87451171875 932.653015136719 6 17 1.1.1.4669.5 1 63.6272 2653.667 63.714 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.036556001752615 5557.88330078125 1112.584 5557.84814453125 1112.57690429688 5 25 1.1.1.4669.7 1 63.6339 101959.1 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Dimethyl(N)@34 missed K-I@20; missed K-L@40 0.0344187989830971 5529.853515625 1106.978 5529.8203125 1106.97131347656 5 24 1.1.1.4670.6 1 63.6513 3750.803 63.689 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0695962011814117 5557.8818359375 794.9904 5557.8115234375 794.980407714844 7 24 1.1.1.4671.4 1 63.6737 38977.68 63.689 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.0216847993433475 5811.041015625 969.5141 5811.01953125 969.510498046875 6 17 1.1.1.4671.7 1 63.6812 2969.86 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; GlyGly(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00319339009001851 5839.0224609375 974.1777 5839.025390625 974.178161621094 6 19 1.1.1.4672.11 1 63.7005 4503.145 63.4395 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0672843009233475 5579.86669921875 798.1311 5579.79931640625 798.121459960938 7 17 1.1.1.4673.5 1 63.7236 3683.552 63.689 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.0307618007063866 5612.82666015625 936.4784 5612.857421875 936.483520507813 6 16 1.1.1.4673.6 1 63.7252 3027.69 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +94(K)@20; Hex(N)@34; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 -0.0614785999059677 5911.92138671875 986.3275 5911.98291015625 986.337768554688 6 20 1.1.1.4673.7 1 63.7269 5386.642 63.689 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Carbamidomethyl(T)@23; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00541851995512843 5838.02392578125 1168.612 5838.0302734375 1168.61328125 5 21 1.1.1.4673.9 1 63.7311 10521.67 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@23; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0479657985270023 5572.888671875 929.8221 5572.84130859375 929.814147949219 6 20 1.1.1.4674.4 1 63.7518 4380.823 63.714 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0410957001149654 5611.8212890625 936.3108 5611.8623046875 936.317626953125 6 21 1.1.1.4674.5 1 63.7552 3233.69 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00661088991910219 5528.8427734375 922.4811 5528.83642578125 922.47998046875 6 24 1.1.1.4675.5 1 63.7733 5104.808 63.714 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0951877981424332 5541.86767578125 924.6519 5541.7724609375 924.636047363281 6 17 1.1.1.4675.6 1 63.775 6026.013 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0273321997374296 5580.83984375 931.1473 5580.86767578125 931.15185546875 6 24 1.1.1.4675.7 1 63.7766 6235.695 63.5147 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0450892001390457 5585.8916015625 931.9892 5585.8466796875 931.981689453125 6 23 1.1.1.4675.8 1 63.7783 3691.528 63.8882 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0581707991659641 5702.97265625 951.5027 5702.9140625 951.492980957031 6 20 1.1.1.4675.9 1 63.78 8611.861 63.714 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; reduced HNE(H)@24; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.0059923199005425 5887.0654296875 982.1849 5887.07177734375 982.185913085938 6 14 1.1.1.4675.10 1 63.7816 1477.846 63.6641 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@28; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0423195995390415 5557.89013671875 927.3223 5557.84814453125 927.315307617188 6 26 1.1.1.4676.3 1 63.7981 139614.3 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Delta:H(4)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0274011008441448 5557.87353515625 1112.582 5557.84814453125 1112.57690429688 5 22 1.1.1.4676.6 1 63.8081 74731.24 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Ammonia-loss(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0436080992221832 5573.86572265625 929.9849 5573.82177734375 929.977600097656 6 21 1.1.1.4677.4 1 63.8262 5228.852 63.8882 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0193224009126425 5528.853515625 1106.778 5528.83642578125 1106.77453613281 5 20 1.1.1.4677.5 1 63.8295 3242.014 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0344923995435238 5557.88232421875 794.9905 5557.84814453125 794.985595703125 7 27 1.1.1.4678.8 1 63.8472 34094.08 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0608757995069027 5579.8603515625 798.1302 5579.79931640625 798.121459960938 7 16 1.1.1.4679.2 1 63.8679 3311.454 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.00836047995835543 5599.8701171875 934.319 5599.8623046875 934.317626953125 6 13 1.1.1.4679.3 1 63.8696 3554.003 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0397531017661095 5590.8916015625 932.8226 5590.85205078125 932.81591796875 6 16 1.1.1.4680.8 1 63.8972 1599.278 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; Deamidated(N)@30; Hex(N)@34; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.0541546009480953 5911.92822265625 986.3287 5911.98291015625 986.337768554688 6 17 1.1.1.4680.14 1 63.9022 5422.94 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@30; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0411695018410683 5571.8720703125 929.6526 5571.83056640625 929.645751953125 6 17 1.1.1.4681.7 1 63.9247 4132.012 63.9879 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0183292999863625 5528.85400390625 922.483 5528.83642578125 922.47998046875 6 23 1.1.1.4682.4 1 63.9462 5857.043 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0185879003256559 5542.8701171875 924.819 5542.85205078125 924.81591796875 6 25 1.1.1.4682.5 1 63.9478 6448.943 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0277849994599819 5544.859375 925.1505 5544.8310546875 925.145812988281 6 22 1.1.1.4682.6 1 63.9503 4469.933 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0197930000722408 5600.87744140625 934.4868 5600.857421875 934.483520507813 6 18 1.1.1.4682.7 1 63.9528 2913.797 63.8882 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0315403006970882 5628.9091796875 939.1588 5628.87744140625 939.153503417969 6 18 1.1.1.4682.8 1 63.9554 1066.433 63.9383 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0366035997867584 5701.966796875 951.3351 5701.93017578125 951.328979492188 6 18 1.1.1.4682.9 1 63.9579 7586.692 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30 missed K-I@20; missed K-L@40 0.0619020015001297 5540.85107421875 924.4824 5540.78857421875 924.472045898438 6 15 1.1.1.4683.3 1 63.9726 4473.044 63.9879 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0423195995390415 5557.89013671875 927.3223 5557.84814453125 927.315307617188 6 26 1.1.1.4683.4 1 63.9759 139614.3 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0386771000921726 5581.853515625 931.3162 5581.81494140625 931.309814453125 6 16 1.1.1.4683.5 1 63.9792 4760.627 63.8882 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Deamidated(N)@26; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0274011008441448 5557.87353515625 1112.582 5557.84814453125 1112.57690429688 5 27 1.1.1.4683.6 1 63.9826 74731.24 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Formyl(K)@40 missed K-I@20; missed K-L@40 0.00118739996105433 5610.84326171875 936.1478 5610.841796875 936.147583007813 6 18 1.1.1.4684.5 1 63.9976 2657.343 63.8882 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@26; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0356394983828068 5529.853515625 1106.978 5529.8203125 1106.97131347656 5 20 1.1.1.4684.9 1 64.0052 3669.583 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Hex(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.0278568007051945 5975.05859375 1196.019 5975.087890625 1196.02478027344 5 15 1.1.1.4684.10 1 64.0077 2827.849 64.038 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@28; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0344923995435238 5557.88232421875 794.9905 5557.84814453125 794.985595703125 7 27 1.1.1.4685.4 1 64.0185 34094.08 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.051503598690033 5572.87744140625 929.8202 5572.826171875 929.811645507813 6 14 1.1.1.4685.7 1 64.0211 4742.914 63.9879 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0318862982094288 5580.8994140625 798.2786 5580.86767578125 798.274047851563 7 22 1.1.1.4686.8 1 64.0493 2629.581 64.1379 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0675071030855179 5557.88232421875 794.9905 5557.81494140625 794.980895996094 7 18 1.1.1.4687.5 1 64.0692 35050.67 63.8133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0639521032571793 5582.90869140625 1117.589 5582.8466796875 1117.57666015625 5 15 1.1.1.4687.13 1 64.0792 53493.27 64.2649 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0180463008582592 5780.990234375 964.5057 5781.0087890625 964.508728027344 6 18 1.1.1.4688.9 1 64.0977 888.3472 63.9879 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.0167564991861582 5976.044921875 997.0148 5976.06201171875 997.017578125 6 16 1.1.1.4688.11 1 64.0994 7513.342 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00540468981489539 5542.85693359375 924.8168 5542.85205078125 924.81591796875 6 21 1.1.1.4689.11 1 64.1244 4430.052 64.0878 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0397562012076378 5557.8876953125 927.3219 5557.84814453125 927.315307617188 6 28 1.1.1.4690.7 1 64.146 127328.7 63.8882 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0605976991355419 5582.9072265625 931.4918 5582.8466796875 931.481750488281 6 21 1.1.1.4690.8 1 64.1477 98302.95 64.3408 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +76(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0271550007164478 5605.87841796875 935.3204 5605.8515625 935.315856933594 6 18 1.1.1.4690.9 1 64.1494 3273.116 64.2649 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20 missed K-I@20; missed K-L@40 0.0325152985751629 5528.833984375 1106.774 5528.7998046875 1106.76721191406 5 19 1.1.1.4691.14 1 64.1778 2687.512 63.9133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0550846010446548 5556.888671875 1112.385 5556.8310546875 1112.37353515625 5 19 1.1.1.4692.13 1 64.2081 40452.95 63.9879 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0270530991256237 5558.87353515625 795.1321 5558.8466796875 795.128234863281 7 16 1.1.1.4693.5 1 64.2206 17308.73 63.9631 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.062752902507782 5582.90966796875 798.5658 5582.8466796875 798.556823730469 7 22 1.1.1.4693.6 1 64.2214 22361.31 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0144517999142408 5556.88232421875 927.1543 5556.86767578125 927.15185546875 6 20 1.1.1.4693.11 1 64.2256 80796.03 63.9879 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0461347997188568 5572.88720703125 929.8218 5572.84130859375 929.814147949219 6 22 1.1.1.4693.12 1 64.2264 3586.628 64.2133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0560178011655808 5582.90380859375 1117.588 5582.8466796875 1117.57666015625 5 15 1.1.1.4694.16 1 64.2555 57520.35 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0687887966632843 5557.88427734375 794.9907 5557.81494140625 794.980895996094 7 19 1.1.1.4696.6 1 64.2979 12535.71 64.2133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00510748010128737 5528.8310546875 922.4791 5528.83642578125 922.47998046875 6 17 1.1.1.4696.10 1 64.3013 3083.01 64.2391 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.037925198674202 5557.8857421875 927.3216 5557.84814453125 927.315307617188 6 27 1.1.1.4697.3 1 64.3222 49161.45 64.3408 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0605976991355419 5582.9072265625 931.4918 5582.8466796875 931.481750488281 6 18 1.1.1.4697.4 1 64.3239 98677.73 64.3408 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +62(K)@20; Deamidated(N)@26; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.028600400313735 5617.8798828125 937.3206 5617.8515625 937.315856933594 6 26 1.1.1.4697.5 1 64.3256 1414.929 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0596868991851807 5568.888671875 1114.785 5568.8310546875 1114.77355957031 5 16 1.1.1.4697.10 1 64.3339 2829.003 64.1129 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.0581362992525101 5556.888671875 1112.385 5556.8310546875 1112.37353515625 5 14 1.1.1.4699.20 1 64.3855 16783.82 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.062752902507782 5582.90966796875 798.5658 5582.8466796875 798.556823730469 7 18 1.1.1.4700.7 1 64.4 22361.31 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; reduced acrolein addition +58(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00419942010194063 5613.87353515625 936.6529 5613.8779296875 936.653564453125 6 17 1.1.1.4700.11 1 64.4033 1869.201 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0605976991355419 5582.9072265625 931.4918 5582.8466796875 931.481750488281 6 22 1.1.1.4701.6 1 64.4315 98677.73 64.3408 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0560178011655808 5582.90380859375 1117.588 5582.8466796875 1117.57666015625 5 15 1.1.1.4701.7 1 64.434 57520.35 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.043742198497057 5568.86328125 929.1512 5568.81982421875 929.143920898438 6 17 1.1.1.4702.5 1 64.4514 3619.604 64.3916 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0652915015816689 5598.90673828125 934.1584 5598.841796875 934.147583007813 6 19 1.1.1.4702.6 1 64.4531 4212.34 64.3916 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0610514990985394 5557.87255859375 794.9891 5557.8115234375 794.980407714844 7 22 1.1.1.4703.5 1 64.4735 9769.567 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; Dioxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0534745007753372 5672.931640625 946.4959 5672.87841796875 946.486999511719 6 24 1.1.1.4703.11 1 64.4785 21935.69 64.6737 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@26; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0393900014460087 5557.88720703125 927.3218 5557.84814453125 927.315307617188 6 27 1.1.1.4704.8 1 64.5013 55602.95 64.2391 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0605976991355419 5582.9072265625 931.4918 5582.8466796875 931.481750488281 6 19 1.1.1.4704.9 1 64.5021 98677.73 64.3408 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.0428779982030392 5556.87353515625 1112.382 5556.8310546875 1112.37353515625 5 15 1.1.1.4706.18 1 64.5609 11258.06 64.5687 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.062752902507782 5582.90966796875 798.5658 5582.8466796875 798.556823730469 7 17 1.1.1.4707.9 1 64.5793 22361.31 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0224786996841431 5672.93701171875 811.4269 5672.9150390625 811.423706054688 7 15 1.1.1.4709.9 1 64.6316 3875.458 64.6469 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.0293607003986835 5688.91796875 949.1603 5688.888671875 949.155395507813 6 12 1.1.1.4709.15 1 64.6367 1095.993 64.5946 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0398349016904831 5556.87109375 794.846 5556.8310546875 794.840270996094 7 24 1.1.1.4710.9 1 64.6584 4614.499 64.6737 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0464500002563 5530.8505859375 922.8157 5530.80419921875 922.807983398438 6 16 1.1.1.4710.14 1 64.6626 1622.804 64.6469 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.048250000923872 5542.900390625 924.824 5542.85205078125 924.81591796875 6 20 1.1.1.4710.15 1 64.6634 1943.742 64.6737 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dioxidation(F)@15; acrolein addition +112(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0534745007753372 5672.931640625 946.4959 5672.87841796875 946.486999511719 6 28 1.1.1.4710.16 1 64.6643 22096.2 64.6737 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.00627327989786863 5672.923828125 1135.592 5672.9150390625 1135.59020996094 5 13 1.1.1.4710.21 1 64.6684 9645.599 64.6469 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0071539799682796 5556.8603515625 927.1507 5556.86767578125 927.15185546875 6 38 1.1.1.4711.14 1 64.6893 28109.57 64.6469 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.0591329000890255 5582.90576171875 931.4916 5582.8466796875 931.481750488281 6 18 1.1.1.4711.15 1 64.6901 70095.32 64.4169 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0432640984654427 5539.84765625 924.3152 5539.8046875 924.308044433594 6 14 1.1.1.4712.12 1 64.7133 2545.457 64.7261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0818803012371063 5583.91259765625 798.7091 5583.83056640625 798.697387695313 7 16 1.1.1.4714.10 1 64.7642 5230.426 64.7522 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0432878993451595 5558.8896484375 795.1344 5558.8466796875 795.128234863281 7 15 1.1.1.4715.7 1 64.7882 3446.772 64.6737 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0529660992324352 5582.89892578125 1117.587 5582.8466796875 1117.57666015625 5 16 1.1.1.4715.19 1 64.7982 31018.39 64.5173 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0798968002200127 5557.89501953125 794.9923 5557.81494140625 794.980895996094 7 17 1.1.1.4717.6 1 64.8393 4638.286 64.7786 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; Dioxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0534745007753372 5672.931640625 946.4959 5672.87841796875 946.486999511719 6 21 1.1.1.4717.17 1 64.8485 22096.2 64.6737 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.00627327989786863 5672.923828125 1135.592 5672.9150390625 1135.59020996094 5 13 1.1.1.4717.21 1 64.8518 9645.599 64.6469 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0291364006698132 5557.876953125 927.3201 5557.84814453125 927.315307617188 6 23 1.1.1.4718.14 1 64.8716 25310.11 64.7786 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0656860992312431 5583.896484375 931.6567 5583.83056640625 931.645751953125 6 19 1.1.1.4718.15 1 64.8725 25660.15 64.7786 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0793168991804123 5583.90966796875 798.7087 5583.83056640625 798.697387695313 7 19 1.1.1.4721.8 1 64.946 8124.616 65.0927 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0794695988297462 5557.89453125 794.9922 5557.81494140625 794.980895996094 7 17 1.1.1.4724.5 1 65.0214 2915.594 65.04 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0280750002712011 5672.9423828125 946.4977 5672.9150390625 946.493103027344 6 19 1.1.1.4724.12 1 65.0272 17293.29 65.1705 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0644233971834183 5557.87548828125 927.3199 5557.8115234375 927.309265136719 6 22 1.1.1.4725.16 1 65.0566 15886.25 65.066 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0682495012879372 5583.89892578125 931.6571 5583.83056640625 931.645751953125 6 16 1.1.1.4725.17 1 65.0574 43945.41 65.1185 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Deamidated(N)@28; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0298424009233713 5557.87841796875 1112.583 5557.84814453125 1112.57690429688 5 20 1.1.1.4725.20 1 65.0599 7182.87 65.1185 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0442675016820431 5672.958984375 811.43 5672.9150390625 811.423706054688 7 13 1.1.1.4726.8 1 65.0767 3167.983 65.1445 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0793168991804123 5583.90966796875 798.7087 5583.83056640625 798.697387695313 7 17 1.1.1.4728.8 1 65.1284 8124.616 65.0927 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0515835992991924 5583.8837890625 1117.784 5583.83056640625 1117.7734375 5 15 1.1.1.4729.18 1 65.1628 28994.87 65.1185 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Dioxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.064460501074791 5672.9423828125 946.4977 5672.87841796875 946.486999511719 6 23 1.1.1.4731.12 1 65.2098 17293.29 65.1705 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0295106004923582 5556.89697265625 794.8497 5556.86767578125 794.845520019531 7 22 1.1.1.4732.10 1 65.234 2261.65 65.1967 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0640204027295113 5556.8955078125 927.1565 5556.8310546875 927.145812988281 6 31 1.1.1.4732.14 1 65.2373 13885.87 64.9621 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(Q)@14; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0682495012879372 5583.89892578125 931.6571 5583.83056640625 931.645751953125 6 17 1.1.1.4732.15 1 65.2382 43945.41 65.1185 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0245831999927759 5672.9384765625 1135.595 5672.9150390625 1135.59020996094 5 12 1.1.1.4732.21 1 65.2432 6658.268 65.1445 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0442675016820431 5672.958984375 811.43 5672.9150390625 811.423706054688 7 15 1.1.1.4734.11 1 65.2873 3167.983 65.1445 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0538639985024929 5556.8837890625 1112.384 5556.8310546875 1112.37353515625 5 13 1.1.1.4735.20 1 65.3209 5964.452 65.3797 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0699177980422974 5583.90087890625 798.7074 5583.83056640625 798.697387695313 7 17 1.1.1.4736.10 1 65.3389 8323.396 65.066 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; Dioxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.052742101252079 5672.93115234375 946.4958 5672.87841796875 946.486999511719 6 22 1.1.1.4738.9 1 65.3908 15029.59 65.3008 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0184799991548061 5556.88671875 927.155 5556.86767578125 927.15185546875 6 28 1.1.1.4739.12 1 65.42 10669.91 65.406 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0693480968475342 5583.89990234375 931.6573 5583.83056640625 931.645751953125 6 20 1.1.1.4739.13 1 65.4208 40209.91 65.1445 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0375575982034206 5673.9365234375 946.6633 5673.89892578125 946.657104492188 6 18 1.1.1.4745.12 1 65.5761 11918.22 65.3797 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@34; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0415872000157833 5557.8896484375 927.3222 5557.84814453125 927.315307617188 6 24 1.1.1.4746.12 1 65.6013 10746.17 65.4584 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0682495012879372 5583.89892578125 931.6571 5583.83056640625 931.645751953125 6 18 1.1.1.4746.13 1 65.6022 17638.03 65.327 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0213695000857115 5673.91845703125 1135.791 5673.89892578125 1135.787109375 5 13 1.1.1.4749.20 1 65.6852 3174.59 65.6401 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@30 missed K-I@20; missed K-L@40 0.0709249004721642 5557.88623046875 794.991 5557.81494140625 794.980895996094 7 13 1.1.1.4750.10 1 65.7026 1507.816 65.6913 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0236421003937721 5673.92236328125 946.661 5673.89892578125 946.657104492188 6 15 1.1.1.4752.12 1 65.7552 9959.398 65.4845 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0555979013442993 5556.88671875 927.1551 5556.8310546875 927.145812988281 6 24 1.1.1.4753.14 1 65.7822 6676.202 65.6913 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0868306010961533 5556.91796875 794.8527 5556.8310546875 794.840270996094 7 10 1.1.1.4758.5 1 65.9028 992.7506 65.8188 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.00573681015521288 5672.92041015625 946.494 5672.9150390625 946.493103027344 6 12 1.1.1.4759.13 1 65.9351 2673.107 65.9214 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0544992983341217 5556.8857421875 927.1549 5556.8310546875 927.145812988281 6 27 1.1.1.4760.13 1 65.9606 5600.949 65.9982 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0689819008111954 5583.89990234375 931.6572 5583.83056640625 931.645751953125 6 16 1.1.1.4762.14 1 66.0129 4189.338 65.8188 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0254730992019176 5673.92431640625 946.6613 5673.89892578125 946.657104492188 6 14 1.1.1.4766.12 1 66.1149 6594.442 66.2588 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0700704976916313 5557.88525390625 794.9909 5557.81494140625 794.980895996094 7 11 1.1.1.4767.12 1 66.141 968.5682 66.1277 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0544992983341217 5556.8857421875 927.1549 5556.8310546875 927.145812988281 6 25 1.1.1.4767.14 1 66.1427 5483.819 66.1801 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0207592006772757 5673.91845703125 1135.791 5673.89892578125 1135.787109375 5 14 1.1.1.4771.21 1 66.2535 3558.794 66.2325 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0254730992019176 5673.92431640625 946.6613 5673.89892578125 946.657104492188 6 15 1.1.1.4773.15 1 66.3004 6594.442 66.2588 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0548655018210411 5556.88671875 927.155 5556.8310546875 927.145812988281 6 22 1.1.1.4774.13 1 66.3251 5705.359 66.3632 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.035989798605442 5556.86767578125 794.8455 5556.8310546875 794.840270996094 7 11 1.1.1.4779.9 1 66.452 1008.58 66.2588 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0254730992019176 5673.92431640625 946.6613 5673.89892578125 946.657104492188 6 17 1.1.1.4780.14 1 66.4822 6594.442 66.2588 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0203109998255968 5556.88818359375 927.1553 5556.86767578125 927.15185546875 6 27 1.1.1.4781.15 1 66.5095 5072.972 66.4672 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0566965006291866 5556.88818359375 927.1553 5556.8310546875 927.145812988281 6 26 1.1.1.4788.14 1 66.6931 5072.972 66.4672 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00529679004102945 5556.873046875 927.1528 5556.86767578125 927.15185546875 6 27 1.1.1.4795.16 1 66.8808 3983.446 66.8371 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0276349000632763 5556.8955078125 927.1565 5556.86767578125 927.15185546875 6 26 1.1.1.4802.16 1 67.0686 3820.926 67.078 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0244130007922649 5672.93896484375 946.4971 5672.9150390625 946.493103027344 6 11 1.1.1.4805.14 1 67.1471 512.5746 67.106 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0297745000571013 5698.96044921875 950.834 5698.9306640625 950.829040527344 6 16 1.1.1.4807.18 1 67.2032 1658.488 67.106 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0508373007178307 5556.88232421875 927.1543 5556.8310546875 927.145812988281 6 28 1.1.1.4809.15 1 67.2554 4811.382 67.239 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0398513004183769 5556.87158203125 927.1525 5556.8310546875 927.145812988281 6 22 1.1.1.4816.12 1 67.4394 6132.026 67.6931 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0526519007980824 5556.88330078125 794.8478 5556.8310546875 794.840270996094 7 11 1.1.1.4820.8 1 67.5442 1021.617 67.5603 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0303300991654396 5556.86181640625 927.1509 5556.8310546875 927.145812988281 6 21 1.1.1.4823.14 1 67.6284 8625.396 67.7204 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@17; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0359633006155491 5555.87353515625 1112.182 5555.8359375 1112.17443847656 5 17 1.1.1.4829.12 1 67.7862 33108.86 67.7204 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0291511006653309 5555.865234375 926.9848 5555.8359375 926.979919433594 6 19 1.1.1.4830.18 1 67.8188 7840.319 67.7732 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.051935900002718 5556.88330078125 927.1545 5556.8310546875 927.145812988281 6 20 1.1.1.4837.12 1 67.9985 4427.612 68.0113 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00493058981373906 5556.87255859375 927.1527 5556.86767578125 927.15185546875 6 21 1.1.1.4844.11 1 68.1872 4294.285 68.2008 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0413160994648933 5556.87255859375 927.1527 5556.8310546875 927.145812988281 6 19 1.1.1.4851.15 1 68.3786 4294.285 68.2008 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0674332976341248 5539.8720703125 924.3193 5539.8046875 924.308044433594 6 14 1.1.1.4498.20 1 59.2339 2216.364 59.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0357186011970043 5573.84619140625 929.9816 5573.81005859375 929.975646972656 6 14 1.1.1.4503.20 1 59.3656 3659.979 59.3981 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; Deamidated(N)@30; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0753180980682373 5816.052734375 970.3494 5815.97705078125 970.336791992188 6 14 1.1.1.4546.17 1 60.5023 14434.56 60.6681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; hexanoyl addition +98(K)@20; Dethiomethyl(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.00360421999357641 5589.8779296875 932.6536 5589.87451171875 932.653015136719 6 15 1.1.1.4557.13 1 60.7858 3696.717 60.7716 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0568763017654419 5701.95068359375 951.3324 5701.8935546875 951.322937011719 6 15 1.1.1.4559.17 1 60.8424 3905.081 60.7716 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0496238991618156 5572.87353515625 1115.582 5572.826171875 1115.57250976563 5 13 1.1.1.4560.21 1 60.8725 84367.71 60.6681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@34; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0394382998347282 5589.85986328125 932.6506 5589.8203125 932.643981933594 6 14 1.1.1.4564.16 1 60.9721 3565.886 61.2151 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0720638036727905 5772.0439453125 963.0146 5771.97216796875 963.002624511719 6 13 1.1.1.4565.15 1 60.9972 10474.7 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0395961999893188 5585.88623046875 931.9883 5585.8466796875 931.981689453125 6 15 1.1.1.4569.17 1 61.1026 5093.586 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.032066598534584 5593.84716796875 933.3151 5593.81494140625 933.309814453125 6 13 1.1.1.4571.12 1 61.151 2845.411 61.1894 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 -0.0504317991435528 5961.05859375 994.517 5961.1083984375 994.525390625 6 15 1.1.1.4571.19 1 61.1569 3966.771 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0492184013128281 5975.03857421875 1196.015 5975.087890625 1196.02478027344 5 15 1.1.1.4576.21 1 61.2869 20380.22 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0234145000576973 5700.9228515625 951.1611 5700.9462890625 951.164978027344 6 15 1.1.1.4584.12 1 61.4829 3070.025 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0631937980651855 5555.86376953125 1112.18 5555.79931640625 1112.16711425781 5 13 1.1.1.4586.13 1 61.5409 108365 61.4448 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@34; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0485933013260365 5589.869140625 932.6521 5589.8203125 932.643981933594 6 14 1.1.1.4587.11 1 61.5581 3419.146 61.5462 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0530139990150929 5540.841796875 792.5561 5540.78857421875 792.548522949219 7 14 1.1.1.4588.8 1 61.5809 4636.531 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0434327982366085 5555.87939453125 926.9872 5555.8359375 926.979919433594 6 16 1.1.1.4591.7 1 61.6559 198349.2 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0468231998383999 5579.8466796875 930.9817 5579.79931640625 930.973876953125 6 14 1.1.1.4597.12 1 61.8124 10849.92 61.7998 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dehydrated(T)@31; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.00134284002706409 5540.8388671875 1109.175 5540.83642578125 1109.17456054688 5 14 1.1.1.4599.18 1 61.868 10522.14 61.8504 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.00190469005610794 5609.81201171875 802.409 5609.81005859375 802.40869140625 7 13 1.1.1.4600.10 1 61.8866 3184.469 61.9773 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.036573801189661 5544.86767578125 925.1519 5544.8310546875 925.145812988281 6 15 1.1.1.4608.16 1 62.0947 7105.319 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0558371990919113 5539.8583984375 1108.979 5539.8046875 1108.96813964844 5 14 1.1.1.4613.18 1 62.2233 9828.981 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 0.0152158001437783 5514.83251953125 920.146 5514.8173828125 920.143493652344 6 13 1.1.1.4615.16 1 62.2722 3698.785 62.3068 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0229515004903078 5975.064453125 996.8514 5975.087890625 996.855224609375 6 14 1.1.1.4617.12 1 62.32 12617.72 62.0535 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 0.00239653000608087 5515.80322265625 1104.168 5515.80126953125 1104.16748046875 5 11 1.1.1.4618.19 1 62.3503 2538.99 62.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0472926013171673 5539.853515625 1108.978 5539.8046875 1108.96813964844 5 13 1.1.1.4620.16 1 62.4007 5949.996 62.4077 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; MDA adduct +62(K)@20; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 0.0182651001960039 5515.81884765625 1104.171 5515.80126953125 1104.16748046875 5 14 1.1.1.4625.14 1 62.5237 2791.607 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0396609008312225 5701.96875 1141.401 5701.93017578125 1141.39331054688 5 15 1.1.1.4625.16 1 62.5271 3964.98 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; Deamidated(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.00920584984123707 5779.96826171875 964.3353 5779.97705078125 964.336791992188 6 14 1.1.1.4629.16 1 62.6255 2860.863 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0347726009786129 5701.96484375 951.3348 5701.93017578125 951.328979492188 6 15 1.1.1.4633.13 1 62.7238 10781.2 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00694556022062898 5779.00048828125 964.174 5778.9931640625 964.172790527344 6 16 1.1.1.4633.14 1 62.7247 3479.153 62.8363 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24 missed K-I@20; missed K-L@40 0.0166056007146835 5514.8369140625 920.1468 5514.8203125 920.14404296875 6 14 1.1.1.4636.6 1 62.7934 3357.982 62.8111 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0343036986887455 5975.05322265625 996.8495 5975.087890625 996.855224609375 6 14 1.1.1.4639.11 1 62.8765 8154.949 62.8363 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0400633998215199 5975.04833984375 1196.017 5975.087890625 1196.02478027344 5 13 1.1.1.4641.20 1 62.9311 6428.713 63.1131 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.051801398396492 5976.03125 997.0125 5976.0830078125 997.021118164063 6 15 1.1.1.4646.14 1 63.0518 15026.54 63.1131 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; HexNAc(N)@34; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.0232635997235775 5988.0595703125 999.0172 5988.0830078125 999.021118164063 6 16 1.1.1.4646.15 1 63.0527 2075.979 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.034340001642704 5542.8486328125 1109.577 5542.8154296875 1109.5703125 5 14 1.1.1.4651.16 1 63.1817 5147.909 63.2136 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.00856280978769064 5609.81884765625 935.9771 5609.81005859375 935.975646972656 6 13 1.1.1.4652.5 1 63.1967 3704.82 63.1384 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; HexNAc(N)@30; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 -0.0804022029042244 5911.91357421875 986.3262 5911.994140625 986.339660644531 6 15 1.1.1.4659.8 1 63.3732 5829.207 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0355050005018711 5701.9658203125 951.3349 5701.93017578125 951.328979492188 6 15 1.1.1.4661.14 1 63.4284 7340.111 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; Deamidated(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0226534996181726 5780 964.3406 5779.97705078125 964.336791992188 6 14 1.1.1.4663.13 1 63.4777 3023.017 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0355149991810322 5572.876953125 929.8201 5572.84130859375 929.814147949219 6 16 1.1.1.4667.5 1 63.5767 6121.76 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0672843009233475 5579.86669921875 798.1311 5579.79931640625 798.121459960938 7 14 1.1.1.4672.5 1 63.6955 3683.552 63.689 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0532601997256279 5542.86865234375 1109.581 5542.8154296875 1109.5703125 5 14 1.1.1.4672.16 1 63.7088 3096.157 63.714 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0120959999039769 5801.046875 967.8484 5801.03515625 967.846435546875 6 16 1.1.1.4679.4 1 63.8713 1454.841 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; Carbamyl(M)@37; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 -0.00114619999658316 5838.02880859375 1168.613 5838.0302734375 1168.61328125 5 13 1.1.1.4680.21 1 63.9081 3621.639 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Hex(N)@30; Deamidated(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.0534222014248371 5911.9296875 986.3289 5911.98291015625 986.337768554688 6 15 1.1.1.4687.10 1 64.0742 5527.155 63.8133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Ammonia-loss(N)@17; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0573314987123013 5541.87890625 1109.383 5541.8203125 1109.37133789063 5 14 1.1.1.4687.12 1 64.0776 2228.876 64.0629 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0570442005991936 5568.88818359375 929.1553 5568.8310546875 929.145812988281 6 15 1.1.1.4688.7 0 64.096 3966.963 64.0878 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(2)C(2)(H)@24; Deamidated(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.00990509986877441 5643.8984375 941.657 5643.88818359375 941.655334472656 6 14 1.1.1.4688.8 1 64.0969 944.9954 64.0129 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0186954997479916 5528.85498046875 922.4831 5528.83642578125 922.47998046875 6 14 1.1.1.4689.10 1 64.1235 5831.651 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0815509036183357 5603.91748046875 801.5669 5603.8359375 801.555236816406 7 13 1.1.1.4691.9 1 64.1728 1546.738 64.2904 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; Deamidated(N)@34; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 -0.123761996626854 5911.96826171875 986.3353 5912.09228515625 986.35595703125 6 13 1.1.1.4694.12 1 64.2522 1662.145 64.2133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@5; acrolein addition +38(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0638832002878189 5568.8837890625 929.1546 5568.81982421875 929.143920898438 6 15 1.1.1.4695.14 1 64.2793 4400.24 64.2133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0652915015816689 5598.90673828125 934.1584 5598.841796875 934.147583007813 6 15 1.1.1.4699.14 1 64.3805 4212.34 64.3916 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(Q)@14; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0672025009989738 5605.88232421875 935.321 5605.81494140625 935.309814453125 6 15 1.1.1.4699.15 1 64.3814 3517.796 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0194278992712498 5528.85546875 922.4832 5528.83642578125 922.47998046875 6 13 1.1.1.4703.10 1 64.4776 2798.411 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0898552983999252 5583.92041015625 931.6607 5583.83056640625 931.645751953125 6 15 1.1.1.4708.14 1 64.6097 69723.3 64.3408 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0560178011655808 5582.90380859375 1117.588 5582.8466796875 1117.57666015625 5 14 1.1.1.4708.20 1 64.6147 57945.57 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0585182011127472 5565.87841796875 928.6537 5565.8203125 928.643981933594 6 14 1.1.1.4709.12 1 64.6342 4107.22 64.5687 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.045583501458168 5582.89208984375 931.4893 5582.8466796875 931.481750488281 6 15 1.1.1.4715.10 1 64.7907 23773.69 64.7522 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0423961989581585 5568.87353515625 929.1529 5568.8310546875 929.145812988281 6 15 1.1.1.4720.10 1 64.9216 2899.058 64.8827 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0557703003287315 5598.89794921875 934.1569 5598.841796875 934.147583007813 6 16 1.1.1.4728.16 1 65.1351 3676.015 64.9621 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(E)@3; acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0684077963232994 5579.86572265625 798.1309 5579.796875 798.121154785156 7 14 1.1.1.4807.9 1 67.1956 755.5637 67.2109 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0405631996691227 5556.8720703125 794.8461 5556.8310546875 794.840270996094 7 12 1.1.1.4860.12 1 68.6192 997.2038 68.632 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0430901013314724 5556.87451171875 927.153 5556.8310546875 927.145812988281 6 20 1.1.1.4872.16 1 68.9475 3073.956 68.9028 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0310054998844862 5556.86181640625 927.1509 5556.8310546875 927.145812988281 6 12 1.1.1.4886.13 1 69.3258 3115.794 69.2289 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0427966006100178 5556.87353515625 1112.382 5556.8310546875 1112.37353515625 5 22 1.1.1.4898.4 1 69.6343 1698.024 69.619 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0474844016134739 5556.87841796875 927.1537 5556.8310546875 927.145812988281 6 27 1.1.1.4899.5 1 69.6557 2815.692 69.6437 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00743693998083472 5556.875 927.1531 5556.86767578125 927.15185546875 6 33 1.1.1.4908.3 1 69.8796 2356.894 69.8907 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0474844016134739 5556.87841796875 927.1537 5556.8310546875 927.145812988281 6 22 1.1.1.4915.5 1 70.0518 1997.102 70.1384 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0459192991256714 5557.8935546875 927.3229 5557.84814453125 927.315307617188 6 23 1.1.1.4922.6 1 70.2285 2185.206 70.264 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0496816001832485 5556.880859375 927.1541 5556.8310546875 927.145812988281 6 22 1.1.1.4944.17 1 70.8065 1936.87 70.8418 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0596005991101265 5557.87158203125 927.3192 5557.8115234375 927.309265136719 6 18 1.1.1.4972.17 1 71.5583 1337.829 71.513 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0339350998401642 5556.86474609375 927.1514 5556.8310546875 927.145812988281 6 10 1.1.1.4979.15 1 71.7441 1362.803 71.701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0346674993634224 5556.8662109375 927.1516 5556.8310546875 927.145812988281 6 12 1.1.1.4986.17 1 71.9343 1459.678 71.8888 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0460195988416672 5556.87646484375 927.1534 5556.8310546875 927.145812988281 6 12 1.1.1.4993.12 1 72.1207 1237.22 72.1334 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0562731996178627 5556.8876953125 927.1552 5556.8310546875 927.145812988281 6 19 1.1.1.5014.18 1 72.6941 1232.51 72.6745 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0328365005552769 5556.86328125 927.1512 5556.8310546875 927.145812988281 6 20 1.1.1.5028.17 1 73.0738 1140.05 73.0284 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0581041015684605 5556.8896484375 927.1555 5556.8310546875 927.145812988281 6 12 1.1.1.5078.15 1 74.4171 1044.808 74.4274 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@34; Oxidation(M)@37; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.0654010027647018 5788.0322265625 965.6793 5787.966796875 965.66845703125 6 13 1.1.1.4549.13 1 60.5781 1626.663 60.5374 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0201660990715027 5573.828125 1115.773 5573.81005859375 1115.76928710938 5 13 1.1.1.4567.20 1 61.0531 32957.57 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; HexNAc(N)@30; Oxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.00431605009362102 5946.00341796875 992.0079 5945.99951171875 992.007202148438 6 14 1.1.1.4575.17 1 61.258 6605.734 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.095565102994442 5539.708984375 792.3943 5539.8046875 792.407958984375 7 12 1.1.1.4581.13 1 61.4073 2181.242 61.4701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0492184013128281 5975.03857421875 1196.015 5975.087890625 1196.02478027344 5 14 1.1.1.4597.19 1 61.8199 18371.05 61.6729 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0319921001791954 5582.87890625 798.5614 5582.8466796875 798.556823730469 7 14 1.1.1.4598.9 1 61.8351 3396.692 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0247923992574215 5579.82373046875 1116.972 5579.79931640625 1116.96716308594 5 13 1.1.1.4603.17 1 61.9687 4780.316 61.9773 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00279928999952972 5587.8583984375 1118.579 5587.8623046875 1118.57971191406 5 14 1.1.1.4610.20 1 62.1487 2524.238 62.1041 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0685423985123634 5800.07177734375 967.6859 5800.00341796875 967.674499511719 6 14 1.1.1.4611.12 1 62.1675 7546.819 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Carbamyl(K)@40 missed K-I@20; missed K-L@40 0.0354440994560719 5800.04833984375 1161.017 5800.0146484375 1161.01013183594 5 11 1.1.1.4624.17 1 62.5003 3069.146 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0784194990992546 5539.8837890625 1108.984 5539.8046875 1108.96813964844 5 11 1.1.1.4627.18 1 62.5766 5963.962 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0449333004653454 5579.84326171875 1116.976 5579.79931640625 1116.96716308594 5 13 1.1.1.4642.11 1 62.9554 3587.654 62.9119 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24 missed K-I@20; missed K-L@40 0.0177041999995708 5514.83837890625 920.147 5514.8203125 920.14404296875 6 13 1.1.1.4643.6 1 62.9698 3377.654 62.8363 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0516468994319439 5579.853515625 1116.978 5579.79931640625 1116.96716308594 5 13 1.1.1.4650.14 1 63.1582 3643.726 63.0629 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0339473001658916 5579.83349609375 1116.974 5579.79931640625 1116.96716308594 5 13 1.1.1.4657.10 1 63.3339 3320.492 63.3392 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.037975799292326 5540.82861328125 1109.173 5540.78857421875 1109.1650390625 5 13 1.1.1.4665.10 1 63.5311 2492.274 63.5147 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@40 missed K-I@20; missed K-L@40 0.0333537012338638 5542.88330078125 1109.584 5542.85205078125 1109.57763671875 5 14 1.1.1.4665.11 1 63.5327 3941.679 63.4143 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0582400001585484 5540.84716796875 924.4818 5540.78857421875 924.472045898438 6 13 1.1.1.4668.7 1 63.5974 5388.757 63.5147 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0616003014147282 5619.892578125 937.656 5619.83056640625 937.645751953125 6 13 1.1.1.4689.12 1 64.126 1176.66 64.2649 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.052234098315239 5599.87841796875 800.9899 5599.82568359375 800.982360839844 7 14 1.1.1.4698.6 1 64.3482 1066.091 64.3408 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0359662994742393 5619.8662109375 937.6517 5619.83056640625 937.645751953125 6 14 1.1.1.4704.10 1 64.5029 1381.982 64.3916 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0818981006741524 5572.908203125 929.8253 5572.826171875 929.811645507813 6 13 1.1.1.4708.13 1 64.6088 2184.738 64.5687 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0510098002851009 5598.89306640625 934.1561 5598.841796875 934.147583007813 6 15 1.1.1.4709.13 1 64.635 4704.505 64.5687 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0549410991370678 5635.88037109375 940.3207 5635.82568359375 940.311584472656 6 14 1.1.1.4718.16 1 64.8733 1023.904 64.7522 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0515835992991924 5583.8837890625 1117.784 5583.83056640625 1117.7734375 5 14 1.1.1.4722.19 1 64.981 28994.87 65.1185 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0634652972221375 5529.84716796875 922.6485 5529.78369140625 922.637939453125 6 13 1.1.1.4742.12 1 65.4987 984.3195 65.3797 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0614784993231297 5610.939453125 936.1639 5610.8779296875 936.153625488281 6 15 1.1.1.4788.15 1 66.694 1550.314 66.6774 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0551746003329754 5556.88671875 927.155 5556.8310546875 927.145812988281 6 8 1.1.1.5050.14 1 73.6595 958.9596 73.6439 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0225830003619194 5556.85302734375 927.1495 5556.8310546875 927.145812988281 6 10 1.1.1.5061.14 1 73.9567 1116.767 73.9139 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dicarbamidomethyl(D)@35; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.0467843003571033 5997.13037109375 1000.529 5997.08349609375 1000.52117919922 6 14 1.1.1.4557.17 1 60.7891 23487.24 60.72 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 -0.00169763003941625 5598.87841796875 1120.783 5598.8779296875 1120.78283691406 5 11 1.1.1.4595.17 1 61.7675 1935.872 61.7998 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0170786995440722 5701.9482421875 1141.397 5701.93017578125 1141.39331054688 5 13 1.1.1.4604.21 1 61.9973 5920.705 62.1041 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24 missed K-I@20; missed K-L@40 0.0279577001929283 5514.8486328125 920.1487 5514.8203125 920.14404296875 6 11 1.1.1.4629.9 1 62.6196 4007.358 62.6095 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HexNAc(N)@17; reduced acrolein addition +58(K)@20; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0694976001977921 5838.02685546875 974.0118 5837.95751953125 974.000183105469 6 14 1.1.1.4665.7 1 63.5261 3793.298 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.0160240996629 5976.04638671875 997.015 5976.06201171875 997.017578125 6 14 1.1.1.4681.10 1 63.9297 7310.551 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0457586012780666 5701.97607421875 951.3366 5701.93017578125 951.328979492188 6 14 1.1.1.4689.13 1 64.1277 6723.915 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(T)@31; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0582193993031979 5572.89990234375 929.8239 5572.84130859375 929.814147949219 6 15 1.1.1.4518.18 1 59.7632 3778.477 59.7974 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0723982006311417 5579.8740234375 1116.982 5579.79931640625 1116.96716308594 5 13 1.1.1.4574.20 1 61.2348 4631.082 61.2409 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; Phospho(T)@31; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 -0.0319163985550404 5912.9375 986.4969 5912.97021484375 986.502258300781 6 14 1.1.1.4651.14 1 63.1783 2924.982 63.3893 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.0230059009045362 5976.03857421875 1196.215 5976.06201171875 1196.21960449219 5 14 1.1.1.4662.7 1 63.4591 10242.55 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@30; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0510366000235081 5579.8486328125 1116.977 5579.79931640625 1116.96716308594 5 12 1.1.1.4664.15 1 63.5078 3081.666 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.00723527977243066 5976.0546875 997.0164 5976.06201171875 997.017578125 6 19 1.1.1.4667.7 1 63.5817 11260.59 63.3642 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.0193198006600142 5976.04296875 997.0144 5976.06201171875 997.017578125 6 17 1.1.1.4674.6 1 63.7585 6610.061 63.689 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0128047997131944 5644.87548828125 941.8198 5644.8623046875 941.817687988281 6 13 1.1.1.4717.16 1 64.8477 1564.133 64.909 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.051503598690033 5572.87744140625 929.8202 5572.826171875 929.811645507813 6 12 1.1.1.4535.19 1 60.2091 20376.48 60.4577 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl(K)@40 missed K-I@20; missed K-L@40 0.0394563004374504 5543.8505859375 792.9859 5543.810546875 792.980224609375 7 13 1.1.1.4567.11 1 61.0456 9228.993 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 -0.0559580996632576 5551.8037109375 1111.368 5551.85888671875 1111.37902832031 5 12 1.1.1.4568.18 1 61.0774 2634.015 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0809168964624405 5555.880859375 926.9874 5555.79931640625 926.973876953125 6 12 1.1.1.4577.10 1 61.3032 195794.2 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0104492995887995 5609.82080078125 802.4102 5609.81005859375 802.40869140625 7 12 1.1.1.4582.9 1 61.4295 2890.819 61.3938 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0475364997982979 5578.86376953125 1116.78 5578.8154296875 1116.77038574219 5 12 1.1.1.4589.21 1 61.6171 4782.734 61.6983 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-I@20; missed K-L@40 0.00285524991340935 5500.80810546875 1101.169 5500.8046875 1101.16821289063 5 11 1.1.1.4595.16 1 61.7659 0 -1 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.000622986990492791 5609.810546875 802.4088 5609.81005859375 802.40869140625 7 12 1.1.1.4608.14 1 62.093 2429.785 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0382248982787132 5609.84814453125 935.982 5609.81005859375 935.975646972656 6 12 1.1.1.4626.16 1 62.5498 4126.284 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.0539973005652428 5839.033203125 1168.814 5838.97802734375 1168.80285644531 5 13 1.1.1.4631.17 1 62.6801 6613.743 62.4836 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0434587001800537 5975.04443359375 996.848 5975.087890625 996.855224609375 6 13 1.1.1.4632.11 1 62.7003 8329.729 62.7106 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.030672000721097 5976.03125 997.0125 5976.06201171875 997.017578125 6 19 1.1.1.4644.10 1 63.0073 15026.54 63.1131 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dehydrated(T)@31; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.063596598803997 5540.8984375 1109.187 5540.83642578125 1109.17456054688 5 11 1.1.1.4648.19 1 63.1062 6104.202 62.8363 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0726028010249138 5541.84326171875 1109.376 5541.7724609375 1109.36181640625 5 13 1.1.1.4656.10 1 63.3089 3640.015 63.3392 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Carbamidomethyl(T)@23; reduced HNE(H)@24; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0157086998224258 5838.0087890625 1168.609 5837.99365234375 1168.60607910156 5 15 1.1.1.4659.15 1 63.384 11597.38 63.3392 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Hex(N)@17; reduced HNE(H)@24; Deamidated(N)@34; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 -0.0171312000602484 5976.0546875 997.0164 5976.07177734375 997.019226074219 6 17 1.1.1.4660.5 1 63.4024 11260.59 63.3642 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@30; Deamidated(N)@34; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0378682017326355 5606.8369140625 935.4801 5606.79931640625 935.473815917969 6 14 1.1.1.4680.9 1 63.8981 1226.744 63.8882 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0422743000090122 5542.8583984375 1109.579 5542.8154296875 1109.5703125 5 12 1.1.1.4680.17 1 63.9047 3066.133 63.8882 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0777553021907806 5582.88818359375 1117.585 5582.810546875 1117.5693359375 5 12 1.1.1.4680.19 1 63.9064 2394.755 63.9133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.000495475018396974 5615.85595703125 936.9833 5615.85693359375 936.983459472656 6 12 1.1.1.4681.8 1 63.9263 1971.878 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0509543009102345 5539.85546875 924.3165 5539.8046875 924.308044433594 6 12 1.1.1.4697.2 1 64.3206 3344.846 64.2133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; reduced acrolein addition +58(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.159027993679047 5561.95751953125 928.0002 5561.798828125 927.973754882813 6 14 1.1.1.4698.8 1 64.3498 5918.2 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.00517641007900238 5634.8466796875 940.1484 5634.841796875 940.147583007813 6 12 1.1.1.4705.7 1 64.5323 1116.12 64.4418 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 0.0318481996655464 5528.86376953125 1106.78 5528.8330078125 1106.77380371094 5 12 1.1.1.4705.8 1 64.5348 948.6374 64.5173 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0510098002851009 5598.89306640625 934.1561 5598.841796875 934.147583007813 6 13 1.1.1.4708.15 1 64.6105 4704.505 64.5687 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.0325030013918877 5976.02978515625 997.0122 5976.06201171875 997.017578125 6 13 1.1.1.4715.17 1 64.7965 1331.017 64.7786 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0603988990187645 5541.8330078125 924.6461 5541.7724609375 924.636047363281 6 13 1.1.1.4731.10 1 65.2081 1068.409 65.1185 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0507711991667748 5572.876953125 929.8201 5572.826171875 929.811645507813 6 12 1.1.1.4738.8 1 65.39 1137.029 65.3797 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0512607991695404 5557.86865234375 1112.581 5557.81494140625 1112.5703125 5 12 1.1.1.4762.19 1 66.0171 4071.081 65.947 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0429158993065357 5527.84765625 922.3152 5527.8046875 922.308044433594 6 10 1.1.1.4805.12 1 67.1454 334.4141 67.106 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.103757001459599 5541.87646484375 792.7039 5541.7724609375 792.689086914063 7 12 1.1.1.4574.11 1 61.2273 8196.521 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0273703001439571 5604.83984375 935.1473 5604.86767578125 935.15185546875 6 13 1.1.1.4600.14 1 61.8899 2223.378 61.9261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@24; Deamidated(N)@34; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.0581482015550137 5772.0302734375 963.0123 5771.97216796875 963.002624511719 6 12 1.1.1.4645.8 1 63.0217 2395.676 63.1885 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.00324394996277988 5636.8544921875 806.2722 5636.857421875 806.272583007813 7 11 1.1.1.4700.8 1 64.4008 686.1884 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0743528008460999 5540.86279296875 924.4844 5540.78857421875 924.472045898438 6 12 1.1.1.4704.7 1 64.5004 3121.711 64.2391 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0545229017734528 5570.8642578125 929.4847 5570.810546875 929.475646972656 6 11 1.1.1.4728.14 1 65.1334 1920.946 65.0927 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Met->Hcy(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0987059995532036 5524.9033203125 921.8245 5524.8046875 921.80810546875 6 13 1.1.1.4515.19 1 59.6837 4181.113 59.7175 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.00829633977264166 5571.8037109375 1115.368 5571.79443359375 1115.3662109375 5 10 1.1.1.4574.19 1 61.234 5573.292 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0482192002236843 5975.03955078125 996.8472 5975.087890625 996.855224609375 6 15 1.1.1.4577.13 1 61.3057 42016.14 61.4701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; Deamidated(N)@34; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 0.0422435998916626 5810.02978515625 969.3456 5809.98779296875 969.338562011719 6 11 1.1.1.4606.13 1 62.0415 3438.15 62.2816 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0433586984872818 5573.853515625 1115.778 5573.81005859375 1115.76928710938 5 12 1.1.1.4609.17 1 62.1226 5230.49 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0332050994038582 5975.05419921875 996.8497 5975.087890625 996.855224609375 6 14 1.1.1.4612.16 1 62.1963 18584.61 61.9261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0364544987678528 5700.98193359375 815.4333 5700.9462890625 815.428161621094 7 12 1.1.1.4618.9 1 62.3419 2640.542 62.3068 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; Deamidated(N)@34; Oxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0562902987003326 5844.04931640625 975.0155 5843.9931640625 975.006164550781 6 12 1.1.1.4623.15 1 62.4733 2569.524 62.3571 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.0539973005652428 5839.033203125 1168.814 5838.97802734375 1168.80285644531 5 12 1.1.1.4624.18 1 62.502 6613.743 62.4836 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.011446500197053 5528.84423828125 922.4813 5528.8330078125 922.479431152344 6 10 1.1.1.4626.11 1 62.5456 19221.69 62.4836 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.064377099275589 5800.068359375 1161.021 5800.00341796875 1161.00793457031 5 13 1.1.1.4631.16 1 62.6784 2577.316 62.6095 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@34; Delta:H(2)C(2)(K)@40 missed K-I@20; missed K-L@40 0.079354003071785 5589.89990234375 932.6572 5589.8203125 932.643981933594 6 13 1.1.1.4661.12 1 63.4267 3269.92 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; Hex(N)@34; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 -0.034570500254631 5975.05322265625 1196.018 5975.087890625 1196.02478027344 5 13 1.1.1.4677.6 1 63.8329 3639.052 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.047120600938797 5975.041015625 996.8474 5975.087890625 996.855224609375 6 9 1.1.1.4678.17 1 63.8547 5508.245 63.8381 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30 missed K-I@20; missed K-L@40 0.0505498014390469 5540.83935546875 924.4805 5540.78857421875 924.472045898438 6 12 1.1.1.4690.6 1 64.1452 4027.334 64.1129 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0169293005019426 5611.845703125 802.6995 5611.8623046875 802.701843261719 7 14 1.1.1.4693.7 1 64.2222 796.2433 64.0129 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; ONE addition +154(K)@20; reduced HNE(H)@24; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 -0.163046002388 5936.96044921875 990.5007 5937.1240234375 990.527893066406 6 14 1.1.1.4693.19 1 64.2322 1530.666 64.2391 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(E)@13; acrolein addition +94(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.05788179859519 5838.08837890625 974.022 5838.0302734375 974.012329101563 6 14 1.1.1.4696.13 1 64.3038 1011.866 64.2904 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Hex(N)@17; HPNE addition +172(K)@20; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.0619462989270687 5936.95263671875 990.4994 5937.0146484375 990.509704589844 6 14 1.1.1.4700.16 1 64.4075 1551.734 64.3157 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0672025009989738 5605.88232421875 935.321 5605.81494140625 935.309814453125 6 13 1.1.1.4706.15 1 64.5584 3517.796 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@40 missed K-I@20; missed K-L@40 0.0678979009389877 5528.86767578125 922.4852 5528.7998046875 922.473937988281 6 12 1.1.1.4712.11 1 64.7125 1664.973 64.7004 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0812499970197678 5569.89306640625 929.3228 5569.8115234375 929.309265136719 6 13 1.1.1.4713.11 1 64.7386 3119.372 64.7786 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Acetyl@N-term; Deamidated(N)@17; acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.0681826993823051 5599.8935546875 934.3229 5599.82568359375 934.311584472656 6 13 1.1.1.4713.12 1 64.7394 3451.915 64.5687 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0768226981163025 5571.87158203125 929.6525 5571.79443359375 929.6396484375 6 12 1.1.1.4721.12 1 64.9493 2530.602 64.909 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@17; reduced acrolein addition +58(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.0611636005342007 5586.8916015625 932.1559 5586.83056640625 932.145690917969 6 13 1.1.1.4728.15 1 65.1342 8583.477 65.0927 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0850235968828201 5557.89990234375 794.993 5557.81494140625 794.980895996094 7 11 1.1.1.4742.8 1 65.4954 2088.213 65.4845 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0561649017035961 5583.88671875 931.6551 5583.83056640625 931.645751953125 6 11 1.1.1.4798.16 1 66.9611 1134.201 66.8902 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0165526997298002 5699.93115234375 950.9958 5699.91455078125 950.993041992188 6 11 1.1.1.4800.16 1 67.0142 1176.179 67.2109 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0764051005244255 5572.90185546875 929.8243 5572.826171875 929.811645507813 6 11 1.1.1.4802.17 1 67.0694 643.0357 67.106 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(E)@3; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0701401978731155 5578.8837890625 930.8212 5578.81298828125 930.809448242188 6 13 1.1.1.4803.16 1 67.0966 3490.147 67.239 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0561433993279934 5557.87353515625 1112.582 5557.81494140625 1112.5703125 5 10 1.1.1.4564.21 1 60.9762 3597.31 60.9814 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.015001299791038 5992.0419921875 999.6809 5992.056640625 999.683410644531 6 13 1.1.1.4566.16 1 61.0238 4038.849 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Dethiomethyl(M)@37; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.0471533983945847 5604.9326171875 935.1627 5604.88525390625 935.154846191406 6 12 1.1.1.4549.12 1 60.5772 1585.269 60.59 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; Deamidated(N)@34; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.02069460041821 5816.0537109375 1164.218 5816.03466796875 1164.21423339844 5 11 1.1.1.4549.21 1 60.5847 16048.24 60.694 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Oxidation(P)@25; Deamidated(N)@30; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0462905988097191 5643.8984375 941.657 5643.85205078125 941.649291992188 6 13 1.1.1.4571.13 1 61.1519 1615.918 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0469366014003754 5800.05029296875 967.6823 5800.00341796875 967.674499511719 6 12 1.1.1.4602.10 1 61.9371 9691.689 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.00427039992064238 5626.9052734375 938.8248 5626.9091796875 938.825500488281 6 12 1.1.1.4647.8 1 63.0719 2237.629 62.9119 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0495720990002155 5540.8388671875 1109.175 5540.78857421875 1109.1650390625 5 11 1.1.1.4679.8 1 63.878 2535.451 63.8633 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Dehydrated(T)@23; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0266721993684769 5568.888671875 1114.785 5568.8642578125 1114.78015136719 5 13 1.1.1.4681.12 1 63.933 2803.604 64.1129 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Delta:H(2)C(2)(H)@24; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.0324317999184132 5606.8134765625 1122.37 5606.8466796875 1122.37658691406 5 13 1.1.1.4694.17 1 64.2563 1377.911 64.2649 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 0.00987624004483223 5528.84375 1106.776 5528.8330078125 1106.77380371094 5 11 1.1.1.4698.15 1 64.359 1834.95 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.088919498026371 5605.90380859375 801.8507 5605.81494140625 801.838012695313 7 13 1.1.1.4699.8 1 64.3755 2399.905 64.3408 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@26; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0428289994597435 5701.97314453125 951.3361 5701.93017578125 951.328979492188 6 13 1.1.1.4702.8 1 64.4564 2759.776 64.1881 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0157658997923136 5528.85205078125 922.4826 5528.83642578125 922.47998046875 6 12 1.1.1.4727.13 1 65.1065 1292.328 65.0927 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0664184987545013 5583.89697265625 931.6568 5583.83056640625 931.645751953125 6 13 1.1.1.4774.14 1 66.3259 1609.937 66.337 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(E)@3; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0701401978731155 5578.8837890625 930.8212 5578.81298828125 930.809448242188 6 12 1.1.1.4810.15 1 67.2826 3490.147 67.239 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Methyl(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.00342856999486685 5580.87060546875 931.1524 5580.86767578125 931.15185546875 6 14 1.1.1.4839.14 1 68.054 1859.744 67.9058 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0821762979030609 5975.00390625 1196.008 5975.087890625 1196.02478027344 5 10 1.1.1.4634.19 1 62.7541 5333.637 62.8111 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Hex(N)@30; Deamidated(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0602760016918182 5838.0087890625 1168.609 5837.9462890625 1168.59655761719 5 13 1.1.1.4638.18 1 62.8565 8578.145 62.9623 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.041482999920845 5701.97119140625 815.5746 5701.93017578125 815.568725585938 7 12 1.1.1.4628.9 1 62.5943 2409.666 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; GlyGlyGln(K)@20; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.0516601987183094 5864.0234375 978.3445 5863.9716796875 978.335876464844 6 14 1.1.1.4697.7 1 64.3289 1382.326 64.3408 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.062577098608017 5610.94091796875 936.1641 5610.8779296875 936.153625488281 6 12 1.1.1.4762.15 1 66.0137 1443.041 66.024 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@40 missed K-I@20; missed K-L@40 0.0239540003240108 5528.82373046875 922.4779 5528.7998046875 922.473937988281 6 9 1.1.1.4815.10 1 67.4107 798.1452 67.5603 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@5; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0681290999054909 5563.87255859375 928.3194 5563.8046875 928.308044433594 6 11 1.1.1.4629.10 1 62.6205 4943.894 62.6095 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0637715011835098 5539.8681640625 1108.981 5539.8046875 1108.96813964844 5 11 1.1.1.4558.19 1 60.8173 7790.049 60.8778 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; MDA adduct +54(K)@20; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0138672003522515 5609.82421875 802.4107 5609.81005859375 802.40869140625 7 10 1.1.1.4575.9 1 61.2513 2997.4 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0425834991037846 5700.9833984375 1141.204 5700.94287109375 1141.19580078125 5 11 1.1.1.4611.19 1 62.1734 4817.855 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0515835992991924 5583.8837890625 1117.784 5583.83056640625 1117.7734375 5 11 1.1.1.4736.20 1 65.3473 28994.87 65.1185 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0412840992212296 5975.04833984375 1196.017 5975.087890625 1196.02478027344 5 12 1.1.1.4627.20 1 62.5791 5353.14 62.4836 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@40 missed K-I@20; missed K-L@40 0.0428908988833427 5528.84375 1106.776 5528.7998046875 1106.76721191406 5 11 1.1.1.4645.14 1 63.0292 10464.44 62.8867 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@24; Deamidated(N)@34; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.0581482015550137 5772.0302734375 963.0123 5771.97216796875 963.002624511719 6 11 1.1.1.4654.10 1 63.2496 2395.676 63.1885 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.088919498026371 5605.90380859375 801.8507 5605.81494140625 801.838012695313 7 12 1.1.1.4707.10 1 64.5802 2403.912 64.3408 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0286196004599333 5529.845703125 922.6482 5529.81689453125 922.643432617188 6 11 1.1.1.4719.13 1 64.8971 1188.004 64.909 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0515835992991924 5583.8837890625 1117.784 5583.83056640625 1117.7734375 5 12 1.1.1.4739.18 1 65.425 27198.77 65.1445 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0664568990468979 5582.9130859375 931.4928 5582.8466796875 931.481750488281 6 10 1.1.1.4748.11 1 65.652 3732.118 65.6656 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0492184013128281 5975.03857421875 1196.015 5975.087890625 1196.02478027344 5 12 1.1.1.4583.21 1 61.4649 25246.39 61.4193 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.140908002853394 5571.93505859375 929.6631 5571.79443359375 929.6396484375 6 11 1.1.1.4780.13 1 66.4814 465.9484 66.4933 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0430901013314724 5556.87451171875 927.153 5556.8310546875 927.145812988281 6 11 1.1.1.4865.13 1 68.7556 4627.244 68.6853 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.026851600036025 5975.1142578125 996.8597 5975.087890625 996.855224609375 6 11 1.1.1.4686.11 1 64.0543 3699.917 63.9879 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Met->Hcy(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0360860005021095 5524.8408203125 921.8141 5524.8046875 921.80810546875 6 12 1.1.1.4502.20 1 59.3392 1123.98 59.3717 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0442362017929554 5800.04833984375 1161.017 5800.00341796875 1161.00793457031 5 12 1.1.1.4594.20 1 61.7431 8977.26 61.6729 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl(K)@20; reduced HNE(H)@24; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.0558441989123821 5800.07080078125 967.6857 5800.0146484375 967.676391601563 6 10 1.1.1.4687.9 1 64.0726 892.4031 64.0129 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0689819008111954 5583.89990234375 931.6572 5583.83056640625 931.645751953125 6 11 1.1.1.4755.11 1 65.8309 4189.338 65.8188 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0191665999591351 5515.82373046875 1104.172 5515.8046875 1104.16821289063 5 12 1.1.1.4570.17 1 61.1292 12590.07 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Dethiomethyl(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0312707014381886 5544.8583984375 1109.979 5544.82763671875 1109.97277832031 5 11 1.1.1.4564.20 1 60.9754 3193.698 60.9555 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0138672003522515 5609.82421875 802.4107 5609.81005859375 802.40869140625 7 9 1.1.1.4576.6 1 61.2744 2997.4 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0461369007825851 5571.83837890625 1115.375 5571.79443359375 1115.3662109375 5 10 1.1.1.4582.19 1 61.4379 3847.822 61.4448 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; Delta:H(2)C(2)(K)@40 missed K-I@20; missed K-L@40 0.048258401453495 5581.86376953125 1117.38 5581.81494140625 1117.37036132813 5 12 1.1.1.4631.14 1 62.6751 2682.532 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.057396300137043 5573.86865234375 1115.781 5573.81005859375 1115.76928710938 5 11 1.1.1.4660.6 1 63.4057 3184.37 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 -0.0173636991530657 5624.87646484375 938.4867 5624.8935546875 938.489562988281 6 9 1.1.1.4704.11 1 64.5038 759.895 64.4921 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0721556022763252 5540.86083984375 924.4841 5540.78857421875 924.472045898438 6 11 1.1.1.4723.13 1 65.0021 2347.304 64.7261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0555444993078709 5557.87060546875 794.9888 5557.81494140625 794.980895996094 7 8 1.1.1.4812.11 1 67.3324 865.538 67.239 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.062389001250267 5540.8486328125 1109.177 5540.78857421875 1109.1650390625 5 11 1.1.1.4633.19 1 62.7288 7402.517 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; Carbamyl(M)@37; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.0110603999346495 5838.03857421875 1168.615 5838.0302734375 1168.61328125 5 11 1.1.1.4687.15 1 64.0826 3405.369 64.0878 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; Oxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0838740020990372 5801.04345703125 1161.216 5800.96240234375 1161.19970703125 5 10 1.1.1.4549.20 1 60.5839 2487.975 60.5374 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@40 missed K-I@20; missed K-L@40 0.0435012988746166 5528.84375 1106.776 5528.7998046875 1106.76721191406 5 11 1.1.1.4577.18 1 61.3099 92586.23 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0495720990002155 5540.8388671875 1109.175 5540.78857421875 1109.1650390625 5 10 1.1.1.4585.16 1 61.5116 9513.003 61.7237 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0261115003377199 5582.87353515625 1117.582 5582.8466796875 1117.57666015625 5 11 1.1.1.4631.15 1 62.6767 2558.679 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.00408565020188689 5976.05859375 1196.219 5976.06201171875 1196.21960449219 5 12 1.1.1.4670.9 1 63.6588 4040.958 63.689 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.7299978733063 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0204907990992069 5701.95068359375 951.3324 5701.93017578125 951.328979492188 6 12 1.1.1.4551.16 1 60.6325 3905.081 60.7716 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.7299978733063 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.0539973005652428 5839.033203125 1168.814 5838.97802734375 1168.80285644531 5 11 1.1.1.4617.16 1 62.3267 6613.743 62.4836 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.7299978733063 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0769390016794205 5540.86572265625 792.5595 5540.78857421875 792.548522949219 7 10 1.1.1.4686.7 1 64.0476 898.2449 64.038 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.7299978733063 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; HexNAc(N)@34; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 -0.0479508005082607 5937.9619140625 990.6676 5938.009765625 990.675598144531 6 13 1.1.1.4695.16 1 64.281 1504.391 64.3157 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.7299978733063 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(E)@3; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.060317400842905 5578.87353515625 1116.782 5578.81298828125 1116.76989746094 5 9 1.1.1.4805.18 1 67.1504 14095.29 67.239 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.5400021076202 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0378299988806248 5701.96875 1141.401 5701.93017578125 1141.39331054688 5 12 1.1.1.4666.10 1 63.5578 2731.997 63.5397 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.3699977397919 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0550846010446548 5556.888671875 1112.385 5556.8310546875 1112.37353515625 5 11 1.1.1.4685.17 1 64.0327 40452.95 63.9879 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.3299970626831 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Hex(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.02968779951334 5975.05859375 1196.019 5975.087890625 1196.02478027344 5 10 1.1.1.4605.21 1 62.0228 11319.26 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.3299970626831 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(E)@13; acrolein addition +94(K)@20; reduced HNE(H)@24; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0547178015112877 5838.048828125 974.0154 5837.99365234375 974.006225585938 6 13 1.1.1.4637.11 1 62.8227 2823.314 62.9875 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.3299970626831 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0227437000721693 5542.83837890625 1109.575 5542.8154296875 1109.5703125 5 11 1.1.1.4641.17 1 62.9286 11199.05 62.8867 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.3299970626831 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.00175227003637701 5637.84326171875 940.6478 5637.84130859375 940.647521972656 6 11 1.1.1.4690.10 1 64.1511 1228.083 64.3408 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; Hex(N)@34; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.00428484985604882 5947.0234375 1190.412 5947.02001953125 1190.41125488281 5 9 1.1.1.4574.21 1 61.2357 8459.154 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.000322984007652849 5512.8134765625 1103.57 5512.8115234375 1103.56958007813 5 11 1.1.1.4579.15 1 61.3598 4545.121 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0422743000090122 5542.8583984375 1109.579 5542.8154296875 1109.5703125 5 11 1.1.1.4582.18 0 61.4371 7516.751 61.4193 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Hex(N)@17; reduced HNE(H)@24; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 -0.0482192002236843 5975.03955078125 996.8472 5975.087890625 996.855224609375 6 14 1.1.1.4591.12 1 61.6642 42016.14 61.4701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0317039005458355 5527.83837890625 1106.575 5527.8046875 1106.56823730469 5 9 1.1.1.4604.19 1 61.9957 4309.946 61.9773 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.0246507991105318 5839.00244140625 974.1744 5838.97802734375 974.170227050781 6 11 1.1.1.4623.14 1 62.4725 2495.234 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.048258401453495 5581.86376953125 1117.38 5581.81494140625 1117.37036132813 5 10 1.1.1.4626.21 1 62.554 2682.532 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.109384998679161 5540.8984375 1109.187 5540.78857421875 1109.1650390625 5 10 1.1.1.4641.16 1 62.9278 5936.2 62.8617 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0348310992121696 5581.84814453125 1117.377 5581.81494140625 1117.37036132813 5 11 1.1.1.4642.12 1 62.9571 3295.632 63.0125 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0726028010249138 5541.84326171875 1109.376 5541.7724609375 1109.36181640625 5 11 1.1.1.4658.14 1 63.3589 3640.015 63.3392 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.033364400267601 5812.037109375 969.6801 5812.00341796875 969.674499511719 6 10 1.1.1.4664.8 1 63.4986 3652.966 63.4644 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@12; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0342026017606258 5603.8701171875 934.9856 5603.8359375 934.979919433594 6 11 1.1.1.4713.13 1 64.7403 1460.065 64.7261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0610261000692844 5557.87841796875 1112.583 5557.81494140625 1112.5703125 5 10 1.1.1.4779.18 1 66.4595 3283.27 66.4933 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0610261000692844 5557.87841796875 1112.583 5557.81494140625 1112.5703125 5 9 1.1.1.4787.19 1 66.6704 3283.27 66.4933 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(E)@3; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.060317400842905 5578.87353515625 1116.782 5578.81298828125 1116.76989746094 5 10 1.1.1.4814.21 1 67.393 14095.29 67.239 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0799973011017 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0445747002959251 5580.87548828125 931.1532 5580.8310546875 931.145812988281 6 10 1.1.1.4817.12 1 67.4664 1572.831 67.5333 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.7999985218048 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Cation:K(D)@35; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 -0.0239741001278162 5947.0234375 1190.412 5947.04833984375 1190.4169921875 5 11 1.1.1.4567.21 1 61.054 8459.154 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.7999985218048 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Hex(N)@30; Deamidated(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.0691687986254692 5911.91357421875 986.3262 5911.98291015625 986.337768554688 6 11 1.1.1.4664.10 1 63.5003 5829.207 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.7999985218048 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Dethiomethyl(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.063331201672554 5570.908203125 1115.189 5570.84326171875 1115.17590332031 5 12 1.1.1.4689.15 1 64.131 2520.742 64.0629 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.7999985218048 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@12; MDA adduct +54(K)@20; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.00513797020539641 5635.83056640625 940.3124 5635.82568359375 940.311584472656 6 11 1.1.1.4698.9 1 64.3507 1595.241 64.366 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.4699974060059 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@34; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.0532680004835129 5625.7666015625 938.6351 5625.8203125 938.643981933594 6 10 1.1.1.4553.19 1 60.687 1732.23 60.694 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.4699974060059 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0155819999054074 5514.8330078125 920.1461 5514.8173828125 920.143493652344 6 9 1.1.1.4685.6 1 64.0202 860.5804 63.9879 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.1000015735626 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0441453009843826 5557.85888671875 927.3171 5557.81494140625 927.309814453125 6 15 1.1.1.4870.15 1 68.8925 2789.215 68.9569 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.1000015735626 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0310054998844862 5556.86181640625 927.1509 5556.8310546875 927.145812988281 6 17 1.1.1.4879.16 1 69.1377 3115.794 69.2289 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0573243983089924 5573.86767578125 929.9852 5573.81005859375 929.975646972656 6 10 1.1.1.4511.19 1 59.5762 3032.167 59.5037 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; Hex(N)@34; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.0330247990787029 5991.0283203125 999.512 5991.0615234375 999.517517089844 6 11 1.1.1.4570.14 1 61.1267 2995.093 61.1112 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; Hex(N)@34; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.00307592004537582 5977.04833984375 1196.417 5977.0458984375 1196.41650390625 5 11 1.1.1.4570.21 1 61.1326 7953.024 61.3684 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.0498866997659206 5512.76123046875 919.8008 5512.8115234375 919.809204101563 6 11 1.1.1.4578.14 1 61.332 8128.62 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.0510494001209736 5975.03857421875 1196.015 5975.087890625 1196.02478027344 5 11 1.1.1.4590.21 1 61.6423 19951.03 61.5717 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0184614006429911 5700.96337890625 1141.2 5700.9462890625 1141.19653320313 5 11 1.1.1.4596.13 1 61.7929 4138.847 62.028 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.00532842986285686 5514.822265625 920.1443 5514.8173828125 920.143493652344 6 9 1.1.1.4607.11 1 62.0652 3301.116 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@34; Delta:H(2)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0467622987926006 5589.8671875 932.6518 5589.8203125 932.643981933594 6 11 1.1.1.4620.9 1 62.3924 3056.683 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; Carbamyl(M)@37; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.00148715998511761 5838.03173828125 974.0126 5838.0302734375 974.012329101563 6 11 1.1.1.4651.13 1 63.1767 3724.323 63.264 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Deamidated(N)@34; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0795421972870827 5702.95751953125 951.5002 5702.8779296875 951.486938476563 6 12 1.1.1.4693.17 1 64.2306 2654.973 64.2133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0503628998994827 5583.87841796875 1117.783 5583.83056640625 1117.7734375 5 10 1.1.1.4750.18 1 65.7092 4169.241 65.717 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0493938997387886 5610.927734375 936.1619 5610.8779296875 936.153625488281 6 12 1.1.1.4763.14 1 66.0387 1599.978 66.1277 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0949171036481857 5583.92333984375 1117.792 5583.83056640625 1117.7734375 5 11 1.1.1.4767.20 1 66.1477 4167.748 65.947 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; Oxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0306444000452757 5901.08154296875 984.5209 5901.05078125 984.515808105469 6 8 1.1.1.4775.16 1 66.3538 539.3227 66.337 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0455265007913113 5571.83837890625 1115.375 5571.79443359375 1115.3662109375 5 8 1.1.1.4809.19 1 67.2587 1204.339 67.239 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 96.1000025272369 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@30; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0413299016654491 5702.95361328125 1141.598 5702.9140625 1141.59008789063 5 11 1.1.1.4659.14 1 63.3824 2549.539 63.5147 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 94.7700023651123 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Dethiomethyl(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.0197458993643522 5544.80859375 925.142 5544.82763671875 925.145263671875 6 10 1.1.1.4521.19 1 59.8435 1015.931 59.7974 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 94.7700023651123 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; Hex(N)@34; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.00654180999845266 5977.0390625 997.1805 5977.0458984375 997.181579589844 6 11 1.1.1.4697.9 1 64.3322 2020.032 64.2133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 94.7700023651123 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0514086000621319 5584.91357421875 1117.99 5584.8623046875 1117.97973632813 5 10 1.1.1.4759.20 1 65.9409 4788.993 65.9982 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 93.9300000667572 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0727647021412849 5540.86376953125 1109.18 5540.78857421875 1109.1650390625 5 9 1.1.1.4704.15 1 64.5104 1511.117 64.7004 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 92.9499983787537 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0344064012169838 5701.96484375 951.3347 5701.93017578125 951.328979492188 6 11 1.1.1.4647.9 1 63.0728 7553.033 62.8867 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 91.7999982833862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0614573992788792 5572.88671875 797.134 5572.826171875 797.125305175781 7 7 1.1.1.4609.6 1 62.1117 3668.029 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 91.7999982833862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0341680012643337 5701.9638671875 1141.4 5701.93017578125 1141.39331054688 5 11 1.1.1.4639.14 1 62.8815 2547.651 62.8363 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 91.7999982833862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0457586012780666 5701.97607421875 951.3366 5701.93017578125 951.328979492188 6 11 1.1.1.4654.9 1 63.2487 5300.033 63.2389 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 91.7999982833862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0666614025831223 5540.853515625 1109.178 5540.78857421875 1109.1650390625 5 9 1.1.1.4687.11 1 64.0759 2194.044 64.1129 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.4699981212616 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; Deamidated(N)@34; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.02069460041821 5816.0537109375 1164.218 5816.03466796875 1164.21423339844 5 8 1.1.1.4556.21 1 60.7663 16048.24 60.694 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.4699981212616 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.107993997633457 5603.9619140625 935.0009 5603.853515625 934.98291015625 6 11 1.1.1.4557.15 1 60.7875 1583.805 60.7977 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.4699981212616 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 0.0104865999892354 5528.84375 1106.776 5528.8330078125 1106.77380371094 5 8 1.1.1.4563.19 1 60.9486 92351.77 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.4699981212616 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 0.000721274991519749 5528.833984375 1106.774 5528.8330078125 1106.77380371094 5 8 1.1.1.4666.8 1 63.5545 4091.66 63.4143 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.4699981212616 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0261240992695093 5626.93505859375 938.8298 5626.9091796875 938.825500488281 6 10 1.1.1.4699.16 1 64.3822 1347.641 64.3157 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.4699981212616 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0438233017921448 5635.90625 940.325 5635.8623046875 940.317626953125 6 7 1.1.1.4743.14 1 65.5261 858.8541 65.4845 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.4699981212616 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0537007004022598 5572.8798828125 929.8206 5572.826171875 929.811645507813 6 8 1.1.1.4824.15 1 67.656 787.6189 67.7204 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.4699981212616 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.0149197997525334 5528.81787109375 922.4769 5528.8330078125 922.479431152344 6 7 1.1.1.4827.14 1 67.7364 484.5503 67.7204 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 90.2599990367889 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.114499002695084 5556.94580078125 927.1649 5556.8310546875 927.145812988281 6 12 1.1.1.5086.13 1 74.6313 961.9913 74.6702 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 89.3700003623962 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0646523013710976 5557.8798828125 927.3206 5557.81494140625 927.309814453125 6 13 1.1.1.4885.16 1 69.301 2306.609 69.1743 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 88.4899973869324 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0789339989423752 5557.8935546875 927.3229 5557.81494140625 927.309814453125 6 13 1.1.1.4929.16 1 70.4086 2185.206 70.264 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 87.610000371933 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.0467519983649254 5556.8779296875 927.1536 5556.8310546875 927.145812988281 6 13 1.1.1.5000.17 1 72.314 1346.149 72.3767 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 87.610000371933 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0946805030107498 5557.91015625 927.3256 5557.81494140625 927.309814453125 6 12 1.1.1.5043.15 1 73.4736 883.1749 73.4837 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 87.1599972248077 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0460718981921673 5539.8486328125 1108.977 5539.8046875 1108.96813964844 5 7 1.1.1.4634.14 1 62.75 6102.31 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 85.1400017738342 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0445975996553898 5637.8857421875 940.6549 5637.84130859375 940.647521972656 6 9 1.1.1.4706.16 1 64.5593 851.1839 64.5946 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 85.1400017738342 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@30; Formyl(K)@40 missed K-I@20; missed K-L@40 0.0634678974747658 5701.95751953125 951.3335 5701.8935546875 951.322937011719 6 10 1.1.1.4709.16 1 64.6375 1206.307 64.5687 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 85.1400017738342 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0158204007893801 5699.9306640625 950.9957 5699.91455078125 950.993041992188 6 8 1.1.1.4815.14 1 67.414 1181.4 67.2109 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 82.8400015830994 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0463640987873077 5585.8935546875 1118.186 5585.8466796875 1118.17651367188 5 10 1.1.1.4603.18 1 61.9695 2816.059 61.9516 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 82.8400015830994 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0917759984731674 5581.90673828125 931.3251 5581.81494140625 931.309814453125 6 8 1.1.1.4786.13 1 66.639 866.3412 66.7308 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 80.4199993610382 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0449209995567799 5556.87646484375 927.1533 5556.8310546875 927.145812988281 6 9 1.1.1.5035.15 1 73.2591 1141.343 73.3229 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 80.2799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0626763999462128 5557.8779296875 794.9898 5557.81494140625 794.980895996094 7 10 1.1.1.4867.11 1 68.8081 690.1263 68.8756 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 80.2799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0855256021022797 5557.900390625 927.324 5557.81494140625 927.309814453125 6 10 1.1.1.5021.20 1 72.8866 1071.877 73.0014 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 80.2600026130676 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0440840981900692 5609.85400390625 935.983 5609.81005859375 935.975646972656 6 8 1.1.1.4691.11 1 64.1745 2144.517 63.9383 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 80.2600026130676 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0675555020570755 5582.9140625 931.493 5582.8466796875 931.481750488281 6 8 1.1.1.4769.13 1 66.1943 1884.642 66.1537 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 70.9100008010864 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; Oxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0680219009518623 5801.02978515625 967.8456 5800.96240234375 967.834289550781 6 8 1.1.1.4694.11 1 64.2513 870.7006 64.0878 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 70.9100008010864 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0708644986152649 5605.8857421875 935.3216 5605.81494140625 935.309814453125 6 9 1.1.1.4734.15 1 65.2906 1723.472 65.0927 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 63.5999977588654 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0186184998601675 5701.943359375 1141.396 5701.9267578125 1141.392578125 5 10 1.1.1.4632.14 1 62.7053 3360.962 62.5844 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 63.5999977588654 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0303722992539406 5700.916015625 951.1599 5700.9462890625 951.164978027344 6 9 1.1.1.4721.13 1 64.9502 817.5488 64.936 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 63.5999977588654 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0154927000403404 5698.94580078125 950.8316 5698.9306640625 950.829040527344 6 8 1.1.1.4782.13 1 66.5339 1026.289 66.4154 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 63.5999977588654 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Deamidated(N)@30; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0770990997552872 5573.8876953125 929.9885 5573.81005859375 929.975646972656 6 8 1.1.1.4851.16 1 68.3794 316.282 68.3349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 53.7599980831146 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.100539997220039 5557.9150390625 927.3265 5557.81494140625 927.309814453125 6 9 1.1.1.5054.17 1 73.7699 788.6309 73.7243 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 47.6099997758865 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0846322998404503 5581.89990234375 931.3239 5581.81494140625 931.309814453125 6 8 1.1.1.4890.11 1 69.4315 700.9533 69.3377 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 44.8000013828278 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dioxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0502661988139153 5588.86865234375 1118.781 5588.82080078125 1118.771484375 5 9 1.1.1.4551.19 1 60.635 2663.441 60.4845 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 44.8000013828278 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.0868597999215126 5527.8916015625 922.3225 5527.8046875 922.308044433594 6 9 1.1.1.4554.11 1 60.7064 1910.39 60.4577 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 44.3899989128113 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0869902968406677 5557.90185546875 927.3243 5557.81494140625 927.309814453125 6 9 1.1.1.5069.16 1 74.1747 975.9484 74.049 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 41.3700014352798 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@26; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0527864992618561 5585.8935546875 1118.186 5585.84326171875 1118.17590332031 5 10 1.1.1.4713.19 1 64.7453 6825.454 64.7786 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 38.1399989128113 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0363151989877224 5530.85205078125 922.8159 5530.8154296875 922.809875488281 6 10 1.1.1.4735.12 1 65.3142 838.6472 65.3797 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 35.1000010967255 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.0546328015625477 5542.8701171875 792.8459 5542.8154296875 792.838073730469 7 7 1.1.1.4661.8 1 63.4234 1911.555 63.3642 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 32.480001449585 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.047723300755024 5557.86279296875 794.9877 5557.81494140625 794.980895996094 7 7 1.1.1.4961.15 1 71.2608 353.0931 71.1092 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 27.0799994468689 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +38(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.0634846016764641 5565.88330078125 1114.184 5565.8203125 1114.17126464844 5 9 1.1.1.4712.19 1 64.7192 2567.525 64.6469 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 27.0799994468689 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.0804238021373749 5581.8955078125 931.3232 5581.81494140625 931.309814453125 6 8 1.1.1.4778.14 1 66.43 1018.188 66.3894 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 27.0799994468689 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.0235217995941639 5584.8857421875 931.8216 5584.8623046875 931.817687988281 6 7 1.1.1.4815.11 1 67.4115 1109.399 67.239 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 26.5399992465973 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.0270099006593227 5610.81494140625 936.1431 5610.841796875 936.147583007813 6 11 1.1.1.4553.18 1 60.6862 1436.812 60.6681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 26.5399992465973 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.0218838006258011 5817.0283203125 1164.413 5817.0087890625 1164.40905761719 5 10 1.1.1.4569.21 1 61.1059 1642.534 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 26.5399992465973 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20 missed K-I@20; missed K-L@40 0.00683540012687445 5672.92138671875 946.4942 5672.9150390625 946.493103027344 6 11 1.1.1.4571.15 1 61.1535 3010.431 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 26.5399992465973 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.0206946991384029 5608.8056640625 935.8082 5608.826171875 935.811645507813 6 11 1.1.1.4583.13 1 61.4582 3957.482 61.2665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 26.5399992465973 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.0225201994180679 5811.01904296875 1163.211 5810.998046875 1163.20690917969 5 11 1.1.1.4621.9 1 62.4277 2443.432 62.4581 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 26.5399992465973 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.02905029989779 5592.8017578125 933.1409 5592.8310546875 933.145812988281 6 11 1.1.1.4695.15 1 64.2801 1065.532 64.2649 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 26.5399992465973 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0453193001449108 5556.87890625 1112.383 5556.8310546875 1112.37353515625 5 11 1.1.1.4713.18 1 64.7444 12660.98 64.6737 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 26.5399992465973 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0245831999927759 5672.9384765625 1135.595 5672.9150390625 1135.59020996094 5 10 1.1.1.4725.21 1 65.0608 6658.268 65.1445 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 26.5399992465973 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0270245000720024 5672.943359375 1135.596 5672.9150390625 1135.59020996094 5 10 1.1.1.4746.21 1 65.6088 6414.525 65.3534 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 25.33999979496 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.0587324015796185 5579.85791015625 930.9836 5579.79931640625 930.973876953125 6 7 1.1.1.4856.17 1 68.5155 638.1021 68.5241 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 22.409999370575 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.0181131009012461 5594.82861328125 1119.973 5594.8466796875 1119.97668457031 5 10 1.1.1.4554.17 1 60.7114 1724.476 60.694 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 22.409999370575 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0119936997070909 5614.884765625 936.8214 5614.873046875 936.819458007813 6 11 1.1.1.4568.13 1 61.0732 4918.006 61.1378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 22.409999370575 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.0284148994833231 5613.86865234375 1123.781 5613.84130859375 1123.77551269531 5 11 1.1.1.4579.17 1 61.3631 2527.776 61.1638 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 22.409999370575 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0368070006370544 5572.86328125 1115.58 5572.826171875 1115.57250976563 5 11 1.1.1.4617.14 1 62.3234 5136.836 62.1548 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 22.409999370575 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.0422999002039433 5572.86865234375 1115.581 5572.826171875 1115.57250976563 5 11 1.1.1.4647.17 1 63.0811 3809.265 62.9372 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 21.3699996471405 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.0363587997853756 5819.060546875 970.8507 5819.0244140625 970.844665527344 6 11 1.1.1.4575.16 1 61.2571 2319 61.0851 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 21.3699996471405 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17 missed K-I@20; missed K-L@40 0.027717100456357 5501.818359375 1101.371 5501.7890625 1101.36511230469 5 11 1.1.1.4605.18 1 62.0203 4090.216 62.1295 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 18.5699999332428 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.0154080996289849 5597.8623046875 933.9843 5597.8466796875 933.981689453125 6 11 1.1.1.4557.14 1 60.7866 3661.24 60.6681 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 18.3699995279312 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; Deamidated(N)@34; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.00855263974517584 5812.013671875 1163.41 5812.00341796875 1163.40795898438 5 7 1.1.1.4645.15 1 63.0309 2081.411 62.8363 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 17.7200004458427 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.0184799004346132 5672.93359375 1135.594 5672.9150390625 1135.59020996094 5 10 1.1.1.4739.21 1 65.4275 6375.357 65.3534 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 41.3700014352798 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLP acrolein addition +112(K)@20; acrolein addition +112(K)@40; Deamidated(N)@48 cleaved P-R@C-term; missed K-I@20; missed K-L@40; missed R-V@50 -0.0858509987592697 6393.19677734375 1066.54 6393.2841796875 1066.5546875 6 10 1.1.1.4576.18 1 61.2844 2983.364 61.3684 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 89.7300004959106 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR acrolein addition +112(K)@40; Arg->GluSA(R)@58 missed K-I@20; missed K-L@40; missed R-V@50 -0.0970844030380249 6393.19677734375 1066.54 6393.29541015625 1066.55651855469 6 11 1.1.1.4576.18 1 61.2844 2983.364 61.3684 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LSSPATLNSR -0.00213735993020236 1044.55432128906 523.2844 1044.55639648438 523.285461425781 2 15 1.1.1.3148.4 1 25.0584 461581.5 25.2378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LSSPATLNSR -0.00213735993020236 1044.55432128906 523.2844 1044.55639648438 523.285461425781 2 17 1.1.1.3155.4 1 25.2283 463052.6 25.2378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LSSPATLNSR -0.00213735993020236 1044.55432128906 523.2844 1044.55639648438 523.285461425781 2 11 1.1.1.3164.14 1 25.4462 463052.6 25.2378 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LSSPATLNSR Deamidated(N)@8 -0.00216698995791376 1045.53833007813 523.7764 1045.54040527344 523.777465820313 2 15 1.1.1.3172.7 1 25.6478 11122.5 25.68 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 LSSPATLNSR -0.00286975991912186 1044.5537109375 523.2841 1044.55639648438 523.285461425781 2 8 1.1.1.3125.7 1 24.4972 436.3034 24.5336 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.6599981784821 LSSPATLNSR Acetyl@N-term 0.00181760999839753 1086.56872558594 544.2916 1086.56689453125 544.290771484375 2 12 1.1.1.3280.10 1 28.2676 1542.355 28.2549 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.759997844696 LSSPATLNSR Delta:H(2)C(2)@N-term -0.00337973004207015 1070.56872558594 536.2916 1070.57202148438 536.293273925781 2 11 1.1.1.3233.9 1 27.1183 2384.132 27.1269 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.409999370575 LSSPATLNSR Delta:H(2)C(2)@N-term 0.00125883996952325 1070.5732421875 536.2939 1070.57202148438 536.293273925781 2 10 1.1.1.3240.8 1 27.2878 1595.692 27.2736 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 89.0100002288818 LSSPATLNSR Delta:H(2)C(2)@N-term -0.00569901010021567 1070.56652832031 536.2905 1070.57202148438 536.293273925781 2 10 1.1.1.3226.5 1 26.9437 2246.239 27.0044 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 86.3200008869171 LSSPATLNSR Delta:H(2)C(2)@N-term -0.00337973004207015 1070.56872558594 536.2916 1070.57202148438 536.293273925781 2 7 1.1.1.3254.7 1 27.6282 593.5453 27.5667 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 81.7600011825562 LSSPATLNSR Dioxidation(P)@4 -0.00431045982986689 1076.54187011719 539.2782 1076.54614257813 539.280395507813 2 9 1.1.1.3153.8 1 25.179 1072.787 25.2621 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 52.7899980545044 LSSPATLNSR -0.00311390007846057 1044.55322265625 523.2839 1044.55639648438 523.285461425781 2 9 1.1.1.3141.8 1 24.8906 50262.77 25.1163 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 28.0000001192093 LSSPATLNSR -0.0087289996445179 1044.54772949219 523.2811 1044.55639648438 523.285461425781 2 5 1.1.1.3100.11 1 23.862 866.9204 23.7514 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 87.1599972248077 NFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@15 cleaved P-N@N-term; missed K-L@15 -0.0155586004257202 2845.44873046875 949.4902 2845.46435546875 949.495422363281 3 7 1.1.1.4693.16 1 64.2297 550.9008 64.2649 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 85.1400017738342 NFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@9; acrolein addition +38(K)@15 cleaved P-N@N-term; missed K-L@15 0.0176336001604795 2786.40844726563 697.6094 2786.39086914063 697.60498046875 4 9 1.1.1.4555.9 1 60.7305 2598.201 60.72 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN Deamidated(N)@1; acrolein addition +112(K)@2; MDA adduct +62(K)@8; Carbamidomethyl(C)@10 missed K-V@8 -0.0121665997430682 2855.3828125 952.8016 2855.39526367188 952.8056640625 3 12 1.1.1.4756.15 1 65.8598 5918.597 65.8701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN Delta:H(4)C(2)(K)@8; Carbamidomethyl(C)@10 missed K-V@8 -0.00423851981759071 2708.37036132813 903.7974 2708.37451171875 903.798767089844 3 14 1.1.1.4404.16 1 56.7764 4696.661 56.7599 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN Deamidated(N)@1; acrolein addition +112(K)@2; MDA adduct +62(K)@8; Carbamidomethyl(C)@10 missed K-V@8 -0.0121665997430682 2855.3828125 952.8016 2855.39526367188 952.8056640625 3 10 1.1.1.4763.16 1 66.0404 5918.597 65.8701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.8900005817413 NKPGVYTKVCNYVNWIQQTIAAN acrolein addition +94(K)@2; acrolein addition +38(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 -0.0207559000700712 2813.36376953125 938.7952 2813.384765625 938.802185058594 3 10 1.1.1.4565.14 1 60.9963 8468.575 60.9814 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.3299970626831 NKPGVYTKVCNYVNWIQQTIAAN Formyl@N-term; MDA adduct +54(K)@2; acrolein addition +94(K)@8; Carbamidomethyl(C)@10 missed K-V@8 -0.0144667001441121 2856.3759765625 953.1326 2856.39038085938 953.137451171875 3 10 1.1.1.4781.16 1 66.5103 2339.101 66.337 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.079998254776 NKPGVYTKVCNYVNWIQQTIAAN Deamidated(N)@1; acrolein addition +112(K)@2; MDA adduct +62(K)@8; Carbamidomethyl(C)@10 missed K-V@8 -0.0205892007797956 2855.37475585938 952.7988 2855.39526367188 952.8056640625 3 8 1.1.1.4801.15 1 67.0401 1273.086 66.9433 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 85.1400017738342 NKPGVYTKVCNYVNWIQQTIAAN MDA adduct +62(K)@2; acrolein addition +112(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 -0.0191243998706341 2855.37622070313 952.7993 2855.39526367188 952.8056640625 3 8 1.1.1.4742.14 1 65.5004 6110.874 65.5889 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 70.9100008010864 NKPGVYTKVCNYVNWIQQTIAAN Deamidated(N)@1; acrolein addition +112(K)@2; MDA adduct +62(K)@8; Carbamidomethyl(C)@10 missed K-V@8 -0.012932900339365 2855.38208007813 714.8528 2855.39526367188 714.856079101563 4 6 1.1.1.4770.5 1 66.2139 904.5759 66.1801 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 67.330002784729 NKPGVYTKVCNYVNWIQQTIAAN MDA adduct +62(K)@2; acrolein addition +112(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 -0.0127159003168344 2855.3828125 952.8015 2855.39526367188 952.8056640625 3 8 1.1.1.4727.16 1 65.109 8307.94 65.04 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 27.0799994468689 NKPGVYTKVCNYVNWIQQTIAAN acrolein addition +56(K)@2; acrolein addition +76(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 -0.0216316003352404 2813.36303710938 704.348 2813.384765625 704.353454589844 4 7 1.1.1.4558.5 1 60.8056 2314.527 60.8242 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 85.1400017738342 PNFNGNTLDNDIMLIKLSSPATLNSR cleaved H-P@N-term; missed K-L@16 0.0283725000917912 2844.47216796875 949.1647 2844.44409179688 949.1552734375 3 8 1.1.1.4630.13 1 62.6483 1097.469 62.6349 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 80.2600026130676 PNFNGNTLDNDIMLIKLSSPATLNSR cleaved H-P@N-term; missed K-L@16 -0.00513467006385326 2844.43896484375 949.1536 2844.44409179688 949.1552734375 3 7 1.1.1.4745.13 1 65.5769 514.4114 65.4584 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; MDA adduct +62(K)@23; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 -0.0244046002626419 5975.03955078125 996.8472 5975.06396484375 996.851257324219 6 17 1.1.1.4577.13 1 61.3057 42016.14 61.4701 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@23; Deamidated(N)@33; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 -0.00939041003584862 5975.05419921875 996.8497 5975.06396484375 996.851257324219 6 16 1.1.1.4612.16 1 62.1963 18584.61 61.9261 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; MDA adduct +62(K)@23; Deamidated(N)@31; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 -0.0167532991617918 5976.03125 997.0125 5976.0478515625 997.015258789063 6 20 1.1.1.4644.10 1 63.0073 15026.54 63.1131 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; MDA adduct +62(K)@23; Deamidated(N)@33; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.0066834301687777 5976.0546875 997.0164 5976.0478515625 997.015258789063 6 18 1.1.1.4660.5 1 63.4024 11260.59 63.3642 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@23; Deamidated(N)@29; Deamidated(N)@33; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.0066834301687777 5976.0546875 997.0164 5976.0478515625 997.015258789063 6 20 1.1.1.4667.7 1 63.5817 11260.59 63.3642 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; MDA adduct +62(K)@23; Deamidated(N)@31; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 -0.00540114007890224 5976.04296875 997.0144 5976.0478515625 997.015258789063 6 18 1.1.1.4674.6 1 63.7585 6610.061 63.689 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Gln->pyro-Glu@N-term; acrolein addition +56(K)@23; Delta:H(2)C(2)(H)@27; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 -0.040242001414299 5977.0390625 997.1805 5977.07958984375 997.187194824219 6 15 1.1.1.4697.9 1 64.3322 2020.032 64.2133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.8900005817413 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Gln->pyro-Glu@N-term; reduced HNE(H)@7; Deamidated(N)@20; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.0311325006186962 6054.1845703125 1010.038 6054.15234375 1010.03271484375 6 14 1.1.1.4662.4 1 63.4499 4590.83 63.4896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.6400008201599 SCAAAGTECLISGWGNTK Delta:H(4)C(2)@N-term; Carbamidomethyl(C)@2; Carbamidomethyl(C)@9; Delta:H(4)C(2)(K)@18 -0.00930063985288143 1937.88806152344 646.97 1937.89758300781 646.97314453125 3 15 1.1.1.3938.11 1 44.8503 25929.63 44.7865 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 96.2100028991699 SCAAAGTECLISGWGNTK Delta:H(4)C(2)@N-term; Carbamidomethyl(C)@2; Carbamidomethyl(C)@9; Delta:H(4)C(2)(K)@18 0.00900947954505682 1937.90637207031 646.9761 1937.89758300781 646.97314453125 3 11 1.1.1.3967.12 1 45.5876 1857.324 45.4985 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 92.1999990940094 SCAAAGTECLISGWGNTK Delta:H(4)C(2)@N-term; Carbamidomethyl(C)@2; Carbamidomethyl(C)@9; Delta:H(4)C(2)(K)@18 -0.00930063985288143 1937.88806152344 646.97 1937.89758300781 646.97314453125 3 13 1.1.1.3945.10 1 45.0243 26480.95 44.7865 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 22.6400002837181 SQWVVSAAHCYKSRIQVRLGEHNIDVLEGNEQFINAAK Carbamidomethyl(C)@10 cleaved N-S@N-term; missed K-S@12; missed R-I@14; missed R-L@18 -0.0625621974468231 4366.138671875 1092.542 4366.203125 1092.55798339844 4 8 1.1.1.3908.19 1 44.0976 1746.038 44.1045 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 80.5800020694733 SRIQVRLGEHNIDVLEGNEQFINAAK Cation:Na(E)@9; Deamidated(N)@11 missed R-I@2; missed R-L@6 0.0182590000331402 2972.5263671875 991.8494 2972.50805664063 991.84326171875 3 11 1.1.1.3887.21 1 43.5683 11788.47 43.4468 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 82.5600028038025 TLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@10 cleaved N-T@N-term; missed K-L@10 -0.00518104992806911 2229.19946289063 1115.607 2229.20385742188 1115.60925292969 2 8 1.1.1.4188.18 1 51.2547 2115.545 51.2623 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 VATVSLPR -0.000789177021943033 841.50146484375 421.758 841.502136230469 421.758361816406 2 9 1.1.1.3510.3 1 33.9475 2042.808 33.9432 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 VATVSLPR 0.000858738028910011 841.503051757813 421.7588 841.502136230469 421.758361816406 2 9 1.1.1.3534.2 1 34.538 2212.477 34.5337 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 VATVSLPR -0.00139951996970922 841.500854492188 421.7577 841.502136230469 421.758361816406 2 8 1.1.1.3556.4 1 35.0785 2357.658 35.1479 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 VATVSLPR -0.00493948021903634 841.497253417969 421.7559 841.502136230469 421.758361816406 2 8 1.1.1.3489.2 1 33.4271 3830.623 33.2999 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 VATVSLPR -0.00299760000780225 841.499267578125 421.7569 841.502136230469 421.758361816406 2 5 1.1.1.5055.3 1 73.7854 262.4717 73.7514 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 VATVSLPR Formyl@N-term 0.00168342003598809 869.498901367188 435.7567 869.4970703125 435.755798339844 2 11 1.1.1.3727.4 1 39.4382 2149.456 39.4576 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 VATVSLPR Dehydrated(T)@3 -0.00443569989874959 823.487243652344 412.7509 823.491577148438 412.753082275391 2 8 1.1.1.3349.2 1 29.9598 5136.7 29.7106 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 VATVSLPR Oxidation(P)@7 -0.00360962003469467 857.493469238281 429.754 857.4970703125 429.755798339844 2 12 1.1.1.3319.3 1 29.2248 14287.06 29.145 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 VATVSLPR Delta:H(2)C(2)@N-term 0.000405141006922349 867.518249511719 434.7664 867.517822265625 434.766174316406 2 10 1.1.1.3554.2 1 35.0275 30093.27 35.2754 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 99.0000009536743 VATVSLPR -0.000972278008703142 841.501281738281 421.7579 841.502136230469 421.758361816406 2 9 1.1.1.3446.3 1 32.3675 6734.91 32.3877 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.6599981784821 VATVSLPR Oxidation(P)@7 -0.00360962003469467 857.493469238281 429.754 857.4970703125 429.755798339844 2 10 1.1.1.3305.6 0 28.881 15059.77 29.0466 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.2100009918213 VATVSLPR Delta:H(2)C(2)@N-term -0.00302073010243475 867.514892578125 434.7647 867.517822265625 434.766174316406 2 10 1.1.1.3778.2 1 40.7443 6061.282 40.8142 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 98.0599999427795 VATVSLPR Dehydrated(T)@3 -0.00321502005681396 823.488464355469 412.7515 823.491577148438 412.753082275391 2 10 1.1.1.3321.4 1 29.2733 74052.62 29.145 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.9600012302399 VATVSLPR 0.00183527998160571 841.504089355469 421.7593 841.502136230469 421.758361816406 2 8 1.1.1.3520.2 1 34.1939 1960.061 34.165 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.9200005531311 VATVSLPR Dehydrated(T)@3 -0.00144503999035805 823.490051269531 412.7523 823.491577148438 412.753082275391 2 10 1.1.1.3307.5 1 28.9298 72979.7 29.1203 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.759997844696 VATVSLPR Oxidation(P)@7 -0.00360962003469467 857.493469238281 429.754 857.4970703125 429.755798339844 2 11 1.1.1.3312.3 1 29.0509 15059.77 29.0466 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.759997844696 VATVSLPR Dehydrated(T)@3 -0.00321502005681396 823.488464355469 412.7515 823.491577148438 412.753082275391 2 10 1.1.1.3314.4 1 29.1009 74052.62 29.145 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.759997844696 VATVSLPR Delta:H(4)C(2)@N-term -0.000456373003544286 869.533081054688 435.7738 869.533447265625 435.774017333984 2 12 1.1.1.3378.4 1 30.6802 1586033 30.6749 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.759997844696 VATVSLPR Delta:H(4)C(2)@N-term -0.000456373003544286 869.533081054688 435.7738 869.533447265625 435.774017333984 2 12 1.1.1.3385.3 1 30.8522 1586033 30.6749 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.759997844696 VATVSLPR Delta:H(4)C(2)@N-term -0.00283669005148113 869.530700683594 435.7726 869.533447265625 435.774017333984 2 12 1.1.1.3413.3 1 31.5429 51482.98 31.2915 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.759997844696 VATVSLPR Delta:H(2)C(2)@N-term 0.000405141006922349 867.518249511719 434.7664 867.517822265625 434.766174316406 2 11 1.1.1.3561.5 1 35.2054 41709.73 35.3796 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.759997844696 VATVSLPR Delta:H(2)C(2)@N-term 0.000405141006922349 867.518249511719 434.7664 867.517822265625 434.766174316406 2 12 1.1.1.3568.3 1 35.3855 41709.73 35.3796 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.759997844696 VATVSLPR Delta:H(2)C(2)@N-term 0.000405141006922349 867.518249511719 434.7664 867.517822265625 434.766174316406 2 10 1.1.1.3575.3 1 35.5691 41709.73 35.3796 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.759997844696 VATVSLPR Delta:H(2)C(2)@N-term 0.00101548002567142 867.518859863281 434.7667 867.517822265625 434.766174316406 2 10 1.1.1.3589.3 1 35.9302 19490.98 36.1796 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.7400004863739 VATVSLPR Formyl@N-term 0.00186652003321797 869.498901367188 435.7567 869.4970703125 435.755798339844 2 7 1.1.1.3720.4 1 39.2557 2159.194 39.5104 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.5899994373322 VATVSLPR Dehydrated(T)@3 -0.00321502005681396 823.488464355469 412.7515 823.491577148438 412.753082275391 2 10 1.1.1.3328.2 1 29.4469 68388.78 29.1942 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.409999370575 VATVSLPR Formyl@N-term 0.0355019010603428 869.532653808594 435.7736 869.4970703125 435.755798339844 2 11 1.1.1.3462.3 1 32.764 9884.766 32.6844 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.409999370575 VATVSLPR Delta:H(2)C(2)@N-term 0.000649277004413307 867.518493652344 434.7665 867.517822265625 434.766174316406 2 9 1.1.1.3582.6 1 35.7553 29894.73 35.4843 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 97.1300005912781 VATVSLPR -0.0140704000368714 841.488098144531 421.7513 841.502136230469 421.758361816406 2 6 1.1.1.3796.2 1 41.1889 1883.955 41.1852 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 96.5499997138977 VATVSLPR Delta:H(4)C(2)@N-term -0.000883609987795353 869.532653808594 435.7736 869.533447265625 435.774017333984 2 10 1.1.1.3420.5 1 31.7148 41329.25 31.7088 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 96.5499997138977 VATVSLPR Delta:H(2)C(2)@N-term 0.000649277004413307 867.518493652344 434.7665 867.517822265625 434.766174316406 2 11 1.1.1.3603.3 1 36.2872 28494.72 36.282 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 96.2999999523163 VATVSLPR Formyl@N-term 0.0355019010603428 869.532653808594 435.7736 869.4970703125 435.755798339844 2 9 1.1.1.3448.4 1 32.4188 48116.78 32.1647 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 96.0200011730194 VATVSLPR Delta:H(4)C(2)@N-term; Oxidation(P)@7 -0.00590679980814457 885.5224609375 443.7685 885.528381347656 443.771453857422 2 11 1.1.1.3376.7 1 30.6333 13322.96 30.7243 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 95.4100012779236 VATVSLPR Delta:H(4)C(2)@N-term -0.000639474019408226 869.532897949219 435.7737 869.533447265625 435.774017333984 2 10 1.1.1.3441.5 1 32.2453 80948.56 32.1139 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 95.4100012779236 VATVSLPR Delta:H(2)C(2)@N-term 0.00345683004707098 867.521301269531 434.7679 867.517822265625 434.766174316406 2 10 1.1.1.3617.2 1 36.6407 19705.09 36.3845 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 95.0100004673004 VATVSLPR -0.0136431995779276 841.488464355469 421.7515 841.502136230469 421.758361816406 2 6 1.1.1.3788.2 1 40.9912 1691.572 41.0616 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 94.7000026702881 VATVSLPR Delta:H(4)C(2)@N-term -0.000883609987795353 869.532653808594 435.7736 869.533447265625 435.774017333984 2 11 1.1.1.3399.3 1 31.1993 192327.2 30.9466 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 94.3000018596649 VATVSLPR Pro->pyro-Glu(P)@7 -0.00293151009827852 855.478454589844 428.7465 855.4814453125 428.747985839844 2 11 1.1.1.3307.6 1 28.9315 28555.67 29.0712 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 94.0199971199036 VATVSLPR -0.0132769998162985 841.488891601563 421.7517 841.502136230469 421.758361816406 2 6 1.1.1.3817.2 1 41.7306 1578.207 41.6991 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 93.8700020313263 VATVSLPR Pro->pyro-Glu(P)@7 -0.00335874990560114 855.478088378906 428.7463 855.4814453125 428.747985839844 2 11 1.1.1.3328.3 1 29.4511 25002.62 29.1942 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 93.4099972248077 VATVSLPR Delta:H(4)C(2)@N-term -0.00186015001963824 869.531677246094 435.7731 869.533447265625 435.774017333984 2 11 1.1.1.3392.3 1 31.0251 987288.4 30.7736 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 93.4099972248077 VATVSLPR Delta:H(4)C(2)@N-term -0.000639474019408226 869.532897949219 435.7737 869.533447265625 435.774017333984 2 10 1.1.1.3427.7 1 31.8918 80699.85 32.0882 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 93.4099972248077 VATVSLPR Delta:H(4)C(2)@N-term -0.000456373003544286 869.533081054688 435.7738 869.533447265625 435.774017333984 2 9 1.1.1.3469.4 1 32.9379 12407.9 33.1273 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 93.4099972248077 VATVSLPR Delta:H(2)C(2)@N-term 0.000649277004413307 867.518493652344 434.7665 867.517822265625 434.766174316406 2 10 1.1.1.3596.3 1 36.1078 28494.72 36.282 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 93.0800020694733 VATVSLPR -0.00298639992251992 841.499267578125 421.7569 841.502136230469 421.758361816406 2 7 1.1.1.3601.3 1 36.2362 1518.053 36.2052 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 92.9099977016449 VATVSLPR Delta:H(2)C(2)@N-term 0.000649277004413307 867.518493652344 434.7665 867.517822265625 434.766174316406 2 10 1.1.1.3610.6 1 36.4707 28494.72 36.282 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 92.1999990940094 VATVSLPR Delta:H(2)C(2)@N-term -0.00143385003320873 867.516479492188 434.7655 867.517822265625 434.766174316406 2 8 1.1.1.3792.2 1 41.0907 5405.281 40.8391 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 88.0200028419495 VATVSLPR Delta:H(2)C(2)@N-term -0.00302073010243475 867.514892578125 434.7647 867.517822265625 434.766174316406 2 7 1.1.1.3785.4 1 40.9187 6061.282 40.8142 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 87.279999256134 VATVSLPR Dehydrated(T)@3 -0.00425260001793504 823.487243652344 412.7509 823.491577148438 412.753082275391 2 6 1.1.1.3335.2 1 29.6154 35074.11 29.3665 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 87.279999256134 VATVSLPR Delta:H(4)C(2)@N-term -0.000456373003544286 869.533081054688 435.7738 869.533447265625 435.774017333984 2 9 1.1.1.3371.7 1 30.5093 1586033 30.6749 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 84.1899991035461 VATVSLPR Deamidated(R)@8 0.0221931003034115 842.50830078125 422.2614 842.486145019531 422.250366210938 2 10 1.1.1.3314.5 1 29.1018 410329.2 29.145 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 83.3100020885468 VATVSLPR -0.00204673991538584 841.500061035156 421.7573 841.502136230469 421.758361816406 2 6 1.1.1.3732.2 1 39.568 905.0392 39.6935 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 83.0099999904633 VATVSLPR Dioxidation(P)@7 -0.00368673005141318 873.48828125 437.7514 873.492004394531 437.753265380859 2 11 1.1.1.3319.4 1 29.2265 27204.77 29.0466 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 83.0099999904633 VATVSLPR Formyl@N-term 0.0361122004687786 869.533264160156 435.7739 869.4970703125 435.755798339844 2 8 1.1.1.3536.2 1 34.5871 2446.482 34.5582 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 81.7600011825562 VATVSLPR Delta:H(4)C(2)@N-term -0.000456373003544286 869.533081054688 435.7738 869.533447265625 435.774017333984 2 7 1.1.1.3379.3 1 30.704 1586033 30.6749 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 80.4199993610382 VATVSLPR Pro->pyro-Glu(P)@7 -0.00293151009827852 855.478454589844 428.7465 855.4814453125 428.747985839844 2 10 1.1.1.3314.6 1 29.1026 28555.67 29.0712 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 80.4199993610382 VATVSLPR Delta:H(4)C(2)@N-term -0.000456373003544286 869.533081054688 435.7738 869.533447265625 435.774017333984 2 8 1.1.1.3476.2 1 33.1062 12399.63 33.1273 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 79.9799978733063 VATVSLPR -0.000545040995348245 841.501647949219 421.7581 841.502136230469 421.758361816406 2 7 1.1.1.3542.3 1 34.7343 2127.498 34.6074 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 79.9799978733063 VATVSLPR -0.00579395005479455 841.496459960938 421.7555 841.502136230469 421.758361816406 2 6 1.1.1.3610.4 1 36.469 1263.121 36.5379 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 78.9900004863739 VATVSLPR Delta:H(4)C(2)@N-term -0.000639474019408226 869.532897949219 435.7737 869.533447265625 435.774017333984 2 10 1.1.1.3434.7 1 32.0713 80948.56 32.1139 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 77.4699985980988 VATVSLPR Delta:H(4)C(2)@N-term 0.000337067001964897 869.533874511719 435.7742 869.533447265625 435.774017333984 2 6 1.1.1.3517.4 1 34.121 2553.435 34.1896 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 73.3900010585785 VATVSLPR -0.000972278008703142 841.501281738281 421.7579 841.502136230469 421.758361816406 2 9 1.1.1.3453.3 1 32.5437 6734.91 32.3877 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 57.5800001621246 VATVSLPR -0.0104694003239274 841.49169921875 421.7531 841.502136230469 421.758361816406 2 6 1.1.1.3831.3 1 42.098 1351.186 41.9327 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 55.9899985790253 VATVSLPR 0.00307692005299032 841.505249023438 421.7599 841.502136230469 421.758361816406 2 4 1.1.1.4567.2 1 61.0381 692.5951 61.0332 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 54.9399971961975 VATVSLPR Dehydrated(T)@3 -0.00400845985859632 823.487670898438 412.7511 823.491577148438 412.753082275391 2 5 1.1.1.3342.2 1 29.7882 7284.589 29.5382 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 54.9399971961975 VATVSLPR Delta:H(4)C(2)@N-term -0.000883609987795353 869.532653808594 435.7736 869.533447265625 435.774017333984 2 9 1.1.1.3406.3 1 31.3695 81070 31.1194 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 54.9399971961975 VATVSLPR Delta:H(4)C(2)@N-term -0.00167705002240837 869.531860351563 435.7732 869.533447265625 435.774017333984 2 7 1.1.1.3528.4 1 34.3956 2491.195 34.4355 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 53.1499981880188 VATVSLPR -0.0110798003152013 841.491088867188 421.7528 841.502136230469 421.758361816406 2 6 1.1.1.3803.2 1 41.3636 1866.668 41.3595 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 52.7899980545044 VATVSLPR -0.00298639992251992 841.499267578125 421.7569 841.502136230469 421.758361816406 2 9 1.1.1.3474.2 1 33.0577 5671.49 33.078 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 49.889999628067 VATVSLPR Delta:H(4)C(2)@N-term -0.00265358993783593 869.530883789063 435.7727 869.533447265625 435.774017333984 2 9 1.1.1.3455.4 1 32.5936 9202.431 32.586 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 47.4999994039536 VATVSLPR -0.000972278008703142 841.501281738281 421.7579 841.502136230469 421.758361816406 2 9 1.1.1.3376.4 1 30.6308 44273.14 30.3766 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 44.6799993515015 VATVSLPR Delta:H(4)C(2)@N-term -0.00247049005702138 869.531066894531 435.7728 869.533447265625 435.774017333984 2 8 1.1.1.3553.3 1 35.0063 3121.224 35.0979 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 43.3899998664856 VATVSLPR -0.000545040995348245 841.501647949219 421.7581 841.502136230469 421.758361816406 2 8 1.1.1.3549.3 1 34.9075 2377.209 34.8526 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 40.3299987316132 VATVSLPR -0.00298639992251992 841.499267578125 421.7569 841.502136230469 421.758361816406 2 9 1.1.1.3432.3 1 32.016 16065.71 31.8582 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 40.3299987316132 VATVSLPR -0.00335259991697967 841.498901367188 421.7567 841.502136230469 421.758361816406 2 7 1.1.1.3563.2 1 35.2544 2337.691 35.2754 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 35.4099988937378 VATVSLPR -0.000545040995348245 841.501647949219 421.7581 841.502136230469 421.758361816406 2 8 1.1.1.3308.4 1 28.9535 1732009 29.0958 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 34.1199994087219 VATVSLPR Pro->pyro-Glu(P)@7 0.0320409014821053 855.513488769531 428.764 855.4814453125 428.747985839844 2 8 1.1.1.3419.2 1 31.6885 5534.345 31.8834 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 29.1500002145767 VATVSLPR -0.000545040995348245 841.501647949219 421.7581 841.502136230469 421.758361816406 2 8 1.1.1.3315.4 1 29.1255 1732009 29.0958 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 28.9200007915497 VATVSLPR -0.000545040995348245 841.501647949219 421.7581 841.502136230469 421.758361816406 2 7 1.1.1.3322.3 1 29.297 1732009 29.0958 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 28.0000001192093 VATVSLPR -0.00316950003616512 841.499084472656 421.7568 841.502136230469 421.758361816406 2 8 1.1.1.3467.3 1 32.887 5669.024 32.8563 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 27.7700006961823 VATVSLPR -0.000545040995348245 841.501647949219 421.7581 841.502136230469 421.758361816406 2 10 1.1.1.3313.3 1 29.0755 1732009 29.0958 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 27.7700006961823 VATVSLPR -0.000545040995348245 841.501647949219 421.7581 841.502136230469 421.758361816406 2 10 1.1.1.3327.5 1 29.4249 1687740 29.1696 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 25.6599992513657 VATVSLPR -0.00518361991271377 841.4970703125 421.7558 841.502136230469 421.758361816406 2 8 1.1.1.3383.3 1 30.8028 13475.89 30.8478 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 25.6599992513657 VATVSLPR -0.00554982014000416 841.496704101563 421.7556 841.502136230469 421.758361816406 2 9 1.1.1.3411.2 1 31.4922 13251.72 31.537 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 25.6599992513657 VATVSLPR -0.00536671979352832 841.496887207031 421.7557 841.502136230469 421.758361816406 2 8 1.1.1.3439.3 1 32.1958 15478.85 31.934 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 22.3800003528595 VATVSLPR -0.00298639992251992 841.499267578125 421.7569 841.502136230469 421.758361816406 2 8 1.1.1.3481.3 1 33.2337 5671.49 33.078 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 20.4899996519089 VATVSLPR -0.00518361991271377 841.4970703125 421.7558 841.502136230469 421.758361816406 2 8 1.1.1.3390.4 1 30.9764 13671.4 30.8725 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 15.9999996423721 VATVSLPR -0.00485430005937815 841.497253417969 421.7559 841.502136230469 421.758361816406 2 6 1.1.1.3756.4 1 40.1871 980.2371 40.1803 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 15.9999996423721 VATVSLPR 0.00454493006691337 841.506652832031 421.7606 841.502136230469 421.758361816406 2 5 1.1.1.3988.2 1 46.1186 1243.893 46.1133 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 36.1000001430511 VATVSLPRSCAAAGTECLISGWGNTK Carbamidomethyl(C)@10; Carbamidomethyl(C)@17; Delta:H(4)C(2)(K)@26 missed R-S@8 -0.00111141998786479 2733.35693359375 912.1262 2733.35791015625 912.126525878906 3 9 1.1.1.4083.20 1 48.5754 3567.307 48.5561 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 94.3599998950958 VRLGEHNIDVLEGNEQFINAAK Carbamyl@N-term cleaved Q-V@N-term; missed R-L@2 -0.0283049996942282 2508.244140625 837.0886 2508.27221679688 837.097961425781 3 13 1.1.1.3880.20 1 43.3894 3723.053 43.4975 3 61.24 61.24 75.7799983024597 66.3699984550476 66.3699984550476 cont|000143; cont|000023 pdb|1FNI_A| A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% Polydocanol [Sus scrofa (contaminant)]; gi|494360|pdb|1MCT|A Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From Bitter Gourd [Sus scrofa (Contaminant)] 0 87.1500015258789 VRLGEHNIDVLEGNEQFINAAK Carbamyl@N-term cleaved Q-V@N-term; missed R-L@2 -0.0283049996942282 2508.244140625 837.0886 2508.27221679688 837.097961425781 3 12 1.1.1.3887.16 1 43.5641 3723.053 43.4975 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 AGTELVNFLSYF cleaved F-V@C-term 0.0065912501886487 1359.677734375 680.8461 1359.67102050781 680.842834472656 2 7 1.1.1.4843.11 1 68.1594 351.4318 68.1729 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 AGTELVNFLSYFVELGTQPA cleaved A-T@C-term -0.00407776981592178 2155.07983398438 719.3672 2155.08374023438 719.368530273438 3 17 1.1.1.5125.11 1 75.6449 18076.29 75.5527 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term -0.00424510985612869 2256.12744140625 1129.071 2256.13134765625 1129.07299804688 2 21 1.1.1.5112.16 1 75.313 34459.13 75.3731 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 AGTELVNFLSYFVELGTQPATQ -0.00250863004475832 2384.18774414063 795.7365 2384.18994140625 795.737243652344 3 22 1.1.1.5114.7 1 75.3563 122792.9 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 -0.00221304991282523 2349.08154296875 784.0344 2349.08349609375 784.035095214844 3 19 1.1.1.4668.4 1 63.5949 11012.48 63.3392 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 -0.0124324997887015 2981.35498046875 994.7923 2981.36743164063 994.796447753906 3 15 1.1.1.4808.15 1 67.2287 9504.528 67.239 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 -0.00342131010256708 3208.52734375 803.1391 3208.53076171875 803.139953613281 4 12 1.1.1.4813.10 1 67.3571 10502.55 67.239 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.00210074009373784 4162.0146484375 833.4102 4162.0126953125 833.409790039063 5 11 1.1.1.4788.10 1 66.6898 2023.56 66.5459 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 -0.00858242996037006 2283.17016601563 762.064 2283.1787109375 762.066833496094 3 12 1.1.1.5056.10 1 73.8181 8098.869 73.9678 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 -0.00806144997477531 2384.21728515625 1193.116 2384.22631835938 1193.12048339844 2 12 1.1.1.5056.21 1 73.8273 6979.222 73.5372 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 -0.0152107998728752 2512.26953125 838.4305 2512.28491210938 838.435607910156 3 13 1.1.1.5085.15 1 74.6063 1773.513 74.4543 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 KEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@4; Oxidation(M)@24 cleaved A-K@N-term; missed K-E@1; missed K-D@21 0.0033306700643152 3109.4658203125 778.3737 3109.46240234375 778.372863769531 4 17 1.1.1.4558.7 1 60.8073 2550.878 60.8242 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00651074014604092 3291.53930664063 1098.187 3291.53149414063 1098.18444824219 3 14 1.1.1.4769.17 1 66.1976 6252.822 65.9214 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.00736476015299559 3518.70263671875 880.6829 3518.69482421875 880.681030273438 4 14 1.1.1.4766.10 1 66.1132 7101.55 66.3632 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.00900947023183107 4472.18603515625 746.3716 4472.1767578125 746.370056152344 6 14 1.1.1.4725.5 1 65.0474 1808.248 65.1185 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 SKEQLTPLIK missed K-E@2 -0.00508415000513196 1155.68127441406 578.8479 1155.68627929688 578.850463867188 2 10 1.1.1.3368.16 1 30.4421 1037.777 30.4265 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 SKEQLTPLIKK missed K-E@2; missed K-K@10 0.00167525000870228 1283.78283691406 428.9349 1283.78125 428.934387207031 3 13 1.1.1.3165.4 1 25.463 106788.8 25.5074 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 SPELQAEAK -0.000800894980784506 971.49169921875 486.7531 971.492370605469 486.753479003906 2 8 1.1.1.3037.7 1 22.3826 598.3228 22.5672 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 SPELQAEAKSYFEK missed K-S@9 -0.00413388991728425 1625.78942871094 542.9371 1625.79370117188 542.938537597656 3 13 1.1.1.3637.11 1 37.1457 14634.49 37.0573 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 SYFEKSKEQLTPLIK missed K-S@5; missed K-E@7 0.0014519999967888 1809.98913574219 604.337 1809.98767089844 604.336486816406 3 21 1.1.1.3655.10 1 37.6047 58213.5 37.5199 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 SYFEKSKEQLTPLIKK missed K-S@5; missed K-E@7; missed K-K@15 -0.0029368600808084 1938.07958984375 647.0338 1938.08264160156 647.034790039063 3 15 1.1.1.3477.17 1 33.1451 18628.36 33.2507 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 VKSPELQAEAK missed K-S@2 -9.42589977057651E-05 1198.65563964844 600.3351 1198.65576171875 600.335144042969 2 16 1.1.1.3049.6 1 22.6789 9274.553 22.6405 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 VKSPELQAEAKSYFEK missed K-S@2; missed K-S@11 0.00524605996906757 1852.96252441406 464.2479 1852.95703125 464.246551513672 4 11 1.1.1.3572.7 1 35.4936 9260.414 35.4057 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 VKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ acrolein addition +112(K)@2; acrolein addition +112(K)@11; acrolein addition +94(K)@26; HPNE addition +172(K)@27 missed K-S@2; missed K-S@11; missed K-S@16; missed K-E@18; missed K-K@26; missed K-A@27 -0.0086481599137187 5975.1552734375 996.8665 5975.1640625 996.867919921875 6 15 1.1.1.5109.16 1 75.2362 1808.143 75.2456 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 1.07572078704834 98.5199987888336 SPELQAEAKSYFEKSKEQLTPLIKK missed K-S@9; missed K-S@14; missed K-E@16; missed K-K@24 0.00819849036633968 2891.57299804688 723.9005 2891.564453125 723.898376464844 4 13 1.1.1.3952.19 1 45.2094 3557.638 45.2164 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.151195302605629 96.7199981212616 DLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ acrolein addition +38(K)@7; acrolein addition +76(K)@23; HPNE addition +172(K)@31; HPNE addition +172(K)@32 missed K-V@5; missed K-S@7; missed K-S@16; missed K-S@21; missed K-E@23; missed K-K@31; missed K-A@32 0.0317602008581162 6559.4921875 1094.256 6559.462890625 1094.25109863281 6 15 1.1.1.5108.19 1 75.2132 9897.176 75.2456 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.0301183573901653 85.3799998760223 DLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPAT reduced acrolein addition +96(K)@7; acrolein addition +94(K)@23; reduced acrolein addition +96(K)@31; HPNE addition +172(K)@32 cleaved T-Q@C-term; missed K-V@5; missed K-S@7; missed K-S@16; missed K-S@21; missed K-E@23; missed K-K@31; missed K-A@32 0.0469780005514622 6431.45166015625 919.7861 6431.404296875 919.779357910156 7 12 1.1.1.5115.14 0 75.3874 2439.413 75.3478 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.0282604098320007 97.2800016403198 MKLLAATVLLLTICSLEGALVRRQAKEPCVESLVSQYFQTVTDYGK Oxidation(M)@1; acrolein addition +94(K)@2; Carbamidomethyl(C)@14; HPNE addition +172(K)@26; Carbamidomethyl(C)@29 missed K-L@2; missed R-R@22; missed R-Q@23; missed K-E@26 -0.0799537003040314 5480.82177734375 783.9818 5480.9013671875 783.9931640625 7 8 1.1.1.4708.7 1 64.6038 829.8574 64.5946 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.0181813929229975 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQA Carbamidomethyl(C)@3; HPNE addition +172(K)@25; HPNE addition +172(K)@27; Deamidated(Q)@32 cleaved A-E@C-term; missed K-D@20; missed K-V@25; missed K-S@27 -0.0123533001169562 4163.03466796875 833.6142 4163.046875 833.616638183594 5 11 1.1.1.4761.11 1 65.9846 5519.496 65.8445 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.0127807697281241 92.4499988555908 SYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ acrolein addition +112(K)@7; Deamidated(Q)@9; acrolein addition +112(K)@15; acrolein addition +112(K)@16 missed K-S@5; missed K-E@7; missed K-K@15; missed K-A@16 -0.0202866997569799 4641.3828125 1161.353 4641.4033203125 1161.35815429688 4 13 1.1.1.5113.20 1 75.3418 990.3416 75.3478 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.0114410435780883 93.9300000667572 VKSPELQAEAKSYFEKS cleaved S-K@C-term; missed K-S@2; missed K-S@11; missed K-S@16 0.0146749000996351 1940.00366210938 647.6752 1939.98913574219 647.670288085938 3 11 1.1.1.4027.12 1 47.1406 2277.802 47.102 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.00130484171677381 99.0000009536743 AKEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@2; Carbamidomethyl(C)@5; Oxidation(M)@25 cleaved Q-A@N-term; missed K-E@2; missed K-D@22; missed K-V@27 -0.0121074002236128 3560.72973632813 891.1897 3560.74194335938 891.192749023438 4 12 1.1.1.4796.10 1 66.9022 3580.86 66.7576 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.000434511806815863 99.0000009536743 AKEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@2; Carbamidomethyl(C)@5; Oxidation(M)@25 cleaved Q-A@N-term; missed K-E@2; missed K-D@22 -0.0271383002400398 3333.55126953125 834.3951 3333.57861328125 834.401916503906 4 12 1.1.1.4768.14 1 66.1691 4269.426 66.2325 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.000434511806815863 72.5499987602234 LMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +96(K)@4; ONE addition +154(K)@6; hexanoyl addition +98(K)@30; hexanoyl addition +98(K)@31 cleaved D-L@N-term; missed K-V@4; missed K-S@6; missed K-S@15; missed K-S@20; missed K-E@22; missed K-K@30; missed K-A@31 0.0194253996014595 6432.490234375 1073.089 6432.47265625 1073.08605957031 6 11 1.1.1.5111.18 1 75.2892 3436 75.3478 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYF cleaved F-V@C-term -0.00512715987861156 1359.666015625 680.8403 1359.67102050781 680.842834472656 2 10 1.1.1.4829.6 1 67.7812 1377.001 67.799 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYF cleaved F-V@C-term -0.00512715987861156 1359.666015625 680.8403 1359.67102050781 680.842834472656 2 8 1.1.1.4836.7 1 67.9683 1377.001 67.799 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYF cleaved F-V@C-term -0.00512715987861156 1359.666015625 680.8403 1359.67102050781 680.842834472656 2 7 1.1.1.4822.9 1 67.5984 1354.849 67.799 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPA cleaved A-T@C-term -0.000974492984823883 2155.08325195313 1078.549 2155.08374023438 1078.54919433594 2 20 1.1.1.5119.20 1 75.4947 9311.257 75.5527 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPA cleaved A-T@C-term -0.000974492984823883 2155.08325195313 1078.549 2155.08374023438 1078.54919433594 2 17 1.1.1.5126.20 1 75.6789 9311.257 75.5527 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 87.610000371933 AGTELVNFLSYFVELGTQPA Cation:Na(E)@14 cleaved A-T@C-term 0.00182477000635117 2177.0673828125 1089.541 2177.06567382813 1089.54016113281 2 10 1.1.1.5120.21 1 75.5215 1503.877 75.5527 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT Cation:Na(E)@14 cleaved T-Q@C-term -0.0085350601002574 2278.10546875 1140.06 2278.11328125 1140.06396484375 2 21 1.1.1.5115.18 1 75.3907 6423.361 75.3731 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT Cation:Na(E)@14 cleaved T-Q@C-term -0.0085350601002574 2278.10546875 1140.06 2278.11328125 1140.06396484375 2 20 1.1.1.5116.18 1 75.4161 6423.361 75.3731 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.00119656999595463 2256.1328125 753.0515 2256.13134765625 753.051086425781 3 13 1.1.1.5117.5 1 75.4309 93636.3 75.3731 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.00119656999595463 2256.1328125 753.0515 2256.13134765625 753.051086425781 3 23 1.1.1.5119.8 1 75.4847 93636.3 75.3731 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.00119656999595463 2256.1328125 753.0515 2256.13134765625 753.051086425781 3 21 1.1.1.5125.12 1 75.6458 93921.73 75.3731 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term -0.0024654099252075 2256.12866210938 753.0502 2256.13134765625 753.051086425781 3 20 1.1.1.5126.9 1 75.6698 72760.93 75.3985 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT Methyl(E)@14 cleaved T-Q@C-term 0.0110496003180742 2270.15747070313 1136.086 2270.14697265625 1136.08081054688 2 15 1.1.1.5126.21 1 75.6798 768.4645 75.685 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT Delta:H(2)C(2)@N-term cleaved T-Q@C-term -0.00395049992948771 2282.14306640625 761.7216 2282.14697265625 761.722961425781 3 18 1.1.1.5129.16 1 75.7555 3373.697 75.7915 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term -0.00393019989132881 2256.12719726563 753.0497 2256.13134765625 753.051086425781 3 10 1.1.1.5133.16 1 75.8622 9793.312 75.579 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 86.7200016975403 AGTELVNFLSYFVELGTQPAT Deamidated(Q)@18; Oxidation(P)@19 cleaved T-Q@C-term 0.0464311987161636 2273.15747070313 1137.586 2273.1103515625 1137.5625 2 11 1.1.1.5119.21 1 75.4955 8139.549 75.3731 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 80.2799999713898 AGTELVNFLSYFVELGTQPAT Deamidated(Q)@18; Oxidation(P)@19 cleaved T-Q@C-term 0.0464311987161636 2273.15747070313 1137.586 2273.1103515625 1137.5625 2 11 1.1.1.5112.17 1 75.3138 8139.549 75.3731 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 75.2499997615814 AGTELVNFLSYFVELGTQPAT Deamidated(Q)@18; Oxidation(P)@19 cleaved T-Q@C-term 0.0446201004087925 2273.15502929688 758.7256 2273.1103515625 758.710754394531 3 11 1.1.1.5115.3 1 75.3782 5720.833 75.3731 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 63.5200023651123 AGTELVNFLSYFVELGTQPAT Cation:Na(E)@14 cleaved T-Q@C-term -0.00446644006296992 2278.10888671875 760.3769 2278.11328125 760.37841796875 3 10 1.1.1.5112.6 1 75.3046 8768.76 75.3731 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 63.5200023651123 AGTELVNFLSYFVELGTQPAT Deamidated(N)@7; Methyl(E)@14 cleaved T-Q@C-term 0.0226004999130964 2271.1533203125 1136.584 2271.13110351563 1136.57287597656 2 8 1.1.1.5127.21 1 75.7064 642.328 75.685 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Deamidated(N)@7 0.0104496004059911 2385.1845703125 796.0688 2385.17407226563 796.065307617188 3 11 1.1.1.5106.8 1 75.1532 63540.27 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ -0.00250863004475832 2384.18774414063 795.7365 2384.18994140625 795.737243652344 3 21 1.1.1.5107.11 1 75.1811 122792.9 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Cation:Na@C-term -0.00708658993244171 2406.1650390625 803.0623 2406.171875 803.064575195313 3 22 1.1.1.5108.7 1 75.2032 11271.38 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ -0.00194818002637476 2384.18725585938 1193.101 2384.18994140625 1193.10229492188 2 25 1.1.1.5109.20 1 75.2395 32382.86 75.2456 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Cation:Na(E)@14 0.00302778999321163 2406.17529296875 1204.095 2406.171875 1204.09326171875 2 21 1.1.1.5109.21 1 75.2404 4500.96 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Cation:Na(E)@14 0.00302778999321163 2406.17529296875 1204.095 2406.171875 1204.09326171875 2 24 1.1.1.5110.21 1 75.2661 4500.96 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Deamidated(N)@7; Oxidation(F)@8 0.0538462996482849 2401.22338867188 1201.619 2401.1689453125 1201.591796875 2 17 1.1.1.5111.19 1 75.29 4281.891 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Cation:Na(E)@14 0.00302778999321163 2406.17529296875 1204.095 2406.171875 1204.09326171875 2 23 1.1.1.5111.20 1 75.2917 4500.96 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Cation:Na@C-term 0.00302778999321163 2406.17529296875 1204.095 2406.171875 1204.09326171875 2 17 1.1.1.5112.19 1 75.3155 4500.96 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ -0.00194818002637476 2384.18725585938 1193.101 2384.18994140625 1193.10229492188 2 23 1.1.1.5116.20 1 75.4186 32382.86 75.2456 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ -0.00194818002637476 2384.18725585938 1193.101 2384.18994140625 1193.10229492188 2 23 1.1.1.5117.19 1 75.4426 32382.86 75.2456 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Methyl(E)@14 0.000995601993054152 2398.20654296875 800.4095 2398.20556640625 800.4091796875 3 18 1.1.1.5121.12 1 75.54 4837.548 75.579 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ -0.00121578003745526 2384.189453125 1193.102 2384.18994140625 1193.10229492188 2 19 1.1.1.5121.21 1 75.5475 28072.89 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Methyl(T)@17 0.00650375988334417 2398.21142578125 1200.113 2398.20556640625 1200.11010742188 2 17 1.1.1.5122.20 1 75.573 862.892 75.579 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Delta:H(2)C(2)@N-term -0.000347749009961262 2410.20556640625 804.4091 2410.20556640625 804.4091796875 3 22 1.1.1.5125.13 1 75.6466 5333.364 75.685 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.00684054009616375 2384.197265625 1193.106 2384.18994140625 1193.10229492188 2 12 1.1.1.5128.21 1 75.7332 3186.823 75.4494 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.00298434006981552 2384.19311523438 795.7383 2384.18994140625 795.737243652344 3 11 1.1.1.5135.16 1 75.9156 6722.438 75.6319 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Deamidated(N)@7 0.0232664998620749 2385.19750976563 796.0731 2385.17407226563 796.065307617188 3 10 1.1.1.5135.17 1 75.9164 3712.785 75.6319 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Delta:H(2)C(2)@N-term -0.000347749009961262 2410.20556640625 804.4091 2410.20556640625 804.4091796875 3 13 1.1.1.5132.17 1 75.8362 5333.364 75.685 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.1000015735626 AGTELVNFLSYFVELGTQPATQ Cation:K(E)@14 -0.00124760996550322 2422.14453125 808.3888 2422.14599609375 808.389221191406 3 15 1.1.1.5109.8 1 75.2295 2225.178 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 88.4899973869324 AGTELVNFLSYFVELGTQPATQ Deamidated(N)@7; Oxidation(F)@8 0.0538462996482849 2401.22338867188 1201.619 2401.1689453125 1201.591796875 2 11 1.1.1.5115.21 1 75.3932 4281.891 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 88.4899973869324 AGTELVNFLSYFVELGTQPATQ Oxidation(F)@12 0.0225213002413511 2400.20727539063 1201.111 2400.18481445313 1201.09973144531 2 9 1.1.1.5122.21 1 75.5738 764.4114 75.5527 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 87.610000371933 AGTELVNFLSYFVELGTQPATQ Deamidated(Q)@18; Oxidation(P)@19 0.0520734004676342 2401.220703125 801.4142 2401.1689453125 801.396911621094 3 13 1.1.1.5108.6 1 75.2024 4135.06 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 80.2799999713898 AGTELVNFLSYFVELGTQPATQ Cation:Na(E)@14 -0.00708658993244171 2406.1650390625 803.0623 2406.171875 803.064575195313 3 11 1.1.1.5115.6 1 75.3807 11271.38 75.2713 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 42.739999294281 AGTELVNFLSYFVELGTQPATQ Cation:Na(E)@14 -0.00653730006888509 2406.16528320313 803.0624 2406.171875 803.064575195313 3 8 1.1.1.5122.14 1 75.568 7085.03 75.2969 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.079998254776 AKEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@2; Carbamidomethyl(C)@5; Oxidation(M)@25 cleaved Q-A@N-term; missed K-E@2; missed K-D@22 -0.0063869901932776 3333.572265625 834.4003 3333.57861328125 834.401916503906 4 10 1.1.1.4790.9 1 66.7423 1488.044 66.6774 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 25.8799999952316 CVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@1; Oxidation(M)@21 cleaved P-C@N-term; missed K-D@18 0.0227247998118401 2755.294921875 919.4389 2755.27197265625 919.431274414063 3 8 1.1.1.4554.10 1 60.7056 1684.098 60.72 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 94.6300029754639 DLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +96(K)@7; acrolein addition +94(K)@23; reduced acrolein addition +96(K)@31; HPNE addition +172(K)@32 missed K-V@5; missed K-S@7; missed K-S@16; missed K-S@21; missed K-E@23; missed K-K@31; missed K-A@32 0.0562051013112068 6559.51953125 938.0815 6559.462890625 938.073425292969 7 17 1.1.1.5109.14 0 75.2345 8271.906 75.2456 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 32.480001449585 DLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ Carbamidomethyl@N-term; MDA adduct +62(K)@5; reduced acrolein addition +58(K)@7; ONE addition +154(K)@32 missed K-V@5; missed K-S@7; missed K-S@16; missed K-S@21; missed K-E@23; missed K-K@31; missed K-A@32 0.117348000407219 6432.490234375 1073.089 6432.37451171875 1073.06970214844 6 10 1.1.1.5111.18 1 75.2892 3436 75.3478 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 -0.000565151975024492 2349.0830078125 784.0349 2349.08349609375 784.035095214844 3 18 1.1.1.4646.7 1 63.046 9562.104 63.264 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 -0.000983673962764442 2349.08325195313 1175.549 2349.08349609375 1175.54907226563 2 14 1.1.1.4647.18 1 63.0828 5099.344 63.264 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 -0.00166375003755093 2349.08154296875 784.0345 2349.08349609375 784.035095214844 3 20 1.1.1.4654.3 1 63.2437 10773.68 63.3392 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 -0.00166375003755093 2349.08154296875 784.0345 2349.08349609375 784.035095214844 3 21 1.1.1.4661.7 1 63.4225 10773.68 63.3392 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 -0.000983673962764442 2349.08325195313 1175.549 2349.08349609375 1175.54907226563 2 18 1.1.1.4667.8 1 63.5842 4873.144 63.3642 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 -0.001716069993563 2349.08129882813 1175.548 2349.08349609375 1175.54907226563 2 18 1.1.1.4673.10 1 63.7336 3833.116 63.4644 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 0.00401234021410346 2349.08740234375 784.0364 2349.08349609375 784.035095214844 3 22 1.1.1.4675.3 1 63.77 2498.329 63.689 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 0.0236737001687288 2349.107421875 1175.561 2349.08349609375 1175.54907226563 2 14 1.1.1.4679.10 1 63.883 902.2111 63.8133 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 -0.000198951995116659 2349.0830078125 784.035 2349.08349609375 784.035095214844 3 17 1.1.1.4686.6 1 64.046 1537.786 63.9383 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 -0.00220433995127678 2349.08129882813 1175.548 2349.08349609375 1175.54907226563 2 12 1.1.1.4688.17 1 64.1077 756.1262 64.0129 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 -0.000565151975024492 2349.0830078125 784.0349 2349.08349609375 784.035095214844 3 16 1.1.1.4693.4 1 64.2197 1342.608 64.1881 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 0.0124348998069763 2349.095703125 784.0392 2349.08349609375 784.035095214844 3 16 1.1.1.4701.5 1 64.429 799.662 64.4418 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.3699977397919 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 -0.000739541021175683 2349.08325195313 1175.549 2349.08349609375 1175.54907226563 2 10 1.1.1.4660.7 1 63.4091 5275.259 63.264 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 80.2600026130676 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3; Deamidated(Q)@10 0.0323002003133297 2350.09936523438 1176.057 2350.0673828125 1176.041015625 2 6 1.1.1.4698.16 1 64.3607 490.6327 64.3408 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 26.5399992465973 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 0.00016724799934309 2349.08374023438 784.0352 2349.08349609375 784.035095214844 3 8 1.1.1.4715.6 1 64.7873 878.6073 64.7786 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.0102717997506261 2981.3779296875 994.7999 2981.36743164063 994.796447753906 3 18 1.1.1.4738.11 1 65.3925 79861.18 65.5889 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.0062276697717607 2981.37377929688 746.3507 2981.36743164063 746.34912109375 4 16 1.1.1.4739.6 1 65.415 23093.78 65.6656 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.0102717997506261 2981.3779296875 994.7999 2981.36743164063 994.796447753906 3 19 1.1.1.4745.16 1 65.5794 80897.81 65.5889 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.00500700995326042 2981.37255859375 746.3504 2981.36743164063 746.34912109375 4 17 1.1.1.4747.5 1 65.6216 25086.03 65.6913 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.00500700995326042 2981.37255859375 746.3504 2981.36743164063 746.34912109375 4 24 1.1.1.4748.2 1 65.6445 25086.03 65.6913 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.0100886998698115 2981.37768554688 994.7998 2981.36743164063 994.796447753906 3 18 1.1.1.4752.14 1 65.7569 89040.77 65.6913 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.00451873987913132 2981.3720703125 746.3503 2981.36743164063 746.34912109375 4 14 1.1.1.4757.6 1 65.878 21871.26 65.8445 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.0100886998698115 2981.37768554688 994.7998 2981.36743164063 994.796447753906 3 18 1.1.1.4759.14 1 65.9359 85946.96 65.8701 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.00451873987913132 2981.3720703125 746.3503 2981.36743164063 746.34912109375 4 16 1.1.1.4764.7 1 66.0589 21871.26 65.8445 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.00451873987913132 2981.3720703125 746.3503 2981.36743164063 746.34912109375 4 11 1.1.1.4765.4 1 66.0823 22085.92 65.8445 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.0100886998698115 2981.37768554688 994.7998 2981.36743164063 994.796447753906 3 18 1.1.1.4766.17 1 66.1191 87403 65.8445 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.0110042002052069 2981.37841796875 994.8001 2981.36743164063 994.796447753906 3 21 1.1.1.4773.18 1 66.3029 63821.94 66.024 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.00514505989849567 2981.37280273438 994.7982 2981.36743164063 994.796447753906 3 17 1.1.1.4780.15 1 66.4831 47725.51 66.2062 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; acrolein addition +76(K)@20; Methyl(E)@24; ONE addition +154(K)@25 missed K-D@20 0.0214485991746187 3209.5400390625 803.3923 3209.51879882813 803.386962890625 4 17 1.1.1.4787.6 1 66.6596 25657.32 66.3894 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.00441265990957618 2981.37182617188 994.7979 2981.36743164063 994.796447753906 3 18 1.1.1.4787.17 1 66.6688 29393.77 66.3894 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 -0.00108032999560237 2981.36645507813 994.7961 2981.36743164063 994.796447753906 3 13 1.1.1.4794.17 1 66.855 14959.96 66.7308 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.00459575979039073 2981.3720703125 994.798 2981.36743164063 994.796447753906 3 14 1.1.1.4801.18 1 67.0426 12572.71 67.0503 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 -0.00134046003222466 2981.3662109375 746.3488 2981.36743164063 746.34912109375 4 15 1.1.1.4809.6 1 67.2478 2340.423 67.239 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 -0.00144651997834444 2981.3662109375 994.796 2981.36743164063 994.796447753906 3 13 1.1.1.4815.17 1 67.4165 6486.292 67.5063 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.0074483398348093 2981.375 746.351 2981.36743164063 746.34912109375 4 17 1.1.1.4821.5 1 67.5683 1907.117 67.5063 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 -0.00144651997834444 2981.3662109375 994.796 2981.36743164063 994.796447753906 3 12 1.1.1.4822.17 1 67.6051 6486.292 67.5063 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.00404646014794707 2981.37158203125 994.7978 2981.36743164063 994.796447753906 3 13 1.1.1.4829.9 1 67.7837 3456.575 67.6931 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 -0.00427005998790264 2981.36328125 746.3481 2981.36743164063 746.34912109375 4 12 1.1.1.4830.8 1 67.8104 1016.099 67.7204 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(Y)@11; Oxidation(M)@23 missed K-D@20 0.0156890992075205 2997.37719726563 1000.133 2997.3623046875 1000.12805175781 3 14 1.1.1.4759.15 1 65.9368 1331.683 65.8958 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(F)@12; Oxidation(M)@23 missed K-D@20 0.00964684970676899 2997.37109375 1000.131 2997.3623046875 1000.12805175781 3 14 1.1.1.4766.18 1 66.1199 1036.199 66.0498 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Dioxidation(M)@23 missed K-D@20 0.00213976996019483 2997.365234375 1000.129 2997.3623046875 1000.12805175781 3 12 1.1.1.4825.15 1 67.6829 4231.844 67.6931 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 -0.00520117022097111 2963.35131835938 988.7911 2963.35693359375 988.792907714844 3 13 1.1.1.4973.18 1 71.5862 1539.237 71.674 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Deamidated(Q)@13; Oxidation(M)@23 missed K-D@20 0.0241350997239351 2982.37573242188 746.6012 2982.3515625 746.595153808594 4 11 1.1.1.4819.9 1 67.518 1256.542 67.5063 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Dioxidation(M)@23 missed K-D@20 0.0323147997260094 2997.39501953125 750.356 2997.3623046875 750.347839355469 4 11 1.1.1.4821.7 1 67.57 1077.086 67.5603 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Deamidated(Q)@13; Oxidation(M)@23 missed K-D@20 0.0246233008801937 2982.37622070313 746.6013 2982.3515625 746.595153808594 4 11 1.1.1.4770.6 1 66.2147 7522.601 66.1801 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Acetyl(S)@9; Deamidated(Q)@10; Oxidation(M)@23 missed K-D@20 0.0400415994226933 3024.40112304688 1009.141 3024.36206054688 1009.1279296875 3 11 1.1.1.4787.18 1 66.6696 303.6716 66.5986 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; acrolein addition +76(K)@20; Dehydrated(D)@21 missed K-D@20 -0.00904889963567257 3023.38427734375 1008.802 3023.39331054688 1008.80505371094 3 9 1.1.1.4852.17 1 68.4065 1076.652 68.4959 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.0799973011017 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Dioxidation(M)@23 missed K-D@20 0.00213976996019483 2997.365234375 1000.129 2997.3623046875 1000.12805175781 3 9 1.1.1.4828.18 1 67.7655 4231.844 67.6931 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.079998254776 EPCVESLVSQYFQTVTDYGKDLMEK Oxidation(P)@2; Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 -0.00115601997822523 2997.36206054688 1000.128 2997.3623046875 1000.12805175781 3 9 1.1.1.4714.15 1 64.7684 3360.484 64.7786 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.079998254776 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Dioxidation(M)@23 missed K-D@20 0.00213976996019483 2997.365234375 1000.129 2997.3623046875 1000.12805175781 3 9 1.1.1.4832.18 1 67.8711 4231.844 67.6931 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.9499983787537 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Deamidated(Q)@13; Oxidation(M)@23 missed K-D@20 0.0246233008801937 2982.37622070313 746.6013 2982.3515625 746.595153808594 4 9 1.1.1.4779.7 1 66.4503 7276.266 66.1801 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.8900003433228 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Acetyl(K)@20; Oxidation(M)@23 missed K-D@20 -0.00572003005072474 3023.3720703125 1008.798 3023.3779296875 1008.79992675781 3 12 1.1.1.4861.19 1 68.6525 923.6755 68.6037 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 90.4699981212616 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Dioxidation(M)@23 missed K-D@20 -0.00078982301056385 2997.36206054688 1000.128 2997.3623046875 1000.12805175781 3 8 1.1.1.4818.17 1 67.4978 3832.749 67.5603 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 85.1400017738342 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Dioxidation(M)@23 missed K-D@20 0.0193511005491018 2997.38330078125 1000.135 2997.3623046875 1000.12805175781 3 7 1.1.1.4839.16 1 68.0556 2208.976 67.9058 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 67.330002784729 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Deamidated(Q)@13; Oxidation(M)@23 missed K-D@20 0.016566900536418 2982.3681640625 746.5993 2982.3515625 746.595153808594 4 7 1.1.1.4804.4 1 67.1124 1961.284 66.9433 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 44.8000013828278 EPCVESLVSQYFQTVTDYGKDLMEK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; Deamidated(Q)@13; reduced acrolein addition +58(K)@20; Oxidation(M)@23 missed K-D@20 0.00631059007719159 3022.38818359375 1008.47 3022.3828125 1008.46820068359 3 7 1.1.1.4774.15 1 66.3268 1946.014 66.1537 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 34.2299997806549 EPCVESLVSQYFQTVTDYGKDLMEK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 -0.00483496999368072 2963.35205078125 988.7913 2963.35693359375 988.792907714844 3 6 1.1.1.4967.18 1 71.4247 1476.005 71.6206 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 24.719999730587 EPCVESLVSQYFQTVTDYGKDLMEK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@25 missed K-D@20 -0.00904889963567257 3023.38427734375 1008.802 3023.39331054688 1008.80505371094 3 4 1.1.1.4845.17 1 68.2192 910.3558 68.3091 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.0100060002878308 3208.541015625 803.1425 3208.53076171875 803.139953613281 4 13 1.1.1.4741.5 1 65.4659 28873.55 65.717 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.0100060002878308 3208.541015625 803.1425 3208.53076171875 803.139953613281 4 14 1.1.1.4750.11 1 65.7034 28689.49 65.6913 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.0101274996995926 3208.54125976563 1070.521 3208.53076171875 1070.517578125 3 13 1.1.1.4754.11 1 65.8085 6166.258 65.8701 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.0101274996995926 3208.54125976563 1070.521 3208.53076171875 1070.517578125 3 11 1.1.1.4755.17 1 65.8359 6166.258 65.8701 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.00317028001882136 3208.53369140625 803.1407 3208.53076171875 803.139953613281 4 19 1.1.1.4757.9 1 65.8805 25215.81 65.8445 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.0100060002878308 3208.541015625 803.1425 3208.53076171875 803.139953613281 4 17 1.1.1.4764.9 1 66.0606 35262.37 66.2848 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.00439094984903932 3208.53540039063 803.1411 3208.53076171875 803.139953613281 4 16 1.1.1.4771.5 1 66.2402 45049.47 66.3632 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.00439094984903932 3208.53540039063 803.1411 3208.53076171875 803.139953613281 4 18 1.1.1.4772.5 1 66.2663 45049.47 66.3632 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.00170491996686906 3208.53198242188 1070.518 3208.53076171875 1070.517578125 3 13 1.1.1.4774.18 1 66.3293 10411.78 66.3632 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.00439094984903932 3208.53540039063 803.1411 3208.53076171875 803.139953613281 4 18 1.1.1.4778.7 1 66.4242 45049.47 66.3632 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.00170491996686906 3208.53198242188 1070.518 3208.53076171875 1070.517578125 3 14 1.1.1.4783.19 1 66.5651 7968.902 66.4933 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.00439094984903932 3208.53540039063 803.1411 3208.53076171875 803.139953613281 4 16 1.1.1.4785.6 1 66.6071 46457.84 66.337 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.00439094984903932 3208.53540039063 803.1411 3208.53076171875 803.139953613281 4 17 1.1.1.4792.8 1 66.7945 24463.77 66.7042 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.00447724992409348 3208.53564453125 642.7144 3208.53076171875 642.713439941406 5 10 1.1.1.4795.6 1 66.8724 2194.875 66.7576 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.00390268000774086 3208.53466796875 803.1409 3208.53076171875 803.139953613281 4 16 1.1.1.4799.9 1 66.982 24601.28 66.7042 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.00951774045825005 3208.5400390625 803.1423 3208.53076171875 803.139953613281 4 17 1.1.1.4806.7 1 67.1678 15130.36 67.0503 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 -0.00244477996602654 3208.52807617188 803.1393 3208.53076171875 803.139953613281 4 15 1.1.1.4820.10 1 67.5458 6857.583 67.5063 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.004635080229491 3208.53540039063 803.1411 3208.53076171875 803.139953613281 4 12 1.1.1.4838.7 1 68.0224 2291.909 67.9058 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Carbamidomethyl(D)@21 missed K-D@20; missed K-V@25 0.0085587901994586 3249.56567382813 813.3987 3249.55737304688 813.396606445313 4 13 1.1.1.4825.5 1 67.6745 3290.764 67.6931 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.3299970626831 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Acetyl(S)@6; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.0135262999683619 3250.55493164063 813.646 3250.54150390625 813.642639160156 4 10 1.1.1.4740.10 1 65.4439 1320.896 65.5114 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.0799973011017 EPCVESLVSQYFQTVTDYGKDLMEKVK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; Deamidated(Q)@13; Oxidation(M)@23; reduced acrolein addition +58(K)@25 missed K-D@20; missed K-V@25 0.0200363006442785 3249.56616210938 813.3988 3249.54614257813 813.393798828125 4 9 1.1.1.4806.9 1 67.1694 2131.597 67.239 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 85.1400017738342 EPCVESLVSQYFQTVTDYGKDLMEKVK Oxidation(P)@2; Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.0241196993738413 3224.5498046875 807.1447 3224.52563476563 807.138732910156 4 8 1.1.1.4731.4 1 65.2031 1128.5 65.2747 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 63.5999977588654 EPCVESLVSQYFQTVTDYGKDLMEKVK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; Deamidated(Q)@13; MDA adduct +54(K)@25; MDA adduct +62(K)@27 missed K-D@20; missed K-V@25 0.00708471005782485 3291.54248046875 823.8929 3291.53564453125 823.891174316406 4 6 1.1.1.4763.8 1 66.0337 2258.285 65.8958 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 18.3699995279312 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Carbamidomethyl(K)@27 missed K-D@20; missed K-V@25 0.0088029196485877 3249.56616210938 813.3988 3249.55737304688 813.396606445313 4 8 1.1.1.4807.10 1 67.1965 2131.597 67.239 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 16.9100001454353 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.00353591004386544 3208.53540039063 1070.519 3208.53076171875 1070.517578125 3 10 1.1.1.4751.19 1 65.7357 5919.017 65.6913 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0100351003929973 4162.0224609375 833.4118 4162.0126953125 833.409790039063 5 10 1.1.1.4703.7 1 64.4751 33255.29 64.7261 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0203579999506474 4162.03271484375 694.6794 4162.0126953125 694.676025390625 6 10 1.1.1.4709.7 1 64.63 2098.533 64.6737 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0194952003657818 4162.0322265625 833.4137 4162.0126953125 833.409790039063 5 21 1.1.1.4710.10 1 64.6593 48531.55 64.7786 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0112030003219843 4162.02392578125 694.6779 4162.0126953125 694.676025390625 6 15 1.1.1.4716.5 1 64.8123 3858.345 64.7786 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0210210997611284 4162.03369140625 833.414 4162.0126953125 833.409790039063 5 23 1.1.1.4718.9 1 64.8674 52821.46 64.9621 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.00235166004858911 4162.0146484375 1041.511 4162.0126953125 1041.51037597656 4 12 1.1.1.4722.16 1 64.9785 15402.78 64.9621 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0203579999506474 4162.03271484375 694.6794 4162.0126953125 694.676025390625 6 16 1.1.1.4723.6 1 64.9962 4718.866 64.9621 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.00235166004858911 4162.0146484375 1041.511 4162.0126953125 1041.51037597656 4 15 1.1.1.4723.21 1 65.0087 15402.78 64.9621 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0207158997654915 4162.033203125 833.4139 4162.0126953125 833.409790039063 5 22 1.1.1.4725.11 1 65.0524 61091.59 65.0927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0207158997654915 4162.033203125 833.4139 4162.0126953125 833.409790039063 5 25 1.1.1.4728.9 1 65.1292 61091.59 65.0927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0137663995847106 4162.02587890625 694.6783 4162.0126953125 694.676025390625 6 21 1.1.1.4730.6 1 65.179 5241.413 65.0927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0101639004424214 4162.0224609375 1041.513 4162.0126953125 1041.51037597656 4 12 1.1.1.4730.20 1 65.1906 16864.82 65.0927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0207158997654915 4162.033203125 833.4139 4162.0126953125 833.409790039063 5 18 1.1.1.4732.13 1 65.2365 61091.59 65.0927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0101639004424214 4162.0224609375 1041.513 4162.0126953125 1041.51037597656 4 12 1.1.1.4734.17 1 65.2923 16864.82 65.0927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0116287004202604 4162.0224609375 1041.513 4162.0126953125 1041.51037597656 4 12 1.1.1.4738.15 1 65.3958 14995.61 65.1185 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0225469004362822 4162.03515625 833.4143 4162.0126953125 833.409790039063 5 19 1.1.1.4739.10 1 65.4183 52061.56 65.1445 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.028039900586009 4162.04052734375 833.4154 4162.0126953125 833.409790039063 5 23 1.1.1.4741.6 1 65.4668 39879.5 65.1967 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23; Deamidated(Q)@32 missed K-D@20; missed K-V@25; missed K-S@27 0.0355096012353897 4163.0322265625 833.6137 4162.99658203125 833.606628417969 5 16 1.1.1.4754.7 1 65.8018 6987.742 65.6401 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0185796990990639 4162.03125 833.4135 4162.0126953125 833.409790039063 5 18 1.1.1.4759.8 1 65.9309 7956.525 65.8958 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; reduced acrolein addition +58(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 -0.037186399102211 4204.02294921875 841.8118 4204.0595703125 841.819213867188 5 11 1.1.1.4850.12 1 68.3492 1714.4 68.3888 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; Deamidated(Q)@13; hexanoyl addition +98(K)@20; Dethiomethyl(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 -0.0121531002223492 4179.048828125 836.817 4179.06103515625 836.819458007813 5 14 1.1.1.4725.12 1 65.0533 641.7056 65.066 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Deamidated(Q)@13; acrolein addition +56(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.0194419007748365 4203.0478515625 841.6168 4203.02783203125 841.612854003906 5 12 1.1.1.4742.10 1 65.497 1952.864 65.406 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 0.00255810003727674 4204.041015625 841.8155 4204.03857421875 841.81494140625 5 11 1.1.1.4712.8 1 64.71 1861.443 64.6469 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Carbamidomethyl(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.0103446003049612 4203.04931640625 841.6172 4203.0390625 841.615112304688 5 11 1.1.1.4735.9 1 65.3117 1963.977 65.3797 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 0.00103227002546191 4204.03955078125 841.8152 4204.03857421875 841.81494140625 5 9 1.1.1.4720.7 1 64.9191 1318.024 64.936 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 0.00255810003727674 4204.041015625 841.8155 4204.03857421875 841.81494140625 5 10 1.1.1.4705.6 1 64.5298 1861.443 64.6469 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.3299970626831 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(Y)@11 missed K-D@20; missed K-V@25; missed K-S@27 0.0130340000614524 4162.02587890625 694.6782 4162.0126953125 694.676025390625 6 11 1.1.1.4737.5 1 65.3611 5290.246 65.0927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.0799973011017 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 -0.0160569995641708 4204.02294921875 841.8118 4204.03857421875 841.81494140625 5 8 1.1.1.4843.15 1 68.1627 1757.752 68.4152 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.0799973011017 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; reduced acrolein addition +58(K)@27; Deamidated(Q)@32 missed K-D@20; missed K-V@25; missed K-S@27 0.00171531003434211 4205.0458984375 842.0164 4205.04345703125 842.015991210938 5 9 1.1.1.4847.14 1 68.2705 1350.919 68.3091 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.079998254776 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Dioxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 -0.00332149001769722 4178.00390625 836.6081 4178.00732421875 836.608764648438 5 10 1.1.1.4718.10 1 64.8683 1278.882 64.8051 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.079998254776 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Cation:K(D)@17; acrolein addition +112(K)@20; acrolein addition +112(K)@25; HPNE addition +172(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.0180930998176336 4580.20654296875 917.0486 4580.1884765625 917.044982910156 5 11 1.1.1.4725.14 1 65.0549 3045.283 65.066 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.079998254776 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Dioxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.00125600001774728 4178.0087890625 836.609 4178.00732421875 836.608764648438 5 8 1.1.1.4801.8 1 67.0342 1591.78 67.078 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 90.4699981212616 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.00346208992414176 4204.04248046875 1052.018 4204.03857421875 1052.01684570313 4 7 1.1.1.4848.16 1 68.2997 3455.275 68.3619 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 87.1699988842011 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Dehydrated(T)@16; acrolein addition +76(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 -0.0211743991822004 4204.0185546875 1052.012 4204.03857421875 1052.01684570313 4 13 1.1.1.4897.11 1 69.6105 4063.778 69.4702 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 86.7200016975403 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 -0.000212674000067636 4204.0380859375 841.8149 4204.03857421875 841.81494140625 5 11 1.1.1.4890.9 1 69.4299 2312.195 69.4702 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 85.1400017738342 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Deamidated(Q)@13; acrolein addition +56(K)@36 missed K-D@20; missed K-V@25; missed K-S@27 0.0108971996232867 4203.0390625 841.6151 4203.02783203125 841.612854003906 5 7 1.1.1.4777.12 1 66.4026 2327.65 66.337 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 80.2799999713898 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 -0.0050617097876966 4204.03466796875 1052.016 4204.03857421875 1052.01684570313 4 9 1.1.1.4857.20 1 68.5453 3461.7 68.3619 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 80.2799999713898 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 -0.011897400021553 4204.02685546875 1052.014 4204.03857421875 1052.01684570313 4 10 1.1.1.4864.18 1 68.7328 4023.295 68.7945 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 80.2799999713898 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 -0.00540046999230981 4204.033203125 841.8139 4204.03857421875 841.81494140625 5 10 1.1.1.4885.12 1 69.2976 1836.828 69.3648 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 80.2799999713898 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; MDA adduct +62(K)@25; reduced acrolein addition +58(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.00169595004990697 4248.06689453125 1063.024 4248.064453125 1063.0234375 4 9 1.1.1.5062.20 1 73.9888 2228.407 74.103 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 75.2499997615814 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 -0.0211743991822004 4204.0185546875 1052.012 4204.03857421875 1052.01684570313 4 10 1.1.1.4890.18 1 69.4374 4063.778 69.4702 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 68.5100018978119 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; MDA adduct +62(K)@20; reduced acrolein addition +58(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 0.0021842101123184 4248.06689453125 1063.024 4248.064453125 1063.0234375 4 8 1.1.1.5069.21 1 74.1789 2184.09 74.1302 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 63.5200023651123 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 -0.011897400021553 4204.02685546875 1052.014 4204.03857421875 1052.01684570313 4 8 1.1.1.4871.18 1 68.9221 4023.295 68.7945 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 63.5200023651123 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; MDA adduct +62(K)@25; reduced acrolein addition +58(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 -0.00465145986527205 4248.05859375 1063.022 4248.064453125 1063.0234375 4 7 1.1.1.5019.21 1 72.8327 1773.291 72.9472 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 55.2299976348877 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 -0.00265398994088173 4204.0361328125 841.8145 4204.03857421875 841.81494140625 5 8 1.1.1.4867.12 1 68.8089 1927.396 68.8217 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 41.3700014352798 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23; Deamidated(Q)@32; acrolein addition +56(K)@36 missed K-D@20; missed K-V@25; missed K-S@27 0.0390418991446495 4219.0615234375 844.8196 4219.02294921875 844.811828613281 5 7 1.1.1.4723.11 1 65.0004 1940.557 64.909 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 41.3700014352798 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; acrolein addition +76(K)@20 missed K-D@20; missed K-V@25; missed K-S@27 0.00199729995802045 4204.03857421875 1052.017 4204.03857421875 1052.01684570313 4 7 1.1.1.4839.17 1 68.0565 3011.965 68.2816 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 26.5399992465973 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0106522003188729 4162.0224609375 1041.513 4162.0126953125 1041.51037597656 4 11 1.1.1.4711.21 1 64.6952 12487.17 64.7786 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 26.5399992465973 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0101639004424214 4162.0224609375 1041.513 4162.0126953125 1041.51037597656 4 11 1.1.1.4733.20 1 65.2686 16864.82 65.0927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 26.5399992465973 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.0101639004424214 4162.0224609375 1041.513 4162.0126953125 1041.51037597656 4 11 1.1.1.4735.18 1 65.3192 16864.82 65.0927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 26.5399992465973 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.01095059979707 4162.0234375 833.412 4162.0126953125 833.409790039063 5 10 1.1.1.4802.12 1 67.0653 1382.065 67.0503 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 89.819997549057 GKDLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ acrolein addition +94(K)@2; HPNE addition +172(K)@7; GlnThrGlyGly(K)@33; acrolein addition +112(K)@34 cleaved Y-G@N-term; missed K-D@2; missed K-V@7; missed K-S@9; missed K-S@18; missed K-S@23; missed K-E@25; missed K-K@33; missed K-A@34 -0.0388895012438297 7007.6259765625 1168.945 7007.666015625 1168.95166015625 6 15 1.1.1.5109.19 1 75.2387 1975.718 75.2201 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 -0.00858242996037006 2283.17016601563 762.064 2283.1787109375 762.066833496094 3 18 1.1.1.5063.10 1 74.0074 8098.869 73.9678 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 -0.00858242996037006 2283.17016601563 762.064 2283.1787109375 762.066833496094 3 10 1.1.1.5070.15 1 74.2015 8098.869 73.9678 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 90.2599990367889 KAGTELVNFLSYFVELGTQPA Acetyl@N-term cleaved A-T@C-term; missed K-A@1 -0.012385199777782 2325.1767578125 776.0662 2325.18920898438 776.070373535156 3 10 1.1.1.5130.15 1 75.7813 613.3596 75.7915 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 -0.00293470011092722 2384.22338867188 1193.119 2384.22631835938 1193.12048339844 2 7 1.1.1.5033.21 1 73.2107 9829.587 73.4304 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 -0.00245743989944458 2384.22387695313 795.7486 2384.22631835938 795.749389648438 3 22 1.1.1.5040.14 1 73.3923 30065.61 73.457 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 -0.00317883002571762 2384.22338867188 1193.119 2384.22631835938 1193.12048339844 2 22 1.1.1.5041.21 1 73.4251 10110.31 73.4304 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 -0.00172991002909839 2384.224609375 597.0634 2384.22631835938 597.063842773438 4 13 1.1.1.5045.6 1 73.5194 2945.748 73.4304 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT Cation:Na@C-term cleaved T-Q@C-term; missed K-A@1 -0.0028241400141269 2406.20556640625 803.0758 2406.20825195313 803.076721191406 3 19 1.1.1.5045.11 1 73.5236 4362.158 73.457 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 -0.00245743989944458 2384.22387695313 795.7486 2384.22631835938 795.749389648438 3 22 1.1.1.5047.15 1 73.5801 30065.61 73.457 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 -0.00172991002909839 2384.224609375 597.0634 2384.22631835938 597.063842773438 4 10 1.1.1.5054.5 1 73.7599 2725.376 73.4837 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.00175383000168949 2384.22827148438 795.75 2384.22631835938 795.749389648438 3 17 1.1.1.5054.13 1 73.7666 27518.66 73.4837 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 -0.00439947983250022 2384.22143554688 1193.118 2384.22631835938 1193.12048339844 2 13 1.1.1.5058.21 1 73.8815 1487.487 73.8326 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 -0.0072180200368166 2384.21923828125 795.747 2384.22631835938 795.749389648438 3 19 1.1.1.5061.9 1 73.9525 5584.192 73.8326 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 -0.0072180200368166 2384.21923828125 795.747 2384.22631835938 795.749389648438 3 20 1.1.1.5068.8 1 74.1409 5307.16 73.8596 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 -0.00428842986002564 2384.22216796875 795.748 2384.22631835938 795.749389648438 3 11 1.1.1.5084.7 1 74.5729 1893.154 74.4274 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT Acetyl@N-term cleaved T-Q@C-term; missed K-A@1 -0.00225218990817666 2426.23486328125 809.7522 2426.23706054688 809.7529296875 3 18 1.1.1.5125.14 1 75.6474 3920.703 75.6585 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.1000015735626 KAGTELVNFLSYFVELGTQPAT Cation:Na(E)@15 cleaved T-Q@C-term; missed K-A@1 -0.0028241400141269 2406.20556640625 803.0758 2406.20825195313 803.076721191406 3 14 1.1.1.5038.9 1 73.3345 4362.158 73.457 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.1000015735626 KAGTELVNFLSYFVELGTQPAT Cation:Na@C-term cleaved T-Q@C-term; missed K-A@1 -0.00300723011605442 2406.20532226563 803.0757 2406.20825195313 803.076721191406 3 13 1.1.1.5052.12 1 73.7115 4488.024 73.4304 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.7699973583221 KAGTELVNFLSYFVELGTQPAT Deamidated(Q)@19; Oxidation(P)@20 cleaved T-Q@C-term; missed K-A@1 0.0457160994410515 2401.25122070313 801.4243 2401.20532226563 801.409057617188 3 13 1.1.1.5049.12 1 73.6311 2961.873 73.4304 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 88.4899973869324 KAGTELVNFLSYFVELGTQPAT Carbamidomethyl@N-term cleaved T-Q@C-term; missed K-A@1 -0.00837818998843431 2441.23950195313 814.7538 2441.24780273438 814.756530761719 3 10 1.1.1.5037.14 1 73.3119 934.4022 73.2962 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 80.2799999713898 KAGTELVNFLSYFVELGTQPAT Cation:Na(E)@15 cleaved T-Q@C-term; missed K-A@1 -0.00245794001966715 2406.2060546875 803.0759 2406.20825195313 803.076721191406 3 8 1.1.1.5059.12 1 73.9012 1605.129 73.6172 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 75.2499997615814 KAGTELVNFLSYFVELGTQPAT Deamidated(Q)@19; Oxidation(P)@20 cleaved T-Q@C-term; missed K-A@1 0.0457160994410515 2401.25122070313 801.4243 2401.20532226563 801.409057617188 3 11 1.1.1.5042.11 1 73.4435 2961.873 73.4304 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 75.2499997615814 KAGTELVNFLSYFVELGTQPAT Oxidation(K)@1; Deamidated(N)@8 cleaved T-Q@C-term; missed K-A@1 0.0036033398937434 2401.20874023438 801.4102 2401.20532226563 801.409057617188 3 10 1.1.1.5131.18 1 75.8105 1291.195 75.7649 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 73.1000006198883 KAGTELVNFLSYFVELGTQPAT reduced acrolein addition +58(K)@1; Ammonia-loss(N)@8 cleaved T-Q@C-term; missed K-A@1 0.00536121008917689 2425.2470703125 809.423 2425.24169921875 809.421203613281 3 10 1.1.1.5060.12 1 73.9281 3786.271 73.8596 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 63.5200023651123 KAGTELVNFLSYFVELGTQPAT Cation:K(E)@15 cleaved T-Q@C-term; missed K-A@1 0.0130853001028299 2422.1953125 808.4057 2422.18237304688 808.4013671875 3 7 1.1.1.5043.11 1 73.4702 941.5992 73.4304 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 63.5200023651123 KAGTELVNFLSYFVELGTQPAT Methyl(E)@15 cleaved T-Q@C-term; missed K-A@1 -0.0104884002357721 2398.2314453125 800.4178 2398.24194335938 800.421264648438 3 8 1.1.1.5071.6 1 74.2206 1183.406 74.2923 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.00163426995277405 2512.28686523438 838.4362 2512.28491210938 838.435607910156 3 16 1.1.1.5022.15 1 72.9099 39496.96 73.1091 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 -0.00367428991012275 2512.28125 629.0776 2512.28491210938 629.078491210938 4 9 1.1.1.5023.12 1 72.9345 8836.471 73.1358 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.00200045993551612 2512.287109375 838.4363 2512.28491210938 838.435607910156 3 25 1.1.1.5029.12 1 73.0964 40463.32 73.1358 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ Deamidated(N)@8 missed K-A@1 0.0127608999609947 2513.28173828125 838.7679 2513.26904296875 838.763610839844 3 25 1.1.1.5030.14 1 73.1247 23589.19 73.1091 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1 missed K-A@1 -0.0198733992874622 2570.306640625 857.7762 2570.32690429688 857.782897949219 3 10 1.1.1.5030.15 1 73.1256 1225.165 73.0284 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.00200045993551612 2512.287109375 838.4363 2512.28491210938 838.435607910156 3 24 1.1.1.5036.13 1 73.2842 40463.32 73.1358 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.00218356004916132 2512.287109375 838.4363 2512.28491210938 838.435607910156 3 22 1.1.1.5043.14 1 73.4727 34742.97 73.1891 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.000964224978815764 2512.28564453125 629.0787 2512.28491210938 629.078491210938 4 8 1.1.1.5045.7 1 73.5203 4797.144 73.2427 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.00145248998887837 2512.28662109375 629.0789 2512.28491210938 629.078491210938 4 11 1.1.1.5047.10 1 73.576 3406.656 73.2962 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.000352573988493532 2512.28540039063 838.4357 2512.28491210938 838.435607910156 3 15 1.1.1.5050.12 1 73.6579 12824.98 73.3765 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 -0.00459109991788864 2512.28051757813 838.4341 2512.28491210938 838.435607910156 3 19 1.1.1.5057.14 1 73.8486 4084.114 73.8326 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 -0.00459109991788864 2512.28051757813 838.4341 2512.28491210938 838.435607910156 3 17 1.1.1.5064.13 1 74.0371 4084.114 73.8326 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.00163426995277405 2512.28686523438 838.4362 2512.28491210938 838.435607910156 3 13 1.1.1.5071.11 1 74.2248 1913.66 74.1842 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 -0.0152107998728752 2512.26953125 838.4305 2512.28491210938 838.435607910156 3 14 1.1.1.5078.11 1 74.4138 1773.513 74.4543 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ Acetyl@N-term missed K-A@1 0.00547775020822883 2554.30102539063 852.4409 2554.29541015625 852.439086914063 3 18 1.1.1.5119.15 1 75.4905 5907.337 75.5527 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; Ammonia-loss(N)@8 missed K-A@1 0.00741562992334366 2553.30786132813 852.1099 2553.30029296875 852.107360839844 3 16 1.1.1.5045.16 1 73.5278 4456.495 73.5372 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.3100016117096 KAGTELVNFLSYFVELGTQPATQ Cation:Na(E)@15 missed K-A@1 -0.0135759003460407 2534.25341796875 845.7584 2534.26684570313 845.762939453125 3 22 1.1.1.5027.16 1 73.0461 6930.85 73.1358 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 88.4899973869324 KAGTELVNFLSYFVELGTQPATQ Cation:K(E)@15 missed K-A@1 -0.00316846999339759 2550.23754882813 851.0865 2550.24072265625 851.087585449219 3 11 1.1.1.5028.12 1 73.0696 1608.782 73.1091 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 83.1099987030029 KAGTELVNFLSYFVELGTQPATQ Deamidated(Q)@19; Oxidation(P)@20 missed K-A@1 0.0404600985348225 2529.30419921875 844.1087 2529.26391601563 844.09521484375 3 10 1.1.1.5025.13 1 72.9895 3706.426 73.1091 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 80.2799999713898 KAGTELVNFLSYFVELGTQPATQ Cation:Na(E)@15 missed K-A@1 -0.0135759003460407 2534.25341796875 845.7584 2534.26684570313 845.762939453125 3 17 1.1.1.5034.18 1 73.2349 6930.85 73.1358 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 79.3099999427795 KAGTELVNFLSYFVELGTQPATQ Dioxidation(P)@20 missed K-A@1 0.033594898879528 2544.30810546875 849.11 2544.27490234375 849.098876953125 3 10 1.1.1.5029.13 1 73.0972 216.3552 73.0824 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 74.1900026798248 KAGTELVNFLSYFVELGTQPATQ Methyl(Q)@19 missed K-A@1 -0.00457374006509781 2526.29614257813 843.106 2526.30053710938 843.107482910156 3 9 1.1.1.5069.11 1 74.1706 1896.299 74.0761 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 63.5200023651123 KAGTELVNFLSYFVELGTQPATQ Deamidated(Q)@19; Oxidation(P)@20 missed K-A@1 0.0404600985348225 2529.30419921875 844.1087 2529.26391601563 844.09521484375 3 10 1.1.1.5032.16 1 73.1797 3706.426 73.1091 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 63.5200023651123 KAGTELVNFLSYFVELGTQPATQ Deamidated(N)@8; Oxidation(Y)@12 missed K-A@1 0.0404600985348225 2529.30419921875 844.1087 2529.26391601563 844.09521484375 3 9 1.1.1.5039.14 1 73.3655 3806.942 73.0824 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 63.5200023651123 KAGTELVNFLSYFVELGTQPATQ Cation:Na(E)@15 missed K-A@1 -0.00881536025553942 2534.2578125 845.7599 2534.26684570313 845.762939453125 3 9 1.1.1.5041.14 1 73.4193 6721.314 73.1358 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 34.2299997806549 KAGTELVNFLSYFVELGTQPATQ Cation:K(E)@15 missed K-A@1 -0.00767935020849109 2550.2333984375 638.5656 2550.24072265625 638.567504882813 4 6 1.1.1.5028.6 1 73.0646 454.3057 73.1358 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 21.7199996113777 KAGTELVNFLSYFVELGTQPATQ Oxidation(P)@20 missed K-A@1 0.0318967998027802 2528.31176757813 843.7779 2528.27978515625 843.767211914063 3 7 1.1.1.5062.12 1 73.9821 1187.9 74.0218 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 34.7000002861023 KSYFEKSKEQLTPLIK acrolein addition +94(K)@1; acrolein addition +76(K)@8 cleaved A-K@N-term; missed K-S@1; missed K-S@6; missed K-E@8 -0.0270923003554344 2108.12890625 703.7169 2108.15576171875 703.725891113281 3 9 1.1.1.3652.17 1 37.5361 2494.863 37.5199 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 61.5400016307831 KSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPAT reduced acrolein addition +96(K)@6; hexanoyl addition +98(K)@8; MDA adduct +54(K)@16; acrolein addition +112(K)@17 cleaved A-K@N-term; cleaved T-Q@C-term; missed K-S@1; missed K-S@6; missed K-E@8; missed K-K@16; missed K-A@17 -0.0396387986838818 4664.45068359375 1167.12 4664.4921875 1167.13024902344 4 8 1.1.1.5115.19 1 75.3915 1230.083 75.4494 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 15.6900003552437 PLIKK cleaved T-P@N-term; missed K-K@4 0.0173934996128082 597.438720703125 598.446 597.42138671875 598.428649902344 1 5 1.1.1.3169.15 1 25.5713 327.4791 25.4824 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00990881025791168 3308.56811523438 828.1493 3308.55810546875 828.146789550781 4 13 1.1.1.4565.9 1 60.9922 2628.169 61.0332 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.010619199834764 3291.54223632813 823.8928 3291.53149414063 823.89013671875 4 26 1.1.1.4747.11 1 65.6266 2498.559 65.6913 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00760933011770248 3291.53930664063 1098.187 3291.53149414063 1098.18444824219 3 21 1.1.1.4753.16 1 65.7839 7419.853 65.8445 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.0111074997112155 3291.54248046875 823.8929 3291.53149414063 823.89013671875 4 18 1.1.1.4760.10 1 65.9581 2258.285 65.8958 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00483326008543372 3332.564453125 1111.862 3332.55810546875 1111.85998535156 3 15 1.1.1.4760.17 1 65.9639 9323.217 66.2062 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00760933011770248 3291.53930664063 1098.187 3291.53149414063 1098.18444824219 3 17 1.1.1.4767.18 1 66.146 7073.566 65.8701 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00446707010269165 3332.56103515625 1111.861 3332.55810546875 1111.85998535156 3 20 1.1.1.4767.19 1 66.1468 11070.3 66.2325 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.0101308999583125 3291.54174804688 823.8927 3291.53149414063 823.89013671875 4 17 1.1.1.4768.13 1 66.1683 2278.142 65.8958 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00446707010269165 3332.56103515625 1111.861 3332.55810546875 1111.85998535156 3 21 1.1.1.4774.21 1 66.3318 11070.3 66.2325 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 -0.00206756009720266 3332.55615234375 834.1463 3332.55810546875 834.146789550781 4 23 1.1.1.4776.7 1 66.3725 6796.686 66.2588 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00446707010269165 3332.56103515625 1111.861 3332.55810546875 1111.85998535156 3 22 1.1.1.4777.19 1 66.4084 11070.3 66.2325 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.0262436997145414 3291.55786132813 823.8967 3291.53149414063 823.89013671875 4 11 1.1.1.4781.14 1 66.5086 575.6008 66.4672 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00410086987540126 3332.56103515625 1111.861 3332.55810546875 1111.85998535156 3 17 1.1.1.4781.21 1 66.5145 11277.15 66.2325 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00427989987656474 3332.5625 834.1479 3332.55810546875 834.146789550781 4 18 1.1.1.4784.13 1 66.5867 6563.633 66.3107 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(K)@3; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 -0.00624254997819662 3348.54809570313 1117.19 3348.55297851563 1117.19165039063 3 11 1.1.1.4760.18 1 65.9647 1231.212 65.8701 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.0096508301794529 3332.56762695313 834.1492 3332.55810546875 834.146789550781 4 16 1.1.1.4791.14 1 66.7728 3465.171 66.4933 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.0010177600197494 3291.53344726563 1098.185 3291.53149414063 1098.18444824219 3 11 1.1.1.4774.20 1 66.3309 5095.077 66.0498 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 -0.00353236007504165 3332.55444335938 834.1459 3332.55810546875 834.146789550781 4 14 1.1.1.4798.14 1 66.9595 1396.892 66.9433 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00834172964096069 3291.53930664063 1098.187 3291.53149414063 1098.18444824219 3 9 1.1.1.4739.17 1 65.4241 6239.863 65.5629 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00834172964096069 3291.53930664063 1098.187 3291.53149414063 1098.18444824219 3 11 1.1.1.4746.15 1 65.6038 6239.863 65.5629 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00211634999141097 3291.53344726563 1098.185 3291.53149414063 1098.18444824219 3 6 1.1.1.4800.20 1 67.0176 967.4758 66.9433 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.3300018310547 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Acetyl(K)@3; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 -0.00587187008932233 3333.53637695313 1112.186 3333.5419921875 1112.18798828125 3 16 1.1.1.4945.21 1 70.8365 6041.923 70.7359 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 87.1599972248077 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(K)@3; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 -0.00651346007362008 3348.54663085938 838.1439 3348.55297851563 838.1455078125 4 8 1.1.1.4749.9 1 65.676 624.4678 65.5114 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 84.9300026893616 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Acetyl(K)@3; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 -0.00587187008932233 3333.53637695313 1112.186 3333.5419921875 1112.18798828125 3 14 1.1.1.4936.19 1 70.5959 6041.923 70.7359 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 80.2799999713898 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Acetyl(K)@3; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.00278350990265608 3333.544921875 834.3935 3333.5419921875 834.392822265625 4 11 1.1.1.4935.12 1 70.5634 2022.176 70.7359 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 75.2499997615814 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Acetyl(K)@3; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 -0.00587187008932233 3333.53637695313 1112.186 3333.5419921875 1112.18798828125 3 13 1.1.1.4949.20 1 70.9426 6041.923 70.7359 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.023233400657773 3518.71826171875 880.6868 3518.69482421875 880.681030273438 4 16 1.1.1.4752.7 1 65.751 3618.092 65.717 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.0161534994840622 3518.71142578125 880.6851 3518.69482421875 880.681030273438 4 13 1.1.1.4759.10 1 65.9326 3618.388 65.6656 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.00760889006778598 3518.70263671875 880.6829 3518.69482421875 880.681030273438 4 21 1.1.1.4773.11 1 66.2971 7125.006 66.3632 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.00760889006778598 3518.70263671875 880.6829 3518.69482421875 880.681030273438 4 19 1.1.1.4780.11 1 66.4797 7125.006 66.3632 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.0156653001904488 3518.71044921875 880.6849 3518.69482421875 880.681030273438 4 15 1.1.1.4787.11 1 66.6638 3090.508 66.6774 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.0156653001904488 3518.71044921875 880.6849 3518.69482421875 880.681030273438 4 19 1.1.1.4789.12 1 66.7181 3090.508 66.6774 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.0156653001904488 3518.71044921875 880.6849 3518.69482421875 880.681030273438 4 12 1.1.1.4795.13 1 66.8782 3090.508 66.6774 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.0156653001904488 3518.71044921875 880.6849 3518.69482421875 880.681030273438 4 12 1.1.1.4745.8 1 65.5727 3498.038 65.6656 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.0114991003647447 3559.73291015625 890.9405 3559.72143554688 890.937622070313 4 14 1.1.1.4799.12 1 66.9845 5268.11 66.8106 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.023233400657773 3518.71826171875 880.6868 3518.69482421875 880.681030273438 4 10 1.1.1.4804.8 1 67.1158 1702.969 67.078 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.00515168020501733 3559.7265625 890.9389 3559.72143554688 890.937622070313 4 13 1.1.1.4778.12 1 66.4283 3940.885 66.2325 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.0114991003647447 3559.73291015625 890.9405 3559.72143554688 890.937622070313 4 13 1.1.1.4792.12 1 66.7979 5268.11 66.8106 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.035684198141098 3518.73046875 880.6899 3518.69482421875 880.681030273438 4 9 1.1.1.4811.11 1 67.3051 1084.016 67.239 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.0110109001398087 3559.73266601563 890.9404 3559.72143554688 890.937622070313 4 12 1.1.1.4806.12 1 67.1719 4481.116 67.0503 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.8900005817413 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.00515168020501733 3559.7265625 890.9389 3559.72143554688 890.937622070313 4 11 1.1.1.4763.10 1 66.0354 3882.511 66.2325 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 90.4699981212616 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Dioxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.018291600048542 3534.70825195313 884.6843 3534.68994140625 884.679748535156 4 6 1.1.1.4846.10 1 68.2399 357.4617 68.2278 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 70.279997587204 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Acetyl(K)@3; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 -0.00578519003465772 3560.69970703125 891.1822 3560.70556640625 891.183654785156 4 11 1.1.1.4944.11 1 70.8015 2406.717 70.7359 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.0147056998685002 4472.19189453125 895.4456 4472.1767578125 895.442626953125 5 19 1.1.1.4715.8 1 64.789 11627.29 64.7786 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.026587100699544 4472.20361328125 746.3745 4472.1767578125 746.370056152344 6 13 1.1.1.4718.6 1 64.8649 1386.274 64.8051 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.0140952998772264 4472.1904296875 895.4454 4472.1767578125 895.442626953125 5 18 1.1.1.4722.12 1 64.9751 15741.45 65.066 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.0140952998772264 4472.1904296875 895.4454 4472.1767578125 895.442626953125 5 15 1.1.1.4729.10 1 65.1561 15741.45 65.066 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.0152946002781391 4513.21875 903.651 4513.203125 903.64794921875 5 15 1.1.1.4736.13 1 65.3414 8762.179 65.406 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.0147056998685002 4472.19189453125 895.4456 4472.1767578125 895.442626953125 5 12 1.1.1.4708.11 1 64.6072 11627.29 64.7786 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.015905000269413 4513.21923828125 903.6511 4513.203125 903.64794921875 5 14 1.1.1.4728.11 1 65.1309 7438.568 65.066 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.0336260013282299 4472.2099609375 895.4493 4472.1767578125 895.442626953125 5 11 1.1.1.4747.15 1 65.6299 2896.378 65.6656 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Deamidated(Q)@16; acrolein addition +56(K)@28 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.0271384008228779 4513.21923828125 903.6511 4513.19189453125 903.645690917969 5 11 1.1.1.4722.13 1 64.976 7438.568 65.066 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Deamidated(Q)@16; acrolein addition +56(K)@23 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.0271384008228779 4513.21923828125 903.6511 4513.19189453125 903.645690917969 5 10 1.1.1.4729.11 1 65.157 7438.568 65.066 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.041159201413393 4513.24462890625 753.2147 4513.203125 753.207824707031 6 13 1.1.1.4737.8 1 65.3636 2192.308 65.3797 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.8900005817413 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.00929978955537081 4513.212890625 753.2094 4513.203125 753.207824707031 6 13 1.1.1.4723.8 1 64.9979 2056.357 65.0927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.4699974060059 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26; acrolein addition +56(K)@28 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.000808541022706777 4528.20361328125 906.648 4528.203125 906.647888183594 5 9 1.1.1.4715.9 1 64.7899 1474.78 64.7786 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.079998254776 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(E)@4; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.015964400023222 4529.2138671875 906.8501 4529.1982421875 906.846923828125 5 11 1.1.1.4724.9 1 65.0247 2325.275 64.9621 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.079998254776 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; MDA adduct +62(K)@23; Dethiomethyl(M)@26; Deamidated(Q)@35 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 -0.00454729003831744 4471.173828125 746.2029 4471.17822265625 746.20361328125 6 10 1.1.1.4732.7 1 65.2315 1305.068 65.1445 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 18.3699995279312 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.00858200993388891 4472.1865234375 1119.054 4472.1767578125 1119.05151367188 4 8 1.1.1.4720.17 1 64.9274 2622.85 64.9878 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIK missed K-E@2 -0.00191038998309523 1155.68444824219 578.8495 1155.68627929688 578.850463867188 2 15 1.1.1.3316.14 1 29.1594 27943.43 29.2927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIK missed K-E@2 -0.00191038998309523 1155.68444824219 578.8495 1155.68627929688 578.850463867188 2 16 1.1.1.3323.7 1 29.3315 27943.43 29.2927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIK missed K-E@2 -0.00191038998309523 1155.68444824219 578.8495 1155.68627929688 578.850463867188 2 16 1.1.1.3330.11 1 29.5068 27943.43 29.2927 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIK missed K-E@2 -0.00203245994634926 1155.68432617188 578.8494 1155.68627929688 578.850463867188 2 10 1.1.1.3337.18 1 29.6781 9597.013 29.4156 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIK Acetyl@N-term missed K-E@2 -0.00407793000340462 1197.69287109375 599.8537 1197.69689941406 599.855712890625 2 15 1.1.1.3696.13 1 38.6408 4901.222 38.6527 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.6999988555908 SKEQLTPLIK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-E@2 -0.00494018010795116 1241.71801757813 621.8663 1241.72314453125 621.868835449219 2 11 1.1.1.4043.11 1 47.55 3462.73 47.4862 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.9099988937378 SKEQLTPLIK Acetyl@N-term missed K-E@2 -0.00407793000340462 1197.69287109375 599.8537 1197.69689941406 599.855712890625 2 8 1.1.1.3689.16 1 38.4611 4878.076 38.6527 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.7400004863739 SKEQLTPLIK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-E@2 -0.00494018010795116 1241.71801757813 621.8663 1241.72314453125 621.868835449219 2 9 1.1.1.4036.12 1 47.3708 3462.73 47.4862 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIKK Acetyl(K)@10 missed K-E@2; missed K-K@10 -0.00240385998040438 1325.78942871094 663.902 1325.79187011719 663.903198242188 2 15 1.1.1.3378.14 1 30.6927 2823.836 30.7489 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIKK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-E@2; missed K-K@10 -0.00478339986875653 1369.81323242188 457.6117 1369.81811523438 457.613311767578 3 13 1.1.1.3839.6 1 42.3129 16664.44 42.2244 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.8499999046326 SKEQLTPLIKK Acetyl@N-term missed K-E@2; missed K-K@10 -0.0017298300517723 1325.7900390625 442.9373 1325.79187011719 442.937896728516 3 12 1.1.1.3433.6 1 32.0445 8852.652 32.0882 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.759997844696 SKEQLTPLIKK Acetyl(K)@10 missed K-E@2; missed K-K@10 -0.00240385998040438 1325.78942871094 663.902 1325.79187011719 663.903198242188 2 11 1.1.1.3385.12 1 30.8656 2823.836 30.7489 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.7400004863739 SKEQLTPLIKK Formyl(K)@10; reduced acrolein addition +58(K)@11 missed K-E@2; missed K-K@10 -0.00478339986875653 1369.81323242188 457.6117 1369.81811523438 457.613311767578 3 10 1.1.1.3832.4 1 42.1252 16664.44 42.2244 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.4099972248077 SKEQLTPLIKK Ser->LacticAcid(S)@1; acrolein addition +56(K)@2 missed K-E@2; missed K-K@10 0.013468200340867 1324.80993652344 442.6106 1324.79663085938 442.606140136719 3 9 1.1.1.3180.7 1 25.8154 7725.26 25.8816 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 64.4400000572205 SKEQLTPLIKK Carboxyethyl(K)@10 missed K-E@2; missed K-K@10 0.000199590998818167 1355.80261230469 452.9415 1355.80236816406 452.94140625 3 7 1.1.1.3690.4 1 38.4771 1857.777 38.4184 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 42.0399993658066 SKEQLTPLIKK Carbamyl@N-term missed K-E@2; missed K-K@10 0.00412878999486566 1326.79113769531 443.271 1326.787109375 443.269653320313 3 7 1.1.1.3436.6 1 32.1216 3270.93 32.0882 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAK 0.000175644992850721 971.492492675781 486.7535 971.492370605469 486.753479003906 2 15 1.1.1.3009.4 1 21.6926 47020.02 21.8205 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAK 0.000175644992850721 971.492492675781 486.7535 971.492370605469 486.753479003906 2 15 1.1.1.3016.2 1 21.8554 47020.02 21.8205 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAK 0.000175644992850721 971.492492675781 486.7535 971.492370605469 486.753479003906 2 15 1.1.1.3023.3 1 22.0354 47020.02 21.8205 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAK 0.000175644992850721 971.492492675781 486.7535 971.492370605469 486.753479003906 2 14 1.1.1.3030.2 1 22.2124 6519.644 21.942 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.5499997138977 SPELQAEAK Cation:Na(E)@7 0.000522064976394176 993.474853515625 497.7447 993.474304199219 497.744445800781 2 8 1.1.1.3013.4 1 21.7843 187.8144 21.8205 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 52.7899980545044 SPELQAEAK -7.45587021810934E-06 971.492248535156 486.7534 971.492370605469 486.753479003906 2 7 1.1.1.3044.7 1 22.5553 806.2233 22.6649 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 25.6599992513657 SPELQAEAK -7.45587021810934E-06 971.492248535156 486.7534 971.492370605469 486.753479003906 2 5 1.1.1.3054.8 1 22.796 806.2233 22.6649 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAKSYFEK missed K-S@9 -0.00413388991728425 1625.78942871094 542.9371 1625.79370117188 542.938537597656 3 13 1.1.1.3630.8 1 36.9656 14634.49 37.0573 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAKSYFEK Acetyl(K)@9 missed K-S@9 -0.00380973005667329 1667.80041503906 834.9075 1667.80432128906 834.909423828125 2 18 1.1.1.3877.18 1 43.3089 3030.939 43.3431 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAKSYFEK Formyl(K)@9; reduced acrolein addition +58(K)@14 missed K-S@9 -0.000918800011277199 1711.82971191406 856.9221 1711.83044433594 856.922546386719 2 12 1.1.1.4152.17 1 50.3339 1411.44 50.3425 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAKSYFEK Formyl(K)@9 missed K-S@9 -0.00941208004951477 1653.779296875 827.8969 1653.78857421875 827.901611328125 2 13 1.1.1.3870.19 0 43.1267 1466.679 43.1595 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.759997844696 SPELQAEAKSYFEK Carbamidomethyl(K)@9 missed K-S@9 0.00454314006492496 1682.81982421875 561.9472 1682.81518554688 561.945678710938 3 10 1.1.1.3630.10 1 36.9673 2849.184 37.0067 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.1999990940094 SPELQAEAKSYFEK Ser->LacticAcid(S)@10; acrolein addition +56(K)@14 missed K-S@9 0.0107810003682971 1666.81982421875 556.6139 1666.80895996094 556.610290527344 3 10 1.1.1.3681.9 1 38.2495 2206.848 38.2648 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIK missed K-S@5; missed K-E@7 0.0014519999967888 1809.98913574219 604.337 1809.98767089844 604.336486816406 3 13 1.1.1.3648.15 1 37.434 58213.5 37.5199 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.470002412796 SYFEKSKEQLTPLIK Acetyl(K)@7 missed K-S@5; missed K-E@7 -0.000376596988644451 1851.99792480469 618.3399 1851.99816894531 618.340026855469 3 12 1.1.1.3886.10 1 43.5336 2489.563 43.5735 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.3800003528595 SYFEKSKEQLTPLIK Acetyl(K)@7 missed K-S@5; missed K-E@7 -0.000193496001884341 1851.99829101563 618.34 1851.99816894531 618.340026855469 3 12 1.1.1.3893.9 1 43.7103 2049.468 43.7255 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 26.3799995183945 SYFEKSKEQLTPLIK missed K-S@5; missed K-E@7 0.0014519999967888 1809.98913574219 604.337 1809.98767089844 604.336486816406 3 9 1.1.1.3674.11 1 38.0765 2406.223 37.9909 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIKK missed K-S@5; missed K-E@7; missed K-K@15 0.0184135008603334 1938.10107421875 970.0578 1938.08264160156 970.048583984375 2 17 1.1.1.3480.6 1 33.2209 1132.377 33.2261 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIKK missed K-S@5; missed K-E@7; missed K-K@15 0.0069679100997746 1938.08972167969 485.5297 1938.08264160156 485.527923583984 4 22 1.1.1.3484.4 1 33.3059 82822.64 33.2507 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIKK Acetyl(K)@5 missed K-S@5; missed K-E@7; missed K-K@15 -0.00352608994580805 1980.08972167969 496.0297 1980.09313964844 496.030578613281 4 18 1.1.1.3736.5 1 39.6748 11754.5 39.6418 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIKK Formyl(K)@5; reduced acrolein addition +58(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 -0.00334261008538306 2024.11596679688 675.7126 2024.11938476563 675.713745117188 3 17 1.1.1.4039.17 1 47.4518 4555.863 47.409 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIKK Acetyl(S)@6 missed K-S@5; missed K-E@7; missed K-K@15 -0.000131199994939379 1980.09313964844 661.0383 1980.09313964844 661.038330078125 3 14 1.1.1.3800.12 1 41.2994 3952.939 41.3847 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 95.6200003623962 SYFEKSKEQLTPLIKK Formyl(K)@5; reduced acrolein addition +58(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 -0.0015104899648577 2024.11779785156 507.0367 2024.11938476563 507.037139892578 4 11 1.1.1.4034.4 1 47.3131 5820.469 47.3835 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.7099993228912 SYFEKSKEQLTPLIKK Acetyl(K)@5 missed K-S@5; missed K-E@7; missed K-K@15 -0.000863604014739394 1980.09228515625 661.038 1980.09313964844 661.038330078125 3 10 1.1.1.3729.16 1 39.501 5356.078 39.6418 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.739999294281 SYFEKSKEQLTPLIKK Formyl(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 -0.00801466032862663 1966.06945800781 656.3638 1966.07751464844 656.366455078125 3 9 1.1.1.3764.14 1 40.4046 1014.257 40.3906 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 88.0200028419495 SYFEKSKEQLTPLIKK Acetyl@N-term missed K-S@5; missed K-E@7; missed K-K@15 0.00330969993956387 1980.09655761719 496.0314 1980.09313964844 496.030578613281 4 10 1.1.1.3804.6 1 41.3923 6723.413 41.3847 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 79.2599976062775 SYFEKSKEQLTPLIKK Formyl(K)@5; reduced acrolein addition +58(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 -0.00102222000714391 2024.11853027344 507.0369 2024.11938476563 507.037139892578 4 10 1.1.1.3963.10 1 45.4842 4505.799 45.4475 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 76.3999998569489 SYFEKSKEQLTPLIKK Formyl(K)@5; reduced acrolein addition +58(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 -0.0015104899648577 2024.11779785156 507.0367 2024.11938476563 507.037139892578 4 10 1.1.1.4042.7 1 47.5208 5820.469 47.3835 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 44.6799993515015 SYFEKSKEQLTPLIKK acrolein addition +56(K)@7; Deamidated(Q)@9 missed K-S@5; missed K-E@7; missed K-K@15 0.0151012996211648 1995.10815429688 499.7843 1995.09289550781 499.780487060547 4 9 1.1.1.3477.8 1 33.136 6763.19 33.1521 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 VKSPELQAEAK missed K-S@2 -9.42589977057651E-05 1198.65563964844 600.3351 1198.65576171875 600.335144042969 2 14 1.1.1.3042.8 1 22.5104 9274.553 22.6405 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 VKSPELQAEAK Acetyl@N-term missed K-S@2 -0.00278361001983285 1240.66369628906 621.3391 1240.66625976563 621.340454101563 2 16 1.1.1.3175.11 1 25.7237 8305.906 25.7045 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 VKSPELQAEAK Formyl@N-term missed K-S@2 -0.00436461018398404 1226.64624023438 614.3304 1226.65063476563 614.332580566406 2 10 1.1.1.3164.18 1 25.4495 1882.962 25.4573 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 VKSPELQAEAK Delta:H(2)C(2)(K)@2 missed K-S@2 -0.00554980989545584 1224.66577148438 409.2292 1224.67138671875 409.231079101563 3 10 1.1.1.3126.3 1 24.515 1496.281 24.5582 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.7600028514862 VKSPELQAEAK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-S@2 0.00310547999106348 1284.69567871094 643.3551 1284.69250488281 643.353515625 2 13 1.1.1.3551.3 1 34.964 2236.621 35.1228 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.4099972248077 VKSPELQAEAK Carbamidomethyl@N-term missed K-S@2 -0.00520324986428022 1255.67199707031 419.5646 1255.67724609375 419.566345214844 3 8 1.1.1.3049.3 1 22.6713 912.8533 22.6649 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 84.1899991035461 VKSPELQAEAK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-S@2 0.00310547999106348 1284.69567871094 643.3551 1284.69250488281 643.353515625 2 8 1.1.1.3558.18 1 35.1401 2236.621 35.1228 4 49.34 49.34 100 100 100 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 42.0399993658066 VKSPELQAEAKSYFEK acrolein addition +56(K)@11; Ser->LacticAcid(S)@12 missed K-S@2; missed K-S@11 0.0174649003893137 1893.98974609375 474.5047 1893.97241210938 474.500366210938 4 11 1.1.1.3595.9 1 36.087 3968.007 36.1022 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 AEAESLYQSKYEELQITAGR missed K-Y@10 0.00315214996226132 2285.12060546875 762.7142 2285.11767578125 762.713134765625 3 32 1.1.1.3801.5 1 41.3225 5792.449 41.3595 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 AQYEDIAQK -0.00438037980347872 1064.50952148438 533.262 1064.51379394531 533.264221191406 2 8 1.1.1.3101.9 1 23.8886 1620.093 23.8011 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 FSSCGGGGGSFGAGGGFGSR Carbamidomethyl(C)@4 0.0118803000077605 1764.73950195313 883.377 1764.72741699219 883.370971679688 2 20 1.1.1.3467.11 1 32.9004 1236.873 32.9302 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 0.00571230985224247 2382.9501953125 795.324 2382.94458007813 795.322143554688 3 31 1.1.1.3077.9 1 23.3024 3699.803 23.356 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 GSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYR 0.0126211997121572 3311.31323242188 828.8356 3311.30078125 828.832458496094 4 26 1.1.1.3137.11 1 24.7961 1050.863 24.777 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 LRSEIDNVKK missed R-S@2; missed K-K@9 -0.00365569000132382 1200.67895507813 401.2336 1200.6826171875 401.234832763672 3 13 1.1.1.2969.2 1 20.7977 628.7328 20.8542 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 MSGECAPNVSVSVSTSHTTISGGGSR Oxidation(M)@1; Carbamidomethyl(C)@5 0.00789862032979727 2580.16235351563 861.0614 2580.15454101563 861.058776855469 3 12 1.1.1.3426.21 1 31.8782 1288.045 31.8834 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 NKYEDEINKR missed K-Y@2; missed K-R@9 -0.00258542993105948 1307.64428710938 436.8887 1307.64697265625 436.889587402344 3 12 1.1.1.3026.2 0 22.0996 263.9892 22.0912 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 QISNLQQSISDAEQR -0.00423223013058305 1715.83959960938 572.9538 1715.84387207031 572.955200195313 3 13 1.1.1.3629.11 1 36.9431 2668.267 36.9816 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 SKAEAESLYQSKYEELQITAGR missed K-A@2; missed K-Y@12 0.00144798995461315 2500.24609375 626.0688 2500.24462890625 626.068420410156 4 19 1.1.1.3722.15 1 39.3168 7292.892 39.2493 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 SLDLDSIIAEVK -0.00188761996105313 1301.70593261719 651.8602 1301.70788574219 651.861206054688 2 17 1.1.1.4326.7 1 54.7647 4295.777 54.7559 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 SLDLDSIIAEVKAQYEDIAQK missed K-A@12 -0.00562309008091688 2348.20532226563 783.7424 2348.21118164063 783.744323730469 3 15 1.1.1.4838.5 1 68.0208 3092.656 67.9058 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 SLNNQFASFIDKVR missed K-V@12 -0.000980064040049911 1637.85168457031 546.9578 1637.8525390625 546.958129882813 3 13 1.1.1.4091.11 1 48.7717 5936.43 48.8108 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 SLVNLGGSK -0.00448015984147787 873.487487792969 437.751 873.492004394531 437.753265380859 2 9 1.1.1.3291.5 1 28.531 4786.882 28.6487 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 SLVNLGGSKSISISVAR missed K-S@9 0.00232818000949919 1686.96508789063 563.329 1686.962890625 563.328247070313 3 14 1.1.1.3845.9 1 42.4742 3657.147 42.3835 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 TLLEGEESR -0.0035558498930186 1032.50524902344 517.2599 1032.5087890625 517.261657714844 2 13 1.1.1.3151.12 1 25.1287 5082.259 25.1163 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 TNAENEFVTIK 0.00444068014621735 1264.63452148438 633.3245 1264.6298828125 633.322265625 2 14 1.1.1.3497.14 1 33.6359 2034.415 33.6959 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 TNAENEFVTIKK missed K-K@11 0.00154409999959171 1392.72631835938 465.2494 1392.72485351563 465.248901367188 3 10 1.1.1.3281.8 1 28.2881 7783.511 28.3534 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 YEELQITAGR -0.00365427997894585 1178.58947753906 590.302 1178.59313964844 590.303833007813 2 12 1.1.1.3441.11 1 32.2553 1138.646 32.338 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 1.34678733348846 99.0000009536743 DVDGAYMTK -0.00174192001577467 998.436096191406 500.2253 998.437927246094 500.226226806641 2 7 1.1.1.3115.15 1 24.2485 1369.473 24.3098 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.254925221204758 88.9299988746643 IEISELNRVIQR missed R-V@8 -0.0030878100078553 1468.8330078125 490.6183 1468.83618164063 490.619323730469 3 9 1.1.1.3844.3 0 42.4427 11534.39 42.542 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.189095705747604 84.5899999141693 LNDLEDALQQAK -0.00918264035135508 1356.67932128906 679.3469 1356.6884765625 679.351501464844 2 8 1.1.1.3751.19 1 40.0678 916.7036 40.154 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.0506099946796894 55.3699970245361 QISNLQQSISDAEQRGENALK missed R-G@15 0.000956477015279233 2328.16772460938 777.0632 2328.1669921875 777.062927246094 3 10 1.1.1.3967.16 1 45.5909 4513.389 45.651 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.0172766130417585 28.7999987602234 SGGGFSSGSAGIINYQRR missed R-R@17 -0.00319634005427361 1812.88366699219 605.3018 1812.88671875 605.302856445313 3 8 1.1.1.3476.14 1 33.1162 952.3722 33.1026 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.0145735256373882 25.3600001335144 AEAESLYQSK -0.00520118977874517 1124.52990722656 563.2722 1124.53491210938 563.274780273438 2 4 1.1.1.3105.18 1 23.9935 240.8399 24.0518 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.010550182312727 20.1299995183945 SISISVAR -0.00322036002762616 831.478271484375 416.7464 831.4814453125 416.747985839844 2 8 1.1.1.3320.5 1 29.2495 3902.999 29.2681 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.00700490176677704 99.0000009536743 SYGSGGGSYGSGGGGGGHGSYGSGSSSGGYR Carbamidomethyl@N-term cleaved S-S@N-term 0.012980000115931 2716.09008789063 906.3706 2716.0771484375 906.366271972656 3 15 1.1.1.3080.6 1 23.3749 2971.585 23.4287 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.000869458774104714 69.1399991512299 SLNNQFASFIDKVRFLEQQNQVLQTKWELLQQVDTSTR Deamidated(N)@20; Deamidated(Q)@24 missed K-V@12; missed R-F@14; missed K-W@26 -0.0437720008194447 4553.27587890625 911.6624 4553.31884765625 911.671081542969 5 9 1.1.1.4725.13 1 65.0541 1496.573 64.9621 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.000434511806815863 97.5000023841858 SSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYR cleaved G-S@N-term -7.02827978134155 2739.05932617188 685.7721 2746.08764648438 687.529174804688 4 12 1.1.1.3083.5 1 23.4478 256.1523 23.453 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 27.2199988365173 AEAESLYQSKYEELQITAGR Deamidated(Q)@8 missed K-Y@10 0.0526462011039257 2286.15405273438 572.5458 2286.1015625 572.532653808594 4 7 1.1.1.3802.10 1 41.3451 1370.78 41.3344 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 31.4300000667572 AQYEDIAQK -0.00438037980347872 1064.50952148438 533.262 1064.51379394531 533.264221191406 2 6 1.1.1.3094.8 1 23.7113 1620.093 23.8011 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 0.00571230985224247 2382.9501953125 795.324 2382.94458007813 795.322143554688 3 18 1.1.1.3085.12 1 23.4967 3699.803 23.356 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR Lys-add@N-term; Oxidation(Y)@7 0.00403029983863235 2527.03881835938 843.3535 2527.03442382813 843.352111816406 3 19 1.1.1.3103.11 1 23.9457 272.5547 23.9509 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 GSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYR 0.0266027990728617 3311.3271484375 1104.783 3311.30078125 1104.77416992188 3 13 1.1.1.3135.15 1 24.7474 1761.991 24.777 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 77.3899972438812 IEISELNRVIQR missed R-V@8 -0.0030878100078553 1468.8330078125 490.6183 1468.83618164063 490.619323730469 3 9 1.1.1.3851.7 0 42.6307 11534.39 42.542 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 QISNLQQSISDAEQR -0.00423223013058305 1715.83959960938 572.9538 1715.84387207031 572.955200195313 3 8 1.1.1.3636.11 1 37.1199 2668.267 36.9816 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 94.7499990463257 SGGGGGRFSSCGGGGGSFGAGGGFGSR Arg->GluSA(R)@7; Hex(S)@10; Carbamidomethyl(C)@11 missed R-F@7 -0.0198897998780012 2411.947265625 804.9897 2411.96728515625 804.996398925781 3 12 1.1.1.3848.16 1 42.5591 692.4484 42.5685 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 SKAEAESLYQSKYEELQITAGR missed K-A@2; missed K-Y@12 0.00144798995461315 2500.24609375 626.0688 2500.24462890625 626.068420410156 4 16 1.1.1.3714.17 1 39.1117 7292.892 39.2493 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 SKAEAESLYQSKYEELQITAGR missed K-A@2; missed K-Y@12 -6.2209801399149E-05 2500.24462890625 834.4221 2500.24462890625 834.422119140625 3 9 1.1.1.3715.21 1 39.1408 1586.869 39.2235 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 SLDLDSIIAEVKAQYEDIAQK missed K-A@12 -0.00562309008091688 2348.20532226563 783.7424 2348.21118164063 783.744323730469 3 15 1.1.1.4831.8 1 67.8361 3092.656 67.9058 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 SLDLDSIIAEVKAQYEDIAQK missed K-A@12 0.00120363000314683 2348.21264648438 588.0604 2348.21118164063 588.06005859375 4 9 1.1.1.4834.5 1 67.914 613.6923 67.9058 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 SLVNLGGSK -0.00448015984147787 873.487487792969 437.751 873.492004394531 437.753265380859 2 10 1.1.1.3298.7 1 28.706 4786.882 28.6487 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 SLVNLGGSKSISISVAR missed K-S@9 0.00232818000949919 1686.96508789063 563.329 1686.962890625 563.328247070313 3 12 1.1.1.3838.5 1 42.2855 3657.147 42.3835 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 29.1500002145767 TLLEGEESR -0.0035558498930186 1032.50524902344 517.2599 1032.5087890625 517.261657714844 2 8 1.1.1.3144.8 1 24.9606 5082.259 25.1163 5 39.9 39.9 72.3599970340729 49.0700006484985 39.5999997854233 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 TNAENEFVTIKK missed K-K@11 0.00326933991163969 1392.72802734375 697.3713 1392.72485351563 697.369750976563 2 14 1.1.1.3285.10 0 28.3971 955.591 28.3534 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 AAFTECCQAADK Carbamidomethyl(C)@6; Carbamidomethyl(C)@7 0.00103615003172308 1370.56042480469 686.2875 1370.55944824219 686.287048339844 2 10 1.1.1.3094.13 1 23.7197 821.7333 23.8011 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 ADDKETCFAEEGK Carbamidomethyl(C)@7 missed K-E@4 0.000996773946098983 1498.62548828125 500.5491 1498.62463378906 500.548797607422 3 16 1.1.1.3048.3 1 22.6596 255.0999 22.6405 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 AEFAEVSK -0.00379700004123151 879.430053710938 440.7223 879.433776855469 440.724182128906 2 7 1.1.1.3116.3 1 24.2642 928.2679 24.3098 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 AEFAEVSKLVTDLTK missed K-L@8 -0.00186309998389333 1649.8857421875 550.9692 1649.88757324219 550.969787597656 3 15 1.1.1.4267.2 1 53.2545 4129.418 53.2499 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 AVMDDFAAFVEK Oxidation(M)@3 -0.00389032997190952 1357.61853027344 679.8165 1357.62243652344 679.818481445313 2 19 1.1.1.3903.12 1 43.9658 15556.29 43.9278 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 CCTESLVNR Carbamidomethyl(C)@1; Carbamidomethyl(C)@2 -0.0033351699821651 1137.48742675781 569.751 1137.49072265625 569.752624511719 2 11 1.1.1.3110.15 0 24.1208 1350.711 24.0774 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 ETYGEMADCCAK Oxidation(M)@6; Carbamidomethyl(C)@9; Carbamidomethyl(C)@10 -5.10393983859103E-05 1449.52111816406 725.7678 1449.52099609375 725.767822265625 2 13 1.1.1.2991.4 1 21.2877 136.1174 21.2672 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 KVPQVSTPTLVEVSR missed K-V@1 0.00316908000968397 1638.93359375 547.3185 1638.93041992188 547.317443847656 3 20 1.1.1.3658.5 0 37.6784 33567.93 37.5943 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 LDELRDEGK missed R-D@5 -0.00249599991366267 1073.53283691406 537.7737 1073.53527832031 537.77490234375 2 11 1.1.1.2996.7 1 21.4172 119.7034 21.4225 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 RHPDYSVVLLLR missed R-H@1 -5.74340010643937E-05 1466.83569335938 489.9525 1466.83581542969 489.952545166016 3 15 1.1.1.3895.5 1 43.7574 7624.201 43.7004 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 RPCFSALEVDETYVPK Carbamidomethyl(C)@3 -0.00725262006744742 1909.91711425781 637.6463 1909.92443847656 637.648742675781 3 16 1.1.1.3852.8 1 42.6576 3638.709 42.6476 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 TCVADESAENCDK Carbamidomethyl(C)@2; Carbamidomethyl(C)@11 0.00264213001355529 1497.57385253906 749.7942 1497.57116699219 749.792846679688 2 17 1.1.1.2936.3 1 20.2384 149.0563 20.2437 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 YICENQDSISSK Carbamidomethyl(C)@3 -0.00579075003042817 1442.62902832031 722.3218 1442.634765625 722.324645996094 2 14 1.1.1.3104.12 1 23.9708 2153.578 24.0265 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 1.88605630397797 99.0000009536743 LVAASQAALGL -0.00713041983544827 1012.58465576172 507.2996 1012.59167480469 507.303131103516 2 14 1.1.1.3874.7 1 43.2211 8885.541 43.2119 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 1.15490198135376 99.0000009536743 EFNAETFTFHADICTLSEKER Carbamidomethyl(C)@14 missed K-E@19 0.00432578986510634 2544.16381835938 637.0482 2544.1591796875 637.047058105469 4 13 1.1.1.3998.9 1 46.3861 1617.093 46.4013 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.58335953950882 96.8500018119812 VPQVSTPTLVEVSR -0.00171462004072964 1510.83386230469 756.4242 1510.83544921875 756.425048828125 2 9 1.1.1.3763.17 0 40.3821 2278.687 40.4407 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.129011183977127 78.9900004863739 AAFTECCQAADKAACLLPK Carbamidomethyl(C)@6; Carbamidomethyl(C)@7; Carbamidomethyl(C)@15 missed K-A@12 -0.00102056004106998 2123.9794921875 709.0004 2123.98022460938 709.000671386719 3 11 1.1.1.3824.19 1 41.9258 3733.512 41.9591 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.0840727910399437 69.8499977588654 YLYEIAR 0.00439416989684105 926.490661621094 464.2526 926.486145019531 464.250366210938 2 6 1.1.1.3478.3 0 33.1565 1633.901 33.2507 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.0624821111559868 62.6500010490417 TYETTLEK -0.00265528005547822 983.478454589844 492.7465 983.481140136719 492.747833251953 2 6 1.1.1.3109.9 1 24.0881 1948.299 24.0012 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.0168249271810055 30.2500009536743 NECFLQHKDDNPNLPR Carbamidomethyl(C)@3 missed K-D@8 0.010160299949348 1995.93249511719 499.9904 1995.92211914063 499.98779296875 4 10 1.1.1.3303.13 1 28.8362 1895.454 28.8734 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.0136762224137783 25.560000538826 CCAAADPHECYAK Carbamidomethyl(C)@1; Carbamidomethyl(C)@2; Carbamidomethyl(C)@10 -0.00741920992732048 1551.5830078125 518.2016 1551.59045410156 518.2041015625 3 10 1.1.1.2987.4 1 21.1843 266.6509 21.1896 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.00612308504059911 70.4999983310699 NLGKVGSK Deamidated(N)@1; acrolein addition +56(K)@4; MDA adduct +54(K)@8 missed K-V@4 0.00624084006994963 912.497863769531 457.2562 912.491638183594 457.253112792969 2 9 1.1.1.3316.9 1 29.1543 14330.6 29.0466 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.000434511806815863 76.5900015830994 VFDEFKPLVEEPQNLIK -0.0228416007012129 2044.0654296875 682.3624 2044.08813476563 682.369995117188 3 10 1.1.1.4164.15 1 50.6378 5240.405 50.6736 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 85.5300009250641 AAFTECCQAADK Carbamidomethyl(C)@6; Carbamidomethyl(C)@7 0.00103615003172308 1370.56042480469 686.2875 1370.55944824219 686.287048339844 2 7 1.1.1.3101.12 1 23.8936 821.7333 23.8011 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 99.0000009536743 AVMDDFAAFVEK Oxidation(M)@3 -0.00389032997190952 1357.61853027344 679.8165 1357.62243652344 679.818481445313 2 13 1.1.1.3896.10 1 43.7868 15556.29 43.9278 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 99.0000009536743 CCTESLVNR Carbamidomethyl(C)@1; Carbamidomethyl(C)@2 -0.0033351699821651 1137.48742675781 569.751 1137.49072265625 569.752624511719 2 8 1.1.1.3103.8 0 23.9407 1350.711 24.0774 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 97.1300005912781 KVPQVSTPTLVEVSR missed K-V@1 -0.00367474998347461 1638.92687988281 820.4707 1638.93041992188 820.472534179688 2 8 1.1.1.3651.14 0 37.5089 6736.135 37.6191 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 99.0000009536743 LVAASQAALGL -0.00713041983544827 1012.58465576172 507.2996 1012.59167480469 507.303131103516 2 11 1.1.1.3881.8 1 43.4052 8885.541 43.2119 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 93.2399988174438 LVAASQAALGL Deamidated(Q)@6 0.019208200275898 1013.59484863281 507.8047 1013.57568359375 507.795135498047 2 9 1.1.1.3875.7 1 43.2476 3463.034 43.2381 6 29.94 29.94 87.5199973583221 37.5999987125397 29.8900008201599 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 16.3100004196167 TYETTLEK -0.00265528005547822 983.478454589844 492.7465 983.481140136719 492.747833251953 2 5 1.1.1.3102.10 1 23.9113 1948.299 24.0012 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 EIETYHNLLEGGQEDFESSGAGK -0.0010807600338012 2509.12353515625 837.3818 2509.12451171875 837.382080078125 3 20 1.1.1.3833.21 1 42.1666 1861.961 42.1718 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 FSSSSGYGGGSSR -0.00167888996656984 1234.51989746094 618.2672 1234.521484375 618.268005371094 2 16 1.1.1.2980.2 1 21.0033 803.7129 21.0603 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 GGGGSFGYSYGGGSGGGFSASSLGGGFGGGSR 0.0167789999395609 2704.17065429688 902.3975 2704.15380859375 902.391906738281 3 30 1.1.1.3954.19 1 45.261 8133.193 45.2422 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 GGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGK -0.00407114019617438 3222.27026367188 806.5748 3222.2744140625 806.575866699219 4 28 1.1.1.3131.9 1 24.6502 2121.977 24.6069 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 GGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGKSSHS missed K-S@40 0.0367900989949703 3620.46606445313 906.1238 3620.42919921875 906.114624023438 4 14 1.1.1.3094.14 1 23.7213 935.1569 23.7514 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 GGSGGSYGGGGSGGGYGGGSGSR -0.000193771003978327 1790.72021484375 597.914 1790.72045898438 597.9140625 3 27 1.1.1.2954.3 1 20.5081 619.411 20.5458 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 GGSGGSYGGGSGSGGGSGGGYGGGSGGGHSGGSGGGHSGGSGGNYGGGSGSGGGSGGGYGGGSGSR 0.0401306003332138 4971.96923828125 995.4011 4971.92919921875 995.393127441406 5 28 1.1.1.3016.3 1 21.8638 1211.511 21.8691 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 HGVQELEIELQSQLSK -0.00246837991289794 1836.95568847656 919.4851 1836.95812988281 919.486328125 2 12 1.1.1.4031.20 1 47.25 715.8692 47.2818 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 HGVQELEIELQSQLSKK missed K-K@16 0.0161162000149488 1965.0693359375 492.2746 1965.05310058594 492.270538330078 4 12 1.1.1.3978.3 1 45.8607 660.1737 45.8557 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 SGGGGGGGLGSGGSIR 0.00145451002754271 1231.59204101563 616.8033 1231.59057617188 616.802551269531 2 13 1.1.1.3055.15 1 22.8237 2087.774 22.8823 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 SRSGGGGGGGLGSGGSIR cleaved L-S@N-term; missed R-S@2 -0.00268970988690853 1474.72082519531 492.5809 1474.7236328125 492.581817626953 3 13 1.1.1.2996.6 1 21.4139 468.6956 21.474 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 STMQELNSR -5.47495001228526E-05 1064.49206542969 533.2533 1064.49206542969 533.253295898438 2 10 1.1.1.3070.4 1 23.1273 541.4081 23.1873 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 TLNDMRQEYEQLIAK missed R-Q@6 -0.00247217994183302 1850.91723632813 617.9797 1850.91967773438 617.98046875 3 15 1.1.1.3956.11 1 45.3054 14159.71 45.3447 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 1.61978900432587 99.0000009536743 NYSPYYNTIDDLKDQIVDLTVGNNK missed K-D@13 0.0162892993539572 2901.41967773438 726.3622 2901.4033203125 726.358093261719 4 9 1.1.1.4521.13 1 59.8385 1059.288 59.8504 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0.0190880633890629 97.3200023174286 SLGGGFGGGSR cleaved S-S@N-term -0.00175173999741673 950.455261230469 476.2349 950.456970214844 476.235778808594 2 7 1.1.1.3151.8 1 25.1246 870.6581 25.0921 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0.0159229654818773 30.0000011920929 TLLDIDNTR -0.00105359998997301 1059.55505371094 530.7848 1059.55603027344 530.785278320313 2 7 1.1.1.3554.8 1 35.0325 1480.623 35.0979 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0.00700490176677704 15.4100000858307 IGLGGRGGSGGSYGR missed R-G@6 -0.00530300987884402 1349.67456054688 450.8988 1349.68005371094 450.900604248047 3 7 1.1.1.3105.9 1 23.986 2377.405 24.0265 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 EIETYHNLLEGGQEDFESSGAGK -0.0010807600338012 2509.12353515625 837.3818 2509.12451171875 837.382080078125 3 17 1.1.1.3831.20 1 42.1122 1861.961 42.1718 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 79.7999978065491 ESSGAGKI cleaved F-E@N-term; cleaved I-G@C-term; missed K-I@7 -3.0090000629425 744.367309570313 745.3746 747.376281738281 748.383544921875 1 6 1.1.1.5014.16 1 72.6925 585.9166 72.7018 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 GGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGK 0.0111942999064922 3222.28442382813 1075.102 3222.2744140625 1075.09875488281 3 25 1.1.1.3127.12 1 24.553 3087.88 24.6312 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 GGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGK 0.0111942999064922 3222.28442382813 1075.102 3222.2744140625 1075.09875488281 3 19 1.1.1.3134.7 1 24.7232 3087.88 24.6312 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 GGSGGSYGGGSGSGGGSGGGYGGGSGGGHSGGSGGGHSGGSGGNYGGGSGSGGGSGGGYGGGSGSR 0.051681000739336 4971.978515625 1244.002 4971.92919921875 1243.98950195313 4 17 1.1.1.3015.5 1 21.8395 1205.206 21.8691 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 98.8900005817413 HGVQELEIELQSQLSKK missed K-K@16 0.00385983008891344 1965.05676269531 656.0262 1965.05310058594 656.024963378906 3 11 1.1.1.3982.13 1 45.9714 1860.219 45.9327 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 78.2400012016296 KAALEKSLEDTK Formyl(K)@1; ONE addition +154(K)@6; acrolein addition +112(K)@12 missed K-A@1; missed K-S@6 -0.00275745010003448 1625.87341308594 542.9651 1625.87634277344 542.966064453125 3 8 1.1.1.3241.10 0 27.3139 1005.308 27.4935 7 27.67 27.67 60.5099976062775 47.6700007915497 45.7500010728836 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 STMQELNSR 0.00299693993292749 1064.4951171875 533.2548 1064.49206542969 533.253295898438 2 10 1.1.1.3078.3 1 23.3207 509.0405 23.2355 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 2 99.0000009536743 ALEESNYELEGK -0.00140394002664834 1380.63952636719 691.327 1380.64086914063 691.327697753906 2 15 1.1.1.3292.19 1 28.5691 1976.563 28.6238 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 2 99.0000009536743 GSLGGGFSSGGFSGGSFSR 0.00201472989283502 1706.76684570313 854.3907 1706.76489257813 854.389709472656 2 22 1.1.1.3775.10 1 40.6828 7292.313 40.5653 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 2 99.0000009536743 NVSTGDVNVEMNAAPGVDLTQLLNNMR 0.0120296999812126 2871.3974609375 958.1398 2871.38549804688 958.135803222656 3 21 1.1.1.4547.20 1 60.5313 2936.079 60.5636 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 2 99.0000009536743 SLLEGEGSSGGGGR -0.00387122994288802 1261.58605957031 631.8003 1261.58984375 631.802185058594 2 12 1.1.1.3137.9 1 24.7927 810.0511 24.7527 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 2 99.0000009536743 SQYEQLAEQNR 0.0126010002568364 1364.64465332031 683.3296 1364.63208007813 683.323303222656 2 18 1.1.1.3157.5 1 25.2811 390.9909 25.2863 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 2 99.0000009536743 SSSKGSLGGGFSSGGFSGGSFSR cleaved I-S@N-term; missed K-G@4 -0.00434448989108205 2095.95141601563 699.6578 2095.95581054688 699.659240722656 3 20 1.1.1.3638.20 1 37.1788 3465.668 37.1592 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 2 99.0000009536743 SSSSGSVGESSSKGP cleaved P-R@C-term; missed K-G@13 -0.00245481007732451 1338.58752441406 670.301 1338.58996582031 670.30224609375 2 17 1.1.1.2806.2 1 18.18 225.2188 18.0673 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 2 99.0000009536743 TIDDLKNQILNLTTDNANILLQIDNAR missed K-N@6 0.0184320006519556 3051.63818359375 1018.22 3051.6201171875 1018.21392822266 3 18 1.1.1.4675.11 1 63.7833 1758.532 63.689 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 2 99.0000009536743 VLDELTLTK -0.00277682999148965 1030.58825683594 516.3014 1030.59106445313 516.302795410156 2 8 1.1.1.3645.10 1 37.3516 1499.741 37.3661 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 2 99.0000009536743 VTMQNLNDRLASYLDKVR missed R-L@9; missed K-V@16 0.00211546989157796 2135.11767578125 534.7867 2135.11572265625 534.786193847656 4 11 1.1.1.4079.7 1 48.463 3801.53 48.48 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 1.03151702880859 99.0000009536743 ISSSKGSLGGGFSSGGFSGGSFSR missed K-G@5 -0.0109038995578885 2209.02905273438 737.3503 2209.0400390625 737.353942871094 3 10 1.1.1.3685.18 1 38.3589 1593.166 38.4184 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0.28066873550415 91.6100025177002 VTMQNLNDR 0.00287854997441173 1089.52673339844 545.7706 1089.52368164063 545.769104003906 2 9 1.1.1.3150.7 1 25.1086 829.6372 25.1163 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0.204119980335236 87.8499984741211 DAEAWFNEK -0.00353638990782201 1108.47912597656 555.2468 1108.48254394531 555.24853515625 2 7 1.1.1.3627.6 1 36.8891 676.0926 36.833 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0.139063373208046 81.9599986076355 LAADDFRLKYENEVALR missed R-L@7; missed K-Y@9 0.00455165980383754 2022.05810546875 506.5218 2022.05346679688 506.520629882813 4 11 1.1.1.3823.9 1 41.8917 7576.286 41.9591 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0.021819481626153 38.2699996232986 ALEESNYELEGKIKEWYEKHGNSHQGEPR missed K-I@12; missed K-E@14; missed K-H@19 -0.00578003982082009 3456.62768554688 577.1119 3456.63354492188 577.112854003906 6 11 1.1.1.3836.8 1 42.2348 2304.522 42.2777 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0.0159229654818773 30.7599991559982 NHEEEMKDLR missed K-D@7 -0.000831714016385376 1299.5869140625 434.2029 1299.58776855469 434.203186035156 3 6 1.1.1.2996.4 1 21.408 162.2608 21.4482 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0.0154726868495345 30.5099993944168 LAADDFR 0.00106018001679331 806.393249511719 404.2039 806.392272949219 404.203399658203 2 7 1.1.1.3187.2 1 25.9842 1748.843 25.98 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0.0136762224137783 28.1100004911423 SQYEQLAEQNRK missed R-K@11 -0.00443777022883296 1492.72265625 498.5815 1492.72705078125 498.582946777344 3 7 1.1.1.3102.11 1 23.9121 3516.714 23.8259 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0.0114410435780883 24.0299999713898 LKYENEVALR missed K-Y@2 -0.0067114201374352 1233.66491699219 412.2289 1233.67175292969 412.231201171875 3 6 1.1.1.3294.3 1 28.6036 1431.937 28.6734 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0.000869458774104714 45.8000004291534 VRALEESN cleaved N-Y@C-term; missed R-A@2 0.0235622990876436 916.485046386719 459.2498 916.46142578125 459.237976074219 2 5 1.1.1.4043.4 1 47.5442 1488.69 47.4603 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0 99.0000009536743 ALEESNYELEGK -0.00140394002664834 1380.63952636719 691.327 1380.64086914063 691.327697753906 2 10 1.1.1.3299.21 1 28.7425 1976.563 28.6238 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0 99.0000009536743 GSLGGGFSSGGFSGGSFSR 0.00201472989283502 1706.76684570313 854.3907 1706.76489257813 854.389709472656 2 25 1.1.1.3768.14 1 40.5069 7292.313 40.5653 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0 98.0300009250641 GSLGGGFSSGGFSGGSFSR 0.00921669974923134 1706.77404785156 854.3943 1706.76489257813 854.389709472656 2 9 1.1.1.3798.21 1 41.2543 521.854 41.2099 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0 99.0000009536743 SLLEGEGSSGGGGR 0.00784722995012999 1261.59790039063 631.8062 1261.58984375 631.802185058594 2 15 1.1.1.3128.12 1 24.5758 911.452 24.7041 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0 99.0000009536743 SSSSGSVGESSSKGP cleaved P-R@C-term; missed K-G@13 -0.00245481007732451 1338.58752441406 670.301 1338.58996582031 670.30224609375 2 23 1.1.1.2792.2 1 18.0081 230.1695 18.0452 8 21.74 21.74 43.9099997282028 29.3300002813339 25.1599997282028 cont|000136 cra|hCP1812051| keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) [Homo sapiens (contaminant)] 0 99.0000009536743 TIDDLKNQILNLTTDNANILLQIDNAR missed K-N@6 0.0222771000117064 3051.64111328125 1018.221 3051.6201171875 1018.21392822266 3 21 1.1.1.4668.15 1 63.6091 1758.532 63.689 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 AYWDIMISNHQNSNR Oxidation(M)@6; Deamidated(N)@9 0.0169897004961967 1864.8330078125 622.6183 1864.81628417969 622.612670898438 3 16 1.1.1.3679.10 1 38.2012 5683.359 38.1649 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 EALQGVGDMGR Oxidation(M)@9 -0.00313026993535459 1147.52612304688 574.7703 1147.52917480469 574.771850585938 2 16 1.1.1.3101.10 1 23.8903 5896.955 23.8755 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 ESWRSFFKEALQGVGDMGR Oxidation(M)@17 cleaved S-E@N-term; missed R-S@4; missed K-E@8 0.00238715996965766 2215.05053710938 739.3574 2215.04809570313 739.356628417969 3 16 1.1.1.4207.14 1 51.7355 9760.531 51.7976 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 GNYDAAQR -0.00563766015693545 893.393493652344 447.704 893.399169921875 447.706848144531 2 9 1.1.1.2536.2 1 16.04 147.835 16.0939 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 GNYDAAQRGPGGVWAAK missed R-G@8 0.000630778027698398 1716.83386230469 573.2852 1716.83325195313 573.285034179688 3 18 1.1.1.3328.4 1 29.4552 11606.79 29.3665 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 GNYDAAQRGPGGVWAAKLISR Acetyl(K)@17 missed R-G@8; missed K-L@17 -5.1776700274786E-05 2228.14501953125 743.7223 2228.14501953125 743.722290039063 3 25 1.1.1.4023.20 1 47.0442 3580.032 47.0503 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 GPGGVWAAK -0.00327059999108315 841.441467285156 421.728 841.444641113281 421.729583740234 2 15 1.1.1.3177.2 1 25.7583 5444.806 25.7533 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 -0.00507281022146344 1656.78784179688 829.4012 1656.79296875 829.403747558594 2 15 1.1.1.3794.8 1 41.1526 12697.59 40.8887 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 SRVYLQGLIDCYLFGNSSTVLEDSK Carbamidomethyl(C)@11 missed R-V@2 0.987387001514435 2864.3935546875 955.8051 2863.40625 955.476013183594 3 15 1.1.1.4558.17 1 60.8156 930.097 60.7977 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 1.42021656036377 99.0000009536743 SNEKAEEWGR missed K-A@4 -0.00172537995968014 1204.54565429688 402.5225 1204.54724121094 402.523040771484 3 9 1.1.1.2997.2 1 21.4313 717.1773 21.4811 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0.0695604085922241 99.0000009536743 AYWDIMISNHQNSNRYLYAR Dioxidation(W)@3; Oxidation(M)@6 missed R-Y@15 -0.00164995004888624 2562.16943359375 641.5496 2562.1708984375 641.550048828125 4 15 1.1.1.3761.13 1 40.3264 14245.38 40.3646 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0.00261361571028829 88.5999977588654 DIMISNHQNSNRYLYAR Oxidation(M)@3 cleaved W-D@N-term; missed R-Y@12 0.0157431997358799 2110.01733398438 528.5116 2110.00146484375 528.507629394531 4 10 1.1.1.3358.13 1 30.1901 807.1279 30.202 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 AYWDIMISNHQNSNR Oxidation(M)@6 -0.00184011005330831 1863.83056640625 622.2841 1863.83227539063 622.28466796875 3 16 1.1.1.3677.9 1 38.1496 10299.89 38.1649 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 AYWDIMISNHQNSNR Dioxidation(W)@3; Oxidation(M)@6 0.00361159001477063 1895.82580566406 632.9492 1895.82202148438 632.947937011719 3 15 1.1.1.3597.17 1 36.1453 7887.051 36.0509 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 AYWDIMISNHQNSNR Oxidation(M)@6; Deamidated(N)@12 -0.0031514500733465 1864.81286621094 622.6116 1864.81628417969 622.612670898438 3 12 1.1.1.3730.16 1 39.5272 1965.256 39.5366 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 AYWDIMISNHQNSNR Dioxidation(W)@3; Oxidation(M)@6 0.00361159001477063 1895.82580566406 632.9492 1895.82202148438 632.947937011719 3 12 1.1.1.3604.15 1 36.3228 7975.442 36.0509 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 98.3699977397919 AYWDIMISNHQNSNR Oxidation(M)@6 -0.00184011005330831 1863.83056640625 622.2841 1863.83227539063 622.28466796875 3 13 1.1.1.3684.14 1 38.3297 10299.89 38.1649 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 97.1300005912781 AYWDIMISNHQNSNR Oxidation(M)@6 0.00328672002069652 1863.83569335938 622.2858 1863.83227539063 622.28466796875 3 10 1.1.1.3699.10 1 38.716 1636.234 38.7564 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 96.5499997138977 AYWDIMISNHQNSNR Dioxidation(W)@3; Oxidation(M)@6 0.00361159001477063 1895.82580566406 632.9492 1895.82202148438 632.947937011719 3 11 1.1.1.3590.14 1 35.9643 7887.051 36.0509 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 81.8400025367737 AYWDIMISNHQNSNR Oxidation(M)@6; Deamidated(N)@9 0.013327700085938 1864.82958984375 622.6171 1864.81628417969 622.612670898438 3 8 1.1.1.3698.13 1 38.6926 1118.231 38.7046 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 58.6499989032745 AYWDIMISNHQNSNR Oxidation(M)@6; Deamidated(N)@9 -0.0031514500733465 1864.81286621094 622.6116 1864.81628417969 622.612670898438 3 7 1.1.1.3730.15 1 39.5264 1965.256 39.5366 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 57.5800001621246 AYWDIMISNHQNSNR Oxidation(M)@6 -0.00220630993135273 1863.82983398438 622.2839 1863.83227539063 622.28466796875 3 11 1.1.1.3670.3 1 37.9731 10208.46 38.1649 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 42.0399993658066 AYWDIMISNHQNSNR Trp->Kynurenin(W)@3; Oxidation(M)@6 1.70813000295311E-05 1867.82702636719 623.6163 1867.8271484375 623.616333007813 3 8 1.1.1.3632.16 1 37.0225 938.3815 37.0067 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 42.0399993658066 AYWDIMISNHQNSNR Trp->Kynurenin(W)@3; Oxidation(M)@6 -0.000767163990531117 1867.82653808594 467.9639 1867.8271484375 467.964050292969 4 6 1.1.1.3635.4 1 37.0886 954.4338 37.0067 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 23.9199995994568 AYWDIMISNHQNSNR Dioxidation(W)@3; Oxidation(M)@6; Deamidated(N)@9 0.0182282999157906 1896.82409667969 633.282 1896.80603027344 633.275939941406 3 10 1.1.1.3598.15 1 36.1693 3731.091 36.0509 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 AYWDIMISNHQNSNRYLYAR Dioxidation(W)@3; Oxidation(M)@6; Deamidated(N)@12 missed R-Y@15 0.000639493984635919 2563.15576171875 641.7962 2563.15502929688 641.796020507813 4 15 1.1.1.3836.13 1 42.2389 8746.933 42.2244 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 AYWDIMISNHQNSNRYLYAR Dioxidation(W)@3; Oxidation(M)@6 missed R-Y@15 0.0044534201733768 2562.17529296875 641.5511 2562.1708984375 641.550048828125 4 14 1.1.1.3783.9 1 40.8784 5532.956 40.6897 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 96.5499997138977 AYWDIMISNHQNSNRYLYAR Oxidation(M)@6 missed R-Y@15 0.000645759981125593 2530.181640625 633.5527 2530.18115234375 633.552551269531 4 12 1.1.1.3831.13 1 42.1064 41213.31 42.1718 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 91.619998216629 AYWDIMISNHQNSNRYLYAR Trp->Kynurenin(W)@3; Oxidation(M)@6 missed R-Y@15 0.000755086017306894 2534.17700195313 634.5515 2534.17602539063 634.55126953125 4 11 1.1.1.3808.16 1 41.5043 8579.618 41.5403 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 90.9900009632111 AYWDIMISNHQNSNRYLYAR Dioxidation(W)@3; Oxidation(M)@6 missed R-Y@15 0.00568642001599073 2562.1767578125 855.0662 2562.1708984375 855.064270019531 3 10 1.1.1.3762.20 1 40.3586 3754.739 40.3646 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 88.8400018215179 AYWDIMISNHQNSNRYLYAR Dioxidation(W)@3; Oxidation(M)@6 missed R-Y@15 -0.00848572980612516 2562.16259765625 641.5479 2562.1708984375 641.550048828125 4 11 1.1.1.3791.8 1 41.0727 3352.229 40.8142 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 86.2100005149841 AYWDIMISNHQNSNRYLYAR Oxidation(M)@6; Deamidated(N)@9 missed R-Y@15 -0.000726751983165741 2531.16455078125 633.7984 2531.16528320313 633.798583984375 4 10 1.1.1.3870.11 1 43.1201 14855.51 43.2381 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 64.4400000572205 AYWDIMISNHQNSNRYLYAR Dioxidation(W)@3; Oxidation(M)@6 missed R-Y@15 0.00605261977761984 2562.17700195313 855.0663 2562.1708984375 855.064270019531 3 10 1.1.1.3777.10 1 40.731 1682.635 40.7147 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 60.6100022792816 AYWDIMISNHQNSNRYLYAR Dioxidation(W)@3; Oxidation(M)@6 missed R-Y@15 0.00347688002511859 2562.17456054688 641.5509 2562.1708984375 641.550048828125 4 10 1.1.1.3769.9 1 40.5284 5053.36 40.5653 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 58.6499989032745 AYWDIMISNHQNSNRYLYAR Oxidation(M)@6; Deamidated(N)@9 missed R-Y@15 0.0161185991019011 2531.18139648438 633.8026 2531.16528320313 633.798583984375 4 9 1.1.1.3862.11 1 42.9133 3734.619 42.7754 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 35.5800002813339 AYWDIMISNHQNSNRYLYAR Oxidation(M)@6; Deamidated(N)@9 missed R-Y@15 0.0130807003006339 2531.17797851563 844.7333 2531.16528320313 844.72900390625 3 8 1.1.1.3873.19 1 43.205 3988.707 43.2381 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 86.3200008869171 EALQGVGDMGR Dioxidation(M)@9 0.00193465000484139 1163.52612304688 582.7703 1163.52404785156 582.769348144531 2 5 1.1.1.3123.19 1 24.4532 252.7905 24.4601 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 15.6700000166893 EALQGVGDMGR Oxidation(M)@9 -0.00313026993535459 1147.52612304688 574.7703 1147.52917480469 574.771850585938 2 6 1.1.1.3108.10 1 24.0689 5896.955 23.8755 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 ESWRSFFKEALQGVGDMGR Oxidation(M)@17 cleaved S-E@N-term; missed R-S@4; missed K-E@8 0.00238715996965766 2215.05053710938 739.3574 2215.04809570313 739.356628417969 3 14 1.1.1.4205.17 1 51.6868 9760.531 51.7976 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 ESWRSFFKEALQGVGDMGR Oxidation(M)@17 cleaved S-E@N-term; missed R-S@4; missed K-E@8 0.00238715996965766 2215.05053710938 739.3574 2215.04809570313 739.356628417969 3 12 1.1.1.4213.17 1 51.8912 9760.531 51.7976 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 ESWRSFFKEALQGVGDMGR Oxidation(M)@17 cleaved S-E@N-term; missed R-S@4; missed K-E@8 0.00412257015705109 2215.05224609375 554.7703 2215.04809570313 554.769287109375 4 11 1.1.1.4214.8 1 51.9091 10164.05 51.7976 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 GNYDAAQR -0.00368458009324968 893.395446777344 447.705 893.399169921875 447.706848144531 2 10 1.1.1.2601.2 1 16.5549 144.2085 16.5352 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 31.1599999666214 GNYDAAQR -0.00344043993391097 893.395690917969 447.7051 893.399169921875 447.706848144531 2 8 1.1.1.2579.2 1 16.3805 177.516 16.3529 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 19.6299999952316 GNYDAAQR -0.00588179985061288 893.393249511719 447.7039 893.399169921875 447.706848144531 2 7 1.1.1.2557.2 1 16.2063 174.4044 16.2196 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 GNYDAAQRGPGGVWAAK missed R-G@8 0.000630778027698398 1716.83386230469 573.2852 1716.83325195313 573.285034179688 3 16 1.1.1.3321.14 1 29.2816 11606.79 29.3665 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 GNYDAAQRGPGGVWAAK missed R-G@8 0.000799782981630415 1716.83410644531 859.4243 1716.83325195313 859.423889160156 2 18 1.1.1.3324.13 1 29.3612 1937.157 29.3172 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 GNYDAAQRGPGGVWAAK missed R-G@8 0.000799782981630415 1716.83410644531 859.4243 1716.83325195313 859.423889160156 2 14 1.1.1.3331.11 1 29.533 1937.157 29.3172 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 GNYDAAQRGPGGVWAAK missed R-G@8 0.00429280009120703 1716.83728027344 573.2864 1716.83325195313 573.285034179688 3 14 1.1.1.3335.9 1 29.6229 11671.05 29.3665 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 98.9400029182434 GNYDAAQRGPGGVWAAK Trp->Kynurenin(W)@14 missed R-G@8 0.00830527953803539 1720.83630371094 574.6194 1720.828125 574.616638183594 3 13 1.1.1.3280.11 1 28.2693 4265.405 28.2795 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 97.759997844696 GNYDAAQRGPGGVWAAK Dioxidation(W)@14 missed R-G@8 0.000201880000531673 1748.82348632813 583.9484 1748.82299804688 583.948303222656 3 12 1.1.1.3276.13 1 28.1692 19815.51 28.1316 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 80.4199993610382 GNYDAAQRGPGGVWAAK Dioxidation(W)@14 missed R-G@8 0.00917383003979921 1748.83239746094 583.9514 1748.82299804688 583.948303222656 3 8 1.1.1.3287.11 1 28.4378 850.6888 28.4514 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 78.9900004863739 GNYDAAQRGPGGVWAAK Dioxidation(W)@14 missed R-G@8 0.000201880000531673 1748.82348632813 583.9484 1748.82299804688 583.948303222656 3 10 1.1.1.3269.15 1 27.9988 19815.51 28.1316 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 66.2400007247925 GNYDAAQRGPGGVWAAK missed R-G@8 0.000996980001218617 1716.833984375 573.2853 1716.83325195313 573.285034179688 3 11 1.1.1.3342.6 1 29.794 5011.099 29.5382 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 36.5500003099442 GNYDAAQRGPGGVWAAK missed R-G@8 -0.000284728012047708 1716.83288574219 573.2849 1716.83325195313 573.285034179688 3 11 1.1.1.3314.13 1 29.1101 10577.3 29.2927 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 16.5199995040894 GNYDAAQRGPGGVWAAK missed R-G@8 0.0108844004571438 1716.84387207031 573.2886 1716.83325195313 573.285034179688 3 9 1.1.1.3356.7 1 30.1407 945.4283 30.1527 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 GNYDAAQRGPGGVWAAKLISR Trp->Hydroxykynurenin(W)@14; MDA adduct +54(K)@17 missed R-G@8; missed K-L@17 -0.0100140003487468 2260.12475585938 754.3822 2260.134765625 754.385559082031 3 15 1.1.1.3881.18 1 43.4136 2667.926 43.4213 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 98.7600028514862 GPGGVWAAK Dioxidation(W)@6 0.000667663989588618 873.435302734375 437.7249 873.434448242188 437.724517822266 2 10 1.1.1.3130.3 1 24.6134 2219.622 24.6555 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 -0.00147164997179061 1656.79150390625 553.2711 1656.79296875 553.271606445313 3 21 1.1.1.3779.4 1 40.77 51475.78 40.7894 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR Dioxidation(R)@15 missed K-E@4 -0.00669167004525661 1672.78125 558.601 1672.78796386719 558.603271484375 3 14 1.1.1.3834.7 1 42.1811 2333.991 42.198 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 -0.00110544997733086 1656.79174804688 553.2712 1656.79296875 553.271606445313 3 17 1.1.1.3772.3 1 40.5964 50852.76 40.7894 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 -0.00147164997179061 1656.79150390625 553.2711 1656.79296875 553.271606445313 3 15 1.1.1.3786.4 1 40.9476 51475.78 40.7894 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 -0.00971135962754488 1656.78332519531 829.3989 1656.79296875 829.403747558594 2 16 1.1.1.3801.7 1 41.3292 2047.241 41.4101 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 -0.00641538994386792 1656.78662109375 553.2695 1656.79296875 553.271606445313 3 14 1.1.1.3802.7 1 41.3426 7925.253 41.4874 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 -0.00641538994386792 1656.78662109375 553.2695 1656.79296875 553.271606445313 3 14 1.1.1.3809.7 1 41.5234 7925.253 41.4874 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR Acetyl@N-term; Oxidation(M)@13 missed K-E@4 0.00331823993474245 1698.80688476563 850.4107 1698.80358886719 850.409057617188 2 11 1.1.1.4039.20 1 47.4543 1246.834 47.5121 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 98.8900005817413 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 -0.00678159017115831 1656.78601074219 553.2693 1656.79296875 553.271606445313 3 13 1.1.1.3817.7 1 41.7347 7998.224 41.4874 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 98.3399987220764 SFFKEALQGVGDMGR Ser->LacticAcid(S)@1; acrolein addition +56(K)@4; Oxidation(M)@13 missed K-E@4 0.00469508022069931 1697.81286621094 566.9449 1697.80834960938 566.943359375 3 12 1.1.1.3821.5 1 41.837 2564.304 41.8042 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 98.0300009250641 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 -0.0101995998993516 1656.78283691406 829.3987 1656.79296875 829.403747558594 2 11 1.1.1.3808.20 1 41.5077 1961.636 41.5138 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 94.0199971199036 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 0.0016410700045526 1656.79479980469 553.2722 1656.79296875 553.271606445313 3 9 1.1.1.3835.10 1 42.21 721.024 42.0651 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 92.1999990940094 SFFKEALQGVGDMGR Carbamidomethyl@N-term; Oxidation(M)@13 missed K-E@4 -0.00315567990764976 1713.81127929688 572.2777 1713.814453125 572.278747558594 3 8 1.1.1.3777.6 1 40.7244 695.6017 40.7396 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 89.8400008678436 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 -0.00202095997519791 1656.79077148438 553.2709 1656.79296875 553.271606445313 3 10 1.1.1.3762.10 1 40.3502 1001.116 40.3646 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 77.4699985980988 SNEKAEEWGR Dioxidation(W)@8 missed K-A@4 -0.00194980995729566 1236.53527832031 413.1857 1236.537109375 413.186309814453 3 8 1.1.1.2944.2 1 20.3847 144.8503 20.4152 9 19.49 19.49 86.1500024795532 73.0799973011017 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SRVYLQGLIDCYLFGNSSTVLEDSKSNEK Carbamidomethyl(C)@11 missed R-V@2; missed K-S@25 3.04081988334656 3324.65966796875 832.1722 3321.61865234375 831.411987304688 4 13 1.1.1.4559.10 1 60.8366 1727.252 60.8242 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 2 99.0000009536743 DEMPSPTFLTQVK Oxidation(M)@3 cleaved Q-D@N-term -0.00262349005788565 1507.72021484375 754.8674 1507.72290039063 754.868713378906 2 17 1.1.1.3792.9 1 41.1024 3377.41 41.111 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 2 99.0000009536743 ESLSSYWESAK -0.0050325901247561 1285.57763671875 643.7961 1285.58264160156 643.798583984375 2 13 1.1.1.3730.18 1 39.5289 8920.192 39.4312 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 2 99.0000009536743 STAAMSTYTGIFTDQVLSVLK Oxidation(M)@5 -0.0115563003346324 2248.1181640625 750.38 2248.12963867188 750.383850097656 3 12 1.1.1.4544.12 1 60.4449 4744.869 60.2701 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 2 99.0000009536743 STAAMSTYTGIFTDQVLSVLKGEE Oxidation(M)@5 missed K-G@21 -0.00925019010901451 2563.22705078125 855.4163 2563.236328125 855.419372558594 3 27 1.1.1.4600.11 1 61.8874 37798.15 61.9516 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 2 99.0000009536743 TAAQNLYEK -0.00539642013609409 1036.51342773438 519.264 1036.51892089844 519.266723632813 2 12 1.1.1.3062.3 1 22.9542 6257.813 23.0911 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 2 99.0000009536743 TAAQNLYEKTYLPAVDEKLRDLYSK missed K-T@9; missed K-L@18; missed R-D@20 0.0119014997035265 2928.53540039063 733.1411 2928.52319335938 733.138122558594 4 23 1.1.1.4063.16 1 48.0636 4294.469 48.1494 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 2 99.0000009536743 TQQPQQDEMPSPTFLTQVK Oxidation(M)@9 cleaved G-T@N-term -0.0034992101136595 2218.05346679688 1110.034 2218.0576171875 1110.0361328125 2 21 1.1.1.3771.8 1 40.5824 9774.667 40.615 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 2 99.0000009536743 TQQPQQDEMPSPTFLTQVKESLSSYWESAK Oxidation(M)@9 cleaved G-T@N-term; missed K-E@19 -0.00599218998104334 3485.6240234375 1162.882 3485.62963867188 1162.8837890625 3 18 1.1.1.4517.21 1 59.7388 14336.41 59.6906 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 2 99.0000009536743 TYLPAVDEKLRDLYSK missed K-L@9; missed R-D@11 0.00134389998856932 1910.01623535156 956.0154 1910.01489257813 956.014770507813 2 14 1.1.1.3881.20 1 43.4153 3050.55 43.4468 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0.0141246430575848 99.0000009536743 TAAQNLYEKTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE Oxidation(Y)@11 missed K-T@9; missed K-L@18; missed R-D@20; missed K-S@25; missed K-G@46 0.00514901988208294 5473.75390625 1095.758 5473.7490234375 1095.75708007813 5 11 1.1.1.4735.19 1 65.32 942.2628 65.3534 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 57.8599989414215 AQNLYEKTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE Deamidated(N)@3; acrolein addition +76(K)@16; acrolein addition +94(K)@23; Oxidation(M)@28 cleaved A-A@N-term; missed K-T@7; missed K-L@16; missed R-D@18; missed K-S@23; missed K-G@44 0.00644982978701591 5472.72802734375 913.1286 5472.7216796875 913.127502441406 6 8 1.1.1.4731.8 1 65.2064 850.4695 65.2225 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 DEMPSPTFLTQVK Oxidation(M)@3 cleaved Q-D@N-term -0.00262349005788565 1507.72021484375 754.8674 1507.72290039063 754.868713378906 2 11 1.1.1.3785.10 1 40.9262 3336.354 41.111 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 97.9099988937378 DEMPSPTFLTQVK Oxidation(M)@3 cleaved Q-D@N-term -0.00262349005788565 1507.72021484375 754.8674 1507.72290039063 754.868713378906 2 9 1.1.1.3799.18 1 41.2768 3377.41 41.111 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 ESLSSYWESAK -0.0055208601988852 1285.57702636719 643.7958 1285.58264160156 643.798583984375 2 12 1.1.1.3737.14 1 39.7076 8655.959 39.4312 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 ESLSSYWESAK -0.0050325901247561 1285.57763671875 643.7961 1285.58264160156 643.798583984375 2 13 1.1.1.3723.14 1 39.3419 8920.192 39.4312 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 ESLSSYWESAK Dioxidation(W)@7 0.0041674398817122 1317.57666015625 659.7956 1317.57250976563 659.793518066406 2 11 1.1.1.3580.18 1 35.7126 2163.116 35.6155 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 84.1899991035461 ESLSSYWESAK Dioxidation(W)@7 0.0153975998982787 1317.587890625 659.8012 1317.57250976563 659.793518066406 2 8 1.1.1.3570.21 1 35.4529 1678.982 35.4581 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 78.9900004863739 ESLSSYWESAK Trp->Kynurenin(W)@7 -0.00607032980769873 1289.57153320313 645.793 1289.57751464844 645.796081542969 2 9 1.1.1.3619.4 1 36.6981 870.7264 36.6609 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 57.5800001621246 ESLSSYWESAK -0.00808428041636944 1285.57470703125 643.7946 1285.58264160156 643.798583984375 2 7 1.1.1.3745.13 1 39.9104 2377.644 39.6418 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 STAAMSTYTGIFTDQVLSVLK Oxidation(M)@5 0.000639008998405188 2248.12939453125 1125.072 2248.12963867188 1125.07214355469 2 14 1.1.1.4535.21 1 60.2108 2825.627 60.2976 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 97.079998254776 STAAMSTYTGIFTDQVLSVLK Oxidation(M)@5; Deamidated(Q)@15 0.014041299931705 2249.1279296875 750.7166 2249.11376953125 750.711853027344 3 9 1.1.1.4535.15 1 60.2058 5104.035 60.2976 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 STAAMSTYTGIFTDQVLSVLKGEE Oxidation(M)@5 missed K-G@21 -0.00467270007357001 2563.2314453125 855.4178 2563.236328125 855.419372558594 3 14 1.1.1.4593.12 1 61.711 37834.9 61.9516 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 STAAMSTYTGIFTDQVLSVLKGEE Oxidation(M)@5 missed K-G@21 -0.00925019010901451 2563.22705078125 855.4163 2563.236328125 855.419372558594 3 25 1.1.1.4607.10 1 62.0643 37798.15 61.9516 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 STAAMSTYTGIFTDQVLSVLKGEE Oxidation(M)@5 missed K-G@21 -0.00320790009573102 2563.23291015625 855.4183 2563.236328125 855.419372558594 3 11 1.1.1.4634.6 1 62.7433 1711.841 62.7357 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 STAAMSTYTGIFTDQVLSVLKGEE Oxidation(M)@5 missed K-G@21 -0.00375719997100532 2563.23291015625 855.4182 2563.236328125 855.419372558594 3 14 1.1.1.4641.7 1 62.9203 1861.684 62.9119 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 STAAMSTYTGIFTDQVLSVLKGEE Oxidation(M)@5 missed K-G@21 0.0103414999321103 2563.24682617188 855.4229 2563.236328125 855.419372558594 3 15 1.1.1.4681.5 1 63.9213 885.836 63.9133 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 STAAMSTYTGIFTDQVLSVLKGEE Oxidation(M)@5; Methyl(E)@24 missed K-G@21 0.000538597989361733 2577.25219726563 860.0914 2577.251953125 860.091247558594 3 15 1.1.1.4733.12 1 65.2619 1605.765 65.1967 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 STAAMSTYTGIFTDQVLSVLKGEE Oxidation(M)@5; Methyl(E)@24 missed K-G@21 0.0120738996192813 2577.26391601563 860.0953 2577.251953125 860.091247558594 3 10 1.1.1.4688.4 1 64.0935 1038.663 64.1129 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 98.3699977397919 STAAMSTYTGIFTDQVLSVLKGEE Oxidation(M)@5 missed K-G@21 0.0156513992697001 2563.251953125 855.4246 2563.236328125 855.419372558594 3 9 1.1.1.4694.9 1 64.2497 488.0728 64.2391 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 16.1500006914139 STAAMSTYTGIFTDQVLSVLKGEE Oxidation(M)@5 missed K-G@21 -0.00320790009573102 2563.23291015625 855.4183 2563.236328125 855.419372558594 3 9 1.1.1.4627.9 1 62.5691 1597.478 62.6095 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TAAQNLYEK -0.00539642013609409 1036.51342773438 519.264 1036.51892089844 519.266723632813 2 15 1.1.1.3070.3 1 23.124 6264.88 23.0911 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TAAQNLYEK -0.00185647001489997 1036.51708984375 519.2658 1036.51892089844 519.266723632813 2 7 1.1.1.3084.6 1 23.4638 2158.722 23.2114 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TAAQNLYEK -0.00539642013609409 1036.51342773438 519.264 1036.51892089844 519.266723632813 2 10 1.1.1.3077.6 1 23.2949 6264.88 23.0911 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TAAQNLYEKTYLPAVDEKLRDLYSK missed K-T@9; missed K-L@18; missed R-D@20 0.00937261991202831 2928.53247070313 733.1404 2928.52319335938 733.138122558594 4 15 1.1.1.4054.16 1 47.8347 3965.965 47.8951 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TQQPQQDEMPSPTFLTQVK Oxidation(M)@9 cleaved G-T@N-term 0.00219618994742632 2218.0595703125 740.3605 2218.0576171875 740.359802246094 3 20 1.1.1.3768.13 1 40.5052 15108.73 40.615 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TQQPQQDEMPSPTFLTQVK Oxidation(M)@9 cleaved G-T@N-term -0.0034992101136595 2218.05346679688 1110.034 2218.0576171875 1110.0361328125 2 21 1.1.1.3774.16 1 40.6596 9774.667 40.615 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TQQPQQDEMPSPTFLTQVK Oxidation(M)@9 cleaved G-T@N-term 0.00219618994742632 2218.0595703125 740.3605 2218.0576171875 740.359802246094 3 21 1.1.1.3775.8 1 40.6795 15108.73 40.615 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 97.9099988937378 TQQPQQDEMPSPTFLTQVK Oxidation(M)@9 cleaved G-T@N-term 0.00219618994742632 2218.0595703125 740.3605 2218.0576171875 740.359802246094 3 11 1.1.1.3782.10 1 40.8536 15306.31 40.615 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TQQPQQDEMPSPTFLTQVKESLSSYWESAK Oxidation(M)@9 cleaved G-T@N-term; missed K-E@19 0.00748918019235134 3485.63745117188 872.4166 3485.62963867188 872.414672851563 4 25 1.1.1.4515.17 1 59.682 12603.29 59.6906 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TQQPQQDEMPSPTFLTQVKESLSSYWESAK Oxidation(M)@9; Deamidated(Q)@17 cleaved G-T@N-term; missed K-E@19 0.0148409996181726 3486.62939453125 1163.217 3486.61376953125 1163.21179199219 3 18 1.1.1.4515.21 1 59.6853 8995.403 59.6906 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TQQPQQDEMPSPTFLTQVKESLSSYWESAK Oxidation(M)@9; Dioxidation(W)@26 cleaved G-T@N-term; missed K-E@19 0.0184725001454353 3517.6376953125 880.4167 3517.61962890625 880.412170410156 4 15 1.1.1.4432.17 1 57.502 2095.973 57.4587 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TQQPQQDEMPSPTFLTQVKESLSSYWESAK Oxidation(M)@9; Dioxidation(W)@26 cleaved G-T@N-term; missed K-E@19 0.0184725001454353 3517.6376953125 880.4167 3517.61962890625 880.412170410156 4 13 1.1.1.4425.19 1 57.3222 2095.973 57.4587 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 98.8900005817413 TQQPQQDEMPSPTFLTQVKESLSSYWESAK Oxidation(M)@9 cleaved G-T@N-term; missed K-E@19 -0.00599218998104334 3485.6240234375 1162.882 3485.62963867188 1162.8837890625 3 9 1.1.1.4510.21 1 59.5518 14336.41 59.6906 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TYLPAVDEKLRDLYSK missed K-L@9; missed R-D@11 0.000160276002134196 1910.01489257813 478.511 1910.01489257813 478.511016845703 4 15 1.1.1.3888.6 1 43.5812 30658.6 43.4468 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 TYLPAVDEKLRDLYSK missed K-L@9; missed R-D@11 0.000160276002134196 1910.01489257813 478.511 1910.01489257813 478.511016845703 4 14 1.1.1.3880.7 1 43.3786 30658.6 43.4468 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 98.3699977397919 TYLPAVDEKLRDLYSK missed K-L@9; missed R-D@11 -0.00183715997263789 1910.01306152344 637.6783 1910.01489257813 637.678894042969 3 12 1.1.1.3888.16 1 43.5895 21871.63 43.4468 10 18.01 18.01 78.219997882843 78.219997882843 78.219997882843 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 36.829999089241 TYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE reduced acrolein addition +58(K)@16 missed K-L@9; missed R-D@11; missed K-S@16; missed K-G@37 -0.10207100212574 4497.1865234375 1125.304 4497.28759765625 1125.32922363281 4 7 1.1.1.4886.19 1 69.3308 975.0663 69.3377 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 2 99.0000009536743 DVSSALDKLKEFGNTLEDKAR cleaved P-D@N-term; missed K-L@8; missed K-E@10; missed K-A@19 -0.00324594997800887 2335.19848632813 584.8069 2335.20190429688 584.807739257813 4 16 1.1.1.4191.8 1 51.3228 27585.68 51.4663 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 2 99.0000009536743 DVSSALDKLKEFGNTLEDKARELISR cleaved P-D@N-term; missed K-L@8; missed K-E@10; missed K-A@19; missed R-E@21 0.00607756013050675 2933.55224609375 587.7177 2933.5458984375 587.716430664063 5 14 1.1.1.4723.3 1 64.9937 16027.61 64.9621 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 2 99.0000009536743 IKQSELSAK missed K-Q@2 -0.00373460003174841 1002.56726074219 502.2909 1002.57098388672 502.292755126953 2 11 1.1.1.2886.2 1 19.5513 596.4762 19.3602 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 2 99.0000009536743 MREWFSETFQK Oxidation(M)@1 missed R-E@2 -0.00209952006116509 1503.67944335938 752.847 1503.681640625 752.848083496094 2 18 1.1.1.3677.16 1 38.158 9345.809 38.1649 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 2 99.0000009536743 TPDVSSALDK cleaved G-T@N-term -0.00095973297720775 1031.51245117188 516.7635 1031.51354980469 516.764038085938 2 13 1.1.1.3217.4 1 26.7192 1504.597 26.6874 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 2 99.0000009536743 TPDVSSALDKLKEFGNTLEDKAR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21 -0.00216063996776938 2533.30004882813 634.3323 2533.30249023438 634.332885742188 4 24 1.1.1.4236.8 1 52.4685 46153.32 52.5358 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 2 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.00158138002734631 3131.64819335938 627.3369 3131.64624023438 627.336547851563 5 14 1.1.1.4760.3 1 65.9522 5135.334 66.024 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 1.46852135658264 99.0000009536743 MREWFSETFQKVKEKLKIDS Oxidation(M)@1 missed R-E@2; missed K-V@11; missed K-E@13; missed K-L@15; missed K-I@17 0.0173132997006178 2544.322265625 637.0878 2544.3046875 637.083435058594 4 9 1.1.1.4069.13 1 48.2138 883.7342 48.1748 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0.853872001171112 99.0000009536743 TPDVSSALDKLK cleaved G-T@N-term; missed K-L@10 -0.00346444989554584 1272.68920898438 425.237 1272.69250488281 425.238128662109 3 12 1.1.1.3674.4 1 38.0707 4281.972 38.115 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0.12320502102375 99.0000009536743 TPDVSSALDKLKEFGNTLEDK cleaved G-T@N-term; missed K-L@10; missed K-E@12 -0.012355700135231 2306.15161132813 769.7245 2306.1640625 769.728637695313 3 11 1.1.1.4238.13 1 52.5239 3365.457 52.5358 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0.0250280071049929 50 EFGNTLEDK -0.00186079996638 1051.48022460938 526.7474 1051.48217773438 526.748352050781 2 7 1.1.1.3169.9 1 25.5662 1054.638 25.6063 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0.00305075151845813 83.0099999904633 KQSELSAK cleaved I-K@N-term; missed K-Q@1 -0.00315660005435348 889.483703613281 445.7491 889.486877441406 445.750732421875 2 5 1.1.1.2862.3 1 19.2575 199.9069 19.2747 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0.00261361571028829 97.8399991989136 MREWFSETFQKVKEK Oxidation(M)@1; Dioxidation(W)@4 missed R-E@2; missed K-V@11; missed K-E@13 0.00496156001463532 2019.97729492188 506.0016 2019.97241210938 506.000366210938 4 12 1.1.1.3429.11 1 31.9458 3008.446 31.9594 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0.000434511806815863 83.569997549057 LKEFGNTLEDKAR Delta:H(2)C(2)(K)@2 missed K-E@2; missed K-A@11 0.0292051006108522 1545.84423828125 516.2887 1545.81506347656 516.278991699219 3 10 1.1.1.4258.3 1 53.0251 1850.314 53.0453 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 DVSSALDKLKEFGNTLEDKAR cleaved P-D@N-term; missed K-L@8; missed K-E@10; missed K-A@19 0.00488477991893888 2335.20654296875 779.4095 2335.20190429688 779.407897949219 3 19 1.1.1.4196.17 1 51.4578 6626.061 51.4408 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 DVSSALDKLKEFGNTLEDKAR cleaved P-D@N-term; missed K-L@8; missed K-E@10; missed K-A@19 -0.00324594997800887 2335.19848632813 584.8069 2335.20190429688 584.807739257813 4 18 1.1.1.4198.8 1 51.5012 27585.68 51.4663 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 DVSSALDKLKEFGNTLEDKAR cleaved P-D@N-term; missed K-L@8; missed K-E@10; missed K-A@19 0.00488477991893888 2335.20654296875 779.4095 2335.20190429688 779.407897949219 3 18 1.1.1.4200.15 1 51.5579 6626.061 51.4408 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 DVSSALDKLKEFGNTLEDKAR cleaved P-D@N-term; missed K-L@8; missed K-E@10; missed K-A@19 0.00488477991893888 2335.20654296875 779.4095 2335.20190429688 779.407897949219 3 13 1.1.1.4201.16 1 51.5842 6626.061 51.4408 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 DVSSALDKLKEFGNTLEDKAR cleaved P-D@N-term; missed K-L@8; missed K-E@10; missed K-A@19 -0.00324594997800887 2335.19848632813 584.8069 2335.20190429688 584.807739257813 4 12 1.1.1.4205.9 1 51.6801 27585.68 51.4663 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 DVSSALDKLKEFGNTLEDKARELISR cleaved P-D@N-term; missed K-L@8; missed K-E@10; missed K-A@19; missed R-E@21 0.00607756013050675 2933.55224609375 587.7177 2933.5458984375 587.716430664063 5 12 1.1.1.4730.3 1 65.1765 16027.61 64.9621 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 DVSSALDKLKEFGNTLEDKARELISR cleaved P-D@N-term; missed K-L@8; missed K-E@10; missed K-A@19; missed R-E@21 0.0111742997542024 2933.55688476563 734.3965 2933.5458984375 734.393737792969 4 7 1.1.1.4768.7 1 66.1632 1066.773 65.8958 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 98.0799973011017 DVSSALDKLKEFGNTLEDKARELISR cleaved P-D@N-term; missed K-L@8; missed K-E@10; missed K-A@19; missed R-E@21 0.00607756013050675 2933.55224609375 587.7177 2933.5458984375 587.716430664063 5 8 1.1.1.4716.2 1 64.8098 16027.61 64.9621 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 97.079998254776 DVSSALDKLKEFGNTLEDKARELISR cleaved P-D@N-term; missed K-L@8; missed K-E@10; missed K-A@19; missed R-E@21 0.00336205004714429 2933.54931640625 734.3946 2933.5458984375 734.393737792969 4 8 1.1.1.4728.6 1 65.1267 6975.704 64.936 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 85.1400017738342 DVSSALDKLKEFGNTLEDKARELISR cleaved P-D@N-term; missed K-L@8; missed K-E@10; missed K-A@19; missed R-E@21 -0.00277229002676904 2933.54296875 587.7159 2933.5458984375 587.716430664063 5 6 1.1.1.4761.2 1 65.9771 1755.385 65.9725 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 IKQSELSAK missed K-Q@2 -0.00349046010524035 1002.56744384766 502.291 1002.57098388672 502.292755126953 2 12 1.1.1.2860.2 1 19.2077 966.673 19.2747 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 IKQSELSAK missed K-Q@2 -0.0031242601107806 1002.56787109375 502.2912 1002.57098388672 502.292755126953 2 13 1.1.1.2876.2 1 19.3793 980.8924 19.3175 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 IKQSELSAK Acetyl@N-term missed K-Q@2 -0.00458492012694478 1044.57702636719 523.2958 1044.58154296875 523.298034667969 2 11 1.1.1.3076.6 1 23.2783 1115.412 23.3319 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 21.3300004601479 LSIVLEGPAPAQGTPDVSSALDKLKEFGNTLEDKAR MDA adduct +62(K)@23; reduced acrolein addition +58(K)@25 cleaved V-L@N-term; missed K-L@23; missed K-E@25; missed K-A@34 0.0525959990918636 3886.08911132813 778.2251 3886.03637695313 778.214538574219 5 9 1.1.1.4239.17 1 52.5528 4276.665 52.5358 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 MREWFSETFQK Oxidation(M)@1 missed R-E@2 -0.00209952006116509 1503.67944335938 752.847 1503.681640625 752.848083496094 2 15 1.1.1.3670.8 1 37.9857 9245.177 38.1649 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 MREWFSETFQK Oxidation(M)@1 missed R-E@2 -0.00341919995844364 1503.67834472656 502.2334 1503.681640625 502.234497070313 3 14 1.1.1.3676.2 1 38.1188 22978.26 38.1649 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 MREWFSETFQK Oxidation(M)@1; Trp->Kynurenin(W)@4 missed R-E@2 -0.000465427001472563 1507.67614746094 503.566 1507.67651367188 503.566131591797 3 14 1.1.1.3527.2 1 34.3686 5096.088 34.5092 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 98.8900005817413 MREWFSETFQK Oxidation(M)@1 missed R-E@2 -0.00341919995844364 1503.67834472656 502.2334 1503.681640625 502.234497070313 3 13 1.1.1.3684.6 1 38.323 22978.26 38.1649 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 98.4499990940094 MREWFSETFQK Oxidation(M)@1; Trp->Kynurenin(W)@4 missed R-E@2 -0.000465427001472563 1507.67614746094 503.566 1507.67651367188 503.566131591797 3 13 1.1.1.3541.3 1 34.7122 5096.088 34.5092 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 97.759997844696 MREWFSETFQK Oxidation(M)@1; Dioxidation(W)@4 missed R-E@2 0.000324741995427758 1535.671875 768.8432 1535.67150878906 768.843017578125 2 11 1.1.1.3491.10 1 33.4924 5366.897 33.671 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 97.1300005912781 MREWFSETFQK Oxidation(M)@1 missed R-E@2 -0.00067267200211063 1503.68115234375 502.2343 1503.681640625 502.234497070313 3 12 1.1.1.3691.4 1 38.5031 21348.22 38.2397 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 97.1300005912781 MREWFSETFQK Oxidation(M)@1 missed R-E@2 0.000151283995364793 1503.68188476563 502.2346 1503.681640625 502.234497070313 3 11 1.1.1.3705.8 1 38.8705 5920.362 38.6006 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 97.0099985599518 MREWFSETFQK Oxidation(M)@1; Dioxidation(W)@4 missed R-E@2 0.00153668003622442 1535.67309570313 512.8983 1535.67150878906 512.897766113281 3 12 1.1.1.3498.6 1 33.6532 17478.7 33.6959 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 97.0099985599518 MREWFSETFQK Oxidation(M)@1; Dioxidation(W)@4 missed R-E@2 0.00153668003622442 1535.67309570313 512.8983 1535.67150878906 512.897766113281 3 12 1.1.1.3505.10 1 33.83 17478.7 33.6959 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 96.2999999523163 MREWFSETFQK Oxidation(M)@1; Trp->Hydroxykynurenin(W)@4 missed R-E@2 -0.00368062988854945 1523.66772460938 508.8965 1523.67150878906 508.897766113281 3 12 1.1.1.3474.5 1 33.0627 2976.992 33.078 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 95.0699985027313 MREWFSETFQK Oxidation(M)@1; Dioxidation(W)@4 missed R-E@2 0.00629730988293886 1535.67749023438 512.8998 1535.67150878906 512.897766113281 3 9 1.1.1.3562.10 1 35.2352 2223.171 35.1731 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 93.4099972248077 MREWFSETFQK Oxidation(M)@1; Trp->Kynurenin(W)@4 missed R-E@2 -0.000465427001472563 1507.67614746094 503.566 1507.67651367188 503.566131591797 3 11 1.1.1.3534.5 1 34.543 5096.088 34.5092 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 83.3100020885468 MREWFSETFQK Oxidation(M)@1 missed R-E@2 -0.00341919995844364 1503.67834472656 502.2334 1503.681640625 502.234497070313 3 11 1.1.1.3698.5 1 38.686 10375.89 38.4184 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 83.0099999904633 MREWFSETFQK Oxidation(M)@1; Oxidation(W)@4 missed R-E@2 -0.000190612001460977 1519.67651367188 507.5661 1519.67651367188 507.566131591797 3 9 1.1.1.3576.7 1 35.5986 1302.132 35.5893 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 33.9300006628037 MREWFSETFQKVKEK Oxidation(M)@1 missed R-E@2; missed K-V@11; missed K-E@13 0.0102907000109553 1987.99291992188 498.0055 1987.98254394531 498.0029296875 4 11 1.1.1.3583.6 1 35.7815 2367.888 35.8502 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDK cleaved G-T@N-term 0.00111541000660509 1031.5146484375 516.7646 1031.51354980469 516.764038085938 2 9 1.1.1.3209.5 1 26.5242 1504.597 26.6874 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 96.2999999523163 TPDVSSALDK cleaved G-T@N-term -0.00669691013172269 1031.5068359375 516.7607 1031.51354980469 516.764038085938 2 7 1.1.1.3227.11 1 26.9664 1665.457 26.98 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 98.6999988555908 TPDVSSALDKLK cleaved G-T@N-term; missed K-L@10 -0.00346444989554584 1272.68920898438 425.237 1272.69250488281 425.238128662109 3 9 1.1.1.3681.4 1 38.2454 4281.972 38.115 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 58.6499989032745 TPDVSSALDKLK cleaved G-T@N-term; missed K-L@10 -0.00254894001409411 1272.69006347656 425.2373 1272.69250488281 425.238128662109 3 5 1.1.1.3695.4 1 38.6073 647.7375 38.6267 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKAR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21 0.000222051006858237 2533.30249023438 507.6678 2533.30249023438 507.667755126953 5 19 1.1.1.4243.5 1 52.6453 53016.76 52.5358 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKAR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21 -0.00216063996776938 2533.30004882813 634.3323 2533.30249023438 634.332885742188 4 23 1.1.1.4245.7 1 52.698 46153.32 52.5358 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.0086139403283596 3131.6552734375 522.9498 3131.64624023438 522.948303222656 6 15 1.1.1.4732.3 1 65.2282 8698.693 65.2485 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.00860022008419037 3131.6552734375 627.3383 3131.64624023438 627.336547851563 5 21 1.1.1.4732.4 1 65.229 16791.76 65.2747 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.010444900020957 3131.65673828125 522.9501 3131.64624023438 522.948303222656 6 15 1.1.1.4739.3 1 65.4125 8702.859 65.3534 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.00860022008419037 3131.6552734375 627.3383 3131.64624023438 627.336547851563 5 20 1.1.1.4739.4 1 65.4133 16791.76 65.2747 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.00768472021445632 3131.65405273438 627.3381 3131.64624023438 627.336547851563 5 15 1.1.1.4746.6 1 65.5963 16258.02 65.3534 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 -0.00151203002315015 3131.64501953125 783.9185 3131.64624023438 783.918823242188 4 13 1.1.1.4736.9 1 65.3381 7104.705 65.3797 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.00158138002734631 3131.64819335938 627.3369 3131.64624023438 627.336547851563 5 13 1.1.1.4767.6 1 66.136 5135.334 66.024 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 -0.00238580000586808 3131.64428710938 627.3361 3131.64624023438 627.336547851563 5 10 1.1.1.4781.7 1 66.5028 1178.084 66.5459 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.0086139403283596 3131.6552734375 522.9498 3131.64624023438 522.948303222656 6 11 1.1.1.4725.3 1 65.0457 8571.727 65.2485 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 -0.00151203002315015 3131.64501953125 783.9185 3131.64624023438 783.918823242188 4 12 1.1.1.4735.8 1 65.3108 7104.705 65.3797 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.00982088968157768 3131.65600585938 627.3385 3131.64624023438 627.336547851563 5 9 1.1.1.4723.4 1 64.9946 15141.69 65.2485 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.000665876024868339 3131.64697265625 627.3367 3131.64624023438 627.336547851563 5 8 1.1.1.4788.4 1 66.6848 1025.046 66.7308 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 -0.00151203002315015 3131.64501953125 783.9185 3131.64624023438 783.918823242188 4 11 1.1.1.4733.9 1 65.2594 7104.705 65.3797 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.000665876024868339 3131.64697265625 627.3367 3131.64624023438 627.336547851563 5 8 1.1.1.4795.4 1 66.8707 1025.046 66.7308 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 -0.00151203002315015 3131.64501953125 783.9185 3131.64624023438 783.918823242188 4 9 1.1.1.4745.6 1 65.5711 7104.705 65.3797 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.00676921987906098 3131.65307617188 627.3379 3131.64624023438 627.336547851563 5 10 1.1.1.4753.5 1 65.7747 4404.392 65.8445 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 99.0000009536743 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 -0.00151203002315015 3131.64501953125 783.9185 3131.64624023438 783.918823242188 4 10 1.1.1.4734.10 1 65.2864 7104.705 65.3797 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 98.5400021076202 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.00556783005595207 3131.65185546875 783.9202 3131.64624023438 783.918823242188 4 7 1.1.1.4749.6 1 65.6735 2133.609 65.6656 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 98.0799973011017 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 -0.00151203002315015 3131.64501953125 783.9185 3131.64624023438 783.918823242188 4 9 1.1.1.4740.9 1 65.4431 7104.705 65.3797 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 98.0799973011017 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 -0.00151203002315015 3131.64501953125 783.9185 3131.64624023438 783.918823242188 4 9 1.1.1.4741.4 1 65.4651 7104.705 65.3797 11 16.48 16.48 84.3400001525879 68.6699986457825 68.6699986457825 sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 0 18.3699995279312 TPDVSSALDKLKEFGNTLEDKARELISR cleaved G-T@N-term; missed K-L@10; missed K-E@12; missed K-A@21; missed R-E@23 0.00971254985779524 3131.65649414063 522.95 3131.64624023438 522.948303222656 6 7 1.1.1.4747.3 1 65.6199 8659.052 65.3534 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 2 99.0000009536743 AEFVEVTKLVTDLTK missed K-L@8 0.0053913900628686 1691.93969726563 564.9872 1691.9345703125 564.985473632813 3 11 1.1.1.4323.8 1 54.6884 1687.839 54.7045 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 2 99.0000009536743 HLVDEPQNLIK -0.0094446400180459 1304.69946289063 653.357 1304.70886230469 653.361694335938 2 11 1.1.1.3488.11 1 33.4166 816.3107 33.4482 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 2 99.0000009536743 RHPEYAVSVLLR missed R-H@1 -0.00139948003925383 1438.80310058594 480.6083 1438.80444335938 480.608764648438 3 13 1.1.1.3644.3 1 37.3197 844.397 37.2881 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 2 99.0000009536743 SLHTLFGDELCK Carbamidomethyl(C)@11 0.00184220005758107 1418.68835449219 473.9034 1418.68640136719 473.902740478516 3 12 1.1.1.3798.4 1 41.2402 2814.959 41.2099 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 2 99.0000009536743 TCVADESHAGCEK Carbamidomethyl(C)@2; Carbamidomethyl(C)@11 -0.00178474001586437 1462.57983398438 488.5339 1462.58166503906 488.534515380859 3 9 1.1.1.2837.4 1 18.7881 206.0435 18.7688 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 2 99.0000009536743 VASLRETYGDMADCCEK Oxidation(M)@11; Carbamidomethyl(C)@14; Carbamidomethyl(C)@15 missed R-E@5 0.0115713998675346 2019.84521484375 674.289 2019.83361816406 674.28515625 3 12 1.1.1.3160.15 1 25.3538 503.5647 25.3348 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 2 99.0000009536743 YICDNQDTISSK Carbamidomethyl(C)@3 -0.00579075003042817 1442.62902832031 722.3218 1442.634765625 722.324645996094 2 17 1.1.1.3111.13 1 24.1501 2153.578 24.0265 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 0.00348832807503641 15.0199994444847 LVVSTQTALA -0.00724213989451528 1001.56848144531 501.7915 1001.57568359375 501.795135498047 2 7 1.1.1.3625.2 1 36.8373 1654.501 36.8822 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 0 99.0000009536743 CCTESLVNR Carbamidomethyl(C)@1; Carbamidomethyl(C)@2 -0.0033351699821651 1137.48742675781 569.751 1137.49072265625 569.752624511719 2 8 1.1.1.3103.8 0 23.9407 1350.711 24.0774 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 0 99.0000009536743 CCTESLVNR Carbamidomethyl(C)@1; Carbamidomethyl(C)@2 -0.0033351699821651 1137.48742675781 569.751 1137.49072265625 569.752624511719 2 11 1.1.1.3110.15 0 24.1208 1350.711 24.0774 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 0 99.0000009536743 KVPQVSTPTLVEVSR missed K-V@1 0.00316908000968397 1638.93359375 547.3185 1638.93041992188 547.317443847656 3 20 1.1.1.3658.5 0 37.6784 33567.93 37.5943 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 0 97.1300005912781 KVPQVSTPTLVEVSR missed K-V@1 -0.00367474998347461 1638.92687988281 820.4707 1638.93041992188 820.472534179688 2 8 1.1.1.3651.14 0 37.5089 6736.135 37.6191 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 0 96.8500018119812 VPQVSTPTLVEVSR -0.00171462004072964 1510.83386230469 756.4242 1510.83544921875 756.425048828125 2 9 1.1.1.3763.17 0 40.3821 2278.687 40.4407 12 14.01 18.56 61.7799997329712 20.2600002288818 19.1100001335144 cont|000097 gi|1351907|sp|P02769|ALBU_BOVIN Serum albumin precursor (Allergen Bos d 6) (BSA) [Bos taurus (contaminant)] 0 69.8499977588654 YLYEIAR 0.00439416989684105 926.490661621094 464.2526 926.486145019531 464.250366210938 2 6 1.1.1.3478.3 0 33.1565 1633.901 33.2507 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 2 99.0000009536743 AYSDMREANYIGSDKYFHAR Oxidation(M)@5 missed R-E@6; missed K-Y@15 0.00245101004838943 2409.08325195313 603.2781 2409.08081054688 603.277465820313 4 13 1.1.1.3432.17 1 32.0277 19473.13 31.9087 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 2 99.0000009536743 EANYIGSDKYFHAR missed K-Y@9 0.00481658009812236 1669.78967285156 557.6038 1669.78491210938 557.602233886719 3 13 1.1.1.3347.9 1 29.9216 4073.03 30.0054 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 2 99.0000009536743 FFGHGAEDSLADQAANEWGR -0.00430843979120255 2176.95141601563 1089.483 2176.95629882813 1089.4853515625 2 15 1.1.1.3864.21 1 42.9727 4605.981 43.0298 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 2 99.0000009536743 GPGGVWAAEAISDARENIQR Lys-add@N-term; Trp->Kynurenin(W)@6 missed R-E@15 -0.00405779015272856 2228.12573242188 558.0387 2228.1298828125 558.039733886719 4 19 1.1.1.3793.5 1 41.1204 1689.421 41.1604 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 2 99.0000009536743 RGPGGVWAAEAISDARENIQR missed R-G@1; missed R-E@16 0.00345844007097185 2252.14453125 564.0434 2252.14111328125 564.042541503906 4 15 1.1.1.3871.6 1 43.1417 1054.664 43.1595 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 2 99.0000009536743 SFFSFLGEAFDGAR 0.000669536995701492 1549.72082519531 775.8677 1549.72009277344 775.867370605469 2 11 1.1.1.4623.5 1 62.4649 2369.011 62.332 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 1.72124660015106 99.0000009536743 SGKDPNHFRPAGLPEKY missed K-D@3; missed K-Y@16 -0.000935518008191139 1911.95812988281 478.9968 1911.95910644531 478.9970703125 4 12 1.1.1.3281.10 1 28.2898 21612.55 28.4024 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0.0163737125694752 99.0000009536743 RSFFSFLGEAFDGARDMWR Oxidation(M)@17 cleaved S-R@N-term; missed R-S@1; missed R-D@15 0.00970927998423576 2310.07373046875 578.5257 2310.06396484375 578.523254394531 4 10 1.1.1.4474.4 1 58.5881 2661.085 58.6339 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 AYSDMREANYIGSDKYFHAR Oxidation(M)@5 missed R-E@6; missed K-Y@15 0.0100646000355482 2409.09057617188 482.8254 2409.08081054688 482.823425292969 5 20 1.1.1.3428.8 1 31.9179 35542.74 31.8834 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 27.1200001239777 AYSDMREANYIGSDKYFHAR Oxidation(M)@5 missed R-E@6; missed K-Y@15 0.00245101004838943 2409.08325195313 603.2781 2409.08081054688 603.277465820313 4 9 1.1.1.3421.11 1 31.7445 19473.13 31.9087 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 FFGHGAEDSLADQAANEWGR Dioxidation(W)@18 -0.00782168004661798 2208.93823242188 737.32 2208.94604492188 737.322631835938 3 22 1.1.1.3816.18 1 41.7175 9624.491 41.7516 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 FFGHGAEDSLADQAANEWGR Trp->Kynurenin(W)@18 -0.00259769009426236 2180.94848632813 546.2444 2180.951171875 546.245056152344 4 19 1.1.1.3820.7 1 41.8131 10763 41.7516 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 FFGHGAEDSLADQAANEWGR Dioxidation(W)@18 -0.00782168004661798 2208.93823242188 737.32 2208.94604492188 737.322631835938 3 17 1.1.1.3820.15 1 41.8198 9624.491 41.7516 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 FFGHGAEDSLADQAANEWGR 0.000304431014228612 2176.95654296875 726.6595 2176.95629882813 726.659362792969 3 16 1.1.1.3861.14 1 42.8904 41981.67 43.0298 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 FFGHGAEDSLADQAANEWGR 0.000304431014228612 2176.95654296875 726.6595 2176.95629882813 726.659362792969 3 25 1.1.1.3868.17 1 43.0737 41981.67 43.0298 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 FFGHGAEDSLADQAANEWGR 0.000121329998364672 2176.95654296875 726.6594 2176.95629882813 726.659362792969 3 15 1.1.1.3879.17 1 43.3607 13709.15 43.0822 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 FFGHGAEDSLADQAANEWGR Dioxidation(W)@18 -0.00782168004661798 2208.93823242188 737.32 2208.94604492188 737.322631835938 3 16 1.1.1.3823.19 1 41.9 9624.491 41.7516 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 FFGHGAEDSLADQAANEWGR -0.00430843979120255 2176.95141601563 1089.483 2176.95629882813 1089.4853515625 2 11 1.1.1.3863.21 1 42.9471 4605.981 43.0298 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 FFGHGAEDSLADQAANEWGR Trp->Kynurenin(W)@18 0.0013862899504602 2180.95263671875 727.9915 2180.951171875 727.990966796875 3 12 1.1.1.3823.18 1 41.8992 9009.167 41.7252 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 FFGHGAEDSLADQAANEWGR Oxidation(W)@18 0.00237565999850631 2192.95361328125 731.9918 2192.951171875 731.990966796875 3 13 1.1.1.3800.13 1 41.301 985.9375 41.3096 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 94.1500008106232 FFGHGAEDSLADQAANEWGR Trp->Kynurenin(W)@18 -0.00259769009426236 2180.94848632813 546.2444 2180.951171875 546.245056152344 4 9 1.1.1.3813.8 1 41.6297 10763 41.7516 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 16.9400006532669 FFGHGAEDSLADQAANEWGR Oxidation(W)@18 0.019404100254178 2192.97021484375 731.9974 2192.951171875 731.990966796875 3 7 1.1.1.3695.21 1 38.6215 417.5777 38.6527 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 GPGGVWAAEAISDARENIQR Lys-add@N-term missed R-E@15 -0.0234577991068363 2224.11181640625 557.0352 2224.134765625 557.041015625 4 16 1.1.1.3861.4 1 42.8821 4037.896 42.8763 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 64.4400000572205 GPGGVWAAEAISDARENIQR Lys-add@N-term missed R-E@15 -0.0234577991068363 2224.11181640625 557.0352 2224.134765625 557.041015625 4 9 1.1.1.3854.3 1 42.7046 4037.896 42.8763 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 98.470002412796 RGPGGVWAAEAISDARENIQR Trp->Kynurenin(W)@7 missed R-G@1; missed R-E@16 -0.0315840989351273 2256.1044921875 565.0334 2256.13598632813 565.041259765625 4 10 1.1.1.3744.7 1 39.88 3125.487 39.744 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 86.2100005149841 RGPGGVWAAEAISDARENIQR Dioxidation(W)@7 missed R-G@1; missed R-E@16 -0.00759745994582772 2284.12329101563 572.0381 2284.130859375 572.039978027344 4 8 1.1.1.3791.7 1 41.071 599.9516 41.111 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 81.8400025367737 RGPGGVWAAEAISDARENIQR Trp->Kynurenin(W)@7 missed R-G@1; missed R-E@16 -0.0110766999423504 2256.125 565.0385 2256.13598632813 565.041259765625 4 10 1.1.1.3887.9 1 43.5583 2252.744 43.5481 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 58.6499989032745 RGPGGVWAAEAISDARENIQR Trp->Hydroxykynurenin(W)@7 missed R-G@1; missed R-E@16 -0.00732730980962515 2272.12329101563 569.0381 2272.130859375 569.039978027344 4 10 1.1.1.3846.8 1 42.4995 2674.881 42.5156 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 RSFFSFLGEAFDGARDMWR Oxidation(M)@17 cleaved S-R@N-term; missed R-S@1; missed R-D@15 0.00970927998423576 2310.07373046875 578.5257 2310.06396484375 578.523254394531 4 10 1.1.1.4475.7 1 58.617 2661.085 58.6339 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 99.0000009536743 SFFSFLGEAFDGAR 0.000669536995701492 1549.72082519531 775.8677 1549.72009277344 775.867370605469 2 15 1.1.1.4615.8 1 62.2655 2369.011 62.332 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 17.8000003099442 SGKDPNHFRPAGLPEKY missed K-D@3; missed K-Y@16 -0.000935518008191139 1911.95812988281 478.9968 1911.95910644531 478.9970703125 4 10 1.1.1.3290.7 1 28.508 21612.55 28.4024 13 13.74 13.74 79.5099973678589 79.5099973678589 79.5099973678589 sp|P02735|SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 0 17.5600007176399 SGKDPNHFRPAGLPEKY missed K-D@3; missed K-Y@16 -8.86912021087483E-05 1911.95922851563 638.327 1911.95910644531 638.326965332031 3 10 1.1.1.3283.15 1 28.3482 2798.863 28.3779 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 2 99.0000009536743 ALSSVQESQVAQQAR cleaved D-A@N-term 0.00953345000743866 1600.82641601563 801.4205 1600.81689453125 801.415710449219 2 17 1.1.1.3225.17 1 26.926 457.2779 26.9069 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 2 99.0000009536743 DALSSVQESQVAQQAR -0.0108955996111035 1715.83312988281 858.9238 1715.84387207031 858.92919921875 2 21 1.1.1.3486.20 1 33.3688 1686.929 33.2753 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 2 99.0000009536743 KDALSSVQESQVAQQAR Oxidation(D)@2 cleaved A-K@N-term; missed K-D@1 0.00124443997628987 1859.93493652344 620.9856 1859.93371582031 620.985168457031 3 19 1.1.1.3445.9 1 32.3492 2171.544 32.3627 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 2 99.0000009536743 SEAEDASLLSFMQGYMK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term -0.00355597003363073 1937.83532714844 969.9249 1937.83862304688 969.926635742188 2 15 1.1.1.3887.19 1 43.5666 1938.06 43.5228 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 2 99.0000009536743 SEAEDASLLSFMQGYMKHATK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term; missed K-H@17 -0.0032725699711591 2375.07421875 594.7758 2375.07739257813 594.776611328125 4 18 1.1.1.3671.7 1 38.0054 3403.18 38.0652 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 2 99.0000009536743 TAKDALSSVQESQVAQQAR missed K-D@3 -0.00228994991630316 2016.02136230469 673.0144 2016.02355957031 673.01513671875 3 19 1.1.1.3373.15 1 30.5706 2388.059 30.4764 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0.0338582694530487 99.0000009536743 TKTAKDALSSVQESQVAQQAR acrolein addition +94(K)@5 cleaved A-T@N-term; missed K-T@2; missed K-D@5 -0.0186595004051924 2339.189453125 585.8046 2339.2080078125 585.809326171875 4 14 1.1.1.3451.5 1 32.5004 1405.197 32.4382 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0.000434511806815863 99.0000009536743 ATKTAKDALSSVQESQVAQQAR Acetyl@N-term; MDA adduct +62(K)@3; ONE addition +154(K)@6 cleaved H-A@N-term; missed K-T@3; missed K-D@6 0.0314778983592987 2574.3603515625 859.1274 2574.32885742188 859.116943359375 3 13 1.1.1.3442.15 1 32.2834 3305.487 32.1647 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0.000434511806815863 89.2300009727478 EDASLLSFMQGYMK Oxidation(M)@9; Oxidation(M)@13 cleaved A-E@N-term 0.00375307002104819 1650.73071289063 826.3726 1650.72692871094 826.370727539063 2 9 1.1.1.3846.19 1 42.5087 739.7822 42.5156 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR 0.00181010004598647 1715.84558105469 572.9558 1715.84387207031 572.955200195313 3 18 1.1.1.3444.7 1 32.3277 84327.32 32.4877 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR Cation:Na(E)@8; Deamidated(Q)@10 0.0108203003183007 1738.82043457031 580.6141 1738.80981445313 580.610534667969 3 20 1.1.1.3449.4 1 32.446 4806.148 32.5122 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR 0.00181010004598647 1715.84558105469 572.9558 1715.84387207031 572.955200195313 3 24 1.1.1.3451.4 1 32.4979 84327.32 32.4877 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR Cation:Na(E)@8 0.000414093985455111 1737.82629394531 580.2827 1737.82580566406 580.282531738281 3 18 1.1.1.3452.4 1 32.5199 5302.551 32.4877 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR 0.00181010004598647 1715.84558105469 572.9558 1715.84387207031 572.955200195313 3 24 1.1.1.3458.7 1 32.6741 84327.32 32.4877 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR 0.0016270000487566 1715.84521484375 572.9557 1715.84387207031 572.955200195313 3 21 1.1.1.3465.15 1 32.8461 62662.82 32.586 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR -0.00295052002184093 1715.8408203125 572.9542 1715.84387207031 572.955200195313 3 20 1.1.1.3472.8 1 33.021 21485.96 32.7581 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR Delta:H(2)C(2)@N-term 0.00227873004041612 1741.86181640625 871.9382 1741.85949707031 871.93701171875 2 24 1.1.1.3477.18 1 33.1468 908.9505 33.1273 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR 0.00181010004598647 1715.84558105469 572.9558 1715.84387207031 572.955200195313 3 19 1.1.1.3479.10 1 33.1871 11162.34 32.9302 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR 0.000711498025339097 1715.84436035156 572.9554 1715.84387207031 572.955200195313 3 17 1.1.1.3486.12 1 33.3613 3913.693 33.2753 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR -0.00203501991927624 1715.841796875 572.9545 1715.84387207031 572.955200195313 3 18 1.1.1.3493.10 1 33.5335 1922.324 33.4976 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR 0.00460691004991531 1715.84851074219 858.9315 1715.84387207031 858.92919921875 2 20 1.1.1.3500.14 1 33.7138 924.0355 33.7454 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR 0.00748624000698328 1715.85131835938 572.9577 1715.84387207031 572.955200195313 3 18 1.1.1.3501.8 1 33.7318 1471.195 33.7702 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR 0.0158370994031429 1715.85961914063 858.9371 1715.84387207031 858.92919921875 2 20 1.1.1.3510.15 1 33.9626 691.7422 33.9678 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR Methyl(E)@8 -0.000564272981137037 1729.85913085938 865.9368 1729.85949707031 865.93701171875 2 18 1.1.1.3580.21 1 35.7151 2590.216 35.7731 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR Methyl(E)@8 -0.000564272981137037 1729.85913085938 865.9368 1729.85949707031 865.93701171875 2 25 1.1.1.3587.14 1 35.8933 2590.216 35.7731 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR -0.00918665993958712 1715.83471679688 858.9246 1715.84387207031 858.92919921875 2 13 1.1.1.3588.21 1 35.9202 618.7309 35.9003 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR Cation:Na(E)@8 0.0046254200860858 1737.83056640625 580.2841 1737.82580566406 580.282531738281 3 16 1.1.1.3459.6 1 32.6937 5247.289 32.5122 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 DALSSVQESQVAQQAR Methyl(E)@8 0.000897808989975601 1729.8603515625 577.6274 1729.85949707031 577.627136230469 3 12 1.1.1.3580.11 1 35.7068 3871.737 35.8254 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 97.9200005531311 DALSSVQESQVAQQAR Cation:Na(E)@8; Deamidated(Q)@10 0.0366374999284744 1738.84619140625 580.6227 1738.80981445313 580.610534667969 3 12 1.1.1.3475.10 1 33.0907 546.1387 33.1273 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 74.0800023078918 FMQGYMKHATKTAKDALSSVQESQVAQQAR cleaved S-F@N-term; missed K-H@7; missed K-T@11; missed K-D@14 3.0003399848938 3341.65063476563 836.4199 3338.64990234375 835.669799804688 4 7 1.1.1.3689.21 1 38.4652 449.3948 38.5485 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 74.9300003051758 GWVTDGFSSLKDYWSTVK Dioxidation(W)@2; Dioxidation(W)@14 missed K-D@11 0.00688759004697204 2138.98657226563 714.0028 2138.97973632813 714.00048828125 3 9 1.1.1.4140.17 1 50.0282 1642.267 50.0113 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 97.9200005531311 KDALSSVQESQVAQQAR Oxidation(D)@2 cleaved A-K@N-term; missed K-D@1 0.00124443997628987 1859.93493652344 620.9856 1859.93371582031 620.985168457031 3 13 1.1.1.3452.6 1 32.5233 2171.544 32.3627 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 SEAEDASLLSFMQGYMK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term 0.000228108998271637 1937.83911132813 969.9268 1937.83862304688 969.926635742188 2 24 1.1.1.3859.15 1 42.8458 38962.32 43.0822 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 SEAEDASLLSFMQGYMK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term 0.00597359007224441 1937.8447265625 646.9555 1937.83862304688 646.953491210938 3 25 1.1.1.3866.12 1 43.017 71911.75 43.2645 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 SEAEDASLLSFMQGYMK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term 0.00560738984495401 1937.84436035156 646.9554 1937.83862304688 646.953491210938 3 26 1.1.1.3873.14 1 43.2008 75734.73 43.2645 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 SEAEDASLLSFMQGYMK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term 0.000960512028541416 1937.83972167969 969.9271 1937.83862304688 969.926635742188 2 26 1.1.1.3874.21 1 43.2328 68064.48 43.2645 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 SEAEDASLLSFMQGYMK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term 0.00560738984495401 1937.84436035156 646.9554 1937.83862304688 646.953491210938 3 21 1.1.1.3880.11 1 43.3819 75734.73 43.2645 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 SEAEDASLLSFMQGYMK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term 0.000228108998271637 1937.83911132813 969.9268 1937.83862304688 969.926635742188 2 18 1.1.1.3894.18 1 43.743 1425.059 43.7508 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 SEAEDASLLSFMQGYMK Oxidation(M)@12; Dioxidation(M)@16 cleaved A-S@N-term 0.0162457004189491 1953.84985351563 977.9322 1953.83361816406 977.924072265625 2 15 1.1.1.3920.21 1 44.4025 694.1881 44.3824 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 96.7299997806549 SEAEDASLLSFMQGYMK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term 0.0125652002170682 1937.85131835938 646.9577 1937.83862304688 646.953491210938 3 10 1.1.1.3837.14 1 42.2666 1397.573 42.2509 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 87.1500015258789 SEAEDASLLSFMQGYMK Oxidation(M)@12; Dioxidation(M)@16 cleaved A-S@N-term 0.0126358000561595 1953.84643554688 652.2894 1953.83361816406 652.28515625 3 10 1.1.1.3886.12 1 43.5353 1296.034 43.5228 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 SEAEDASLLSFMQGYMKHATK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term; missed K-H@17 0.00307494006119668 2375.08056640625 594.7774 2375.07739257813 594.776611328125 4 21 1.1.1.3678.9 1 38.1762 4192.704 38.4184 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 SEAEDASLLSFMQGYMKHATK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term; missed K-H@17 0.00283080991357565 2375.080078125 594.7773 2375.07739257813 594.776611328125 4 18 1.1.1.3692.12 1 38.5358 11246.48 38.6786 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 SEAEDASLLSFMQGYMKHATK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term; missed K-H@17 0.00283080991357565 2375.080078125 594.7773 2375.07739257813 594.776611328125 4 19 1.1.1.3699.9 1 38.7152 11246.48 38.6786 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 SEAEDASLLSFMQGYMKHATK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term; missed K-H@17 -0.00351669988594949 2375.07421875 594.7758 2375.07739257813 594.776611328125 4 16 1.1.1.3685.13 1 38.3547 7929.98 38.6006 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 SEAEDASLLSFMQGYMKHATK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term; missed K-H@17 0.000663328974042088 2375.078125 792.7 2375.07739257813 792.69970703125 3 15 1.1.1.3673.7 1 38.0574 1423.389 38.0652 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 98.6999988555908 SEAEDASLLSFMQGYMKHATK Oxidation(M)@12; reduced acrolein addition +58(K)@17 cleaved A-S@N-term; missed K-H@17 -0.0385476015508175 2417.08569335938 806.7025 2417.12426757813 806.715393066406 3 13 1.1.1.3845.18 1 42.4817 8693.11 42.3835 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 97.9099988937378 SEAEDASLLSFMQGYMKHATK Oxidation(M)@12; reduced acrolein addition +58(K)@17 cleaved A-S@N-term; missed K-H@17 -0.0385476015508175 2417.08569335938 806.7025 2417.12426757813 806.715393066406 3 13 1.1.1.3838.19 1 42.2972 8693.11 42.3835 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 96.4800000190735 SEAEDASLLSFMQGYMKHATK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term; missed K-H@17 0.00469155004248023 2375.08203125 792.7013 2375.07739257813 792.69970703125 3 11 1.1.1.3701.21 1 38.777 3777.295 38.6786 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 93.2399988174438 SEAEDASLLSFMQGYMKHATK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term; missed K-H@17 -0.000252174999332055 2375.07690429688 792.6996 2375.07739257813 792.69970703125 3 10 1.1.1.3678.14 1 38.1845 1377.324 38.2147 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 81.8400025367737 SEAEDASLLSFMQGYMKHATK Oxidation(M)@12; Oxidation(M)@16 cleaved A-S@N-term; missed K-H@17 0.000663328974042088 2375.078125 792.7 2375.07739257813 792.69970703125 3 8 1.1.1.3674.21 1 38.0849 1423.389 38.0652 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 69.9000000953674 SEAEDASLLSFMQGYMKHATK Oxidation(M)@12; reduced acrolein addition +58(K)@17 cleaved A-S@N-term; missed K-H@17 -0.0427589006721973 2417.08154296875 806.7011 2417.12426757813 806.715393066406 3 9 1.1.1.3831.19 1 42.1114 7422.091 42.3571 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR Deamidated(Q)@10 missed K-D@3 0.0183685999363661 2017.02575683594 673.3492 2017.00756835938 673.343139648438 3 13 1.1.1.3334.11 1 29.605 21788.96 29.8337 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR missed K-D@3 0.00440939981490374 2016.02746582031 1009.021 2016.02355957031 1009.01910400391 2 6 1.1.1.3337.21 1 29.6806 4898.165 29.8582 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR Carbamidomethyl@N-term missed K-D@3 0.00298310001380742 2073.04809570313 692.0233 2073.04516601563 692.022277832031 3 21 1.1.1.3339.15 1 29.7301 1598.522 29.7847 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR missed K-D@3 0.00464920001104474 2016.02819824219 505.0143 2016.02355957031 505.01318359375 4 19 1.1.1.3344.6 1 29.8446 7456.925 29.8337 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR missed K-D@3 0.00210447004064918 2016.02600097656 673.0159 2016.02355957031 673.01513671875 3 26 1.1.1.3344.11 1 29.853 49704.37 29.8337 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR missed K-D@3 0.00464920001104474 2016.02819824219 505.0143 2016.02355957031 505.01318359375 4 17 1.1.1.3351.4 1 30.013 7456.925 29.8337 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR missed K-D@3 0.00210447004064918 2016.02600097656 673.0159 2016.02355957031 673.01513671875 3 26 1.1.1.3351.10 1 30.0247 49704.37 29.8337 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR missed K-D@3 0.00155517004895955 2016.02526855469 673.0157 2016.02355957031 673.01513671875 3 19 1.1.1.3358.21 1 30.1967 34244.78 29.9318 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR missed K-D@3 0.00155517004895955 2016.02526855469 673.0157 2016.02355957031 673.01513671875 3 17 1.1.1.3366.16 1 30.3922 6950.67 30.128 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR Methyl(E)@11 missed K-D@3 0.00391867989674211 2030.04345703125 677.6884 2030.03930664063 677.68701171875 3 21 1.1.1.3467.8 1 32.8953 3614.618 32.9302 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR Acetyl@N-term missed K-D@3 -0.00440842984244227 2058.02978515625 687.0172 2058.0341796875 687.018676757813 3 18 1.1.1.3589.18 1 35.9427 13780.57 36.0509 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR Acetyl@N-term missed K-D@3 -0.00440842984244227 2058.02978515625 687.0172 2058.0341796875 687.018676757813 3 22 1.1.1.3596.18 1 36.1204 13780.57 36.0509 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR Formyl@N-term; reduced acrolein addition +58(K)@3 missed K-D@3 -0.00975066982209682 2102.05126953125 1052.033 2102.06030273438 1052.03747558594 2 18 1.1.1.3861.20 1 42.8963 909.8973 42.9269 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR Formyl@N-term missed K-D@3 0.0111736003309488 2044.02978515625 682.3505 2044.0185546875 682.346801757813 3 12 1.1.1.3571.19 1 35.4774 1834.464 35.5367 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR Methyl(E)@11 missed K-D@3 -0.0200674999505281 2030.01940917969 677.6804 2030.03930664063 677.68701171875 3 13 1.1.1.3342.9 1 29.799 725.2856 29.8828 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR missed K-D@3 0.00464920001104474 2016.02819824219 505.0143 2016.02355957031 505.01318359375 4 12 1.1.1.3348.3 1 29.941 7456.925 29.8337 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 99.0000009536743 TAKDALSSVQESQVAQQAR Acetyl@N-term missed K-D@3 -0.00440842984244227 2058.02978515625 687.0172 2058.0341796875 687.018676757813 3 13 1.1.1.3603.17 1 36.2989 14557.98 36.0257 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 98.470002412796 TAKDALSSVQESQVAQQAR acrolein addition +56(K)@3; Oxidation(D)@4 missed K-D@3 0.00125414994545281 2088.0458984375 697.0226 2088.04467773438 697.022155761719 3 11 1.1.1.3761.17 1 40.3297 1622.151 40.3906 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 98.3299970626831 TAKDALSSVQESQVAQQAR Formyl@N-term missed K-D@3 0.0111736003309488 2044.02978515625 682.3505 2044.0185546875 682.346801757813 3 11 1.1.1.3578.17 1 35.6592 1834.464 35.5367 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 97.409999370575 TAKDALSSVQESQVAQQAR Deamidated(Q)@10; Deamidated(Q)@13 missed K-D@3 -0.018283499404788 2017.97314453125 673.665 2017.99157714844 673.671142578125 3 12 1.1.1.3404.9 1 31.3354 2951.893 31.4143 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 73.9300012588501 TAKDALSSVQESQVAQQAR acrolein addition +56(K)@3 missed K-D@3 -0.00356920994818211 2072.0458984375 691.6893 2072.0498046875 691.690551757813 3 9 1.1.1.3697.20 1 38.6725 1034.191 38.6527 14 12.03 12.03 58.5900008678436 58.5900008678436 40.4000014066696 sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 0 97.5899994373322 TKTAKDALSSVQESQVAQQAR MDA adduct +54(K)@2; acrolein addition +56(K)@5; Deamidated(Q)@12 cleaved A-T@N-term; missed K-T@2; missed K-D@5 -0.00550164002925158 2356.181640625 786.4011 2356.18701171875 786.402954101563 3 11 1.1.1.3591.21 1 35.9954 1311.388 36.0257 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 2 99.0000009536743 DGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@12; Oxidation(M)@14; Oxidation(M)@17; Oxidation(M)@22 -0.0044546602293849 3540.72924804688 886.1896 3540.73364257813 886.190673828125 4 19 1.1.1.4578.13 1 61.3312 8852.697 61.1378 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 2 99.0000009536743 ERGRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@16; Oxidation(M)@18; Oxidation(M)@21; Oxidation(M)@26 missed R-G@2; missed R-D@4 0.00833501014858484 4039.00805664063 808.8089 4039 808.807250976563 5 28 1.1.1.4401.11 1 56.6946 9828.208 56.6304 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 2 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@14; Oxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 -0.0139579996466637 3753.84204101563 939.4678 3753.85620117188 939.471313476563 4 25 1.1.1.4488.21 1 58.9712 21992.69 58.7655 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 2 99.0000009536743 SGVQQLIQYYQDQK -0.00253299996256828 1696.83972167969 849.4271 1696.84204101563 849.428283691406 2 19 1.1.1.4025.21 1 47.0968 6278.638 47.0247 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 2 99.0000009536743 SLPTEDCENEKEQAVHNVVQLLPGVGTFYNLGTALYYATQNCLGK Carbamidomethyl(C)@7; Carbamidomethyl(C)@42 missed K-E@11 0.00527217984199524 5040.43359375 1009.094 5040.42724609375 1009.0927734375 5 13 1.1.1.5030.18 1 73.1281 1650.084 73.0284 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 2 99.0000009536743 SYDLDPGAGSLEI -0.00405204016715288 1335.615234375 668.8149 1335.61938476563 668.817016601563 2 15 1.1.1.4037.13 1 47.3971 4597.522 47.4862 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 DGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@12; Oxidation(M)@14; Oxidation(M)@17; Oxidation(M)@22 -0.0044546602293849 3540.72924804688 886.1896 3540.73364257813 886.190673828125 4 18 1.1.1.4563.14 1 60.9444 8756.112 61.1378 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 DGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@12; Oxidation(M)@14; Oxidation(M)@17; Oxidation(M)@22 0.00872852001339197 3540.74243164063 886.1929 3540.73364257813 886.190673828125 4 18 1.1.1.4588.9 1 61.5818 3398.939 61.4701 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 DGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@12; Oxidation(M)@14; Oxidation(M)@17; Oxidation(M)@22 0.00116039998829365 3540.73486328125 886.191 3540.73364257813 886.190673828125 4 21 1.1.1.4595.8 1 61.7584 2914.488 61.7237 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 DGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@12; Oxidation(M)@14; Oxidation(M)@17; Oxidation(M)@22 0.0162966009229422 3540.75024414063 886.1948 3540.73364257813 886.190673828125 4 18 1.1.1.4602.6 1 61.9338 2448.092 61.9516 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 DGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@12; Oxidation(M)@14; Oxidation(M)@17; Oxidation(M)@22 0.00237198988907039 3540.73608398438 709.1545 3540.73364257813 709.153991699219 5 12 1.1.1.4573.7 1 61.1982 1839.772 61.1112 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 DGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@12; Oxidation(M)@14; Dioxidation(M)@22; Deamidated(R)@35 0.027122600004077 3541.74487304688 886.4435 3541.71752929688 886.436706542969 4 15 1.1.1.4571.7 1 61.1469 7650.813 61.1112 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 DGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@12; Oxidation(M)@14; Oxidation(M)@17; Oxidation(M)@22 0.00512772984802723 3540.740234375 1181.254 3540.73364257813 1181.25183105469 3 12 1.1.1.4588.12 1 61.5868 1435.502 61.5211 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 DGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@12; Oxidation(M)@14; Oxidation(M)@17; Oxidation(M)@22 -0.00183004001155496 3540.73120117188 1181.251 3540.73364257813 1181.25183105469 3 12 1.1.1.4571.21 1 61.1585 4471.584 61.1378 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 DGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@12; Oxidation(M)@14; Oxidation(M)@17; Oxidation(M)@22 -0.00659062014892697 3540.72827148438 1181.25 3540.73364257813 1181.25183105469 3 11 1.1.1.4581.18 1 61.414 1655.371 61.4193 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 98.8900005817413 DGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@12; Oxidation(M)@14; Oxidation(M)@17; Oxidation(M)@22 -0.00323399994522333 3540.73046875 886.1899 3540.73364257813 886.190673828125 4 10 1.1.1.4609.8 1 62.1134 1595.292 62.1041 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@14; Oxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 0.0036195800639689 3753.85986328125 939.4722 3753.85620117188 939.471313476563 4 16 1.1.1.4446.20 1 57.8687 14216.01 58.1097 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@14; Oxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 0.00337544991634786 3753.85986328125 939.4722 3753.85620117188 939.471313476563 4 21 1.1.1.4453.19 1 58.0502 14260.49 58.1097 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@14; Oxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 0.00605536019429564 3753.8623046875 751.7797 3753.85620117188 751.778503417969 5 29 1.1.1.4455.16 1 58.1003 5266.811 58.1097 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@14; Oxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 0.00337544991634786 3753.85986328125 939.4722 3753.85620117188 939.471313476563 4 24 1.1.1.4460.20 1 58.2344 14260.49 58.1097 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@14; Oxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 0.000867531984113157 3753.85693359375 751.7787 3753.85620117188 751.778503417969 5 22 1.1.1.4464.14 1 58.3338 3252.382 58.4234 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@14; Oxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 0.00215479009784758 3753.85864257813 939.4719 3753.85620117188 939.471313476563 4 22 1.1.1.4467.19 1 58.4166 8429.13 58.3448 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@14; Oxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 0.010211200453341 3753.86645507813 939.4739 3753.85620117188 939.471313476563 4 22 1.1.1.4474.19 1 58.6006 10437.35 58.6076 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@14; Oxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 -0.000963467988185585 3753.85522460938 751.7783 3753.85620117188 751.778503417969 5 28 1.1.1.4480.17 1 58.7569 6937.538 58.7655 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@14; Oxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 -0.0139579996466637 3753.84204101563 939.4678 3753.85620117188 939.471313476563 4 27 1.1.1.4481.21 1 58.7868 21992.69 58.7655 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@14; Oxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 -0.000963467988185585 3753.85522460938 751.7783 3753.85620117188 751.778503417969 5 23 1.1.1.4488.14 1 58.9654 6937.538 58.7655 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Oxidation(M)@14; Oxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 -0.0115165999159217 3753.84448242188 939.4684 3753.85620117188 939.471313476563 4 17 1.1.1.4495.18 1 59.1535 17919.6 58.8709 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Cation:Na(D)@11; Carbamyl(M)@24 missed R-D@2 -0.00170846004039049 3754.86254882813 751.9798 3754.8642578125 751.980163574219 5 15 1.1.1.4472.17 1 58.5463 3215.355 58.5548 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 GRDGAIDLGYDLLMTMAGMSGGPMGLAISAALKPALR Deamidated(R)@2; Dioxidation(M)@16; Oxidation(M)@19; Oxidation(M)@24 missed R-D@2 0.00955882016569376 3754.84936523438 751.9772 3754.84033203125 751.975341796875 5 13 1.1.1.4492.13 1 59.07 6680.854 58.7921 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 91.5799975395203 PTEDCENEKEQAVHNVVQLLPGVGTFYNLGTALYYATQNCLGK Carbamidomethyl(C)@5; Carbamyl(K)@9; reduced HNE(H)@14; Carbamidomethyl(C)@40 cleaved L-P@N-term; missed K-E@9 -0.0163266006857157 5041.43359375 1009.294 5041.44775390625 1009.29681396484 5 13 1.1.1.5045.21 1 73.5319 932.4151 73.5639 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 98.0300009250641 SGVQQLIQYYQDQK -0.00253299996256828 1696.83972167969 849.4271 1696.84204101563 849.428283691406 2 12 1.1.1.4018.18 1 46.9142 6278.638 47.0247 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 98.9499986171722 SGVQQLIQYYQDQKDANISQPETTKEGLR Hex(1)HexNAc(1)NeuAc(1)(N)@17 missed K-D@14; missed K-E@25 0.0101854996755719 3992.896484375 999.2314 3992.88623046875 999.228820800781 4 15 1.1.1.4003.21 1 46.5266 19394.02 46.5059 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 SLPTEDCENEKEQAVHNVVQLLPGVGTFYNLGTALYYATQNCLGK Carbamidomethyl(C)@7; Carbamidomethyl(C)@42 missed K-E@11 0.0153425997123122 5040.44384765625 1009.096 5040.42724609375 1009.0927734375 5 18 1.1.1.4997.17 1 72.2331 12629.27 72.4309 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 SLPTEDCENEKEQAVHNVVQLLPGVGTFYNLGTALYYATQNCLGK Carbamidomethyl(C)@7; Carbamidomethyl(C)@42 missed K-E@11 0.00620535993948579 5040.43359375 841.0795 5040.42724609375 841.078491210938 6 13 1.1.1.5005.14 1 72.4469 1588.218 72.4309 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 SLPTEDCENEKEQAVHNVVQLLPGVGTFYNLGTALYYATQNCLGK Carbamidomethyl(C)@7; Carbamidomethyl(C)@42 missed K-E@11 0.0153425997123122 5040.44384765625 1009.096 5040.42724609375 1009.0927734375 5 16 1.1.1.5010.19 1 72.5862 12674.53 72.4309 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 SLPTEDCENEKEQAVHNVVQLLPGVGTFYNLGTALYYATQNCLGK Carbamidomethyl(C)@7; Carbamidomethyl(C)@42 missed K-E@11 0.0147323003038764 5040.44384765625 1009.096 5040.42724609375 1009.0927734375 5 12 1.1.1.5019.20 1 72.8319 9800.802 72.5397 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 SLPTEDCENEKEQAVHNVVQLLPGVGTFYNLGTALYYATQNCLGK Carbamidomethyl(C)@7; Carbamidomethyl(C)@42 missed K-E@11 0.0122910002246499 5040.4384765625 1009.095 5040.42724609375 1009.0927734375 5 15 1.1.1.5023.18 1 72.9395 5601.301 72.6475 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 SLPTEDCENEKEQAVHNVVQLLPGVGTFYNLGTALYYATQNCLGK Carbamidomethyl(C)@7; Carbamidomethyl(C)@42 missed K-E@11 0.0302955992519856 5040.45849609375 1009.099 5040.42724609375 1009.0927734375 5 9 1.1.1.5042.21 1 73.4518 794.8823 73.4034 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 88.4899973869324 SLPTEDCENEKEQAVHNVVQLLPGVGTFYNLGTALYYATQNCLGK Carbamidomethyl(C)@7; Oxidation(P)@23; Carbamidomethyl(C)@42 missed K-E@11 0.0336124002933502 5056.45361328125 1012.298 5056.42236328125 1012.29174804688 5 10 1.1.1.5005.21 1 72.4527 832.8397 72.4036 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 63.5200023651123 SLPTEDCENEKEQAVHNVVQLLPGVGTFYNLGTALYYATQNCLGK Carbamidomethyl(C)@7; reduced acrolein addition +58(K)@11; Ammonia-loss(N)@17; Carbamidomethyl(C)@42 missed K-E@11 0.0424699001014233 5081.48388671875 1017.304 5081.44287109375 1017.29583740234 5 8 1.1.1.5031.20 1 73.1563 685.034 73.1624 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 65.4399991035461 SLPTEDCENEKEQAVHNVVQLLPGVGTFYNLGTALYYATQNCLGKAR Carbamidomethyl(C)@7; Dehydrated(T)@33; Deamidated(N)@41; Carbamidomethyl(C)@42; reduced acrolein addition +58(K)@45 missed K-E@11; missed K-A@45 0.0201703999191523 5308.603515625 1062.728 5308.5810546875 1062.72351074219 5 11 1.1.1.4969.20 1 71.4799 3396.669 71.513 15 12 12 41.5600001811981 41.5600001811981 40.9099996089935 sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=1 0 99.0000009536743 SYDLDPGAGSLEI -0.00405204016715288 1335.615234375 668.8149 1335.61938476563 668.817016601563 2 12 1.1.1.4044.9 1 47.5737 4597.522 47.4862 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 GFSSGSAVVSGGSR 0.00861783046275377 1253.60864257813 627.8116 1253.59997558594 627.807312011719 2 14 1.1.1.3153.11 1 25.184 976.3589 25.1892 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 GGSISGGGYGSGGGKHSSGGGSRGGSSSGGGYGSGGGGSSSVK missed K-H@15; missed R-G@23 0.991461992263794 3492.51977539063 874.1372 3491.5283203125 873.889343261719 4 15 1.1.1.3008.6 1 21.668 166.8136 21.6733 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 NLDLDSIIAEVK -0.00107797002419829 1328.71765136719 665.3661 1328.71875 665.366638183594 2 9 1.1.1.4326.9 0 54.7664 1759.272 54.7559 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 NLDLDSIIAEVKAQYEEIAQR missed K-A@12 0.000714269001036882 2417.24438476563 806.7554 2417.24389648438 806.755187988281 3 16 1.1.1.4911.6 0 69.9562 974.0447 69.9896 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 SISISVAGGGGGFGAAGGFGGR -0.00565959978848696 1837.90148925781 919.958 1837.90710449219 919.960815429688 2 21 1.1.1.3941.20 1 44.9325 1699.121 44.9377 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0.454692870378494 98.9099979400635 YLDGLTAER 9.66142979450524E-05 1036.51904296875 519.2668 1036.51892089844 519.266723632813 2 10 1.1.1.3406.7 1 31.3762 2058.212 31.3652 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0.421360790729523 98.769998550415 GGGFGGGSSFGGGSGFSGGGFGGGGFGGGR -0.0027101500891149 2398.00732421875 1200.011 2398.01123046875 1200.01281738281 2 9 1.1.1.3959.21 1 45.3909 949.7114 45.3961 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0.0048037082888186 35.929998755455 LLEGEECR Carbamidomethyl(C)@7 0.0023235899861902 1004.46209716797 503.2383 1004.45971679688 503.237121582031 2 9 1.1.1.3053.2 0 22.7801 186.7562 22.7612 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 88.9299988746643 IEISELNRVIQR missed R-V@8 -0.0030878100078553 1468.8330078125 490.6183 1468.83618164063 490.619323730469 3 9 1.1.1.3844.3 0 42.4427 11534.39 42.542 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 77.3899972438812 IEISELNRVIQR missed R-V@8 -0.0030878100078553 1468.8330078125 490.6183 1468.83618164063 490.619323730469 3 9 1.1.1.3851.7 0 42.6307 11534.39 42.542 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 99.0000009536743 SISISVAGGGGGFGAAGGFGGR 0.000906538974959403 1837.90808105469 613.6433 1837.90710449219 613.643005371094 3 14 1.1.1.3940.10 1 44.8981 1618.018 44.9125 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 98.3699977397919 SISISVAGGGGGFGAAGGFGGR 0.000906538974959403 1837.90808105469 613.6433 1837.90710449219 613.643005371094 3 11 1.1.1.3947.8 1 45.0734 1618.018 44.9125 16 10.88 10.95 60.0899994373322 23.6300006508827 21.7500001192093 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 28.9400011301041 TAAENDFVTLKK Carbamyl@N-term; Methyl(D)@6 missed K-K@11 0.00326932989992201 1392.72802734375 697.3713 1392.72485351563 697.369750976563 2 14 1.1.1.3285.10 0 28.3971 955.591 28.3534 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 2 99.0000009536743 CPNPPVQENFDVNKYLGR Carbamidomethyl(C)@1 missed K-Y@14 -0.00256130006164312 2146.02392578125 716.3486 2146.02661132813 716.349487304688 3 22 1.1.1.3870.13 1 43.1217 25955.3 43.2119 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 2 99.0000009536743 KMTVTDQVNCPK Oxidation(M)@2; Carbamidomethyl(C)@10 missed K-M@1 0.00346660008653998 1435.68334960938 479.5684 1435.67993164063 479.567260742188 3 9 1.1.1.2982.6 1 21.0551 185.2355 21.0603 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 2 99.0000009536743 MTVTDQVNCPK Oxidation(M)@1; Carbamidomethyl(C)@9 -0.00233809999190271 1307.58264160156 654.7986 1307.5849609375 654.799743652344 2 18 1.1.1.3050.4 1 22.7079 6671.62 22.6405 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 2 99.0000009536743 MTVTDQVNCPKLS Oxidation(M)@1; Carbamidomethyl(C)@9 missed K-L@11 0.00346378004178405 1507.70471191406 754.8596 1507.70104980469 754.857788085938 2 17 1.1.1.3297.17 1 28.6929 4185.289 28.7727 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 2 99.0000009536743 NPNLPPETVDSLKNILTSNNIDVKK missed K-N@13; missed K-K@24 0.00534577015787363 2762.48681640625 921.8362 2762.4814453125 921.834411621094 3 11 1.1.1.4169.20 1 50.769 3065.894 50.8771 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 0.00612308504059911 42.3099994659424 WYEIEKIPTTFENGR missed K-I@6 -0.000196737993974239 1881.92590332031 628.3159 1881.92614746094 628.315979003906 3 9 1.1.1.3950.15 1 45.1554 1740.084 45.2164 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 0.00524305552244186 39.1400009393692 VLNQELR -0.00615416001528502 870.486267089844 436.2504 870.492309570313 436.253448486328 2 8 1.1.1.3120.7 1 24.3671 4985.639 24.4091 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 0.00348832807503641 29.5100003480911 NPNLPPETVDSLK 0.00669780978932977 1422.74230957031 712.3784 1422.73547363281 712.375 2 10 1.1.1.3585.6 1 35.8449 684.7833 35.8502 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 0 99.0000009536743 CPNPPVQENFDVNKYLGR Carbamidomethyl(C)@1 missed K-Y@14 -0.00256130006164312 2146.02392578125 716.3486 2146.02661132813 716.349487304688 3 12 1.1.1.3877.14 1 43.3056 25955.31 43.2119 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 0 79.2599976062775 CPNPPVQENFDVNKYLGR Carbamidomethyl(C)@1; Ammonia-loss(N)@3 missed K-Y@14 0.00788755994290113 2129.00732421875 1065.511 2129 1065.50732421875 2 7 1.1.1.4026.20 1 47.1219 1631.068 47.179 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 0 99.0000009536743 MTVTDQVNCPK Oxidation(M)@1; Carbamidomethyl(C)@9 -0.00233809999190271 1307.58264160156 654.7986 1307.5849609375 654.799743652344 2 16 1.1.1.3043.6 1 22.5341 6671.62 22.6405 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 0 99.0000009536743 MTVTDQVNCPKLS Oxidation(M)@1; Carbamidomethyl(C)@9 missed K-L@11 0.00346378004178405 1507.70471191406 754.8596 1507.70104980469 754.857788085938 2 18 1.1.1.3304.21 1 28.8681 4185.289 28.7727 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 0 99.0000009536743 NPNLPPETVDSLKNILTSNNIDVKK missed K-N@13; missed K-K@24 0.00958228018134832 2762.49096679688 691.63 2762.4814453125 691.627624511719 4 15 1.1.1.4164.16 1 50.6386 13773.01 50.8261 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 0 99.0000009536743 NPNLPPETVDSLKNILTSNNIDVKK missed K-N@13; missed K-K@24 0.00884987041354179 2762.490234375 691.6298 2762.4814453125 691.627624511719 4 13 1.1.1.4168.16 1 50.7402 14280.19 50.8513 17 10.02 10.02 41.2699997425079 29.6299993991852 29.6299993991852 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 0 99.0000009536743 NPNLPPETVDSLKNILTSNNIDVKK missed K-N@13; missed K-K@24 0.00884987041354179 2762.490234375 691.6298 2762.4814453125 691.627624511719 4 18 1.1.1.4177.11 1 50.9657 14280.19 50.8513 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 2 99.0000009536743 KYTYNYEAESSSGVPGTADSR missed K-Y@1 0.00379039999097586 2281.01733398438 761.3464 2281.01342773438 761.345092773438 3 14 1.1.1.3306.21 1 28.9186 862.2662 28.9484 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 2 99.0000009536743 TFQIPGYTVPVVNVEVSPFTIEMSAFGYVFPK -0.00414534006267786 3562.80517578125 1188.609 3562.80981445313 1188.61059570313 3 11 1.1.1.5073.20 1 74.2862 2687.345 74.157 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 2 99.0000009536743 TSSFALNLPTLPEVKFPEVDVLTKYSQPEDSLIPFFEITVPESQLTVSQFTLPK missed K-F@15; missed K-Y@24 0.0133640998974442 6066.18359375 1214.244 6066.169921875 1214.2412109375 5 9 1.1.1.5071.21 1 74.2331 6084.58 74.1302 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 1.92081785202026 99.0000009536743 IAELSATAQEIIK 0.000789390003774315 1385.77746582031 693.896 1385.77661132813 693.895568847656 2 12 1.1.1.3864.16 1 42.9685 981.0007 43.0037 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0.0213630516082048 93.4499979019165 TLQGIPQMIGEVIR Oxidation(M)@8 -0.0049519999884069 1569.85009765625 785.9323 1569.85485839844 785.934692382813 2 9 1.1.1.4046.19 1 47.6329 1744.258 47.6398 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0.00130484171677381 88.0800008773804 FLDSNIKFSHVEKLGNNPVSKGLLIFDASSSWGPQMSASVHLDSKKK ONE addition +154(K)@7; reduced acrolein addition +58(K)@21; reduced HNE(H)@41; acrolein addition +56(K)@47 missed K-F@7; missed K-L@13; missed K-G@21; missed K-K@45; missed K-K@46 -0.0700538009405136 5568.88818359375 929.1553 5568.9580078125 929.1669921875 6 10 1.1.1.4688.7 0 64.096 3966.963 64.0878 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0.000869458774104714 95.4599976539612 EEEMLENVSLVCPK Oxidation(M)@4; Carbamidomethyl(C)@12 cleaved A-E@N-term -0.00419186009094119 1691.7705078125 846.8925 1691.77465820313 846.894592285156 2 7 1.1.1.3699.19 1 38.7235 569.8912 38.7305 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0.000434511806815863 73.6500024795532 ITLPDFRLPEIAIPEFIIPTLNLNDFQVPDLHIPEFQLPHISHTIEVPTFGK Oxidation(P)@34 missed R-L@7 0.0546188987791538 5987.24658203125 998.8817 5987.19189453125 998.87255859375 6 11 1.1.1.5101.20 1 75.0324 2016.242 75.0116 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 38.1399989128113 KDLKSKEVPEAR MDA adduct +62(K)@1; ONE addition +154(K)@6 cleaved I-K@N-term; missed K-D@1; missed K-S@4; missed K-E@6 0.0112747000530362 1614.90942382813 539.3104 1614.89807128906 539.306640625 3 5 1.1.1.4515.5 1 59.672 14121.64 59.6636 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 34.1199994087219 KGVISIPR cleaved I-K@N-term; missed K-G@1 -0.00921745970845222 868.540283203125 435.2774 868.549438476563 435.281982421875 2 5 1.1.1.3634.4 1 37.0632 1682.03 36.9318 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 48.3999997377396 KITEVALMGHLSCDTKEERKIKGVISIPRL MDA adduct +54(K)@1; Carbamidomethyl(C)@13; hexanoyl addition +98(K)@22 cleaved L-Q@C-term; missed K-I@1; missed K-E@16; missed R-K@19; missed K-I@20; missed K-G@22; missed R-L@29 -0.02132230065763 3572.95727539063 894.2466 3572.978515625 894.251953125 4 9 1.1.1.5102.16 0 75.0565 73120.88 75.0659 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 16.8699994683266 KMEPKDK ONE addition +154(K)@1; acrolein addition +56(K)@5; MDA adduct +62(K)@7 missed K-M@1; missed K-D@5 0.0257222000509501 1146.62524414063 574.3199 1146.59948730469 574.307006835938 2 4 1.1.1.4072.8 1 48.2859 1995.056 48.3019 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 23.5300004482269 LIKDLKSK acrolein addition +94(K)@3; HPNE addition +172(K)@6; MDA adduct +54(K)@8 missed K-D@3; missed K-S@6 -0.0332087986171246 1263.73571777344 422.2525 1263.76904296875 422.263610839844 3 3 1.1.1.4962.2 1 71.2769 177.7557 71.298 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 25.1500010490417 SITNPLAVLCEFISQSIKSFDR Carbamidomethyl(C)@10; ONE addition +154(K)@18 cleaved H-S@N-term; missed K-S@18 -0.00309856003150344 2678.39624023438 670.6063 2678.39892578125 670.606994628906 4 9 1.1.1.3317.14 0 29.189 28287.06 29.3665 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 27.2199988365173 SQAIATKK Deamidated(Q)@2; acrolein addition +112(K)@8 missed K-K@7 -0.000406934006605297 958.533081054688 480.2738 958.533508300781 480.274017333984 2 4 1.1.1.3794.3 1 41.1417 2114.011 41.3096 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 99.0000009536743 TFQIPGYTVPVVNVEVSPFTIEMSAFGYVFPK -0.00414534006267786 3562.80517578125 1188.609 3562.80981445313 1188.61059570313 3 15 1.1.1.5066.20 1 74.0969 2687.345 74.157 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 99.0000009536743 TFQIPGYTVPVVNVEVSPFTIEMSAFGYVFPK -8.45242975628935E-05 3562.80981445313 891.7097 3562.80981445313 891.709716796875 4 15 1.1.1.5069.12 1 74.1714 1227.376 74.157 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 79.3099999427795 TSSFALNLPTLPEVKFPEVDVLTKYSQPEDSLIPFFEITVPESQLTVSQFTLPK Cation:Na(E)@37 missed K-F@15; missed K-Y@24 0.0343277007341385 6088.1884765625 1218.645 6088.15185546875 1218.63757324219 5 10 1.1.1.5067.21 1 74.125 736.3152 74.1302 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 20.8100005984306 TTKQSFDLSVKAQYK MDA adduct +62(K)@3; MDA adduct +62(K)@15 missed K-Q@3; missed K-A@11 0.0588130988180637 1867.01049804688 623.3441 1866.95166015625 623.324462890625 3 4 1.1.1.5034.9 1 73.2274 150.967 73.4034 18 7.95 7.95 54.2599976062775 5.41299991309643 2.93700005859137 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 43.0599987506866 TTKQSFDLSVKAQYKK ONE addition +154(K)@11; MDA adduct +54(K)@15; acrolein addition +38(K)@16 missed K-Q@3; missed K-A@11; missed K-K@15 0.0682182013988495 2117.20922851563 530.3096 2117.14086914063 530.29248046875 4 5 1.1.1.4442.6 1 57.7531 3251.926 57.7447 19 4.63 4.63 19.4399997591972 10.1400002837181 10.1400002837181 sp|P27169|PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens GN=PON1 PE=1 SV=2 2 99.0000009536743 LNALREVQPVELPNCNLVK Carbamidomethyl(C)@15 missed R-E@5 -0.00855830032378435 2205.185546875 736.0691 2205.19409179688 736.071960449219 3 15 1.1.1.3928.13 1 44.5977 3157.521 44.635 19 4.63 4.63 19.4399997591972 10.1400002837181 10.1400002837181 sp|P27169|PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens GN=PON1 PE=1 SV=2 1.45593166351318 99.0000009536743 AKLIALTLLGMGLALFR Oxidation(M)@11 cleaved M-A@N-term; missed K-L@2 0.00149179995059967 1816.10229492188 606.3747 1816.10083007813 606.374206542969 3 6 1.1.1.4961.6 1 71.2533 449.6671 71.1631 19 4.63 4.63 19.4399997591972 10.1400002837181 10.1400002837181 sp|P27169|PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens GN=PON1 PE=1 SV=2 1.17392539978027 99.0000009536743 EVQPVELPNCNLVK Carbamidomethyl(C)@10 0.00217489991337061 1637.84692382813 819.9307 1637.8447265625 819.929626464844 2 12 1.1.1.3788.12 1 41.0054 1265.75 41.0369 19 4.63 4.63 19.4399997591972 10.1400002837181 10.1400002837181 sp|P27169|PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens GN=PON1 PE=1 SV=2 0 99.0000009536743 AKLIALTLLGMGLALFR Oxidation(M)@11 cleaved M-A@N-term; missed K-L@2 -0.000705392973031849 1816.10021972656 606.374 1816.10083007813 606.374206542969 3 7 1.1.1.4954.7 1 71.0651 522.5934 71.0286 20 4 4 54.5499980449677 20.0000002980232 20.0000002980232 sp|P81605|DCD_HUMAN; cont|000124 Dermcidin OS=Homo sapiens GN=DCD PE=1 SV=2; spt|P81605| Dermcidin precursor (Preproteolysin) (Contains: Survival-promoting peptide; DCD-1) [Homo sapiens (contaminant)] 2 99.0000009536743 DAVEDLESVGK 0.000268406001850963 1160.55651855469 581.2855 1160.55615234375 581.285339355469 2 12 1.1.1.3628.5 1 36.9148 1306.033 36.9318 20 4 4 54.5499980449677 20.0000002980232 20.0000002980232 sp|P81605|DCD_HUMAN; cont|000124 Dermcidin OS=Homo sapiens GN=DCD PE=1 SV=2; spt|P81605| Dermcidin precursor (Preproteolysin) (Contains: Survival-promoting peptide; DCD-1) [Homo sapiens (contaminant)] 2 99.0000009536743 ENAGEDPGLAR -0.00334871001541615 1127.51733398438 564.7659 1127.52075195313 564.767639160156 2 11 1.1.1.3026.4 1 22.1113 221.0352 22.1165 20 4 4 54.5499980449677 20.0000002980232 20.0000002980232 sp|P81605|DCD_HUMAN; cont|000124 Dermcidin OS=Homo sapiens GN=DCD PE=1 SV=2; spt|P81605| Dermcidin precursor (Preproteolysin) (Contains: Survival-promoting peptide; DCD-1) [Homo sapiens (contaminant)] 0 27.6600003242493 SSLLEKGLDGAK missed K-G@6 -0.0320967994630337 1216.63427734375 609.3244 1216.66625976563 609.340454101563 2 7 1.1.1.3364.15 1 30.3414 995.1996 30.3766 21 4 4 17.509999871254 7.96499997377396 7.96499997377396 sp|Q86YZ3|HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 2 99.0000009536743 QSLGHGQHGSGSGQSPSPSR Gln->pyro-Glu@N-term -0.000709559011738747 1929.8671875 644.2963 1929.86779785156 644.296508789063 3 24 1.1.1.2959.2 1 20.6172 170.6669 20.6225 21 4 4 17.509999871254 7.96499997377396 7.96499997377396 sp|Q86YZ3|HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 2 99.0000009536743 SSSSGQHGSGLGESSGFGHHESSSGQSSSYSQHGSGSGHSSGYGQHGSR 0.0276688002049923 4747.97900390625 950.6031 4747.951171875 950.597534179688 5 14 1.1.1.3005.8 1 21.593 405.3914 21.5727 21 4 4 17.509999871254 7.96499997377396 7.96499997377396 sp|Q86YZ3|HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 0 99.0000009536743 SSSSGQHGSGLGESSGFGHHESSSGQSSSYSQHGSGSGHSSGYGQHGSR 0.032463300973177 4747.98388671875 792.3379 4747.951171875 792.33251953125 6 26 1.1.1.3002.2 1 21.5152 1211.232 21.5727 21 4 4 17.509999871254 7.96499997377396 7.96499997377396 sp|Q86YZ3|HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 0 99.0000009536743 SSSSGQHGSGLGESSGFGHHESSSGQSSSYSQHGSGSGHSSGYGQHGSR 0.0437772981822491 4747.9951171875 679.2923 4747.951171875 679.286010742188 7 17 1.1.1.3005.7 1 21.5905 616.9323 21.5727 22 4 4 46.3099986314774 8.80699977278709 8.80699977278709 sp|P02760|AMBP_HUMAN Protein AMBP OS=Homo sapiens GN=AMBP PE=1 SV=1 2 99.0000009536743 KEDSCQLGYSAGPCMGMTSR Carbamidomethyl(C)@5; Carbamidomethyl(C)@14; Oxidation(M)@15; Oxidation(M)@17 missed K-E@1 0.0165963005274534 2265.92895507813 756.3169 2265.91235351563 756.311340332031 3 17 1.1.1.3152.12 1 25.1597 453.3877 25.165 22 4 4 46.3099986314774 8.80699977278709 8.80699977278709 sp|P02760|AMBP_HUMAN Protein AMBP OS=Homo sapiens GN=AMBP PE=1 SV=1 2 99.0000009536743 TVAACNLPIVR Carbamidomethyl(C)@5 -0.00907466001808643 1212.65588378906 607.3352 1212.66491699219 607.339721679688 2 13 1.1.1.3617.5 1 36.6457 1927.293 36.5871 23 3.77 7.86 45.0800001621246 11.1900001764297 8.13599973917007 sp|P13647|K2C5_HUMAN Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 2 99.0000009536743 VSLAGACGVGGYGSR Carbamidomethyl(C)@7 -0.00032999599352479 1409.671875 705.8432 1409.67211914063 705.843322753906 2 7 1.1.1.3438.19 1 32.1828 464.1132 32.1394 23 3.77 7.86 45.0800001621246 11.1900001764297 8.13599973917007 sp|P13647|K2C5_HUMAN Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 1.76955056190491 99.0000009536743 ISISTSGGSFR -0.00180272001307458 1110.56530761719 556.2899 1110.56689453125 556.290771484375 2 9 1.1.1.3436.17 1 32.1308 1290.989 32.1647 23 3.77 7.86 45.0800001621246 11.1900001764297 8.13599973917007 sp|P13647|K2C5_HUMAN Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 0 30.3799986839294 ISISTSGGSFR -0.00180272001307458 1110.56530761719 556.2899 1110.56689453125 556.290771484375 2 8 1.1.1.3443.7 1 32.3014 1290.989 32.1647 23 3.77 7.86 45.0800001621246 11.1900001764297 8.13599973917007 sp|P13647|K2C5_HUMAN Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 0 35.929998755455 LLEGEECR Carbamidomethyl(C)@7 0.0023235899861902 1004.46209716797 503.2383 1004.45971679688 503.237121582031 2 9 1.1.1.3053.2 0 22.7801 186.7562 22.7612 23 3.77 7.86 45.0800001621246 11.1900001764297 8.13599973917007 sp|P13647|K2C5_HUMAN Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 0 99.0000009536743 NKYEDEINKR missed K-Y@2; missed K-R@9 -0.00258542993105948 1307.64428710938 436.8887 1307.64697265625 436.889587402344 3 12 1.1.1.3026.2 0 22.0996 263.9892 22.0912 23 3.77 7.86 45.0800001621246 11.1900001764297 8.13599973917007 sp|P13647|K2C5_HUMAN Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 0 99.0000009536743 NLDLDSIIAEVK -0.00107797002419829 1328.71765136719 665.3661 1328.71875 665.366638183594 2 9 1.1.1.4326.9 0 54.7664 1759.272 54.7559 23 3.77 7.86 45.0800001621246 11.1900001764297 8.13599973917007 sp|P13647|K2C5_HUMAN Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 0 79.3099999427795 NLDLDSIIAEVKAQYEEIANR Methyl(N)@20 missed K-A@12 0.000714269001036882 2417.24438476563 806.7554 2417.24389648438 806.755187988281 3 16 1.1.1.4911.6 0 69.9562 974.0447 69.9896 23 3.77 7.86 45.0800001621246 11.1900001764297 8.13599973917007 sp|P13647|K2C5_HUMAN Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 0 56.1800003051758 QLDSIVGER -0.0114783002063632 1015.51824951172 508.7664 1015.52984619141 508.772186279297 2 6 1.1.1.3303.16 1 28.8387 628.8146 28.8481 23 3.77 7.86 45.0800001621246 11.1900001764297 8.13599973917007 sp|P13647|K2C5_HUMAN Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 0 48.6000001430511 RISISTSGGSFR missed R-I@1 -0.0180860999971628 1266.64990234375 423.2239 1266.66809082031 423.229949951172 3 6 1.1.1.3301.4 1 28.7784 260.2584 28.7978 24 2.87 2.87 42.5500005483627 32.9800009727478 28.1899988651276 sp|O95445|APOM_HUMAN Apolipoprotein M OS=Homo sapiens GN=APOM PE=1 SV=2 2 99.0000009536743 NQEACELSNN Carbamidomethyl(C)@5 -0.0030504500027746 1177.46411132813 589.7393 1177.46691894531 589.740783691406 2 16 1.1.1.2992.2 1 21.3136 606.6649 21.2154 24 2.87 2.87 42.5500005483627 32.9800009727478 28.1899988651276 sp|O95445|APOM_HUMAN Apolipoprotein M OS=Homo sapiens GN=APOM PE=1 SV=2 0.645891547203064 99.0000009536743 CVEEFKSLTSCLDSK Carbamidomethyl(C)@1; Carbamidomethyl(C)@11 missed K-S@6 -0.00643537985160947 1801.81628417969 901.9154 1801.82263183594 901.918579101563 2 12 1.1.1.3765.13 1 40.4337 650.7685 40.4156 24 2.87 2.87 42.5500005483627 32.9800009727478 28.1899988651276 sp|O95445|APOM_HUMAN Apolipoprotein M OS=Homo sapiens GN=APOM PE=1 SV=2 0.218244627118111 98.3500003814697 AFLLTPR -0.00525176990777254 816.48046875 409.2475 816.485778808594 409.250152587891 2 6 1.1.1.3635.2 1 37.0869 1413.798 36.9816 24 2.87 2.87 42.5500005483627 32.9800009727478 28.1899988651276 sp|O95445|APOM_HUMAN Apolipoprotein M OS=Homo sapiens GN=APOM PE=1 SV=2 0.00130484171677381 55.8600008487701 MKDGLCVPR Oxidation(M)@1; Carbamidomethyl(C)@6 missed K-D@2 0.00521714985370636 1090.53161621094 546.2731 1090.5263671875 546.270446777344 2 8 1.1.1.3123.15 1 24.4499 659.9393 24.4601 24 2.87 2.87 42.5500005483627 32.9800009727478 28.1899988651276 sp|O95445|APOM_HUMAN Apolipoprotein M OS=Homo sapiens GN=APOM PE=1 SV=2 0.000434511806815863 96.069997549057 PVDNIVFNMAAGSAPMQLHLR Oxidation(M)@9; Oxidation(M)@16 cleaved D-P@N-term 0.0212312005460262 2312.16162109375 771.7278 2312.140625 771.720825195313 3 10 1.1.1.3936.16 1 44.8024 992.3384 44.8622 24 2.87 2.87 42.5500005483627 32.9800009727478 28.1899988651276 sp|O95445|APOM_HUMAN Apolipoprotein M OS=Homo sapiens GN=APOM PE=1 SV=2 0 35.4099988937378 AFLLTPR -0.00525176990777254 816.48046875 409.2475 816.485778808594 409.250152587891 2 6 1.1.1.3628.2 1 36.9107 1413.798 36.9816 24 2.87 2.87 42.5500005483627 32.9800009727478 28.1899988651276 sp|O95445|APOM_HUMAN Apolipoprotein M OS=Homo sapiens GN=APOM PE=1 SV=2 0 98.3699977397919 CVEEFKSLTSCLDSK Carbamidomethyl(C)@1; Carbamidomethyl(C)@11 missed K-S@6 0.00124923000112176 1801.82373046875 601.6152 1801.82263183594 601.614807128906 3 11 1.1.1.3765.4 1 40.4212 1599.475 40.4156 24 2.87 2.87 42.5500005483627 32.9800009727478 28.1899988651276 sp|O95445|APOM_HUMAN Apolipoprotein M OS=Homo sapiens GN=APOM PE=1 SV=2 0 99.0000009536743 NQEACELSNN Carbamidomethyl(C)@5 -0.0030504500027746 1177.46411132813 589.7393 1177.46691894531 589.740783691406 2 14 1.1.1.2985.3 1 21.1325 606.6649 21.2154 25 2 2 35.4400008916855 2.43599992245436 0.79169999808073 sp|Q8WWZ7|ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 2 99.0000009536743 EVISRITHALDLK MDA adduct +54(K)@13 missed R-I@5 0.00997710041701794 1547.87731933594 774.9459 1547.8671875 774.940856933594 2 10 1.1.1.4527.14 0 59.9974 2629.179 60.0348 25 2 2 35.4400008916855 2.43599992245436 0.79169999808073 sp|Q8WWZ7|ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 0.000434511806815863 68.8799977302551 ISGIQKTYRKK Deamidated(Q)@5; MDA adduct +54(K)@6; acrolein addition +38(K)@10 missed K-T@6; missed R-K@9; missed K-K@10 0.0310861002653837 1413.82897949219 472.2836 1413.79797363281 472.273284912109 3 4 1.1.1.4321.2 1 54.6319 1298.51 54.653 25 2 2 35.4400008916855 2.43599992245436 0.79169999808073 sp|Q8WWZ7|ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 0 16.9100001454353 EVISRITHALDLK MDA adduct +54(K)@13 missed R-I@5 0.00997710041701794 1547.87731933594 774.9459 1547.8671875 774.940856933594 2 8 1.1.1.4535.16 0 60.2066 2629.179 60.0348 25 2 2 35.4400008916855 2.43599992245436 0.79169999808073 sp|Q8WWZ7|ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 0 62.2099995613098 FRNLSTKSK Deamidated(N)@3; hexanoyl addition +98(K)@7; reduced acrolein addition +58(K)@9 cleaved F-F@N-term; missed R-N@2; missed K-S@7 -0.0145094003528357 1236.69323730469 619.3539 1236.70776367188 619.361145019531 2 4 1.1.1.4947.7 1 70.8783 128.023 70.8684 25 2 2 35.4400008916855 2.43599992245436 0.79169999808073 sp|Q8WWZ7|ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 0 43.6699986457825 ISGIQKTYRKKGEN hexanoyl addition +98(K)@6 cleaved N-V@C-term; missed K-T@6; missed R-K@9; missed K-K@10; missed K-G@11 -0.00805593002587557 1718.95983886719 573.9939 1718.96789550781 573.99658203125 3 5 1.1.1.4260.3 1 53.0762 8450.382 53.0453 25 2 2 35.4400008916855 2.43599992245436 0.79169999808073 sp|Q8WWZ7|ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 0 35.1599991321564 ISGIQKTYRKKGEN ONE addition +154(K)@6; MDA adduct +62(K)@10; reduced acrolein addition +58(K)@11 cleaved N-V@C-term; missed K-T@6; missed R-K@9; missed K-K@10; missed K-G@11 0.0208545997738838 1895.07250976563 948.5435 1895.05163574219 948.533081054688 2 7 1.1.1.4321.18 1 54.6453 6040.671 54.653 25 2 2 35.4400008916855 2.43599992245436 0.79169999808073 sp|Q8WWZ7|ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 0 19.539999961853 LKPGDKPHK acrolein addition +76(K)@2; reduced acrolein addition +96(K)@6 cleaved F-L@N-term 0.00225929007865489 1190.68347167969 596.349 1190.68115234375 596.347839355469 2 4 1.1.1.4173.7 1 50.8602 1332.088 50.8005 25 2 2 35.4400008916855 2.43599992245436 0.79169999808073 sp|Q8WWZ7|ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 0 50.7099986076355 SGGQKRK Deamidated(Q)@4; reduced acrolein addition +96(K)@5; acrolein addition +112(K)@7 cleaved L-S@N-term; missed K-R@5; missed R-K@6 0.0135639002546668 968.542663574219 485.2786 968.529113769531 485.271820068359 2 5 1.1.1.3747.7 1 39.9558 946.2895 39.9223 26 2 2 62.8099977970123 6.53299987316132 3.76899987459183 sp|O14791|APOL1_HUMAN; sp|O14791-2|APOL1_HUMAN Apolipoprotein L1 OS=Homo sapiens GN=APOL1 PE=1 SV=5; Isoform B of Apolipoprotein L1 OS=Homo sapiens GN=APOL1 2 99.0000009536743 VTEPISAESGEQVER 0.00345672992989421 1629.7880859375 815.9013 1629.78454589844 815.899597167969 2 20 1.1.1.3258.9 1 27.7328 823.2552 27.6891 26 2 2 62.8099977970123 6.53299987316132 3.76899987459183 sp|O14791|APOL1_HUMAN; sp|O14791-2|APOL1_HUMAN Apolipoprotein L1 OS=Homo sapiens GN=APOL1 PE=1 SV=5; Isoform B of Apolipoprotein L1 OS=Homo sapiens GN=APOL1 0.000869458774104714 50.9299993515015 VTEPISAESGEQVERVNEPSILEMSR Oxidation(M)@24 missed R-V@15 0.014185699634254 2901.41674804688 968.1462 2901.40258789063 968.141479492188 3 10 1.1.1.3797.15 1 41.2295 2011.088 41.2596 27 2 2 52.1499991416931 3.34899984300137 3.34899984300137 sp|P01009|A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 2 99.0000009536743 ITPNLAEFAFSLYR -0.00138982001226395 1640.85485839844 821.4347 1640.85620117188 821.435424804688 2 9 1.1.1.4561.12 1 60.8914 557.1257 60.8509 28 2 2 92.4499988555908 14.1499996185303 14.1499996185303 sp|P0CG06|LAC3_HUMAN Ig lambda-3 chain C regions OS=Homo sapiens GN=IGLC3 PE=1 SV=1 2 99.0000009536743 SYSCQVTHEGSTVEK Carbamidomethyl(C)@4 -0.0058110598474741 1710.74609375 571.256 1710.751953125 571.257934570313 3 14 1.1.1.3051.2 1 22.7319 1520.988 22.7612 29 2 2 71.0500001907349 21.0500001907349 21.0500001907349 sp|P62988|UBIQ_HUMAN Ubiquitin OS=Homo sapiens GN=RPS27A PE=1 SV=1 2 99.0000009536743 TITLEVEPSDTIENVK -0.00444171018898487 1786.91564941406 894.4651 1786.92004394531 894.46728515625 2 16 1.1.1.3869.20 1 43.1017 1964.259 43.1595 30 2 2 63.7799978256226 8.66099968552589 8.66099968552589 sp|P55056|APOC4_HUMAN Apolipoprotein C-IV OS=Homo sapiens GN=APOC4 PE=1 SV=1 2 99.0000009536743 MKELLETVVNR Oxidation(M)@1 missed K-E@2 0.00270520010963082 1346.7255859375 449.9158 1346.72277832031 449.914886474609 3 12 1.1.1.3496.2 1 33.6003 3382.906 33.6214 31 1.92 2 41.2499994039536 6.25 6.25 cont|000046 gi|4887006|gb|AAD32140.1|AF123251_1 kappa-casein precursor [Bos taurus (contaminant)] 1.92081785202026 99.0000009536743 YIPIQYVLSR 0.00212522991932929 1250.70446777344 626.3595 1250.70227050781 626.358459472656 2 8 1.1.1.4106.11 1 49.1543 2063.412 49.1425 32 1.89 2 27.6800006628037 11.6099998354912 11.6099998354912 cont|000021 gi|459292|gb|AAB29137.1| beta-casein A3 [Bos taurus (contaminant)] 1.88605630397797 99.0000009536743 DMPIQAFLLYQEPVLGPVRGPFPIIV missed R-G@19 -0.00944236014038324 2908.5830078125 970.535 2908.59252929688 970.5380859375 3 11 1.1.1.5091.19 1 74.7698 3268.011 74.8541 32 1.89 2 27.6800006628037 11.6099998354912 11.6099998354912 cont|000021 gi|459292|gb|AAB29137.1| beta-casein A3 [Bos taurus (contaminant)] 0.000869458774104714 20.4199999570847 AVPYPQR -0.00240919995121658 829.442260742188 415.7284 829.444641113281 415.729583740234 2 6 1.1.1.3089.4 1 23.5845 672.7823 23.502 32 1.89 2 27.6800006628037 11.6099998354912 11.6099998354912 cont|000021 gi|459292|gb|AAB29137.1| beta-casein A3 [Bos taurus (contaminant)] 0 99.0000009536743 DMPIQAFLLYQEPVLGPVRGPFPIIV Oxidation(M)@2 missed R-G@19 -0.00172525004018098 2924.58544921875 975.8691 2924.58740234375 975.869750976563 3 21 1.1.1.5019.19 1 72.8311 1623.09 72.7837 32 1.89 2 27.6800006628037 11.6099998354912 11.6099998354912 cont|000021 gi|459292|gb|AAB29137.1| beta-casein A3 [Bos taurus (contaminant)] 0 99.0000009536743 DMPIQAFLLYQEPVLGPVRGPFPIIV Oxidation(M)@2; Deamidated(Q)@11 missed R-G@19 0.00720268022269011 2925.57836914063 976.2001 2925.57153320313 976.19775390625 3 14 1.1.1.5022.21 1 72.9149 1043.917 72.7837 32 1.89 2 27.6800006628037 11.6099998354912 11.6099998354912 cont|000021 gi|459292|gb|AAB29137.1| beta-casein A3 [Bos taurus (contaminant)] 0 80.4199993610382 DMPIQAFLLYQEPVLGPVRGPFPIIV Oxidation(M)@2 missed R-G@19 -0.00172525004018098 2924.58544921875 975.8691 2924.58740234375 975.869750976563 3 7 1.1.1.5012.20 1 72.6415 1623.09 72.7837 33 1.85 2 11.1400000751019 3.29100005328655 3.29100005328655 sp|Q9Y3Q8|T22D4_HUMAN TSC22 domain family protein 4 OS=Homo sapiens GN=TSC22D4 PE=1 SV=2 1.85387206077576 99.0000009536743 LPNGEPSPDPGGK MDA adduct +54(K)@13 0.0132197998464108 1317.63342285156 440.2184 1317.6201171875 440.213989257813 3 12 1.1.1.3201.5 1 26.331 1954.613 26.4193 34 1.37 1.37 14.0000000596046 0.185700005386025 0.185700005386025 sp|Q8NCM8|DYHC2_HUMAN; sp|Q8NCM8-2|DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=3; Isoform 2 of Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 1.36653172969818 99.0000009536743 VADTIVAK MDA adduct +54(K)@8 0.00895535014569759 869.494873046875 435.7547 869.48583984375 435.750183105469 2 9 1.1.1.3357.5 1 30.1587 5376.841 29.9073